Citrus Sinensis ID: 007629
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 595 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LV37 | 510 | Mitogen-activated protein | yes | no | 0.818 | 0.954 | 0.858 | 0.0 | |
| Q5Z9J0 | 580 | Mitogen-activated protein | yes | no | 0.926 | 0.95 | 0.734 | 0.0 | |
| Q9LM33 | 589 | Mitogen-activated protein | no | no | 0.939 | 0.949 | 0.765 | 0.0 | |
| Q9C9U4 | 576 | Mitogen-activated protein | no | no | 0.932 | 0.963 | 0.712 | 0.0 | |
| Q6L5F7 | 582 | Mitogen-activated protein | no | no | 0.810 | 0.828 | 0.774 | 0.0 | |
| Q5VP69 | 501 | Mitogen-activated protein | no | no | 0.796 | 0.946 | 0.772 | 0.0 | |
| Q0E459 | 506 | Mitogen-activated protein | no | no | 0.784 | 0.922 | 0.788 | 0.0 | |
| A2X0M1 | 506 | Mitogen-activated protein | N/A | no | 0.784 | 0.922 | 0.788 | 0.0 | |
| Q53N72 | 498 | Mitogen-activated protein | no | no | 0.798 | 0.953 | 0.746 | 0.0 | |
| Q75KK8 | 542 | Mitogen-activated protein | no | no | 0.673 | 0.739 | 0.847 | 0.0 |
| >sp|Q9LV37|MPK9_ARATH Mitogen-activated protein kinase 9 OS=Arabidopsis thaliana GN=MPK9 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 865 bits (2236), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/489 (85%), Positives = 455/489 (93%), Gaps = 2/489 (0%)
Query: 93 MDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH 152
MDPHKK ALETEFFTEYGEASRYQIQEVIGKGSYGVV SA+DTH+GE+VAIKKINDVFEH
Sbjct: 1 MDPHKKVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEH 60
Query: 153 VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD 212
VSDATRILREIKLLRLLRHPDIVEIKH+MLPPSRREF+DIYVVFELMESDLHQVIKANDD
Sbjct: 61 VSDATRILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDD 120
Query: 213 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272
LTPEHYQFFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKICDFGLARVSFNDAPS
Sbjct: 121 LTPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPS 180
Query: 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332
AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD+
Sbjct: 181 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDI 240
Query: 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPK 392
MTDLLGTP E+I+RIRNEKARRYLG+MR+K PVPF+HKFP+ DPLAL LL RLLAFDPK
Sbjct: 241 MTDLLGTPPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPK 300
Query: 393 DRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQ 452
DRP+AEEALADPYF+GLANVDREPSTQPI KLEFEFERRK+ K+DVRE+IYREILEYHPQ
Sbjct: 301 DRPSAEEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQ 360
Query: 453 MLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKD 512
MLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEE+YGKGE+ +PLQRQHASLPRERVPAPK
Sbjct: 361 MLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPRERVPAPKK 420
Query: 513 ENAGQNNDY-GRTADSVAATLQSPPT-ENANTEEQNGINRPNCSARSLLKSASISASKCV 570
EN N+D R+ S+ TL+SPPT ++ ++ +NG ++ SARSLLKSASISASKC+
Sbjct: 421 ENGSHNHDIENRSIASLVTTLESPPTSQHEGSDYRNGTSQTGYSARSLLKSASISASKCI 480
Query: 571 GVKDRTDRE 579
G+K R E
Sbjct: 481 GMKPRNKSE 489
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q5Z9J0|MPK12_ORYSJ Mitogen-activated protein kinase 12 OS=Oryza sativa subsp. japonica GN=MPK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 844 bits (2181), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/584 (73%), Positives = 472/584 (80%), Gaps = 33/584 (5%)
Query: 1 MGGSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQ 60
MGG TLVDG RR F R + S + +S+N ++SS
Sbjct: 1 MGGGGTLVDGFRRLFHRRT----------------ASGSNQSSNAGEEAASSD------- 37
Query: 61 QLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEV 120
L + +D D L+ IR I+ P P ++ HKK+ +E EFFTEYGEAS+YQIQEV
Sbjct: 38 -LEVADDPDLVALRSIR----IRVPKRKMPLPVESHKKNTVEMEFFTEYGEASQYQIQEV 92
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
IGKGSYGVV +AVDT TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI
Sbjct: 93 IGKGSYGVVAAAVDTRTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 152
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
MLPPSRREF+DIYVVFELMESDLHQVI+ANDDLTPEHYQFFLYQLLR LKYIH ANVFHR
Sbjct: 153 MLPPSRREFQDIYVVFELMESDLHQVIRANDDLTPEHYQFFLYQLLRALKYIHAANVFHR 212
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 300
DLKPKNILAN+DCKLKICDFGLAR SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP
Sbjct: 213 DLKPKNILANSDCKLKICDFGLARASFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 272
Query: 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 360
AIDIWSIGCIFAE+LTG+PLFPGKNVVHQLD++TDLLGTPS+E++SRIRNEKARRYL +M
Sbjct: 273 AIDIWSIGCIFAELLTGRPLFPGKNVVHQLDIITDLLGTPSSETLSRIRNEKARRYLSTM 332
Query: 361 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP 420
RKK VPFS KF N DPLAL LLERLLAFDPKDR +AEEALADPYF LANV+REPS P
Sbjct: 333 RKKHAVPFSQKFRNTDPLALRLLERLLAFDPKDRSSAEEALADPYFASLANVEREPSRHP 392
Query: 421 ISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFA 480
ISKLEFEFERRKL KDDVRE+IYREILEYHPQMLQEY++GGEQ SF+YPSGVDRFKRQFA
Sbjct: 393 ISKLEFEFERRKLTKDDVRELIYREILEYHPQMLQEYMKGGEQISFLYPSGVDRFKRQFA 452
Query: 481 HLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQN-NDYGRTADSVAATLQSPP--- 536
HLEE+Y KGER +PLQR+HASLPRERV KD QN ND R+ADSVA T SPP
Sbjct: 453 HLEENYSKGERGSPLQRKHASLPRERVGVSKDGYNQQNTNDQERSADSVARTTVSPPMSQ 512
Query: 537 -TENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTDRE 579
+ + QNG+ + S+RS LKSASISASKCV VKD + E
Sbjct: 513 DAQQHGSAGQNGVTSTDLSSRSYLKSASISASKCVAVKDNKEPE 556
|
May be involved in defense signaling pathway. Phosphorylates EREBP1 transcriptional activator in vitro. Enhances DNA-binding activity of EREBP1 to the GCC box element of pathogenesis-related (PR) gene promoters. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9LM33|MPK8_ARATH Mitogen-activated protein kinase 8 OS=Arabidopsis thaliana GN=MPK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 842 bits (2176), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 450/588 (76%), Positives = 495/588 (84%), Gaps = 29/588 (4%)
Query: 1 MGGSSTLVDGVRRW-FQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHL 59
MGG LVDGVRRW FQR S +++S+++NNNNNN+ N+ + SSSS+ + +
Sbjct: 1 MGGGGNLVDGVRRWLFQRPSSSSSSSSSNNNNNNH---EQPIFNSSSFSSSSNPNHSANS 57
Query: 60 QQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQE 119
+L I ED DFSGL LI VPKR P MDPHKK ETEFFTEYGEA+RYQIQE
Sbjct: 58 GELIIEEDLDFSGLTLINVPKRNHLP-------MDPHKKG--ETEFFTEYGEANRYQIQE 108
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 179
V+GKGSYGVV SAVD+HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD+VEIKH
Sbjct: 109 VVGKGSYGVVASAVDSHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDVVEIKH 168
Query: 180 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH 239
IMLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY+H ANVFH
Sbjct: 169 IMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYVHAANVFH 228
Query: 240 RDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT 299
RDLKPKNILANADCKLKICDFGLARVSFNDAP+AIFWTDYVATRWYRAPELCGSFFSKYT
Sbjct: 229 RDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVATRWYRAPELCGSFFSKYT 288
Query: 300 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS 359
PAIDIWS+GCIFAEML GKPLFPGKNVVHQLDLMTD LGTP ESISRIRNEKARRYL S
Sbjct: 289 PAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDLMTDFLGTPPPESISRIRNEKARRYLSS 348
Query: 360 MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQ 419
MRKKQPVPFSHKFP ADPLAL LLERLLAFDPKDR +AE+ALADPYF GL+N +REP+TQ
Sbjct: 349 MRKKQPVPFSHKFPKADPLALRLLERLLAFDPKDRASAEDALADPYFSGLSNSEREPTTQ 408
Query: 420 PISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQF 479
PISKLEF+FER+KL KDDVRE+IYREILEYHPQML+EYLRGG+Q SFMYPSGVDRFKRQF
Sbjct: 409 PISKLEFDFERKKLVKDDVRELIYREILEYHPQMLEEYLRGGDQLSFMYPSGVDRFKRQF 468
Query: 480 AHLEEHYGK-----GERSTPLQRQHASLPRERVPAPKDENAGQNNDYG-RTADSVAATLQ 533
AHLEE+ GK G RST L R HASLPRERVPAP E A +++D R A +VA+TL+
Sbjct: 469 AHLEENQGKPGAAGGGRSTALHRHHASLPRERVPAPNGETAEESSDVERRAAAAVASTLE 528
Query: 534 SPPTENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTDREVT 581
S +N SAR+L+KSASIS SKC+GV+ +TD+E T
Sbjct: 529 SEEADNGG----------GYSARNLMKSASISGSKCIGVQSKTDKEDT 566
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9C9U4|MPK15_ARATH Mitogen-activated protein kinase 15 OS=Arabidopsis thaliana GN=MPK15 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 839 bits (2168), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/587 (71%), Positives = 477/587 (81%), Gaps = 32/587 (5%)
Query: 1 MGGSSTLVDGVRRW--FQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQH 58
MGG LVDGVRRW FQR +++S+NN++ N + S+ ++ +
Sbjct: 1 MGGGGNLVDGVRRWLFFQRRPSSSSSSNNHDQIQN-------------PPTVSNPNDDED 47
Query: 59 LQQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQ 118
L++LT D S L+ I+V +R P+ KK EFFTEYGEA+RYQIQ
Sbjct: 48 LKKLT-----DPSKLRQIKVQQRNHLPM---------EKKGIPNAEFFTEYGEANRYQIQ 93
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
EV+GKGSYGVVGSA+DTHTGERVAIKKINDVF+H+SDATRILREIKLLRLL HPD+VEIK
Sbjct: 94 EVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDATRILREIKLLRLLLHPDVVEIK 153
Query: 179 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 238
HIMLPPSRREF+D+YVVFELMESDLHQVIKANDDLTPEH+QFFLYQLLRGLKY+H ANVF
Sbjct: 154 HIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRGLKYVHAANVF 213
Query: 239 HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY 298
HRDLKPKNILANADCKLKICDFGLARVSFNDAP+AIFWTDYVATRWYRAPELCGSFFSKY
Sbjct: 214 HRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVATRWYRAPELCGSFFSKY 273
Query: 299 TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLG 358
TPAIDIWS+GCIFAEML GKPLFPGKNVVHQLD+MTD LGTP E+IS+IRN+KARRYLG
Sbjct: 274 TPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDFLGTPPPEAISKIRNDKARRYLG 333
Query: 359 SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPST 418
+MRKKQPVPFS KFP ADP AL LLERL+AFDPKDRP+AEEALADPYF+GL++ REPST
Sbjct: 334 NMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPSAEEALADPYFNGLSSKVREPST 393
Query: 419 QPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQ 478
QPISKLEFEFER+KL KDD+RE+IYREILEYHPQML+EYLRGG Q SFMYPSGVDRF+RQ
Sbjct: 394 QPISKLEFEFERKKLTKDDIRELIYREILEYHPQMLEEYLRGGNQLSFMYPSGVDRFRRQ 453
Query: 479 FAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQ--NNDYGRTADSVAATLQSPP 536
FAHLEE+ G G RS LQRQHASLPRERVPA K+E + N+ RT +VA+TL SP
Sbjct: 454 FAHLEENQGPGGRSNALQRQHASLPRERVPASKNETVEERSNDIERRTTAAVASTLDSPK 513
Query: 537 TENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTDREVTAV 583
+ E SAR+L+KS+SIS SKC+GV+ +T+ E + V
Sbjct: 514 A-SQQAEGTENGGGGGYSARNLMKSSSISGSKCIGVQSKTNIEDSIV 559
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q6L5F7|MPK17_ORYSJ Mitogen-activated protein kinase 17 OS=Oryza sativa subsp. japonica GN=MPK17 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 798 bits (2060), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/497 (77%), Positives = 424/497 (85%), Gaps = 15/497 (3%)
Query: 83 QFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVA 142
P+ P MDP KK E +FFTEYGEA+RY++ EVIGKGSYGVV +AVDT TGERVA
Sbjct: 76 HLPVRTEPRRMDPSKK---EPDFFTEYGEANRYKVSEVIGKGSYGVVAAAVDTQTGERVA 132
Query: 143 IKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESD 202
IKKINDVF+HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF+DIYV+FELMESD
Sbjct: 133 IKKINDVFDHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYVIFELMESD 192
Query: 203 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262
LHQVIKANDDLTPEH+QFFLYQLLRG+KYIH A+VFHRDLKPKNILANADCKLK+CDFGL
Sbjct: 193 LHQVIKANDDLTPEHHQFFLYQLLRGMKYIHAASVFHRDLKPKNILANADCKLKVCDFGL 252
Query: 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP 322
ARVSFND PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+LTGKPLFP
Sbjct: 253 ARVSFNDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAELLTGKPLFP 312
Query: 323 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHL 382
GKNVVHQLDLMTDLLGTPS ES+++IRNEKARRYL +MRKK VPF+ KFP DP+ALHL
Sbjct: 313 GKNVVHQLDLMTDLLGTPSAESLAKIRNEKARRYLSNMRKKPRVPFTKKFPGVDPMALHL 372
Query: 383 LERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMI 442
LERLLAFDPKDRP+AEEAL DPYF+GLAN +REP QPISKLEFEFE+RKLAKDDVRE+I
Sbjct: 373 LERLLAFDPKDRPSAEEALTDPYFNGLANSEREPIAQPISKLEFEFEKRKLAKDDVRELI 432
Query: 443 YREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASL 502
YREILEYHP MLQEYLRGG+Q SFMYPSGVDRFKRQFAHLEE KGE+S+P RQ+ASL
Sbjct: 433 YREILEYHPHMLQEYLRGGDQMSFMYPSGVDRFKRQFAHLEEGVSKGEKSSPQLRQNASL 492
Query: 503 PRERVPAPKDENAGQNNDYGRTADSVAATLQSPPTENANTEEQNGINRPNCSARSLLKSA 562
PRER N +G + P + T +GI++P SARSLLKS
Sbjct: 493 PRER---------AIGNKHGDDEYHAKLNVGEKPCHASVT---DGISKPLMSARSLLKSE 540
Query: 563 SISASKCVGVKDRTDRE 579
SISASKC+G K + DR+
Sbjct: 541 SISASKCIGEKPKQDRD 557
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5VP69|MPK16_ORYSJ Mitogen-activated protein kinase 16 OS=Oryza sativa subsp. japonica GN=MPK16 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 783 bits (2023), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/483 (77%), Positives = 422/483 (87%), Gaps = 9/483 (1%)
Query: 97 KKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA 156
KK + E EFF+EYG+ASRY++ EV+GKGSYGVV +AVDTHTG RVAIKKINDVFEH+SDA
Sbjct: 4 KKGSGEPEFFSEYGDASRYEVTEVVGKGSYGVVAAAVDTHTGGRVAIKKINDVFEHISDA 63
Query: 157 TRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE 216
TRILREIKLLRLLRHPDIVEIKHIMLPPSRREF+DIY++FELMESDLHQVIKANDDLTPE
Sbjct: 64 TRILREIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYIIFELMESDLHQVIKANDDLTPE 123
Query: 217 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276
H+QFFLYQLLRG+KYIH A+VFHRDLKPKNILANADCK+KICDFGLARVSF+D PSAIFW
Sbjct: 124 HHQFFLYQLLRGMKYIHAASVFHRDLKPKNILANADCKVKICDFGLARVSFDDTPSAIFW 183
Query: 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 336
TDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAEML GKPLFPGKNVVHQLDLMTDL
Sbjct: 184 TDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLMGKPLFPGKNVVHQLDLMTDL 243
Query: 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
LG+PS E+ISRIRNEKARRYLG+MRKK VPFS KFP ADP+ALHLLERLLAFDPKDRPT
Sbjct: 244 LGSPSGETISRIRNEKARRYLGNMRKKPRVPFSQKFPGADPMALHLLERLLAFDPKDRPT 303
Query: 397 AEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQE 456
A EAL DPYF GLAN +REP QPISKLEFEFERRKLAKDDVRE+IYREILEYHPQM+Q+
Sbjct: 304 AAEALTDPYFTGLANSEREPIAQPISKLEFEFERRKLAKDDVRELIYREILEYHPQMMQK 363
Query: 457 YLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAG 516
YLRGG+Q++F+YPSGVDRFKRQFAHLEE +G++++P RQH SLPRERV DE
Sbjct: 364 YLRGGDQSNFLYPSGVDRFKRQFAHLEEGVAQGDKTSPQLRQHVSLPRERVVRNGDE-PD 422
Query: 517 QNNDYGRTADSVAATLQSPPTENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRT 576
DY + + P ++ T +G+N+P SAR+ LKS SI AS+CV +K++
Sbjct: 423 PTADY-----CIKLHVGEQPGHSSVT---DGLNKPLLSARNFLKSESIGASQCVVIKEKR 474
Query: 577 DRE 579
+++
Sbjct: 475 EKD 477
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q0E459|MPK13_ORYSJ Mitogen-activated protein kinase 13 OS=Oryza sativa subsp. japonica GN=MPK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 760 bits (1963), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/473 (78%), Positives = 416/473 (87%), Gaps = 6/473 (1%)
Query: 104 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI 163
EFFTEYGEAS+YQIQEV+GKGSYGVV +AVDTHTGERVAIKKINDVFEHVSDA RILREI
Sbjct: 2 EFFTEYGEASQYQIQEVVGKGSYGVVAAAVDTHTGERVAIKKINDVFEHVSDAIRILREI 61
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 223
K+LRLLRHPDIV IKHIMLPP+RREF+DIYVVFELMESDLHQVI+AN DL+PEH++FFLY
Sbjct: 62 KVLRLLRHPDIVVIKHIMLPPTRREFRDIYVVFELMESDLHQVIEANHDLSPEHHRFFLY 121
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
QLL LKYIH+ANVFHRDLKPKNILAN+DCKLKICDFGLARV+FND+PS IFWTDYVATR
Sbjct: 122 QLLCALKYIHSANVFHRDLKPKNILANSDCKLKICDFGLARVAFNDSPSTIFWTDYVATR 181
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTG+PLFPG+NVVHQLDL+TDLLGTPS+E
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEILTGRPLFPGRNVVHQLDLITDLLGTPSSE 241
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
++SRIRNE AR YL M++K P+PFSHKF NADPLAL LLERLLAFDPKDRPTAEEALAD
Sbjct: 242 TLSRIRNENARGYLTGMQRKHPIPFSHKFHNADPLALRLLERLLAFDPKDRPTAEEALAD 301
Query: 404 PYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQ 463
PYF G++ + REPS P+SK EFEFERRKL KDDVREMIYREILEYHPQMLQEY+RGGEQ
Sbjct: 302 PYFRGISKLSREPSRLPVSKFEFEFERRKLTKDDVREMIYREILEYHPQMLQEYIRGGEQ 361
Query: 464 TSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDE-NAGQNNDYG 522
SF+YPSGVDRFKRQFAHLEE+Y +GERSTPL+RQHASLPRERV + D N +N+
Sbjct: 362 ISFLYPSGVDRFKRQFAHLEENYSRGERSTPLRRQHASLPRERVCSSVDSNNQDSDNEER 421
Query: 523 RTADSVAATLQSPP-----TENANTEEQNGINRPNCSARSLLKSASISASKCV 570
R S+A T+ SPP +N + NGI N + + LKSASISAS C+
Sbjct: 422 RAISSIARTMISPPRSQEKGKNRASAYPNGIINLNSNPKIYLKSASISASTCI 474
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|A2X0M1|MPK13_ORYSI Mitogen-activated protein kinase 13 OS=Oryza sativa subsp. indica GN=MPK13 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 760 bits (1963), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/473 (78%), Positives = 416/473 (87%), Gaps = 6/473 (1%)
Query: 104 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI 163
EFFTEYGEAS+YQIQEV+GKGSYGVV +AVDTHTGERVAIKKINDVFEHVSDA RILREI
Sbjct: 2 EFFTEYGEASQYQIQEVVGKGSYGVVAAAVDTHTGERVAIKKINDVFEHVSDAIRILREI 61
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 223
K+LRLLRHPDIV IKHIMLPP+RREF+DIYVVFELMESDLHQVI+AN DL+PEH++FFLY
Sbjct: 62 KVLRLLRHPDIVVIKHIMLPPTRREFRDIYVVFELMESDLHQVIEANHDLSPEHHRFFLY 121
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
QLL LKYIH+ANVFHRDLKPKNILAN+DCKLKICDFGLARV+FND+PS IFWTDYVATR
Sbjct: 122 QLLCALKYIHSANVFHRDLKPKNILANSDCKLKICDFGLARVAFNDSPSTIFWTDYVATR 181
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTG+PLFPG+NVVHQLDL+TDLLGTPS+E
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEILTGRPLFPGRNVVHQLDLITDLLGTPSSE 241
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
++SRIRNE AR YL M++K P+PFSHKF NADPLAL LLERLLAFDPKDRPTAEEALAD
Sbjct: 242 TLSRIRNENARGYLTGMQRKHPIPFSHKFHNADPLALRLLERLLAFDPKDRPTAEEALAD 301
Query: 404 PYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQ 463
PYF G++ + REPS P+SK EFEFERRKL KDDVREMIYREILEYHPQMLQEY+RGGEQ
Sbjct: 302 PYFRGISKLSREPSRLPVSKFEFEFERRKLTKDDVREMIYREILEYHPQMLQEYIRGGEQ 361
Query: 464 TSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDE-NAGQNNDYG 522
SF+YPSGVDRFKRQFAHLEE+Y +GERSTPL+RQHASLPRERV + D N +N+
Sbjct: 362 ISFLYPSGVDRFKRQFAHLEENYSRGERSTPLRRQHASLPRERVCSSVDSNNQDSDNEER 421
Query: 523 RTADSVAATLQSPP-----TENANTEEQNGINRPNCSARSLLKSASISASKCV 570
R S+A T+ SPP +N + NGI N + + LKSASISAS C+
Sbjct: 422 RAISSIARTMISPPRSQEKGKNRASAYPNGIINLNSNPKIYLKSASISASTCI 474
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q53N72|MPK15_ORYSJ Mitogen-activated protein kinase 15 OS=Oryza sativa subsp. japonica GN=MPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 749 bits (1933), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/481 (74%), Positives = 402/481 (83%), Gaps = 6/481 (1%)
Query: 104 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI 163
+FFTEYGE +RY+I+EVIGKGSYGVV SA+DTHTGE+VAIKKIND+FEHVSDATRILREI
Sbjct: 2 DFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGEKVAIKKINDIFEHVSDATRILREI 61
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 223
KLLRLLRHPDIVEIKHI+LPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 121
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV+F+D P+AIFWTDYVATR
Sbjct: 122 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYVATR 181
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD++TDLLGTPSTE
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSTE 241
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+ISRIRNEKARRYL SMR+K+P+PF+ KFPNADPLAL LLER+L+F+PKDRP AEEALAD
Sbjct: 242 AISRIRNEKARRYLSSMRRKKPIPFTQKFPNADPLALRLLERMLSFEPKDRPNAEEALAD 301
Query: 404 PYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQ 463
PYF +ANVDREPS QP++KLEFEFERR++ K+D+RE+IYR+ILEYHP ML+EYL G E
Sbjct: 302 PYFRNIANVDREPSAQPVTKLEFEFERRRITKEDIRELIYRDILEYHPNMLREYLEGTES 361
Query: 464 TSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDE-----NAGQN 518
FMYPS VD FK+QFA+LEEHY KG + P +RQH SLPR V D N ++
Sbjct: 362 AGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPRPSVLYSDDRPQNTANIAED 421
Query: 519 NDYGRTADSVAATLQSPPTENANTEEQNGINRPNCSARSLLKSASISASKCVGVKD-RTD 577
D+ Q + AN Q G RP S L+ + S S + RTD
Sbjct: 422 LSKCVLGDNTQKMHQGSASVCANRVPQGGAARPGKVVGSALRYGNCSTSTAEQYEHRRTD 481
Query: 578 R 578
R
Sbjct: 482 R 482
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q75KK8|MPK14_ORYSJ Mitogen-activated protein kinase 14 OS=Oryza sativa subsp. japonica GN=MPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 743 bits (1919), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/401 (84%), Positives = 378/401 (94%)
Query: 104 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI 163
+FFTEYGE +RY+I+EVIGKGSYGVV SA+DTHTG++VAIKKIND+FEHVSDATRILREI
Sbjct: 2 DFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGDKVAIKKINDIFEHVSDATRILREI 61
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 223
KLLRLLRHPDIVEIKHI+LPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 121
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV+F+D P+AIFWTDY+ATR
Sbjct: 122 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYIATR 181
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD++TDLLGTPS E
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSPE 241
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+ISRIRNEKARRYL SMR+K+P+PF+ KFPNADPLA+ LLER+LAFDPKDRP+AEEALAD
Sbjct: 242 TISRIRNEKARRYLNSMRRKKPIPFTQKFPNADPLAMRLLERMLAFDPKDRPSAEEALAD 301
Query: 404 PYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQ 463
PYF +ANVDREPS QPI+KLEFEFERR++ K+D+RE+IYREILEYHP+ML+E+L G E
Sbjct: 302 PYFKNIANVDREPSAQPITKLEFEFERRRITKEDIRELIYREILEYHPKMLREFLEGTES 361
Query: 464 TSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPR 504
T FMYPS VD FK+QFA+LEEHY KG + P +RQH SLPR
Sbjct: 362 TGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPR 402
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 595 | ||||||
| 399106776 | 594 | MAP kinase [Nicotiana tabacum] | 0.937 | 0.939 | 0.808 | 0.0 | |
| 449439123 | 647 | PREDICTED: mitogen-activated protein kin | 0.963 | 0.885 | 0.785 | 0.0 | |
| 359491016 | 601 | PREDICTED: mitogen-activated protein kin | 0.963 | 0.953 | 0.787 | 0.0 | |
| 449497497 | 647 | PREDICTED: mitogen-activated protein kin | 0.963 | 0.885 | 0.784 | 0.0 | |
| 399106778 | 590 | MAP kinase [Nicotiana tabacum] | 0.937 | 0.945 | 0.781 | 0.0 | |
| 224135517 | 548 | predicted protein [Populus trichocarpa] | 0.868 | 0.943 | 0.840 | 0.0 | |
| 255587177 | 613 | big map kinase/bmk, putative [Ricinus co | 0.944 | 0.916 | 0.779 | 0.0 | |
| 350539521 | 575 | mitogen-activated protein kinase 16 [Sol | 0.917 | 0.949 | 0.782 | 0.0 | |
| 356512988 | 594 | PREDICTED: mitogen-activated protein kin | 0.956 | 0.957 | 0.794 | 0.0 | |
| 9294059 | 619 | MAP kinase [Arabidopsis thaliana] | 0.862 | 0.828 | 0.825 | 0.0 |
| >gi|399106776|gb|AFP20221.1| MAP kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 950 bits (2456), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 470/581 (80%), Positives = 506/581 (87%), Gaps = 23/581 (3%)
Query: 1 MGGSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNN-FDSNNKKSNNINTSSSSSSHEGQHL 59
MGG +T VDG RRWFQR S T + ++N ++ +SNN + I+ S
Sbjct: 1 MGGGNTFVDGFRRWFQRRSTTTTTTTIVHSNADSILNSNNFEKKPIHFSE---------- 50
Query: 60 QQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQE 119
++LTI+EDFD SGLKLI VPKR+ FP TMDPHKK+ E EFFTEYGEASRYQIQE
Sbjct: 51 EELTIIEDFDISGLKLISVPKRVDFPF-----TMDPHKKNTQEAEFFTEYGEASRYQIQE 105
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 179
VIGKGSYGVV SAVDT TGERVAIKKI+DVFEHVSDATRILREIKLLRLLRHPDIVEIKH
Sbjct: 106 VIGKGSYGVVASAVDTKTGERVAIKKIHDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 165
Query: 180 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH 239
IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH
Sbjct: 166 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH 225
Query: 240 RDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT 299
RDLKPKNILANADCKLKICDFGLARVSFND PSAIFWTDYVATRWYRAPELCGSFFSKYT
Sbjct: 226 RDLKPKNILANADCKLKICDFGLARVSFNDTPSAIFWTDYVATRWYRAPELCGSFFSKYT 285
Query: 300 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS 359
PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP E++++IRNEKARRYL +
Sbjct: 286 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPPPETVAKIRNEKARRYLSN 345
Query: 360 MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQ 419
MRKK PVPFS KFP+ DP AL LLE LLAFDPKDRP+AEEAL DPYF GL+NVDREPST
Sbjct: 346 MRKKPPVPFSQKFPHVDPFALRLLECLLAFDPKDRPSAEEALGDPYFRGLSNVDREPSTH 405
Query: 420 PISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTS-FMYPSGVDRFKRQ 478
PISKLEFEFERRKLAK+DVRE+IYREILEYHPQMLQEYLRGG+QTS FMYPSGVDRFKRQ
Sbjct: 406 PISKLEFEFERRKLAKEDVRELIYREILEYHPQMLQEYLRGGDQTSGFMYPSGVDRFKRQ 465
Query: 479 FAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNNDY-GRTADSVAATLQSPP- 536
FAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDE + QN+D+ RT+ SVA+TLQSPP
Sbjct: 466 FAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDETSSQNDDFEKRTSASVASTLQSPPG 525
Query: 537 ----TENANTEEQNGINRPNCSARSLLKSASISASKCVGVK 573
+EN++ QNG N+ N SARSLLKSASISASKC+ VK
Sbjct: 526 QSEGSENSDANMQNGPNKANYSARSLLKSASISASKCIEVK 566
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439123|ref|XP_004137337.1| PREDICTED: mitogen-activated protein kinase 9-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 933 bits (2411), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/626 (78%), Positives = 523/626 (83%), Gaps = 53/626 (8%)
Query: 3 GSSTLVDGVRRWFQRHSFTNNSN-----------------NNNNNNNNNFD--SNNKKSN 43
GS TLVDGVRRWFQR + +++S+ N N N + FD N S
Sbjct: 2 GSGTLVDGVRRWFQRRTSSSSSSTSNSNSNFSSNSDSSDPNLNYPNLHKFDYVDNGGVSG 61
Query: 44 NINTSS-----SSSSH------------EGQHLQQLTIVED--FDFSGLKLIRVPKRIQF 84
+ SS SS +H EG L+QL ED D+S LKLI+VPKRI
Sbjct: 62 DQLLSSDLRAQSSIAHKRKPLRKQTQLGEGGILEQLPEEEDDDLDYSALKLIKVPKRINH 121
Query: 85 ---PIAPTP-ATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGER 140
P P P A MD HKK LETEFFTEYGEASRYQ+QE+IGKGSYGVVGSAVDTHT E+
Sbjct: 122 FRNPPPPLPSALMDSHKKGGLETEFFTEYGEASRYQVQEIIGKGSYGVVGSAVDTHTDEK 181
Query: 141 VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME 200
VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF+DIYVVFELME
Sbjct: 182 VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYVVFELME 241
Query: 201 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260
SDLHQVIKANDDLTPEH+QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF
Sbjct: 242 SDLHQVIKANDDLTPEHHQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 301
Query: 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 320
GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL
Sbjct: 302 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 361
Query: 321 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLAL 380
FPGKNVVHQLDLMTD+LGTPS+ESI+RIRNEKARRYL +MR+KQPVP + KFPNADPLAL
Sbjct: 362 FPGKNVVHQLDLMTDVLGTPSSESIARIRNEKARRYLSNMRRKQPVPLTQKFPNADPLAL 421
Query: 381 HLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVRE 440
LL+RLLAFDPKDRPTAEEALADPYF GLANVDREPSTQPISKLEFEFERRKL KDDVRE
Sbjct: 422 RLLQRLLAFDPKDRPTAEEALADPYFQGLANVDREPSTQPISKLEFEFERRKLTKDDVRE 481
Query: 441 MIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHA 500
+IYREILEYHPQMLQEYLR GEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHA
Sbjct: 482 LIYREILEYHPQMLQEYLRSGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHA 541
Query: 501 SLPRERVPAPKDENAGQNNDY-GRTADSVAATLQSPP------TENANTEEQNGINRPNC 553
SLPRER+PAPKDE AGQ+ND GR +VA +LQSPP +ENAN EQNG N+PN
Sbjct: 542 SLPRERIPAPKDE-AGQHNDLEGR---NVATSLQSPPKSQGDGSENANGNEQNGQNKPNY 597
Query: 554 SARSLLKSASISASKCVGVKDRTDRE 579
SARSLLKSASISASKC+GVK R D E
Sbjct: 598 SARSLLKSASISASKCIGVKPRKDLE 623
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491016|ref|XP_003634202.1| PREDICTED: mitogen-activated protein kinase 9-like [Vitis vinifera] gi|297734305|emb|CBI15552.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 931 bits (2407), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/594 (78%), Positives = 507/594 (85%), Gaps = 21/594 (3%)
Query: 3 GSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINT-----SSSSSSHEGQ 57
GS TLVDGVRRWFQR S T+++ NN++ ++ S T SS+S++
Sbjct: 2 GSGTLVDGVRRWFQRRSSTSSTTTTTTTNNDSNNAAIHASCVFVTEVHAQSSASATQPRP 61
Query: 58 HLQQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQI 117
H ++ + L LI+VPKR MDPHKK ETEFFTEYGEASRYQ+
Sbjct: 62 HHKKRQPQDPEAAPALTLIKVPKR---------RPMDPHKKGMPETEFFTEYGEASRYQV 112
Query: 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 177
QEV+GKGSYGVVGSA+DTHTGE+VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI
Sbjct: 113 QEVVGKGSYGVVGSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 172
Query: 178 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
KHIMLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV
Sbjct: 173 KHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 232
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 297
FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK
Sbjct: 233 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 292
Query: 298 YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYL 357
YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS ESI+RIRNEKARRYL
Sbjct: 293 YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSAESIARIRNEKARRYL 352
Query: 358 GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPS 417
+MRKK +PFS KFP+ADPLALHL+ERLLAFDPKDRPTAEEALADPYF GLANVDREPS
Sbjct: 353 STMRKKPSIPFSQKFPDADPLALHLVERLLAFDPKDRPTAEEALADPYFDGLANVDREPS 412
Query: 418 TQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKR 477
TQPISKLEFEFERRKL KDDVRE+IYREILEYHPQMLQEYLRGG+QTSFMYPSGVDRFKR
Sbjct: 413 TQPISKLEFEFERRKLTKDDVRELIYREILEYHPQMLQEYLRGGDQTSFMYPSGVDRFKR 472
Query: 478 QFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNNDY-GRTADSVAATLQSPP 536
QFAHLEEHYGKGERSTPLQRQHASLPRERV AP +E A +N ++ R+A SVA TL+SPP
Sbjct: 473 QFAHLEEHYGKGERSTPLQRQHASLPRERVCAPINEAADENKEFEKRSAASVATTLESPP 532
Query: 537 T----ENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTDREVTAVILH 586
E N E NG ++PN SARSLLKSASISASKC+GVK++ D E ++ H
Sbjct: 533 KAEGLEKGNVE--NGPSKPNQSARSLLKSASISASKCIGVKEQKDVEEETIVEH 584
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449497497|ref|XP_004160419.1| PREDICTED: mitogen-activated protein kinase 9-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 931 bits (2407), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 491/626 (78%), Positives = 523/626 (83%), Gaps = 53/626 (8%)
Query: 3 GSSTLVDGVRRWFQRHSFTNNSN-----------------NNNNNNNNNFD--SNNKKSN 43
GS TLVDGVRRWFQR + +++S+ N + N + FD N S
Sbjct: 2 GSGTLVDGVRRWFQRRTSSSSSSTSNSNSNFSSNSDSSDPNLSYPNLHKFDYVDNGGVSG 61
Query: 44 NINTSS-----SSSSH------------EGQHLQQLTIVED--FDFSGLKLIRVPKRIQF 84
+ SS SS +H EG L+QL ED D+S LKLI+VPKRI
Sbjct: 62 DQLLSSDLRAQSSIAHKRKPLRKQTQLGEGGILEQLPEEEDDDLDYSALKLIKVPKRINH 121
Query: 85 ---PIAPTP-ATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGER 140
P P P A MD HKK LETEFFTEYGEASRYQ+QE+IGKGSYGVVGSAVDTHT E+
Sbjct: 122 FRNPPPPLPSALMDSHKKGGLETEFFTEYGEASRYQVQEIIGKGSYGVVGSAVDTHTDEK 181
Query: 141 VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME 200
VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF+DIYVVFELME
Sbjct: 182 VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYVVFELME 241
Query: 201 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260
SDLHQVIKANDDLTPEH+QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF
Sbjct: 242 SDLHQVIKANDDLTPEHHQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 301
Query: 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 320
GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL
Sbjct: 302 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 361
Query: 321 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLAL 380
FPGKNVVHQLDLMTD+LGTPS+ESI+RIRNEKARRYL +MR+KQPVP + KFPNADPLAL
Sbjct: 362 FPGKNVVHQLDLMTDVLGTPSSESIARIRNEKARRYLSNMRRKQPVPLTQKFPNADPLAL 421
Query: 381 HLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVRE 440
LL+RLLAFDPKDRPTAEEALADPYF GLANVDREPSTQPISKLEFEFERRKL KDDVRE
Sbjct: 422 RLLQRLLAFDPKDRPTAEEALADPYFQGLANVDREPSTQPISKLEFEFERRKLTKDDVRE 481
Query: 441 MIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHA 500
+IYREILEYHPQMLQEYLR GEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHA
Sbjct: 482 LIYREILEYHPQMLQEYLRSGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHA 541
Query: 501 SLPRERVPAPKDENAGQNNDY-GRTADSVAATLQSPP------TENANTEEQNGINRPNC 553
SLPRER+PAPKDE AGQ+ND GR +VA +LQSPP +ENAN EQNG N+PN
Sbjct: 542 SLPRERIPAPKDE-AGQHNDLEGR---NVATSLQSPPKSQGDGSENANGNEQNGQNKPNY 597
Query: 554 SARSLLKSASISASKCVGVKDRTDRE 579
SARSLLKSASISASKC+GVK R D E
Sbjct: 598 SARSLLKSASISASKCIGVKPRKDLE 623
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|399106778|gb|AFP20222.1| MAP kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 928 bits (2398), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/581 (78%), Positives = 502/581 (86%), Gaps = 23/581 (3%)
Query: 1 MGGSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQ 60
MGG T VDGV RWFQR ++N + ++ +K +N + + + Q
Sbjct: 1 MGGGGTFVDGVLRWFQRR----------HSNEDAILTDLQKPHNTHLQERAEDNN----Q 46
Query: 61 QLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEV 120
+ TI EDFD +GLKLI+VPKR+ FPI+ ++MDP KK+ALETEFFTEYGEASRYQ+QEV
Sbjct: 47 EFTITEDFDITGLKLIKVPKRLSFPIS-AHSSMDPLKKNALETEFFTEYGEASRYQVQEV 105
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
IGKGSYGVVGSAVDTHTGERVAIKKINDVF+HVSDATRILREIKLLRLLRHPDIVEIKHI
Sbjct: 106 IGKGSYGVVGSAVDTHTGERVAIKKINDVFDHVSDATRILREIKLLRLLRHPDIVEIKHI 165
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
MLPPSRREFKDIYVVFELMESDLHQVIKAN+DLT EHYQFFLYQL+RGLKYIHTAN+FHR
Sbjct: 166 MLPPSRREFKDIYVVFELMESDLHQVIKANNDLTAEHYQFFLYQLMRGLKYIHTANIFHR 225
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 300
DLKPKNILANADCKLKICDFGLARVSFND PSAIFWTDYVATRWYRAPELCGSFFSKYTP
Sbjct: 226 DLKPKNILANADCKLKICDFGLARVSFNDVPSAIFWTDYVATRWYRAPELCGSFFSKYTP 285
Query: 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 360
AIDIWSIGCIFAE+L+GKPLFPGKNVVHQLDL+TDLLGTP E++++IRNEKARRYL SM
Sbjct: 286 AIDIWSIGCIFAELLSGKPLFPGKNVVHQLDLITDLLGTPPPETVAKIRNEKARRYLSSM 345
Query: 361 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP 420
RKKQPVPF KFPNADPLAL LLERL+AFDPKDRP+AEEAL+DPYF GL+N D EPS P
Sbjct: 346 RKKQPVPFEKKFPNADPLALRLLERLIAFDPKDRPSAEEALSDPYFRGLSNADHEPSRPP 405
Query: 421 ISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTS-FMYPSGVDRFKRQF 479
ISKLEFEFE+RKLAK+DVRE+IYREILEYHPQMLQEYL GG+QTS FMYPSGVDRFKRQF
Sbjct: 406 ISKLEFEFEKRKLAKEDVRELIYREILEYHPQMLQEYLSGGDQTSGFMYPSGVDRFKRQF 465
Query: 480 AHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNNDYGRTADSVAATLQSPP--- 536
AHLEEHYGKGERSTPLQRQHASLPRERVPAPK++ + QNND + +V+ LQS P
Sbjct: 466 AHLEEHYGKGERSTPLQRQHASLPRERVPAPKNDTSSQNNDCEKR--TVSTALQSSPGQS 523
Query: 537 --TENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDR 575
+EN+ QNG N+ N SARSLLKSASISASKCV VK+R
Sbjct: 524 EGSENSIVGTQNGSNQANNSARSLLKSASISASKCVEVKNR 564
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224135517|ref|XP_002322093.1| predicted protein [Populus trichocarpa] gi|222869089|gb|EEF06220.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 898 bits (2321), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/528 (84%), Positives = 473/528 (89%), Gaps = 11/528 (2%)
Query: 60 QQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQE 119
+QLT++EDFD S LKLIRVPKR FP +TM KK + E +FFTEYGEAS+YQ+QE
Sbjct: 3 EQLTVIEDFDISDLKLIRVPKRFHFPPG---STMGLQKKGSAEADFFTEYGEASQYQVQE 59
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 179
VIGKGSYGVVGSA+D+HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH
Sbjct: 60 VIGKGSYGVVGSAIDSHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 119
Query: 180 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH 239
IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH
Sbjct: 120 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH 179
Query: 240 RDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT 299
RDLKPKNILANADCKLKICDFGLARVSFNDAPSAI WTDYVATRWYRAPELCGSFFSKYT
Sbjct: 180 RDLKPKNILANADCKLKICDFGLARVSFNDAPSAILWTDYVATRWYRAPELCGSFFSKYT 239
Query: 300 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS 359
PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP ESIS+IRNEKARRYL +
Sbjct: 240 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPPPESISKIRNEKARRYLSN 299
Query: 360 MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQ 419
MRKK PVPF KFPN DPLAL LLE LLAFDPKDRPTAEEALA+PYF+GL+NV+ EPSTQ
Sbjct: 300 MRKKPPVPFPQKFPNVDPLALRLLEGLLAFDPKDRPTAEEALANPYFNGLSNVECEPSTQ 359
Query: 420 PISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQF 479
PISKLEFEFERRK+ KDDVRE+IYREILEYHPQML+EYLRGGEQTSFMYPSGVDRFKRQF
Sbjct: 360 PISKLEFEFERRKITKDDVRELIYREILEYHPQMLKEYLRGGEQTSFMYPSGVDRFKRQF 419
Query: 480 AHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNNDYGR-TADSVAATLQSPP-- 536
AHLEEHYGKGERSTPLQRQHASLPRERVPAPKDE A Q+ D R TA S+A +L+S P
Sbjct: 420 AHLEEHYGKGERSTPLQRQHASLPRERVPAPKDETAAQSTDIERQTAPSIAKSLKSLPGL 479
Query: 537 -----TENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTDRE 579
+E+ QNG ++PN S RSLLKS+SISASKCV VK + D E
Sbjct: 480 QQADGSEDVTVAAQNGSSKPNYSNRSLLKSSSISASKCVVVKPKGDSE 527
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587177|ref|XP_002534166.1| big map kinase/bmk, putative [Ricinus communis] gi|223525753|gb|EEF28215.1| big map kinase/bmk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 896 bits (2315), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/602 (77%), Positives = 503/602 (83%), Gaps = 40/602 (6%)
Query: 3 GSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINT--------------- 47
GS TLVDGVRRWFQR + NN+ ++ + + + S + SN+
Sbjct: 2 GSGTLVDGVRRWFQRRNNNNNNTSSASASASASASTSTSSNHYINNCIKSNKNKNNNNYR 61
Query: 48 SSSSSSHEGQHLQQ---LTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETE 104
SS G +++ LT++E+FD +GLK IRVPKRI T +MDPHKK + E E
Sbjct: 62 SSGQPDLSGGVVEEENKLTVIEEFDLTGLKCIRVPKRI------THFSMDPHKKGSAEAE 115
Query: 105 FFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK 164
FFTEYGEASRYQ+QEV+GKGSYGVVGSA+DTHTGE+VAIKKINDVFEHVSDATRILREIK
Sbjct: 116 FFTEYGEASRYQVQEVVGKGSYGVVGSAIDTHTGEKVAIKKINDVFEHVSDATRILREIK 175
Query: 165 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQ 224
LLRLLRHPDIVEIKHIMLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQ
Sbjct: 176 LLRLLRHPDIVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQ 235
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW
Sbjct: 236 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 295
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP ES
Sbjct: 296 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPPPES 355
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
ISRIRNEKARRYLGSMRKKQPVP S KFPNADPLAL LLERLLAFDPKDRPTAEEALAD
Sbjct: 356 ISRIRNEKARRYLGSMRKKQPVPLSQKFPNADPLALSLLERLLAFDPKDRPTAEEALADT 415
Query: 405 YFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQT 464
YFHGLANV+REPST PISKLEFEFERRKLAKDD ILEYHPQMLQEYLRGGEQT
Sbjct: 416 YFHGLANVEREPSTNPISKLEFEFERRKLAKDD--------ILEYHPQMLQEYLRGGEQT 467
Query: 465 SFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNNDY-GR 523
SFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPA K+E A Q+ND+ R
Sbjct: 468 SFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPASKEEIAEQSNDFESR 527
Query: 524 TADSVAATLQSPPTENAN------TEEQNGINRPNCSARSLLKSASISASKCVGVKDRTD 577
A SV T+QSP AN T +NG +P+ + RSLLKSASISASKC+GV+ R D
Sbjct: 528 IATSVITTVQSPRVSQANGLDSATTVTENGPCKPHPN-RSLLKSASISASKCIGVQPRRD 586
Query: 578 RE 579
E
Sbjct: 587 LE 588
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350539521|ref|NP_001233915.1| mitogen-activated protein kinase 16 [Solanum lycopersicum] gi|335353086|gb|AEH42672.1| mitogen-activated protein kinase 16 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 890 bits (2299), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/574 (78%), Positives = 486/574 (84%), Gaps = 28/574 (4%)
Query: 1 MGGSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQ 60
MGGSST VDGV RWF TN +N S+ + E QH
Sbjct: 1 MGGSSTFVDGVLRWFHHRRHTNEDAILTQTHN---------------STDTHLQEKQH-- 43
Query: 61 QLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEV 120
+ TI EDFDF+GLKLI+VPKR PI+ + ++MDP KK+ALETEFFTEYGEASRYQ+QEV
Sbjct: 44 EFTITEDFDFTGLKLIKVPKRFHLPISSSSSSMDPTKKNALETEFFTEYGEASRYQVQEV 103
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
IGKGSYGVVGSAVDTHTGERVAIKKINDVF+HVSDATRILREIKLLRLLRHPDIVEIKHI
Sbjct: 104 IGKGSYGVVGSAVDTHTGERVAIKKINDVFDHVSDATRILREIKLLRLLRHPDIVEIKHI 163
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
MLPPSRREFKDIYVVFELMESDLHQVIKAN+DLT EHYQFFLYQLLRGLKYIHTAN+FHR
Sbjct: 164 MLPPSRREFKDIYVVFELMESDLHQVIKANNDLTHEHYQFFLYQLLRGLKYIHTANIFHR 223
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 300
DLKPKNILANADCKLKICDFGLARVSFND PSAIFWTDYVATRWYRAPELCGSFFSKYTP
Sbjct: 224 DLKPKNILANADCKLKICDFGLARVSFNDVPSAIFWTDYVATRWYRAPELCGSFFSKYTP 283
Query: 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 360
AIDIWSIGCIFAE+L+GKPLFPGKNVVHQLDL+TDLLGTP E++++IRNEKARRYL SM
Sbjct: 284 AIDIWSIGCIFAELLSGKPLFPGKNVVHQLDLITDLLGTPPPETVAKIRNEKARRYLSSM 343
Query: 361 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP 420
RKKQPV F+ KFPNADPLAL LLERLLAFDPKDRP+AEE L DPYFHGL+N DREP P
Sbjct: 344 RKKQPVGFAKKFPNADPLALRLLERLLAFDPKDRPSAEEGLEDPYFHGLSNADREPCRPP 403
Query: 421 ISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTS-FMYPSGVDRFKRQF 479
ISKLEFEFE+RKLAKDDVRE+IYREILEYHPQMLQEYL G +QTS FMYPSGVDRFKRQF
Sbjct: 404 ISKLEFEFEKRKLAKDDVRELIYREILEYHPQMLQEYLSGADQTSGFMYPSGVDRFKRQF 463
Query: 480 AHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNNDYGRTADSVAATLQSPPTEN 539
AHLEEH GKGE P+ RQHASLPRERVPAPKD+ + QNND + +V+ TLQSPPT++
Sbjct: 464 AHLEEHAGKGEHGAPILRQHASLPRERVPAPKDDTSSQNNDCEKK--TVSTTLQSPPTQS 521
Query: 540 ANTEEQNGINRPNCSARSLLKSASISASKCVGVK 573
+E N SARSLLKSASIS SKCV VK
Sbjct: 522 EGSE--------NYSARSLLKSASISGSKCVEVK 547
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356512988|ref|XP_003525196.1| PREDICTED: mitogen-activated protein kinase 15-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 887 bits (2291), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/580 (79%), Positives = 503/580 (86%), Gaps = 11/580 (1%)
Query: 1 MGGSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQ 60
MGG TLV+G+RR FQR + +++S++++++NN N +NN + + +S
Sbjct: 1 MGGGGTLVEGIRRLFQRRASSSSSSDHHDHNNVN--ANNSLVLVRDLRAQLASIPNTLHP 58
Query: 61 QLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEV 120
DFDFS LK I+VP +I F P++MD HKK A ETEFFTEYGEAS+YQIQEV
Sbjct: 59 DSDSDFDFDFSTLKPIKVPSQIPF----RPSSMDHHKKGAPETEFFTEYGEASQYQIQEV 114
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
+GKGSYGVVGSA+DTHTGE+VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI
Sbjct: 115 VGKGSYGVVGSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 174
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
MLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEH+QFFLYQLLRGLKYIHTANVFHR
Sbjct: 175 MLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRGLKYIHTANVFHR 234
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 300
DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP
Sbjct: 235 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 294
Query: 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 360
AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP ESI+RIRNEKA+RYL SM
Sbjct: 295 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPPPESIARIRNEKAKRYLNSM 354
Query: 361 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP 420
RKKQP+PFS KFPNADPLAL LLERLLAFDPKDRP+AEEAL+DPYF GLAN+DREPSTQP
Sbjct: 355 RKKQPIPFSQKFPNADPLALRLLERLLAFDPKDRPSAEEALSDPYFTGLANMDREPSTQP 414
Query: 421 ISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFA 480
ISKLEFEFERRKL KDDVRE+IYREILEYHPQMLQEYLRGG+QTSFMYPSGVDRFKRQFA
Sbjct: 415 ISKLEFEFERRKLTKDDVRELIYREILEYHPQMLQEYLRGGDQTSFMYPSGVDRFKRQFA 474
Query: 481 HLEEHYGKGERST-PLQRQHASLPRERVPAPKDENAGQNNDYGRTADSVAATLQSPPTEN 539
HLEEHYGKGERST PLQRQHASLPR+RV APKDE+ QNND + + S LQ P +
Sbjct: 475 HLEEHYGKGERSTPPLQRQHASLPRQRVCAPKDESK-QNNDSEKPSGS---NLQQSPPGS 530
Query: 540 ANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTDRE 579
T QNG ++PN SARSLLKSASISASKCV +K D E
Sbjct: 531 DETGAQNGTSKPNYSARSLLKSASISASKCVVLKQNKDPE 570
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|9294059|dbj|BAB02016.1| MAP kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 883 bits (2281), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/522 (82%), Positives = 470/522 (90%), Gaps = 9/522 (1%)
Query: 60 QQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQE 119
+ ++V DFD SGL IRV +R MDPHKK ALETEFFTEYGEASRYQIQE
Sbjct: 84 KSFSLVRDFDLSGLNCIRVSRRNYI-------LMDPHKKVALETEFFTEYGEASRYQIQE 136
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 179
VIGKGSYGVV SA+DTH+GE+VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH
Sbjct: 137 VIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 196
Query: 180 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH 239
+MLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK+IHTANVFH
Sbjct: 197 VMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKFIHTANVFH 256
Query: 240 RDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT 299
RDLKPKNILAN+DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT
Sbjct: 257 RDLKPKNILANSDCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT 316
Query: 300 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS 359
PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD+MTDLLGTP E+I+RIRNEKARRYLG+
Sbjct: 317 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIMTDLLGTPPPEAIARIRNEKARRYLGN 376
Query: 360 MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQ 419
MR+K PVPF+HKFP+ DPLAL LL RLLAFDPKDRP+AEEALADPYF+GLANVDREPSTQ
Sbjct: 377 MRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKDRPSAEEALADPYFYGLANVDREPSTQ 436
Query: 420 PISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQF 479
PI KLEFEFERRK+ K+DVRE+IYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQF
Sbjct: 437 PIPKLEFEFERRKITKEDVRELIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQF 496
Query: 480 AHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNNDY-GRTADSVAATLQSPPT- 537
AHLEE+YGKGE+ +PLQRQHASLPRERVPAPK EN N+D R+ S+ TL+SPPT
Sbjct: 497 AHLEENYGKGEKGSPLQRQHASLPRERVPAPKKENGSHNHDIENRSIASLVTTLESPPTS 556
Query: 538 ENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTDRE 579
++ ++ +NG ++ SARSLLKSASISASKC+G+K R E
Sbjct: 557 QHEGSDYRNGTSQTGYSARSLLKSASISASKCIGMKPRNKSE 598
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 595 | ||||||
| TAIR|locus:2092717 | 510 | MPK9 "MAP kinase 9" [Arabidops | 0.818 | 0.954 | 0.785 | 7e-212 | |
| TAIR|locus:2194040 | 589 | ATMPK8 [Arabidopsis thaliana ( | 0.939 | 0.949 | 0.690 | 1.7e-208 | |
| TAIR|locus:2027814 | 576 | MPK15 "MAP kinase 15" [Arabido | 0.865 | 0.894 | 0.697 | 8.2e-201 | |
| TAIR|locus:2179609 | 567 | MPK16 "mitogen-activated prote | 0.690 | 0.724 | 0.788 | 1.3e-180 | |
| TAIR|locus:2052357 | 606 | MPK20 "MAP kinase 20" [Arabido | 0.759 | 0.745 | 0.710 | 3.1e-177 | |
| TAIR|locus:2049552 | 486 | MPK17 "MAP kinase 17" [Arabido | 0.737 | 0.903 | 0.715 | 1.4e-172 | |
| TAIR|locus:2089576 | 598 | MPK19 "MAP kinase 19" [Arabido | 0.689 | 0.685 | 0.737 | 8.7e-166 | |
| TAIR|locus:2024887 | 615 | MPK18 "mitogen-activated prote | 0.737 | 0.713 | 0.679 | 3e-165 | |
| DICTYBASE|DDB_G0286353 | 529 | erkA "mitogen-activated protei | 0.605 | 0.680 | 0.466 | 6.2e-85 | |
| TAIR|locus:2124943 | 376 | MPK4 "MAP kinase 4" [Arabidops | 0.588 | 0.930 | 0.437 | 4.1e-81 |
| TAIR|locus:2092717 MPK9 "MAP kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2048 (726.0 bits), Expect = 7.0e-212, P = 7.0e-212
Identities = 384/489 (78%), Positives = 419/489 (85%)
Query: 93 MDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH 152
MDPHKK ALETEFFTEYGEASRYQIQEVIGKGSYGVV SA+DTH+GE+VAIKKINDVFEH
Sbjct: 1 MDPHKKVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEH 60
Query: 153 VSDATXXXXXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD 212
VSDAT HPDIVEIKH+MLPPSRREF+DIYVVFELMESDLHQVIKANDD
Sbjct: 61 VSDATRILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDD 120
Query: 213 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272
LTPEHYQFFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKICDFGLARVSFNDAPS
Sbjct: 121 LTPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPS 180
Query: 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332
AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD+
Sbjct: 181 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDI 240
Query: 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPK 392
MTDLLGTP E+I+RIRNEKARRYLG+MR+K PVPF+HKFP+ DP AFDPK
Sbjct: 241 MTDLLGTPPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPK 300
Query: 393 DRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQ 452
DRP+AEEALADPYF+GLANVDREPSTQPI KLEFEFERRK+ K+DVRE+IYREILEYHPQ
Sbjct: 301 DRPSAEEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQ 360
Query: 453 MLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKD 512
MLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEE+YGKGE+ +PLQRQHASLPRERVPAPK
Sbjct: 361 MLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPRERVPAPKK 420
Query: 513 ENAGQNNDY-GRTADSVAATLQSPPT-ENANTEEQNGINRPNCXXXXXXXXXXXXXXXCV 570
EN N+D R+ S+ TL+SPPT ++ ++ +NG ++ C+
Sbjct: 421 ENGSHNHDIENRSIASLVTTLESPPTSQHEGSDYRNGTSQTGYSARSLLKSASISASKCI 480
Query: 571 GVKDRTDRE 579
G+K R E
Sbjct: 481 GMKPRNKSE 489
|
|
| TAIR|locus:2194040 ATMPK8 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2016 (714.7 bits), Expect = 1.7e-208, P = 1.7e-208
Identities = 406/588 (69%), Positives = 438/588 (74%)
Query: 1 MGGSSTLVDGVRRW-FQRHXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXHEGQHL 59
MGG LVDGVRRW FQR H
Sbjct: 1 MGGGGNLVDGVRRWLFQRPSSSSSSSSSNNNNNNHEQPIFNSSSFSSSSNPN--HSANS- 57
Query: 60 QQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQE 119
+L I ED DFSGL LI VPKR P MDPHKK ETEFFTEYGEA+RYQIQE
Sbjct: 58 GELIIEEDLDFSGLTLINVPKRNHLP-------MDPHKKG--ETEFFTEYGEANRYQIQE 108
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATXXXXXXXXXXXXXHPDIVEIKH 179
V+GKGSYGVV SAVD+HTGERVAIKKINDVFEHVSDAT HPD+VEIKH
Sbjct: 109 VVGKGSYGVVASAVDSHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDVVEIKH 168
Query: 180 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH 239
IMLPPSRREF+DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY+H ANVFH
Sbjct: 169 IMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYVHAANVFH 228
Query: 240 RDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT 299
RDLKPKNILANADCKLKICDFGLARVSFNDAP+AIFWTDYVATRWYRAPELCGSFFSKYT
Sbjct: 229 RDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVATRWYRAPELCGSFFSKYT 288
Query: 300 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS 359
PAIDIWS+GCIFAEML GKPLFPGKNVVHQLDLMTD LGTP ESISRIRNEKARRYL S
Sbjct: 289 PAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDLMTDFLGTPPPESISRIRNEKARRYLSS 348
Query: 360 MRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPTAEEALADPYFHGLANVDREPSTQ 419
MRKKQPVPFSHKFP ADP AFDPKDR +AE+ALADPYF GL+N +REP+TQ
Sbjct: 349 MRKKQPVPFSHKFPKADPLALRLLERLLAFDPKDRASAEDALADPYFSGLSNSEREPTTQ 408
Query: 420 PISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQF 479
PISKLEF+FER+KL KDDVRE+IYREILEYHPQML+EYLRGG+Q SFMYPSGVDRFKRQF
Sbjct: 409 PISKLEFDFERKKLVKDDVRELIYREILEYHPQMLEEYLRGGDQLSFMYPSGVDRFKRQF 468
Query: 480 AHLEEHYGK-----GERSTPLQRQHASLPRERVPAPKDENAGQNNDYGR-TADSVAATLQ 533
AHLEE+ GK G RST L R HASLPRERVPAP E A +++D R A +VA+TL+
Sbjct: 469 AHLEENQGKPGAAGGGRSTALHRHHASLPRERVPAPNGETAEESSDVERRAAAAVASTLE 528
Query: 534 SPPTENANTEEQNGINRPNCXXXXXXXXXXXXXXXCVGVKDRTDREVT 581
S +N G + N C+GV+ +TD+E T
Sbjct: 529 SEEADNGG-----GYSARNLMKSASISGSK-----CIGVQSKTDKEDT 566
|
|
| TAIR|locus:2027814 MPK15 "MAP kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1899 (673.5 bits), Expect = 8.2e-201, Sum P(2) = 8.2e-201
Identities = 371/532 (69%), Positives = 418/532 (78%)
Query: 54 HEGQHLQQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEAS 113
++ + L++LT D S L+ I+V +R P+ KK EFFTEYGEA+
Sbjct: 43 NDDEDLKKLT-----DPSKLRQIKVQQRNHLPM---------EKKGIPNAEFFTEYGEAN 88
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATXXXXXXXXXXXXXHPD 173
RYQIQEV+GKGSYGVVGSA+DTHTGERVAIKKINDVF+H+SDAT HPD
Sbjct: 89 RYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDATRILREIKLLRLLLHPD 148
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
+VEIKHIMLPPSRREF+D+YVVFELMESDLHQVIKANDDLTPEH+QFFLYQLLRGLKY+H
Sbjct: 149 VVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRGLKYVH 208
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP+AIFWTDYVATRWYRAPELCGS
Sbjct: 209 AANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVATRWYRAPELCGS 268
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353
FFSKYTPAIDIWS+GCIFAEML GKPLFPGKNVVHQLD+MTD LGTP E+IS+IRN+KA
Sbjct: 269 FFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDFLGTPPPEAISKIRNDKA 328
Query: 354 RRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPTAEEALADPYFHGLANVD 413
RRYLG+MRKKQPVPFS KFP ADP AFDPKDRP+AEEALADPYF+GL++
Sbjct: 329 RRYLGNMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPSAEEALADPYFNGLSSKV 388
Query: 414 REPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVD 473
REPSTQPISKLEFEFER+KL KDD+RE+IYREILEYHPQML+EYLRGG Q SFMYPSGVD
Sbjct: 389 REPSTQPISKLEFEFERKKLTKDDIRELIYREILEYHPQMLEEYLRGGNQLSFMYPSGVD 448
Query: 474 RFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQ-NNDYGR-TADSVAAT 531
RF+RQFAHLEE+ G G RS LQRQHASLPRERVPA K+E + +ND R T +VA+T
Sbjct: 449 RFRRQFAHLEENQGPGGRSNALQRQHASLPRERVPASKNETVEERSNDIERRTTAAVAST 508
Query: 532 LQSPPTENANTEEQNGINRPNCXXXXXXXXXXXXXXXCVGVKDRTDREVTAV 583
L SP +NG C+GV+ +T+ E + V
Sbjct: 509 LDSPKASQQAEGTENG-GGGGYSARNLMKSSSISGSKCIGVQSKTNIEDSIV 559
|
|
| TAIR|locus:2179609 MPK16 "mitogen-activated protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1753 (622.1 bits), Expect = 1.3e-180, P = 1.3e-180
Identities = 325/412 (78%), Positives = 359/412 (87%)
Query: 94 DPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV 153
D KKS++E +FFTEYGE SRY+I+EVIGKGSYGVV SA DTHTGE+VAIKKIND+FEHV
Sbjct: 4 DHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIFEHV 63
Query: 154 SDATXXXXXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDL 213
SDAT HPDIVEIKHI+LPPSRREF+DIYVVFELMESDLHQVIKANDDL
Sbjct: 64 SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKANDDL 123
Query: 214 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273
TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV+FND P+A
Sbjct: 124 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
Query: 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 333
IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDLM
Sbjct: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDLM 243
Query: 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKD 393
TD+LGTPS E+I R+RNEKARRYL SMRKK+P+PFSHKFP+ DP +F+PKD
Sbjct: 244 TDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFEPKD 303
Query: 394 RPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQM 453
RPTAEEALAD YF GLA V+REPS QP++KLEFEFERR++ K+DVRE+IYRE LEYHP+M
Sbjct: 304 RPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYHPKM 363
Query: 454 LQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQ-HASLPR 504
L+EYL G E T+FMYPS V+ FK+QFA+LEEHY G P +RQ HASLPR
Sbjct: 364 LKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPR 415
|
|
| TAIR|locus:2052357 MPK20 "MAP kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1704 (604.9 bits), Expect = 3.1e-177, Sum P(2) = 3.1e-177
Identities = 322/453 (71%), Positives = 370/453 (81%)
Query: 94 DPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV 153
D KK+ LE EFF++YG+A+R+++QEVIGKGSYGVV SA+DT TGE+VAIKKI+D+FEH+
Sbjct: 4 DNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIFEHI 63
Query: 154 SDATXXXXXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDL 213
SDA HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDL
Sbjct: 64 SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDL 123
Query: 214 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273
T EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARV+FND P+
Sbjct: 124 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183
Query: 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 333
IFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAE+L GKPLFPGKNVVHQLDLM
Sbjct: 184 IFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQLDLM 243
Query: 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKD 393
TDLLGTPS ++ISR+RNEKARRYL SMRKK P+PF+ KFPNADP AFDPKD
Sbjct: 244 TDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFDPKD 303
Query: 394 RPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQM 453
RPTAEEALADPYF GLA V+REPS QPI+K+EFEFERRK+ K+D+RE+I REILEYHPQ+
Sbjct: 304 RPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYHPQL 363
Query: 454 LQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERV-PAPKD 512
L++++ G ++ SF+YPS VD+F+RQFAHLEE+ GK PL+R+HASLPR V +
Sbjct: 364 LKDHMNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPRSTVIHSTAV 423
Query: 513 ENAGQNNDYGRTADSVAATLQSPPTENANTEEQ 545
GQ T T Q+ P +A + Q
Sbjct: 424 ARGGQPKLMNNTNTLNPETTQNIPFNHATIQAQ 456
|
|
| TAIR|locus:2049552 MPK17 "MAP kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1677 (595.4 bits), Expect = 1.4e-172, P = 1.4e-172
Identities = 319/446 (71%), Positives = 367/446 (82%)
Query: 101 LETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATXXX 160
LE EFFTEYGEAS+YQIQEV+GKGSYGVV SA HTG +VAIKK+ +VFEHVSDA
Sbjct: 2 LEKEFFTEYGEASQYQIQEVVGKGSYGVVASAECPHTGGKVAIKKMTNVFEHVSDAIRIL 61
Query: 161 XXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQF 220
HPDIVEIKHIMLPP R+EFKDIYVVFELMESDLH V+K NDDLTP+H+QF
Sbjct: 62 REIKLLRLLRHPDIVEIKHIMLPPCRKEFKDIYVVFELMESDLHHVLKVNDDLTPQHHQF 121
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
FLYQLLRGLK++H+A+VFHRDLKPKNILANADCK+KICD GLARVSF D+PSA+FWTDYV
Sbjct: 122 FLYQLLRGLKFMHSAHVFHRDLKPKNILANADCKIKICDLGLARVSFTDSPSAVFWTDYV 181
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
ATRWYRAPELCGSF+S YTPAID+WS+GCIFAEMLTGKPLFPGKNVVHQL+L+TDLLGTP
Sbjct: 182 ATRWYRAPELCGSFYSNYTPAIDMWSVGCIFAEMLTGKPLFPGKNVVHQLELVTDLLGTP 241
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPTAEEA 400
S ++SRIRNEKAR+YLG+MR+K PVPF+HKFPN DP AFDPKDRP+AEEA
Sbjct: 242 SPITLSRIRNEKARKYLGNMRRKDPVPFTHKFPNIDPVALKLLQRLIAFDPKDRPSAEEA 301
Query: 401 LADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRG 460
LADPYF GLANVD EPS QPISKLEFEFERRKL +DDVRE++YREILEYHPQMLQEYL+G
Sbjct: 302 LADPYFQGLANVDYEPSRQPISKLEFEFERRKLTRDDVRELMYREILEYHPQMLQEYLQG 361
Query: 461 GEQTS--FMYPSGVDRFKRQFAHLEEHYGKGER--STPLQRQHASLPRERVPAPKDENAG 516
E + F+YPSGVD+FK++FA LEEH E S P QR++ SLPRERV + +DE G
Sbjct: 362 EENINSHFLYPSGVDQFKQEFARLEEHNDDEEEHNSPPHQRKYTSLPRERVCSSEDE--G 419
Query: 517 QNNDYGRTADSVAATLQSPPTENANT 542
++ + +++ S + P T N T
Sbjct: 420 SDSVHAQSS-SASVVFTPPQTPNTAT 444
|
|
| TAIR|locus:2089576 MPK19 "MAP kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1613 (572.9 bits), Expect = 8.7e-166, P = 8.7e-166
Identities = 303/411 (73%), Positives = 344/411 (83%)
Query: 97 KKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA 156
KK+ E EFFTEYG+A+RY+I EVIGKGSYGVV +A+DT TGE+VAIKKINDVFEHVSDA
Sbjct: 7 KKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVFEHVSDA 66
Query: 157 TXXXXXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE 216
HPDIVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKANDDLT E
Sbjct: 67 LRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTRE 126
Query: 217 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276
H+QFFLYQ+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVSFND P+ +FW
Sbjct: 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDTPTTVFW 186
Query: 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 336
TDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLDL+TDL
Sbjct: 187 TDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
Query: 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPT 396
LGTP +E+I+ +RNEKAR+YL MRKK VPFS KFPNADP AFDPKDRPT
Sbjct: 247 LGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFDPKDRPT 306
Query: 397 AEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQE 456
A EALADPYF LA V+REPS QPISK+EFEFERR+L KDD+RE+IYREILEYHPQ+L++
Sbjct: 307 AAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYHPQLLKD 366
Query: 457 YLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERV 507
Y+ E +SF+YPS + ++QFA+LEE+ GK P R+HASLPR V
Sbjct: 367 YMNS-EGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPRSAV 416
|
|
| TAIR|locus:2024887 MPK18 "mitogen-activated protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1608 (571.1 bits), Expect = 3.0e-165, P = 3.0e-165
Identities = 301/443 (67%), Positives = 358/443 (80%)
Query: 97 KKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA 156
KK E EFFTEYG+A+RY+I EVIGKGSYGVV +A+DTHTGE+VAIKKINDVFEH+SDA
Sbjct: 7 KKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVFEHISDA 66
Query: 157 TXXXXXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE 216
HPDIVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKANDDLT E
Sbjct: 67 LRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTRE 126
Query: 217 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276
H+QFFLYQ+LR LK++HTANV+HRDLKPKNILANA+CKLK+CDFGLARV+FND P+ +FW
Sbjct: 127 HHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDTPTTVFW 186
Query: 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 336
TDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAE+LTGKPLFPGK+VVHQL+L+TDL
Sbjct: 187 TDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQLELITDL 246
Query: 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKDRPT 396
LGTP +E+IS +RN+KAR+YL MRKK PV FS KF ADP AFDPKDRPT
Sbjct: 247 LGTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFDPKDRPT 306
Query: 397 AEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQE 456
EALADPYF GL+ ++REPS+Q ISK+EFEFERR+L KDD+RE+IYREILEYHPQ+L++
Sbjct: 307 PAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYHPQLLKD 366
Query: 457 YLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAG 516
Y+ G E ++F+YPS + ++QF +LEE+ + PL+R+HASLPR V + +
Sbjct: 367 YMSGSEGSNFVYPSAIGHLRQQFTYLEENSSRNGPVIPLERKHASLPRSTVHSTVVHSTS 426
Query: 517 QNNDYGRTADSVAATLQSPPTEN 539
Q N G T DS + + P++N
Sbjct: 427 QPN-LGAT-DSRRVSFE--PSKN 445
|
|
| DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 850 (304.3 bits), Expect = 6.2e-85, P = 6.2e-85
Identities = 173/371 (46%), Positives = 237/371 (63%)
Query: 86 IAPTPATMDPHKKSALETEFF--TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAI 143
+ P P T D + + F +++ RY I + IG G+YGVV SA D TGE+VAI
Sbjct: 118 LMPPPPTSDTSNFNDNISYFVYGSQFTVPRRYSIVKCIGHGAYGVVCSAKDNLTGEKVAI 177
Query: 144 KKINDVFEHVSDATXXXXXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDL 203
KKI+ F+++ D H +++ IK I+ P S+ +F+D+Y+V ELM++DL
Sbjct: 178 KKISKAFDNLKDTKRTLREIHLLRHFKHENLISIKDILKPNSKEQFEDVYIVSELMDTDL 237
Query: 204 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263
HQ+I + L+ +H Q+F+YQ+LRGLK+IH+ANV HRDLKP N+L N DC LKICD GLA
Sbjct: 238 HQIITSPQPLSDDHCQYFVYQMLRGLKHIHSANVLHRDLKPSNLLINEDCLLKICDLGLA 297
Query: 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323
RV DA F T+YVATRWYRAPE+ S+ +KYT AIDIWS+GCIFAE+L KPLF G
Sbjct: 298 RVE--DATHQGFMTEYVATRWYRAPEVILSW-NKYTKAIDIWSVGCIFAELLGRKPLFQG 354
Query: 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXX 383
K+ +HQ+ L+ + +G+PS E I I NE+AR+++ +M + V F++ FP A+P
Sbjct: 355 KDYIHQITLIIETIGSPSEEDICNIANEQARQFIRNMGNQPKVNFANMFPKANPDAIDLL 414
Query: 384 XXXXAFDPKDRPTAEEALADPYFHGLANVDREPSTQPIS--KLEFEFERRKLAKDDVREM 441
FDP R T EEALA PYF L +PS +PI K FE L +D ++E+
Sbjct: 415 ERMLYFDPSKRLTVEEALAHPYFQSL----HDPSDEPICLHKFSLNFEAWDLNRDLLKEL 470
Query: 442 IYREILEYHPQ 452
IY E+L YHP+
Sbjct: 471 IYNEMLAYHPE 481
|
|
| TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 814 (291.6 bits), Expect = 4.1e-81, P = 4.1e-81
Identities = 157/359 (43%), Positives = 229/359 (63%)
Query: 96 HKKSALETEFFTEYGEASRYQIQEV--IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV 153
H S ++ + E SR + + IG+G+YG+V +A ++ TGE VAIKKI + F+++
Sbjct: 22 HGGSYVQYNVYGNLFEVSRKYVPPLRPIGRGAYGIVCAATNSETGEEVAIKKIGNAFDNI 81
Query: 154 SDATXXXXXXXXXXXXXHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDL 213
DA H +++ +K I+ PP R F D+Y+V+ELM++DLHQ+I++N L
Sbjct: 82 IDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIRSNQPL 141
Query: 214 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273
T +H +FFLYQLLRGLKY+H+ANV HRDLKP N+L NA+C LK+ DFGLAR
Sbjct: 142 TDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKLGDFGLARTK----SET 197
Query: 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 333
F T+YV TRWYRAPEL + S+YT AIDIWS+GCI E +T +PLFPGK+ VHQL L+
Sbjct: 198 DFMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLI 256
Query: 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPXXXXXXXXXXAFDPKD 393
T+L+G+P S+ +R++ ARRY+ + + F+ +FPN FDP
Sbjct: 257 TELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSR 316
Query: 394 RPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQ 452
R T +EAL PY L +++ EP + F+FE+ L +++++E+IYRE ++++PQ
Sbjct: 317 RITVDEALCHPYLAPLHDINEEPVC--VRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LV37 | MPK9_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8588 | 0.8184 | 0.9549 | yes | no |
| Q5Z9J0 | MPK12_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7345 | 0.9260 | 0.95 | yes | no |
| Q6L5F7 | MPK17_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7746 | 0.8100 | 0.8281 | no | no |
| Q9C9U4 | MPK15_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7120 | 0.9327 | 0.9635 | no | no |
| A2X0M1 | MPK13_ORYSI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7885 | 0.7848 | 0.9229 | N/A | no |
| Q9LM33 | MPK8_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7653 | 0.9394 | 0.9490 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.24 | 0.979 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 595 | |||
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.0 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.0 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-161 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-149 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-142 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-125 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-123 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-122 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-109 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-107 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-103 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-101 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-94 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-93 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-91 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-91 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-90 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-89 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-88 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-85 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-85 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-83 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-83 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-81 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-80 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-75 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-72 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-72 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-71 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-70 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-70 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-69 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-69 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-68 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-65 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-64 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-64 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-63 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-63 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-63 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-63 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-63 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-62 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-60 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-59 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-59 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-59 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-55 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-55 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-54 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-54 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-51 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-49 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-47 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-46 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-45 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-45 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-45 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-44 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-43 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-41 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-40 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-38 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-38 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-36 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-34 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-32 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-30 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-30 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-24 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-22 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-21 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-19 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 7e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-16 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-15 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-04 | |
| pfam07655 | 95 | pfam07655, Secretin_N_2, Secretin N-terminal domai | 0.002 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 746 bits (1927), Expect = 0.0
Identities = 312/338 (92%), Positives = 327/338 (96%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RY+IQEVIGKGSYGVV SA+DTHTGE+VAIKKINDVFEHVSDATRILREIKLLRLLRHPD
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH+QFFLYQLLR LKYIH
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
TANVFHRDLKPKNILANADCKLKICDFGLARV+FND P+AIFWTDYVATRWYRAPELCGS
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353
FFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDL+TDLLGTPS E+ISR+RNEKA
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240
Query: 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413
RRYL SMRKKQPVPFS KFPNADPLAL LLERLLAFDPKDRPTAEEALADPYF GLA V+
Sbjct: 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300
Query: 414 REPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
REPS QPI+KLEFEFERR+L K+DVRE+IYREILEYHP
Sbjct: 301 REPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 535 bits (1380), Expect = 0.0
Identities = 188/332 (56%), Positives = 244/332 (73%), Gaps = 2/332 (0%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RY++ + IG G+YGVV SAVD TG +VAIKKI++VF+ + DA RILREIKLLR LRH +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
I+ + I+ PPS +F D+Y+V ELME+DLH+VIK+ LT +H Q+FLYQ+LRGLKY+H
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ANV HRDLKP NIL N++C LKICDFGLAR D F T+YV TRWYRAPEL S
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353
S+YT AIDIWS+GCIFAE+LT KPLFPG++ + QL+L+ ++LGTPS E + I +EKA
Sbjct: 181 -SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239
Query: 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413
R YL S+ KK P S FP A P A+ LLE++L FDPK R TA+EALA PY L + +
Sbjct: 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299
Query: 414 REPSTQPISKLEFEFERRKLAKDDVREMIYRE 445
EP +P +F F+ +L +++++E+IY E
Sbjct: 300 DEPVAKPPFDFDF-FDDDELTEEELKELIYEE 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 463 bits (1193), Expect = e-161
Identities = 187/339 (55%), Positives = 246/339 (72%), Gaps = 6/339 (1%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
++Y + IG+G+YG+V SA ++ T E+VAIKKI + F++ DA R LREIKLLR L H
Sbjct: 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHE 64
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+++ IK IM PP R F D+Y+V+ELM++DLHQ+I+++ L+ +H Q+FLYQLLRGLKYI
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+ANV HRDLKP N+L NA+C LKICDFGLAR + F T+YV TRWYRAPEL
Sbjct: 125 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD---FMTEYVVTRWYRAPELLL 181
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
+ S+YT AID+WS+GCIFAE+L KPLFPGK+ VHQL L+T+LLG+PS E + IRNEK
Sbjct: 182 N-CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412
ARRY+ S+ F+ FP+A+PLA+ LLE++L FDP R T EEALA PY L +
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300
Query: 413 DREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
EP Q + F+FE L ++D++E+IY E+L YHP
Sbjct: 301 SDEPVCQ--TPFSFDFEEDALTEEDIKELIYNEMLAYHP 337
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 432 bits (1112), Expect = e-149
Identities = 173/342 (50%), Positives = 236/342 (69%), Gaps = 16/342 (4%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
RYQ IG+G+YG+V SA TG +VAIKKI+ FEH + R LREIK+LR +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP-FEHQTFCQRTLREIKILRRFKH 62
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+I+ I I+ PPS F D+Y+V ELME+DL+++IK L+ +H Q+FLYQ+LRGLKY
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH-LSNDHIQYFLYQILRGLKY 121
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
IH+ANV HRDLKP N+L N +C LKICDFGLAR++ + F T+YVATRWYRAPE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
+ YT AIDIWS+GCI AEML+ +PLFPGK+ +HQL+L+ +LGTPS E ++ I +
Sbjct: 182 LNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY---FHG 408
+AR Y+ S+ K VP++ FPNADP AL LL+++L F+P R T EEALA PY +H
Sbjct: 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH- 299
Query: 409 LANVDREPSTQPISKLEFEFE---RRKLAKDDVREMIYREIL 447
+PS +P+++ F F+ L K+ ++E+I+ EI+
Sbjct: 300 ------DPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIM 335
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 414 bits (1066), Expect = e-142
Identities = 175/334 (52%), Positives = 241/334 (72%), Gaps = 5/334 (1%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
SRY+ E IG G+YGVV SA+DT +G++VAIKKI F+ + A R LRE+K+LR +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+I+ I+ I+ PP +FKD+YVV +LMESDLH +I ++ LT EH ++FLYQLLRGLKYI
Sbjct: 65 NIIAIRDILRPPGA-DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWYRAPELC 291
H+ANV HRDLKP N+L N DC+L+I DFG+AR +S + F T+YVATRWYRAPEL
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
S +YT AID+WS+GCIFAEML + LFPGKN VHQL L+ +LG+PS E ++RI ++
Sbjct: 184 LSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411
+ R+Y+ ++ +KQPVP+S FP A P AL LL ++L FDP++R T E+AL P+ +
Sbjct: 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302
Query: 412 VDREPSTQPISKLEFEFERRKLAKDDVREMIYRE 445
D EP+ P +F+FE +L+++ ++E I +E
Sbjct: 303 PDDEPTCPP--PFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 371 bits (954), Expect = e-125
Identities = 155/339 (45%), Positives = 212/339 (62%), Gaps = 13/339 (3%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-H 171
+Y+I + +GKG+YG+V A+D T E VA+KKI D F + +DA R REI L+ L H
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 172 PDIVEIKHIMLPPSRREF-KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
P+IV++ +++ + E KDIY+VFE ME+DLH VI+AN L H ++ +YQLL+ LK
Sbjct: 67 PNIVKLLNVI----KAENDKDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLKALK 121
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARV--SFNDAPSAIFWTDYVATRWYRAP 288
YIH+ NV HRDLKP NIL N+DC++K+ DFGLAR + P TDYVATRWYRAP
Sbjct: 122 YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 289 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
E L GS ++YT +D+WS+GCI EML GKPLFPG + ++QL+ + +++G PS E I
Sbjct: 182 EILLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
I++ A L S+ + P P A AL LL++LL F+P R TAEEAL PY
Sbjct: 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299
Query: 408 GLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREI 446
N EP + + + KL+ + R +Y EI
Sbjct: 300 QFHNPSDEPVLPYPITIPLD-DNVKLSVAEYRNKLYEEI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 367 bits (945), Expect = e-123
Identities = 152/346 (43%), Positives = 216/346 (62%), Gaps = 12/346 (3%)
Query: 107 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 166
T + RYQ +G G+YG V SA DT TG +VAIKK++ F+ A R RE++LL
Sbjct: 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68
Query: 167 RLLRHPDIVEIKHIMLPPSRRE-FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 225
+ + H +++ + + P S E F+D+Y+V LM +DL+ ++K L+ +H QF +YQ+
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK-LSDDHIQFLVYQI 127
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
LRGLKYIH+A + HRDLKP NI N DC+LKI DFGLAR + ++ T YVATRWY
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------TGYVATRWY 181
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
RAPE+ ++ Y +DIWS+GCI AE+LTGK LFPG + + QL + +L+GTP E +
Sbjct: 182 RAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+I +E AR Y+ S+ + F F A+PLA+ LLE++L DP R TA EALA PY
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300
Query: 406 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
+ + EP P + FE R L D+ +E++Y+EI+ + P
Sbjct: 301 LAEYHDPEDEPVAPPYDQS---FESRDLTVDEWKELVYKEIMNFKP 343
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 362 bits (932), Expect = e-122
Identities = 170/337 (50%), Positives = 223/337 (66%), Gaps = 9/337 (2%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHT--GERVAIKKINDVFEHVSDATRILREIKLLRLLR- 170
RY++ + +G+G+YG+V SA + T E VAIKKI +VF A R LRE+KLLR R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
H +I + + M F ++Y+ ELME+DLHQ+I++ LT H+Q F+YQ+L GLK
Sbjct: 61 HKNITCL-YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWYRAPE 289
YIH+ANV HRDLKP N+L NADC+LKICDFGLAR S N +A F T+YVATRWYRAPE
Sbjct: 120 YIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ SF YT AID+WS+GCI AE+L KP+F GK+ V QL+ + +LGTP E++SRI
Sbjct: 180 IMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409
+ KA+ Y+ S+ PF FPNA+PLAL LLE+LLAFDP R + EEAL PY
Sbjct: 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298
Query: 410 ANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREI 446
+ D EP Q FE E + +++R+MI E+
Sbjct: 299 HDPDDEPVCQKPFDFSFESED---SMEELRDMIIEEV 332
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 331 bits (850), Expect = e-109
Identities = 162/346 (46%), Positives = 224/346 (64%), Gaps = 24/346 (6%)
Query: 105 FFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK 164
F T + +RY + +G G++G+V SA D TG+ VAIKKI F A R RE+K
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 165 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQ 224
LL+ LRH +I+ + I + P +DIY V EL+ +DLH+++ + L + Q+FLYQ
Sbjct: 62 LLKHLRHENIISLSDIFISP----LEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQ 116
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
+LRGLKY+H+A V HRDLKP NIL N +C LKICDFGLAR+ T YV+TR+
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM------TGYVSTRY 170
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
YRAPE+ ++ KY +DIWS GCIFAEML GKPLFPGK+ V+Q ++TDLLGTP +
Sbjct: 171 YRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
I+ I +E R++ S+ K++PVPFS KF NADP A+ LLE++L FDP+ R +A EALA P
Sbjct: 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289
Query: 405 Y---FHGLANVDREPSTQPISKLEFE--FERRKLAKDDVREMIYRE 445
Y +H +P+ +P+++ +F+ F L D + M+Y E
Sbjct: 290 YLAPYH-------DPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 324 bits (833), Expect = e-107
Identities = 136/294 (46%), Positives = 178/294 (60%), Gaps = 13/294 (4%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
YQ IG+G+YGVV A D TGE VAIKKI FE LREIKLL+ L HP+I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 233
+++ + D+Y+VFE M++DL+++IK L + +LYQLL+GL + H
Sbjct: 61 IKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCG 292
+ + HRDLKP+N+L N + LK+ DFGLAR +T YV TRWYRAPE L G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSF---GSPVRPYTHYVVTRWYRAPELLLG 172
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
Y+ +DIWS+GCIFAE+L+ +PLFPGK+ + QL + LGTP E + +
Sbjct: 173 DKG--YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-L 229
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
AR Y S KK +P FPNA P AL LL ++L +DP R TAE+ALA PYF
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 312 bits (803), Expect = e-103
Identities = 126/296 (42%), Positives = 174/296 (58%), Gaps = 18/296 (6%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRHP 172
Y+ E +G+G+YGVV A D TGE VA+KKI ++ + LREI LL+ L+HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKY 231
+IV++ ++ + +Y+VFE + DL + + L+P + +YQLLRGL Y
Sbjct: 59 NIVKLLDVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-L 290
H+ + HRDLKP+NIL N D LK+ DFGLAR +F +T V T WYRAPE L
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLAR-AFGIPLRT--YTHEVVTLWYRAPEIL 170
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
GS Y+ A+DIWS+GCIFAEM+TGKPLFPG + + QL + +LGTP+ ES +
Sbjct: 171 LGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV-- 226
Query: 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
K Y + K P P DP + LL ++L ++P R +A+EAL PYF
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 312 bits (800), Expect = e-101
Identities = 148/354 (41%), Positives = 211/354 (59%), Gaps = 32/354 (9%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
IG G++GVV S D G+RVA+KK+ +VF+++ R+ RE+K+L +H +++ I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
+ PP F++IYVV ELM+SDLH++I + L+ +H + FLYQ+LRGLKY+H+A + HR
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYT 299
D+KP N+L N++C LKICDFGLARV D + T V T++YRAPE L GS YT
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQYYRAPEILMGS--RHYT 183
Query: 300 PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS 359
A+DIWS+GCIFAE+L + LF ++ + QLDL+TDLLGTPS E++ E AR ++
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC-EGARAHILR 242
Query: 360 MRKKQP---VPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY-------FHG- 408
K P V ++ A+HLL R+L FDP R +A +ALA PY +H
Sbjct: 243 GPHKPPSLPVLYTLSSQATHE-AVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTC 301
Query: 409 ------------LANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYH 450
+ D EPS P E+E + V+E +++ ILE
Sbjct: 302 MCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSV--RQVKEELHQFILEQQ 353
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 292 bits (749), Expect = 2e-94
Identities = 147/339 (43%), Positives = 215/339 (63%), Gaps = 12/339 (3%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RYQ +G G+YG V +A DT TG RVA+KK++ F+ + A R RE++LL+ ++H +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 174 IVEIKHIMLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+LRGLKYI
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYI 136
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+A++ HRDLKP N+ N DC+LKI DFGLAR + ++ T YVATRWYRAPE+
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM------TGYVATRWYRAPEIML 190
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
++ Y +DIWS+GCI AE+LTG+ LFPG + + QL L+ L+GTP E + +I +E
Sbjct: 191 NWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412
AR Y+ S+ + + F++ F A+PLA+ LLE++L D R TA +ALA YF +
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309
Query: 413 DREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
D EP P + FE R L D+ + + Y E++ + P
Sbjct: 310 DDEPVADPYDQ---SFESRDLLIDEWKSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 286 bits (735), Expect = 7e-93
Identities = 116/302 (38%), Positives = 172/302 (56%), Gaps = 29/302 (9%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLLRHPD 173
Y++ + +G G++G V A + TGE VAIKK+ F + LRE+K L +L HP+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKY 231
IV++K + RE ++Y VFE ME +L+Q++K + + +YQ+L+GL +
Sbjct: 60 IVKLKEV-----FRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL- 290
IH FHRDLKP+N+L + +KI DFGLAR + P +TDYV+TRWYRAPE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEIL 170
Query: 291 --CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
S Y+ +DIW++GCI AE+ T +PLFPG + + QL + +LGTP+ +
Sbjct: 171 LRSTS----YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE- 225
Query: 349 RNEKARRYLGSMR----KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+ + + P PNA P A+ L++ +L +DPK RPTA +AL P
Sbjct: 226 ----GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281
Query: 405 YF 406
YF
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 280 bits (719), Expect = 6e-91
Identities = 109/293 (37%), Positives = 150/293 (51%), Gaps = 40/293 (13%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
Y+I E +G+GS+G V A D TG+ VAIK I D RILREIK+L+ L+HP+I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKHPNI 59
Query: 175 VEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
V + + +Y+V E E DL ++K L+ + +F+L Q+L L+Y+H
Sbjct: 60 VRLYDVFEDE-----DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ + HRDLKP+NIL + D +K+ DFGLAR T +V T Y APE+
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL----TTFVGTPEYMAPEVLLG 170
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353
Y A+DIWS+G I E+LTGKP FPG + QL + +G P
Sbjct: 171 --KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKP------------- 212
Query: 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
PF + P A L+ +LL DP+ R TAEEAL P+F
Sbjct: 213 -----------KPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 281 bits (722), Expect = 6e-91
Identities = 119/302 (39%), Positives = 174/302 (57%), Gaps = 25/302 (8%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRHP 172
Y+ IG+G+YG V A + TGE VA+KKI E+ + I +REIKLL+ LRHP
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHP 58
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLRGLKY 231
+IV +K I+ + IY+VFE M+ DL ++ T + ++ QLL GL+Y
Sbjct: 59 NIVRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-L 290
+H+ + HRD+K NIL N D LK+ DFGLAR + SA + T+ V T WYR PE L
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADY-TNRVITLWYRPPELL 173
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
G+ ++Y P +D+WS+GCI AE+ GKP+F G + QL+ + +L G+P+ E+ +
Sbjct: 174 LGA--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231
Query: 351 EKARRYLGSMRKKQPVP------FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+ +++ K+P F H DP AL LL++LL DPK R +A++AL
Sbjct: 232 LP---WFENLKPKKPYKRRLREFFKHLI---DPSALDLLDKLLTLDPKKRISADQALQHE 285
Query: 405 YF 406
YF
Sbjct: 286 YF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 282 bits (724), Expect = 1e-90
Identities = 140/339 (41%), Positives = 202/339 (59%), Gaps = 13/339 (3%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RY + +G G+YG V SA+D TGE+VAIKK++ F+ A R RE+ LL+ ++H +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 174 IVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
++ + + S EF+D Y+V M++DL +++ L+ + Q+ +YQ+L GLKYI
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYI 133
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+A + HRDLKP N+ N DC+LKI DFGLAR + DA T YV TRWYRAPE+
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA--DAE----MTGYVVTRWYRAPEVIL 187
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
++ Y +DIWS+GCI AEMLTGK LF GK+ + QL + + G P E + ++ ++
Sbjct: 188 NWM-HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412
A+ Y+ S+ K FS FP A P A+ LLE++L D R TA EAL PYF +
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306
Query: 413 DREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
D E QP E KL+ D+ ++ IY+E+ + P
Sbjct: 307 DEETEQQPYDD---SLENEKLSVDEWKKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 279 bits (714), Expect = 4e-89
Identities = 136/340 (40%), Positives = 209/340 (61%), Gaps = 12/340 (3%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
RY+ + +G G+YG V SA+D TG +VAIKK+ F+ A R RE++LL+ ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 173 DIVEIKHIMLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+++ + + P S F D Y+V M +DL +++K ++ L+ + QF +YQ+L+GLKY
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKY 133
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
IH A + HRDLKP N+ N DC+LKI DFGLAR + ++ T YV TRWYRAPE+
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM------TGYVVTRWYRAPEVI 187
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
++ YT +DIWS+GCI AEMLTGKPLF G + + QL + + GTPS E + ++++E
Sbjct: 188 LNWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411
A+ Y+ + + + F PNA+PLA+++LE++L D + R TA EALA PYF +
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306
Query: 412 VDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
+ E P + F+ + ++ + + + EIL + P
Sbjct: 307 PEDETEAPP---YDDSFDEVDQSLEEWKRLTFTEILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 277 bits (709), Expect = 2e-88
Identities = 138/339 (40%), Positives = 209/339 (61%), Gaps = 12/339 (3%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RYQ +G G+YG V SA DT ++VA+KK++ F+ + A R RE++LL+ ++H +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 174 IVEIKHIMLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
++ + + P S F ++Y+V LM +DL+ ++K L+ EH QF +YQLLRGLKYI
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYI 134
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+A + HRDLKP N+ N DC+L+I DFGLAR + ++ T YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM------TGYVATRWYRAPEIML 188
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
++ Y +DIWS+GCI AE+L GK LFPG + + QL + +++GTPS E + +I +E
Sbjct: 189 NWM-HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412
AR+Y+ S+ F A+PLA+ LLE++L D R +A EALA PYF +
Sbjct: 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307
Query: 413 DREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
+ EP +P + E ++ ++ +E+ Y E+ + P
Sbjct: 308 EDEPEAEPYDE---SPENKERTIEEWKELTYEEVSSFKP 343
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 267 bits (685), Expect = 2e-85
Identities = 121/299 (40%), Positives = 174/299 (58%), Gaps = 20/299 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RY+I IG+G++G+V A D TGE VA+KK+ + LREIK L+ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 232
+V++ + S +V E M SDL +V++ + L + ++ LL+G+ Y+
Sbjct: 61 VVKLLDVFPHGSG-----FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC- 291
H + HRDLKP N+L +AD LKI DFGLAR+ + P ++ VATRWYRAPEL
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL--YSHQVATRWYRAPELLY 173
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN- 350
G+ KY P +D+W++GCIFAE+L G PLFPG+N + QL ++ LGTP+ E+ + +
Sbjct: 174 GA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231
Query: 351 ---EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
K + +P+P FP+A P AL LL+ LL +DP R +A EAL PYF
Sbjct: 232 PDYNKIT-----FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 267 bits (685), Expect = 3e-85
Identities = 125/300 (41%), Positives = 168/300 (56%), Gaps = 20/300 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRI--LREIKLLRLLR 170
RY+ + +G+G+Y VV A D TG VAIKKI + D LREIKLL+ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGL 229
HP+I+ + + S I +VFE ME+DL +VIK LTP + ++ LRGL
Sbjct: 61 HPNIIGLLDVFGHKSN-----INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+Y+H+ + HRDLKP N+L +D LK+ DFGLAR SF P+ T V TRWYRAPE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGS-PNRKM-THQVVTRWYRAPE 172
Query: 290 LCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
L F Y +D+WS+GCIFAE+L P PG + + QL + + LGTP+ E+
Sbjct: 173 L---LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
+ + Y+ + P P FP A AL LL+RLL +P R TA +AL PYF
Sbjct: 230 VTSLP--DYV-EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 261 bits (670), Expect = 3e-83
Identities = 116/296 (39%), Positives = 168/296 (56%), Gaps = 12/296 (4%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y++ V+G+G+YGVV + TGE VAIKK + + LRE+K+LR LRH +
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 232
IV +K RR+ + +Y+VFE +E L ++++A+ L P+ + +++QLL+ + Y
Sbjct: 62 IVNLKEAF----RRKGR-LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LC 291
H+ N+ HRD+KP+NIL + LK+CDFG AR A A TDYVATRWYRAPE L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFAR--ALRARPASPLTDYVATRWYRAPELLV 174
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
G + Y +D+W+IGCI AE+L G+PLFPG + + QL L+ LG +
Sbjct: 175 GD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 352 KARRYLGSMRKKQPVPFSHKFPNA-DPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ QP ++P AL L+ L DPK+R T +E L PYF
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 263 bits (673), Expect = 7e-83
Identities = 132/348 (37%), Positives = 202/348 (58%), Gaps = 24/348 (6%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
RYQ + IG G+ G+V +A DT TG+ VAIKK++ F++V+ A R RE+ L++L+ H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 173 DIVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+I+ + ++ P S EF+D+Y+V ELM+++L QVI DL E + LYQ+L G+K+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKH 133
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+H+A + HRDLKP NI+ +DC LKI DFGLAR A ++ T YV TR+YRAPE+
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRYYRAPEVI 189
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
Y +DIWS+GCI EM+ G LFPG + + Q + + + LGTPS E +SR+
Sbjct: 190 LGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL-QP 246
Query: 352 KARRYLGSMRKKQPVPFSHKFP---------NADPL----ALHLLERLLAFDPKDRPTAE 398
R Y+ + K F FP + + L A LL ++L DP+ R + +
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306
Query: 399 EALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREI 446
+AL PY + + E P + + + R+ ++ +E+IY+E+
Sbjct: 307 DALQHPYIN-VWYDPSEVEAPPPAPYDHSIDEREHTVEEWKELIYKEV 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 257 bits (658), Expect = 8e-81
Identities = 143/359 (39%), Positives = 192/359 (53%), Gaps = 52/359 (14%)
Query: 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI---LREIKL 165
+ SRY +G GS G+V SAVD+ +RVA+KKI ++D + LREIK+
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV-----LTDPQSVKHALREIKI 55
Query: 166 LRLLRHPDIVEIKHIMLPPSRR---------EFKDIYVVFELMESDLHQVIKANDDLTPE 216
+R L H +IV++ ++ P E +Y+V E ME+DL V++ L+ E
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEE 114
Query: 217 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPSAIF 275
H + F+YQLLRGLKYIH+ANV HRDLKP N+ N D LKI DFGLAR+ +
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD 335
++ + T+WYR+P L S + YT AID+W+ GCIFAEMLTGKPLF G H+L+ M
Sbjct: 175 LSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGA---HELEQMQL 230
Query: 336 LLGTPSTESISRIRNE-----------KARRYLGSMRKKQPVPFSHKFPNADPLALHLLE 384
+L ES+ +R E R G R+ P P +P AL LE
Sbjct: 231 IL-----ESVPVVREEDRNELLNVIPSFVRNDGGEPRR----PLRDLLPGVNPEALDFLE 281
Query: 385 RLLAFDPKDRPTAEEALADPYFHGLANVDREP-STQPISKLEFEFERRKLAKDDVREMI 442
++L F+P DR TAEEAL PY + EP S P +E E DD+ M
Sbjct: 282 QILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFH-IEDEL-------DDILLMT 332
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 1e-80
Identities = 97/293 (33%), Positives = 144/293 (49%), Gaps = 34/293 (11%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
Y++ +G GS+G V A TG+ VA+K + E REI++LR L HP+I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 175 VEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
V + + +Y+V E E DL + L+ + + Q+LRGL+Y+H
Sbjct: 61 VRLIDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ + HRDLKP+NIL + + +KI DFGLA+ + S T +V T WY APE+
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVL-L 171
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353
+ Y P +D+WS+G I E+LTGKP F G+N++ QL + I RI
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL------------QLIRRI----- 214
Query: 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ ++ A L+++ L DP RPTAEE L P+F
Sbjct: 215 ------LGPPLEFDEPKWSSGSEE-AKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 2e-75
Identities = 120/302 (39%), Positives = 164/302 (54%), Gaps = 25/302 (8%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRHP 172
Y+ I +G+YGVV A D TGE VA+KK+ E + I LREI +L L+HP
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQHP 64
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKY 231
+IV +K +++ IY+V E +E DL +++ + + QLL G+ +
Sbjct: 65 NIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-L 290
+H + HRDLK N+L N LKICDFGLAR + +T V T WYRAPE L
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKP--YTQLVVTLWYRAPELL 178
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES---ISR 347
G+ +Y+ AID+WS+GCIFAE+LT KPLFPGK+ + QL+ + LLGTP+ + S
Sbjct: 179 LGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 348 IRNEKARRYLGSMRKKQPV-PFSHKFPNA--DPLALHLLERLLAFDPKDRPTAEEALADP 404
+ K + K P KFP LL RLL +DP R +AE+AL P
Sbjct: 237 LPGAKKKT-----FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291
Query: 405 YF 406
YF
Sbjct: 292 YF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 235 bits (601), Expect = 1e-72
Identities = 113/316 (35%), Positives = 165/316 (52%), Gaps = 34/316 (10%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLR 170
Y+I +G+G++G V A TG VA+KKI + + D I LREIK+L+ L+
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKLK 65
Query: 171 HPDIVEIKHIML---PPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLL 226
HP++V + + + S+R+ +Y+V M+ DL +++ LT + ++ QLL
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP--------SAIFWTD 278
G+ Y+H ++ HRD+K NIL + LKI DFGLAR P +T+
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 279 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337
V TRWYR PEL G +YT A+DIW IGC+FAEM T +P+ GK+ + QL L+ L
Sbjct: 186 LVVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243
Query: 338 GTPSTESISRIR-------NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFD 390
GTP+ E+ R Y ++ + +F P L LL +LL+ D
Sbjct: 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE--------RFGKLGPEGLDLLSKLLSLD 295
Query: 391 PKDRPTAEEALADPYF 406
P R TA +AL PYF
Sbjct: 296 PYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 2e-72
Identities = 116/308 (37%), Positives = 161/308 (52%), Gaps = 37/308 (12%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA---TRILREIKLLRLLR- 170
Y+ IG+G+YG V A D +TG VA+KK+ +S+ LREI LL+ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57
Query: 171 --HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK--ANDDLTPEHYQFFLYQLL 226
HP+IV + + P + +VFE ++ DL + L PE + + QLL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYVATRWY 285
RG+ ++H+ + HRDLKP+NIL +D ++KI DFGLAR+ SF A+ T V T WY
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MAL--TSVVVTLWY 172
Query: 286 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE- 343
RAPE L S Y +D+WS+GCIFAE+ +PLF G + QLD + D++G PS E
Sbjct: 173 RAPEVLLQ---SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 344 -----SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
S+ R S P F P L LL+++L F+P R +A
Sbjct: 230 WPRNVSLPRS----------SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAF 279
Query: 399 EALADPYF 406
EAL PYF
Sbjct: 280 EALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 231 bits (590), Expect = 4e-71
Identities = 127/295 (43%), Positives = 167/295 (56%), Gaps = 25/295 (8%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRHPDIVEIK 178
IG+G+YG+V A DT +GE VA+KK+ ++ D I LREI LL LRHP+IVE+K
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 179 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANV 237
+++ + I++V E E DL ++ + + + QLLRGL+Y+H +
Sbjct: 73 EVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFS 296
HRDLK N+L LKI DFGLAR + + T V T WYRAPE L G +
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLART-YGLPAKPM--TPKVVTLWYRAPELLLGC--T 184
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI----SRIRNEK 352
YT AID+W++GCI AE+L KPL PGK+ + QLDL+ LLGTP+ ESI S +
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGFSDLPL-- 241
Query: 353 ARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
++ KQP HKFP L LL LL +DPK R TAEEAL YF
Sbjct: 242 VGKF---TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 2e-70
Identities = 113/297 (38%), Positives = 173/297 (58%), Gaps = 20/297 (6%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPD 173
Y+I IG+G++ V A TG+ AIK + F+ + LREI+ LR L HP+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPN 59
Query: 174 IVEIKHIML-PPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLRGLKY 231
I+ + ++ + R + +VFELM+ +L+++IK PE + ++YQLL+ L +
Sbjct: 60 ILRLIEVLFDRKTGR----LALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-- 289
+H +FHRD+KP+NIL D LK+ DFG R ++ P +T+Y++TRWYRAPE
Sbjct: 116 MHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP----YTEYISTRWYRAPECL 170
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
L + Y P +DIW++GC+F E+L+ PLFPG N + Q+ + D+LGTP E + + R
Sbjct: 171 LTDGY---YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ Y + K+ PNA L LL++LLA+DP +R TA++AL PYF
Sbjct: 228 KSRHMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 227 bits (582), Expect = 3e-70
Identities = 122/298 (40%), Positives = 167/298 (56%), Gaps = 21/298 (7%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD---ATRILREIKLLRLLRH 171
YQ E IG+G+YGVV A D TGE VA+KKI E + +T I REI LL+ L H
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAI-REISLLKELNH 57
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGL 229
P+IV + ++ ++ +Y+VFE ++ DL + + L P + +LYQLL+G+
Sbjct: 58 PNIVRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
Y H+ V HRDLKP+N+L + + LK+ DFGLAR +F +T V T WYRAPE
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFGVPVRT--YTHEVVTLWYRAPE 169
Query: 290 -LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
L GS Y+ +DIWSIGCIFAEM+ +PLFPG + + QL + LGTP + +
Sbjct: 170 ILLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
Y + K S PN D L LL ++L +DP R +A+ AL PYF
Sbjct: 228 --TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 227 bits (581), Expect = 3e-69
Identities = 129/369 (34%), Positives = 210/369 (56%), Gaps = 29/369 (7%)
Query: 99 SALETEFFT-EYGEAS-----RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH 152
S +++F++ + +++ RYQ + IG G+ G+V +A DT G VA+KK++ F++
Sbjct: 1 SEEDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN 60
Query: 153 VSDATRILREIKLLRLLRHPDIVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKAND 211
+ A R RE+ LL+ + H +I+ + ++ P S EF+D+Y+V ELM+++L QVI
Sbjct: 61 QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM-- 118
Query: 212 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271
+L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI DFGLAR A
Sbjct: 119 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AC 174
Query: 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD 331
+ T YV TR+YRAPE+ Y +DIWS+GCI E++ G +F G + + Q +
Sbjct: 175 TNFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232
Query: 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPN--------ADPL----A 379
+ + LGTPS E ++R++ R Y+ + + + F FP+ D L A
Sbjct: 233 KVIEQLGTPSAEFMNRLQ-PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQA 291
Query: 380 LHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVR 439
LL ++L DP R + +EAL PY + E P + + E R+ A ++ +
Sbjct: 292 RDLLSKMLVIDPDKRISVDEALRHPYITVWYD-PAEAEAPPPQIYDAQLEEREHAIEEWK 350
Query: 440 EMIYREILE 448
E+IY+E+++
Sbjct: 351 ELIYKEVMD 359
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 4e-69
Identities = 115/296 (38%), Positives = 171/296 (57%), Gaps = 17/296 (5%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
++ E +G+G+Y V + TGE VA+K+I+ E + +T I REI L++ L+H +I
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-REISLMKELKHENI 60
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKY 231
V + ++ ++ + +VFE M+ DL + + + L P + F YQLL+G+ +
Sbjct: 61 VRLHDVIHTENK-----LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-L 290
H V HRDLKP+N+L N +LK+ DFGLAR +F P F + V T WYRAP+ L
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLAR-AFG-IPVNTFSNE-VVTLWYRAPDVL 172
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
GS Y+ +IDIWS+GCI AEM+TG+PLFPG N QL + ++GTP+ + I
Sbjct: 173 LGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230
Query: 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
Y + + P FP+ADPL + LL RLL +P+ R +A +AL P+F
Sbjct: 231 --LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 5e-68
Identities = 117/324 (36%), Positives = 168/324 (51%), Gaps = 39/324 (12%)
Query: 114 RYQIQEVIGKGSYGVVGSAV--DTHTGERVAIKKI---NDVFEHVSDATRILREIKLLRL 168
+Y+I+ IG+G+YG V A + G+ AIKK + + +S + REI LLR
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA--CREIALLRE 58
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK-----ANDDLTPEHYQFFLY 223
L+H ++V + + L + + +Y++F+ E DL Q+IK + P + L+
Sbjct: 59 LKHENVVSLVEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCK----LKICDFGLARVSFNDAPSAIFWTD- 278
Q+L G+ Y+H+ V HRDLKP NIL + +KI D GLAR+ FN + D
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPLKPLADLDP 174
Query: 279 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---------VH 328
V T WYRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F G+
Sbjct: 175 VVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232
Query: 329 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFS------HKFPNADPLALHL 382
QL+ + ++LGTP+ + I+ L K + P + K D L
Sbjct: 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292
Query: 383 LERLLAFDPKDRPTAEEALADPYF 406
L +LL +DP R TAEEAL PYF
Sbjct: 293 LRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 213 bits (545), Expect = 8e-65
Identities = 117/304 (38%), Positives = 170/304 (55%), Gaps = 30/304 (9%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI----LREIKLLRLL 169
+Y+ IG+GSYGVV + TG+ VAIKK F D I LREI++L+ L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQL 57
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRG 228
+HP++V + + RR+ K +++VFE + + ++ N PEH + ++Q L+
Sbjct: 58 KHPNLVNLIEVF----RRKRK-LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQA 112
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
+ + H N HRD+KP+NIL ++K+CDFG AR+ +TDYVATRWYRAP
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRWYRAP 169
Query: 289 EL-CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG--TPSTESI 345
EL G ++Y P +D+W+IGC+FAE+LTG+PL+PGK+ V QL L+ LG P + I
Sbjct: 170 ELLVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227
Query: 346 SRIRNEKARRYLGSMRKKQP---VPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
++ + +P P KFPN AL L+ L DP +R + EE L
Sbjct: 228 FS-----TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282
Query: 403 DPYF 406
PYF
Sbjct: 283 HPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 1e-64
Identities = 114/304 (37%), Positives = 170/304 (55%), Gaps = 19/304 (6%)
Query: 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
+G+ Y+ + +G+GSY V TG+ VA+K+I E + T I RE LL+
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKD 59
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLR 227
L+H +IV + I+ K + +VFE +++DL Q + L+ + + FL+QLLR
Sbjct: 60 LKHANIVTLHDII-----HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR 114
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL Y H V HRDLKP+N+L + +LK+ DFGLAR PS + ++ V T WYR
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA--KSVPSKTY-SNEVVTLWYRP 171
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG-KNVVHQLDLMTDLLGTPSTESI 345
P+ L GS ++Y+ ++D+W +GCIF EM TG+PLFPG +V QL + +LGTP+ E+
Sbjct: 172 PDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229
Query: 346 SRI-RNEKARRYLGSMRKKQPVPFSHKFPNAD--PLALHLLERLLAFDPKDRPTAEEALA 402
+ N + + Y S P P + P D P L + L ++PK R +A EA+
Sbjct: 230 PGVSSNPEFKPY--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287
Query: 403 DPYF 406
PYF
Sbjct: 288 HPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 213 bits (543), Expect = 7e-64
Identities = 120/324 (37%), Positives = 169/324 (52%), Gaps = 43/324 (13%)
Query: 112 ASRY-QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR------------ 158
+ RY Q +G+G+YG V A DT TG+ VAIKK+ + E +D T+
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMCGIHF 65
Query: 159 -ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH 217
LRE+K++ ++H +I+ + + + +F I +V ++M SDL +V+ LT
Sbjct: 66 TTLRELKIMNEIKHENIMGLVDVYV---EGDF--INLVMDIMASDLKKVVDRKIRLTESQ 120
Query: 218 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF-- 275
+ L Q+L GL +H HRDL P NI N+ KI DFGLAR S
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 276 ---------WTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
T V T WYRAPEL G+ KY A+D+WS+GCIFAE+LTGKPLFPG+N
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
Query: 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS---MRKKQPVPFSHKFPNADPLALHL 382
+ QL + +LLGTP+ + N + L ++P FPNA A+ L
Sbjct: 239 EIDQLGRIFELLGTPNED------NWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDL 292
Query: 383 LERLLAFDPKDRPTAEEALADPYF 406
L+ LL +P +R +A+EAL YF
Sbjct: 293 LQSLLKLNPLERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 1e-63
Identities = 128/352 (36%), Positives = 200/352 (56%), Gaps = 29/352 (8%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RYQ + IG G+ G+V +A D VAIKK++ F++ + A R RE+ L++ + H +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 174 IVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
I+ + ++ P S EF+D+Y+V ELM+++L QVI+ +L E + LYQ+L G+K++
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHL 142
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+A + HRDLKP NI+ +DC LKI DFGLAR A ++ T YV TR+YRAPE+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
Y +DIWS+GCI EM+ G LFPG + + Q + + + LGTP E + +++
Sbjct: 199 GM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ-PT 255
Query: 353 ARRYLGSMRKKQPVPFSHKFPN----AD--------PLALHLLERLLAFDPKDRPTAEEA 400
R Y+ + K F FP+ AD A LL ++L D R + +EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 401 LADPYFHGLANVDREPS--TQPISKL-EFEFERRKLAKDDVREMIYREILEY 449
L PY NV +PS P K+ + + + R+ ++ +E+IY+E+++
Sbjct: 316 LQHPYI----NVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 363
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 210 bits (535), Expect = 2e-63
Identities = 116/295 (39%), Positives = 166/295 (56%), Gaps = 15/295 (5%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+Q E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+I
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYI 232
V++ ++ +Y+VFE + DL + + A+ + + +L+QLL+GL +
Sbjct: 62 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LC 291
H+ V HRDLKP+N+L N + +K+ DFGLAR +F P + T V T WYRAPE L
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEILL 173
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
G + Y+ A+DIWS+GCIFAEM+T + LFPG + + QL + LGTP + +
Sbjct: 174 GCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
Y S K FS P D LL ++L +DP R +A+ ALA P+F
Sbjct: 232 P--DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 4e-63
Identities = 119/308 (38%), Positives = 178/308 (57%), Gaps = 38/308 (12%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI-LREIKLLRLLRHP 172
+Y+ ++G+GSYG+V TG+ VAIKK + E +I +REI++L+ LRH
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLES-EDDKMVKKIAMREIRMLKQLRHE 60
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY---------QFFLY 223
++V ++ RR+ K +Y+VFE ++ H V+ DDL E Y + +L+
Sbjct: 61 NLVN----LIEVFRRK-KRLYLVFEFVD---HTVL---DDL--EKYPNGLDESRVRKYLF 107
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
Q+LRG+++ H+ N+ HRD+KP+NIL + +K+CDFG AR AP ++ TDYVATR
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVY-TDYVATR 164
Query: 284 WYRAPEL-CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
WYRAPEL G +KY A+DIW++GC+ EMLTG+PLFPG + + QL + LG
Sbjct: 165 WYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN--- 219
Query: 343 ESISRIRNEKARRYLGS-MR---KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
I R + + L + MR K+ P +FP L L L ++ L DP DRP++
Sbjct: 220 -LIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS 278
Query: 399 EALADPYF 406
+ L +F
Sbjct: 279 QLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 208 bits (532), Expect = 5e-63
Identities = 118/302 (39%), Positives = 174/302 (57%), Gaps = 27/302 (8%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI--NDVFEHV-SDATRILREIKLLRLLR 170
+Y+ E IG+G+YG V A + T E VA+K++ +D E V S A LREI LL+ L+
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LREICLLKELK 57
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGL 229
H +IV + ++ + + +VFE + DL + + N D+ PE + F++QLL+GL
Sbjct: 58 HKNIVRLYDVLHSDKK-----LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+ H+ NV HRDLKP+N+L N + +LK+ DFGLAR +F P + + V T WYR P+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFG-IPVRCYSAE-VVTLWYRPPD 169
Query: 290 -LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES--- 344
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG +V QL + LLGTP+ ES
Sbjct: 170 VLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG 227
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+S++ + K + + P + LL+ LL +P R +AEEAL P
Sbjct: 228 VSKLPDYKPYPMYPAT-----TSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282
Query: 405 YF 406
YF
Sbjct: 283 YF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 211 bits (537), Expect = 6e-63
Identities = 127/350 (36%), Positives = 200/350 (57%), Gaps = 29/350 (8%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RYQ + IG G+ G+V +A D VAIKK++ F++ + A R RE+ L++ + H +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 174 IVEIKHIMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
I+ + ++ P S EF+D+Y+V ELM+++L QVI+ +L E + LYQ+L G+K++
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHL 135
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+A + HRDLKP NI+ +DC LKI DFGLAR A ++ T YV TR+YRAPE+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRYYRAPEVIL 191
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
Y +DIWS+GCI EM+ K LFPG++ + Q + + + LGTP E + +++
Sbjct: 192 GM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 248
Query: 353 ARRYLGSMRKKQPVPFSHKFPN----AD--------PLALHLLERLLAFDPKDRPTAEEA 400
R Y+ + K + F FP+ AD A LL ++L DP R + +EA
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308
Query: 401 LADPYFHGLANVDREPS---TQPISKLEFEFERRKLAKDDVREMIYREIL 447
L PY NV +P+ P + + + R+ ++ +E+IY+E++
Sbjct: 309 LQHPYI----NVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 4e-62
Identities = 112/292 (38%), Positives = 167/292 (57%), Gaps = 16/292 (5%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
E IG+G+YGVV + TG+ VA+KKI E + +REI LL+ L+HP+IV ++
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 179 HIMLPPSRREFKDIYVVFELMESDLHQ---VIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
+++ SR +Y++FE + DL + + + E + +LYQ+L+G+ + H+
Sbjct: 66 DVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSF 294
V HRDLKP+N+L + +K+ DFGLAR +F P ++ T V T WYRAPE L GS
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFG-IPVRVY-THEVVTLWYRAPEVLLGS- 176
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354
+Y+ +DIWSIG IFAEM T KPLF G + + QL + +LGTP+ + +
Sbjct: 177 -PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV--TSLP 233
Query: 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
Y + K + N D L LLE++L +DP R +A++AL PYF
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 4e-60
Identities = 114/308 (37%), Positives = 154/308 (50%), Gaps = 19/308 (6%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRL 168
E S+Y+ IG+G++G V A T + VA+KK+ + E+ + I LREIK+L+L
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQL 67
Query: 169 LRHPDIV---EIKHIMLPPSRREFKDIYVVFELMESDLHQVIK-ANDDLTPEHYQFFLYQ 224
L+H ++V EI P R Y+VFE E DL ++ N T + +
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYVATR 283
LL GL YIH + HRD+K NIL D LK+ DFGLAR S + +T+ V T
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 284 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
WYR PE L G Y P ID+W GCI AEM T P+ G HQL L++ L G+ +
Sbjct: 188 WYRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245
Query: 343 ESISRIRN----EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
E + +K G RK V K DP AL L+++LL DP R A+
Sbjct: 246 EVWPGVDKLELFKKMELPQGQKRK---VKERLKPYVKDPHALDLIDKLLVLDPAKRIDAD 302
Query: 399 EALADPYF 406
AL +F
Sbjct: 303 TALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 1e-59
Identities = 111/300 (37%), Positives = 164/300 (54%), Gaps = 16/300 (5%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH-PD 173
Y+ E IG+G+YG V A D +TG+ VA+KK + LREI LL++L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRG 228
IV + + + +Y+VFE ++SDL + + +N L + + F+YQLL+G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 229 LKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
+ + H V HRDLKP+N+L + LKI D GL R +F+ + +T + T WYRA
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKS--YTHEIVTLWYRA 179
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
PE L GS + Y+ +DIWS+GCIFAEM +PLFPG + + QL + LLGTP+ +
Sbjct: 180 PEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ R + +P S P+ P L LL+++L +DP R +A+ AL PYF
Sbjct: 238 GVSK---LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 200 bits (509), Expect = 2e-59
Identities = 116/306 (37%), Positives = 172/306 (56%), Gaps = 22/306 (7%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y+ E IG+G+YGVV A D T E +A+KKI E + +REI LL+ ++H +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY--QFFLYQLLRGLKY 231
IV ++ ++ R +Y+VFE ++ DL + + ++ D + +LYQ+LRG+ Y
Sbjct: 63 IVRLQDVVHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 232 IHTANVFHRDLKPKNILANADCK-LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 289
H+ V HRDLKP+N+L + LK+ DFGLAR +F P F T V T WYRAPE
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFG-IPVRTF-THEVVTLWYRAPEI 174
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES---IS 346
L GS Y+ +DIWS+GCIFAEM+ KPLFPG + + +L + +LGTP+ E+ ++
Sbjct: 175 LLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ + Y + K P + P +P + LL ++L DP R TA AL YF
Sbjct: 233 SLPD-----YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
Query: 407 HGLANV 412
L +
Sbjct: 288 KDLGDA 293
|
Length = 294 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 200 bits (509), Expect = 2e-59
Identities = 111/301 (36%), Positives = 161/301 (53%), Gaps = 18/301 (5%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+ I IG+G+YG V A D TGE VA+KK+ E +REIK+LR L H +I
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 175 VEIKHIMLPPS-----RREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRG 228
V +K I+ +++ Y+VFE M+ DL ++++ + +H + F+ QLL G
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEG 128
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
L Y H N HRD+K NIL N ++K+ DFGLAR ++ + +T+ V T WYR P
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR--LYNSEESRPYTNKVITLWYRPP 186
Query: 289 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE---S 344
E L G +Y PAID+WS GCI E+ T KP+F + QL+L++ L G+P
Sbjct: 187 ELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+ ++ + R++ FS P AL LL+ +L DP R TAEEAL P
Sbjct: 245 VIKLPYFNTMKPKKQYRRRLREEFSF-IP---TPALDLLDHMLTLDPSKRCTAEEALNSP 300
Query: 405 Y 405
+
Sbjct: 301 W 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 2e-55
Identities = 84/294 (28%), Positives = 129/294 (43%), Gaps = 35/294 (11%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ E++G+GS+G V A+D TGE +A+K + + + + REI++L L+HP+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
IV E + + E + L ++K L + + Q+L GL Y+
Sbjct: 61 IVRYYGSER---DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+ + HRD+K NIL ++D +K+ DFG A+ D + T ++ APE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
+Y A DIWS+GC EM TGKP + + M L S+ I
Sbjct: 177 G--EEYGRAADIWSLGCTVIEMATGKPPWS-----ELGNPMAALYKIGSSGEPPEI---- 225
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
P S A L + L DPK RPTA+E L P+
Sbjct: 226 ------------PEHLS-------EEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 6e-55
Identities = 116/305 (38%), Positives = 167/305 (54%), Gaps = 16/305 (5%)
Query: 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
+G+ Y + +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKD 60
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 227
L+H +IV + I+ K + +VFE ++ DL Q + + H + FL+QLLR
Sbjct: 61 LKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLR 115
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL Y H V HRDLKP+N+L N +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTY-SNEVVTLWYRP 172
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
P+ L GS + Y+ ID+W +GCIF EM TG+PLFPG V QL + +LGTP+ E+
Sbjct: 173 PDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230
Query: 347 RI-RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
I NE+ + Y + K + + P D LL +LL F+ + R +AEEA+ PY
Sbjct: 231 GILSNEEFKSY--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288
Query: 406 FHGLA 410
FH L
Sbjct: 289 FHCLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 1e-54
Identities = 116/305 (38%), Positives = 170/305 (55%), Gaps = 16/305 (5%)
Query: 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
+G+ Y E +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKD 60
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 227
L+H +IV + I+ K + +VFE ++ DL Q + ++ H + FLYQ+LR
Sbjct: 61 LKHANIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILR 115
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL Y H V HRDLKP+N+L N +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTY-SNEVVTLWYRP 172
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
P+ L GS S+Y+ ID+W +GCIF EM +G+PLFPG V +L L+ LLGTP+ E+
Sbjct: 173 PDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230
Query: 347 RI-RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
I N++ + Y + K +P P + P D + LL + L ++ K R +AEEA+ Y
Sbjct: 231 GISSNDEFKNY--NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288
Query: 406 FHGLA 410
F L
Sbjct: 289 FRSLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 1e-54
Identities = 115/301 (38%), Positives = 169/301 (56%), Gaps = 16/301 (5%)
Query: 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
+G+ Y + +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKN 59
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 227
L+H +IV + I+ + + +VFE ++SDL Q + +L H + F++QLLR
Sbjct: 60 LKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLR 114
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL Y H + HRDLKP+N+L N +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARA--KSVPTKTY-SNEVVTLWYRP 171
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
P+ L GS ++Y+ ID+W +GCI EM TG+P+FPG V +L L+ LLGTP+ E+
Sbjct: 172 PDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229
Query: 347 RI-RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
I NE+ R YL + QP+ +H P D + LL LL ++ K R +AE AL Y
Sbjct: 230 GITSNEEFRSYLFPQYRAQPL-INHA-PRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287
Query: 406 F 406
F
Sbjct: 288 F 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 6e-51
Identities = 102/296 (34%), Positives = 169/296 (57%), Gaps = 11/296 (3%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+++++ V+G+G+YGVV T E VAIKK D E+ LRE+K+LR L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKY 231
+IVE+K RR K +Y+VFE +E ++ ++++ + + PE + ++YQL++ + +
Sbjct: 61 NIVELKEAF----RRRGK-LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
H ++ HRD+KP+N+L + + LK+CDFG AR + ++ +A + T+YVATRWYR+PEL
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR-NLSEGSNANY-TEYVATRWYRSPELL 173
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
+ Y A+D+WS+GCI E+ G+PLFPG++ + QL + +LG E + +
Sbjct: 174 --LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231
Query: 352 KARRYLGSMRKKQPVPFSHKFPNA-DPLALHLLERLLAFDPKDRPTAEEALADPYF 406
L P ++ + L L++ LL +P DR E+ L P F
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 2e-49
Identities = 116/306 (37%), Positives = 173/306 (56%), Gaps = 23/306 (7%)
Query: 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
+G A+ Y E +G+GSY V + G+ VA+K I+ E T I RE LL+
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-REASLLKG 59
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQ-VIKANDDLTPEHYQFFLYQLLR 227
L+H +IV + I+ F VFE M +DL Q +I+ L P + + F++QLLR
Sbjct: 60 LKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR 114
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL YIH ++ HRDLKP+N+L + +LK+ DFGLAR PS + ++ V T WYR
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSE-VVTLWYRP 171
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG-KNVVHQLDLMTDLLGTPSTES- 344
P+ L G+ + Y+ A+DIW GCIF EML G+P FPG +V QL+ + +LG P+ ++
Sbjct: 172 PDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229
Query: 345 --ISRIRNEKARRYLGSMRKKQPVPFSH--KFPNADPLALHLLERLLAFDPKDRPTAEEA 400
+S++ N K +L ++ V + + P A+ LA ++L PKDR +A++A
Sbjct: 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLA----SQMLMMFPKDRISAQDA 285
Query: 401 LADPYF 406
L PYF
Sbjct: 286 LLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 5e-49
Identities = 69/197 (35%), Positives = 108/197 (54%), Gaps = 13/197 (6%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
+G+G +G V A D TG++VAIK I S +LREI++L+ L HP+IV++ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 181 MLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVF 238
+ +Y+V E E L ++K N+ L+ + L Q+L GL+Y+H+ +
Sbjct: 60 FEDENH-----LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 239 HRDLKPKNIL-ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 297
HRDLKP+NIL + + K+K+ DFGL+++ +D V T Y APE+
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGTPAYMAPEVL-LGKGY 170
Query: 298 YTPAIDIWSIGCIFAEM 314
Y+ DIWS+G I E+
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 1e-47
Identities = 108/302 (35%), Positives = 162/302 (53%), Gaps = 22/302 (7%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLLR-- 170
+Y+ IG+G+YG V A D G R VA+K++ +RE+ +LR L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 171 -HPDIVEIKHI-MLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLL 226
HP++V + + + + RE K + +VFE ++ DL + + + E + ++QLL
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYVATRWY 285
RGL ++H+ V HRDLKP+NIL + ++K+ DFGLAR+ SF A +++ V T WY
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-----VVTLWY 175
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
RAPE+ S Y +D+WS+GCIFAEM KPLF G + V QL + D++G P E
Sbjct: 176 RAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233
Query: 346 SRIRNEKA-RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+ A R + QP+ + D L LL + L F+P R +A AL+ P
Sbjct: 234 P---RDVALPRQAFHSKSAQPI--EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 288
Query: 405 YF 406
YF
Sbjct: 289 YF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-46
Identities = 91/303 (30%), Positives = 143/303 (47%), Gaps = 55/303 (18%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRH 171
+Y+I + IGKGS+G V G+ +K+I+ ++S+ R L E+K+L+ L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID--LSNMSEKEREDALNEVKILKKLNH 58
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKA---NDDLTPEHYQ--FFLYQL 225
P+I IK+ S E + +V E + DL Q IK PE Q + QL
Sbjct: 59 PNI--IKYYE---SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE-QILDWFVQL 112
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
LKY+H+ + HRD+KP+NI ++ +K+ DFG+++V + A V T +Y
Sbjct: 113 CLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA---KTVVGTPYY 169
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
+PELC + Y DIWS+GC+ E+ T K F G+N L+L
Sbjct: 170 LSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELAL----------- 213
Query: 346 SRIRNEKARRYLGSMRKKQPVP--FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+I + P+P +S + N L+ LL DP++RP+ + L
Sbjct: 214 -KILKG----------QYPPIPSQYSSELRN-------LVSSLLQKDPEERPSIAQILQS 255
Query: 404 PYF 406
P+
Sbjct: 256 PFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 167 bits (422), Expect = 3e-46
Identities = 83/303 (27%), Positives = 131/303 (43%), Gaps = 35/303 (11%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA-TRILREIKLLRLLRHPD 173
Y+I +G+GS+G V A D + VA+K + E S R LREI++L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 174 -IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD---LTPEHYQFFLYQLLRGL 229
IV++ V+ + L ++K L+ F L Q+L L
Sbjct: 59 NIVKLYDFFQDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 230 KYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARV---SFNDAPSAIFWTDYVATRWY 285
+Y+H+ + HRD+KP+NIL + D +K+ DFGLA++ + + + V T Y
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 286 RAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
APE+ G + + + DIWS+G E+LTG P F G+ ++
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-----------QT 223
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+ I + P A LL++LLA DPK+R ++ L+
Sbjct: 224 LKIILELPTPSLASPLSPSNP-------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 405 YFH 407
Sbjct: 277 LLA 279
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 2e-45
Identities = 79/299 (26%), Positives = 129/299 (43%), Gaps = 55/299 (18%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
++I E IGKG +G V A TG+ VAIK I + +I+ EI++L+ +HP+I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNI 59
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPE-HYQFFLYQLLRGLKYI 232
V+ L +++V E L ++K+ + E + +LL+GL+Y+
Sbjct: 60 VKYYGSYLKKDE-----LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+ + HRD+K NIL +D ++K+ DFGL+ +D + V T ++ APE+
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTM---VGTPYWMAPEVI- 169
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
Y DIWS+G E+ GKP +
Sbjct: 170 -NGKPYDYKADIWSLGITAIELAEGKPPY------------------------------- 197
Query: 353 ARRYLGSMR------KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
L M+ P + +D L++ L +P+ RPTAE+ L P+
Sbjct: 198 --SELPPMKALFKIATNGPPGLRNPEKWSDEFK-DFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 2e-45
Identities = 120/432 (27%), Positives = 203/432 (46%), Gaps = 69/432 (15%)
Query: 20 FTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQQLTIVEDFDFSGLKLIRVP 79
+ ++ N + F+ N+KK + S ++++ E + ++ I D + R P
Sbjct: 13 YEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDED-EEKMIDNDIN-------RSP 64
Query: 80 KRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGE 139
+ Y++ +IG GS+GVV A+ T E
Sbjct: 65 NK--------------------------------SYKLGNIIGNGSFGVVYEAICIDTSE 92
Query: 140 RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFKDIY--VVF 196
+VAIKK+ + D RE+ +++ L H +I+ +K ++ K+I+ VV
Sbjct: 93 KVAIKKV------LQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146
Query: 197 ELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 252
E + +H+ +K N L + + YQL R L YIH+ + HRDLKP+N+L + +
Sbjct: 147 EFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPN 206
Query: 253 C-KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCI 310
LK+CDFG A+ S Y+ +R+YRAPEL G+ + YT ID+WS+GCI
Sbjct: 207 THTLKLCDFGSAKNLLAGQRS----VSYICSRFYRAPELMLGA--TNYTTHIDLWSLGCI 260
Query: 311 FAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSH 370
AEM+ G P+F G++ V QL + +LGTP+ + + + A ++ K
Sbjct: 261 IAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKD---LKK 317
Query: 371 KFPNADP-LALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE 429
FP P A++ + + L ++P R EALADP+F L R+P + ++ +
Sbjct: 318 VFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL----RDPCIKLPKYIDKLPD 373
Query: 430 RRKLAKDDVREM 441
+++EM
Sbjct: 374 LFNFCDAEIKEM 385
|
Length = 440 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-45
Identities = 93/296 (31%), Positives = 142/296 (47%), Gaps = 45/296 (15%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
YQ+ ++IG+G++GVV ++ TG+ VAIK+I+ I++EI LL+ L+HP+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 231
IV K+I S +Y++ E E+ L Q+IK PE ++YQ+L+GL Y
Sbjct: 61 IV--KYI---GSIETSDSLYIILEYAENGSLRQIIKKFGPF-PESLVAVYVYQVLQGLAY 114
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFNDAPSAIFWTDYVATRWYRAPEL 290
+H V HRD+K NIL D +K+ DFG+A +++ V T ++ APE+
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD----ASVVGTPYWMAPEV 170
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
S + A DIWS+GC E+LTG P + + L+ M L RI
Sbjct: 171 IE--MSGASTASDIWSLGCTVIELLTGNPPY------YDLNPMAALF---------RIVQ 213
Query: 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ P+P P L + DP RPTA++ L P+
Sbjct: 214 D----------DHPPLP-----EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-44
Identities = 105/306 (34%), Positives = 151/306 (49%), Gaps = 31/306 (10%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR--- 170
+Y+ IG G+YG V A D H+G VA+K + +RE+ LL+ L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 171 HPDIVEIKHIMLPP-SRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLR 227
HP+IV + + + RE K + +VFE ++ DL + L E + + Q LR
Sbjct: 61 HPNIVRLMDVCATSRTDRETK-VTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYVATRWYR 286
GL ++H + HRDLKP+NIL + ++K+ DFGLAR+ S A T V T WYR
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-----LTPVVVTLWYR 174
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE--- 343
APE+ S Y +D+WS+GCIFAEM KPLF G + QL + DL+G P +
Sbjct: 175 APEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232
Query: 344 ---SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
++ R G+ + P P P + LL +L F+P R +A A
Sbjct: 233 RDVTLPR----------GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRA 282
Query: 401 LADPYF 406
L P+F
Sbjct: 283 LQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-43
Identities = 112/310 (36%), Positives = 171/310 (55%), Gaps = 25/310 (8%)
Query: 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
+G+A Y+ E +G+GSY V G+ VA+K I E + T I RE LL+
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKG 59
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLR 227
L+H +IV + I+ + + +VFE + +DL Q + K L PE+ + FL+QLLR
Sbjct: 60 LKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL YIH + HRDLKP+N+L + +LK+ DFGLAR PS + ++ V T WYR
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTY-SNEVVTLWYRP 171
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG-KNVVHQLDLMTDLLGTPSTE-- 343
P+ L GS ++Y+ +D+W +GCIF EM+ G FPG K++ QL+ + +LGTP+ +
Sbjct: 172 PDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229
Query: 344 ----SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
S+ + E+ Y ++ S+ +A+ LA +LL PK+R +A+
Sbjct: 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSY-VNHAEDLA----SKLLQCFPKNRLSAQA 284
Query: 400 ALADPYFHGL 409
AL+ YF L
Sbjct: 285 ALSHEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 9e-41
Identities = 91/305 (29%), Positives = 141/305 (46%), Gaps = 56/305 (18%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 172
Y++ E IGKGS+G V G+ + K+I+ + ++++ + ++ E+ +LR L+HP
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHP 59
Query: 173 DIVE-IKHIMLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEHY--QFFLYQL 225
+IV I+ ++ +Y+V E E DL Q+I K E + + QL
Sbjct: 60 NIVRYYDRIIDRSNQT----LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT-QL 114
Query: 226 LRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
L L H + V HRDLKP NI +A+ +K+ DFGLA++ +D+ A YV
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA---KTYV 171
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
T +Y +PE Y DIWS+GC+ E+ P F +N QL L
Sbjct: 172 GTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQL-------- 218
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
S+I+ K RR P +S L +++ +L DP RP+ EE
Sbjct: 219 ----ASKIKEGKFRRI--------PYRYS------SELNE-VIKSMLNVDPDKRPSTEEL 259
Query: 401 LADPY 405
L P
Sbjct: 260 LQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 115/320 (35%), Positives = 164/320 (51%), Gaps = 45/320 (14%)
Query: 121 IGKGSYGVVGSAV--DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
+G+G+YG V A D A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 179 HIMLPPSRREFKDIYVVFELMESDL------HQVIKAND---DLTPEHYQFFLYQLLRGL 229
+ L + R+ ++++F+ E DL H+ KAN L + LYQ+L G+
Sbjct: 65 KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 230 KYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVSFNDAPSAIFWTD-YVATRW 284
Y+H V HRDLKP NIL + ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 285 YRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-------NVVH--QLDLMT 334
YRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238
Query: 335 DLLGTPSTESISRIRNEKARRYL-GSMRKKQPVPFS-------HKFPNADPLALHLLERL 386
+++G P+ + I+ L R+ S HK D A HLL++L
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV-KPDSKAFHLLQKL 297
Query: 387 LAFDPKDRPTAEEALADPYF 406
L DP R T+E+A+ DPYF
Sbjct: 298 LTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 2e-39
Identities = 115/320 (35%), Positives = 162/320 (50%), Gaps = 45/320 (14%)
Query: 121 IGKGSYGVVGSA--VDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
+G+G+YG V A D + A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 179 HIMLPPSRREFKDIYVVFELMESDL------HQVIKAND---DLTPEHYQFFLYQLLRGL 229
+ L S R+ ++++F+ E DL H+ KAN L + LYQ+L G+
Sbjct: 65 KVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 230 KYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVSFNDAPSAIFWTD-YVATRW 284
Y+H V HRDLKP NIL + ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 285 YRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-------NVVH--QLDLMT 334
YRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238
Query: 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFS--------HKFPNADPLALHLLERL 386
++G P+ + IR L ++ S HK D LL++L
Sbjct: 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKV-KPDSKVFLLLQKL 297
Query: 387 LAFDPKDRPTAEEALADPYF 406
L DP R T+E+AL DPYF
Sbjct: 298 LTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 89/307 (28%), Positives = 139/307 (45%), Gaps = 69/307 (22%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI---NDVFEHVSDATRILREIKLLRLLRH 171
Y+ E IG+G+ G V A D TG+ VAIKK+ E I+ EI +++ +H
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKE------LIINEILIMKDCKH 74
Query: 172 PDIVE-IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRG 228
P+IV+ S +++VV E M+ L +I N + + ++L+G
Sbjct: 75 PNIVDYYD------SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQG 128
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTDY 279
L+Y+H+ NV HRD+K NIL + D +K+ DFG A R S
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV------------ 176
Query: 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339
V T ++ APE+ Y P +DIWS+G + EM G+P + + + L L+T G
Sbjct: 177 VGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGI 233
Query: 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
P ++N + +S +F + L + L DP+ RP+AEE
Sbjct: 234 P------PLKNPEK--------------WSPEFKD-------FLNKCLVKDPEKRPSAEE 266
Query: 400 ALADPYF 406
L P+
Sbjct: 267 LLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 90/295 (30%), Positives = 135/295 (45%), Gaps = 35/295 (11%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
R+Q IG G++G V +AV+ TGE +A+K+I I E+K+L LL+HP+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 174 IVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+V+ + + RE +Y+ E L ++++ L + + QLL GL Y+
Sbjct: 61 LVKYYGVEV---HRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYL 115
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFNDAPSAIFWTDYVATRWYRAPEL- 290
H+ + HRD+KP NI + + +K+ DFG A ++ N T Y APE+
Sbjct: 116 HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
G + A DIWS+GC+ EM TGK + +LD N
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPW------SELD------------------N 211
Query: 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
E + K P+P S + P L+R L DPK RPTA E L P+
Sbjct: 212 EFQIMFHVGAGHKPPIPDSLQ---LSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 6e-38
Identities = 82/296 (27%), Positives = 129/296 (43%), Gaps = 56/296 (18%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
+GKGS+G V TG+ A+K + + + + L E +L + HP IV++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLH 59
Query: 179 HIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
F+ +Y+V E +L + + E +F+ +++ L+Y+H+
Sbjct: 60 --------YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHS 111
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ +RDLKP+NIL +AD +K+ DFGLA+ ++ + T Y APE+
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLLG- 167
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354
Y A+D WS+G + EMLTGKP F ++ E +I
Sbjct: 168 -KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---------------EIYEKI------ 205
Query: 355 RYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDRPT---AEEALADPYF 406
K P+ +FP P A L+ LL DP R AEE A P+F
Sbjct: 206 -------LKDPL----RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 84/299 (28%), Positives = 128/299 (42%), Gaps = 69/299 (23%)
Query: 119 EVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 172
+ +G+G++G V VA+K + E S+ LRE +++R L HP
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK---EDASEQQIEEFLREARIMRKLDHP 61
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLK 230
++V++ + +Y+V E ME DL ++ N L+ F Q+ RG++
Sbjct: 62 NVVKLLGVCTEEEP-----LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME 116
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------R 283
Y+ + N HRDL +N L + +KI DFGL+R ++D DY R
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYRKRGGKLPIR 168
Query: 284 WYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPS 341
W APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 169 WM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS---------------- 208
Query: 342 TESISRIRNEKARRYLGS-MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
NE+ YL + R QP PN P L+ + A DP+DRPT E
Sbjct: 209 --------NEEVLEYLKNGYRLPQP-------PNCPPELYDLMLQCWAEDPEDRPTFSE 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 80/300 (26%), Positives = 124/300 (41%), Gaps = 70/300 (23%)
Query: 119 EVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 172
+ +G+G++G V VA+K + + S+ LRE +++R L HP
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE---DASEQQIEEFLREARIMRKLDHP 61
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGL 229
+IV++ + + +V E M DL ++ N L+ F Q+ RG+
Sbjct: 62 NIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 282
+Y+ + N HRDL +N L + +KI DFGL+R ++D DY
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYKVKGGKLPI 168
Query: 283 RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTP 340
RW APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 169 RWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS--------------- 209
Query: 341 STESISRIRNEKARRYLGS-MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
N + YL R +P PN P L+ + A DP+DRPT E
Sbjct: 210 ---------NAEVLEYLKKGYRLPKP-------PNCPPELYKLMLQCWAEDPEDRPTFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 89/327 (27%), Positives = 140/327 (42%), Gaps = 84/327 (25%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK---------- 164
++ ++IG+GS+ V A + T + AIK + D ++++E K
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIK--------ILDKRQLIKEKKVKYVKIEKEV 54
Query: 165 LLRLLRHPDIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQF 220
L RL HP I+++ + F+D +Y V E + +L Q I+ L + +F
Sbjct: 55 LTRLNGHPGIIKLYY--------TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF 106
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV--------------- 265
+ ++L L+Y+H+ + HRDLKP+NIL + D +KI DFG A+V
Sbjct: 107 YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 266 --SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323
+ + +V T Y +PEL + D+W++GCI +MLTGKP F G
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRG 224
Query: 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLL 383
N L +I + F FP P A L+
Sbjct: 225 SN--------EYLT-------FQKILKLE-------------YSFPPNFP---PDAKDLI 253
Query: 384 ERLLAFDPKDRPTA----EEALADPYF 406
E+LL DP+DR +E A P+F
Sbjct: 254 EKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 39/291 (13%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+ +V+G+GS GVV TG+ A+KKI+ V ++LRE+K LR P +V
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ I +V E M+ L ++K + + Q+L+GL Y+HT
Sbjct: 63 KCYGAFYKEGE-----ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 235 -ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
++ HRD+KP N+L N+ ++KI DFG+++V + T +V T Y +PE
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNT-FVGTVTYMSPERIQG 174
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353
Y+ A DIWS+G E GK F +LM + P + + +
Sbjct: 175 --ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232
Query: 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
R + L DPK RP+A E L P
Sbjct: 233 R--------------------------DFISACLQKDPKKRPSAAELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 86/300 (28%), Positives = 140/300 (46%), Gaps = 51/300 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN------DVFEHVSDATRILREIKLLR 167
R++ E++G GS+G V ++ G+ A+K+++ E V ++ +EI LL
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK---QLEQEIALLS 57
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLL 226
L+HP+IV+ + RE ++Y+ EL+ L +++K + + Q+L
Sbjct: 58 KLQHPNIVQYLG-----TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL 112
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWY 285
GL+Y+H N HRD+K NIL + + +K+ DFG+A+ V F + + ++
Sbjct: 113 LGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-----FAKSFKGSPYW 167
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ Y A DIWS+GC EM TGKP + QL E +
Sbjct: 168 MAPEVIAQ-QGGYGLAADIWSLGCTVLEMATGKPPW------SQL------------EGV 208
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+ + +G ++ P+P H A L L+R DP RPTA E L P+
Sbjct: 209 AAVFK------IGRSKELPPIP-DHLSDEAKDFILKCLQR----DPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 84/307 (27%), Positives = 128/307 (41%), Gaps = 62/307 (20%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKI--------NDVFEHVSDATRILREIKLLRLLR 170
E+IGKG+YG V A++ TGE +A+K++ + EI+ L+ L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLH------------QVIKANDDLTPEHY 218
H +IV+ Y+ FE E L ++ +
Sbjct: 67 HLNIVQ----------------YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV 110
Query: 219 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 278
+FF Q+L GL Y+H+ + HRDLK N+L +AD KI DFG+++ S +D
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS-DDIYDNDQNMS 169
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338
+ ++ APE+ S+ Y+ +DIWS+GC+ EM G+
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR-------------------- 209
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
S A LG+ R P+P N P+AL L +P +RPTA
Sbjct: 210 ----RPWSDEEAIAAMFKLGNKRSAPPIP-PDVSMNLSPVALDFLNACFTINPDNRPTAR 264
Query: 399 EALADPY 405
E L P+
Sbjct: 265 ELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 7e-31
Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 53/288 (18%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS-DATR-ILREIKLLRLLRHP 172
+++ VIGKG++G V T + A+K +N + V + R +L E ++L+ L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQELNHP 60
Query: 173 DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 228
+V + F+D +Y+V +L+ DL + + E +F++ +++
Sbjct: 61 FLVNL--------WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA 112
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
L+Y+H+ + HRD+KP NIL + + I DF +A D + T T Y AP
Sbjct: 113 LEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT----TSTSGTPGYMAP 168
Query: 289 ELCGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
E+ + Y+ A+D WS+G E L GK + G S +
Sbjct: 169 EV---LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH----------------SRTIRDQ 209
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPL-ALHLLERLLAFDPKDR 394
IR ++ V +P A+ + +LL DP+ R
Sbjct: 210 IRA---------KQETADVL----YPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 52/295 (17%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD-ATRILREIKLLRLLRH 171
+ + E IGKGS+G V A+D T + VAIK I+ E D I +EI+ L R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRS 58
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 227
P I + L S+ ++++ E DL + K L + F L ++L
Sbjct: 59 PYITKYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLL 109
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFNDAPSAIFWTDYVATRWYR 286
GL+Y+H HRD+K NIL + + +K+ DFG++ +++ + F V T ++
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF----VGTPFWM 165
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
APE+ S Y DIWS+G E+ G+P P + L M L
Sbjct: 166 APEVIKQ--SGYDEKADIWSLGITAIELAKGEP--P----LSDLHPMRVLF--------- 208
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
I G+ FS F D ++L L + DPK+RP+A+E L
Sbjct: 209 LIPKNNPPSLEGNK-------FSKPF--KDFVSLCLNK-----DPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 75/300 (25%), Positives = 129/300 (43%), Gaps = 64/300 (21%)
Query: 116 QIQEVIGKGSYGVV--GSAVDTH--TGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
++ + +G+G++G V G+ T +VA+K + + + L E +++ L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLSH 60
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 229
P+IV + + + + +Y+V E M DL ++ + + LT + Q+ +G+
Sbjct: 61 PNIVRLLGVCT-----QGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 282
+Y+ + N HRDL +N L + +KI DFGL+R + D Y
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD-------YYRKRGGGKLPI 168
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPS 341
+W APE K+T D+WS G + E+ T G+ +PG +
Sbjct: 169 KWM-APESL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS---------------- 209
Query: 342 TESISRIRNEKARRYLGSM-RKKQPVPFSHKFPNADPLALH-LLERLLAFDPKDRPTAEE 399
NE+ L R +P N P L+ L+ + A+DP+DRPT E
Sbjct: 210 --------NEEVLELLEDGYRLPRP-------ENC-PDELYELMLQCWAYDPEDRPTFSE 253
|
Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 81/301 (26%), Positives = 136/301 (45%), Gaps = 50/301 (16%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKIND---VFEHVSDATRILREIKLLRLLRHPDIVEI 177
I KG+YG V A TG+ AIK I + ++ D ++L E +L + P +V++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD--QVLTERDILSQAQSPYVVKL 58
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
+ S + K++Y+V E + DL +++ L + + ++ +++ L+Y+H+
Sbjct: 59 YY-----SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY-----VATRWYRAPELC 291
+ HRDLKP NIL +++ LK+ DFGL++V + + V T Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
++ +D WS+GCI E L G P F G+ E I N
Sbjct: 174 LG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETP---------------EEIFQNILNG 216
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA---EEALADPYFHG 408
K + + + A+ L+ +LL DP+ R A EE P+F G
Sbjct: 217 K-------------IEWP-EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
Query: 409 L 409
+
Sbjct: 263 I 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 71/208 (34%), Positives = 113/208 (54%), Gaps = 20/208 (9%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 172
++I++ IGKG + VV A+ G VA+KK+ +FE + R L+EI LL+ L HP
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIK---ANDDLTPEH--YQFFLYQLL 226
++ IK++ S E ++ +V EL ++ DL ++IK L PE +++F QL
Sbjct: 63 NV--IKYL---ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF-VQLC 116
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
L+++H+ + HRD+KP N+ A +K+ D GL R F+ +A V T +Y
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAH--SLVGTPYYM 173
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEM 314
+PE + Y DIWS+GC+ EM
Sbjct: 174 SPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 76/306 (24%), Positives = 123/306 (40%), Gaps = 75/306 (24%)
Query: 119 EVIGKGSYGVV--GSAVDTHTGER-VAIKKINDVFEHVSDATR--ILREIKLLRLLRHPD 173
+ +G+G++G V G VA+K + E S+ R L+E ++++ L HP+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK---EDASEEERKDFLKEARVMKKLGHPN 57
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN---------DDLTPEHYQFFLY 223
+V + + E + +Y+V E ME DL ++ + L+ + F
Sbjct: 58 VVRLLGVCT-----EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT- 282
Q+ +G++Y+ + HRDL +N L D +KI DFGL+R ++D Y
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD-------DYYRKKT 165
Query: 283 ------RWYRAPELCGSFFS-KYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 334
RW APE S +T D+WS G + E+ T G +PG
Sbjct: 166 GGKLPIRWM-APE---SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG----------- 210
Query: 335 DLLGTPSTESISRIRNEKARRYLGS-MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD 393
+ NE+ YL R +P + L+ DP+D
Sbjct: 211 -------------LSNEEVLEYLRKGYRLPKPEYCPDELYE-------LMLSCWQLDPED 250
Query: 394 RPTAEE 399
RPT E
Sbjct: 251 RPTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 85/299 (28%), Positives = 136/299 (45%), Gaps = 54/299 (18%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+ I E +G+GSYG V A+ TG+ VAIK + V E + + I++EI +L+ P I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQE---IIKEISILKQCDSPYI 60
Query: 175 VEIKHIMLPPSRREFKDIYVVFELME-------SDLHQVIKANDDLTPEHYQFFLYQLLR 227
V+ S + D+++V ME SD+ ++ N LT E LYQ L+
Sbjct: 61 VKYY-----GSYFKNTDLWIV---MEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLK 110
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL+Y+H+ HRD+K NIL N + + K+ DFG++ + + T ++ A
Sbjct: 111 GLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR---NTVIGTPFWMA 167
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
PE+ Y DIWS+G EM GKP P ++ +I
Sbjct: 168 PEVIQE--IGYNNKADIWSLGITAIEMAEGKP--PYSDI-------------HPMRAIFM 210
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
I N+ P +S +F + +++ L DP++RP+A + L P+
Sbjct: 211 IPNKPPPTL------SDPEKWSPEFND-------FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 80/290 (27%), Positives = 128/290 (44%), Gaps = 48/290 (16%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR---ILREIKLLRLLRHPDIVEI 177
IG+GS G+V A D TG +VA+KK++ + R + E+ ++R +HP+IVE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD-----LRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 178 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
L +++VV E +E I + + E +L+ L ++H V
Sbjct: 82 YSSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGV 136
Query: 238 FHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
HRD+K +IL +D ++K+ DFG A+VS + P V T ++ APE+
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVS-KEVPRR---KSLVGTPYWMAPEVISR--L 190
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356
Y +DIWS+G + EM+ G+P + P +++ RIR+
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLQAMKRIRDNLP--- 232
Query: 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
P P L+R+L DP R TA E L P+
Sbjct: 233 ----------PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 77/303 (25%), Positives = 124/303 (40%), Gaps = 45/303 (14%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
Y++ EVIG G+ VV +A+ E+VAIK+I D+ + + + +E++ + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKA--NDDLTPEHY-QFFLYQLLRG 228
++V+ S ++++V + L ++K+ E L ++L+G
Sbjct: 60 NVVKYY-----TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP-SAIFWTDYVATRWYRA 287
L+Y+H+ HRD+K NIL D +KI DFG++ + + +V T + A
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP----LFPGKNVVHQLDLMTDLLGTPSTE 343
PE+ Y DIWS G E+ TG P K LM L P +
Sbjct: 175 PEVMEQ-VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQNDPPSL 227
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+S F ++ L DP RPTAEE L
Sbjct: 228 ETGA----------------DYKKYSKSFRK-------MISLCLQKDPSKRPTAEELLKH 264
Query: 404 PYF 406
+F
Sbjct: 265 KFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 83/299 (27%), Positives = 128/299 (42%), Gaps = 53/299 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRH 171
Y V+GKG++G T V K++N +S+ R L EI +L LL+H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN--LTRLSEKERRDALNEIVILSLLQH 58
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDD-LTPEHY-QFFLYQL 225
P+I+ + F D + ME L+ I L E ++L+Q+
Sbjct: 59 PNIIAYYN--------HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
+ + YIH A + HRD+K NI +K+ DFG++++ ++ A V T +Y
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA---ETVVGTPYY 167
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
+PELC KY DIW++GC+ E+LT K F N L+L+ ++ T +
Sbjct: 168 MSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTPVV 222
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
S Y + L+ LL DP+ RPTA+E L P
Sbjct: 223 S--------VYSSELIS-------------------LVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 88/308 (28%), Positives = 126/308 (40%), Gaps = 63/308 (20%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
Y++ + IG G+YG V A D TGE VAIK I E D I +EI +L+ RHP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHP 60
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRG 228
+IV L RR+ +++V E D++QV L+ + + L+G
Sbjct: 61 NIVAYFGSYL---RRD--KLWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKG 113
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTDY 279
L Y+H HRD+K NIL D +K+ DFG++ R SF
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF------------ 161
Query: 280 VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338
+ T ++ APE Y DIW++G E+ +P P M DL
Sbjct: 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP--P----------MFDL-- 207
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA-DPLALHLLERLLAFDPKDRPTA 397
R L + K P K P+ +++ L DPK RPTA
Sbjct: 208 -------------HPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTA 254
Query: 398 EEALADPY 405
+ L P+
Sbjct: 255 TKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 77/293 (26%), Positives = 127/293 (43%), Gaps = 43/293 (14%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
++I IGKGS+GVV V A+K+I+ + + + E ++L L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKY 231
I++ S + + +V E E+ DLH+++K L + F Q+L GL +
Sbjct: 62 --IRYY---ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+H+ + HRD+K N+ +A +KI D G+A++ + + F V T +Y +PELC
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC 173
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
Y D+W++G + E TGK F N Q L I +I
Sbjct: 174 ED--KPYNEKSDVWALGVVLYECCTGKHPFDANN---QGAL------------ILKI--- 213
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+R P P S + L+++ L D + RP + L +P
Sbjct: 214 --------IRGVFP-PVSQMY---SQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 80/294 (27%), Positives = 119/294 (40%), Gaps = 48/294 (16%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS----DATRILREIKLLRLLRHPDIV 175
+G G+ GVV + TG+ +A+K I + +ILRE+ +L P IV
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTI-----RLEINEAIQKQILRELDILHKCNSPYIV 62
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIH 233
DI + E M+ L +++K PE +L+GL Y+H
Sbjct: 63 GFYGAFY----NN-GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 234 TA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
+ HRD+KP NIL N+ ++K+CDFG++ N +V T Y APE
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-----TFVGTSSYMAPERIQ 172
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
+ Y+ DIWS+G E+ TG+ FP E + I NE
Sbjct: 173 G--NDYSVKSDIWSLGLSLIELATGR--FPYPP--ENDPPDGIF------ELLQYIVNEP 220
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
P S KF P + L DP++RP+ +E L P+
Sbjct: 221 P-----------PRLPSGKFS---PDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 83/299 (27%), Positives = 131/299 (43%), Gaps = 53/299 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRH 171
+++ + +GKGSYG V + A+K+++ +S R + EI++L + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNH 58
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI---KANDDLTPEH--YQFFLYQL 225
P+I+ K L ++ + +V E DL + I K L PE ++ F+ QL
Sbjct: 59 PNIISYKEAFLDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QL 112
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
LRGL+ +H + HRDLK NIL A+ +KI D G+++V + + T Y
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-----IGTPHY 167
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ Y+ DIWS+GC+ EM T P F ++ M DL
Sbjct: 168 MAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARS-------MQDL--------- 209
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
R K P P + + D + + +L PK RP ++ LA P
Sbjct: 210 ----------RYKVQRGKYP-PIPPIY-SQD--LQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 75/299 (25%), Positives = 133/299 (44%), Gaps = 46/299 (15%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR-----ILREIKLLRLL 169
++ +++G+G++G V D TG +A+K++ F+ S T+ + EI+LL+ L
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVP--FDPDSPETKKEVNALECEIQLLKNL 61
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 228
+H IV+ + R+ + + + E M + +KA LT + + Q+L G
Sbjct: 62 QHERIVQYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG 116
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
++Y+H+ + HRD+K NIL ++ +K+ DFG ++ S T ++ +P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
E+ Y D+WS+GC EMLT KP P E+++ I
Sbjct: 177 EVISG--EGYGRKADVWSVGCTVVEMLTEKP--PWAEF----------------EAMAAI 216
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ + P + P + P A + L R + K RP+AEE L +
Sbjct: 217 FK---------IATQPTNP---QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 73/286 (25%), Positives = 129/286 (45%), Gaps = 40/286 (13%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
IG+GS G+V A + H+G +VA+K ++ + E+ ++R +H ++VE+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
L ++++V+ E ++ I + L E +L+ L Y+H+ V HR
Sbjct: 87 YLVG-----EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 300
D+K +IL D ++K+ DFG D P V T ++ APE+ + Y
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISR--TPYGT 196
Query: 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 360
+DIWS+G + EM+ G+P + + V +++ R+R+
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPV---------------QAMKRLRDS--------- 232
Query: 361 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
P P P+ LER+L +P++R TA+E L P+
Sbjct: 233 ----PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 89/305 (29%), Positives = 132/305 (43%), Gaps = 64/305 (20%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKK--INDVFEHVSDATRIL-----REIKLLRLLRHP 172
+IG GS+G V ++ +GE +A+K+ + V D R + REI LL+ L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+IV+ L YV + + L+ + L + F+ Q+L+GL Y+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLV----RNFVRQILKGLNYL 122
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFN--------DAPS---AIFWTDYV 280
H + HRD+K NIL + +KI DFG++ ++ N PS ++FW
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM--- 179
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
APE+ + YT DIWS+GC+ EMLTGK FP T L
Sbjct: 180 ------APEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPD---------CTQL---- 218
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
++I +I E A P S+ A LE+ D RPTA E
Sbjct: 219 --QAIFKI-GENAS----------PEIPSNISSEAI----DFLEKTFEIDHNKRPTAAEL 261
Query: 401 LADPY 405
L P+
Sbjct: 262 LKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 71/215 (33%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN---DVFEHVSDATRILREIKLLRLL 169
S YQ E+IG+G+YG V TG VA+K IN + VSD I RE+ LL L
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSD---IQREVALLSQL 56
Query: 170 RHPDIVEIKH----IMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 224
R I + P ++++ E E + ++KA + ++ + +
Sbjct: 57 RQSQPPNITKYYGSYLKGPR------LWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIRE 109
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
+L LKYIH V HRD+K NIL +K+CDFG+A N S + +V T +
Sbjct: 110 VLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVA-ALLNQNSSK--RSTFVGTPY 166
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 319
+ APE+ Y DIWS+G EM TG P
Sbjct: 167 WMAPEVITE-GKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 82/305 (26%), Positives = 131/305 (42%), Gaps = 46/305 (15%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-R 170
+++ EVIG+G+YG V A TG+ VAIK ++ + + I E +LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE---EEEIKEEYNILRKYSN 61
Query: 171 HPDIVEIKHIMLPPSRREFKD-IYVVFELME----SDLHQ-VIKANDDLTPEHYQFFLYQ 224
HP+I + + D +++V EL +DL + + K L E + L +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
LRGL Y+H V HRD+K +NIL + ++K+ DFG++ D+ T ++ T +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNT-FIGTPY 178
Query: 285 YRAPE--LCG-SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
+ APE C + Y D+WS+G E+ GKP D+
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL--------CDM-------HP 223
Query: 342 TESISRI-RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
++ +I RN K P +S KF + L + + RP EE
Sbjct: 224 MRALFKIPRNP-------PPTLKSPENWSKKFN-------DFISECLIKNYEQRPFMEEL 269
Query: 401 LADPY 405
L P+
Sbjct: 270 LEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 82/299 (27%), Positives = 129/299 (43%), Gaps = 53/299 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRH 171
+Y+ V+G+G++G+V + V IK+I E ++ R E ++L+LL H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP--VEQMTKDERLAAQNECQVLKLLSH 58
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI-KANDDLTPEH--YQFFLYQLLR 227
P+I+E L E K + +V E L + I K + L E FF+ Q+L
Sbjct: 59 PNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV-QILL 112
Query: 228 GLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARV-SFNDAPSAIFWTDYVATRWY 285
L ++HT + HRDLK +NIL + +KI DFG++++ S + V T Y
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-----VGTPCY 167
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
+PELC Y DIW++GC+ E+ + K F N+ P+
Sbjct: 168 ISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANL-------------PAL--- 209
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
L M P S ++ P L+ +L DP RP + +A P
Sbjct: 210 ----------VLKIMSGTF-APISDRY---SPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 93/318 (29%), Positives = 131/318 (41%), Gaps = 68/318 (21%)
Query: 104 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI 163
E+ EY E + V+GKG+YG+V +A D T R+AIK+I + + EI
Sbjct: 2 EYEYEYDENGE---RVVLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEI 56
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-------SDLHQV----IKANDD 212
L L+H +IV+ + S F I+ ME S L + +K N+
Sbjct: 57 ALHSYLKHRNIVQY---LGSDSENGFFKIF-----MEQVPGGSLSALLRSKWGPLKDNEQ 108
Query: 213 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFG----LARVSF 267
F+ Q+L GLKY+H + HRD+K N+L N +KI DFG LA ++
Sbjct: 109 TI----IFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN- 163
Query: 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
P + T Y APE+ Y DIWS+GC EM TGKP F
Sbjct: 164 ---PCT---ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF------ 211
Query: 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLL 387
+ LG P +A + M K P A + + R
Sbjct: 212 IE-------LGEP-----------QAAMFKVGMFKIHP-EIPESLSAE---AKNFILRCF 249
Query: 388 AFDPKDRPTAEEALADPY 405
DP R +A + L DP+
Sbjct: 250 EPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 76/286 (26%), Positives = 128/286 (44%), Gaps = 40/286 (13%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
IG+GS G+V A + HTG++VA+KK++ + E+ ++R H ++V++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
L +++VV E +E I + + E +LR L Y+H V HR
Sbjct: 88 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 300
D+K +IL +D ++K+ DFG + P V T ++ APE+ Y
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISRL--PYGT 197
Query: 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 360
+DIWS+G + EM+ G+P + P +++ RIR+ R
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPY---------------FNEPPLQAMRRIRDNLPPR----- 237
Query: 361 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
V SHK + + L+ +L +P R TA+E L P+
Sbjct: 238 -----VKDSHKVSS---VLRGFLDLMLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 5e-23
Identities = 73/223 (32%), Positives = 112/223 (50%), Gaps = 15/223 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RY+I + IG+GS+G + A E IK+I+ V + +E+ LL ++HP+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLY--QLLRGLK 230
IV S +E +++V E + DL + I + Q + Q+ GLK
Sbjct: 61 IVTFFA-----SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 231 YIHTANVFHRDLKPKNILANADCKL-KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+IH + HRD+K +NI + + + K+ DFG+AR ND S V T +Y +PE
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LND--SMELAYTCVGTPYYLSPE 172
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332
+C + Y DIWS+GC+ E+ T K F G N +HQL L
Sbjct: 173 ICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA---TRILREIKLLRLLRHPDIVEI 177
+G G +G V A+K + H+ + I E ++L HP IV++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKR--HIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 178 KHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
R FKD ++ LME +L +++ +F++ ++ +Y+H
Sbjct: 59 --------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ +RDLKP+N+L +++ +K+ DFG A+ + + WT + T Y APE+
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---WT-FCGTPEYVAPEII-- 164
Query: 294 FFSK-YTPAIDIWSIGCIFAEMLTGKPLF 321
+K Y ++D WS+G + E+LTG+P F
Sbjct: 165 -LNKGYDFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 43/295 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y + IG+GS+G G++ IK+IN + +E+ +L ++HP+
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQF--FLYQLLRGLK 230
IV+ + S E ++Y+V + E DL++ I A + Q + Q+ LK
Sbjct: 61 IVQYQE-----SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
++H + HRD+K +NI D +K+ DFG+ARV + A + T +Y +PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA---RTCIGTPYYLSPEI 172
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
C + Y DIW++GC+ EM T K F N M +L+ + IR
Sbjct: 173 CEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGN-------MKNLV-------LKIIR- 215
Query: 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
GS PV SH + L L +R +P+DRP+ L +
Sbjct: 216 -------GSY---PPVS-SHYSYDLRNLVSQLFKR----NPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 40/286 (13%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
IG+GS G+V A +G+ VA+KK++ + E+ ++R +H ++VE+ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240
L +++VV E +E I + + E +L+ L +H V HR
Sbjct: 86 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP 300
D+K +IL D ++K+ DFG + P V T ++ APEL Y P
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELISRL--PYGP 195
Query: 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSM 360
+DIWS+G + EM+ G+P + P +++ IR+ + L ++
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPY---------------FNEPPLKAMKMIRDNLPPK-LKNL 239
Query: 361 RKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
K P L+RLL DP R TA E L P+
Sbjct: 240 HK------------VSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 9e-22
Identities = 77/303 (25%), Positives = 126/303 (41%), Gaps = 56/303 (18%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR----ILREIKLLRLLRHPDI 174
+ +G G++ A D TG +A+K++ V S+ + +EI+L+ L HP I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 175 VEIKHIMLPPSRREFKDIYVVF-ELM-----ESDLHQVIKANDDLTPEHYQFFLYQLLRG 228
+ ML + + +F E M L + + + + QLLRG
Sbjct: 66 IR----MLGATCE--DSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN----YTEQLLRG 115
Query: 229 LKYIHTANVFHRDLKPKNILANADCK-LKICDFGLA-RVSFNDAPSAIFWTDYVATRWYR 286
L Y+H + HRD+K N+L ++ + L+I DFG A R++ + F + T +
Sbjct: 116 LSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL---LGTPSTE 343
APE+ +Y + D+WS+GC+ EM T KP + + + L L+ + P
Sbjct: 176 APEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP--- 230
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+P H P + L LE P+DRP + E L
Sbjct: 231 ---------------------SIP-EHLSPGLRDVTLRCLEL----QPEDRPPSRELLKH 264
Query: 404 PYF 406
P F
Sbjct: 265 PVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 21/217 (9%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPD 173
+QI +G+G YG V A TGE VA+K++ + R +L E +L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGL 229
+V++ + F+D ++ ME D ++ L+ +H +F++ ++ +
Sbjct: 63 LVKLLY--------AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV 114
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+H HRDLKP+N L +A +K+ DFGL++ A S + DY+ APE
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYM------APE 168
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV 326
+ Y +D WS+GC+ E L G P F G
Sbjct: 169 VLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 71/213 (33%), Positives = 109/213 (51%), Gaps = 18/213 (8%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
+Y + V+G+GS+G ++ ++ A+K+I + +R +E LL ++HP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR--KEAVLLAKMKHP 58
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIK-ANDDLTPEH--YQFFLYQLLRG 228
+IV K S +Y+V E + DL Q IK L PE Q+F+ Q+ G
Sbjct: 59 NIVAFKE-----SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV-QMCLG 112
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
+++IH V HRD+K KNI + K+K+ DFG AR+ + P A + YV T +Y P
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGA-YACTYVGTPYYVPP 169
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
E+ + Y DIWS+GCI E+ T K F
Sbjct: 170 EIWENM--PYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK--KINDVF-----EHVSDATRILREIKLLR 167
++ + +G GS+G V +G+ A+K + EHV L E ++L+
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHV------LNEKRILQ 56
Query: 168 LLRHPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLY 223
+RHP +V + F+D +Y+V E + +L ++ + +F+
Sbjct: 57 SIRHPFLVNLYG--------SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA 108
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFNDAPSAIFWTDYVAT 282
Q++ L+Y+H+ ++ +RDLKP+N+L ++D +KI DFG A RV +T T
Sbjct: 109 QVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT------YT-LCGT 161
Query: 283 RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLF 321
Y APE+ SK Y A+D W++G + EML G P F
Sbjct: 162 PEYLAPEI---ILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 5e-21
Identities = 77/294 (26%), Positives = 132/294 (44%), Gaps = 42/294 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y E IG+G+ G V +A+D TG+ VAIK+IN + I+ EI +++ L++P+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPN 77
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
IV L +++VV E + + + + L+ L+++H
Sbjct: 78 IVNFLDSFLVGD-----ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
V HRD+K N+L D +K+ DFG A+++ P + V T ++ APE+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT----PEQSKRSTMVGTPYWMAPEVVT 188
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
Y P +DIWS+G + EM+ G+P + +N + L L+ GTP ++ ++
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEKL---- 241
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
P+ L R L D + R +A+E L P+
Sbjct: 242 -----------------------SPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 6e-21
Identities = 88/300 (29%), Positives = 134/300 (44%), Gaps = 54/300 (18%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 172
Y V+GKGSYG V G++ IKK+N + S R +E +LL L+HP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN--LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DL-HQVIKANDDLTPEH--YQFFLYQLLRG 228
+IV + E +Y+V E DL H++ + L PE+ ++F+ Q+
Sbjct: 60 NIVAYRE----SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV-QIAMA 114
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV--SFNDAPSAIFWTDYVATRWYR 286
L+Y+H ++ HRDLK +N+ +K+ D G+ARV + D S + T Y Y
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY-----YM 169
Query: 287 APELCGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
+PEL F +K Y D+W++GC EM T K F K+ M L +
Sbjct: 170 SPEL---FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-------MNSL--------V 211
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
RI K P+P + P L+ +L+ P+ RP+ + L PY
Sbjct: 212 YRIIEGKL----------PPMPKDY-----SPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 83/329 (25%), Positives = 129/329 (39%), Gaps = 70/329 (21%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+++ +VIG+G++G V D TG+ A+K + + +R + +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI------ 54
Query: 173 DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 228
+ + + F+D +Y+V E M DL ++ D E +F++ +L+
Sbjct: 55 -LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLA----------------RVSFNDAPS 272
L +H HRD+KP NIL +AD +K+ DFGL
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 273 AIFWTDY----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
+ D+ V T Y APE L G+ Y D WS+G I EML G P F
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT---PYGLECDWWSLGVILYEMLYGFPPF 230
Query: 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH 381
E+ ++I N K L P P A+
Sbjct: 231 YSDT---------------LQETYNKIINWK--ESLR-------FPPDPPVS---PEAID 263
Query: 382 LLERLLAFDPKDR-PTAEEALADPYFHGL 409
L+ RLL DP+DR + EE + P+F G+
Sbjct: 264 LICRLLC-DPEDRLGSFEEIKSHPFFKGI 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 8e-21
Identities = 78/300 (26%), Positives = 132/300 (44%), Gaps = 46/300 (15%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI----NDVFEHVSDATRILREIKLLRLLR 170
+ EV+GKG+YG V + T+ G+ +A+K++ ++V + ++ E+ LL+ L+
Sbjct: 2 WTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 229
H +IV+ L + I + E + + ++ L + + Q+L G+
Sbjct: 61 HVNIVQYLGTCL-----DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGV 115
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLAR----VSFNDAPSAIFWTDYVATRWY 285
Y+H V HRD+K N++ + +K+ DFG AR V + S + + + T ++
Sbjct: 116 AYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYW 174
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ S Y DIWSIGC EM TGKP S+
Sbjct: 175 MAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPL---------------------ASM 211
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
R+ A Y+G+ R P F A A+ + L D +RP+A + L +
Sbjct: 212 DRL---AAMFYIGAHRGLMP-RLPDSFSAA---AIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 8e-21
Identities = 68/228 (29%), Positives = 113/228 (49%), Gaps = 15/228 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y E IG+G+ G V +A+D TG+ VAIK++N + I+ EI ++R +HP+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRENKHPN 77
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
IV L +++VV E + + + + L+ L+++H
Sbjct: 78 IVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 132
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
+ V HRD+K NIL D +K+ DFG A+++ P + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT----PEQSKRSTMVGTPYWMAPEVVT 188
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
Y P +DIWS+G + EM+ G+P + +N + L L+ GTP
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 9e-21
Identities = 86/303 (28%), Positives = 129/303 (42%), Gaps = 55/303 (18%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHT--GERVAIKKINDVFE-HVSDATRILREIKLLRLLR 170
RY +Q+ +GKGS+G V D ER+ + K V E + ++ + +E +LL L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLH---QVIKANDDLTPEHYQF-FLYQL 225
HP IV+ L E ++ E E DL + +K E+ + QL
Sbjct: 61 HPAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
L G+ Y+H + HRDLK KNI + LKI DFG++R+ A T + T +Y
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA---TTFTGTPYY 171
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL--GTPSTE 343
+PE Y DIWS+GCI EM F G+N L ++ ++ TPS
Sbjct: 172 MSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPTPS-- 224
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH-LLERLLAFDPKDRPTAEEALA 402
P L+ +++ +L DP RP+A E L
Sbjct: 225 ----------------------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
Query: 403 DPY 405
+P+
Sbjct: 257 NPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 42/217 (19%)
Query: 121 IGKGSYGVVGSA----VDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLRHPDI 174
+G+G +G V + +TGE+VA+K +N +H SD REI++LR L H +I
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTLDHENI 68
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLY--QLLRG 228
V+ K + P R + ++ E + S D Q + + + L+ Q+ +G
Sbjct: 69 VKYKGVCEKPGGRSLR---LIMEYLPSGSLRDYLQRHRDQIN----LKRLLLFSSQICKG 121
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV---------SFNDAPSAIFWTDY 279
+ Y+ + HRDL +NIL ++ +KI DFGLA+V S IFW Y
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW--Y 179
Query: 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
APE C SK++ A D+WS G E+ T
Sbjct: 180 -------APE-CLR-TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 97/350 (27%), Positives = 148/350 (42%), Gaps = 74/350 (21%)
Query: 104 EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRI 159
E F++ + IG GS+G V A D T E VAIKK++ E D I
Sbjct: 6 ELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD---I 62
Query: 160 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME------SDLHQVIKANDDL 213
++E++ L+ LRHP+ +E K L RE + + +ME SD+ +V K L
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYL----RE----HTAWLVMEYCLGSASDILEVHK--KPL 112
Query: 214 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273
+ L+GL Y+H+ HRD+K NIL +K+ DFG A + +P+
Sbjct: 113 QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---SPAN 169
Query: 274 IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLD 331
F V T ++ APE+ + +Y +D+WS+G E+ K PLF ++
Sbjct: 170 SF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMN 218
Query: 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP 391
M+ L +S + +S F N ++ L P
Sbjct: 219 AMSALYHIAQNDSPTL----------------SSNDWSDYFRN-------FVDSCLQKIP 255
Query: 392 KDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREM 441
+DRP++EE L + V RE I L +R KD VRE+
Sbjct: 256 QDRPSSEELLKHRF------VLRERPPTVIIDL---IQR---TKDAVREL 293
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 27/221 (12%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN--DVF-----EHVSDATRILREIKL 165
+ + +G G++G V D + A+K + +V +HV + R+L+E+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-- 58
Query: 166 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 224
HP I+ L + + + +Y++ E + +L ++ + + F+ +
Sbjct: 59 ----SHPFIIR-----LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
++ L+Y+H+ + +RDLKP+NIL + + +K+ DFG A+ + WT T
Sbjct: 110 IVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WT-LCGTPE 163
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
Y APE+ S + A+D W++G + EML G P F N
Sbjct: 164 YLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 68/236 (28%), Positives = 116/236 (49%), Gaps = 15/236 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y E IG+G+ G V +A+D TG+ VAIK++N + I+ EI ++R ++P+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPN 77
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
IV L +++VV E + + + + L+ L ++H
Sbjct: 78 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
+ V HRD+K NIL D +K+ DFG A+++ P + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT----PEQSKRSTMVGTPYWMAPEVVT 188
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
Y P +DIWS+G + EM+ G+P + +N + L L+ GTP ++ R+
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPERL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 66/236 (27%), Positives = 117/236 (49%), Gaps = 15/236 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y E IG+G+ G V +A+D TG+ VAI+++N + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
IV L +++VV E + + + + L+ L+++H
Sbjct: 79 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
+ V HRD+K NIL D +K+ DFG A+++ P + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT----PEQSKRSTMVGTPYWMAPEVVT 189
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
Y P +DIWS+G + EM+ G+P + +N + L L+ GTP ++ ++
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKL 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 68/210 (32%), Positives = 112/210 (53%), Gaps = 20/210 (9%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLR 170
+ +QI++ IG+G + V A + VA+KK+ +FE + R ++EI LL+ L
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLN 60
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEH--YQFFLYQ 224
HP++ IK++ S E ++ +V EL ++ DL Q+I K L PE +++F+ Q
Sbjct: 61 HPNV--IKYL---DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-Q 114
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
L ++++H+ V HRD+KP N+ A +K+ D GL R + +A V T +
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPY 171
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEM 314
Y +PE + Y DIWS+GC+ EM
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 29/230 (12%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGER-VAIKKIN--------DVFEHVSDATRILREIKL 165
Y + E +G G++G V + G+ +A+K+IN D E I+ E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 166 LR-LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEH--Y 218
++ LRHP+IV L R +Y+V +L+E + +K E +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDR-----LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 219 QFFLYQLLRGLKYIHTAN-VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 277
F+ Q++ L+Y+H + HRDL P NI+ D K+ I DFGLA+ ++ T
Sbjct: 117 NIFV-QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES----KLT 171
Query: 278 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
V T Y PE+ + Y D+W+ GCI +M T +P F N++
Sbjct: 172 SVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 5e-20
Identities = 84/285 (29%), Positives = 136/285 (47%), Gaps = 42/285 (14%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDIVEIKH 179
IG GS+G V A ++HT E VA+KK++ + ++ + I++E+K L+ L+HP+ +E K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 180 IMLPPSRREFKDIYVVFELME------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
L K+ + + +ME SDL +V K L + L+GL Y+H
Sbjct: 89 CYL-------KE-HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH 138
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ N+ HRD+K NIL ++K+ DFG A S +P+ +V T ++ APE+ +
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---SPA----NSFVGTPYWMAPEVILA 191
Query: 294 F-FSKYTPAIDIWSIGCIFAEMLTGKP-LFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
+Y +D+WS+G E+ KP LF ++ M+ L +S + NE
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMNAMSALYHIAQNDSPTLQSNE 244
Query: 352 KARRYLGSMRKKQPVPFS-HKFPNADPLALHLLERLLAFDPKDRP 395
+ G V + K P P + LL F +DRP
Sbjct: 245 WTDSFRGF------VDYCLQKIPQERPASAELLRH--DFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 7e-20
Identities = 70/221 (31%), Positives = 112/221 (50%), Gaps = 33/221 (14%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATR--ILREIKL 165
+AS +I++VIG G +G V S G+R VAIK + + ++ R L E +
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASI 58
Query: 166 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 224
+ HP+I+ ++ ++ + K + +V E ME+ L ++ +D QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVV-----TKSKPVMIVTEYMENGSLDAFLRKHDG------QFTVIQ 107
Query: 225 L---LRG----LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 277
L LRG +KY+ HRDL +NIL N++ K+ DFGL+RV D P A + T
Sbjct: 108 LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEAAYTT 166
Query: 278 D--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ RW APE + K+T A D+WS G + E+++
Sbjct: 167 RGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 7/208 (3%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN---DVFEHVSDATRILREIKLLRLLRH 171
+++ +++G+G++G V D TG +A+K++ D E + + EI+LL+ LRH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
IV+ + P ++ I+V + + + +KA LT + + Q+L+G+ Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLS-IFVEY-MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+H+ + HRD+K NIL ++ +K+ DFG ++ S T ++ +PE+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKP 319
Y D+WS+ C EMLT KP
Sbjct: 182 SG--EGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 9/211 (4%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN---DVFEHVSDATRILREIKLLRLL 169
+ +++ +++G+G++G V D TG +A+K++ + E + + EI+LL+ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRG 228
H IV+ + P R + E M + +K+ LT + + Q+L G
Sbjct: 62 LHERIVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEG 118
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
+ Y+H+ + HRD+K NIL ++ +K+ DFG ++ S T ++ +P
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 319
E+ Y DIWS+GC EMLT KP
Sbjct: 179 EVISG--EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 91/303 (30%), Positives = 142/303 (46%), Gaps = 51/303 (16%)
Query: 105 FFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR-ILREI 163
FF E E ++E IG GS+G V A D T E VAIKK++ + ++ + I++E+
Sbjct: 18 FFKEDPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEV 76
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM---ESDLHQVIKANDDLTPEHYQF 220
K L+ ++HP+ +E K L RE ++V E SDL +V K L
Sbjct: 77 KFLQRIKHPNSIEYKGCYL----RE-HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAA 129
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
+ L+GL Y+H+ N+ HRD+K NIL ++K+ DFG A ++ +P+ +V
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA---SPA----NSFV 182
Query: 281 ATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLG 338
T ++ APE+ + +Y +D+WS+G E+ K PLF ++ M+ L
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMNAMSALYH 235
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
ES + NE +S F N L + P+DRPT+E
Sbjct: 236 IAQNESPTLQSNE----------------WSDYFRNFVDSCLQKI-------PQDRPTSE 272
Query: 399 EAL 401
E L
Sbjct: 273 ELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-19
Identities = 87/294 (29%), Positives = 128/294 (43%), Gaps = 52/294 (17%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV---SDATRILREIKLLRLLRHPDIVEI 177
IGKGS+G V T A+K I H+ S+ T L E +L + P IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRK--AHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
K P + +Y+V + +L ++ +F+ +LL L+ +H N
Sbjct: 59 KFSFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN 113
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
V +RDLKP+NIL + + +CDFGL +++ D + T Y APEL
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT---NTFCGTPEYLAPELLLGH-- 168
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356
YT A+D W++G + EMLTG P F +NV NE R+
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----------------------NEMYRKI 205
Query: 357 LGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR---PTAEEALADPYF 406
L ++P+ +FP D A LL LL+ DP R A+E P+F
Sbjct: 206 L-----QEPL----RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 66/219 (30%), Positives = 113/219 (51%), Gaps = 20/219 (9%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLR 170
+ ++I++ IG+G + V A G VA+KK+ +F+ + R ++EI LL+ L
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLN 60
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEH--YQFFLYQ 224
HP++++ + E ++ +V EL ++ DL ++I K L PE +++F+ Q
Sbjct: 61 HPNVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-Q 114
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
L L+++H+ V HRD+KP N+ A +K+ D GL R + +A V T +
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPY 171
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323
Y +PE + Y DIWS+GC+ EM + F G
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 7e-19
Identities = 101/439 (23%), Positives = 171/439 (38%), Gaps = 65/439 (14%)
Query: 16 QRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQQLTIVEDFDFSGLKL 75
+ + ++ NN+ + + ++ +N+ S S E + + +
Sbjct: 22 APVNALSGNSPKANNSASTGQTTSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAA--- 78
Query: 76 IRVPKRIQFPIAPTPATMDPHKKSAL----------ETEFFTEYGE-----ASRYQIQEV 120
K+ P KK + E F+ GE R++I +
Sbjct: 79 --TTKQATTTPTTNVEVAPPPKKKKVTYALPNQSREEGHFYVVLGEDIDVSTQRFKILSL 136
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
+G+G++G V A D E A+K + +V ++ DA +I EI+ + +R D + +
Sbjct: 137 LGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDA-KI--EIQFMEKVRQADPADRFPL 193
Query: 181 MLPPSRREFKD----IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA- 235
M +R F++ + +V L I + + H ++Q L Y HT
Sbjct: 194 M--KIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL 251
Query: 236 NVFHRDLKPKNILANAD----------------CKLKICDFGLARVSFNDAPSAIFWTDY 279
++ H DLKP+NIL C+++ICD G + +AI
Sbjct: 252 HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSRTAI----- 305
Query: 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339
V+TR YR+PE+ Y+ D+WS+GCI E+ TGK L+ + + L LM LG
Sbjct: 306 VSTRHYRSPEVVLGLGWMYS--TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR 363
Query: 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPN-----------ADPLALHLLERLLA 388
+E R E+AR S + +P D L L+ LL
Sbjct: 364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423
Query: 389 FDPKDRPTAEEALADPYFH 407
+D + R A + PY
Sbjct: 424 YDRQKRLNARQMTTHPYVL 442
|
Length = 467 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 79/299 (26%), Positives = 135/299 (45%), Gaps = 61/299 (20%)
Query: 121 IGKGSYGVVG----SAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIV 175
+GKG++G V + +TGE VA+KK+ + EH+ D REI++L+ L+H +IV
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD---FEREIEILKSLQHDNIV 68
Query: 176 EIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLY--QLLRGLKYI 232
+ K + RR + +V E L L ++ + + +H + LY Q+ +G++Y+
Sbjct: 69 KYKGVCYSAGRRNLR---LVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQICKGMEYL 124
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFND---------APSAIFWTDYVATR 283
+ HRDL +NIL ++ ++KI DFGL +V D S IFW
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY------ 178
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
APE SK++ A D+WS G + E+ T +D +P E
Sbjct: 179 ---APESLTE--SKFSVASDVWSFGVVLYELFT----------------YSDKSCSPPAE 217
Query: 344 SISRIRNEKAR-----RYLGSMRKKQPVPFSHKFPNADPLALH-LLERLLAFDPKDRPT 396
+ + N+K + ++ +P P P ++ +++ DP RP+
Sbjct: 218 FMRMMGNDKQGQMIVYHLIELLKNNGRLP----APPGCPAEIYAIMKECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 70/243 (28%), Positives = 116/243 (47%), Gaps = 24/243 (9%)
Query: 119 EVIGKGSYG---VVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+V+G+GS+G +V G+ A+K + V D R E +L + HP IV
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
++ + + +Y++ + + DL + T E +F+L +L L ++H+
Sbjct: 62 KLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 116
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ +RDLKP+NIL + + +K+ DFGL++ S + A + T Y APE+
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR- 172
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL----LGTP---STESISR 347
+T + D WS G + EMLTG F GK + + MT + LG P S E+ S
Sbjct: 173 -RGHTQSADWWSFGVLMFEMLTGSLPFQGK---DRKETMTMILKAKLGMPQFLSPEAQSL 228
Query: 348 IRN 350
+R
Sbjct: 229 LRA 231
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 67/241 (27%), Positives = 106/241 (43%), Gaps = 42/241 (17%)
Query: 111 EASRYQIQ--EVIGKGSYGVVGSAV-DTHTGERVAIKKINDVFEHVSDATRILREIKLLR 167
E R ++ +G G +G V + T +VA+K + L+E ++++
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLK---PGTMSPEAFLQEAQIMK 56
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQ 224
LRH +V++ + S E IY+V E M L +K+ + L Q
Sbjct: 57 KLRHDKLVQLYAVC---SEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQ 111
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWT 277
+ G+ Y+ + N HRDL +NIL + KI DFGLAR+ +D +A I WT
Sbjct: 112 IAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT 171
Query: 278 DYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
APE G F K D+WS G + E++T G+ +PG V+ Q++
Sbjct: 172 ---------APEAANYGRFTIKS----DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE 218
Query: 332 L 332
Sbjct: 219 R 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 118 QEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
Q+VIG G +G V + G + VAIK + + L E ++ H +I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNI 68
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLYQLLRGLKYI 232
+ ++ ++ +FK ++ E ME+ L + ++ +D + + L + G+KY+
Sbjct: 69 IRLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD--YVATRWYRAPEL 290
N HRDL +NIL N++ + K+ DFGL+RV D P + T + RW APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRW-TAPEA 181
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ K+T A D+WS G + E+++
Sbjct: 182 IA--YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-18
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 137 TGERVAIKKINDVFEHVSDA---TRILREIKLLRLLRHPDIVE-IKHIMLPPSRREFKDI 192
TG VAIK + + + R RE L L HP+IV + PP +
Sbjct: 2 TGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-----L 54
Query: 193 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI-LAN 250
+ VFE + L +V+ A+ L + Q+L L H + HRDLKP+NI ++
Sbjct: 55 FAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114
Query: 251 ADCK--LKICDFGLAR----VSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAID 303
+ K+ DFG+ V D + T+ + T Y APE L G TP D
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG---EPVTPNSD 171
Query: 304 IWSIGCIFAEMLTGKPLFPGKNV 326
+++ G IF E LTG+ + G +V
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASV 194
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 23/229 (10%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRH 171
+ ++ +G G +G V + RVAIK + +D D + E++ L+ LRH
Sbjct: 6 EEFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQK---EVQALKRLRH 61
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRG 228
++ + + +Y++ ELME L +++ + L Q+ G
Sbjct: 62 KHLISL-FAVCSVGE----PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD--YVATRWYR 286
+ Y+ N HRDL +NIL D K+ DFGLAR+ D ++ + + +W
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED----VYLSSDKKIPYKW-T 171
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 334
APE ++ D+WS G + EM T G+ +PG N D +T
Sbjct: 172 APEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 117 IQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATRI--LREIKLLRLLRH 171
I++VIG G +G V G++ VAIK + SD R+ L E ++ H
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDH 64
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 229
P+I+ ++ ++ ++ + + ++ E ME+ L + ++ ND T L + G+
Sbjct: 65 PNIIRLEGVV---TKS--RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD--YVATRWYRA 287
KY+ N HRDL +NIL N++ K+ DFGL+R + A + T + RW A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW-TA 176
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
PE + K+T A D+WS G + E+++
Sbjct: 177 PEAIA--YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 77/299 (25%), Positives = 119/299 (39%), Gaps = 49/299 (16%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKH 179
+GKG +G V + TG+ A KK++ + L E K+L + IV + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 180 IMLPPSRREFKDIYVVFELMES-DLH-QVIKANDDLTPE-HYQFFLYQLLRGLKYIHTAN 236
D+ +V LM DL + + PE F+ Q++ GL+++H
Sbjct: 61 AFETKD-----DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
+ +RDLKP+N+L + ++I D GLA V T Y APE+
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKI---KGRAGTPGYMAPEVLQG--E 169
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356
Y ++D +++GC EM+ G+ F R R EK +
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF-------------------------RQRKEKVEKE 204
Query: 357 -LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 409
L + V + KF P A L E LL DP+ R +A+E P F L
Sbjct: 205 ELKRRTLEMAVEYPDKF---SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 8e-18
Identities = 76/302 (25%), Positives = 122/302 (40%), Gaps = 67/302 (22%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
I KG++G V A TG+ AIK +L++ ++ + ++ + I
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIK--------------VLKKSDMIAKNQVTNVKAERAI 49
Query: 181 MLPPSRREF----------KD-IYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRG 228
M+ + KD +Y+V E L D +IK L + + ++ +++ G
Sbjct: 50 MMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLG 109
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
++ +H + HRD+KP+N+L + LK+ DFGL+R + +V T Y AP
Sbjct: 110 VEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPDYLAP 162
Query: 289 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
E + G D WS+GC+ E L G P F TP
Sbjct: 163 ETILG---VGDDKMSDWWSLGCVIFEFLFGYPPFHA--------------ETPD-AVFDN 204
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA---EEALADP 404
I +RR K+ P A+ L+ RLL DP R A +E + P
Sbjct: 205 I---LSRRINWPEEVKE---------FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252
Query: 405 YF 406
+F
Sbjct: 253 FF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 80/308 (25%), Positives = 124/308 (40%), Gaps = 77/308 (25%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDT-HTGER--VAIK--KINDVFEHVSDATRILREIKLLR 167
+ IG+G +G V V E+ VA+K K S + L+E ++R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMR 62
Query: 168 LLRHPDIVE-IKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQ 224
HP IV+ I I P +++V EL +L ++ N L + YQ
Sbjct: 63 QFDHPHIVKLIGVITENP-------VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQ 115
Query: 225 LLRGLKYIHTANVFHRDLKPKNIL-ANADCKLKICDFGLARVSFNDAPSAIFWTD----Y 279
L L Y+ + HRD+ +N+L ++ DC +K+ DFGL+R + + Y
Sbjct: 116 LSTALAYLESKRFVHRDIAARNVLVSSPDC-VKLGDFGLSR-----------YLEDESYY 163
Query: 280 VATR------WYRAPELCGSFFSKYTPAIDIWSIG-CIFAEMLTG-KPLFPGKNVVHQLD 331
A++ W APE F ++T A D+W G C++ ++ G KP
Sbjct: 164 KASKGKLPIKWM-APESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQ---------- 210
Query: 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP 391
G + + I RI E R P+P PN P L+ + A+DP
Sbjct: 211 ------GVKNNDVIGRI--ENGERL--------PMP-----PNCPPTLYSLMTKCWAYDP 249
Query: 392 KDRPTAEE 399
RP E
Sbjct: 250 SKRPRFTE 257
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 71/291 (24%), Positives = 126/291 (43%), Gaps = 39/291 (13%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIN---DVFEHVSDATRILREIKLLRLLRHPDIV 175
+++G+G++G V D TG +A K++ + E + + + EI+LL+ L+H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ + R K + + E M + +KA LT + + Q+L G+ Y+H+
Sbjct: 68 QYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ HRD+K NIL ++ +K+ DFG ++ S T ++ +PE+
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG- 183
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354
Y D+WS+GC EMLT KP + + + + P+ + +E AR
Sbjct: 184 -EGYGRKADVWSLGCTVVEMLTEKPPWAE---YEAMAAIFKIATQPTNPQLPSHISEHAR 239
Query: 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+LG + + + RP+AEE L P+
Sbjct: 240 DFLGC---------------------------IFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 25/218 (11%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDIVEIKH 179
IG GS+G V A D E VAIKK++ + ++ + I++E++ L+ LRHP+ ++ +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 180 IMLPPSRREFKDIYVVFELME------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
L RE + + +ME SDL +V K L + L+GL Y+H
Sbjct: 83 CYL----RE----HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ N+ HRD+K NIL + +K+ DFG A + AP+ +V T ++ APE+ +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APA----NXFVGTPYWMAPEVILA 185
Query: 294 F-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQL 330
+Y +D+WS+G E+ KP N + L
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 72/293 (24%), Positives = 128/293 (43%), Gaps = 41/293 (13%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
+G+G+ G V +TG A+K I + +ILRE+++ + + P IV+
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 181 MLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQ-LLRGLKYIHTA 235
L S I + E E +++ +K E + + +L+GL Y+H+
Sbjct: 68 FLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSF 294
+ HRD+KP NIL ++K+CDFG++ N + T +Y APE + G
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-----FTGTSFYMAPERIQG-- 177
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFP--GKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
Y+ D+WS+G E+ + FP G+ + ++L++ I + N +
Sbjct: 178 -KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS---------YIVNMPNPE 227
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+ G+ K +S +F +++ L DP RPT + L P+
Sbjct: 228 LKDEPGNGIK-----WSEEFK-------DFIKQCLEKDPTRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 4e-17
Identities = 71/267 (26%), Positives = 112/267 (41%), Gaps = 37/267 (13%)
Query: 160 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 219
L E LL+ + HP ++ +K ++ + V SDL+ + P
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLV---SGAITCM--VLPHYSSDLYTYLTKRSRPLPIDQA 159
Query: 220 FFLY-QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 278
+ Q+L GL+Y+H + HRD+K +NI N ++ I D G A+ AP+ +
Sbjct: 160 LIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-APAFLGLAG 218
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLF---------PGKNV-V 327
V T APE+ KY DIWS G + EML +F K+
Sbjct: 219 TVET---NAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273
Query: 328 HQLDLMTDLLGTPS---TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH--- 381
H L +++ L P + SR+ Y R+ P++ ++P + L
Sbjct: 274 HLLKIISTLKVHPEEFPRDPGSRLVRGFI-EYASLERQ----PYT-RYPCFQRVNLPIDG 327
Query: 382 --LLERLLAFDPKDRPTAEEALADPYF 406
L+ ++L FD RP+AEE L P F
Sbjct: 328 EFLVHKMLTFDAAMRPSAEEILNYPMF 354
|
Length = 357 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 83/304 (27%), Positives = 126/304 (41%), Gaps = 57/304 (18%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
++I +G G++G V A TG A K I E + + EI +L +HP+I
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNI 64
Query: 175 VEIKH---------IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 225
V + I++ EF D + +M + LT ++ Q+
Sbjct: 65 VGLYEAYFYENKLWILI-----EFCDGGALDSIML-------ELERGLTEPQIRYVCRQM 112
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
L L ++H+ V HRDLK NIL D +K+ DFG VS + + ++ T ++
Sbjct: 113 LEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFG---VSAKNKSTLQKRDTFIGTPYW 169
Query: 286 RAPEL--CGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
APE+ C +F Y DIWS+G E+ +P P H+L+ M LL +
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--PH----HELNPMRVLLKILKS 223
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
E + QP +S F + L+ L DP DRPTA E L
Sbjct: 224 EPPTL---------------DQPSKWSSSFND-------FLKSCLVKDPDDRPTAAELLK 261
Query: 403 DPYF 406
P+
Sbjct: 262 HPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 6e-17
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 121 IGKGSYGVVGSAVDTHTGE-----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+G G +GVV H G+ VAIK I E + E K++ L HP++V
Sbjct: 12 LGSGQFGVV------HLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLV 62
Query: 176 EIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFL---YQLLRGLKY 231
++ + + + I++V E M + L ++ ++ L + ++Y
Sbjct: 63 QLYGVCT-----KQRPIFIVTEYMANGCLLNYLRERKGK--LGTEWLLDMCSDVCEAMEY 115
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+ + HRDL +N L D +K+ DFGLAR +D ++ T + +W PE+
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-PVKW-APPEVF 173
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGK 324
+S+++ D+WS G + E+ + GK +
Sbjct: 174 D--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 121 IGKGSYGVVGSAVDTHTGE-----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+G G +GVV H G+ +VAIK IN+ D + E K++ L HP +V
Sbjct: 12 LGSGQFGVV------HLGKWRAQIKVAIKAINEGAMSEED---FIEEAKVMMKLSHPKLV 62
Query: 176 EIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
++ + + K +Y+V E ME+ L+ + + L+ + + G++Y+
Sbjct: 63 QLYGVCT-----QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ HRDL +N L ++ +K+ DFG+ R +D ++ + +W PE+
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKW-SPPEVFN- 174
Query: 294 FFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325
FSKY+ D+WS G + E+ T GK F K+
Sbjct: 175 -FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 77/318 (24%), Positives = 125/318 (39%), Gaps = 85/318 (26%)
Query: 116 QIQEVIGKGSYGVV--GSA---VDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
I+E +G+GS+G+V G A V RVAIK +N+ + + L E +++
Sbjct: 10 LIRE-LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFN 67
Query: 171 HPDIVEIKHIML---PPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDLTPEHYQ 219
+V + ++ P VV ELM + DL +++ N L P Q
Sbjct: 68 CHHVVRLLGVVSTGQPT--------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 220 FFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276
F+ ++ G+ Y+ HRDL +N + D +KI DFG+ R I+
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DIYE 171
Query: 277 TDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVV 327
TDY + RW APE +T D+WS G + EM T + + G +
Sbjct: 172 TDYYRKGGKGLLPVRWM-APESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-- 226
Query: 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGS---MRKKQPVPFSHKFPNADPLALHLLE 384
NE+ +++ + + P D L L L+
Sbjct: 227 ----------------------NEEVLKFVIDGGHLDLPENCP--------DKL-LELMR 255
Query: 385 RLLAFDPKDRPTAEEALA 402
++PK RPT E ++
Sbjct: 256 MCWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 9e-17
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIK--------KINDVFEHVSDATRILREIK 164
S +++ E +G GS+G V A TGE AIK K+ V +HV+ IL E
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV-QHVAQEKSILME-- 74
Query: 165 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQ 224
L HP IV + +R F +VV + + L + + +D+ +F+ +
Sbjct: 75 ----LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVA----KFYHAE 126
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
L+ +Y+H+ ++ +RDLKP+N+L + +K+ DFG A+ P F T
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTF--TLCGTPE 180
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
Y APE+ S + A+D W++G + E + G P F
Sbjct: 181 YLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 79/288 (27%), Positives = 124/288 (43%), Gaps = 33/288 (11%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
+G G+ G V TG +A KK+ + S +ILRE++++ R P IV
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 181 MLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN-VF 238
L + +I + E M+ L ++ K + E ++ GL Y++ + +
Sbjct: 72 FLNEN-----NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIM 126
Query: 239 HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY 298
HRD+KP NIL N+ ++K+CDFG++ N +V T Y +PE KY
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-----FVGTSTYMSPERIQG--GKY 179
Query: 299 TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLG 358
T D+WS+G E+ GK FP D D +G + + +I E R
Sbjct: 180 TVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGI--LDLLQQIVQEPPPR--- 232
Query: 359 SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+P S FP ++ L DP +RPT ++ A P F
Sbjct: 233 -------LP-SSDFP---EDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 33/217 (15%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATR--ILREIKLLRLLR 170
+I+EVIG G +G V G+R VAIK + + ++ R L E ++
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFD 63
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQL---L 226
HP+I+ ++ + + SR + ++ E ME+ L ++ ND QF + QL L
Sbjct: 64 HPNIIHLEGV-VTKSR----PVMIITEFMENGALDSFLRQNDG------QFTVIQLVGML 112
Query: 227 RG----LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY--- 279
RG +KY+ N HRDL +NIL N++ K+ DFGL+R +D + +
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172
Query: 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ RW APE + K+T A D+WS G + E+++
Sbjct: 173 IPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLL-RHPDIVEI 177
V+GKGS+G V A T E A+K + DV D + E ++L L +HP + ++
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 178 KHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
R +F +ME DL I+ + +F+ +++ GL+++H
Sbjct: 62 HSCFQTKDR--------LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSF-NDAPSAIFWTDYVATRWYRAPELCG 292
+ +RDLK N+L +++ +KI DFG+ + ++ F T Y APE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF----CGTPDYIAPEILS 169
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
+ Y PA+D W++G + EML G+ F G +
Sbjct: 170 --YQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 76/294 (25%), Positives = 128/294 (43%), Gaps = 40/294 (13%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+++ + IG G+YG V A + +TGE AIK I E D + +EI +++ +H +I
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
V L RR+ +++ E L + L+ + + L+GL Y+H
Sbjct: 69 VAYFGSYL---RRD--KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
+ HRD+K NIL + +K+ DFG+ A+++ A F + T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF----IGTPYWMAPEVAA 179
Query: 293 -SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
Y DIW++G E+ +P + + L LMT P
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP---------- 229
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+ K + +S+ F H ++ L +PK RPTAE+ L P+
Sbjct: 230 ---------KLKDKMKWSNSFH-------HFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVEI 177
+G G+ GVV + +G +A K I+ E + A R I+RE+K+L P IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIH--LE-IKPAIRNQIIRELKVLHECNSPYIVGF 64
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFL-YQLLRGLKYIHTA 235
+I + E M+ L QV+K + PE+ + +LRGL Y+
Sbjct: 65 YGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRI-PENILGKISIAVLRGLTYLREK 118
Query: 236 -NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGS 293
+ HRD+KP NIL N+ ++K+CDFG++ + ++ +V TR Y +PE L G
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQG- 172
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFP 322
+ YT DIWS+G EM G+ +P
Sbjct: 173 --THYTVQSDIWSLGLSLVEMAIGR--YP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 81/307 (26%), Positives = 129/307 (42%), Gaps = 53/307 (17%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
+GKG+YG V + TG +A+K+I + S +I+ E+ +L P IV+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLT---PEH-YQFFLYQLLRGLKYIHTA- 235
+Y+ E M++ + A T PE + Y +++GLK++
Sbjct: 68 FFIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE----LC 291
N+ HRD+KP N+L N + ++K+CDFG VS N S + T+ + + Y APE
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFG---VSGNLVAS-LAKTN-IGCQSYMAPERIKSGG 177
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK---NVVHQLDLMTDLLGTPSTESISRI 348
+ YT D+WS+G EM G+ +P + N+ QL + D G P T
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT------ 229
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408
P +S A + + L P RPT + L P+
Sbjct: 230 ---------------LPSGYS-------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267
Query: 409 LANVDRE 415
N D +
Sbjct: 268 YKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 19/216 (8%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK---KINDVFEHVSDATRILREIKLLRLLRH 171
++I E IGKG+YG V + G A+K I+DV E + IL+ L H
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS-----LPNH 78
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLTPEHYQFFLYQLL 226
P++V+ + + +++V EL + ++ L + LY L
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
GL+++H + HRD+K NIL + +K+ DFG VS + + V T ++
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWM 195
Query: 287 APELCG---SFFSKYTPAIDIWSIGCIFAEMLTGKP 319
APE+ + Y D+WS+G E+ G P
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 76/296 (25%), Positives = 123/296 (41%), Gaps = 50/296 (16%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDI 174
Q QE++G G+ G V A T +A+K I D+ + +I+ E+++L P I
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPYI 61
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEH-YQFFLYQLLRGLK 230
+ +R I + E M+ D+++ I PEH +++GL
Sbjct: 62 IGFYGAFFVENR-----ISICTEFMDGGSLDVYRKI-------PEHVLGRIAVAVVKGLT 109
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
Y+ + + HRD+KP N+L N ++K+CDFG++ N YV T Y APE
Sbjct: 110 YLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA-----KTYVGTNAYMAPER 164
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
+Y D+WS+G F E+ G+ +P + LL E +
Sbjct: 165 ISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL-- 220
Query: 351 EKARRYLGSMRKKQPV-PFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
PV FS KF +H + + + PK+RP E + P+
Sbjct: 221 --------------PVGQFSEKF-------VHFITQCMRKQPKERPAPENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 64/249 (25%), Positives = 101/249 (40%), Gaps = 62/249 (24%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKI--NDVFE-----HVSDATRILREIKLLRLLRH 171
+VIG+G++G V TG A+KK+ +++ E HV IL E +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD------N 60
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 227
P +V++ + F+D ++ +ME D+ ++ D T E +F++ + +
Sbjct: 61 PWVVKLYY--------SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL 112
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGL------------ARVSFNDAPSAIF 275
+ IH HRD+KP N+L +A +K+ DFGL R+ + PS
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 276 WTDY-----------------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 312
V T Y APE+ + Y D WS+G I
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMY 230
Query: 313 EMLTGKPLF 321
EML G P F
Sbjct: 231 EMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK---KINDVFEHVSDATRILREIKLLRLLRH 171
++I E IGKG+YG V ++ G + A+K I+D+ E + IL+ L H
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKA-----LSDH 74
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQ-VIKANDDLTPEHYQFFLYQLL 226
P++V+ + + +++V EL +DL + +K + + + L++ L
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
GL+++H HRD+K NIL + +K+ DFG VS + + V T ++
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWM 191
Query: 287 APELCG---SFFSKYTPAIDIWSIGCIFAEMLTGKP 319
APE+ S Y D+WS+G E+ G P
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 77/283 (27%), Positives = 117/283 (41%), Gaps = 41/283 (14%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
E IGKGS+G V +D T E VAIK I D+ E + I +EI +L P I
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 179 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 238
L ++ ++++ E + + L + L ++L+GL Y+H+
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI 123
Query: 239 HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY 298
HRD+K N+L + +K+ DFG+A D + I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAG-QLTD--TQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 299 TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLG 358
DIWS+G E+ G+P L M L P
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNS------DLHPMRVLFLIPKNSP-------------P 219
Query: 359 SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
++ + PF +E L DP+ RPTA+E L
Sbjct: 220 TLEGQYSKPFK-----------EFVEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 43/228 (18%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
++ IGKG +G V + + G++VA+K + D + A L E ++ LRHP++V
Sbjct: 9 KLGATIGKGEFGDV--MLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLV 63
Query: 176 EIKHIMLPPSRREFKDIYVVFELME---------SDLHQVIKANDDLTPEHYQFFLYQLL 226
++ ++L + +Y+V E M S VI L F +
Sbjct: 64 QLLGVVL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG------FALDVC 112
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF---WTDYVATR 283
G++Y+ N HRDL +N+L + D K+ DFGLA+ + S WT
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT------ 166
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GK---PLFPGKNVV 327
APE K++ D+WS G + E+ + G+ P P K+VV
Sbjct: 167 ---APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 80/269 (29%), Positives = 117/269 (43%), Gaps = 39/269 (14%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHP 172
V+G+G +G V A TGE AIK + D E + RI + RHP
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIF---ETANSERHP 62
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+V + + V E DL I + P F+ ++ GL+Y
Sbjct: 63 FLVNLFACFQTEDH-----VCFVMEYAAGGDLMMHIHTDVFSEPRA-VFYAACVVLGLQY 116
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYVATRWYRAPE 289
+H + +RDLK N+L + + +KI DFGL + + F D S + T + APE
Sbjct: 117 LHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-----FCGTPEFLAPE 171
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD-LMTDLLGTP---STESI 345
+ + YT A+D W +G + EML G+ FPG + D ++ D + P S E+I
Sbjct: 172 VLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAI 229
Query: 346 SRIRNEKAR---RYLGSMR------KKQP 365
S +R R R LGS KKQP
Sbjct: 230 SIMRRLLRRNPERRLGSGEKDAEDVKKQP 258
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+GKGS+G V A T E AIK + DV D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 179 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
H R +Y V E + DL I+ H F+ ++ GL ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVS-FNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
+RDLK N++ +A+ +KI DFG+ + + F + F T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF----CGTPDYIAPEIIA--YQ 176
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
Y ++D W+ G + EML G+P F G++
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 55/216 (25%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 119 EVIGKGSYGVV--GSAVDTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
VIGKG +G V G+ +D+ + A+K +N + + + + L+E +++ HP+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 176 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT 234
+ I LP E + V+ + DL I++ + T + F Q+ +G++Y+ +
Sbjct: 60 SLLGICLPS---EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS 116
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
HRDL +N + + +K+ DFGLAR I+ +Y + + +L +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYYSVHNHTGAKLPVKW 168
Query: 295 FS-------KYTPAIDIWSIGCIFAEMLT-GKPLFP 322
+ K+T D+WS G + E++T G P +P
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEI 177
+V+GKGS+G V A T E AIK + DV D + E ++L L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA------- 53
Query: 178 KHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
KH L F+ +F +ME DL I+ + +F+ ++ L ++H
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
V +RDLK NIL +A+ K+ DFG+ + + + T + T Y APE+
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQE 170
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
+Y P++D W++G + EM+ G+P F N
Sbjct: 171 L--EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 76/328 (23%), Positives = 127/328 (38%), Gaps = 78/328 (23%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEI 177
+++GKG G V TG+ A+K ++ + R+L E ++L L HP + +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 178 KHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHT 234
S + + +V + +L ++++ L+ E +F+ ++L L+Y+H
Sbjct: 67 YA-----SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT----------------- 277
+ +RDLKP+NIL + + + DF L++ S + P +
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQS-DVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 278 ----------DYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK 324
+V T Y APE+ G + A+D W++G + EML G F G
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDG-----HGSAVDWWTLGILLYEMLYGTTPFKGS 235
Query: 325 NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLE 384
N R+E L K+ V F P A L+
Sbjct: 236 N-----------------------RDETFSNIL-----KKEVTF-PGSPPVSSSARDLIR 266
Query: 385 RLLAFDPKDR----PTAEEALADPYFHG 408
+LL DP R A E P+F G
Sbjct: 267 KLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 36/237 (15%)
Query: 111 EASRYQIQEV--IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
E R IQ + +G G +G V + +T VA+K + D L E ++++
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLK---PGTMDPKDFLAEAQIMKK 57
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQL 225
LRHP ++++ + + E IY+V ELM+ L + ++ L Q+
Sbjct: 58 LRHPKLIQLYAVC---TLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTD 278
G+ Y+ N HRDL +N+L + K+ DFGLARV D A I WT
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT- 171
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
APE + +++++ D+WS G + E++T G+ +PG V+ Q+D
Sbjct: 172 --------APE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKIND-VFEHVSDATRILREIKLLR---LLRHPDIVE 176
IGKG++G V T A+K ++ + + E +L L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 177 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
+K S D+Y+V + M +L ++ + + +F++ +L+ L+++H
Sbjct: 61 LKFSFQTDS-----DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 295
++ +RDLKP+NIL +A + +CDFGL++ + D + + T Y APE+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT---NTFCGTTEYLAPEVLLD-E 171
Query: 296 SKYTPAIDIWSIGCIFAEMLTG 317
YT +D WS+G + EM G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 5e-15
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLR-HPDIVE 176
V+GKGS+G V A +G A+K + DV D + E ++L L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 177 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
+ P R ++ V E + DL I+ + +F+ ++ L ++H
Sbjct: 61 LYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVS-FNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ +RDLK N+L + + K+ DFG+ + FN ++ F T Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF----CGTPDYIAPEILQEM 171
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
Y P++D W++G + EML G F +N
Sbjct: 172 L--YGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 11/208 (5%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+GKGS+G V A T E AIK + DV D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 179 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
H R +Y V E + DL I+ H F+ ++ GL ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 297
+RDLK N++ +++ +KI DFG+ + + D + + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT---KTFCGTPDYIAPEIIA--YQP 177
Query: 298 YTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
Y ++D W+ G + EML G+ F G++
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 71/300 (23%), Positives = 127/300 (42%), Gaps = 52/300 (17%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEI 177
+++GKG++G V + TG+ A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 178 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
K+ R F Y +L + + + +F+ +++ L Y+H+ +V
Sbjct: 61 KYSFQTHDRLCFVMEYA----NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 297
+RDLK +N++ + D +KI DFGL + +D + + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--ND 171
Query: 298 YTPAIDIWSIGCIFAEMLTGKPLFPGK--NVVHQLDLMTDLLGTPSTESISRIRNEKARR 355
Y A+D W +G + EM+ G+ F + + +L LM ++
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI------------------- 212
Query: 356 YLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 409
+FP P A LL LL DPK R A+E + +F +
Sbjct: 213 ---------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
E IGKGS+G V +D T + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 179 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 238
L ++ ++++ E + + L L ++L+GL Y+H+
Sbjct: 69 GSYLKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 123
Query: 239 HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY 298
HRD+K N+L + ++K+ DFG+A D + I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAG-QLTD--TQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 299 TPAIDIWSIGCIFAEMLTGKP 319
DIWS+G E+ G+P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 120 VIGKGSYGVVGSAVDTH---TGERVAIK--KINDVFEHVSDATRILREIKLLRLLRHPDI 174
V+GKG YG V TG+ A+K K + + D E +L ++HP I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 175 VEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
V++ + + +Y++ E L +L ++ + F+L ++ L+++H
Sbjct: 63 VDLIYAFQTGGK-----LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ +RDLKP+NIL +A +K+ DFGL + S ++ + T Y APE+
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE---GTVTHTFCGTIEYMAPEILMR 174
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
S + A+D WS+G + +MLTG P F +N
Sbjct: 175 --SGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 117 IQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+QE IG G +G+V G ++ +VAIK I + D + E +++ L HP +
Sbjct: 9 VQE-IGSGQFGLVWLGYWLEK---RKVAIKTIREGAMSEED---FIEEAQVMMKLSHPKL 61
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLYQLLRGLKYI 232
V++ + E I +VFE ME L ++A + E + G+ Y+
Sbjct: 62 VQLYGVCT-----ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL 116
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
++NV HRDL +N L + +K+ DFG+ R +D ++ T + +W +PE+
Sbjct: 117 ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVKW-SSPEVFS 174
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLT 316
FSKY+ D+WS G + E+ +
Sbjct: 175 --FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 121 IGKGSYGVVGSAVDTHTGER---VAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVE 176
+G G++G V V + VA+K + EH + LRE ++ L HP IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ--EHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 177 IKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
+ + + +V EL L + +K ++ + +Q+ G+ Y+ +
Sbjct: 61 LIGVCKGEP------LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLAR-VSFND----APSAIFWTDYVATRWYRAPEL 290
+ HRDL +N+L + KI DFG++R + A +A W +WY APE
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW----PLKWY-APE- 168
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLT--GKPL--FPGKNVVHQLD 331
C ++ K++ D+WS G E + KP G V+ L+
Sbjct: 169 CINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 69/248 (27%), Positives = 111/248 (44%), Gaps = 31/248 (12%)
Query: 85 PIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIK 144
P+ P ++ S+ + S + IG G+ G V + TG A+K
Sbjct: 46 PLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK 105
Query: 145 KINDVFEHVSDATR--ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESD 202
I + + D R I REI++LR + HP++V+ H M + +I V+ E M+
Sbjct: 106 VI---YGNHEDTVRRQICREIEILRDVNHPNVVKC-HDMFDHN----GEIQVLLEFMDGG 157
Query: 203 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262
+ D+ Q+L G+ Y+H ++ HRD+KP N+L N+ +KI DFG+
Sbjct: 158 SLEGTHIADEQFLADVAR---QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGV 214
Query: 263 ARV---SFNDAPSAIFWTDYVATRWYRAPE-----LCGSFFSKYTPAIDIWSIGCIFAEM 314
+R+ + + S+ V T Y +PE L + Y A DIWS+G E
Sbjct: 215 SRILAQTMDPCNSS------VGTIAYMSPERINTDLNHGAYDGY--AGDIWSLGVSILEF 266
Query: 315 LTGKPLFP 322
G+ FP
Sbjct: 267 YLGR--FP 272
|
Length = 353 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-15
Identities = 82/328 (25%), Positives = 128/328 (39%), Gaps = 64/328 (19%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
E + + I E G+ G + +D T E V IK E +LR +
Sbjct: 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIK--------AGQRGGTATEAHILRAIN 141
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
HP I+++K ++ ++DL+ + A ++ +LR ++
Sbjct: 142 HPSIIQLKGTFTYNKF-----TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQ 196
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY----- 285
Y+H + HRD+K +NI N + + DFG +A F D A ++Y
Sbjct: 197 YLHENRIIHRDIKAENIFINHPGDVCLGDFG----------AACFPVDINANKYYGWAGT 246
Query: 286 ---RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNV------VHQLDLMTD 335
APEL Y PA+DIWS G + EM T LF + Q+ L+
Sbjct: 247 IATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304
Query: 336 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLE----------R 385
GT E + Y+G +K S + P + PL +L E +
Sbjct: 305 RSGTHPNEFPIDAQANLDEIYIGLAKK------SSRKPGSRPLWTNLYELPIDLEYLICK 358
Query: 386 LLAFDPKDRPTAE--------EALADPY 405
+LAFD RP+AE + + DPY
Sbjct: 359 MLAFDAHHRPSAEALLDFAAFQDIPDPY 386
|
Length = 391 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-15
Identities = 83/298 (27%), Positives = 122/298 (40%), Gaps = 51/298 (17%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+GKG +G V + TG+ A KK+ + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 179 HIMLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ E KD + +V LM DL H N E F+ ++ GL+ +H
Sbjct: 67 YAY------ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ +RDLKP+NIL + ++I D GLA + P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAPEVVKN- 175
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354
+YT + D W +GC+ EM+ GK F R R EK +
Sbjct: 176 -ERYTFSPDWWGLGCLIYEMIEGKSPF-------------------------RQRKEKVK 209
Query: 355 RYLGSMR-KKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYF 406
R R K+ +S KF A + +LL DP R AEE A P+F
Sbjct: 210 REEVERRVKEDQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 13/209 (6%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRL-LRHPDIVEI 177
V+GKGS+G V A T E AIK + DV D + E ++L L HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT-- 59
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
H+ +E ++ V E + DL I+++ +F+ +++ GL+++H
Sbjct: 60 -HLFCTFQTKEH--LFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
+ +RDLK N+L + D +KI DFG+ + + N A + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA---STFCGTPDYIAPEILKG--Q 171
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
KY ++D WS G + EML G+ F G++
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 9e-15
Identities = 64/250 (25%), Positives = 118/250 (47%), Gaps = 19/250 (7%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEI 177
+++GKG++G V + +G+ A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 178 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
K+ R F YV + L + ++D T +F+ +++ L Y+H+ +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT----RFYGAEIVSALDYLHSGKI 116
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 297
+RDLK +N++ + D +KI DFGL + DA + + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLED--ND 171
Query: 298 YTPAIDIWSIGCIFAEMLTGKPLFPGKN--VVHQLDLMTDLLGTPSTESISRIRNEKARR 355
Y A+D W +G + EM+ G+ F ++ + +L LM D+ R + A+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI-------KFPRTLSADAKS 224
Query: 356 YLGSMRKKQP 365
L + K P
Sbjct: 225 LLSGLLIKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLRL 168
+ + +V+G G++G V V GE+ VAIK + + ++ IL E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN-KEILDEAYVMAS 65
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLL 226
+ HP +V + I L + ++ +LM L V D++ ++ + Q+
Sbjct: 66 VDHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
+G+ Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM- 178
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLM 333
A E YT D+WS G E++T G + G V DL+
Sbjct: 179 ALESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 15/211 (7%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLL-RHPDIVE 176
+++GKGS+G V A T + AIK + DV D + E ++L L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT- 59
Query: 177 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
H+ +E +++ V E + DL I++ F+ +++ GL+++H+
Sbjct: 60 --HLYCTFQTKE--NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVS-FNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ +RDLK NIL + D +KI DFG+ + + DA + F T Y APE+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF----CGTPDYIAPEIL--L 169
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
KY ++D WS G + EML G+ F G +
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKL-LRLLRHPDI 174
++ E +G+G+YGVV TG +A+K+I R+L ++ + +R + P
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYT 62
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK---ANDDLTPEHYQFFL----YQLLR 227
V + RE D+++ E+M++ L + K PE L +++
Sbjct: 63 VTFYGALF----RE-GDVWICMEVMDTSLDKFYKKVYDKGLTIPED---ILGKIAVSIVK 114
Query: 228 GLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
L+Y+H+ +V HRD+KP N+L N + ++K+CDFG++ + + T + Y
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS----VAKTIDAGCKPYM 170
Query: 287 APELCGSFFSK--YTPAIDIWSIGCIFAEMLTGKPLFP 322
APE ++ Y D+WS+G E+ TG+ FP
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGR--FP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 75/310 (24%), Positives = 128/310 (41%), Gaps = 58/310 (18%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLLRHPD 173
+ ++ ++G+G +G V + TG+ A+K + + E + +L + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 174 IVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRG 228
I ++++ F+D +Y+V E DL ++ +D E QF+L +L+
Sbjct: 63 IPQLQY--------AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA 114
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFG-LARVSFNDAPSAIFWTDYVATRWYRA 287
+ +H HRD+KP+N+L + +K+ DFG AR++ N + V T Y A
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN---KMVNSKLPVGTPDYIA 171
Query: 288 PELC----GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
PE+ G Y D WS+G I EM+ G+ F +
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---------------K 216
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLA----LHLLERLLAFDPKDRPTAEE 399
+ + I N + R+L KFP DP L L++ LL K+R E
Sbjct: 217 TYNNIMNFQ--RFL-------------KFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEG 259
Query: 400 ALADPYFHGL 409
P+F +
Sbjct: 260 LCCHPFFSKI 269
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 34/219 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRH 171
+ + E+IG+G +G V +TG++VA+K I DV A L E ++ L H
Sbjct: 6 QKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHH 58
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDL---TPEHYQFFLYQLLR 227
++V + ++L +Y+V ELM + +L ++ + QF L +
Sbjct: 59 KNLVRLLGVIL------HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL-DVAE 111
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF---WTDYVATRW 284
G++Y+ + + HRDL +NIL + D K+ DFGLARV ++ WT
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT------- 164
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFP 322
APE K++ D+WS G + E+ + G+ +P
Sbjct: 165 --APEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 77/302 (25%), Positives = 123/302 (40%), Gaps = 51/302 (16%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+GKG +G V + TG+ A K++ + + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 179 HIMLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ E KD + +V +M DL H N E F+ ++L GL+ +H
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
N +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAV----KIPEGESIRGRVGTVGYMAPEVLNN- 175
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354
+YT + D W +GC+ EM+ G+ F G+ +++ E+
Sbjct: 176 -QRYTLSPDYWGLGCLIYEMIEGQSPFRGRK--------------------EKVKREEVD 214
Query: 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 414
R + + FS + A + + LL DPK R +E G V R
Sbjct: 215 RRVLETEEVYSAKFSEE-------AKSICKMLLTKDPKQRLGCQE-------EGAGEVKR 260
Query: 415 EP 416
P
Sbjct: 261 HP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 13/216 (6%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIND-VFEHVSDATRILREIK-LLRLLRHPDIVE 176
+VIGKGS+G V A G+ A+K + + + + I+ E LL+ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 177 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
+ + S + + +Y V + + +L ++ +F+ ++ L Y+H+
Sbjct: 61 LHY-----SFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 295
N+ +RDLKP+NIL ++ + + DFGL + + + T + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRK-- 170
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD 331
Y +D W +G + EML G P F ++V D
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
E IGKGS+G V +D T + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 179 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF-----LYQLLRGLKYIH 233
L ++ ++++ E + A D L + F L ++L+GL Y+H
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGG-----SALDLLRAGPFDEFQIATMLKEILKGLDYLH 118
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ HRD+K N+L + +K+ DFG+A D + I +V T ++ APE+
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAG-QLTD--TQIKRNTFVGTPFWMAPEVIQQ 175
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKP 319
S Y DIWS+G E+ G+P
Sbjct: 176 --SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+GKGS+G V A T E AIK + DV D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 179 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
H R +Y V E + DL I+ F+ ++ GL ++H +
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK 297
+RDLK N++ +++ +KI DFG+ + D + + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT---RTFCGTPDYIAPEIIA--YQP 177
Query: 298 YTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
Y ++D W+ G + EML G+P F G++
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIK--KINDVFEHVSDATRILREIKLLRLLRHPDIVE 176
E IGKG++G V V VA+K + + + L+E ++L+ HP+IV+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPD---LKRKFLQEAEILKQYDHPNIVK 56
Query: 177 IKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ + + + + IY+V EL+ S L + K + LT + G++Y+ +
Sbjct: 57 LIGVCV-----QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
N HRDL +N L + LKI DFG++R + + +W APE
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEALN-- 168
Query: 295 FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325
+ +YT D+WS G + E + G +PG +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 44/225 (19%)
Query: 116 QIQEVIGKGSYGVVGSAV-DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
++ + +G G +G V + HT +VAIK + + L E L++ L+HP +
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHT--KVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRL 63
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL------- 226
V + ++ + IY++ E ME+ L +K TPE + + +L+
Sbjct: 64 VRLYAVVTQ------EPIYIITEYMENGSLVDFLK-----TPEGIKLTINKLIDMAAQIA 112
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDY 279
G+ +I N HRDL+ NIL + KI DFGLAR+ ++ +A I WT
Sbjct: 113 EGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT-- 170
Query: 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
APE + +T D+WS G + E++T G+ +PG
Sbjct: 171 -------APEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 77/320 (24%), Positives = 122/320 (38%), Gaps = 59/320 (18%)
Query: 120 VIGKGSYG--VVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVE 176
+IGK +V A T VA+KKIN D D + +EI R L+HP+I+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILP 63
Query: 177 IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY---------QFFLYQLLR 227
+ S ++YVV LM + +DL H+ F L +L
Sbjct: 64 YVTSFIVDS-----ELYVVSPLMA------YGSCEDLLKTHFPEGLPELAIAFILKDVLN 112
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDF---------GLARVSFNDAP-SAIF-- 275
L YIH+ HR +K +IL + D K+ + G + +D P S++
Sbjct: 113 ALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 276 -WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMT 334
W +PE+ Y DI+S+G E+ G P K++ L+
Sbjct: 173 PWL---------SPEVLQQNLQGYNEKSDIYSVGITACELANG--HVPFKDMPATQMLLE 221
Query: 335 DLLGTP------ST--ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 386
+ GT ST + ++ + R P++ F +E
Sbjct: 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTF---SEHFHQFVELC 278
Query: 387 LAFDPKDRPTAEEALADPYF 406
L DP+ RP+A + L +F
Sbjct: 279 LQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 70/240 (29%), Positives = 111/240 (46%), Gaps = 38/240 (15%)
Query: 111 EASRYQIQEV--IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
E R I+ V +G G +G V + +VA+K + V L E L++
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQ---AFLEEANLMKT 57
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDD---LTPEHYQFFLYQ 224
L+H +V + ++ ++ E IY++ E M + L +K+++ L P+ F Q
Sbjct: 58 LQHDKLVRLYAVV---TKEE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-Q 111
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWT 277
+ G+ YI N HRDL+ N+L + KI DFGLARV ++ +A I WT
Sbjct: 112 IAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT 171
Query: 278 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDL 336
APE F +T D+WS G + E++T GK +PG + D+M+ L
Sbjct: 172 ---------APEAIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
Q+ + +G G +G V +VA+K + L E ++++ LRH +V
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 176 EIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLRGLKYI 232
++ ++ S IY+V E M + L +K + + Q+ G+ YI
Sbjct: 65 QLYAVV---SEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYVATRWY 285
N HRDL+ NIL KI DFGLAR+ ++ +A I WT
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT-------- 170
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325
APE + + ++T D+WS G + E++T G+ +PG N
Sbjct: 171 -APE--AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 75/291 (25%), Positives = 124/291 (42%), Gaps = 40/291 (13%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
Y++ + +G G+YG V A + HTGE A+K I E D + I +EI +++ +H +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
V L SR + +++ E L + L+ + + L+GL Y+H
Sbjct: 69 VAYFGSYL--SREK---LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
+ HRD+K NIL + +K+ DFG+ A+++ A F + T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF----IGTPYWMAPEVAA 179
Query: 293 -SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
Y DIW++G E+ +P + + L LM+ P
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP---------- 229
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
+ K +S F N ++ L +PK RPTAE L
Sbjct: 230 ---------KLKDKTKWSSTFHNFVKIS-------LTKNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 65/253 (25%), Positives = 118/253 (46%), Gaps = 25/253 (9%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEI 177
+++GKG++G V + TG A+K + +V + + E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
K+ R F V E +L + T E +F+ +++ L+Y+H+ +
Sbjct: 61 KYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
V +RD+K +N++ + D +KI DFGL + +D + + T Y APE+ +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--N 170
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH----QLDLMTDLLGTPSTESISRIRNEK 352
Y A+D W +G + EM+ G+ P N H +L LM ++ R + +
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEI-------RFPRTLSPE 221
Query: 353 ARRYLGSMRKKQP 365
A+ L + KK P
Sbjct: 222 AKSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 116 QIQEVIGKGSYGVVGSAV-DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
++++ +G G +G V A + HT +VA+K + V L E +++ L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKL 63
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
V++ ++ +E IY++ E M D + + + P+ F Q+ G+
Sbjct: 64 VKLHAVV----TKE--PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA-QIAEGMA 116
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYVATR 283
+I N HRDL+ NIL +A KI DFGLARV ++ +A I WT
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT------ 170
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
APE F +T D+WS G + E++T G+ +PG
Sbjct: 171 ---APEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 67/257 (26%), Positives = 110/257 (42%), Gaps = 52/257 (20%)
Query: 119 EVIGKGSYGVV-----GSAVDTHTGERVAIKKINDVFEHVSDATR-ILREIKLLRLLRHP 172
+G+G++G V + E VA+K + + +DA + RE +LL +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQHE 68
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND--------------DLTPEH 217
+IV+ + E +VFE ME DL++ ++++ +LT
Sbjct: 69 NIVKFYGVCT-----EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123
Query: 218 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 277
Q+ G+ Y+ + + HRDL +N L D +KI DFG++R ++ T
Sbjct: 124 LLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--------DVYTT 175
Query: 278 DY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GK-PLFPGKN-- 325
DY + RW PE + K+T D+WS G + E+ T GK P + N
Sbjct: 176 DYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232
Query: 326 VVHQLDLMTDLLGTPST 342
V+ + LL P T
Sbjct: 233 VIECITQGR-LLQRPRT 248
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 78/300 (26%), Positives = 124/300 (41%), Gaps = 49/300 (16%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+GKG +G V + TG+ A KK+ + + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 179 HIMLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ E KD + +V LM DL H F+ ++ GL+ +H
Sbjct: 67 YAY------ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIKGRVGTVGYMAPEVVKN- 175
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354
+YT + D W++GC+ EM+ G+ +P + +I+ E+
Sbjct: 176 -ERYTFSPDWWALGCLLYEMIAGQ--------------------SPFQQRKKKIKREEVE 214
Query: 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 409
R + K+ +S KF P A L + LL DPK+R A E P F +
Sbjct: 215 RLV----KEVQEEYSEKF---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 26/254 (10%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEI 177
+++GKG++G V + TG A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA- 235
K+ R F V E +L + + + +F+ +++ L Y+H+
Sbjct: 61 KYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 295
NV +RDLK +N++ + D +KI DFGL + D + + T Y APE+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED-- 170
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH----QLDLMTDLLGTPSTESISRIRNE 351
+ Y A+D W +G + EM+ G+ P N H +L LM ++ R +
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEI-------RFPRTLSP 221
Query: 352 KARRYLGSMRKKQP 365
+A+ L + KK P
Sbjct: 222 EAKSLLSGLLKKDP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 33/213 (15%)
Query: 119 EVIGKGSYGVVGSAV-DTHTGER--VAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDI 174
+ +G GS+GVV T G+ VA+K + + +SD L+E ++ L H ++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS--DKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 175 VEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQF-FLYQLLRGLKY 231
+ + ++L + +V EL S L ++ K + Q+ G++Y
Sbjct: 59 IRLYGVVLTHP------LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRY 112
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWYR---- 286
+ + HRDL +NIL +D K+KI DFGL R + N+ D+ +
Sbjct: 113 LESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--------DHYVMEEHLKVPF 164
Query: 287 ---APELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
APE ++ A D+W G EM T
Sbjct: 165 AWCAPESLR--TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 77/308 (25%), Positives = 135/308 (43%), Gaps = 49/308 (15%)
Query: 115 YQIQEVIGKGSYG---VVGSAVDTHTGERVAIKKINDVF----EHVSDATRILREIKLLR 167
+++ +V+G G+YG +V TG+ A+K + + TR R + L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNV--LE 59
Query: 168 LLRH-PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL 226
+R P +V + + ++ YV M + L+Q D+ + + +F+ +++
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEII 115
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
L+++H + +RD+K +NIL +++ + + DFGL++ ++ + + T Y
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTIEYM 173
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
APE+ + A+D WS+G + E+LTG F L G +T+S
Sbjct: 174 APEIIRG-KGGHGKAVDWWSLGILIFELLTGASPF-------------TLEGERNTQS-- 217
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEAL 401
E +RR L + P P P A LL +LL DPK R A E
Sbjct: 218 ----EVSRRIL---KCDPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIK 265
Query: 402 ADPYFHGL 409
P+F GL
Sbjct: 266 EHPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 85/320 (26%), Positives = 135/320 (42%), Gaps = 52/320 (16%)
Query: 116 QIQEVIGK---GSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
++ E+IG+ G++G V A + TG A K I E + + EI++L HP
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHP 69
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLK 230
IV+ +L + K ++++ E I D LT Q Q+L L+
Sbjct: 70 YIVK----LLGAFYWDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQ 124
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
Y+H+ + HRDLK N+L D +K+ DFG VS + + ++ T ++ APE+
Sbjct: 125 YLHSMKIIHRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPEV 181
Query: 291 CGSFFSKYTP---AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
K TP DIWS+G EM +P H+L+ M LL +E +
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH------HELNPMRVLLKIAKSEPPTL 235
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
QP +S +F + L+ L P+ RP+A + L P+
Sbjct: 236 ---------------SQPSKWSMEFRD-------FLKTALDKHPETRPSAAQLLEHPF-- 271
Query: 408 GLANVDREPSTQPISKLEFE 427
V S +P+ +L E
Sbjct: 272 ----VSSVTSNRPLRELVAE 287
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 180
+G G YG V V VA+K + E + L+E +++ ++HP++V++ +
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 181 ML--PPSRREFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTA 235
PP Y++ E M +L ++ + ++ + Q+ ++Y+
Sbjct: 71 CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYVATRWYRAP 288
N HRDL +N L + +K+ DFGL+R+ D +A I WT AP
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---------AP 174
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
E ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 175 E--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 73/309 (23%), Positives = 132/309 (42%), Gaps = 52/309 (16%)
Query: 115 YQIQEVIGKGSYG---VVGSAVDTHTGERVAIKKINDV--------FEHVSDATRILREI 163
+++ V+G G+YG +V G+ A+K + EH TR R++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH----TRTERQV 57
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 223
L + R P +V + + ++ YV + + L+Q + T + ++
Sbjct: 58 -LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIA 112
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
+++ L ++H + +RD+K +NIL +++ + + DFGL++ + + + T
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--SFCGTI 170
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
Y APE+ + A+D WS+G + E+LTG F T E
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF-----------------TVDGE 213
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEA 400
S ++E +RR L K +P PF A +++LL DPK R A+E
Sbjct: 214 QNS--QSEISRRIL----KSKP-PFPKTM---SAEARDFIQKLLEKDPKKRLGANGADEI 263
Query: 401 LADPYFHGL 409
P+F G+
Sbjct: 264 KNHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
A +++ EV+G G+YG V TG+ AIK + DV E + I EI +L+ H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTE--DEEEEIKLEINMLKKYSH 71
Query: 172 PDIVEIKHIML----PPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLY 223
+ + PP + +++V E +DL + K N L + +
Sbjct: 72 HRNIATYYGAFIKKSPPGHDD--QLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICR 128
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
++LRGL ++H V HRD+K +N+L + ++K+ DFG VS + ++ T
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTP 185
Query: 284 WYRAPELCG---SFFSKYTPAIDIWSIGCIFAEMLTGKP 319
++ APE+ + + Y DIWS+G EM G P
Sbjct: 186 YWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 81/314 (25%), Positives = 128/314 (40%), Gaps = 62/314 (19%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKI--NDVFEHVSDATRILREIKLLRLLRH-- 171
+ IG G+ G V TG +A+K++ E RIL ++ ++ L H
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK---RILMDLDVV-LKSHDC 73
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL-YQLLRGLK 230
P IV+ + S D+++ ELM + L +++K PE + +++ L
Sbjct: 74 PYIVKCYGYFITDS-----DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALH 128
Query: 231 YIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA-TR----- 283
Y+ V HRD+KP NIL +A +K+CDFG++ D A TR
Sbjct: 129 YLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG----------RLVDSKAKTRSAGCA 178
Query: 284 WYRAPELCG--SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
Y APE KY D+WS+G E+ TG+ FP KN + +++T
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLT------- 229
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+I E+ + FS F + ++ L D + RP E L
Sbjct: 230 -----KILQEEPPSLPPNEG------FSPDFCS-------FVDLCLTKDHRKRPKYRELL 271
Query: 402 ADPYF--HGLANVD 413
P+ + A VD
Sbjct: 272 QHPFIRRYETAEVD 285
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 21/201 (10%)
Query: 121 IGKGSYGVVGSAV-DTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
+G G++G V + E+ VA+K + + + +LRE +++ L +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 179 HIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
I E + +V EL E L++ ++ N +T ++ ++Q+ G+KY+ N
Sbjct: 63 GIC------EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFND-----APSAIFWTDYVATRWYRAPELCG 292
HRDL +N+L KI DFGL++ D A + W +WY APE C
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW----PVKWY-APE-CM 170
Query: 293 SFFSKYTPAIDIWSIGCIFAE 313
+++ K++ D+WS G + E
Sbjct: 171 NYY-KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 76/310 (24%), Positives = 124/310 (40%), Gaps = 66/310 (21%)
Query: 114 RY-QIQEVIGKGSYGVVG----SAVDTHTGERVAIKKINDVFEHVSDATRILR-----EI 163
RY + V+G+G +G V + TGE VA+K + + + EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK------RECGQQNTSGWKKEI 57
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFF 221
+L+ L H +IV+ K S + K + ++ E + S + K +L F
Sbjct: 58 NILKTLYHENIVKYKGCC---SEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLA--QLLLF 112
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA----------RVSFNDAP 271
Q+ G+ Y+H+ + HRDL +N+L + D +KI DFGLA RV D
Sbjct: 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR-EDGD 171
Query: 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLFPGKNVVHQ 329
S +FW A E K++ A D+WS G E+LT P K
Sbjct: 172 SPVFWY---------AVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-- 218
Query: 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLAL-HLLERLLA 388
+++G P ++ + R + + + +P P P + L++
Sbjct: 219 -----EMIG-PKQGQMTVV------RLIELLERGMRLP----CPKNCPQEVYILMKNCWE 262
Query: 389 FDPKDRPTAE 398
+ K RPT
Sbjct: 263 TEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 13/210 (6%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEI 177
+V+GKGS+G V A GE A+K + DV D + E ++L L +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF--L 58
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
H+ +E ++ V E + DL I+ F+ +++ GL+++H+
Sbjct: 59 THLYCTFQTKE--HLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVS-FNDAPSAIFWTDYVATRWYRAPELCGSFF 295
+ +RDLK N++ + D +KI DFG+ + + F D ++ F T Y APE+
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF----CGTPDYIAPEILQGL- 171
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
KYT ++D WS G + EML G+ F G +
Sbjct: 172 -KYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 34/224 (15%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
E+ R +++ +G+G +G V T RVAIK + L+E ++++ LR
Sbjct: 6 ESLRLEVK--LGQGCFGEVWMGTWNGT-TRVAIKTLK---PGTMSPEAFLQEAQVMKKLR 59
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLR 227
H +V++ ++ + IY+V E M + L +K Q Q+
Sbjct: 60 HEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYV 280
G+ Y+ N HRDL+ NIL + K+ DFGLAR+ ++ +A I WT
Sbjct: 114 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT--- 170
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
APE + + ++T D+WS G + E+ T G+ +PG
Sbjct: 171 ------APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 19/220 (8%)
Query: 114 RYQIQEVIGKGSYGVVGSAV-----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
+ +G G++G V A + +VA+K + H S+ ++ E+K++
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSSEREALMSELKIMSH 94
Query: 169 L-RHPDIVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDD--LTPEHYQFFLYQ 224
L H +IV L + I V+ E DL ++ + LT E F YQ
Sbjct: 95 LGNHENIVN-----LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
+ +G+ ++ + N HRDL +N+L +KICDFGLAR ND+ + + +W
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
APE F YT D+WS G + E+ + G +PG
Sbjct: 210 M-APE--SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRH---PDIV 175
+IG+G +G V TG+ A+K ++ + T L E +L L+ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ + P + F + +LM DLH + + + + +F+ +++ GL+++H
Sbjct: 61 CMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVLQK- 169
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV--VHQLDLMT 334
+ Y + D +S+GC+ ++L G F H++D MT
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 12/185 (6%)
Query: 136 HTGERVAIK--KINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193
+TGE+VA+K K H++D + +EI++LR L H +IV+ K I K
Sbjct: 31 NTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHENIVKYKGICTEDGGNGIK--- 84
Query: 194 VVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251
++ E + S L + + N + + + + Q+ +G+ Y+ + HRDL +N+L +
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 144
Query: 252 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 311
+ ++KI DFGL + D D + ++ APE SK+ A D+WS G
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL--IQSKFYIASDVWSFGVTL 202
Query: 312 AEMLT 316
E+LT
Sbjct: 203 YELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 37/235 (15%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
E+ R ++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 6 ESLRLDVK--LGQGCFGEVWMGTWNGT-TKVAIKTLK---PGTMMPEAFLQEAQIMKKLR 59
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLR 227
H +V + ++ + IY+V E M + L +K D + Q Q+
Sbjct: 60 HDKLVPLYAVV------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYV 280
G+ YI N HRDL+ NIL + KI DFGLAR+ ++ +A I WT
Sbjct: 114 GMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWT--- 170
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
APE + + ++T D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 171 ------APE--AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 69/307 (22%), Positives = 136/307 (44%), Gaps = 46/307 (14%)
Query: 115 YQIQEVIGKGSYGVVG--SAVDTH-TGERVAIKKINDVF----EHVSDATRILREIKLLR 167
+++ +V+G G+YG V V H +G+ A+K + ++ TR R++ L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV-LEH 60
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR 227
+ + P +V + + ++ Y+ + + L Q + + Q + +++
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVL 116
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
L+++H + +RD+K +NIL +++ + + DFGL++ D + + T Y A
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMA 174
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
P++ + A+D WS+G + E+LTG F + +
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF-------------------TVDGEKN 215
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR----PT-AEEALA 402
+ E +RR L K +P P+ + LA +++RLL DPK R P+ A+E
Sbjct: 216 SQAEISRRIL----KSEP-PYPQEM---SALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267
Query: 403 DPYFHGL 409
P+F +
Sbjct: 268 HPFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 13/216 (6%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIND-VFEHVSDATRILREIK-LLRLLRHPDIVE 176
+VIGKGS+G V A G A+K + + I+ E LL+ L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 177 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
+ + + +Y V + + +L ++ +F+ ++ + Y+H+
Sbjct: 61 LHYSFQTAEK-----LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 295
N+ +RDLKP+NIL ++ + + DFGL + + + + T Y APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRK-- 170
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD 331
Y +D W +G + EML G P F ++V D
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 12/221 (5%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV--SDATRILREIKLLRL 168
+A Y + +VIG+G++G V V + ++V K+ FE + SD+ E ++
Sbjct: 41 KAEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 228
P +V+ L + ++ K +Y+V E M + +N D+ + +F+ +++
Sbjct: 100 ANSPWVVQ-----LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLA 154
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
L IH+ + HRD+KP N+L + LK+ DFG D + V T Y +P
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISP 212
Query: 289 ELCGSFFSK--YTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
E+ S Y D WS+G EML G F ++V
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 183 PPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL 242
P S + D V L+ D + + D L+ F YQ+ RG++++ + N HRDL
Sbjct: 211 PASYKGSNDSEVK-NLLSDDGSEGLTTLDLLS------FTYQVARGMEFLASKNCVHRDL 263
Query: 243 KPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAI 302
+N+L +KICDFGLAR +D+ + ++ +W APE F + YT
Sbjct: 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APE--SIFDNLYTTLS 320
Query: 303 DIWSIGCIFAEMLT-GKPLFPG 323
D+WS G + E+ + G +PG
Sbjct: 321 DVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-12
Identities = 70/232 (30%), Positives = 98/232 (42%), Gaps = 37/232 (15%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRHP 172
RY I +IGKG G V A D RVA+KKI D+ E+ R LRE K+ L HP
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR----- 227
IV + I + Y+ ++S L V + + + L
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 228 --GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-----------VSFNDA---- 270
++Y+H+ V HRDLKP NIL ++ I D+G A + ++
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 271 -----PSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLT 316
P I V T Y APE L G S+ T DI+++G I +MLT
Sbjct: 183 SSMTIPGKI-----VGTPDYMAPERLLGVPASEST---DIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
A +++ E++G G+YG V TG+ AIK ++ + + I +EI +L+ H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSH 61
Query: 172 PDIVEIKHIML----PPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLY 223
+ + PP + +++V E +DL + K N L E +
Sbjct: 62 HRNIATYYGAFIKKNPPGMDD--QLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICR 118
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
++LRGL ++H V HRD+K +N+L + ++K+ DFG VS + ++ T
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTP 175
Query: 284 WYRAPELCG---SFFSKYTPAIDIWSIGCIFAEMLTGKP 319
++ APE+ + + Y D+WS+G EM G P
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 58/223 (26%), Positives = 109/223 (48%), Gaps = 25/223 (11%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
++ + IGKG +G V + + G +VA+K I ++ + A L E ++ LRH ++V
Sbjct: 9 KLLQTIGKGEFGDV--MLGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 176 EIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYI 232
++ +++ E +Y+V E M + L +++ L + F + ++Y+
Sbjct: 63 QLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
N HRDL +N+L + D K+ DFGL + + S+ T + +W APE
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKW-TAPEALR 172
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLT-GK---PLFPGKNVVHQLD 331
K++ D+WS G + E+ + G+ P P K+VV +++
Sbjct: 173 E--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 119 EVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 176
E++GKG++G V G+ D VA+K + + L E ++L+ HP+IV+
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTP---VAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVK 56
Query: 177 IKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ + ++R+ IY+V EL+ L + K D+L + F G+ Y+ +
Sbjct: 57 LIGVC---TQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES 111
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
N HRDL +N L + LKI DFG++R +D + + +W APE
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKW-TAPEALN-- 167
Query: 295 FSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
+ +Y+ D+WS G + E + G +PG
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 66/285 (23%), Positives = 119/285 (41%), Gaps = 50/285 (17%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
E IG+G++G V S VA+K + A + L+E ++L+ HP+IV +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRLI 59
Query: 179 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR-------GLKY 231
+ + + IY+V EL++ L E + + +L++ G++Y
Sbjct: 60 GVC-----TQKQPIYIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+ + + HRDL +N L LKI DFG++R + ++ + +W APE
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL 168
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
+ +Y+ D+WS G + E + LG ++S N+
Sbjct: 169 N--YGRYSSESDVWSFGILLWEAFS--------------------LGAVPYANLS---NQ 203
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
+ R + + +P P+A L+ER +DP RP+
Sbjct: 204 QTREAI---EQGVRLPCPELCPDA---VYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 66/246 (26%), Positives = 113/246 (45%), Gaps = 55/246 (22%)
Query: 113 SRYQIQEVIGKGSYG--VVGSAVDTHTGER---VAIKKI-NDVFEHVSDATRILREIKLL 166
R + + +G+G++G V AV VA+K + +D E D + ++ E++++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK--DLSDLVSEMEMM 69
Query: 167 RLL-RHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKAN-------------- 210
+++ +H +I+ +L +E +YVV E +L ++A
Sbjct: 70 KMIGKHKNIIN----LLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 211 --DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
+ LT + F YQ+ RG++++ + HRDL +N+L D +KI DFGLAR
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR---- 180
Query: 269 DAPSAIFWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT--G 317
I DY + +W APE + F + YT D+WS G + E+ T G
Sbjct: 181 ----DIHHIDYYRKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGG 232
Query: 318 KPLFPG 323
P +PG
Sbjct: 233 SP-YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 18/222 (8%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRH---PDIV 175
+IG+G +G V TG+ A+K ++ + T L E +L L+ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ + P + F + +LM DLH + + + +F+ +++ GL+++H
Sbjct: 61 CMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVLQKG 170
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV--HQLDLMT 334
+ Y + D +S+GC+ ++L G F H++D MT
Sbjct: 171 VA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 3e-12
Identities = 78/330 (23%), Positives = 129/330 (39%), Gaps = 56/330 (16%)
Query: 113 SRYQIQEVIGKGSYG-VVGSAVDTHTGERVAIKKINDVFEHVSDATRIL----------- 160
+ +++ + + G++G + A+ T E A + +N + R++
Sbjct: 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAA 207
Query: 161 ----REIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND---DL 213
EI L L H +I++I+ I+ + + Y++ + + DL+ +
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEA-----NTYMITQKYDFDLYSFMYDEAFDWKD 262
Query: 214 TPEHYQF--FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND-A 270
P Q + QLL ++YIH + HRD+K +NI N D K+ + DFG A +
Sbjct: 263 RPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322
Query: 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP----GKNV 326
W VAT +PE+ Y DIWS G I +ML+ P G
Sbjct: 323 AFDYGWVGTVAT---NSPEILAG--DGYCEITDIWSCGLILLDMLS-HDFCPIGDGGGKP 376
Query: 327 VHQLDLMTDLLGTPSTE----------SISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD 376
QL + D L E I + A + + + +P ++P
Sbjct: 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYP--- 433
Query: 377 PLALHLLERLLAFDPKDRPTAEEALADPYF 406
L ++L FD RP A E LA P F
Sbjct: 434 ------LVKMLTFDWHLRPGAAELLALPLF 457
|
Length = 501 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 21/219 (9%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV---SDATRILREIK-LLRLLRHPDIV 175
VIGKGS+G V A G+ A+K + + + + I+ E LL+ ++HP +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQK--KAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ + S + +Y V + + +L ++ +F+ ++ L Y+H+
Sbjct: 60 GLHY-----SFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYVATRWYRAPELCG 292
N+ +RDLKP+NIL ++ + + DFGL + + + S + T Y APE+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-----FCGTPEYLAPEVLR 169
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD 331
Y +D W +G + EML G P F ++ D
Sbjct: 170 K--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 78/307 (25%), Positives = 121/307 (39%), Gaps = 62/307 (20%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDV-------FEHVSDATRILREIKLLRLLRHPD 173
+GKG +G V + TG+ A KK+N +E RIL ++ H
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSR 53
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTP---EHYQ-FFLYQLLRG 228
+ + L + + D+ +V +M DL I D+ P E F+ Q++ G
Sbjct: 54 FI----VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
L+++H + +RDLKP+N+L + D ++I D GLA V D S Y T + AP
Sbjct: 110 LEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKT--KGYAGTPGFMAP 166
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
EL +Y ++D +++G EM+ + F R
Sbjct: 167 ELLQG--EEYDFSVDYFALGVTLYEMIAARGPF-------------------------RA 199
Query: 349 RNEKA-RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALA 402
R EK + L V + KF A + E LLA DP+ R +
Sbjct: 200 RGEKVENKELKQRILNDSVTYPDKFSPA---SKSFCEALLAKDPEKRLGFRDGNCDGLRT 256
Query: 403 DPYFHGL 409
P F L
Sbjct: 257 HPLFRDL 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 61/223 (27%), Positives = 108/223 (48%), Gaps = 21/223 (9%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA-TRILREIKLLRLLRHPD 173
++I +VIG+G++G V HT ER+ KI + +E + A T RE + +L + D
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHT-ERIYAMKILNKWEMLKRAETACFREER--NVLVNGD 59
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHY-QFFLYQLLRG 228
I + F+D ++ +M+ DL ++ +D PE +F++ +++
Sbjct: 60 CQWITTL-----HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND----APSAIFWTDYVATRW 284
+ IH + HRD+KP N+L + + +++ DFG D + A+ DY++
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
+A E KY P D WS+G EML G+ F +++V
Sbjct: 175 LQAME---DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERV----AIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+V+G G++G V + GE V AIK +N+ ++ + E ++ + HP +
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMDEALIMASMDHPHL 71
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
V + + L P+ I +V +LM L V + D++ + + Q+ +G+ Y+
Sbjct: 72 VRLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
+ HRDL +N+L + +KI DFGLAR+ D + +W L
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM---ALEC 182
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLT--GKP 319
+ K+T D+WS G E++T GKP
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 34/236 (14%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGER-----VAIKKINDVFEHVSDATRILREIKLLRLLR 170
+ + +G+G +G V A R VA+K + + S+ +L E LL+ +
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVN 61
Query: 171 HPDIVEI-----------------KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD- 212
HP ++++ K+ L RE + + + + + + N D
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 213 --LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270
LT F +Q+ RG++Y+ + HRDL +N+L K+KI DFGL+R + +
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 271 PSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT--GKPLFPG 323
+ +W A E S F YT D+WS G + E++T G P +PG
Sbjct: 182 SYVKRSKGRIPVKWM-AIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVEIK 178
+G G+ GVV +G +A K I+ + A R I+RE+++L P IV
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 179 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN- 236
+I + E M+ L QV+K + E +LRGL Y+ +
Sbjct: 70 GAFYSDG-----EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFF 295
+ HRD+KP NIL N+ ++K+CDFG++ + ++ +V TR Y +PE L G+ +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHY 179
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFP 322
S + DIWS+G E+ G+ P
Sbjct: 180 SVQS---DIWSMGLSLVELAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 20/128 (15%)
Query: 208 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267
+ LT E + +Q+ RG++++ + HRDL +NIL + + +KICDFGLAR +
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 268 NDAPSAIFWTDYVAT-------RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT-GK 318
D DYV +W APE S F K YT D+WS G + E+ + G
Sbjct: 225 KDP-------DYVRKGDARLPLKWM-APE---SIFDKVYTTQSDVWSFGVLLWEIFSLGA 273
Query: 319 PLFPGKNV 326
+PG +
Sbjct: 274 SPYPGVQI 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 40/212 (18%)
Query: 192 IYVVFELMESDLHQVIKANDDL-----TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246
++ F+ S + DDL T E + +Q+ RG++++ + HRDL +N
Sbjct: 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARN 204
Query: 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIW 305
IL + + +KICDFGLAR + D + + +W APE S F K YT D+W
Sbjct: 205 ILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM-APE---SIFDKVYTTQSDVW 260
Query: 306 SIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQ 364
S G + E+ + G +PG +I E +R R +
Sbjct: 261 SFGVLLWEIFSLGASPYPG----------------------VQINEEFCQRLKDGTRMRA 298
Query: 365 PVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
P NA P ++ DPK+RPT
Sbjct: 299 P-------ENATPEIYRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 13/216 (6%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKIND-VFEHVSDATRILREIK-LLRLLRHPDIVE 176
+VIGKGS+G V A + A+K + + I+ E LL+ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 177 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
+ + +Y V + + +L ++ +F+ ++ L Y+H+
Sbjct: 61 LHFSFQTADK-----LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 115
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 295
N+ +RDLKP+NIL ++ + + DFGL + N + T + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTST-FCGTPEYLAPEVLHK-- 170
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD 331
Y +D W +G + EML G P F +N D
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 21/234 (8%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
++I +G G++G V A + TG A K I+ E + + EI +L HP+I
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNI 64
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGLKYI 232
V+ +L E +++++ E + + LT + Q L L Y+
Sbjct: 65 VK----LLDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H + HRDLK NIL D +K+ DFG VS + + ++ T ++ APE+
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 293 SFFSKYTP---AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
SK P D+WS+G EM +P H+L+ M LL +E
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPH------HELNPMRVLLKIAKSE 224
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 52/224 (23%), Positives = 98/224 (43%), Gaps = 31/224 (13%)
Query: 120 VIGKGSYGVVGSA---VDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 176
++GKG +G V A + + ++VA+K + SD LRE ++ HP++++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 177 IKHIMLPPSRREFKDI-YVVFELME-SDLHQVIKAND------DLTPEHYQFFLYQLLRG 228
+ + L + I V+ M+ DLH + + L + F+ + G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY--------V 280
++Y+ + N HRDL +N + N + + + DFGL++ I+ DY +
Sbjct: 126 MEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK--------KIYSGDYYRQGCASKL 177
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
+W L + YT D+W+ G E++T G+ + G
Sbjct: 178 PVKWLALESLADNV---YTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 69/318 (21%), Positives = 125/318 (39%), Gaps = 77/318 (24%)
Query: 113 SRYQIQE--VIGKGSYGVV----GSAVDTHTGERVAIKKINDVFEHVSDATRIL---REI 163
R +QE +G+G +G V ++ GE + + K + D RE+
Sbjct: 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVK---ALQKTKDENLQSEFRREL 59
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD---------L 213
+ R L H ++V + + RE + Y++ E + DL Q ++A L
Sbjct: 60 DMFRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 214 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273
+ + Q+ G+ ++ A HRDL +N L ++ ++K+ L++ +N
Sbjct: 115 STKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS---- 170
Query: 274 IFWTDY-------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325
+Y + RW APE ++ D+WS G + E+ T G+ F G
Sbjct: 171 ----EYYKLRNALIPLRWL-APE--AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG-- 221
Query: 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH-LLE 384
++D E ++R++ K P P L+ L+
Sbjct: 222 -------LSD------EEVLNRLQAGKLEL---------------PVPEGCPSRLYKLMT 253
Query: 385 RLLAFDPKDRPTAEEALA 402
R A +PKDRP+ E ++
Sbjct: 254 RCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 44/130 (33%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 200 ESDLHQVIKANDDLT--PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 257
+ D+ I D+L E F YQ+ +G+ ++ + N HRDL +NIL KI
Sbjct: 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKI 255
Query: 258 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT- 316
CDFGLAR ND+ + + +W APE F YT D+WS G + E+ +
Sbjct: 256 CDFGLARDIRNDSNYVVKGNARLPVKWM-APE--SIFNCVYTFESDVWSYGILLWEIFSL 312
Query: 317 GKPLFPGKNV 326
G +PG V
Sbjct: 313 GSSPYPGMPV 322
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVEIK 178
+G G+ GVV +G +A K I+ + A R I+RE+++L P IV
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 179 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN- 236
+I + E M+ L QV+K + + +++GL Y+ +
Sbjct: 70 GAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFF 295
+ HRD+KP NIL N+ ++K+CDFG++ + ++ +V TR Y +PE L G+ +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHY 179
Query: 296 SKYTPAIDIWSIGCIFAEMLTGK-PLFP 322
S + DIWS+G EM G+ P+ P
Sbjct: 180 SVQS---DIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 38/115 (33%), Positives = 61/115 (53%), Gaps = 6/115 (5%)
Query: 211 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270
LT E + +Q+ +G++++ + HRDL +NIL + + +KICDFGLAR + D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD- 232
Query: 271 PSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT-GKPLFPG 323
P + D + APE + F + YT D+WS G + E+ + G +PG
Sbjct: 233 PDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 12/221 (5%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV--SDATRILREIKLLRL 168
+A Y++ +VIG+G++G V T + A+K ++ FE + SD+ E ++
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK-FEMIKRSDSAFFWEERDIMAF 99
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 228
P +V++ + ++ + +Y+V E M + +N D+ + +F+ +++
Sbjct: 100 ANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA 154
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
L IH+ HRD+KP N+L + LK+ DFG + + V T Y +P
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MVRCDTAVGTPDYISP 212
Query: 289 ELCGSFFSK--YTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
E+ S Y D WS+G EML G F ++V
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 57/236 (24%), Positives = 102/236 (43%), Gaps = 48/236 (20%)
Query: 114 RYQIQEVIGKGSYGVV--------------GSAVDTHTGERVAIKKINDVFEHVSDATR- 158
+ +++E +G+G +G V G+ VA+K + +D T+
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR------ADVTKT 59
Query: 159 ----ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI------ 207
L+EIK++ L++P+I+ + + + + ++ E ME+ DL+Q +
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDD-----PLCMITEYMENGDLNQFLSQREIE 114
Query: 208 ----KANDDLTPEHYQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260
AN+ + LY Q+ G+KY+ + N HRDL +N L +KI DF
Sbjct: 115 STFTHANN-IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADF 173
Query: 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
G++R ++ I + RW + K+T A D+W+ G EM T
Sbjct: 174 GMSRNLYSGDYYRIQGRAVLPIRWMAWESI---LLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 121 IGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
+G G++G V V ++ VAIK + + E S ++RE +++ L +P IV +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 179 HIMLPPSRREFKDIYVVFELMESD-LHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTAN 236
+ E + + +V E+ L++ + D++T + ++Q+ G+KY+ N
Sbjct: 62 GVC------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARV-----SFNDAPSAIFWTDYVATRWYRAPELC 291
HRDL +N+L KI DFGL++ S+ A SA W +WY APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW----PLKWY-APECI 170
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLT--GKP 319
F K++ D+WS G E + KP
Sbjct: 171 N--FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 47/226 (20%)
Query: 119 EVIGKGSYGVVGSAVDTHTGER-----VAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
E +G+G++G V T ER VAIK + + E +E +L+ L+HP+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPN 69
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQ----------VIKANDDLTPEH---YQ 219
IV + + + + ++FE + DLH+ V + D T +
Sbjct: 70 IVCLLGVCT-----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 220 FFL---YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276
FL Q+ G++Y+ + + HRDL +N L +KI DFGL+R I+
Sbjct: 125 DFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR--------DIYS 176
Query: 277 TDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM 314
DY + RW PE + K+T DIWS G + E+
Sbjct: 177 ADYYRVQSKSLLPVRWM-PPE--AILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 13/219 (5%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA-TRILREIKLLRLLRHPD 173
++I +VIG+G++G V + V ++V KI + +E + A T RE + + +
Sbjct: 3 FEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 174 IVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 231
+ H ++ ++Y+V + + DL ++ +D PE +F+L +++ +
Sbjct: 62 WITTLHYAF----QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+H + HRD+KP NIL + + +++ DFG D + + V T Y +PE+
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPEIL 175
Query: 292 GSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
+ KY P D WS+G EML G+ F +++V
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 119 EVIGKGSYGVVGSAVDTHTGER----VAIKKIND-----VFEHVSDATRILREIKLLRLL 169
+++G G +G V + G+ VAIK I D F+ ++D + + L
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD------HMLAMGSL 66
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 227
H IV + I S + +V +L S L V + D L P+ + Q+ +
Sbjct: 67 DHAYIVRLLGICPGAS------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
G+ Y+ + HR+L +NIL +D ++I DFG+A + + D + +W
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM-- 178
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
L F +YT D+WS G EM++
Sbjct: 179 -ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 37/218 (16%)
Query: 202 DLHQVIKA--NDDLTPEHYQ--FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 257
DL++ IK + L + Y+ YQ++ L +H+ + HRDLK NI +K+
Sbjct: 151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKL 210
Query: 258 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG 317
DFG ++ ++D+ S + + T +Y APEL +Y+ D+WS+G I E+LT
Sbjct: 211 GDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTL 267
Query: 318 KPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADP 377
F G + Q ++M +L K P P P +
Sbjct: 268 HRPFKGPS---QREIMQQVL----------------------YGKYDPFP----CPVSSG 298
Query: 378 LALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDRE 415
+ LL+ LL+ +P RPT ++ L + +AN+ ++
Sbjct: 299 MKA-LLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQD 335
|
Length = 478 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 65/236 (27%), Positives = 104/236 (44%), Gaps = 53/236 (22%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH--------- 171
IG+G++G V + +G +A+K+I +T +E K RLL
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIR--------STVDEKEQK--RLLMDLDVVMRSSD 61
Query: 172 -PDIVEIKHIMLPPSRREFK--DIYVVFELMESDL-------HQVIKANDDLTPEHYQFF 221
P IV+ + F+ D ++ ELM+ L ++V+K+ PE
Sbjct: 62 CPYIVKFYGAL-------FREGDCWICMELMDISLDKFYKYVYEVLKSV---IPEE---I 108
Query: 222 L----YQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276
L ++ L Y+ + HRD+KP NIL + + +K+CDFG++ + +I
Sbjct: 109 LGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD----SIAK 164
Query: 277 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG-KNVVHQL 330
T R Y APE + S Y D+WS+G E+ TGK +P +V QL
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 72/298 (24%), Positives = 126/298 (42%), Gaps = 55/298 (18%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEI-- 177
+GKG +G V + +TG+ A KK++ + S L E ++L + P IV +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 178 -----KHIMLPPSRREFKDI-YVVFELMES--DLHQVIKANDDLTPEHYQFFLYQLLRGL 229
H+ L S D+ Y ++ + E ++ +VI + Q+ G+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVI------------HYSAQITCGI 108
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
++H+ ++ +RD+KP+N+L + ++ D GLA V D + T T Y APE
Sbjct: 109 LHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTI---TQRAGTNGYMAPE 164
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ Y+ +D +++GC EM+ G+ P K+ ++ +
Sbjct: 165 ILKE--EPYSYPVDWFAMGCSIYEMVAGRT--PFKDHKEKVA-----------------K 203
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
E RR L + V F H+ N + + LA P+DR + E DP H
Sbjct: 204 EELKRRTL-----EDEVKFEHQ--NFTEESKDICRLFLAKKPEDRLGSREKNDDPRKH 254
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 78/306 (25%), Positives = 135/306 (44%), Gaps = 41/306 (13%)
Query: 107 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 166
T +A +Y I V+G G+ G V A GE A+K ++ +D R E+ L
Sbjct: 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCL 85
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLT---PEHYQ 219
IV+ R +++ ++ +++ DL Q IK+ EH
Sbjct: 86 LNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEA 145
Query: 220 FFLY-QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 278
L+ Q+L + ++H+ ++ HRD+K NIL ++ +K+ DFG +++ + T
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT- 204
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338
+ T +Y APE+ Y+ D++S+G + E+LT K F G+N+ ++M L
Sbjct: 205 FCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMHKTL- 258
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
A RY P+P P+ P ++ LL+ DPK RP++
Sbjct: 259 --------------AGRY-------DPLP-----PSISPEMQEIVTALLSSDPKRRPSSS 292
Query: 399 EALADP 404
+ L P
Sbjct: 293 KLLNMP 298
|
Length = 496 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 66/267 (24%), Positives = 104/267 (38%), Gaps = 44/267 (16%)
Query: 161 REIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQF 220
REI +L+ + H I+ + H + R + +V + DL + + L E
Sbjct: 135 REIDILKTISHRAIINLIH-----AYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAIT 189
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILAN-----------ADCKLKICDFGLARVSFND 269
+LL L Y+H + HRD+K +NI + A CKL D
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP---------D 240
Query: 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV--- 326
P W+ + T +PEL Y DIWS G + EM GK V
Sbjct: 241 TPQCYGWSGTLET---NSPEL--LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295
Query: 327 VHQLD-----LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVP--FSHKFPNADPLA 379
QL + L P S + ++ K +Y +R +P + D
Sbjct: 296 SSQLRSIIRCMQVHPLEFPQNGSTNLCKHFK--QYAIVLRPPYTIPPVIRKYGMHMD--V 351
Query: 380 LHLLERLLAFDPKDRPTAEEALADPYF 406
+L+ ++L FD + RP+A++ L+ P F
Sbjct: 352 EYLIAKMLTFDQEFRPSAQDILSLPLF 378
|
Length = 392 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
F Q+ +G+ ++ + N HRD+ +N+L KICDFGLAR ND+ + +
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
+W APE F YT D+WS G + E+ + GK +PG
Sbjct: 277 PVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 70/235 (29%), Positives = 104/235 (44%), Gaps = 49/235 (20%)
Query: 121 IGKGSYGVV--GSAVD---THTGE-RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+G G++G V G+A D +G RVA+K + + L+E L+ HP+I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL------- 226
V++ + L + Y++ ELME DL ++ L +LL
Sbjct: 62 VKLLGVCL-----LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 227 RGLKYIHTANVFHRDLKPKNILA-----NADCKLKICDFGLARVSFNDAPSAIFWTDY-- 279
+G Y+ + HRDL +N L +AD +KI DFGLAR I+ +DY
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--------DIYKSDYYR 168
Query: 280 ------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325
+ RW APE L G F T D+WS G + E+LT G+ +P N
Sbjct: 169 KEGEGLLPVRWM-APESLLDGKF----TTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 64/247 (25%), Positives = 102/247 (41%), Gaps = 53/247 (21%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN--DVFE-----HVSDATRILREIKLLR 167
++ +VIG+G++G V TG A+K + D+ E H+ IL E L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 226
+++ + S ++ ++Y++ E + D+ ++ D LT E QF++ + +
Sbjct: 63 VVK-----------MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV 111
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-------RVSF------------ 267
+ IH HRD+KP N+L ++ +K+ DFGL R F
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 268 -----NDAPSAIFWT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM 314
N A W V T Y APE+ + Y D WS+G I EM
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEM 229
Query: 315 LTGKPLF 321
L G P F
Sbjct: 230 LIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 62/246 (25%), Positives = 103/246 (41%), Gaps = 59/246 (23%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
+VIG+G++G V TG A+K ILR+ +L + I +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMK--------------ILRKADMLEKEQVAHIRAER 52
Query: 179 HIMLPP----------SRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR 227
I++ S ++ +++Y++ E + D+ ++ D L+ E QF++ + +
Sbjct: 53 DILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL 112
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-------RVSF-----NDAPSAIF 275
+ IH HRD+KP N+L +A +K+ DFGL R F ++ PS
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 276 WTDYVATR----W----------------YRAPELCGSFFSKYTPAIDIWSIGCIFAEML 315
+ + + R W Y APE+ + Y D WS+G I EML
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEML 230
Query: 316 TGKPLF 321
G P F
Sbjct: 231 IGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 43/199 (21%)
Query: 141 VAIKKINDVFEHVSDATRI--LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198
VA+K + SD R L+E+K+L L P+I + L + + ++ E
Sbjct: 49 VAVKVLRP---DASDNAREDFLKEVKILSRLSDPNIARL----LGVCTVD-PPLCMIMEY 100
Query: 199 ME-SDLHQVIKANDDLTPEH--------YQFFLY---QLLRGLKYIHTANVFHRDLKPKN 246
ME DL+Q ++ + T + LY Q+ G++Y+ + N HRDL +N
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160
Query: 247 ILANADCKLKICDFGLARVSF-ND-------APSAIFWTDYVATRWYRAPELCGSFF-SK 297
L + +KI DFG++R + +D AP I RW A E S K
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPI--------RWM-AWE---SVLLGK 208
Query: 298 YTPAIDIWSIGCIFAEMLT 316
+T D+W+ G E+LT
Sbjct: 209 FTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
F YQ+ G++++ + N HRDL +N+L +KICDFGLAR D+ + ++
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKP 319
+W APE F + YT D+WS G + E+ T G P
Sbjct: 304 PLKWM-APE--SIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 72/305 (23%), Positives = 123/305 (40%), Gaps = 48/305 (15%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
+I G+YG V T +R A+KKIN + ++ E +L +P +V
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVS-- 65
Query: 179 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
+ S + + +V E +E D ++K L + + + + + L+Y+H +
Sbjct: 66 ---MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF-WTDYVATRWYRAPELCGS--- 293
HRDLKP N+L + +K+ DFGL+++ + ++ TR + ++CG+
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 294 ------FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
Y +D W++G I E L G F G D +L G ++ I
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-------DTPEELFGQVISDDIEW 235
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEALADP 404
++A AD A L+ RLL +P +R A E
Sbjct: 236 PEGDEA-------------------LPAD--AQDLISRLLRQNPLERLGTGGAFEVKQHR 274
Query: 405 YFHGL 409
+F GL
Sbjct: 275 FFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 66/300 (22%), Positives = 115/300 (38%), Gaps = 65/300 (21%)
Query: 119 EVIGKGSYGVVGSA---VDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDI 174
+++G+G +G V D + +VA+K + D+ + S+ L E ++ HP++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNV 63
Query: 175 VEIKHIMLPPSRRE-FKDIYVVFELME-SDLHQ-VIKANDDLTPEHYQF-----FLYQLL 226
+++ + S + V+ M+ DLH ++ + PE F+ +
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY------- 279
G++Y+ N HRDL +N + D + + DFGL++ I+ DY
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYYRQGRIA 175
Query: 280 -VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLL 337
+ +W L YT D+W+ G E+ T G+ +PG
Sbjct: 176 KMPVKWIAIESLADRV---YTSKSDVWAFGVTMWEIATRGQTPYPG-------------- 218
Query: 338 GTPSTESISRIRNEKARRYL-GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
+ N + YL R KQP + L+ DPKDRPT
Sbjct: 219 ----------VENHEIYDYLRHGNRLKQP-------EDCLDELYDLMYSCWRADPKDRPT 261
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 47/225 (20%)
Query: 121 IGKGSYGVVGSAVDTH---TGER--VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+G+G++G V A + ++ VA+K + + E S RE +LL +L+H IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIV 70
Query: 176 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND---------------DLTPEHYQ 219
+ E + + +VFE M DL++ ++++ LT
Sbjct: 71 RFYGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 220 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 279
Q+ G+ Y+ + + HRDL +N L +KI DFG++R I+ TDY
Sbjct: 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYSTDY 177
Query: 280 --------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ RW PE + K+T DIWS G + E+ T
Sbjct: 178 YRVGGRTMLPIRWM-PPE--SILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+GKG +G V + TG+ A KK+ + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 179 HIMLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ E KD + +V +M DL H N + F+ +L GL+ +
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINN- 175
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLF 321
KYT + D W +GC+ EM+ G+ F
Sbjct: 176 -EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 64/293 (21%), Positives = 113/293 (38%), Gaps = 46/293 (15%)
Query: 119 EVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 176
+ +G+G +G V G + +VA+K + S+ L E ++ HP+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 177 IKHIMLPPSRRE-FKDIYVVFELME-SDLHQVI---KANDD---LTPEHYQFFLYQLLRG 228
+ + L E + V+ M+ DLH + + D L + F+ + G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
++Y+ + + HRDL +N + N + + + DFGL++ +N + +W
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
L YT D+WS G E+ T G+ +PG
Sbjct: 185 SLADRV---YTTKSDVWSFGVTMWEIATRGQTPYPG------------------------ 217
Query: 348 IRNEKARRYL-GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
+ N + YL R KQP P+ L+ +PKDRP+ E
Sbjct: 218 VENSEIYDYLRQGNRLKQP-------PDCLDGLYSLMSSCWLLNPKDRPSFET 263
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 160 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTP 215
L+EIK++ L+ P+I+ + + + + ++ E ME+ DL+Q + + +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 216 EHYQFFLY--------QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267
Y Q+ G+KY+ + N HRDL +N L + +KI DFG++R +
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ I + RW + K+T A D+W+ G E+LT
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESI---LLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 30/204 (14%)
Query: 192 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250
+++V E + DL ++ L EH +F+ ++ L ++H + +RDLK N+L +
Sbjct: 71 LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 310
AD +K+ D+G+ + + + + T Y APE+ +Y ++D W++G +
Sbjct: 131 ADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRG--EEYGFSVDWWALGVL 185
Query: 311 FAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSH 370
EM+ G+ F D++TD + + + ++ EK R + K
Sbjct: 186 MFEMMAGRSPF---------DIITDNPDMNTEDYLFQVILEKPIRIPRFLSVK------- 229
Query: 371 KFPNADPLALHLLERLLAFDPKDR 394
A H+L+ L DPK+R
Sbjct: 230 --------ASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 20/203 (9%)
Query: 121 IGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
+G G +GVV G + VAIK I E + E K++ L H +V++
Sbjct: 12 LGTGQFGVVKYGKWRGQYD---VAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLY 65
Query: 179 HIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
+ + + IY+V E M + L+ + + P + G+ Y+ +
Sbjct: 66 GVC-----TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
HRDL +N L + +K+ DFGL+R +D ++ + + RW PE+ +S
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PVRW-SPPEVL--LYS 176
Query: 297 KYTPAIDIWSIGCIFAEMLT-GK 318
K++ D+W+ G + E+ + GK
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 6e-10
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 28/192 (14%)
Query: 141 VAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198
VA+K + D SD R RE +LL L+H IV+ + + E + +VFE
Sbjct: 38 VAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EGDPLIMVFEY 88
Query: 199 ME-SDLHQVIKAN-------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 244
M+ DL++ ++A+ +LT Q+ G+ Y+ + + HRDL
Sbjct: 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 148
Query: 245 KNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 304
+N L + +KI DFG++R ++ + + RW PE + K+T D+
Sbjct: 149 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDV 205
Query: 305 WSIGCIFAEMLT 316
WS+G + E+ T
Sbjct: 206 WSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 57/240 (23%)
Query: 121 IGKGSYGVV----GSAVDTHTGER---VAIKKINDVFEHVSDATRILREIKLLRLL-RHP 172
+G+G +G V +D ++ VA+K + D D ++ E++L++L+ +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHK 78
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFL--------- 222
+I+ + + +YV+ E + +L + ++A P+ Y F +
Sbjct: 79 NIINLLGVCTQEG-----PLYVIVEYAAKGNLREFLRARRPPGPD-YTFDITKVPEEQLS 132
Query: 223 --------YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR +
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--------GV 184
Query: 275 FWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT--GKPLFPG 323
DY + +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 185 HDIDYYKKTSNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 39/115 (33%), Positives = 57/115 (49%), Gaps = 6/115 (5%)
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR N +
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200
Query: 283 RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTD 335
+W APE + F + YT D+WS G + E+ T G +PG V L+ +
Sbjct: 201 KWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 61/243 (25%), Positives = 106/243 (43%), Gaps = 39/243 (16%)
Query: 89 TPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYG-VVGSAVDTHTGERVAIKKIN 147
+ +T +P +K+ ++ E F +G GS+G V+ + VAIK+
Sbjct: 15 SDSTKEPKRKNKMKYEDF---------NFIRTLGTGSFGRVILATYKNEDFPPVAIKR-- 63
Query: 148 DVFEHVS-----DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD---IYVVFE-L 198
FE + E K+L + HP V + FKD +Y+V E +
Sbjct: 64 --FEKSKIIKQKQVDHVFSERKILNYINHPFCVNL--------YGSFKDESYLYLVLEFV 113
Query: 199 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258
+ + ++ N + F+ Q++ +Y+ + N+ +RDLKP+N+L + D +K+
Sbjct: 114 IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMT 173
Query: 259 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK 318
DFG A+V + T Y APE+ + + A D W++G E+L G
Sbjct: 174 DFGFAKVVDTRTYT------LCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGC 225
Query: 319 PLF 321
P F
Sbjct: 226 PPF 228
|
Length = 340 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 26/212 (12%)
Query: 121 IGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
IG G +G V G A + RV +K++ + L+E++ R L HP++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNV---- 57
Query: 179 HIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYI 232
+ E +V E DL +++N + Q ++ GL ++
Sbjct: 58 -LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD---YVATRWYRAPE 289
H A+ H DL +N AD +KI D+GLA P + T V RW APE
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLA---LEQYPEDYYITKDCHAVPLRWL-APE 172
Query: 290 LCGSFFS-----KYTPAIDIWSIGCIFAEMLT 316
L T +IWS+G E+ T
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 13/205 (6%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLL-RHPDIVEI 177
VIG+GSY V T A+K I ++ D + E + HP +V +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
SR ++ V E + DL ++ L EH +F+ ++ L ++H
Sbjct: 62 HSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
+ +RDLK N+L +A+ +K+ D+G+ + + + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLF 321
Y ++D W++G + EM+ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 40/112 (35%), Positives = 56/112 (50%), Gaps = 24/112 (21%)
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY--- 279
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR I DY
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--------DIHHIDYYKK 198
Query: 280 -----VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT--GKPLFPG 323
+ +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 199 TTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 39/116 (33%), Positives = 58/116 (50%), Gaps = 8/116 (6%)
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282
YQ+ RG++Y+ + HRDL +N+L + +KI DFGLAR N +
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203
Query: 283 RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLT--GKPLFPGKNVVHQLDLMTD 335
+W APE + F + YT D+WS G + E+ T G P +PG V L+ +
Sbjct: 204 KWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLLKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 57/201 (28%), Positives = 82/201 (40%), Gaps = 26/201 (12%)
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG---LARVSFNDAPSAIFWTDYV 280
QLL + YIH + HRD+K +N+L N + + DFG AR S+ S F
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW----STPFHYGIA 323
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIG-CIFAEMLTGKPLFPGKN-------------V 326
T APE+ YTP++DIWS G IF + LF +
Sbjct: 324 GTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRI 381
Query: 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 386
+ Q + D + SR+ ++ R + R P ++ D +L+ R
Sbjct: 382 IRQAQVHVDEF---PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRA 438
Query: 387 LAFDPKDRPTAEEALADPYFH 407
L FD RP+A E L P F
Sbjct: 439 LTFDGARRPSAAELLRLPLFQ 459
|
Length = 461 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 33/186 (17%)
Query: 155 DATR-----ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIK 208
DA + L+E+K+L L+ P+I+ + + + + + ++ E ME+ DL+Q +
Sbjct: 57 DANKNARNDFLKEVKILSRLKDPNIIRLLGVCV-----DEDPLCMITEYMENGDLNQFLS 111
Query: 209 A----------NDDLTPEH------YQFFLY---QLLRGLKYIHTANVFHRDLKPKNILA 249
+ ND + P H Y L+ Q+ G+KY+ + N HRDL +N L
Sbjct: 112 SHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV 171
Query: 250 NADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 309
+ +KI DFG++R + I + RW A E K+T A D+W+ G
Sbjct: 172 GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWM-AWECI--LMGKFTTASDVWAFGV 228
Query: 310 IFAEML 315
E+L
Sbjct: 229 TLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 14/212 (6%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV--SDATRILREIKLLRLLRHP 172
+ + +VIG+G++G V + + A+K ++ FE + SD+ E ++
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAHANSE 103
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
IV++ + K +Y+V E M + +N D+ + +F+ +++ L I
Sbjct: 104 WIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAI 158
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLA-RVSFNDAPSAIFWTDYVATRWYRAPELC 291
H+ HRD+KP N+L + LK+ DFG ++ DA + V T Y +PE+
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM---DANGMVRCDTAVGTPDYISPEVL 215
Query: 292 GS--FFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
S Y D WS+G EML G F
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 34/226 (15%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERV--AIKKINDVFEHVSDATRILREIKLL-RLLRHP 172
+ Q+VIG+G++G V A G R+ AIK++ + + D E+++L +L HP
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHP 68
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFE---------------LMESDLHQVI--KANDDLTP 215
+I+ +++ R + +Y+ E ++E+D I L+
Sbjct: 69 NII---NLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 216 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275
+ F + RG+ Y+ HRDL +NIL + KI DFGL+R +
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM- 182
Query: 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM--LTGKP 319
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 183 --GRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLL-RLLRHPDIVEI 177
VIG+GSY V T A+K + ++ D + E + + HP +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
SR ++ V E + DL ++ L EH +F+ ++ L Y+H
Sbjct: 62 HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
+ +RDLK N+L +++ +K+ D+G+ + + + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLF 321
Y ++D W++G + EM+ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 59/246 (23%), Positives = 97/246 (39%), Gaps = 59/246 (23%)
Query: 111 EASRYQIQEV--IGKGSYGVVGSA-----VDTHTGERVAIKKINDVFEHVSDATR--ILR 161
E R I+ V IG+G++G V A + VA+K + E S + R
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQR 57
Query: 162 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND--------- 211
E L+ HP+IV++ + K + ++FE M DL++ ++
Sbjct: 58 EAALMAEFDHPNIVKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSH 112
Query: 212 -------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258
L+ Q+ G+ Y+ HRDL +N L + +KI
Sbjct: 113 STSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 172
Query: 259 DFGLARVSFNDAPSAIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCI 310
DFGL+R I+ DY + RW PE F+++YT D+W+ G +
Sbjct: 173 DFGLSR--------NIYSADYYKASENDAIPIRWM-PPE--SIFYNRYTTESDVWAYGVV 221
Query: 311 FAEMLT 316
E+ +
Sbjct: 222 LWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
++I +VIG+G++G V AV V +K V+ A +IL + ++L+
Sbjct: 3 FEILKVIGRGAFGEV--AV-------VKMKNTGQVY-----AMKILNKWEMLKRAETACF 48
Query: 175 VEIKHIMLPPSRR-------EFKD---IYVVFEL-MESDLHQVI-KANDDLTPEHYQFFL 222
E + +++ RR F+D +Y+V + + DL ++ K D L + +F+L
Sbjct: 49 REERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVSFNDAPSAIFWTD 278
+++ + +H HRD+KP N+L + + +++ DFG L + A+ D
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD 168
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
Y++ +A E +Y P D WS+G EML G+ F +++V
Sbjct: 169 YISPEILQAME---DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 9e-09
Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 38/248 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+ Y++ + IG G +G V T E K I+ + ++++ E+ ++R L+H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDL---TPEHYQF-FLYQLLR 227
+IV L + ++ +Y++ E ++ DL + I+ + EH QLL
Sbjct: 73 NIVRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 228 GLKYIHT-------ANVFHRDLKPKNILANADCK-----------------LKICDFGLA 263
L Y H V HRDLKP+NI + + KI DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 264 R-VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP 322
+ + + V T +Y +PEL Y D+W++GCI E+ +GK F
Sbjct: 190 KNIGIESMAHSC-----VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244
Query: 323 GKNVVHQL 330
N QL
Sbjct: 245 KANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 50/237 (21%)
Query: 117 IQEVIGKGSYGVVGSA-----VDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
++ +G+G++G V A T VA+K + D ++ RE +LL L+H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQH 66
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA----------------NDDLT 214
IV+ + + + +VFE M+ DL++ ++A +L
Sbjct: 67 EHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 215 PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274
Q+ G+ Y+ + + HRDL +N L A+ +KI DFG++R +
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--------DV 173
Query: 275 FWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GK-PLF 321
+ TDY + RW PE + K+T D+WS G I E+ T GK P F
Sbjct: 174 YSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 23/222 (10%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGER---VAIKKINDVFEHVSDATRILREIKLLR 167
S + E +G+ +G V G T GE+ VAIK + D E E +
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRS 63
Query: 168 LLRHPDIVEI-------KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD------LT 214
L+HP+IV + + + + S D++ F +M S V +DD L
Sbjct: 64 RLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE-FLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 215 PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274
P + + Q+ G++++ + +V H+DL +N+L +KI D GL R + +
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 275 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ RW +PE + K++ DIWS G + E+ +
Sbjct: 183 MGNSLLPIRWM-SPE--AIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 51/221 (23%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTG--ERVAIKKINDVFEHVSDA--TRILREIKLL 166
R + +++ +G++G + G +D G E V +K + D H S+ T +L+E LL
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESCLL 62
Query: 167 RLLRHPDIVEIKH----------IMLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTP 215
L H +I+ I H ++ P + K L E++ Q + +
Sbjct: 63 YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH- 121
Query: 216 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275
Q+ G+ Y+H V H+D+ +N + + + ++KI D L+R F +
Sbjct: 122 -----MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ +W L +S A D+WS G + E++T
Sbjct: 177 DNENRPVKWMALESLVNKEYSS---ASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 14/203 (6%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIK-KINDVFEHVSDAT--RILREIKLLRLLRHPDIV 175
+V+G G++G V + GE+V I I ++ E S IL E ++ + +P +
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 176 EIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
+ I L + + ++ +LM L V + D++ ++ + Q+ +G+ Y+
Sbjct: 73 RLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ HRDL +N+L +KI DFGLA++ D V +W +
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI--- 183
Query: 294 FFSKYTPAIDIWSIGCIFAEMLT 316
YT D+WS G E++T
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 47/234 (20%)
Query: 111 EASRYQIQEV--IGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LR 161
E SR +I + +G+GS+G+V G+A D GE RVA+K +N E S RI L
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN---ESASLRERIEFLN 58
Query: 162 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDL 213
E +++ +V + ++ + + VV ELM DL +++ N
Sbjct: 59 EASVMKGFTCHHVVRLLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 113
Query: 214 TPEHYQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270
P Q + ++ G+ Y++ HRDL +N + D +KI DFG+ R
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR------ 167
Query: 271 PSAIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
I+ TDY + RW L F+ + D+WS G + E+ +
Sbjct: 168 --DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIK-KINDVFEHVSDAT--RILREIKLLRLLRHPDIVE 176
V+G G++G V + GE V I I + E+ S IL E ++ + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 177 IKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ I L + + +V +LM L V + D + + + Q+ +G+ Y+
Sbjct: 74 LLGICLTST------VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD--YVATRWYRAPELCG 292
+ HRDL +N+L + +KI DFGLAR+ D + D V +W +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKVPIKWMALESI-- 183
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLT--GKPL--FPGKNV 326
++T D+WS G E++T KP P + +
Sbjct: 184 -LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 40/152 (26%), Positives = 58/152 (38%), Gaps = 47/152 (30%)
Query: 215 PEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL----------- 262
PE +F++ +L ++ +H HRD+KP NIL + D +K+ DFGL
Sbjct: 99 PEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158
Query: 263 -----ARVSFNDAPSAIFWTD----------------------------YVATRWYRAPE 289
+ + + + W D V T Y APE
Sbjct: 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE 218
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
+ YT D WS+G I EML G+P F
Sbjct: 219 VL--LRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 41/220 (18%)
Query: 121 IGKGSYGVV-----GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+G+GS+G+V V RVAIK +N+ + + L E +++ +V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVV 72
Query: 176 EIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDLTPEHYQFFLY---Q 224
+ ++ + + V+ ELM DL +++ N P + + +
Sbjct: 73 RLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY----- 279
+ G+ Y++ HRDL +N + D +KI DFG+ R I+ TDY
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIYETDYYRKGG 179
Query: 280 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ RW L F+ Y+ D+WS G + E+ T
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 25/160 (15%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLR 167
+ +VIGKG++G V TG+ A+K + D HV +L E
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD--- 59
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLY 223
P +V + + F+D ++ +ME DL ++ D + + +F++
Sbjct: 60 ---SPWVVSLYY--------SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA 108
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263
+ + ++ +H HRD+KP NIL + +K+ DFGL+
Sbjct: 109 ECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 50/194 (25%), Positives = 87/194 (44%), Gaps = 27/194 (13%)
Query: 141 VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE-LM 199
VAIK + D + +E L+ L HP+IV +L +E + + ++FE L
Sbjct: 37 VAIKTLKD-INNPQQWGEFQQEASLMAELHHPNIV----CLLGVVTQE-QPVCMLFEYLN 90
Query: 200 ESDLHQVI-----------KANDDLTP----EHYQFF--LYQLLRGLKYIHTANVFHRDL 242
+ DLH+ + +++D T +H F Q+ G++Y+ + H+DL
Sbjct: 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDL 150
Query: 243 KPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAI 302
+NIL +KI D GL+R ++ + + RW PE + K++
Sbjct: 151 AARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM-PPE--AIMYGKFSSDS 207
Query: 303 DIWSIGCIFAEMLT 316
DIWS G + E+ +
Sbjct: 208 DIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 41/150 (27%), Positives = 57/150 (38%), Gaps = 47/150 (31%)
Query: 215 PEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL----------- 262
E +F++ +L ++ +H HRD+KP NIL + D +K+ DFGL
Sbjct: 99 EEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158
Query: 263 -------ARV-SFNDAPSAIFWT-----------------------DYVATRWYRAPELC 291
R S PS + V T Y APE+
Sbjct: 159 YYQKGDHHRQDSME--PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL 216
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
+ YT D WS+G I EML G+P F
Sbjct: 217 LR--TGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 74/319 (23%), Positives = 118/319 (36%), Gaps = 45/319 (14%)
Query: 120 VIGKG--SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 177
VIG+G V A TGE V +++IN T + E+ + +L HP+IV
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 178 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ---------FFLYQLLRG 228
+ + + +++VV M + DL H+ + L +L+
Sbjct: 65 RATFIADN-----ELWVVTSFM------AYGSAKDLICTHFMDGMSELAIAYILQGVLKA 113
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY----VATRW 284
L YIH HR +K +IL + D K+ + N D+ V
Sbjct: 114 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP 173
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT----- 339
+ +PE+ Y DI+S+G E+ G P K++ L+ L GT
Sbjct: 174 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDMPATQMLLEKLNGTVPCLL 231
Query: 340 -----PSTESISRIRNEKARRYLG------SMRKKQPVPFSHKFPNA-DPLALHLLERLL 387
P+ E + A LG + R SH + P H +E+ L
Sbjct: 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCL 291
Query: 388 AFDPKDRPTAEEALADPYF 406
+P RP+A L +F
Sbjct: 292 QRNPDARPSASTLLNHSFF 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 20/208 (9%)
Query: 121 IGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
IG G +G V G +T +V +K++ V V + + L E + R L+H ++++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELR-VSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 179 HIMLPPSRREFKDIYVVFELME-SDLH---QVIKANDDLTPE--HYQFFLYQLLRGLKYI 232
E +V E DL + + + +TP+ Q ++ GL ++
Sbjct: 62 GQC-----TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H N H DL +N L AD +KI D+GL+ + + +V RW APEL
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APELVD 175
Query: 293 SFFSKY-----TPAIDIWSIGCIFAEML 315
T ++WS+G E+
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 39/147 (26%), Positives = 56/147 (38%), Gaps = 46/147 (31%)
Query: 219 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA--------------- 263
+F++ +L ++ +H HRD+KP NIL + D +K+ DFGL
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG 163
Query: 264 -RVSFNDAPSAIFWTD----------------------------YVATRWYRAPELCGSF 294
V + + W D V T Y APE+
Sbjct: 164 DHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--L 221
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLF 321
+ YT D WS+G I EML G+P F
Sbjct: 222 RTGYTQLCDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERV--AIKKINDVFEHVSDATRILREIKLL-RLLRHP 172
+ ++VIG+G++G V A+ G ++ AIK + + F +D E+++L +L HP
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHP 63
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFE----------LMESDLHQVIKANDDLTPEH---YQ 219
+I+ +++ R + +Y+ E L +S +V++ + EH
Sbjct: 64 NII---NLLGACENRGY--LYIAIEYAPYGNLLDFLRKS---RVLETDPAFAKEHGTAST 115
Query: 220 FFLYQLLR-------GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272
QLL+ G++Y+ HRDL +N+L + KI DFGL+R
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM--LTGKP 319
+ + RW L +S YT D+WS G + E+ L G P
Sbjct: 176 TM---GRLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 36/119 (30%), Positives = 61/119 (51%), Gaps = 12/119 (10%)
Query: 202 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDF 260
DL ++K L+ + + QL+ L +H N+ H D+K +N+L + A ++ +CD+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154
Query: 261 GLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGK 318
GL ++ PS Y T Y +PE + G Y + D W++G + E+LTGK
Sbjct: 155 GLCKII--GTPSC-----YDGTLDYFSPEKIKGHN---YDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 61/255 (23%), Positives = 98/255 (38%), Gaps = 52/255 (20%)
Query: 111 EASRYQIQ--EVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREI 163
E R I +G G++G V + +VA+K + + D + L E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEA 60
Query: 164 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFL 222
++ H +IV + + R +++ ELM DL ++ N +
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTM 115
Query: 223 YQLLR-------GLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLARVSFNDA 270
LL G KY+ + HRD+ +N L CK KI DFG+AR
Sbjct: 116 KDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLT--CKGPGRVAKIADFGMAR------ 167
Query: 271 PSAIFWTDY--------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKP 319
I+ Y + +W PE L G F SK D+WS G + E+ + G
Sbjct: 168 --DIYRASYYRKGGRAMLPIKWM-PPEAFLDGIFTSK----TDVWSFGVLLWEIFSLGYM 220
Query: 320 LFPGKNVVHQLDLMT 334
+PG+ ++ +T
Sbjct: 221 PYPGRTNQEVMEFVT 235
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 20/210 (9%)
Query: 118 QEVIGKGSYG-VVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
QE IG G +G V+ S + T TG RV +K++ + L++ R+L+HP+I+
Sbjct: 1 QE-IGNGWFGKVLLSEIYTDTGVARVVVKELK-ANASSKEQNEFLQQGDPYRILQHPNIL 58
Query: 176 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLY----QLLRGLK 230
+ + E +VFE E DL + L ++ G+
Sbjct: 59 QCLGQCV-----EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
++H N H DL +N +D +K+ D+G+ + + V RW APEL
Sbjct: 114 HMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APEL 172
Query: 291 CGSFF-----SKYTPAIDIWSIGCIFAEML 315
G F ++ T ++W++G E+
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 30/221 (13%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERV--AIKKINDVFEHVSDATRILREIKLL-RLLRHPDIV 175
+VIG+G++G V A G R+ AIK++ + + D E+++L +L HP+I+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 176 EIKHIMLPPSRREFKDIYVVFELMESDL-----HQVIKANDDLTPEH---YQFFLYQLLR 227
+++ R + + + + + L +V++ + + QLL
Sbjct: 60 ---NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 228 -------GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
G+ Y+ HRDL +NIL + KI DFGL+R + +
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM---GRL 173
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM--LTGKP 319
RW L +S YT D+WS G + E+ L G P
Sbjct: 174 PVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 19/42 (45%), Positives = 29/42 (69%)
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263
+ Q+L GL+ +H + HRD+KP+N+L D ++KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 58/224 (25%), Positives = 82/224 (36%), Gaps = 60/224 (26%)
Query: 219 QFFLYQLLRGLKYIHTANVFHRDLKPKNIL-ANADCKLKICDFGLA---RVSFNDAPSAI 274
Q + Q+L L +H+ + HRD+KP+NI+ + KI D G A RV N P
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPK-- 315
Query: 275 FWTDYVATRWYRAPELCGSFFSKYTPA----------------------IDIWSIGCIFA 312
+++ Y APE S TP+ DI+S G IF
Sbjct: 316 ---EFLLDPRYAAPE--QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 313 EMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY-LGSMRKKQPVPFSHK 371
+M FP L +D + I R K Y L + RK S
Sbjct: 371 QM-----AFPN--------LRSD------SNLIQFNRQLKRNDYDLVAWRKLVEPRASPD 411
Query: 372 FPNA-------DPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408
LL+ ++ F + R +A+ ALA PYF
Sbjct: 412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDR 455
|
Length = 566 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 16/101 (15%)
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVSFNDAPSAIFWTDY 279
+++ L +H + RDL P NIL + +++ F + +A
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVE------- 145
Query: 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 320
Y APE+ G S+ T A D WS+G I E+LTGK L
Sbjct: 146 ---NMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 17/155 (10%)
Query: 121 IGKGSYGVVGSAVDTHTGERVAIK------KINDVFEHVSDATRILREIKLLRLLRHPDI 174
I +G++G V + + A+K IN H A R L L + P I
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAER-----DALALSKSPFI 66
Query: 175 VEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
V + + S + ++Y+V E L+ D+ ++ E ++ ++ L Y+H
Sbjct: 67 VHLYY-----SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
+ HRDLKP N+L + + +K+ DFGL++V+ N
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 74/326 (22%), Positives = 132/326 (40%), Gaps = 50/326 (15%)
Query: 116 QIQEVIGKG--SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR-EIKLLRLLRHP 172
++Q IG+G + V A T TG V ++ I D+ + + L+ E+ L RHP
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHP 59
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGL 229
+I+ + S ++V+ M + ++K + ++ L+ LRGL
Sbjct: 60 NIMTSWTVFTTGSW-----LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGL 114
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY----VATRWY 285
Y+H HR++K +IL + D + + + A D+ + +
Sbjct: 115 NYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPW 174
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST--- 342
+PEL Y DI+S+G E+ TG+ P ++++ L+ L G P +
Sbjct: 175 LSPELLRQDLYGYNVKSDIYSVGITACELATGR--VPFQDMLRTQMLLQKLKGPPYSPLD 232
Query: 343 -----ESISRIRNEKA---------------RRYLGSMRKKQPVP--FSHKFPNADPLAL 380
SR++N ++ + + S R + P FS F N
Sbjct: 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQN------ 286
Query: 381 HLLERLLAFDPKDRPTAEEALADPYF 406
L+E L DP+ RP+A L+ +F
Sbjct: 287 -LVELCLQQDPEKRPSASSLLSHAFF 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 48/214 (22%), Positives = 87/214 (40%), Gaps = 21/214 (9%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATR--ILREIKL 165
+ +I+ ++G G +G + +R VAI + SD R L E
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRA---GCSDKQRRGFLAEALT 59
Query: 166 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLY 223
L H +IV ++ ++ + + +V E M + L ++ ++ L L
Sbjct: 60 LGQFDHSNIVRLEGVITRGN-----TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP 114
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-DYVAT 282
L G+KY+ H+ L +L N+D KI F + D AI+ T +
Sbjct: 115 GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEAIYTTMSGKSP 171
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ APE + ++ A D+WS G + E+++
Sbjct: 172 VLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|219500 pfam07655, Secretin_N_2, Secretin N-terminal domain | Back alignment and domain information |
|---|
Score = 37.3 bits (87), Expect = 0.002
Identities = 11/39 (28%), Positives = 23/39 (58%)
Query: 19 SFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQ 57
S T+ S +++ +N+++ SN+ + ++SSS S G
Sbjct: 20 SVTSGSVSSSGSNSSSSSSNSSNGGSSSSSSSGDSSSGT 58
|
This is a short domain found in bacterial type II/III secretory system proteins. The architecture of these proteins suggest that this family may be functionally analogous to pfam03958. Length = 95 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 595 | |||
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.4 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.09 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.03 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.91 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.9 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.89 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.85 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.75 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.38 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.36 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.32 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.23 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.1 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.09 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.06 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.92 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.9 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.79 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.73 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.7 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.59 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.52 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.46 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.46 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.36 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.3 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.12 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.96 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.95 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.83 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.8 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.8 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.76 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.75 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.29 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.22 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.18 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.72 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.41 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.38 | |
| PLN02236 | 344 | choline kinase | 95.32 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.18 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.01 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.7 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.19 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.93 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.92 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 92.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 92.04 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 91.01 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 90.67 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 90.34 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 90.13 | |
| PTZ00296 | 442 | choline kinase; Provisional | 88.67 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-74 Score=580.18 Aligned_cols=337 Identities=60% Similarity=0.996 Sum_probs=318.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
...+|..++.||+|+||+|+.|.++.+|+.||||+|.+.+.+...+++.+||+++|+.++|+||+.+++++.++..+.++
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 35567778999999999999999999999999999998899999999999999999999999999999999998888899
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
++|+|+|+|+.||.++|+.++.|++++++++++||++||+|+|+.+|+||||||+|+|++.++.+||||||+|+.....
T Consensus 100 DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~- 178 (359)
T KOG0660|consen 100 DVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF- 178 (359)
T ss_pred eeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence 9999999999999999999988999999999999999999999999999999999999999999999999999987655
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
....++|.|+.|+||+|||++... ..|+.++||||+||||+|||+|++.|+|++..+|+.+|..++|+|+.+.+..+.+
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred CcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 455668999999999999998764 8999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHHH
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e~ 430 (595)
++++.|+.+++..++.+|...|+++++.++|||++||.+||.+|+|++|+|+||||..+++++.||..++.... ++.
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~---~~~ 334 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS---FEH 334 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc---ccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999988776543 445
Q ss_pred hhhcHHHHHHHHHHHHHhhChhh
Q 007629 431 RKLAKDDVREMIYREILEYHPQM 453 (595)
Q Consensus 431 ~~~~~~~~~~~i~~ei~~~~~~~ 453 (595)
. +..+++++++|+|++.++|+.
T Consensus 335 ~-~~~~~~r~~i~~e~~~~~~~~ 356 (359)
T KOG0660|consen 335 E-LTEEELRELIYKEILDFHPDV 356 (359)
T ss_pred c-ccHHHHHHHHHHHHHhhCccc
Confidence 5 889999999999999999875
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-62 Score=479.15 Aligned_cols=288 Identities=36% Similarity=0.668 Sum_probs=249.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|+.+.++|+|+||+||+|+++.||+.||||++.....+....+-.+|||++|++|+|||+|.++++| +....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 468899999999999999999999999999999976555555567789999999999999999999999 555679
Q ss_pred EEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
++|||||+.++.+.+... ..++++.++.+++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.....
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-- 154 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-- 154 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence 999999998877777655 47999999999999999999999999999999999999999999999999999977532
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
...+|+|+.|+||+|||++.|. ..|+..+||||+||++.||++|.++|+|+++.+|+..|...+|...+..+.-....
T Consensus 155 -gd~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -cchhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 2237899999999999999884 78999999999999999999999999999999999999999999887765544322
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
....=+..-....+.++...+++++..+.||+++||..||.+|++.+|+|.||||.++
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 1111011111234556778899999999999999999999999999999999999764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-61 Score=495.35 Aligned_cols=286 Identities=40% Similarity=0.711 Sum_probs=256.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~ 190 (595)
.+||.++++||.|+||.||+|+.+.+|..||||++++.+....+... +||++.|++|. |||||+|.+++.+.. .
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~----~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDND----R 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccC----c
Confidence 46899999999999999999999999999999999988777665544 68999999999 999999999995443 3
Q ss_pred cEEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+|||||+.+|+++++.. ..|++..++.|++||++||+|+|.+|++||||||||||+.....|||+|||+||.+...
T Consensus 84 ~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 84 ILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 79999999999999999865 47999999999999999999999999999999999999998889999999999976554
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.+ +|+|+.|+||+|||+++.. ..|+.++||||+|||++|+.+-+++|+|.++.+|+.+|++++|+|..+.+..-.
T Consensus 164 pP----YTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 164 PP----YTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred CC----cchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 43 7899999999999998874 789999999999999999999999999999999999999999999988766531
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
.-+..+--.++...+.++...++++++++.+||.+||.+||.+||||+|+|+||||+.
T Consensus 239 -~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~ 296 (538)
T KOG0661|consen 239 -NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQV 296 (538)
T ss_pred -HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence 2233333456667788888999999999999999999999999999999999999974
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-58 Score=485.98 Aligned_cols=338 Identities=92% Similarity=1.454 Sum_probs=306.2
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++.+.||+|+||.||+|++..+|..||||++............+.+|+.+|+.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999975444445566788999999999999999999998766555566799
Q ss_pred EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCc
Q 007629 194 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (595)
Q Consensus 194 lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 273 (595)
+|||||+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998654433333
Q ss_pred ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHH
Q 007629 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (595)
Q Consensus 274 ~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~ 353 (595)
..+...+||+.|+|||++.+....++.++|||||||++|||++|++||.+.+...++..+.+.+|.|....+..+.....
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 240 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 34456789999999999865435789999999999999999999999999999999999999999999999999888888
Q ss_pred HHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHHHhhh
Q 007629 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKL 433 (595)
Q Consensus 354 ~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~ 433 (595)
..++..+....+.++...++..++.+.+||.+||..||++|||++|+|+||||+++......+..+++...++.++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (338)
T cd07859 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRL 320 (338)
T ss_pred HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhc
Confidence 88888888888888888888999999999999999999999999999999999998888888888999999999999999
Q ss_pred cHHHHHHHHHHHHHhhCh
Q 007629 434 AKDDVREMIYREILEYHP 451 (595)
Q Consensus 434 ~~~~~~~~i~~ei~~~~~ 451 (595)
..+++++.+++++++|||
T Consensus 321 ~~~~~~~~~~~~~~~~~~ 338 (338)
T cd07859 321 TKEDVRELIYREILEYHP 338 (338)
T ss_pred CHHHHHHHHHHHHHhcCC
Confidence 999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-59 Score=449.49 Aligned_cols=285 Identities=42% Similarity=0.707 Sum_probs=247.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
.+|..+++||+|.||+||+|++..||+.||||+|+.......-....+|||+.|+.++|+||+.++++|-.. ..+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-----~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-----SNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-----Cce
Confidence 578999999999999999999999999999999975433223345678999999999999999999999443 469
Q ss_pred EEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
.||+|||+.||..+|+... .|+..+++.|+.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+.....
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9999999999999998654 799999999999999999999999999999999999999999999999999998754433
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
. .+..+.|+||+|||++.|. ..|+..+||||.|||++||+.|.|.|+|+++.+|+..|...+|+|.++.|..+..-
T Consensus 157 ~---~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 I---QTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred c---cccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 2 2444899999999998874 78999999999999999999999999999999999999999999999888765432
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..|.. +...+..+....|+.++..+.||+.+||.+||.+|+++.|+|+|+||+..
T Consensus 233 --pdY~~-~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 233 --PDYVK-IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred --ccHHH-HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 22211 11223334455899999999999999999999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-58 Score=480.23 Aligned_cols=290 Identities=37% Similarity=0.606 Sum_probs=249.7
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 108 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 108 ~~~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
.....+.|+.+++||+|+||.||+|++..||+.||+|++...........-..|||.||++|.||||++|.++....
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~--- 188 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK--- 188 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---
Confidence 33446789999999999999999999999999999999975544455566778999999999999999999998764
Q ss_pred CcccEEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 188 EFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 188 ~~~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
....+|||||||+.||.-++...+ .|++.+++.||+||+.||+|||++||+|||||.+|||||.+|.+||+|||||+++
T Consensus 189 ~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred CCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 235699999999999999987644 7999999999999999999999999999999999999999999999999999977
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
...... .+|..+.|.||+|||+++|. ..|+.++|+||+||||.||++|++.|+|.++.+|++.|.+++|.|.+..|.
T Consensus 269 ~~~~~~--~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 269 TPSGSA--PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred cCCCCc--ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 554432 36888999999999999985 789999999999999999999999999999999999999999999998876
Q ss_pred HHhhHHHHHHhhhcccCC--CCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 347 RIRNEKARRYLGSMRKKQ--PVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
..+-. ....++... ...+...|...++.+++|+..||..||.+|.||.++|+|+||.
T Consensus 346 ~~kLP----~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 346 VSKLP----HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cccCC----cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 32211 111111111 2234455778899999999999999999999999999999994
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-57 Score=453.31 Aligned_cols=292 Identities=39% Similarity=0.610 Sum_probs=250.2
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 110 ~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
...+.|+.+..|++|+||+||+|+++.|++.||+|+++.......---..+|||.+|.+++|||||.+.++..-.. .
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~ 149 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---M 149 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---c
Confidence 3456799999999999999999999999999999999754333333345689999999999999999999986543 3
Q ss_pred ccEEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+|||||||+.||..++...+ +|...+++.++.|+++||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+..
T Consensus 150 d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 150 DKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred ceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 5699999999999999998765 899999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... .+|..+-|.||+|||++++. ..|+.++|+||+|||++||++++|.|+|+...+|+++|..++|+|....+..+
T Consensus 230 p~k---~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 230 PLK---PYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred Ccc---cCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 432 35788999999999999984 78999999999999999999999999999999999999999999999877665
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCC--HHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNAD--PLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~--~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..-.+... -.+.+.+...+...|+..+ ....+|+..+|.+||.+|.||+|+|+|+||...
T Consensus 306 ~~lp~~k~-~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 306 SELPAVKK-MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred cccchhhc-cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 43322221 1233344445566666554 889999999999999999999999999999863
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-57 Score=462.10 Aligned_cols=262 Identities=35% Similarity=0.597 Sum_probs=218.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh-----hhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-----SDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
.+.|.+.+.||+|+||.|.+|.++.||+.||||+|++..... .....+.+|+++|++|+|||||+++++|..+
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~-- 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP-- 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC--
Confidence 356999999999999999999999999999999997543221 1233467999999999999999999999443
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC---CcEEEcccCc
Q 007629 187 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGL 262 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~---~~vKL~DFGl 262 (595)
...||||||++ |+|++.+-.++.+.++..+.+++||+.||.|||++||+||||||+|||+..+ +.+||+|||+
T Consensus 249 ---ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 249 ---DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ---CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence 45799999998 6999999999999999999999999999999999999999999999999876 8899999999
Q ss_pred ceeccCCCCCcccccccccCCcccccccccccCCCCCC-cceeechhHHHHHHHcCCCCCCCCChHH-HHHHHHhhcCCC
Q 007629 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEMLTGKPLFPGKNVVH-QLDLMTDLLGTP 340 (595)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~-k~DIWSlG~il~eLltG~~pF~~~~~~~-~l~~i~~~lg~p 340 (595)
|+.... ..++.+.||||.|.|||++.+....+.+ ++||||||||||-+|+|.+||.+....- ..++|.+
T Consensus 326 AK~~g~----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~----- 396 (475)
T KOG0615|consen 326 AKVSGE----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK----- 396 (475)
T ss_pred hhcccc----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc-----
Confidence 997642 2346789999999999999764344444 8999999999999999999998765322 2222211
Q ss_pred ChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 341 ~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..-...+..|..++.++++||.+||..||++|||+.|+|+||||+..
T Consensus 397 ----------------------G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 397 ----------------------GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred ----------------------CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 11111224567789999999999999999999999999999999854
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-55 Score=466.34 Aligned_cols=263 Identities=33% Similarity=0.593 Sum_probs=229.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.+|...+.||+|||+.||++++..+|+.||+|+|.+. .......+++.+||+|.+.|+|||||+++++| ++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 5799999999999999999999999999999999653 33445677899999999999999999999999 66678
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|||+|+|. ++|..++++.+.++|.++++|++||+.||.|||+.+|||||||..|||++++.+|||+|||||..+..+.
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999 7999999999999999999999999999999999999999999999999999999999999999876554
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
... .+.||||.|.|||++.. ..++..+||||+|||||.||+|+|||..++..+.+..|...
T Consensus 173 Erk---~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-------------- 233 (592)
T KOG0575|consen 173 ERK---KTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-------------- 233 (592)
T ss_pred ccc---ceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc--------------
Confidence 332 56799999999999987 78999999999999999999999999988876666554321
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREP 416 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~ 416 (595)
.| ..| ..++.+|+|||.+||+.||.+|||++++|.|+||+.-.-+...|
T Consensus 234 ----~Y--------~~P-----~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 234 ----EY--------SMP-----SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred ----Cc--------ccc-----cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 00 011 25688999999999999999999999999999995544444444
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-55 Score=444.57 Aligned_cols=286 Identities=39% Similarity=0.671 Sum_probs=247.6
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
.|.-.+++|.|+||+||+|....+++.||||++-... +.--+|+++|+.+.|||||++..+|......+.-++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4788899999999999999999999999999984221 1224799999999999999999988765544455778
Q ss_pred EEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC-CcEEEcccCcceeccC
Q 007629 194 VVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFN 268 (595)
Q Consensus 194 lV~E~~~g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~-~~vKL~DFGla~~~~~ 268 (595)
+|||||+.+|.++++. +..++.-.++.+++||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+....
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9999999999999984 5689999999999999999999999999999999999999987 9999999999998876
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
..+. ..|..|+.|+|||++.|. ..|+.++||||.|||++||+-|++.|+|++..+|+..|.+++|+|+.+.+..+
T Consensus 179 ~epn----iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 179 GEPN----ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred CCCc----eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 6654 568899999999999884 78999999999999999999999999999999999999999999999998877
Q ss_pred hhHHHHHHhhhcccCCCCCCCC-CCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSH-KFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~ 413 (595)
..... ....+.-.+.++.. .....++++.+|+.++|.++|.+|.++.|+|.||||..+.+++
T Consensus 254 n~~y~---~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 254 NPNYT---EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred Ccccc---cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 55432 11223333445544 5567899999999999999999999999999999999887764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-54 Score=437.61 Aligned_cols=260 Identities=30% Similarity=0.505 Sum_probs=225.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|+++++||+|+||+||.++++.|++.||+|++++.. ....+......|..||..++||+||+++-.| ++..
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccCC
Confidence 468999999999999999999999999999999997532 2334677889999999999999999998887 4556
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
++|+|+||+. |+|+..|++.+.|+++.+++|+.+|+.||.|||++|||||||||+|||+|.+|+++|+|||||+.....
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 7999999998 599999999999999999999999999999999999999999999999999999999999999865443
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
... ..++|||+.|||||++.+ ..|+.++|+|||||++||||+|.+||.+.+.....+.|...-
T Consensus 179 ~~~---t~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k------------ 241 (357)
T KOG0598|consen 179 GDA---TRTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK------------ 241 (357)
T ss_pred CCc---cccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc------------
Confidence 322 245799999999999998 699999999999999999999999999988766555543210
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCC-CCHHHHHHHHhhCcCCCCCCC----CHHHHhcCCCccCCCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRP----TAEEALADPYFHGLANV 412 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~dLl~~~L~~DP~~Rp----ta~elL~Hp~f~~~~~~ 412 (595)
....+. .+.++++||+++|..||++|. .++++-+||||.++.+.
T Consensus 242 -------------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 242 -------------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred -------------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence 011233 688999999999999999996 68999999999987654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-54 Score=433.13 Aligned_cols=261 Identities=27% Similarity=0.474 Sum_probs=220.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++.+.++.||+|..|+||+|+|+.|++.+|+|+|.. .......+++.+|+++++.++||+||++|++|+.... .+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~i 153 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EI 153 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eE
Confidence 466778999999999999999999999999999943 2344567889999999999999999999999975431 49
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+||||+ |+|..+++..+.++|.....++.++++||.|||+ .+||||||||+||||+..|+|||||||.+..+.+.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999 6899999988999999999999999999999996 99999999999999999999999999999876554
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCC--ChHHHHHHHHhhcCCCChhHHHHH
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK--NVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~--~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
...+++||..|||||.+.+ ..|+.++||||||++++||.+|+.||+.. .....++++..+...|+
T Consensus 233 ----~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp------- 299 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP------- 299 (364)
T ss_pred ----hcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC-------
Confidence 2467899999999999998 79999999999999999999999999874 12222333322222111
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
..+... .+++++++||..||++||.+||++.|+|+|||++....
T Consensus 300 -----------------P~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 300 -----------------PRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred -----------------CCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 111111 47899999999999999999999999999999987543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-54 Score=432.31 Aligned_cols=292 Identities=39% Similarity=0.689 Sum_probs=248.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCc-eeeeeeeecCCCc-cCcc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPPSR-REFK 190 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~-~~~~ 190 (595)
..|..+++||+|+||+||+|+++.+|+.||+|++.-.......-....+|+.+|+.|+|+| ||.+++++..... +...
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3577788999999999999999999999999999754443333445689999999999999 9999999976541 3334
Q ss_pred cEEEEEecccccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 191 DIYVVFELMESDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~----~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
.+|+||||++.+|..++.... .++...++.+++||+.||+|||+++|+||||||.||||+.+|.+||+|||+|+..
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 799999999999999998755 5788899999999999999999999999999999999999999999999999955
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
.-... .++..++|.||+|||++.+. ..|+..+||||+|||++||++++++|+|.++.+|+..|.+++|+|..+.+.
T Consensus 171 ~ip~~---~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 171 SIPMR---TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred cCCcc---cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 32222 25777999999999999884 579999999999999999999999999999999999999999999998776
Q ss_pred HHhhHHHHHHhhhcccCC-CCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 347 RIRNEKARRYLGSMRKKQ-PVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
.... ...|-..++... +.++....+..++.+.+|+.+||+.+|.+|.||..+|.||||..+.
T Consensus 247 ~v~~--~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 247 GVSS--LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred Cccc--cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 6432 122222333333 5666677778888999999999999999999999999999998764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-53 Score=452.36 Aligned_cols=348 Identities=28% Similarity=0.452 Sum_probs=265.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.+-|++++.||+|+.|.|.+|++..||+.+|||+|.+... .......+.+||-||+.|.||||+++|++| ++..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence 3568999999999999999999999999999999976532 334456789999999999999999999999 5556
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
++|+|.||++ |.|++++...++|++.++..+++||+.||.|||..+|+||||||+|+|++.+++|||+|||+|.....+
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 7999999998 689999999999999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccCCcccccccccccCCCC-CCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~-~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
. .+.+.||+|.|.|||++.| .+| +.++||||+|||||.||||+.||.+.|....+.++...-
T Consensus 166 k----lLeTSCGSPHYA~PEIV~G--~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~----------- 228 (786)
T KOG0588|consen 166 K----LLETSCGSPHYAAPEIVSG--RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV----------- 228 (786)
T ss_pred c----cccccCCCcccCCchhhcC--CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc-----------
Confidence 2 3577899999999999998 455 578999999999999999999999877655444443210
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCC-----CCCcc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPST-----QPISK 423 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~-----~~~~~ 423 (595)
| +.-..+++++++||.+||.+||.+|+|.+||++|||+.+....+...+. .++..
T Consensus 229 -------------------f-~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~i~s 288 (786)
T KOG0588|consen 229 -------------------F-EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVSVPILS 288 (786)
T ss_pred -------------------c-cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCCcccceee
Confidence 0 1114678999999999999999999999999999999987665433111 11111
Q ss_pred cchHHHHhhhcHHHHHHHHHHHHHhhChhh-HHHHhhCCC-cccccccCcchhhHHHHHHHhhhcCCCCCCCcccccccC
Q 007629 424 LEFEFERRKLAKDDVREMIYREILEYHPQM-LQEYLRGGE-QTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHAS 501 (595)
Q Consensus 424 ~~~~~e~~~~~~~~~~~~i~~ei~~~~~~~-~~~~~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (595)
+. ....+..+-++.|.... ....++. ++..+..++ +.+.+|...++++++...++......--+ ...+.+.
T Consensus 289 ~p---s~~~IDp~Il~~l~iLw-c~~d~~kl~~kLls~~~n~EK~~Y~LLl~~k~r~~~~~~~~~~~kk~---~~~s~~~ 361 (786)
T KOG0588|consen 289 IP---SIQEIDPLILQHLCILW-CGRDPEKLVEKLLSPDDNDEKTLYFLLLRRKRRDSSQLDDFDENKKD---LLGSAAD 361 (786)
T ss_pred cC---CcccCCHHHHhhhhhee-ecCChHHHHHHHcCCCcchhHHHHHHHHHhhccchhhhhhhhhhhhh---hhccccC
Confidence 11 01122223333333222 1222343 334444433 56788999999998888777753222100 1223344
Q ss_pred CCCCcCC
Q 007629 502 LPRERVP 508 (595)
Q Consensus 502 ~~~~~~~ 508 (595)
-||++|+
T Consensus 362 ~p~k~~~ 368 (786)
T KOG0588|consen 362 PPRKRVD 368 (786)
T ss_pred Cchhhhh
Confidence 4888887
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-52 Score=440.43 Aligned_cols=265 Identities=31% Similarity=0.540 Sum_probs=227.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccC
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 188 (595)
...+|.+++.||+|+|++|++|+++.+++.||||++.+... .....+.+.+|-.+|.+| .||.|++|+..| .+
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD 145 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QD 145 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ec
Confidence 35689999999999999999999999999999999865322 122345577888999999 799999999988 44
Q ss_pred cccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
...+|+|+||++ |+|+++|.+.+.|++..+++|+.||+.||+|||++|||||||||||||+|.||++||+|||.|+.+.
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 456999999998 7999999999999999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC----------cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhc
Q 007629 268 NDAPS----------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337 (595)
Q Consensus 268 ~~~~~----------~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~l 337 (595)
..... ......++||..|.+||++.. ...++.+|||+||||||.|+.|.+||.+.+....+..|.++-
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 33221 111256899999999999987 678899999999999999999999999999888777776541
Q ss_pred CCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCC
Q 007629 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (595)
Q Consensus 338 g~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~ 413 (595)
..|. +..++.+.|||+++|..||.+|+|+.+|.+||||.++.+.+
T Consensus 304 ----------------------------y~fp---~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 304 ----------------------------YEFP---EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred ----------------------------ccCC---CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 1122 34568899999999999999999999999999999887654
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=441.32 Aligned_cols=284 Identities=36% Similarity=0.632 Sum_probs=238.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-C-----CceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-H-----PDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~~~~~~ 185 (595)
..+|.|.+.||+|+||.|.+|.+..|++.||||+|+.. .....+...||.+|..|+ | -|||+++++|...
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr- 260 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR- 260 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc-
Confidence 45899999999999999999999999999999999753 344566788999999997 4 4799999999654
Q ss_pred ccCcccEEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC--CcEEEcccC
Q 007629 186 RREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFG 261 (595)
Q Consensus 186 ~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~--~~vKL~DFG 261 (595)
+++|||+|+++.+|+++|+.+. +|+...++.|+.||+.||.+||+.||||+|||||||||..- ..|||+|||
T Consensus 261 ----~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 261 ----NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ----cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 5699999999999999999875 78999999999999999999999999999999999999764 469999999
Q ss_pred cceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCC
Q 007629 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (595)
Q Consensus 262 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~ 341 (595)
.|...... ..+|+.++.|+|||+++| .+|+.++||||||||++||++|.|+|+|.+..+|+..|.+++|.|+
T Consensus 337 SSc~~~q~------vytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 337 SSCFESQR------VYTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred cccccCCc------ceeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 99864222 237899999999999999 7999999999999999999999999999999999999999999999
Q ss_pred hhHHHHHhhHHHHHHhhh----------------------------cccC--CC---CCCCCCCC-CCCHHHHHHHHhhC
Q 007629 342 TESISRIRNEKARRYLGS----------------------------MRKK--QP---VPFSHKFP-NADPLALHLLERLL 387 (595)
Q Consensus 342 ~~~i~~i~~~~~~~~l~~----------------------------~~~~--~~---~~~~~~~~-~~~~~~~dLl~~~L 387 (595)
...+...... ..|+.. .... .| ..+....+ .....+.|||++||
T Consensus 409 ~~mL~~~~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L 486 (586)
T KOG0667|consen 409 PKMLDTAKKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCL 486 (586)
T ss_pred HHHHHhcccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHh
Confidence 9888764322 222222 0011 11 11222233 23456799999999
Q ss_pred cCCCCCCCCHHHHhcCCCccCCCCCC
Q 007629 388 AFDPKDRPTAEEALADPYFHGLANVD 413 (595)
Q Consensus 388 ~~DP~~Rpta~elL~Hp~f~~~~~~~ 413 (595)
.+||.+|+|+.++|+||||.+.....
T Consensus 487 ~~dP~~R~tp~qal~Hpfl~~~~~~~ 512 (586)
T KOG0667|consen 487 EWDPAERITPAQALNHPFLTGTSLER 512 (586)
T ss_pred ccCchhcCCHHHHhcCcccccccccc
Confidence 99999999999999999999765543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=417.96 Aligned_cols=259 Identities=33% Similarity=0.488 Sum_probs=218.9
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..++|.+.+.||+|+||+||+|+++.++..||||.|.+..-.....+.+..||++|+.|+|||||.+++++..+ +
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-----~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-----D 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-----C
Confidence 35689999999999999999999999999999999976544556677789999999999999999999999544 4
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC------CcEEEcccCcc
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD------CKLKICDFGLA 263 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~------~~vKL~DFGla 263 (595)
++|+|||||+ |||.++|+..+.+++..++.|+.||+.||++||+++||||||||.||||+.. -.+||+|||+|
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 6999999999 7999999999999999999999999999999999999999999999999875 45899999999
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
+..... ....+.||+|.|||||++.. .+|+.|+|+||+|+|+|+|++|++||...+..+.+..+.+.-
T Consensus 163 R~L~~~----~~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~------ 230 (429)
T KOG0595|consen 163 RFLQPG----SMAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN------ 230 (429)
T ss_pred hhCCch----hHHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc------
Confidence 987533 23467899999999999976 799999999999999999999999999877654433221110
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
..++.. -...+....+|+..+|+.+|.+|.+..+-+.|+++..
T Consensus 231 --------------------~~~~~~--~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 231 --------------------EIVPVL--PAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred --------------------cccCch--hhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 000100 0123344679999999999999999999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-51 Score=428.96 Aligned_cols=268 Identities=28% Similarity=0.453 Sum_probs=224.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
..++|+++++||+|+||.||+|+.+.||..||+|++++... ...+.+.++.|-.+|....+|.||+|+-.| .+.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence 35789999999999999999999999999999999976432 334567788999999999999999999888 455
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.++||||||++ ||+..+|...+.|+++++++++.+++.||+-||..|+|||||||+|+|||..|++||+|||||.....
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 67999999998 69999999999999999999999999999999999999999999999999999999999999954211
Q ss_pred C-----------------------CCC--cc-------------------cccccccCCcccccccccccCCCCCCccee
Q 007629 269 D-----------------------APS--AI-------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDI 304 (595)
Q Consensus 269 ~-----------------------~~~--~~-------------------~~~~~~gT~~Y~APE~l~~~~~~~~~k~DI 304 (595)
. ... .. .....+|||.|||||++.+ ..|+..+|+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDw 371 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDW 371 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccH
Confidence 0 000 00 0123589999999999998 689999999
Q ss_pred echhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHH
Q 007629 305 WSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLE 384 (595)
Q Consensus 305 WSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~ 384 (595)
||||||+||||.|.|||.+.+..+....|...-. .+ ..| .....+++++|||.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~-----------------~l-------~fP---~~~~~s~eA~DLI~ 424 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE-----------------TL-------KFP---EEVDLSDEAKDLIT 424 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh-----------------hc-------cCC---CcCcccHHHHHHHH
Confidence 9999999999999999999988776666543210 00 000 01234689999999
Q ss_pred hhCcCCCCCCCC---HHHHhcCCCccCCCCCC
Q 007629 385 RLLAFDPKDRPT---AEEALADPYFHGLANVD 413 (595)
Q Consensus 385 ~~L~~DP~~Rpt---a~elL~Hp~f~~~~~~~ 413 (595)
+||. ||.+|.. ++||.+||||+++.+..
T Consensus 425 rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 425 RLLC-DPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred HHhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence 9999 9999975 89999999999987643
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=423.35 Aligned_cols=334 Identities=56% Similarity=0.995 Sum_probs=285.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|.+.+.||+|+||+||+|.+..++..||||++............+.+|+.+++.++||||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45899999999999999999999999999999998754444445567789999999999999999999886654445567
Q ss_pred EEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
+|+||||+.++|.+++...+.+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 162 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG- 162 (337)
T ss_pred EEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999998653321
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
.......+|..|+|||.+... ..++.++|||||||++|+|++|++||.+.+....+..+...+|.+..+.+..+...
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 163 --DFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred --ccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 122456789999999987642 35889999999999999999999999999988889999999999888877766666
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHHHh
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERR 431 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e~~ 431 (595)
....++..........+...++.+++.+.+||++||..||.+|||++++|+||||..+......+..+. .+.+.|+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~--~~~~~~~~~ 317 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQT--PFSFDFEED 317 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCC--ccchhhhhh
Confidence 666666655554444445556778999999999999999999999999999999998877766655543 567788888
Q ss_pred hhcHHHHHHHHHHHHHhhCh
Q 007629 432 KLAKDDVREMIYREILEYHP 451 (595)
Q Consensus 432 ~~~~~~~~~~i~~ei~~~~~ 451 (595)
.+.++++++.|+.|.+.|||
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07858 318 ALTEEDIKELIYNEMLAYHP 337 (337)
T ss_pred hcCHHHHHHHHHHHHhhcCC
Confidence 89999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-51 Score=402.01 Aligned_cols=257 Identities=26% Similarity=0.482 Sum_probs=223.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++++.||.|+||.|.+++++.+|..||+|++++. .......+....|..+|+.+.||+++++++.+ .+..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence 46799999999999999999999999999999998642 22334566788999999999999999999888 4556
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+||||||.+ |.|+.++++.++|++.++++++.||+.||+|||+++|++|||||||||+|.+|.+||+|||+|+.....
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 7999999998 589999999999999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
..+.||||.|+|||++.. ..|+.++|+|||||++|||+.|.+||...+.....+.|...-
T Consensus 198 ------T~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~------------ 257 (355)
T KOG0616|consen 198 ------TWTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK------------ 257 (355)
T ss_pred ------EEEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc------------
Confidence 245799999999999988 789999999999999999999999999998866666654320
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCC-----CCHHHHhcCCCccCCCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGLANV 412 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~R-----pta~elL~Hp~f~~~~~~ 412 (595)
..+ -+-.++.++|||+++|+.|-.+| ....++..||||+++.+.
T Consensus 258 ----------------v~f---P~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 258 ----------------VKF---PSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred ----------------ccC---CcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence 011 12357889999999999999999 357899999999987653
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-50 Score=422.04 Aligned_cols=328 Identities=41% Similarity=0.795 Sum_probs=269.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REF 189 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~ 189 (595)
..++|++++.||+|+||+||+|.+..++..||||++............+.+|+.+|+.++||||+++++++..... ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3578999999999999999999999999999999997544333445667899999999999999999998864322 334
Q ss_pred ccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
..+|++||+++++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~~~~~~~~~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 93 NEVYLVTNLMGADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred CcEEEEeecCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 5689999999999988775 457999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
...++||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+..+.
T Consensus 172 ------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 172 ------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred ------cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 2456899999999998652 468899999999999999999999999999889999999999999888888777
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHH
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE 429 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e 429 (595)
......++..++......+...+...++.+.+||.+||..||.+|||+.|+|+||||..+..+...+...+ .....+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~---~~~~~~ 321 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEP---YDESPE 321 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccCc---cccchh
Confidence 77777776666555444455556677889999999999999999999999999999998766554433322 222334
Q ss_pred HhhhcHHHHHHHHHHHHHhh
Q 007629 430 RRKLAKDDVREMIYREILEY 449 (595)
Q Consensus 430 ~~~~~~~~~~~~i~~ei~~~ 449 (595)
......+++++..+.+...+
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~ 341 (343)
T cd07878 322 NKERTIEEWKELTYEEVSSF 341 (343)
T ss_pred hhhccHHHHHHHHHHHHHhc
Confidence 45556677777777665544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=422.04 Aligned_cols=292 Identities=45% Similarity=0.769 Sum_probs=242.2
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++..........+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47889999999999999999999999999999876544445567889999999999999999999998765544445799
Q ss_pred EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCc
Q 007629 194 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (595)
Q Consensus 194 lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 273 (595)
+||||+.++|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-- 158 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-- 158 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999986533221
Q ss_pred ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHH
Q 007629 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (595)
Q Consensus 274 ~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~ 353 (595)
...+..++|+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+...++..+.+.+|.+..+.+...... .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~-~ 236 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG-A 236 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH-H
Confidence 123456789999999998763 45889999999999999999999999999999999999999999998766554322 2
Q ss_pred HHHhhhcccCCCC--CCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 354 RRYLGSMRKKQPV--PFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 354 ~~~l~~~~~~~~~--~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..++.......+. .........++.+.+||.+||.+||.+|||+.|+|+||||.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 2222222211111 0112234568899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-50 Score=424.15 Aligned_cols=258 Identities=33% Similarity=0.548 Sum_probs=217.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC--C-hhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE--H-VSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSR 186 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~--~-~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 186 (595)
..++|.+.+.||+|+||+|+.|.+..+|..||||++.+... . ....+.+.+|+.+|+.++ ||||+++++++...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-- 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-- 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence 35689999999999999999999999999999998765311 1 123456678999999999 99999999999554
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC-CcEEEcccCcce
Q 007629 187 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLAR 264 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~-~~vKL~DFGla~ 264 (595)
..+|||||||. |+|++.+...++++|.+++.+|.||+.||+|||+.||+||||||+|||++.+ +++||+|||++.
T Consensus 93 ---~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 93 ---TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred ---CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 34999999998 5999999998999999999999999999999999999999999999999999 999999999998
Q ss_pred eccCCCCCcccccccccCCcccccccccccCCC-CC-CcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK-YT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~-~~-~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
... .......+.|||+.|+|||++.+ .. |+ .++||||+|||||.|++|+.||...+.......|..
T Consensus 170 ~~~---~~~~~l~t~cGsp~Y~aPEvl~~--~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------- 237 (370)
T KOG0583|consen 170 ISP---GEDGLLKTFCGSPAYAAPEVLSG--KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------- 237 (370)
T ss_pred ccC---CCCCcccCCCCCcccCCHHHhCC--CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc-------
Confidence 763 11223577899999999999988 34 65 789999999999999999999998665444333211
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
....+...+. ++.+.+||.+||..||.+|+|+.+++.||||+.
T Consensus 238 ---------------------~~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 ---------------------GEFKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ---------------------CCccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1111111111 899999999999999999999999999999986
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-51 Score=427.80 Aligned_cols=257 Identities=33% Similarity=0.578 Sum_probs=228.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|.+.+.||+|+||+||+|+.+.+.+.||||.+.+......+.+.+.+|++|++.|+|||||.+++.| +...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 478999999999999999999999999999999988777778889999999999999999999999988 556789
Q ss_pred EEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 193 YVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 193 ylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
|+|.|||.|+|+.++...+.++|+.++.|++|++.||.|||+.+|+|||+||.|||++..|.+|+||||+|+.... .
T Consensus 77 ~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~---~ 153 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST---N 153 (808)
T ss_pred EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc---C
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999997643 3
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHH
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~ 352 (595)
....+..-|||.|||||++.+ ..|+..+|+||||||+|||++|+|||......+....|.
T Consensus 154 t~vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~------------------ 213 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL------------------ 213 (808)
T ss_pred ceeeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh------------------
Confidence 344677889999999999987 799999999999999999999999997765443333221
Q ss_pred HHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 353 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
+.++.+. ..++..++.||+.+|.+||.+|+|+.+++.|||+++-.
T Consensus 214 ----------~d~v~~p---~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 214 ----------KDPVKPP---STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred ----------cCCCCCc---ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 1122211 26788999999999999999999999999999998643
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=408.25 Aligned_cols=285 Identities=36% Similarity=0.654 Sum_probs=234.2
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 110 ~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
+..++|++.+.||.|+||+||+|.+..++..||+|+++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 75 (288)
T cd07871 2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHT-----E 75 (288)
T ss_pred CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-----C
Confidence 456789999999999999999999999999999999864321 2223467799999999999999999999843 3
Q ss_pred ccEEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+|+||||++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 76 RCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 4689999999999999887654 578999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+..+
T Consensus 156 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 156 PTK---TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred CCc---cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence 221 12445789999999988652 56899999999999999999999999999999999999999999988776654
Q ss_pred hhH-HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 349 RNE-KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 349 ~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
... ....++ .+.....++....+..++++++||.+||.+||.+|||++|+|+||||
T Consensus 232 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 232 TSNEEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccchhhhccc--cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 321 111111 11111222233345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=417.64 Aligned_cols=326 Identities=36% Similarity=0.666 Sum_probs=257.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC-ccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~~~ 190 (595)
.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... .....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46899999999999999999999999999999999765545555677889999999999999999999886543 23445
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 103 ~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 180 (364)
T cd07875 103 DVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180 (364)
T ss_pred eEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC
Confidence 6899999999999888864 48899999999999999999999999999999999999999999999999997543221
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|..+....+..
T Consensus 181 ----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 181 ----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred ----cccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 2245689999999999977 6799999999999999999999999999999999999999999988876655433
Q ss_pred HHHHHHhhhcccCCCCCCCC------------CCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSH------------KFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPST 418 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~------------~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~ 418 (595)
. ...+....+......+.. .....+..+++||.+||..||.+|||+.|+|+||||..+.+....+..
T Consensus 255 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~ 333 (364)
T cd07875 255 T-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 333 (364)
T ss_pred H-HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCCCC
Confidence 2 222222222111111111 112235678999999999999999999999999999876554433322
Q ss_pred CC-CcccchHHHHhhhcHHHHHHHHHHHHHh
Q 007629 419 QP-ISKLEFEFERRKLAKDDVREMIYREILE 448 (595)
Q Consensus 419 ~~-~~~~~~~~e~~~~~~~~~~~~i~~ei~~ 448 (595)
.+ +.. ...+.+....+++++.++.++++
T Consensus 334 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 362 (364)
T cd07875 334 PPKIPD--KQLDEREHTIEEWKELIYKEVMD 362 (364)
T ss_pred CCCCCC--ccchhhhccHHHHHHHHHHHHHc
Confidence 21 212 22344566777888888888754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-49 Score=417.09 Aligned_cols=293 Identities=39% Similarity=0.704 Sum_probs=239.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~~ 190 (595)
..+|++.+.||+|+||.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++..... ....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 468999999999999999999999999999999997654444556778899999999999999999999865432 3345
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+||||++++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 177 (359)
T cd07876 100 DVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 177 (359)
T ss_pred eeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc
Confidence 6899999999998887753 58899999999999999999999999999999999999999999999999997542221
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...++..+...++.|..+.......
T Consensus 178 ----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 178 ----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred ----cCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 1245689999999999977 6799999999999999999999999999998889999999999998876655432
Q ss_pred HHHHHHhhhcccCCCCCCCCCC------------CCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKF------------PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~------------~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~ 413 (595)
....+...........+...+ ...++.+.+||.+||..||++|||+.|+|+||||..+..+.
T Consensus 252 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 325 (359)
T cd07876 252 -TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA 325 (359)
T ss_pred -HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence 223333222222222221111 12467799999999999999999999999999998655443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=413.97 Aligned_cols=332 Identities=51% Similarity=0.887 Sum_probs=273.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++..........
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 46899999999999999999999999999999998632 22234566788999999999999999999887665555667
Q ss_pred EEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
+|+|+||++++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 83 VYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred EEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 999999999999888754 5799999999999999999999999999999999999999999999999999976543322
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
........+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+...++.+..+.+..+...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 22223456899999999987542 46889999999999999999999999999998999999999999988888777666
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHHHh
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERR 431 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e~~ 431 (595)
....++.........++....+..++.+.+||.+||..||.+|||+.|+++||||..+..+..++..++...++++.. .
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~-~ 319 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELF-D 319 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccc-c
Confidence 666666555555445555555677889999999999999999999999999999998877655555444334444433 4
Q ss_pred hhcHHHHHHHHHHHHH
Q 007629 432 KLAKDDVREMIYREIL 447 (595)
Q Consensus 432 ~~~~~~~~~~i~~ei~ 447 (595)
.+.++.+++.|..+|+
T Consensus 320 ~~~~~~~~~~~~~~~~ 335 (336)
T cd07849 320 DLPKEKLKELIFEEIM 335 (336)
T ss_pred ccCHHHHHHHHHHHhc
Confidence 5568888888888875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=399.65 Aligned_cols=331 Identities=36% Similarity=0.677 Sum_probs=281.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REF 189 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~ 189 (595)
...||.-++.+|.|+- .|..|.|..++..||||++...+.....+++..+|..+|..+.|+||++++.+|.+... .++
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3468999999999999 88899999999999999997777777778899999999999999999999999987543 456
Q ss_pred ccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.++|+|||||..+|.+.+. -.+..+.+.++++|++.|++|||+.||+||||||+||+++.++.+||+|||+|+....
T Consensus 94 ~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~- 170 (369)
T KOG0665|consen 94 QEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT- 170 (369)
T ss_pred HhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc-
Confidence 7899999999999999998 3578889999999999999999999999999999999999999999999999985422
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
....+.++.|+.|+|||++.+ ..|.+.+||||+|||+.||++|...|+|++..+|..++.+.+|+|.+..+..+.
T Consensus 171 ---~~~mtpyVvtRyyrapevil~--~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 171 ---DFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred ---ccccCchhheeeccCchheec--cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 245789999999999999998 459999999999999999999999999999999999999999999999888765
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCC------------CCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPN------------ADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPS 417 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~------------~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~ 417 (595)
...+.|...+++.....+...||+ -...+.+|+.+||..||++|.+++++|+||||+-|... .++.
T Consensus 246 -~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~-~ev~ 323 (369)
T KOG0665|consen 246 -PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDP-DEVE 323 (369)
T ss_pred -HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccc-cccc
Confidence 345566665555554555555543 23568999999999999999999999999999955433 3333
Q ss_pred CCCCcccchHHHHhhhcHHHHHHHHHHHHHhhChh
Q 007629 418 TQPISKLEFEFERRKLAKDDVREMIYREILEYHPQ 452 (595)
Q Consensus 418 ~~~~~~~~~~~e~~~~~~~~~~~~i~~ei~~~~~~ 452 (595)
.++....+..++.+..+.++|+++|++|+.++.+.
T Consensus 324 ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~~ 358 (369)
T KOG0665|consen 324 APPPEIYDKQLDEREHTIEEWKELIFKEVQRFEEF 358 (369)
T ss_pred CCCCchhhhhcccccCCHHHHHHHHHHHHHhhccc
Confidence 33333455556677778999999999999998873
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-51 Score=401.27 Aligned_cols=291 Identities=40% Similarity=0.648 Sum_probs=238.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCc----EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~----~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
..|++++.||+|.||.||+|..+.++. .||||+++.......-.....||+.+++.|+||||+.+..+++..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---- 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---- 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence 468999999999999999997665543 799999976544444456678999999999999999999999763
Q ss_pred cccEEEEEecccccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC----CcEEEcc
Q 007629 189 FKDIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICD 259 (595)
Q Consensus 189 ~~~lylV~E~~~g~L~~~i~~~-----~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~----~~vKL~D 259 (595)
...+|+++||.+.||.++|+-. ..++...++.|++||+.|+.|||++.|+||||||.||||..+ |.|||+|
T Consensus 100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 3569999999999999999743 368999999999999999999999999999999999999888 8999999
Q ss_pred cCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCC---------hHHHH
Q 007629 260 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN---------VVHQL 330 (595)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~---------~~~~l 330 (595)
||+|+.+.+.-..-......+.|.||+|||+++|. ..|++++||||+|||++||||-+|.|.+.. ..+|+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999875543332234557899999999999984 789999999999999999999999998764 36799
Q ss_pred HHHHhhcCCCChhHHHHHhhHH-HHHHhhhcccCCCCC-----CCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCC
Q 007629 331 DLMTDLLGTPSTESISRIRNEK-ARRYLGSMRKKQPVP-----FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (595)
Q Consensus 331 ~~i~~~lg~p~~~~i~~i~~~~-~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp 404 (595)
+.|.+++|+|..+.+..+..-. ....+..++.....+ +-+.+..-++.+.+||.+||.+||.+|+|++++|+|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 9999999999998877664322 123333333222211 2223344567799999999999999999999999999
Q ss_pred CccC
Q 007629 405 YFHG 408 (595)
Q Consensus 405 ~f~~ 408 (595)
||..
T Consensus 339 yF~~ 342 (438)
T KOG0666|consen 339 YFTE 342 (438)
T ss_pred cccc
Confidence 9975
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-51 Score=392.77 Aligned_cols=259 Identities=31% Similarity=0.510 Sum_probs=223.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.+.|++.+.||+|.|++|+++.+..||+.+|+|+|+-......+.+.+.+|+.|-+.|+|||||++.+.+ .+...
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccce
Confidence 4579999999999999999999999999999999875444445788899999999999999999998877 34456
Q ss_pred EEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC---cEEEcccCcceecc
Q 007629 192 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVSF 267 (595)
Q Consensus 192 lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~---~vKL~DFGla~~~~ 267 (595)
.|||||+|+| +|..-|-+..-++|..+-.++.||++||.|+|.+||||||+||+|+|+-+.. -+||+|||+|..+.
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 8999999995 7887777667789999999999999999999999999999999999986543 49999999998765
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
....+...+|||.|||||++.. .+|+..+|||+.|||||-||.|.+||.+++..+..+.|...
T Consensus 165 ----~g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g----------- 227 (355)
T KOG0033|consen 165 ----DGEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG----------- 227 (355)
T ss_pred ----CccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc-----------
Confidence 2234678899999999999987 79999999999999999999999999998765555544221
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
.-.-.+..|+.+++.+++|+++||..||.+|+|+.|+|+|||+.+
T Consensus 228 ----------------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 228 ----------------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ----------------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 111123468899999999999999999999999999999999975
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=410.50 Aligned_cols=291 Identities=38% Similarity=0.692 Sum_probs=237.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~~ 190 (595)
.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 468999999999999999999999999999999997655555556778899999999999999999998865432 3345
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+||||++++|.+.+.. .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 173 (355)
T cd07874 96 DVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_pred eeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc
Confidence 6899999999998888754 48899999999999999999999999999999999999999999999999997543221
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+....+..
T Consensus 174 ----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 174 ----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred ----ccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 1245689999999999877 6789999999999999999999999999998888888888899988877665543
Q ss_pred HHHHHHhhhcccCCCCCC-----------C-CCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 351 EKARRYLGSMRKKQPVPF-----------S-HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~-----------~-~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
. ...++..........+ . ......+..+.+||.+||..||.+|||+.|+|+||||..+.+
T Consensus 248 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 248 T-VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred H-HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 2 2223222111110000 0 111224567899999999999999999999999999986654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=421.75 Aligned_cols=285 Identities=27% Similarity=0.437 Sum_probs=225.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCC------ceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP------DIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp------nIv~l~~~~~~~~ 185 (595)
.++|+++++||+|+||+||+|.+..+++.||||+++... ........|+.+++.++|. +|+.+++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~- 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE- 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-
Confidence 468999999999999999999999999999999996421 2233456688887777654 588888887432
Q ss_pred ccCcccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCC-----------
Q 007629 186 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADC----------- 253 (595)
Q Consensus 186 ~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~----------- 253 (595)
..++|||||+++++|.+++...+.+++..++.|+.||+.||.|||+ .|||||||||+|||++.++
T Consensus 204 ---~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 204 ---TGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred ---CceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 3468999999999999999888899999999999999999999998 5999999999999998765
Q ss_pred -----cEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHH
Q 007629 254 -----KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH 328 (595)
Q Consensus 254 -----~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~ 328 (595)
.+||+|||++..... ..+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998863211 1245689999999999987 689999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCC----CC-----CCC--CCCCHHHHHHHHhhCcCCCCCCCCH
Q 007629 329 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVP----FS-----HKF--PNADPLALHLLERLLAFDPKDRPTA 397 (595)
Q Consensus 329 ~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~----~~-----~~~--~~~~~~~~dLl~~~L~~DP~~Rpta 397 (595)
++..+.+.+|.++.++...........++.......+.. +. ..+ ...++.+.|||.+||.+||.+|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 999999999988776554332222222222221111100 00 000 0125678899999999999999999
Q ss_pred HHHhcCCCccCCCC
Q 007629 398 EEALADPYFHGLAN 411 (595)
Q Consensus 398 ~elL~Hp~f~~~~~ 411 (595)
+|+|+||||..+..
T Consensus 433 ~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 433 RQMTTHPYVLKYYP 446 (467)
T ss_pred HHHhcCccccccCC
Confidence 99999999987544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=394.89 Aligned_cols=257 Identities=32% Similarity=0.473 Sum_probs=213.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|+|+++||+|+||.||++.+..+|..||.|.|+-...+....+.+..||.+|++|+|||||++++.-+. ++..-
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchh
Confidence 346999999999999999999999999999999997444455566788999999999999999999884332 22344
Q ss_pred EEEEEeccc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--eeecCCCCCceeeCCCCcEEEcccCc
Q 007629 192 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHT--AN--VFHRDLKPKNILANADCKLKICDFGL 262 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs--~g--IiHrDLKP~NILl~~~~~vKL~DFGl 262 (595)
++||||||+ |||.+.|+. ...++|..++.++.|++.||..+|+ .. |+||||||.||+++.+|.+||+||||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 899999998 799998864 3469999999999999999999999 44 99999999999999999999999999
Q ss_pred ceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
++.+... ..+..+++|||.||+||++.+ .+|+.++||||+||++|||+.-++||.|++.......|...--.
T Consensus 175 ~r~l~s~---~tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~--- 246 (375)
T KOG0591|consen 175 GRFLSSK---TTFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP--- 246 (375)
T ss_pred HhHhcch---hHHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC---
Confidence 9987443 334578999999999999988 79999999999999999999999999999766555555432111
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
|.|- .-++..+..||..|+..||..||+. +|++..+.
T Consensus 247 ----------------------~~p~----~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~ 283 (375)
T KOG0591|consen 247 ----------------------PLPD----EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ 283 (375)
T ss_pred ----------------------CCcH----HHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence 1110 1246678999999999999999987 66665543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=403.13 Aligned_cols=289 Identities=34% Similarity=0.604 Sum_probs=225.8
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 109 ~~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
++..++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 74 (303)
T cd07869 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHT----- 74 (303)
T ss_pred CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEec-----
Confidence 3567899999999999999999999999999999999864322 1223456789999999999999999999854
Q ss_pred cccEEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 189 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 189 ~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
...+|+||||+.++|.+.+... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 75 KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 3468999999999998888664 568999999999999999999999999999999999999999999999999997542
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCC-hHHHHHHHHhhcCCCChhHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~-~~~~l~~i~~~lg~p~~~~i~ 346 (595)
... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.. ...++..+...++.|....+.
T Consensus 155 ~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 155 VPS---HTYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred CCC---ccCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 211 112446789999999998652 468889999999999999999999998754 456677777777777655443
Q ss_pred HHhhHHHHHHh-hhcccCCCCCCCCCCC--CCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 347 RIRNEKARRYL-GSMRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 347 ~i~~~~~~~~l-~~~~~~~~~~~~~~~~--~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..... ..+. ..+....+..+...+. ..++.+.+||.+||++||++|||+.|+|+||||+.+
T Consensus 231 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 231 GVHSL--PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred chhhc--cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 32110 0000 0000001111111111 245779999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=397.57 Aligned_cols=284 Identities=36% Similarity=0.600 Sum_probs=228.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECC-CCcEEEEEEecCccCChhhHHHHHHHHHHHHhc---CCCceeeeeeeecCCCccC
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVFEHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~-~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~ 188 (595)
.+|++.+.||+|+||+||+|.+.. ++..||||+++...........+.+|+.+++.+ .||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 379999999999999999999864 578899999865433333344566788877766 6999999999986544344
Q ss_pred cccEEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 189 FKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
...+|+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 5679999999999999988754 35899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..+.+..+.|..+.+.
T Consensus 161 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 161 SFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cCCc----ccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 3321 1244679999999999876 678999999999999999999999999999989999998888877665432
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
..... . ...+....+.++....+.+++.+.+||.+||+.||++|||+.|+|+||||
T Consensus 235 ~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVAL--P--RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcc--c--chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 21100 0 01112222333344456788899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=406.11 Aligned_cols=328 Identities=52% Similarity=0.935 Sum_probs=277.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||.|+||.||+|.+..+|..||+|++............+.+|+.+|+.++||||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 36899999999999999999999999999999998764444445667889999999999999999999875543 34567
Q ss_pred EEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
+|+||||+.++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 83 VYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999976533222
Q ss_pred C-cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 272 S-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 272 ~-~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. .......+|+.+|+|||.+.+. ..++.++|||||||++|||++|++||.+.+...++..+...+|.|+.+.+..+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred CCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 1 1122346899999999987652 4688999999999999999999999999999999999999999999988877776
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHHH
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e~ 430 (595)
.....++.......+.++...++..++.+.+||.+||+.||.+||++++++.||||.+......++. ....+++.++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 319 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPT--CPPPFDFDFEA 319 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccccc--CCCCCCCChhh
Confidence 6666666666666666666667788999999999999999999999999999999998877666554 34567778888
Q ss_pred hhhcHHHHHHHHH
Q 007629 431 RKLAKDDVREMIY 443 (595)
Q Consensus 431 ~~~~~~~~~~~i~ 443 (595)
.....+.+.+.|.
T Consensus 320 ~~~~~~~~~~~~~ 332 (334)
T cd07855 320 IELSREQLKEAIV 332 (334)
T ss_pred hhcChhhHHHHhh
Confidence 8788777666553
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=395.98 Aligned_cols=285 Identities=34% Similarity=0.645 Sum_probs=225.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||+|+||.||+|+++.++..||||+++...........+.+|+.+++.++||||+++++++. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR-----RRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe-----cCCEE
Confidence 3799999999999999999999999999999998754333344567789999999999999999999884 33568
Q ss_pred EEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+||||+++++...+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99999999876665544 45799999999999999999999999999999999999999999999999999986532221
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|++||++.+....+..+....+..+...+......
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 156 A--NYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred c--cccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 1 1245679999999999877 57899999999999999999999999999888888888887777665544322111
Q ss_pred HHHHHhhhcccCCCCCC-CCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 352 KARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
.............+... .......++.+.+||++||++||++|||++|+|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000000000000000 11123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=404.23 Aligned_cols=329 Identities=57% Similarity=0.961 Sum_probs=281.7
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++.+.||.|+||.||+|.+..++..||||++..........+.+.+|+.+++.++||||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 68999999999999999999999999999999976544345567789999999999999999999998766544556799
Q ss_pred EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCc
Q 007629 194 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (595)
Q Consensus 194 lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 273 (595)
+||||++++|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..........
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99999999999999887899999999999999999999999999999999999999999999999999998764433211
Q ss_pred ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHH
Q 007629 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (595)
Q Consensus 274 ~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~ 353 (595)
.......+|++|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+..+...++.+..+.+..+.....
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred ccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 223456789999999998873 3788999999999999999999999999999999999999999999887776666666
Q ss_pred HHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHHHhhh
Q 007629 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKL 433 (595)
Q Consensus 354 ~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~ 433 (595)
..++.......+.++....+..++.+.+||.+||.+||.+||+++++|.||||+++..+..++..+....+ ..|+...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 318 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDF-DFFDDDEL 318 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcccc-cccchhhc
Confidence 77777666666677777778889999999999999999999999999999999998887776655543333 14677888
Q ss_pred cHHHHHHHHHH
Q 007629 434 AKDDVREMIYR 444 (595)
Q Consensus 434 ~~~~~~~~i~~ 444 (595)
..++.++.|+.
T Consensus 319 ~~~~~~~~~~~ 329 (330)
T cd07834 319 TEEELKELIYE 329 (330)
T ss_pred CHHHHhHHhhc
Confidence 99999888875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=364.44 Aligned_cols=285 Identities=38% Similarity=0.640 Sum_probs=238.5
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
.|.-.++||+|.||+||+|+++.+++.||+|.++-...+.......++||.+|+.|+|.|||+++++.. ..+.+-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-----sdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-----cCceeE
Confidence 466678999999999999999999999999999754444455567899999999999999999999873 345699
Q ss_pred EEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 194 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 194 lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
+|+|||..+|..++.. ++.+..+.++.++.|+++||.|+|++++.||||||.|+||+.+|++||+|||+|+.+.-..
T Consensus 78 lvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv-- 155 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-- 155 (292)
T ss_pred EeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence 9999999999988865 5789999999999999999999999999999999999999999999999999998653221
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
..++..+.|.||++|.++.|. .-|+...|+||.|||++|+.. |+++|+|.+..+|+..|.+++|+|..+.+..+..-
T Consensus 156 -rcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred -EeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 124556889999999998874 669999999999999999985 88999999999999999999999999877654211
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..|...-.-.....|++..|..+..-+||++++|.-+|.+|++|+++|+||||...
T Consensus 234 --pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 234 --PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred --CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 11110000111223455566777778999999999999999999999999999864
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=418.70 Aligned_cols=286 Identities=35% Similarity=0.623 Sum_probs=229.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc---cC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR---RE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---~~ 188 (595)
..+|++++.||+|+||+||+|.+..+++.||||++... .....+|+.+|+.++|||||++++++..... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 45799999999999999999999999999999988532 1233579999999999999999988755432 22
Q ss_pred cccEEEEEecccccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC-cEEEcccCcc
Q 007629 189 FKDIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLA 263 (595)
Q Consensus 189 ~~~lylV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~-~vKL~DFGla 263 (595)
...+|+||||++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 23578999999998877765 345799999999999999999999999999999999999999765 6999999999
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
+....... ...++||+.|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+..+++..+...+|+|..+
T Consensus 219 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 219 KNLLAGQR----SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred hhccCCCC----cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 86533221 2346889999999998652 468999999999999999999999999999999999999999999887
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCC-CCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
.+......... . .++...+..+...++ ..++++++||.+||.+||.+|||+.|+|+||||..+.+
T Consensus 294 ~~~~~~~~~~~-~--~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 294 QLKEMNPNYAD-I--KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHhchhhhc-c--cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 66543221100 0 011111111112222 36788999999999999999999999999999987755
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=397.29 Aligned_cols=275 Identities=29% Similarity=0.447 Sum_probs=226.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..+.|++.++||.|..++||+|+...+++.||||++.-. ....+...+.+|+..|+.++||||++++..|... .
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE-kc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-----~ 97 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE-KCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD-----S 97 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh-hhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-----c
Confidence 356899999999999999999999999999999999632 2233478899999999999999999999998654 4
Q ss_pred cEEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 191 DIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
.+|+||.||. |+++++++.. ..+.|..+..|++++++||.|||.+|-||||||+.||||+.+|.|||+|||.+-.+.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 5999999998 7899999864 469999999999999999999999999999999999999999999999999987666
Q ss_pred CCCCCcccc-cccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 268 NDAPSAIFW-TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 268 ~~~~~~~~~-~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
......... .+++||++|||||++......|+.|+||||||++..||.+|..||..-..... ++..+-+.|+.-...
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLLTLQNDPPTLLTS 255 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHHHhcCCCCCcccc
Confidence 554443333 77899999999999766668899999999999999999999999976554332 344555555422222
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~ 412 (595)
....+.. ...+..++.+|..||.+||.+||||+++|+|+||+.....
T Consensus 256 ~~~~d~~-------------------k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 256 GLDKDED-------------------KKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred cCChHHh-------------------hhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 1111111 1234578999999999999999999999999999876543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=403.07 Aligned_cols=329 Identities=45% Similarity=0.845 Sum_probs=279.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~~ 190 (595)
.++|++.+.||+|+||.||+|++..++..||||++............+.+|+.+++.+.||||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 568999999999999999999999999999999986543334455677899999999999999999988765432 3445
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+|+||++++|.+++.. ..+++..++.++.||++||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred cEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 6899999999999998875 57999999999999999999999999999999999999999999999999999754322
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
...+.+|..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+...++.+.+..+.++..
T Consensus 172 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 172 -----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred -----ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 2445789999999987652 3678899999999999999999999999998888888888899988888887777
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHHH
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e~ 430 (595)
.....++..........+...+...++.+.+||.+||..||.+|||+.++++||||..+.....++. ......++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~---~~~~~~~~~~ 322 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPV---APPYDQSFES 322 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccc---ccccCcchhh
Confidence 7777776666555555555555667899999999999999999999999999999998876655443 2334567889
Q ss_pred hhhcHHHHHHHHHHHHHhhCh
Q 007629 431 RKLAKDDVREMIYREILEYHP 451 (595)
Q Consensus 431 ~~~~~~~~~~~i~~ei~~~~~ 451 (595)
..+..++|+++++.+++.|.|
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07851 323 RDLTVDEWKELVYKEIMNFKP 343 (343)
T ss_pred hhcCHHHHHHHhHHHHHhccC
Confidence 999999999999999998875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=401.92 Aligned_cols=270 Identities=28% Similarity=0.444 Sum_probs=218.0
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC------------ChhhHHHHHHHHHHHHhcCCCcee
Q 007629 108 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE------------HVSDATRILREIKLLRLLRHPDIV 175 (595)
Q Consensus 108 ~~~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~------------~~~~~~~~~~Ei~il~~l~HpnIv 175 (595)
......+|++++.||+|.||+|.+|++..+++.||||++.+... .....+++.+||.||++|.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 33446789999999999999999999999999999999964211 112246789999999999999999
Q ss_pred eeeeeecCCCccCcccEEEEEecccccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc
Q 007629 176 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 254 (595)
Q Consensus 176 ~l~~~~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~~-l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~ 254 (595)
+|+++.-++ ...++|||+|||...-..+.-..++ +++.+++.|++.++.||+|||.+|||||||||+|+||+++|+
T Consensus 172 ~LiEvLDDP---~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 172 KLIEVLDDP---ESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEEeecCc---ccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 999998554 3467999999999544444444455 999999999999999999999999999999999999999999
Q ss_pred EEEcccCcceeccC--CCCCcccccccccCCcccccccccccC--CCCCCcceeechhHHHHHHHcCCCCCCCCChHHHH
Q 007629 255 LKICDFGLARVSFN--DAPSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQL 330 (595)
Q Consensus 255 vKL~DFGla~~~~~--~~~~~~~~~~~~gT~~Y~APE~l~~~~--~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l 330 (595)
|||+|||.+..... +......+...+|||.|||||++.+.. ...+.+.||||+||+||.|+.|+.||-+....+..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 99999999975421 122223345579999999999987632 23456899999999999999999999988876666
Q ss_pred HHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 331 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 331 ~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
+.|... |..+ ...+.+...++|||.+||.+||++|++..++..|||...-
T Consensus 329 ~KIvn~----------------------------pL~f-P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 329 DKIVND----------------------------PLEF-PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHhcC----------------------------cccC-CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 555321 1111 1224567889999999999999999999999999999754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=418.60 Aligned_cols=260 Identities=25% Similarity=0.433 Sum_probs=221.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~ 189 (595)
..+|.++++||+|+||+|++|..+.+++.||||++++.. ....+.+....|..|+.... ||.++.++.+|. ..
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ-----T~ 441 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ-----TK 441 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc-----cC
Confidence 568999999999999999999999999999999997632 34456778889999998886 999999999984 44
Q ss_pred ccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.++|+||||+.|+-...+...+.|++..+++|+..|+.||.|||++||||||||.+|||+|.+|++||+|||+++.....
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred CeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 57999999998533445555678999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. ..+++||||.|||||++.+ ..|+.++|+|||||+|||||.|..||+|++..+..+.|..-
T Consensus 522 g~---~TsTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------------- 583 (694)
T KOG0694|consen 522 GD---RTSTFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------------- 583 (694)
T ss_pred CC---ccccccCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Confidence 22 2367899999999999998 79999999999999999999999999999987777655321
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCCCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLANV 412 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~~~~ 412 (595)
....| ..++.++.+++++||.++|++|.. +++|.+||||+.+.+.
T Consensus 584 -----------~~~yP-------~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 584 -----------EVRYP-------RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred -----------CCCCC-------CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence 00011 246788999999999999999986 5899999999987664
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=412.98 Aligned_cols=255 Identities=31% Similarity=0.533 Sum_probs=221.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
...|...++||+|+.|.||.|+...+++.||||.+..... ...+-++.|+.+|+..+|+|||.+++.|+.. ..
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----de 344 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DE 344 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhccc-----ce
Confidence 4678999999999999999999999999999999964332 3345688999999999999999999988654 45
Q ss_pred EEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+|||||+| +|.+++.. ..++|.++..|.+++++||+|||.+||+|||||.+|||++.+|.+||+|||+|..+....
T Consensus 345 LWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred eEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 9999999994 67776654 469999999999999999999999999999999999999999999999999998776555
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
.+ .++.+|||+|||||++.. ..|++++||||||++++||+-|++||-.++....+.+|..- |+|.
T Consensus 424 ~K---R~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~--------- 488 (550)
T KOG0578|consen 424 SK---RSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPK--------- 488 (550)
T ss_pred Cc---cccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCC---------
Confidence 43 477899999999999987 78999999999999999999999999888877666655431 2222
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
-.....+++.++|||.+||++|+.+|++|.|+|+||||+
T Consensus 489 ------------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 489 ------------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred ------------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 223456899999999999999999999999999999995
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=391.75 Aligned_cols=283 Identities=35% Similarity=0.611 Sum_probs=227.5
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc---CCCceeeeeeeecCCCccCcc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~~~ 190 (595)
+|++.+.||+|+||+||+|.++.+|+.||+|.++...........+.+|+.+++.+ .||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58999999999999999999999999999999865332222234456777777665 699999999998655444456
Q ss_pred cEEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 191 DIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.+++||||+.++|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 78999999999999888764 3589999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+......+..+....+.+....+...
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 161 QMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccc----CCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 221 234578999999999876 67899999999999999999999999998888888888888777665433211
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
.... ...+....+.++....+.++..+.+||.+||++||.+|||+.|+|.||||
T Consensus 235 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLP----RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccc----ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 00111222233344456778899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=395.77 Aligned_cols=290 Identities=37% Similarity=0.651 Sum_probs=237.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 110 ~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
+...+|.+.+.||+|+||.||+|++..++..||||+++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 76 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHT-----D 76 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEee-----C
Confidence 455789999999999999999999999999999999864322 2223456789999999999999999999843 3
Q ss_pred ccEEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+|+||||++++|.+.+...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 77 KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 4689999999999988886644 588999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+..+
T Consensus 157 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 157 PTK---TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred Ccc---ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence 221 12345789999999988652 56889999999999999999999999999998999999999999988776654
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
........ ...+...+.++....+.+++.+.+||.+||..||.+|||+.|+|+||||+.+.
T Consensus 233 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 233 SSNDEFKN-YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred cchhhhhh-hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 33221111 11222233333345567889999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=396.21 Aligned_cols=264 Identities=30% Similarity=0.453 Sum_probs=211.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|...+.||+|+||.||++.+..+|..+|||.+... +....+.+.+|+.+|+.|+|||||++++...... . ..
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-ee
Confidence 34678889999999999999999999999999998643 1122667899999999999999999999743222 1 46
Q ss_pred EEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC-CCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~-~~~vKL~DFGla~~~~~ 268 (595)
++|+|||+. |+|.+++...+ .|++..++.+..||++||+|||++|||||||||+|||++. ++.+||+|||+++....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 899999998 69999999877 7999999999999999999999999999999999999999 79999999999986653
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCC-ChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-NVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~-~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
............||+.|||||++... ....+++|||||||++.||+||.+||... .....+..+.
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig------------- 236 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIG------------- 236 (313)
T ss_pred ccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHh-------------
Confidence 11111223457899999999999841 23335999999999999999999999763 2111111110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
.....| .....+++++++||.+||.+||.+||||+++|.|||.++..
T Consensus 237 ------------~~~~~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 237 ------------REDSLP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ------------ccCCCC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 001111 22345789999999999999999999999999999997643
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=409.93 Aligned_cols=283 Identities=26% Similarity=0.364 Sum_probs=221.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|++++.||+|+||.||+|++..+++.||||+.. ...+.+|+.+|+.|+||||+++++++.. ...
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 157 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTY-----NKF 157 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCe
Confidence 357999999999999999999999999999999753 2346789999999999999999998843 345
Q ss_pred EEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
.|+|||++.++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 158 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 158 TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred eEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 89999999999999998888899999999999999999999999999999999999999999999999999975322211
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCC-------ChHHHHHHHHhhcCCCChhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-------NVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~-------~~~~~l~~i~~~lg~p~~~~ 344 (595)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+. ....++..+...+|.++.+.
T Consensus 238 --~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 238 --NKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred --cccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 11245689999999999877 67999999999999999999999776543 23457777877777765432
Q ss_pred HHHHhhHHHHHHhhhcccCCCCC----CCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVP----FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
...........+..........+ .......++..+.+||.+||++||.+||||+|+|+||||+.+..
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 11100000001111111111111 00111235667999999999999999999999999999987643
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=395.75 Aligned_cols=324 Identities=39% Similarity=0.691 Sum_probs=255.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC-ccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~~~ 190 (595)
..+|++.+.||+|+||.||+|.+..+|..||||++.+..........+.+|+.+++.++||||+++++++.... ..+..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46899999999999999999999999999999998754444455667889999999999999999999886543 23445
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+||||+.++|.+.+... +++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 95 DVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred cEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence 68999999999999888654 8999999999999999999999999999999999999999999999999998653321
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...++..+...+|.|..+....+..
T Consensus 173 ~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 173 M----MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred C----CCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 1 234578999999999877 6789999999999999999999999999998889999999999998876655432
Q ss_pred HHHHHHhhhcccCCCCCCCCC-------------CCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHK-------------FPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPS 417 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~-------------~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~ 417 (595)
. ...+..........++... ....++.+.+||.+||..||.+|||+.|+|.||||+.+........
T Consensus 247 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~~ 325 (353)
T cd07850 247 T-VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVEA 325 (353)
T ss_pred h-hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccCCC
Confidence 2 2222222111111122111 1134567899999999999999999999999999987665433222
Q ss_pred CCCCcccchHHHHhhhcHHHHHHHHHHH
Q 007629 418 TQPISKLEFEFERRKLAKDDVREMIYRE 445 (595)
Q Consensus 418 ~~~~~~~~~~~e~~~~~~~~~~~~i~~e 445 (595)
..+ ...+...+.+....++|+..++.|
T Consensus 326 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T cd07850 326 PPP-APYDHSIDEREHTVEEWKELIYKE 352 (353)
T ss_pred CCC-CccccccccccccHHHHHHHHHhh
Confidence 222 122333455666778888777765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=379.03 Aligned_cols=288 Identities=43% Similarity=0.752 Sum_probs=247.9
Q ss_pred EEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEE
Q 007629 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (595)
Q Consensus 116 ~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV 195 (595)
+--+.||-|+||+||.+.|..+|+.||+|++...+......+++.+|+++|..++|.|++..+++..++...-+..+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 33478999999999999999999999999998888777788999999999999999999999999888776677889999
Q ss_pred EecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 196 FELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 196 ~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
.|+|..||+.+|..-..++.++++-+++||++||+|||+.+|.||||||.|+|++.++.+||||||+|+....+... .
T Consensus 136 TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~--h 213 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL--N 213 (449)
T ss_pred HHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh--h
Confidence 99999999999999999999999999999999999999999999999999999999999999999999976544433 3
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
++..+.|.+|+|||++.|. ..|+.++||||+|||+.|||..+.+|...+...|+++|.+++|+|+.+.+..-.......
T Consensus 214 MTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 5667889999999999884 789999999999999999999999999999999999999999999998876544332222
Q ss_pred HhhhcccCCCCCCCCCCC-----CCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 356 YLGSMRKKQPVPFSHKFP-----NADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~-----~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
.+..-. .+..+...+. ...-++.+++.+||.+||.+|++.++++.|+|...
T Consensus 293 ~LR~~~--k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 293 VLRAGL--RAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred hhccCC--CCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 222211 1222222222 23356899999999999999999999999999864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=391.99 Aligned_cols=330 Identities=44% Similarity=0.822 Sum_probs=273.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC-ccCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREF 189 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~~ 189 (595)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++.... ....
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 357899999999999999999999999999999999754333344567889999999999999999999875432 1233
Q ss_pred ccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
..+|+++++++++|.+++.. ..+++..++.++.||++||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~ 173 (345)
T cd07877 95 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173 (345)
T ss_pred ccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc
Confidence 56899999998899887764 46999999999999999999999999999999999999999999999999998754221
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.....+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+.......+.
T Consensus 174 ------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 174 ------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred ------ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 2345789999999987652 468889999999999999999999999988888888888888888888777666
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHH
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE 429 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e 429 (595)
....+.++..+.......+...+...++.+.+||.+||..||.+||++.++|.||||+++..+..++... ..++.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~---~~~~~~~ 323 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD---PYDQSFE 323 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCC---CccCcch
Confidence 6666666665555444455555556788999999999999999999999999999999887766555432 3555666
Q ss_pred HhhhcHHHHHHHHHHHHHhhCh
Q 007629 430 RRKLAKDDVREMIYREILEYHP 451 (595)
Q Consensus 430 ~~~~~~~~~~~~i~~ei~~~~~ 451 (595)
.+.+..+++....|.|+..+.|
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~ 345 (345)
T cd07877 324 SRDLLIDEWKSLTYDEVISFVP 345 (345)
T ss_pred hcccCHHHHHHHHHHHHHhcCC
Confidence 6677778999999999887754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=388.17 Aligned_cols=265 Identities=27% Similarity=0.405 Sum_probs=221.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.+.|++++.||.|.-|+||+|..+.++..+|+|++.+... ......++..|-.||+.++||.++.||..| +...
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccc
Confidence 4578999999999999999999999999999999975332 234456788899999999999999999998 4456
Q ss_pred cEEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 191 DIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
++|+|||||. |+|+.+.+++ +.|++..+++|+.+++-||+|||..|||+||||||||||.++|+|.|+||.|+....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 7999999998 6899888765 479999999999999999999999999999999999999999999999999875321
Q ss_pred C---------------------------------C-C-------------------CCcccccccccCCccccccccccc
Q 007629 268 N---------------------------------D-A-------------------PSAIFWTDYVATRWYRAPELCGSF 294 (595)
Q Consensus 268 ~---------------------------------~-~-------------------~~~~~~~~~~gT~~Y~APE~l~~~ 294 (595)
. . . +.......++||-.|.|||++.|
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G- 309 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG- 309 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence 0 0 0 00011234689999999999998
Q ss_pred CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCC
Q 007629 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPN 374 (595)
Q Consensus 295 ~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~ 374 (595)
...+.++|+|+|||++||||.|..||.|.+....+..|+. .+ ..+. ..+.
T Consensus 310 -~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~---~~-------------------------l~Fp-~~~~ 359 (459)
T KOG0610|consen 310 -EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG---QP-------------------------LKFP-EEPE 359 (459)
T ss_pred -CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc---CC-------------------------CcCC-CCCc
Confidence 6889999999999999999999999999987666655432 11 1111 1135
Q ss_pred CCHHHHHHHHhhCcCCCCCCCC----HHHHhcCCCccCCCCC
Q 007629 375 ADPLALHLLERLLAFDPKDRPT----AEEALADPYFHGLANV 412 (595)
Q Consensus 375 ~~~~~~dLl~~~L~~DP~~Rpt----a~elL~Hp~f~~~~~~ 412 (595)
++..++|||+++|.+||.+|.. |.||.+||||+++.+.
T Consensus 360 vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 360 VSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred chhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 6688999999999999999999 9999999999998775
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=391.06 Aligned_cols=330 Identities=41% Similarity=0.764 Sum_probs=272.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REF 189 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~ 189 (595)
..++|++.+.||+|+||.||+|.+..+|..||||++............+.+|+.+|+.++||||+++++++..... ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4578999999999999999999999999999999986543333345568899999999999999999998865432 223
Q ss_pred ccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
..+|+||||++++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred ceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 45799999998888888764 57999999999999999999999999999999999999999999999999999754221
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.....+++.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+..+....+.+..+....+.
T Consensus 172 ------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 172 ------MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred ------ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 1345789999999988652 357889999999999999999999999988888888888877777777777766
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHH
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE 429 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e 429 (595)
......+...+....+..+....+.+++.+.+||.+||..||.+|||+.+++.||||+.+.....++.. .++...++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~---~~~~~~~~ 321 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEA---PPYDDSFD 321 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCC---CCccccHH
Confidence 666666665555444444445567788999999999999999999999999999999988765544433 24666678
Q ss_pred HhhhcHHHHHHHHHHHHHhhCh
Q 007629 430 RRKLAKDDVREMIYREILEYHP 451 (595)
Q Consensus 430 ~~~~~~~~~~~~i~~ei~~~~~ 451 (595)
......++|+.+...||+.+.|
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07880 322 EVDQSLEEWKRLTFTEILSFQP 343 (343)
T ss_pred hhccchHHHHHHHHHHHHhcCC
Confidence 8888999999999999998765
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=393.08 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=213.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++.+.||+|+||.||+|+++.+++.||||+++... ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-----EN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-----CC
Confidence 467999999999999999999999999999999986421 122345668899999999999999999998843 35
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 6999999997 589999988889999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
. ...+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+..
T Consensus 172 ~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-------------- 229 (329)
T PTZ00263 172 T------FTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA-------------- 229 (329)
T ss_pred c------ceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------
Confidence 1 23579999999999877 6789999999999999999999999987664333222211
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGL 409 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~ 409 (595)
... .+ ...+++.+.+||.+||..||.+||+ +++++.||||.+.
T Consensus 230 ------------~~~--~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 230 ------------GRL--KF---PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred ------------CCc--CC---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 000 01 1235788999999999999999997 7999999999863
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=394.84 Aligned_cols=259 Identities=31% Similarity=0.513 Sum_probs=222.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~ 189 (595)
...|++.+.||+|.||+||+|+++.||+.||+|+|.+... .......+.+|+.+|+.+. |||||.++++|.. .
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-----~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-----P 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-----C
Confidence 4579999999999999999999999999999999975433 2234567899999999998 9999999999944 4
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC----CcEEEcccCcce
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLAR 264 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~----~~vKL~DFGla~ 264 (595)
..+|+|||+|. |+|++.|... .+++..+..++.||+.|+.|||+.||+||||||+|+|+... +.+|++|||+|.
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 57999999999 6899988876 49999999999999999999999999999999999998653 479999999998
Q ss_pred eccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
.... .......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+.......+..
T Consensus 188 ~~~~----~~~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~--------- 252 (382)
T KOG0032|consen 188 FIKP----GERLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR--------- 252 (382)
T ss_pred EccC----CceEeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc---------
Confidence 7654 123567899999999999986 6899999999999999999999999999886544433221
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.........|+.++..+++||.+||.+||.+|+||.++|+|||++..
T Consensus 253 ------------------~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 253 ------------------GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ------------------CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 11122345688899999999999999999999999999999999865
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=388.38 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=212.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++. +...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-----DQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-----cCCe
Confidence 36999999999999999999999999999999986421 12234556789999999999999999998874 3456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999998 6899999888899999999999999999999999999999999999999999999999999997653221
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 156 ------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------- 213 (291)
T cd05612 156 ------WTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------- 213 (291)
T ss_pred ------ccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 23579999999999877 67899999999999999999999999887654333222110
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 410 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~~ 410 (595)
. ..+ ....++.+.+||++||..||.+||+ ++++++||||..+.
T Consensus 214 ------------~--~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 214 ------------K--LEF---PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred ------------C--cCC---CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 0 011 1235788999999999999999995 99999999998653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=393.01 Aligned_cols=250 Identities=26% Similarity=0.456 Sum_probs=208.3
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEe
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E 197 (595)
+.||+|+||.||+|.+..+|+.||||+++... ........+++|+.+|+.++||||+++++++. ....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ-----THDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----cCCEEEEEEe
Confidence 46999999999999999999999999986432 12234566789999999999999999999884 3456999999
Q ss_pred ccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccc
Q 007629 198 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (595)
Q Consensus 198 ~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 276 (595)
|+. ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~ 152 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC---cc
Confidence 998 58999998888999999999999999999999999999999999999999999999999999875322211 12
Q ss_pred cccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHH
Q 007629 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356 (595)
Q Consensus 277 ~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~ 356 (595)
...+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05571 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (323)
T ss_pred cceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc---------------------
Confidence 45689999999999877 6799999999999999999999999987664333222210
Q ss_pred hhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCC
Q 007629 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 409 (595)
Q Consensus 357 l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~ 409 (595)
.. .. ....+++.+.+||.+||..||++|| ++.++++||||.++
T Consensus 210 -----~~--~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 210 -----EE--IR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred -----CC--CC---CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 00 00 1134688899999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=389.28 Aligned_cols=281 Identities=36% Similarity=0.614 Sum_probs=215.5
Q ss_pred eeeeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEE
Q 007629 118 QEVIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~--~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV 195 (595)
.++||+|+||+||+|+++ .++..||||.+.... ....+.+|+.+|+.++||||+++++++.... ...+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEE
Confidence 467999999999999865 467899999986421 2345678999999999999999999885432 3468999
Q ss_pred EecccccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee----CCCCcEEEcccCc
Q 007629 196 FELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGL 262 (595)
Q Consensus 196 ~E~~~g~L~~~i~~~---------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl----~~~~~vKL~DFGl 262 (595)
|||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 999999998887532 258999999999999999999999999999999999999 4567899999999
Q ss_pred ceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCCh---------HHHHHHH
Q 007629 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---------VHQLDLM 333 (595)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~---------~~~l~~i 333 (595)
|+...............+||+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 98654332222223456899999999998762 4689999999999999999999999975542 4677888
Q ss_pred HhhcCCCChhHHHHHhhHH-HHHHhhhcccCCC--CC----CCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 334 TDLLGTPSTESISRIRNEK-ARRYLGSMRKKQP--VP----FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 334 ~~~lg~p~~~~i~~i~~~~-~~~~l~~~~~~~~--~~----~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
...+|.|....+..+.... ....+..+..... .. +.......+..+.+||.+||++||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8889988877665542110 0011111111000 00 011112346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=388.39 Aligned_cols=327 Identities=50% Similarity=0.837 Sum_probs=263.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCC--CcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHT--GERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~--g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 190 (595)
+|++.+.||+|+||.||+|.+..+ +..||||++..........+.+.+|+.+++.+ .||||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 589999999999999999999888 89999999875443333456778999999999 5999999998754322 2345
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+++||++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 68999999999999999888889999999999999999999999999999999999999999999999999997643222
Q ss_pred CC-cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 271 PS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 271 ~~-~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. ........||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...+|.|..+.+..+.
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred ccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 1112346799999999987652 468899999999999999999999999999999999999999999988877776
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHH
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE 429 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e 429 (595)
......+...+.......+...++..++.+.+||.+||+.||.+|||+.+++.||||..+.++...+.........| +
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~--~ 316 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSF--E 316 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCc--c
Confidence 66555555555555555556666778899999999999999999999999999999998877655554433333333 2
Q ss_pred HhhhcHHHHHHHHHHH
Q 007629 430 RRKLAKDDVREMIYRE 445 (595)
Q Consensus 430 ~~~~~~~~~~~~i~~e 445 (595)
.. -+.++++.+|..+
T Consensus 317 ~~-~~~~~~~~~~~~~ 331 (332)
T cd07857 317 SE-DSMEELRDMIIEE 331 (332)
T ss_pred cc-ccHHHHHHHHhhc
Confidence 22 2456677776554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=386.55 Aligned_cols=253 Identities=29% Similarity=0.539 Sum_probs=221.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecC-ccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIND-VFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~-~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.-||++.+.||+|.||.|.+|++...|+.||||.|++ ...+..+...+.+||.||..|+||||+.+|++| +...
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCc
Confidence 4589999999999999999999999999999999965 345666788899999999999999999999999 4455
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+.|||||.. |+|+++|...+.|++.+++.||+||+.|+.|+|.++++|||||.+|||+|.++++||+||||+..+..+
T Consensus 127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 6999999998 799999999999999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCcccccccccCCcccccccccccCCCC-CCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~-~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.+++++||+|.|.+||++.| .+| ++.+|-|||||+||.|+.|..||.|.+....+.+|...-
T Consensus 207 ----kfLqTFCGSPLYASPEIvNG--~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga----------- 269 (668)
T KOG0611|consen 207 ----KFLQTFCGSPLYASPEIVNG--TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA----------- 269 (668)
T ss_pred ----cHHHHhcCCcccCCccccCC--CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc-----------
Confidence 35788999999999999998 455 578999999999999999999999988655544442210
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
+ ..|..+..+.-||+.||-.+|++|.|++++-.|-|+.
T Consensus 270 -----------Y----------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 270 -----------Y----------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred -----------c----------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 0 1133455689999999999999999999999999985
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=389.11 Aligned_cols=327 Identities=42% Similarity=0.767 Sum_probs=262.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~~ 190 (595)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.+..........+.+|+.+++.++||||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999999999999999987543333334567899999999999999999998864422 2334
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+||||+..+|..++ ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~lv~e~~~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~- 170 (342)
T cd07879 94 DFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE- 170 (342)
T ss_pred eEEEEecccccCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence 57999999998877665 346899999999999999999999999999999999999999999999999998753221
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
.....+|+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+....+..+....|.+.......+..
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 171 -----MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 2345789999999998652 4588899999999999999999999999988888888888888888777665544
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHHH
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e~ 430 (595)
.....+...++......+...++..++.+.+||.+||+.||.+||+++++|.||||..+.+.+.++...+ +...-+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~---~~~~~~~ 321 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP---YDDSLEN 321 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc---ccchhhh
Confidence 4344444443333334445556778899999999999999999999999999999998876555444332 4444556
Q ss_pred hhhcHHHHHHHHHHHHHhhC
Q 007629 431 RKLAKDDVREMIYREILEYH 450 (595)
Q Consensus 431 ~~~~~~~~~~~i~~ei~~~~ 450 (595)
..+..+++..-||.|..++.
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~ 341 (342)
T cd07879 322 EKLSVDEWKKHIYKEVKSFS 341 (342)
T ss_pred hhCCHHHHHHHhhhhhhccC
Confidence 67777888888888765543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=395.06 Aligned_cols=263 Identities=25% Similarity=0.383 Sum_probs=211.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++++.||+|+||+||+|.+..+++.||||++++... .......+.+|+.++..++||+|+++++.+. +...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~-----~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ-----DKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCCe
Confidence 369999999999999999999999999999999864221 1233456788999999999999999999884 3456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+|||||+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999998 5899999888899999999999999999999999999999999999999999999999999987542211
Q ss_pred CC--------------------------------cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCC
Q 007629 271 PS--------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK 318 (595)
Q Consensus 271 ~~--------------------------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~ 318 (595)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCC
Confidence 00 001134589999999999977 67999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCC---CC
Q 007629 319 PLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD---RP 395 (595)
Q Consensus 319 ~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~---Rp 395 (595)
+||.+.+.......+..... ...+.. ...+++.+++||.+|+. +|.+ ||
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~--------------------------~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~ 285 (363)
T cd05628 234 PPFCSETPQETYKKVMNWKE--------------------------TLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAP 285 (363)
T ss_pred CCCCCCCHHHHHHHHHcCcC--------------------------cccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCC
Confidence 99988765444333321100 000111 12367889999999876 5554 58
Q ss_pred CHHHHhcCCCccCCC
Q 007629 396 TAEEALADPYFHGLA 410 (595)
Q Consensus 396 ta~elL~Hp~f~~~~ 410 (595)
+++|+++||||+++.
T Consensus 286 ~~~ei~~hp~f~~~~ 300 (363)
T cd05628 286 GVEEIKTNPFFEGVD 300 (363)
T ss_pred CHHHHhCCCCCCCCC
Confidence 999999999998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=396.13 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=209.8
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
.|++++.||+|+||+||+|++..++..||||++.... ........+.+|+.+|+.++||||+++++++.. ...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-----CCEE
Confidence 6899999999999999999999999999999996422 223345678899999999999999999999843 3569
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++++||+|||++........
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999997 58999998888899999999999999999999999999999999999999999999999999753211000
Q ss_pred C--------------------------------------------cccccccccCCcccccccccccCCCCCCcceeech
Q 007629 272 S--------------------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 307 (595)
Q Consensus 272 ~--------------------------------------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSl 307 (595)
. .......+||+.|+|||++.+ ..|+.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSl 234 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceeeh
Confidence 0 000124579999999999877 678999999999
Q ss_pred hHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhC
Q 007629 308 GCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLL 387 (595)
Q Consensus 308 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L 387 (595)
||++|||++|.+||.+.+.......+.... ..... .....+++++.+||.+||
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~------------------------~~~~~---~~~~~~s~~~~dli~~ll 287 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWE------------------------NTLHI---PPQVKLSPEAVDLITKLC 287 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHccc------------------------cccCC---CCCCCCCHHHHHHHHHHc
Confidence 999999999999998766433322221100 00000 112346889999999966
Q ss_pred cC--CCCCCCCHHHHhcCCCccCC
Q 007629 388 AF--DPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 388 ~~--DP~~Rpta~elL~Hp~f~~~ 409 (595)
.. +|..|++++++++||||..+
T Consensus 288 ~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 288 CSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred cCcccccCCCCHHHHhcCcccCCC
Confidence 54 55559999999999999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=389.65 Aligned_cols=261 Identities=25% Similarity=0.472 Sum_probs=216.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++++.||+|+||.||+|++..+++.||||+++.... .......+.+|+.+|+.++||||+++++++. ....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-----DDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-----cCCE
Confidence 369999999999999999999999999999999864322 2234566889999999999999999999884 3456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+||||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999997 58999998888899999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+....+......
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------- 216 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET----------- 216 (333)
T ss_pred ----ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-----------
Confidence 1245689999999999987 58999999999999999999999999887755444333211000
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
+ ..+. .......+++.+.+||.+||..+|.+||++.++++||||...
T Consensus 217 ---------~--~~~~-~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 217 ---------L--QRPV-YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred ---------c--cCCC-CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 0 0000 111113568899999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=382.86 Aligned_cols=290 Identities=37% Similarity=0.641 Sum_probs=231.8
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 110 ~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
+..++|++.+.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-----~ 76 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----E 76 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEec-----C
Confidence 456789999999999999999999999999999999864322 2223456789999999999999999999843 3
Q ss_pred ccEEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+|+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 77 KSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred CeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 468999999999999888754 4689999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...++.+....+..+
T Consensus 157 ~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 157 PTK---TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred CCC---cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence 211 12344678999999988652 45788999999999999999999999999988888888888888877655433
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
....... ....+...........+.+++.+.+||.+||.+||.+|||++|+|+||||+.+.
T Consensus 233 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 233 LSNEEFK-SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred hcccccc-ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 2110000 000011111111122356788999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=393.83 Aligned_cols=262 Identities=26% Similarity=0.426 Sum_probs=212.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++++.||+|+||+||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-----ENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCe
Confidence 36999999999999999999999999999999996421 122344567889999999999999999999843 456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+|||||. ++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999997 6899999888889999999999999999999999999999999999999999999999999987542211
Q ss_pred CCc-----------------------------------ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHH
Q 007629 271 PSA-----------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML 315 (595)
Q Consensus 271 ~~~-----------------------------------~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLl 315 (595)
... ......+||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhh
Confidence 000 00123479999999999876 67999999999999999999
Q ss_pred cCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC
Q 007629 316 TGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP 395 (595)
Q Consensus 316 tG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp 395 (595)
+|.+||.+.+....+..+... ......+ ....+++.+.+||.+||. +|.+|+
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~------------------------~~~~~~~---~~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINW------------------------KETLQFP---DEVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcC------------------------CCccCCC---CCCCCCHHHHHHHHHHcc-CHhhcC
Confidence 999999887654433322110 0001111 112468899999999997 999999
Q ss_pred C---HHHHhcCCCccCC
Q 007629 396 T---AEEALADPYFHGL 409 (595)
Q Consensus 396 t---a~elL~Hp~f~~~ 409 (595)
+ +.++|+||||++.
T Consensus 286 ~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 286 GNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHhcCCCcCCC
Confidence 8 9999999999865
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=396.37 Aligned_cols=263 Identities=24% Similarity=0.371 Sum_probs=211.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++++.||+|+||.||+|++..+++.||||++.+.. ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-----~~~ 75 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-----KDN 75 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-----CCE
Confidence 36999999999999999999999999999999986422 122345678899999999999999999999843 356
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+|||||+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999998 5899999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred C--------------------------------------------CcccccccccCCcccccccccccCCCCCCcceeec
Q 007629 271 P--------------------------------------------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 306 (595)
Q Consensus 271 ~--------------------------------------------~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWS 306 (595)
. ........+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEe
Confidence 0 0000123579999999999977 67999999999
Q ss_pred hhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhh
Q 007629 307 IGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 386 (595)
Q Consensus 307 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~ 386 (595)
|||++|||++|++||.+.+.......+... ......+ ....+++.+.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------------~~~~~~p---~~~~~s~~~~~li~~l 286 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINW------------------------QTSLHIP---PQAKLSPEASDLIIKL 286 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHcc------------------------CCCcCCC---CcccCCHHHHHHHHHH
Confidence 999999999999999887654332222110 0001111 1235688999999998
Q ss_pred CcCCCCCCCC---HHHHhcCCCccCCC
Q 007629 387 LAFDPKDRPT---AEEALADPYFHGLA 410 (595)
Q Consensus 387 L~~DP~~Rpt---a~elL~Hp~f~~~~ 410 (595)
+. ||.+|++ ++++++||||+.+.
T Consensus 287 ~~-~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 287 CR-GPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred cc-CHhHcCCCCCHHHHhcCCCcCCcC
Confidence 74 9999997 99999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=379.27 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=208.7
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++|++|+.+++++.. ...+|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-----~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-----KDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-----CCeEE
Confidence 788999999999999999999999999999986432 122233457889999999999999999998843 34689
Q ss_pred EEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 194 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|||||. ++|..++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999998 5787777543 368999999999999999999999999999999999999999999999999998643221
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+.......+...+
T Consensus 157 ----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~------------- 217 (285)
T cd05631 157 ----TVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV------------- 217 (285)
T ss_pred ----eecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh-------------
Confidence 1234579999999999987 689999999999999999999999998765322211111100
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 410 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~~ 410 (595)
. ... .......++.+.+||.+||..||.+||+ ++++++||||.++.
T Consensus 218 ----------~-~~~---~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 218 ----------K-EDQ---EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred ----------h-ccc---ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 0 000 1122346888999999999999999997 99999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=383.84 Aligned_cols=320 Identities=49% Similarity=0.867 Sum_probs=268.5
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..++|++.+.||.|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++... ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~ 83 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LE 83 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CC
Confidence 45789999999999999999999999999999999865333334456778999999999999999999988532 23
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+||||++++|..++.. .++++..+..++.||++||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 84 DIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred cEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 5899999999898887764 46889999999999999999999999999999999999999999999999998753221
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
.....+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.........+.+.+|.++.+....+..
T Consensus 162 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 162 -----MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred -----cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 2345788999999987542 4688999999999999999999999999988888888899999999888776655
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHHH
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e~ 430 (595)
.....++.......+.++....+.+++.+.+||.+||+.||++|||+++++.||||.....+..++.. -..+++.++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 313 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVA--EEKFDWSFND 313 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCc--hhhcCCchhc
Confidence 55555555555555566666667788999999999999999999999999999999987766554432 2367888889
Q ss_pred hhhcHHHHHHHHHH
Q 007629 431 RKLAKDDVREMIYR 444 (595)
Q Consensus 431 ~~~~~~~~~~~i~~ 444 (595)
..+..|.|+.|.|.
T Consensus 314 ~~~~~~~~~~~~~~ 327 (328)
T cd07856 314 ADLPVDTWKVMMYS 327 (328)
T ss_pred ccCCHHHHHHHhcC
Confidence 99999999988775
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=370.09 Aligned_cols=262 Identities=29% Similarity=0.500 Sum_probs=216.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-----Ch-hhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-----HV-SDATRILREIKLLRLLR-HPDIVEIKHIMLPPSR 186 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-----~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 186 (595)
.|.-.+.||+|..++|.+|.++.+|..+|+|+|..... .. .-.+...+|+.||+++. ||+|+++.++|..++
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s- 96 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA- 96 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc-
Confidence 46667899999999999999999999999999853211 11 12344578999999985 999999999996554
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 187 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
.+++|+|+|. |.|++++...-.+++...+.||+||++|+.|||..+||||||||+|||++++.++||+|||+|..
T Consensus 97 ----F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 ----FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred ----hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence 4899999998 89999999888999999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCccccccccccc----CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCC
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~ 341 (595)
..... .+...||||+|+|||.+... ...|+..+|+|++|||+|.||.|-+||......-.+.+|...
T Consensus 173 l~~Ge----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG----- 243 (411)
T KOG0599|consen 173 LEPGE----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG----- 243 (411)
T ss_pred cCCch----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc-----
Confidence 65443 35788999999999987432 256889999999999999999999999754433333333221
Q ss_pred hhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 342 ~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
.-..-+..|.+++...+|||.+||+.||.+|+|++|+|+||||.++..
T Consensus 244 ----------------------kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 244 ----------------------KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred ----------------------ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 111123457788889999999999999999999999999999976543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=395.41 Aligned_cols=263 Identities=25% Similarity=0.405 Sum_probs=211.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|.+++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-----AQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCe
Confidence 36999999999999999999999999999999985421 122345667889999999999999999999843 456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+||||+. ++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999997 6899999888889999999999999999999999999999999999999999999999999996322110
Q ss_pred CC--------------------------------------------cccccccccCCcccccccccccCCCCCCcceeec
Q 007629 271 PS--------------------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 306 (595)
Q Consensus 271 ~~--------------------------------------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWS 306 (595)
.. .......+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS 233 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEe
Confidence 00 000012579999999999877 67999999999
Q ss_pred hhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhh
Q 007629 307 IGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 386 (595)
Q Consensus 307 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~ 386 (595)
|||++|||++|.+||.+.+..+.+..+... ... ..+ .....+++.+.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------------~~~--~~~-p~~~~~s~~~~dli~~l 286 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINW------------------------RET--LYF-PDDIHLSVEAEDLIRRL 286 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHcc------------------------CCc--cCC-CCCCCCCHHHHHHHHHH
Confidence 999999999999999887654443333211 000 001 01124678899999999
Q ss_pred CcCCCCCC---CCHHHHhcCCCccCCC
Q 007629 387 LAFDPKDR---PTAEEALADPYFHGLA 410 (595)
Q Consensus 387 L~~DP~~R---pta~elL~Hp~f~~~~ 410 (595)
|. +|.+| +++.|++.||||.+..
T Consensus 287 L~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 287 IT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred hc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 98 77765 5999999999998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=387.25 Aligned_cols=328 Identities=45% Similarity=0.781 Sum_probs=263.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++.+.||+|+||.||+|.+..+|..||||++............+.+|+.+++.+ +||||+++++++... +..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---NDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CCc
Confidence 4679999999999999999999999999999999865444444556678899999999 999999999987432 234
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+||||+.++|..++... .+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 83 DIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred eEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 58999999999999988765 78999999999999999999999999999999999999999999999999998654332
Q ss_pred CC--cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 271 PS--AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 271 ~~--~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.. ......+.||++|+|||++.+. ..++.++|||||||++|+|++|++||.+....+.+..+....+.+..+.+..+
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred ccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 11 1123456899999999987652 56788999999999999999999999999988889999998998888777766
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHH
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEF 428 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~ 428 (595)
........+.........+....++.++..+.+||.+||+.||.+|||+.++++||||+++.....++.........+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~- 319 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD- 319 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCcc-
Confidence 6555555555555444445555667789999999999999999999999999999999988665555433222222221
Q ss_pred HHhhhcHHHHHHHHHHH
Q 007629 429 ERRKLAKDDVREMIYRE 445 (595)
Q Consensus 429 e~~~~~~~~~~~~i~~e 445 (595)
..+++...+.+..+|+|
T Consensus 320 ~~~~~~~~~~~~~~~~~ 336 (337)
T cd07852 320 DNVKLSVAEYRNKLYEE 336 (337)
T ss_pred ccceeeHHHHHhhhhhc
Confidence 34456666666666665
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=389.86 Aligned_cols=263 Identities=30% Similarity=0.482 Sum_probs=215.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++.+.||+|+||+||+|++..+|+.||||+++.... .......+.+|+.+|..++||||+++++++. +...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ-----DEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee-----cCCe
Confidence 379999999999999999999999999999999864322 2234566889999999999999999998874 3456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999997 6899999888889999999999999999999999999999999999999999999999999997654332
Q ss_pred C--------------------------CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCC
Q 007629 271 P--------------------------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK 324 (595)
Q Consensus 271 ~--------------------------~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~ 324 (595)
. ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 0 0011234579999999999987 58999999999999999999999999887
Q ss_pred ChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-HHHHhcC
Q 007629 325 NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-AEEALAD 403 (595)
Q Consensus 325 ~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-a~elL~H 403 (595)
+.......+.... .....+ ....+++.+.+||.+||. ||.+||+ ++++|+|
T Consensus 234 ~~~~~~~~i~~~~------------------------~~~~~p---~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWK------------------------ESLRFP---PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccC------------------------CcccCC---CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 6543333222110 000111 112368899999999998 9999999 9999999
Q ss_pred CCccCCC
Q 007629 404 PYFHGLA 410 (595)
Q Consensus 404 p~f~~~~ 410 (595)
|||+++.
T Consensus 286 p~~~~~~ 292 (350)
T cd05573 286 PFFKGID 292 (350)
T ss_pred CCcCCCC
Confidence 9998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=389.71 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=211.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCC-cEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG-ERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g-~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|++.+.||+|+||.||+|.+..++ ..||+|++.... ........+.+|+.+|+.++||||+++++++.. .
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-----E 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-----C
Confidence 457999999999999999999876554 689999985422 122345678899999999999999999999843 3
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 56899999997 68999999888999999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
. ....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+...
T Consensus 184 ~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~------------ 243 (340)
T PTZ00426 184 R------TYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG------------ 243 (340)
T ss_pred C------cceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC------------
Confidence 1 134689999999999877 67899999999999999999999999876643332222110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~~ 410 (595)
. .. ..+.+++.+.+||++||+.||.+|+ +++++++||||.++.
T Consensus 244 --------------~--~~---~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 244 --------------I--IY---FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred --------------C--CC---CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 0 00 1133578899999999999999995 899999999998754
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=394.45 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=211.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++++.||+|+||.||+|++..+++.||||++.+... .......+.+|+.+|+.++||||+++++.+. +...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-----DKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCE
Confidence 479999999999999999999999999999999864211 1223456789999999999999999999884 3456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+|||||+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999997 6899999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred C----------------------------------------CcccccccccCCcccccccccccCCCCCCcceeechhHH
Q 007629 271 P----------------------------------------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 310 (595)
Q Consensus 271 ~----------------------------------------~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~i 310 (595)
. ........+||+.|||||++.+ ..++.++|||||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccce
Confidence 0 0000123579999999999977 678999999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCC
Q 007629 311 FAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFD 390 (595)
Q Consensus 311 l~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~D 390 (595)
+|||++|+.||.+.+..+....+... ...... .....+++.+.+||.+|+. +
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~------------------------~~~~~~---~~~~~~s~~~~~li~~l~~-~ 285 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINW------------------------ETTLHI---PSQAKLSREASDLILRLCC-G 285 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhcc------------------------CccccC---CCCCCCCHHHHHHHHHHhc-C
Confidence 99999999999887654333222110 000011 1123578899999999874 9
Q ss_pred CCCCC---CHHHHhcCCCccCC
Q 007629 391 PKDRP---TAEEALADPYFHGL 409 (595)
Q Consensus 391 P~~Rp---ta~elL~Hp~f~~~ 409 (595)
|.+|+ ++.++++||||+++
T Consensus 286 p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 286 AEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred HhhcCCCCCHHHHhCCCCcCCC
Confidence 99999 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=388.86 Aligned_cols=258 Identities=28% Similarity=0.525 Sum_probs=224.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++-|.+.+.||+|.|++|.+|++.-||+.||||+|.+...+......+.+|+..|+.++|||||++|++. .....
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQTK 91 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQTK 91 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccce
Confidence 4568999999999999999999999999999999987655555566789999999999999999999998 44567
Q ss_pred EEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee-CCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA-NADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl-~~~~~vKL~DFGla~~~~~ 268 (595)
+|||+|+-+ |+|+++|.++ ..+.|+.+++||.||+.|+.|+|...+|||||||+|+.+ ..-|-|||.|||++..+..
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999998 5999999876 479999999999999999999999999999999999975 5568899999999976654
Q ss_pred CCCCcccccccccCCcccccccccccCCCCC-CcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~-~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
... +++.||+..|.|||+++| ..|+ +++||||||||||.|++|++||...++.+.+-+|.+.--+
T Consensus 172 G~k----L~TsCGSLAYSAPEILLG--DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt-------- 237 (864)
T KOG4717|consen 172 GKK----LTTSCGSLAYSAPEILLG--DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT-------- 237 (864)
T ss_pred cch----hhcccchhhccCchhhhc--CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc--------
Confidence 432 578899999999999998 4565 7899999999999999999999999988877776553211
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
+| ..++.+++|||..||..||++|.+.+||..|+|++....
T Consensus 238 ------------------vP-----shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 238 ------------------VP-----SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred ------------------Cc-----hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 11 236788999999999999999999999999999997654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=383.14 Aligned_cols=248 Identities=32% Similarity=0.491 Sum_probs=206.2
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEecc
Q 007629 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 199 (595)
Q Consensus 121 LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~ 199 (595)
||+|+||.||+|.+..+++.||||+++... ........+.+|+.+|+.++||||+++++++.. ...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-----PEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-----CCeEEEEEcCC
Confidence 799999999999999999999999986422 223345678899999999999999999988843 35689999999
Q ss_pred c-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccccc
Q 007629 200 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 278 (595)
Q Consensus 200 ~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 278 (595)
. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 152 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNT 152 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---cccc
Confidence 8 58999998888899999999999999999999999999999999999999999999999999975432221 1245
Q ss_pred cccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhh
Q 007629 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLG 358 (595)
Q Consensus 279 ~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~ 358 (595)
.+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+.......+..
T Consensus 153 ~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----------------------- 207 (312)
T cd05585 153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----------------------- 207 (312)
T ss_pred ccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------------------
Confidence 689999999999987 6799999999999999999999999987664332221110
Q ss_pred hcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC---CHHHHhcCCCccCC
Q 007629 359 SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP---TAEEALADPYFHGL 409 (595)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp---ta~elL~Hp~f~~~ 409 (595)
. +.. ....+++.+.+||.+||..||.+|| ++.|+|.||||...
T Consensus 208 ---~--~~~---~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 208 ---E--PLR---FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred ---C--CCC---CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 0 111 1134678899999999999999997 58999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=372.70 Aligned_cols=282 Identities=38% Similarity=0.640 Sum_probs=225.2
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++.+.||.|+||.||+|.+..++..||||+++...........+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence 4899999999999999999999999999999986433333334667899999999999999999999854 34689
Q ss_pred EEEecccccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 194 VVFELMESDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 194 lV~E~~~g~L~~~i~~~---~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 99999999888887643 468999999999999999999999999999999999999999999999999997543221
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+......+..+...++.+....+.....
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 R---VYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred c---cccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 1 12334678999999987652 4578899999999999999999999999888777777777777665554433221
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
...+..................+++++.+||.+||..||.+|||+.+++.||||
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 --LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred --hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 111111111111111222345578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=392.18 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=220.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
..|..++.||+|+||.||+|.+..+++.||||++.-. ....+...+.+||.+|..++++||.++|+.|+... .+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-----~L 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-----KL 86 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----cH
Confidence 3577789999999999999999999999999999642 33345678899999999999999999999997654 48
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
+++||||. |.+.++++....+.+.++..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||++........
T Consensus 87 wiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999998 57899998887789999999999999999999999999999999999999999999999999987654433
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
. ..+++|||.|||||++.+ ..|+.|+||||||++.+||++|.|||......
T Consensus 167 r---r~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPm------------------------ 217 (467)
T KOG0201|consen 167 R---RKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPM------------------------ 217 (467)
T ss_pred c---cccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcc------------------------
Confidence 2 367899999999999986 78999999999999999999999999775531
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
+++..+++..|..+.. ..++.+++|+..||.+||+.||+|.++|+|+|++.
T Consensus 218 ---rvlflIpk~~PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 218 ---RVLFLIPKSAPPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ---eEEEeccCCCCCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 2233344444444433 66888999999999999999999999999999986
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=360.02 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=219.4
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 110 ~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
...++|++++.||+|-||.||+|+.+.++..||+|++.+.. .......++.+|+.|...|+||||+++|++|.+.
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~---- 94 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS---- 94 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc----
Confidence 34578999999999999999999999999999999986432 2223356788999999999999999999999554
Q ss_pred cccEEEEEeccc-ccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 189 FKDIYVVFELME-SDLHQVIK--ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~--~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
..+|+++||.. |.|+..+. ....+++..+..+++|++.||.|+|.++||||||||+|+|++.++.+||+|||.+..
T Consensus 95 -~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 95 -KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred -ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 45999999998 78999998 566899999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
.... ...+.|||..|.+||...+ ..++..+|+|++|++.||+|.|.+||...+..+....|.+.
T Consensus 174 ~p~~-----kR~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--------- 237 (281)
T KOG0580|consen 174 APSN-----KRKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--------- 237 (281)
T ss_pred cCCC-----CceeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc---------
Confidence 4311 2467899999999999988 78999999999999999999999999887754444433221
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.-..| ..++..+.|||.+||.++|.+|.+..|++.|||+...
T Consensus 238 ---------------~~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 238 ---------------DLKFP-------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred ---------------cccCC-------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 10111 4578889999999999999999999999999998653
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=374.61 Aligned_cols=282 Identities=37% Similarity=0.614 Sum_probs=224.2
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++.+.||+|+||.||+|++..+|..||+|.++...........+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-----DKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-----CCceE
Confidence 5899999999999999999999999999999986433222333567789999999999999999998843 34689
Q ss_pred EEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 194 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 194 lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
+|+||++++|.+.+.. .+.+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 9999999999888765 46799999999999999999999999999999999999999999999999999975432211
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCC-CCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~p-F~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
......+++.|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+...++..+...++.+....+..+...
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 12345788999999988662 4578999999999999999998766 6777777788888888887766554332211
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
......... .....+....+.+++.+.+||.+||..||.+|||++++|.||||
T Consensus 232 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMY--PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCC--CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000000000 00111233445678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=383.68 Aligned_cols=250 Identities=25% Similarity=0.451 Sum_probs=207.2
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEe
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E 197 (595)
+.||+|+||.||+|.+..+|..||||++.+.. ........+.+|+.+|+.++||||+++++++. ....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ-----TKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCEEEEEEe
Confidence 46999999999999999999999999996432 22334567889999999999999999998884 3356899999
Q ss_pred ccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccc
Q 007629 198 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (595)
Q Consensus 198 ~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 276 (595)
|++ ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~ 152 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TM 152 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc---cc
Confidence 998 58888888888899999999999999999999999999999999999999999999999999875322211 12
Q ss_pred cccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHH
Q 007629 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356 (595)
Q Consensus 277 ~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~ 356 (595)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------- 209 (328)
T cd05593 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (328)
T ss_pred ccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc---------------------
Confidence 44689999999999876 6789999999999999999999999987654332222110
Q ss_pred hhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCC
Q 007629 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 409 (595)
Q Consensus 357 l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~ 409 (595)
.. .. ....+++.+.+||.+||..||.+|+ ++.++++||||.+.
T Consensus 210 -----~~--~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 210 -----ED--IK---FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred -----CC--cc---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 01 1134678899999999999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=382.28 Aligned_cols=250 Identities=26% Similarity=0.449 Sum_probs=207.5
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEe
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E 197 (595)
+.||+|+||.||+|.+..+|..||+|+++.... .......+.+|+.+|+.++||||+++++++.. ...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCEEEEEEe
Confidence 469999999999999999999999999864321 22345567889999999999999999998843 346899999
Q ss_pred ccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccc
Q 007629 198 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (595)
Q Consensus 198 ~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 276 (595)
|++ ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~ 152 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---cc
Confidence 998 58988888888899999999999999999999999999999999999999999999999999875322221 12
Q ss_pred cccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHH
Q 007629 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356 (595)
Q Consensus 277 ~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~ 356 (595)
...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05595 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------- 209 (323)
T ss_pred ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------------
Confidence 34679999999999876 6789999999999999999999999987665433322211
Q ss_pred hhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCC
Q 007629 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 409 (595)
Q Consensus 357 l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~ 409 (595)
... . ....+++.+.+||.+||..||.+|+ ++.++++||||.+.
T Consensus 210 -----~~~--~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 210 -----EEI--R---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred -----CCC--C---CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 000 0 1134678899999999999999998 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=382.87 Aligned_cols=263 Identities=24% Similarity=0.397 Sum_probs=213.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|.+.+.||+|+||+||+|.+..+|+.||||+++.... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-----~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-----KDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCe
Confidence 369999999999999999999999999999999975322 22344567889999999999999999988843 356
Q ss_pred EEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 899999997 6899999876 68999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccccCCccccccccccc----CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~----~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
... ......||+.|+|||++... ...++.++|||||||++|||++|..||.+.+....+..+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--------- 224 (330)
T cd05601 156 KMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--------- 224 (330)
T ss_pred Cce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---------
Confidence 221 12345799999999998631 146788999999999999999999999877654433322211
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
.....+ ...+.+++.+.+||.+||. ||.+|||++++++||||..+.
T Consensus 225 -----------------~~~~~~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 225 -----------------QRFLKF-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred -----------------CCccCC-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 000001 1123578899999999998 999999999999999998653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=379.76 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=210.0
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCC-ceeeeeeeecCCCccCccc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHP-DIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~~~~ 191 (595)
+|++++.||+|+||.||+|.+..+++.||||++.+... .......+..|+.++..+.|+ +|+.+++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----MDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-----CCE
Confidence 58999999999999999999999999999999864321 223456778899999999765 57788887743 346
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 899999998 6899999888889999999999999999999999999999999999999999999999999987532221
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (324)
T cd05587 156 K---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (324)
T ss_pred C---ceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Confidence 1 1234679999999999987 67899999999999999999999999887654433322110
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH-----HHHhcCCCccCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-----EEALADPYFHGL 409 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta-----~elL~Hp~f~~~ 409 (595)
. .. ....+++.+.+||.+||..||.+|+++ +++++||||..+
T Consensus 217 ------------~--~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 217 ------------N--VS---YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred ------------C--CC---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 0 00 112467889999999999999999986 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=387.77 Aligned_cols=280 Identities=23% Similarity=0.307 Sum_probs=217.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~--~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
..+|++++.||+|+||.||+|... .++..||+|.+... ....+|+.+|+.++||||+++++++.. .
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~-----~ 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRW-----K 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEee-----C
Confidence 457999999999999999999754 45678999987532 234589999999999999999998843 3
Q ss_pred ccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
..+|+|||++.++|.+++.....+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 159 ~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 159 STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 56899999999999999977788999999999999999999999999999999999999999999999999999755432
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCC---hHHHHHHHHhhcCCCChhHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN---VVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~---~~~~l~~i~~~lg~p~~~~i~ 346 (595)
... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.. ...++..+.+.++..+.+...
T Consensus 239 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 239 PDT-PQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred ccc-ccccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 221 11235689999999999877 679999999999999999999999997764 345666666666654432211
Q ss_pred HHhh---HHHHHHhhhcccCCCCCCCCCC--CCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 347 RIRN---EKARRYLGSMRKKQPVPFSHKF--PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 347 ~i~~---~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
.... .....+....+ .+......+ ...+..+.+||.+||.+||.+|||+.|+|.||||..
T Consensus 316 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLR--PPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred ccchhHHHHHHhhccccc--CCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 1000 11111111111 111111111 235678999999999999999999999999999975
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=380.42 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=207.2
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.||+|+||+||+|+++.+++.||||++.+.. ........+..|+.++..+ .||||+++++++.. ...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-----~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-----PDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-----CCEEEEEE
Confidence 46999999999999999999999999986432 1223455677899998876 69999999998843 35689999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
||++ ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---~ 152 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---T 152 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---c
Confidence 9998 58999998888999999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~------------------- 211 (320)
T cd05590 153 TSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------------------- 211 (320)
T ss_pred ccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-------------------
Confidence 244679999999999877 67899999999999999999999999887754443332110
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH------HHHhcCCCccCCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA------EEALADPYFHGLA 410 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta------~elL~Hp~f~~~~ 410 (595)
. .. ....+++.+.+||.+||+.||.+||++ +++++||||..+.
T Consensus 212 --------~-~~---~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 212 --------E-VV---YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred --------C-CC---CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 0 00 112367889999999999999999998 9999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=381.67 Aligned_cols=251 Identities=27% Similarity=0.464 Sum_probs=206.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEe
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E 197 (595)
+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+++++.++||||+++++++.. ...+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-----~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-----CCEEEEEEe
Confidence 46999999999999999999999999996532 222345667889999999999999999988843 356999999
Q ss_pred ccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 198 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 198 ~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
|++ ++|..++.....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---T 152 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---c
Confidence 998 5888888888889999999999999999999997 7999999999999999999999999999875322221 1
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05594 153 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------------------- 210 (325)
T ss_pred cccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc--------------------
Confidence 234679999999999877 6789999999999999999999999987664333222210
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~~ 410 (595)
.. .. .-...++.+.+||.+||..||++|+ ++.++++||||.+..
T Consensus 211 ------~~--~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 211 ------EE--IR---FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred ------CC--CC---CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 00 00 0124678899999999999999997 999999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=366.57 Aligned_cols=297 Identities=35% Similarity=0.554 Sum_probs=239.4
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC---cc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS---RR 187 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---~~ 187 (595)
+.+.|+-+.+||+|.||.||+|+.+.+|+.||+|++--..+...--...++|+++|..|+|+|++.++++|-... ..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 456788889999999999999999999999999986321122222345689999999999999999999885432 23
Q ss_pred CcccEEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 188 EFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 188 ~~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
+...+|+||++|+.||.-++... ..|+..+++.++.+++.||.|+|...|+|||+||+|+||+.+|.+||+|||+++.+
T Consensus 95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 44569999999999999999765 57999999999999999999999999999999999999999999999999999765
Q ss_pred cCCC-CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDA-PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~-~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
.... .....++..+.|.||++||+++|. ..|+++.|||..|||+.||+||.+.|.+.....++..|..++|....+.|
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 4322 222235667889999999999985 78999999999999999999999999999999999999999999888877
Q ss_pred HHHhhHHHHHHhhh--cccCCCCCCCCCCC--CCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 346 SRIRNEKARRYLGS--MRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 346 ~~i~~~~~~~~l~~--~~~~~~~~~~~~~~--~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
....+-....-+.. +++..-..+..... .-++.+.||+.+||..||.+|+++.++|.|.||..
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 66544332222211 11111111111111 12678999999999999999999999999999963
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=385.85 Aligned_cols=264 Identities=25% Similarity=0.398 Sum_probs=212.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++++.||+|+||.||+|.+..+++.||||+++... ........+.+|+.++..++||+|+++++.+. +...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-----DKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 36899999999999999999999999999999986422 12234566788999999999999999999884 3456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999998 5899999888899999999999999999999999999999999999999999999999999987432111
Q ss_pred CC--------------------------------cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCC
Q 007629 271 PS--------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK 318 (595)
Q Consensus 271 ~~--------------------------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~ 318 (595)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCC
Confidence 00 000124579999999999877 68999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC---
Q 007629 319 PLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP--- 395 (595)
Q Consensus 319 ~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp--- 395 (595)
+||.+.+.......+... .....+.. ....++.+++||.+|+. ||.+|+
T Consensus 234 ~Pf~~~~~~~~~~~i~~~--------------------------~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~ 285 (360)
T cd05627 234 PPFCSETPQETYRKVMNW--------------------------KETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSN 285 (360)
T ss_pred CCCCCCCHHHHHHHHHcC--------------------------CCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence 999887654433322210 00001111 12367889999999875 999998
Q ss_pred CHHHHhcCCCccCCCC
Q 007629 396 TAEEALADPYFHGLAN 411 (595)
Q Consensus 396 ta~elL~Hp~f~~~~~ 411 (595)
+++++++||||+++.+
T Consensus 286 ~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 286 GVEEIKSHPFFEGVDW 301 (360)
T ss_pred CHHHHhcCCCCCCCCH
Confidence 4899999999997643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=375.54 Aligned_cols=281 Identities=36% Similarity=0.598 Sum_probs=212.7
Q ss_pred eeeeeecCceEEEEEEECC--CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEE
Q 007629 118 QEVIGKGSYGVVGSAVDTH--TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~--~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV 195 (595)
..+||+|+||.||+|.+.. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++.... ...+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEE
Confidence 3679999999999998654 66899999986421 2345678999999999999999999885432 3468999
Q ss_pred EecccccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee----CCCCcEEEcccCc
Q 007629 196 FELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGL 262 (595)
Q Consensus 196 ~E~~~g~L~~~i~~~---------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl----~~~~~vKL~DFGl 262 (595)
|||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 999999998887532 248889999999999999999999999999999999999 5667899999999
Q ss_pred ceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCCh---------HHHHHHH
Q 007629 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---------VHQLDLM 333 (595)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~---------~~~l~~i 333 (595)
++...............+||+.|+|||++.+. ..++.++|||||||++|||+||++||..... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 98654333222223456899999999998652 4588999999999999999999999975432 3567778
Q ss_pred HhhcCCCChhHHHHHhhHH-HHHHhhhcccC--CCC----CCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 334 TDLLGTPSTESISRIRNEK-ARRYLGSMRKK--QPV----PFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 334 ~~~lg~p~~~~i~~i~~~~-~~~~l~~~~~~--~~~----~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
...+|.+..+.+..+.... ........... ... .........+..+.+||.+||..||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 8888887776655432110 00000000000 000 0011112346678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=380.06 Aligned_cols=261 Identities=25% Similarity=0.421 Sum_probs=207.5
Q ss_pred CeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCcc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVF--EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~---~~g~~vAIK~i~~~~--~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 187 (595)
+|++++.||+|+||+||+|++. .++..||+|++.+.. ........+..|+.+|+.++ ||+|+.+++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT---- 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec----
Confidence 4899999999999999999864 478999999986422 12233456788999999995 9999999988843
Q ss_pred CcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
...+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 77 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 77 -EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 356899999998 589999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
....... ....+||+.|+|||++.+. ..++.++|||||||++|||++|..||...........+.
T Consensus 156 ~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~------------ 220 (332)
T cd05614 156 LSEEKER--TYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS------------ 220 (332)
T ss_pred cccCCCc--cccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH------------
Confidence 3322211 2346899999999998762 357889999999999999999999997543211111000
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 409 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~ 409 (595)
.... ....+ ....+++.+.+||.+||..||++|| +++++++||||+..
T Consensus 221 -------~~~~---~~~~~-----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 221 -------RRIL---KCDPP-----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred -------HHHh---cCCCC-----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0000 00111 1134688899999999999999999 88999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=378.38 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=205.7
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHH---HhcCCCceeeeeeeecCCCccCcc
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLL---RLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
|++++.||+|+||.||+|.+..+|+.||||+++... ........+.+|+.++ +.++||||+++++++.. ..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-----~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-----ED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-----CC
Confidence 788999999999999999999999999999996432 1223345667777665 45679999999998843 35
Q ss_pred cEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||+.+ +|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 69999999984 77777654 57999999999999999999999999999999999999999999999999998743222
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 155 ~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------------- 216 (324)
T cd05589 155 GD---RTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------------- 216 (324)
T ss_pred CC---cccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 11 1245689999999999877 67899999999999999999999999887654433322110
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 409 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~ 409 (595)
.+ .....+++.+.+||.+||..||.+|| ++.++++||||+.+
T Consensus 217 --------------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 217 --------------EV----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred --------------CC----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 00 01124678899999999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=377.59 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=206.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.||+|+||.||+|.+..+++.||||+++... ........+..|+.++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-----KDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCeEEEEE
Confidence 46999999999999999999999999986432 1223445677899999866 79999999999843 34689999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
||++ ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---T 152 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---c
Confidence 9998 58988998888899999999999999999999999999999999999999999999999999975432221 1
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~------------------- 211 (321)
T cd05591 153 TTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD------------------- 211 (321)
T ss_pred ccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 245679999999999877 67999999999999999999999999887755444332210
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-------CHHHHhcCCCccCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-------TAEEALADPYFHGL 409 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-------ta~elL~Hp~f~~~ 409 (595)
... ....+++.+.+||.+||..||++|| +++++++||||..+
T Consensus 212 -------~~~-----~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 212 -------DVL-----YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred -------CCC-----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 000 0123578899999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=384.24 Aligned_cols=263 Identities=25% Similarity=0.369 Sum_probs=210.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..+|++.+.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++.. ..
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-----~~ 116 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-----DK 116 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CC
Confidence 468999999999999999999999999999999986421 122334567889999999999999999999843 45
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+|||||. ++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 6999999998 6899888654 6899999999999999999999999999999999999999999999999999865322
Q ss_pred CCCcccccccccCCcccccccccccC--CCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~--~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
. .......+||+.|+|||++.+.. ..++.++|||||||++|||++|++||.+.+....+..+....
T Consensus 196 ~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~---------- 263 (370)
T cd05621 196 G--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK---------- 263 (370)
T ss_pred C--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 1 11224568999999999986521 237889999999999999999999998877544433332110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCC--CCCHHHHhcCCCccCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGL 409 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~--Rpta~elL~Hp~f~~~ 409 (595)
....+. ....++..+++||.+||..++.+ |+++.|+++||||+..
T Consensus 264 ----------------~~~~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 264 ----------------NSLNFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred ----------------cccCCC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 000111 11246788999999999866544 8999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=377.09 Aligned_cols=279 Identities=24% Similarity=0.386 Sum_probs=215.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCE
Confidence 468999999999999999999999999999999986432 22335678899999999999999999999844 346
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~-gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||++ ++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 899999998 58999998888899999999999999999999986 6999999999999999999999999999755322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhH-----
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES----- 344 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~----- 344 (595)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.... ++.+....
T Consensus 158 ~-----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 226 (331)
T cd06649 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI----FGRPVVDGEEGEP 226 (331)
T ss_pred c-----cccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----hcccccccccCCc
Confidence 1 234579999999999987 6799999999999999999999999987664332222 12111000
Q ss_pred -------------H-----HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 345 -------------I-----SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 345 -------------i-----~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
. ...........+..+....+. .......++.+++||.+||.+||++|||+.|+|+||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPP--KLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCCc--CCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 0 000000000111111111110 01123467889999999999999999999999999999
Q ss_pred cCC
Q 007629 407 HGL 409 (595)
Q Consensus 407 ~~~ 409 (595)
+..
T Consensus 305 ~~~ 307 (331)
T cd06649 305 KRS 307 (331)
T ss_pred hhc
Confidence 753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=384.34 Aligned_cols=263 Identities=25% Similarity=0.357 Sum_probs=212.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..+|++.+.||+|+||.||+|.+..++..||||++.+.. ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-----~~ 116 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-----DK 116 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-----CC
Confidence 468999999999999999999999999999999986421 122334557789999999999999999988843 45
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+|||||+ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 6999999997 588888765 46899999999999999999999999999999999999999999999999999765322
Q ss_pred CCCcccccccccCCccccccccccc--CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~--~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.. ......+||+.|+|||++.+. ...++.++|||||||++|||++|++||.+.+.......+...
T Consensus 196 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----------- 262 (370)
T cd05596 196 GM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH----------- 262 (370)
T ss_pred Cc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----------
Confidence 11 112346899999999998652 124788999999999999999999999887754433332210
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCC--CCCHHHHhcCCCccCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGL 409 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~--Rpta~elL~Hp~f~~~ 409 (595)
.....+ .....++..+.+||.+||..+|.+ |++++|+++||||++.
T Consensus 263 ---------------~~~~~~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 263 ---------------KNSLTF-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred ---------------CCcCCC-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 000111 112346889999999999999988 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=373.94 Aligned_cols=280 Identities=34% Similarity=0.578 Sum_probs=228.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC--Cc----eeeeeeeecCC
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH--PD----IVEIKHIMLPP 184 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pn----Iv~l~~~~~~~ 184 (595)
...||.+.+.+|+|+||.|..|.+..++..||||+|+... ...+..+-||.+|.+|.+ |+ +|.+.++|
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--- 160 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--- 160 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh---
Confidence 3679999999999999999999999999999999997532 223445679999999953 22 66666666
Q ss_pred CccCcccEEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC-----------
Q 007629 185 SRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA----------- 251 (595)
Q Consensus 185 ~~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~----------- 251 (595)
+..+++|||+|.|+.++++.+..++ +++..+++.+.+||+++++|||+.+++|.||||||||+.+
T Consensus 161 --dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 161 --DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred --hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 5557899999999999999999875 6899999999999999999999999999999999999642
Q ss_pred ---------CCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCC
Q 007629 252 ---------DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP 322 (595)
Q Consensus 252 ---------~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~ 322 (595)
...|+|+|||.|+...... +..+.|+.|+|||++++ -+++..+||||+||||+||.||..+|+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceecc
Confidence 2358999999998643332 55789999999999999 689999999999999999999999999
Q ss_pred CCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhccc---------------CCCCCCCCCCCCCC---HHHHHHHH
Q 007629 323 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRK---------------KQPVPFSHKFPNAD---PLALHLLE 384 (595)
Q Consensus 323 ~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~---------------~~~~~~~~~~~~~~---~~~~dLl~ 384 (595)
+.+..+++++|..++|..+...+.+.+.++ |+...+- ..+.++.......+ ..+.|||+
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~K---yf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEK---YFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHh---hhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 999999999999999988887777764322 2211110 11222222222222 34789999
Q ss_pred hhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 385 RLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 385 ~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
+||.+||.+|+|+.|+|.||||+.+
T Consensus 388 ~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHHccCccccccHHHHhcCHHhhcC
Confidence 9999999999999999999999865
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=375.94 Aligned_cols=256 Identities=24% Similarity=0.417 Sum_probs=210.7
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCccc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
+|++++.||+|+||.||+|++..++..||||++++... .......+..|+.++..+ .|++|+.+++++.. ...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-----MDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-----CCE
Confidence 48899999999999999999999999999999865321 223345567788888877 48999999888843 356
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+||||++ ++|...+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 899999998 6899999888889999999999999999999999999999999999999999999999999997532221
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05616 156 V---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred C---ccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 1 1245689999999999987 67999999999999999999999999887654443332211
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 410 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~~ 410 (595)
. ..+ ...+++.+.+||.+||+.||.+|++ ..++++||||+.+.
T Consensus 217 ------------~--~~~---p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 217 ------------N--VAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred ------------C--CCC---CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 0 001 1246788999999999999999998 48999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=360.37 Aligned_cols=272 Identities=31% Similarity=0.471 Sum_probs=221.8
Q ss_pred cccCCCCCeEEe-eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCC
Q 007629 107 TEYGEASRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPP 184 (595)
Q Consensus 107 ~~~~~~~~Y~i~-~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 184 (595)
.++...++|.|- ++||-|-.|.|..|.++.||+.+|+|++. +.....+|+++.-.. .|||||.++++|...
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-------DSPKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-------cCHHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 666677788774 68999999999999999999999999884 345677899986655 599999999998543
Q ss_pred CccCcccEEEEEeccc-ccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC---CCcEEEc
Q 007629 185 SRREFKDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKIC 258 (595)
Q Consensus 185 ~~~~~~~lylV~E~~~-g~L~~~i~~~~~--l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~---~~~vKL~ 258 (595)
......+.||||.|+ |+|+..|+..+. |+|.++..|+.||..|+.|||+.+|.||||||+|+|... +..+||+
T Consensus 128 -~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 128 -YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred -ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 355678999999999 589999988764 999999999999999999999999999999999999865 4579999
Q ss_pred ccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcC
Q 007629 259 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338 (595)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg 338 (595)
|||+|+.... ...+.+.|-||+|.|||++.. .+|+..+|+||+|||+|-||+|.+||......
T Consensus 207 DfGFAK~t~~----~~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~----------- 269 (400)
T KOG0604|consen 207 DFGFAKETQE----PGDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----------- 269 (400)
T ss_pred ccccccccCC----CccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCc-----------
Confidence 9999986432 222466789999999999987 68999999999999999999999999875421
Q ss_pred CCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCC
Q 007629 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDRE 415 (595)
Q Consensus 339 ~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~ 415 (595)
..++..-.+|+. .+-......|..++..++|+|++||..+|.+|.|+++++.|||+.+...++..
T Consensus 270 aispgMk~rI~~------------gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~t 334 (400)
T KOG0604|consen 270 AISPGMKRRIRT------------GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQT 334 (400)
T ss_pred cCChhHHhHhhc------------cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCC
Confidence 112222222221 11222345677889999999999999999999999999999999886655443
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=376.26 Aligned_cols=251 Identities=29% Similarity=0.484 Sum_probs=206.1
Q ss_pred eeeeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 118 QEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~---~~g~~vAIK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++.||+|+||.||+|++. .+++.||||+++... ........+.+|+.+|+.++||||+++++++.. ...+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeE
Confidence 367999999999999864 578999999986421 122334567789999999999999999998843 3468
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+||||+. ++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999998 58999998888899999999999999999999999999999999999999999999999999875432221
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..+..
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~---------------- 214 (323)
T cd05584 156 ---VTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK---------------- 214 (323)
T ss_pred ---cccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc----------------
Confidence 1234679999999999877 5788999999999999999999999987765433322211
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCC
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 409 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~ 409 (595)
... ...+.+++.+.+||.+||..||.+|| +++++++||||...
T Consensus 215 ----------~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 215 ----------GKL-----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ----------CCC-----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 000 11234678899999999999999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=373.05 Aligned_cols=291 Identities=41% Similarity=0.648 Sum_probs=231.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||.|+||.||+|.+..+|+.||+|+++...........+.+|+.+++.++|+||+++++++.... ...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence 46899999999999999999999999999999998643322222334668999999999999999999985432 245
Q ss_pred EEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+||||++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 83 IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 8999999999998888753 579999999999999999999999999999999999999999999999999998654322
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
.. .+...+++.|+|||++.+. ..++.++|||||||++|||++|.+||.+.+...++..+...++.+....+..+..
T Consensus 163 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 163 KP---MTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CC---CCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 11 2334568899999988652 4678999999999999999999999999999999999999888887655443221
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
....... .........+...+...++.+.+||.+||.+||++|||++++|+||||+...
T Consensus 239 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 239 LPLVGKF-TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ccccccc-cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 1100000 0011111112223445688999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=366.47 Aligned_cols=282 Identities=40% Similarity=0.651 Sum_probs=226.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
.|++++.||.|+||.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++. +...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence 388999999999999999999999999999998643333333456889999999999999999999884 335689
Q ss_pred EEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 194 VVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 194 lV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
+||||+.++|..++... ..+++..+..++.||+.||+|||+.+++||||+|+||+++.++.+||+|||++........
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 99999998888888653 4689999999999999999999999999999999999999999999999999875432211
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
......+++.|+|||++.+. ..++.++|||||||++|+|+||+.||.+.+....+..+...++.+....+..+..
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (284)
T cd07860 156 ---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS- 230 (284)
T ss_pred ---ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH-
Confidence 12334678999999988652 3468899999999999999999999999988888888888888876654432221
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
...+...+.......+....+.+++.+.+||.+||..||.+|||++++|+||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 231 -LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred -HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 111112222222222233345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=365.52 Aligned_cols=285 Identities=41% Similarity=0.715 Sum_probs=231.6
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++.+.||.|+||.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence 5899999999999999999999999999999987543333445678899999999999999999999844 35689
Q ss_pred EEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 194 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 194 lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
+||||+.++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9999998799998865 45799999999999999999999999999999999999999999999999999986543322
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHH
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~ 352 (595)
.......|+.+|+|||.+.+. ..++.++|||||||++|||++|.+||.+.+....+..+...++.+....+.......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 112345799999999988652 457899999999999999999999999998888888888888887765443322110
Q ss_pred HHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 353 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
.... ..+....+.++...++..+..+.+||++||..||.+|||++++|+||||.
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNK-ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhc-ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000 01122222333445567788999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=374.51 Aligned_cols=264 Identities=23% Similarity=0.411 Sum_probs=210.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++++.||+|+||+||+|++..+++.||||++.+.. ........+.+|+.+++.++|+||+.+++++. +...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-----DENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-----cCCe
Confidence 47999999999999999999999999999999986421 12233456788999999999999999999884 3456
Q ss_pred EEEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999997 689999876 457999999999999999999999999999999999999999999999999998754332
Q ss_pred CCCcccccccccCCccccccccccc---CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~---~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~---------- 223 (331)
T cd05597 156 GTV--QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---------- 223 (331)
T ss_pred CCc--cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC----------
Confidence 211 11234799999999998631 145788999999999999999999999877654433322110
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCC--CCCHHHHhcCCCccCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGL 409 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~--Rpta~elL~Hp~f~~~ 409 (595)
.....+....+.+++.+.+||++||..++++ |++++++++||||.++
T Consensus 224 ----------------~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 224 ----------------KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred ----------------CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 1111122233457889999999999765554 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=378.41 Aligned_cols=251 Identities=31% Similarity=0.444 Sum_probs=204.4
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcE-EEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~-vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
...+.+.||.|+||+||+|.. .|.. ||||++............+.+|+.+|.+++|||||++++++..+.. .+
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~ 115 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SL 115 (362)
T ss_pred HhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ce
Confidence 345566799999999999965 4666 9999997654444446789999999999999999999999965531 58
Q ss_pred EEEEeccc-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCCCCceeeCCCC-cEEEcccCcceecc
Q 007629 193 YVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTAN-VFHRDLKPKNILANADC-KLKICDFGLARVSF 267 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~aL~yLHs~g-IiHrDLKP~NILl~~~~-~vKL~DFGla~~~~ 267 (595)
+||||||+ |+|.+++.. ...++...+..|+.||++||.|||+++ ||||||||+|||++.++ ++||||||+++...
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 99999998 689999987 578999999999999999999999999 99999999999999998 99999999998754
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
... ...+...||+.|||||++.+....|+.|+||||||+++|||+||+.||.+.........+...
T Consensus 196 ~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~----------- 261 (362)
T KOG0192|consen 196 ISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG----------- 261 (362)
T ss_pred ccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-----------
Confidence 322 123447899999999999841258999999999999999999999999987762222211111
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+.+.+ ...++.+..|+.+||..||.+||+..+++.
T Consensus 262 -------------~~Rp~~p-----~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 262 -------------GLRPPIP-----KECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -------------CCCCCCC-----ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 0111111 126788999999999999999999998875
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=374.54 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=204.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.||+|+||.||+|.++.+|..||||+++.... .......+..|+.++..+ +||+|+++++++. +...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE-----eCCEEEEEE
Confidence 469999999999999999999999999965321 122345567788888754 8999999999884 345699999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
||+. ++|..++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN---R 152 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---c
Confidence 9998 58999998888899999999999999999999999999999999999999999999999999874322111 1
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-------------------- 210 (316)
T cd05620 153 ASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-------------------- 210 (316)
T ss_pred eeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 345689999999999987 6799999999999999999999999987765333222210
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH-HHHhcCCCccCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-EEALADPYFHGL 409 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta-~elL~Hp~f~~~ 409 (595)
..+ .....+++.+.+||.+||..||.+||++ +++++||||+..
T Consensus 211 -------~~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 211 -------DTP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred -------CCC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 000 0012367889999999999999999997 589999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=362.43 Aligned_cols=258 Identities=34% Similarity=0.585 Sum_probs=211.9
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lyl 194 (595)
|++++.||+|+||+||+|.+..+++.||+|++..............+|+.+++.++||||+++++++.. ...+|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 899999999999999999999999999999997643333333345679999999999999999999854 456899
Q ss_pred EEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCc
Q 007629 195 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (595)
Q Consensus 195 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 273 (595)
||||+.+ +|.+++.....+++..+..++.||++||+|||+.||+||||||+|||++.++.++|+|||.+..... ..
T Consensus 76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~---~~ 152 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE---NN 152 (260)
T ss_dssp EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS---TT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc
Confidence 9999996 8999998788899999999999999999999999999999999999999999999999999976411 11
Q ss_pred ccccccccCCccccccccc-ccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHH
Q 007629 274 IFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (595)
Q Consensus 274 ~~~~~~~gT~~Y~APE~l~-~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~ 352 (595)
.......+|..|+|||++. + ..++.++||||||+++|+|++|..||...........+..........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 221 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS--------- 221 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH---------
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhcccccccc---------
Confidence 2235678999999999987 4 678999999999999999999999998875445444443322111100
Q ss_pred HHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 353 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
... ........+.+||.+||..||++||++.++++||||
T Consensus 222 ------~~~---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 222 ------SSQ---------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ------HTT---------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ------ccc---------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 000 001112679999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=376.02 Aligned_cols=250 Identities=28% Similarity=0.478 Sum_probs=204.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHH-HHHhcCCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.||+|+||+||+|.+..+|+.||||++.... ........+..|.. +++.++||||+++++++.. ...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence 46999999999999999999999999986422 12223455666665 4678999999999988843 35689999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---T 152 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---c
Confidence 9998 58999998888999999999999999999999999999999999999999999999999999875322221 1
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------------------- 210 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN-------------------- 210 (323)
T ss_pred cccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 244679999999999877 6799999999999999999999999988765433322211
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH----HHHhcCCCccCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYFHGL 409 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta----~elL~Hp~f~~~ 409 (595)
.+. ...+..++.+.+||.+||+.||.+||++ .++++||||..+
T Consensus 211 --------~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 211 --------KPL---RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred --------CCC---CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 000 1124568889999999999999999997 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=364.20 Aligned_cols=282 Identities=37% Similarity=0.680 Sum_probs=218.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-----KRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEE
Confidence 47999999999999999999999999999999986432222233557899999999999999999998843 3568
Q ss_pred EEEEeccccc-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~g~-L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+||||+++. |..++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9999999965 444555556799999999999999999999999999999999999999999999999999986543221
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
......++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.............
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ---cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 12345688999999997652 45788999999999999999999999998877777666665554333211111000
Q ss_pred HHHHHhhhcccCC---CCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 352 KARRYLGSMRKKQ---PVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 352 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
.+...+.... ..+....++.++..+.+||.+||..||++||++.|++.||||
T Consensus 232 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 ---QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ---cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000000000 111122345678889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=373.28 Aligned_cols=265 Identities=23% Similarity=0.404 Sum_probs=211.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++.+.||+|+||.||+++++.+++.||+|++.+.. ........+..|+.++..++|++|+.+++++.. ...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-----ENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----CCE
Confidence 36999999999999999999999999999999986421 112233457789999999999999999998843 356
Q ss_pred EEEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 899999997 689999976 467999999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccCCccccccccccc---CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~---~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
.. ......+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~---------- 223 (332)
T cd05623 156 GT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---------- 223 (332)
T ss_pred Cc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC----------
Confidence 21 112345799999999998631 246889999999999999999999999887654443333210
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCC--CCCHHHHhcCCCccCCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGLA 410 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~--Rpta~elL~Hp~f~~~~ 410 (595)
....++......+++.+.+||.+||..++.+ |++++|+++||||.++.
T Consensus 224 ----------------~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 224 ----------------KERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred ----------------CccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 1111222334567899999999999765554 68999999999998753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=373.29 Aligned_cols=250 Identities=28% Similarity=0.471 Sum_probs=203.7
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHh-cCCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRL-LRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.||+|+||+||+|.+..+++.||||+++.... .......+..|..++.. +.||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 469999999999999999999999999875321 22334556677777765 479999999998843 35699999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
||++ ++|..++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~---~ 152 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG---K 152 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC---c
Confidence 9997 68999998888899999999999999999999999999999999999999999999999999975432221 2
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05592 153 ASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-------------------- 210 (316)
T ss_pred cccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245689999999999877 6789999999999999999999999988765433322211
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH-HHHhcCCCccCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-EEALADPYFHGL 409 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta-~elL~Hp~f~~~ 409 (595)
..+ ..-..+++.+.+||.+||..||.+||++ .++++||||..+
T Consensus 211 -------~~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 211 -------DRP----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred -------CCC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 000 0112357889999999999999999986 588999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=374.66 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=203.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.||+|+||.||+|.+..+++.||||++++... .......+.+|+.+++.+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-----CCEEEEEE
Confidence 469999999999999999999999999975322 223455678899999988 69999999999843 35689999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
|||+ ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---c
Confidence 9998 58988888888999999999999999999999999999999999999999999999999999874322111 1
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+...... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----------~~~~~~~~-----~~~~ 215 (329)
T cd05588 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD----------NPDQNTED-----YLFQ 215 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccc----------cccccchH-----HHHH
Confidence 245689999999999987 678999999999999999999999996422100 00000000 0000
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC------HHHHhcCCCccCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT------AEEALADPYFHGL 409 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt------a~elL~Hp~f~~~ 409 (595)
. +.... .. .-..+++.+.+||.+||..||.+|++ ++++++||||..+
T Consensus 216 ~---~~~~~-~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 216 V---ILEKQ-IR---IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred H---HHcCC-CC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 0 00111 11 11346788999999999999999987 7999999999754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=375.55 Aligned_cols=250 Identities=29% Similarity=0.457 Sum_probs=206.6
Q ss_pred eeeeecCceEEEEEEE---CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEE
Q 007629 119 EVIGKGSYGVVGSAVD---THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~---~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV 195 (595)
+.||+|+||.||++++ ..+|+.||+|++............+.+|+.+|+.++||||+++++++.. ...+|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-----EGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCEEEEE
Confidence 6799999999999976 3578999999997533333344567789999999999999999999843 3568999
Q ss_pred Eeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcc
Q 007629 196 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274 (595)
Q Consensus 196 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 274 (595)
|||++ ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--- 153 (318)
T cd05582 77 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--- 153 (318)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC---
Confidence 99997 68999998888899999999999999999999999999999999999999999999999999976433221
Q ss_pred cccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHH
Q 007629 275 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354 (595)
Q Consensus 275 ~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~ 354 (595)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 154 ~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~------------------ 213 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA------------------ 213 (318)
T ss_pred ceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC------------------
Confidence 1234689999999999876 67889999999999999999999999877654433322110
Q ss_pred HHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCC
Q 007629 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGL 409 (595)
Q Consensus 355 ~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~ 409 (595)
... ....+++.+.+||.+||+.||.+||+ +++++.||||..+
T Consensus 214 --------~~~-----~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 214 --------KLG-----MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred --------CCC-----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 000 11246788999999999999999999 7889999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=364.92 Aligned_cols=288 Identities=37% Similarity=0.638 Sum_probs=227.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++.+.||.|+||.||+|.+..+|+.||||+++...........+.+|+.+++.+. ||||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3699999999999999999999999999999998654333333456788999999995 699999999886544333345
Q ss_pred EEEEEecccccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC-CCcEEEcccCccee
Q 007629 192 IYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARV 265 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~~-----~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~-~~~vKL~DFGla~~ 265 (595)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999998887643 35799999999999999999999999999999999999998 88999999999975
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
....... .....+++.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+..+...++.|....+
T Consensus 161 ~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPVKS---YTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cCCCccc---cCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 4322111 2334678999999987652 45789999999999999999999999998888877777777777766544
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
.......... ......+.......+..++.+.+||.+||..||.+||++.|+|.||||+
T Consensus 237 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWH---EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchh---hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 3221111000 0111122222233456788999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=363.58 Aligned_cols=285 Identities=37% Similarity=0.669 Sum_probs=223.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 110 ~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
+..++|++.+.||.|+||.||+|.++.+++.||||.+...... .....+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~ 75 (291)
T cd07844 2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHT-----K 75 (291)
T ss_pred CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEec-----C
Confidence 4567899999999999999999999999999999998643222 122346789999999999999999999843 3
Q ss_pred ccEEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
...|+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 76 KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred CeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 568999999999999988764 4689999999999999999999999999999999999999999999999999875322
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCC-hHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~-~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
... ......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.. ..+++..+.+.++.+..+.+..
T Consensus 156 ~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 156 PSK---TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231 (291)
T ss_pred CCc---cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence 111 12234578899999988652 457889999999999999999999998776 5677777888888877655433
Q ss_pred HhhHHHHHHhh-hcccCCCCCCCCCCCCCC--HHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 348 IRNEKARRYLG-SMRKKQPVPFSHKFPNAD--PLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 348 i~~~~~~~~l~-~~~~~~~~~~~~~~~~~~--~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
+... ..+.. ......+.+....++..+ ..+.+||.+||..||.+|||+.++|+||||
T Consensus 232 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 232 VSSN--PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhc--cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 3211 00000 000111122222333444 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=365.54 Aligned_cols=294 Identities=36% Similarity=0.550 Sum_probs=226.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc---c
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR---R 187 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---~ 187 (595)
..++|++.+.||+|+||.||+|.+..++..||||++............+.+|+.+++.++||||+++++++..... .
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3568999999999999999999999999999999986433322333456789999999999999999998865432 2
Q ss_pred CcccEEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 188 EFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 188 ~~~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
....+|+||||+.++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++...
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 234679999999999988886543 7899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCC-cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...... ........++..|+|||++.+. ..++.++|||||||++|||++|.+||.+.+...++..+..+.|..+.+.+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 332211 1112345688999999987652 45788999999999999999999999999888888888888887665543
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCC--CCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSH--KFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
...........+. +.......... .....++.+.+||.+||..||.+|||++|+|+||||
T Consensus 249 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 249 PGVDKLELFKKME-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccccchhhhhhcc-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 3221111100000 00000000000 011235778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=365.05 Aligned_cols=286 Identities=42% Similarity=0.674 Sum_probs=230.8
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC---hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH---VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
+|++.+.||+|+||.||+|.+..+|+.||||++...... ......+..|+.+++.++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 588999999999999999999999999999998653322 2234556789999999999999999999854 35
Q ss_pred cEEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||+.++|.+++.... .+++..+..++.||++||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 689999999889999998766 7999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
... .....+++.|+|||.+.+. ..++.++|||||||++|||++|.+||.+.+..+.+..+...++.+....+....
T Consensus 156 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NRK---MTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Ccc---ccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 211 2334678899999987542 467889999999999999999999999988888888887777777655443221
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
.. ..+ .......+.+....+...+..+.+||.+||.+||++|||+.|+|+||||++...
T Consensus 232 ~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 232 SL--PDY-VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred cc--ccc-ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 11 011 111122233334455667889999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=376.24 Aligned_cols=258 Identities=27% Similarity=0.358 Sum_probs=201.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++|+||+++++++. ....
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFD-----HNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEec-----cCCe
Confidence 457889999999999999999999999999999985432 2233567889999999999999999999884 3456
Q ss_pred EEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+|||||.+ +|.. ...+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 147 IQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 8999999985 5543 2346678888999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCCccccccccccc---CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~---~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
. .....+||..|+|||++... ...++.++|||||||++|||++|+.||......+....+..
T Consensus 223 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~------------ 287 (353)
T PLN00034 223 D---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA------------ 287 (353)
T ss_pred c---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH------------
Confidence 1 12346899999999987431 12345689999999999999999999974332111111100
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.....+ ......+++.+.+||.+||..||.+|||+.|+|+||||.+-
T Consensus 288 ------------~~~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 288 ------------ICMSQP---PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ------------HhccCC---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 000000 11123567889999999999999999999999999999864
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=367.12 Aligned_cols=292 Identities=38% Similarity=0.641 Sum_probs=229.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc---cC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR---RE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---~~ 188 (595)
.++|++.+.||.|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999999999999999985432222223456789999999999999999998765432 23
Q ss_pred cccEEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 189 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 189 ~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
...+|+||||+.++|...+... ..+++..++.++.||++||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 4568999999999888877653 479999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCC--------cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCC
Q 007629 268 NDAPS--------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339 (595)
Q Consensus 268 ~~~~~--------~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~ 339 (595)
..... ....+...|++.|+|||++.+. ..++.++|||||||++|||++|++||.+.+.......+....+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 32211 1122445789999999987652 45889999999999999999999999999988888888888887
Q ss_pred CChhHHHHHhhHHHHHHhh-hcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 340 PSTESISRIRNEKARRYLG-SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 340 p~~~~i~~i~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
+....+...... ..... ......+..+...+....+.+.+||.+||..||.+|||+.|++.||||
T Consensus 246 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 246 PTEETWPGWRSL--PGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CChhhchhhhhc--ccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 765543322110 00000 111111222223445566889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=372.03 Aligned_cols=259 Identities=23% Similarity=0.396 Sum_probs=203.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.||+|+||.||+|.+..+++.||+|++++... .......+.+|+.++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence 469999999999999999999999999975422 233455678899988776 79999999998843 35689999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
||+. ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~ 152 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---c
Confidence 9998 58988888888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.......+ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------~~~~~~~~~~----~~~ 216 (329)
T cd05618 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NPDQNTEDYL----FQV 216 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcC----------CcccccHHHH----HHH
Confidence 234689999999999987 678999999999999999999999995321000 0000000000 000
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC------HHHHhcCCCccCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT------AEEALADPYFHGL 409 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt------a~elL~Hp~f~~~ 409 (595)
.+ ..... .....+..+.+||.+||..||.+||+ +.++++||||+.+
T Consensus 217 i~---~~~~~-----~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 217 IL---EKQIR-----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred Hh---cCCCC-----CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 00 00111 12346788999999999999999998 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=371.67 Aligned_cols=250 Identities=25% Similarity=0.440 Sum_probs=206.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.||+|+||+||+|.+..++..||||++++.. ........+.+|+.+++.+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-----~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-----KDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 46999999999999999999999999987432 1223455677899999888 69999999998843 34699999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
||+. ++|...+...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---T 152 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---c
Confidence 9998 58988888888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (318)
T cd05570 153 TSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-------------------- 210 (318)
T ss_pred ccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234579999999999987 6789999999999999999999999987764333222211
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH-----HHHhcCCCccCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-----EEALADPYFHGL 409 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta-----~elL~Hp~f~~~ 409 (595)
..+ . ....+++.+.+||++||..||.+||++ .++++||||+..
T Consensus 211 -------~~~-~---~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 211 -------DEV-R---YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred -------CCC-C---CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 000 0 112467889999999999999999999 999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=390.28 Aligned_cols=266 Identities=25% Similarity=0.368 Sum_probs=216.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc---cC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR---RE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---~~ 188 (595)
..+|++.+.||+|+||+||+|.+..+|+.||||++............+.+|+.+|..+.|+||+++++.+..... ..
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 468999999999999999999999999999999986544444556778899999999999999999887654321 11
Q ss_pred cccEEEEEeccc-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcc
Q 007629 189 FKDIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla 263 (595)
...+++||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 224789999998 6899888642 46899999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
+......... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 191 ~~~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~------- 260 (496)
T PTZ00283 191 KMYAATVSDD-VGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG------- 260 (496)
T ss_pred eecccccccc-ccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-------
Confidence 8654322111 1245689999999999987 67999999999999999999999999877653332222110
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
... ...+.+++.+.+||.+||..||.+||++.++|+|||++.+.
T Consensus 261 ------------------~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 261 ------------------RYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred ------------------CCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 000 11245688999999999999999999999999999987543
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=370.56 Aligned_cols=264 Identities=23% Similarity=0.398 Sum_probs=211.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++.+.||+|+||.||+|++..+++.||||++.+.. ........+..|+.++..+.|++|+.+++++. +...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-----~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ-----DENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 47999999999999999999999999999999986421 12223445778999999999999999999884 3456
Q ss_pred EEEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999997 689999976 467999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCCcccccccccccC---CCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~---~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
.. ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------- 222 (331)
T cd05624 156 GT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (331)
T ss_pred Cc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc-----------
Confidence 21 1123357999999999886421 3578899999999999999999999987765433332211
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCC--CCCHHHHhcCCCccCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGL 409 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~--Rpta~elL~Hp~f~~~ 409 (595)
.....++...+..++..+.+||.+||..++.+ |++++++++||||+++
T Consensus 223 ---------------~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 223 ---------------HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred ---------------CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 01111223334567889999999999976655 5789999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=362.27 Aligned_cols=259 Identities=26% Similarity=0.426 Sum_probs=221.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|..+++||+|.||.|.+|+.+.+++.||||++++.. ....+....+.|-.+|+..+||.+..+.-.| ....
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCc
Confidence 357888999999999999999999999999999997632 3344566778899999999999999887666 3445
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||.. |.|+..+.....|+++.++++-.+|+.||.|||+.+||+||||.+|+|+|.+|++||+|||+++.....
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 6999999998 589999988889999999999999999999999999999999999999999999999999999854333
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. ...++||||.|+|||++.. ..|+.++|+|.+||++|||++|+.||...+....+++|.-. .+
T Consensus 322 g~---t~kTFCGTPEYLAPEVleD--nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e----------d~- 385 (516)
T KOG0690|consen 322 GD---TTKTFCGTPEYLAPEVLED--NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME----------DL- 385 (516)
T ss_pred cc---eeccccCChhhcCchhhcc--ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh----------hc-
Confidence 22 2467899999999999987 78999999999999999999999999988876655555310 00
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLAN 411 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~~~ 411 (595)
..-..++++++.||..+|.+||++|.. |.|+.+|+||.++.+
T Consensus 386 --------------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 386 --------------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred --------------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence 011357899999999999999999975 899999999998765
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=377.26 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=209.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..+|++.+.||+|+||.||+|.++.+++.||+|++.+.. ........+.+|+.+++.++||||+++++++.. ..
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-----~~ 116 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-----DR 116 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----CC
Confidence 468999999999999999999999999999999986421 122334557789999999999999999998843 35
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+|||||+ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 6999999997 578888765 46899999999999999999999999999999999999999999999999999865322
Q ss_pred CCCcccccccccCCcccccccccccC--CCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~--~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.. ......+||+.|+|||++.+.. ..++.++|||||||++|||++|.+||.+.+.......+...
T Consensus 196 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~----------- 262 (371)
T cd05622 196 GM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH----------- 262 (371)
T ss_pred Cc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 21 1123568999999999986521 23789999999999999999999999887754433332211
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCC--CCCHHHHhcCCCccCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGL 409 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~--Rpta~elL~Hp~f~~~ 409 (595)
.....+. ....+++.+.+||.+||..++.+ |++++++++||||++.
T Consensus 263 ---------------~~~~~~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 263 ---------------KNSLTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred ---------------CCcccCC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 0001111 12457889999999999844433 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=370.11 Aligned_cols=256 Identities=23% Similarity=0.399 Sum_probs=208.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCccc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~ 191 (595)
+|++.+.||+|+||.||+|.++.+|+.||||++.+... .......+..|+.++..+. |++|+.+++++.. ...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-----VDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-----CCE
Confidence 47889999999999999999999999999999864321 2234456778999998886 5677788887743 346
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 899999998 6899999888889999999999999999999999999999999999999999999999999987532221
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05615 156 V---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred c---cccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 1 1234579999999999877 67899999999999999999999999887654333322110
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 410 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~~ 410 (595)
.. .....+++.+.+|+.+||..||.+|++ .+++++||||..+.
T Consensus 217 ------------~~-----~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 217 ------------NV-----SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred ------------CC-----CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 00 011245788999999999999999997 58999999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=370.30 Aligned_cols=251 Identities=25% Similarity=0.432 Sum_probs=204.4
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHh-cCCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRL-LRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.||+|+||+||+|.+..+++.||||+++.... ..........|..++.. +.||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-----KENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-----CCEEEEEE
Confidence 469999999999999999999999999865321 12234556778888876 489999999999843 34699999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
||++ ++|..++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---K 152 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---c
Confidence 9997 68999998878899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05619 153 TCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-------------------- 210 (316)
T ss_pred eeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 234679999999999877 6789999999999999999999999987664333222110
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHH-HHhcCCCccCCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE-EALADPYFHGLA 410 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~-elL~Hp~f~~~~ 410 (595)
..+. + ...++..+.+||.+||..||.+||++. ++++||||..+.
T Consensus 211 -------~~~~-~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 211 -------DNPC-Y---PRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred -------CCCC-C---CccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 0000 0 123577899999999999999999996 999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=370.81 Aligned_cols=297 Identities=42% Similarity=0.673 Sum_probs=227.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-----
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR----- 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 186 (595)
..+|.+.+.||.|+||.||+|.+..+|..||+|++.... ....+.+.+|+.+|+.++||||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 478999999999999999999999999999999986432 2345668899999999999999999988755321
Q ss_pred ----cCcccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC-CCcEEEcccC
Q 007629 187 ----REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFG 261 (595)
Q Consensus 187 ----~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~-~~~vKL~DFG 261 (595)
.+...+|+||||++++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 82 VGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 12246899999999998887754 47999999999999999999999999999999999999975 5578999999
Q ss_pred cceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCC
Q 007629 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (595)
Q Consensus 262 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~ 341 (595)
++.................|+..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.......+.+....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 997653222111112334689999999986542 4688899999999999999999999998887776666655554444
Q ss_pred hhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCC
Q 007629 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (595)
Q Consensus 342 ~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~ 413 (595)
.+............ ..........++....+..+..+.+||.+||..||.+|||+.++|+||||+.+..+.
T Consensus 240 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~ 310 (342)
T cd07854 240 EEDRNELLNVIPSF-VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPF 310 (342)
T ss_pred hHHhhhhhhhhhhh-hhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCc
Confidence 43322221111111 110111112222333456788999999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=372.89 Aligned_cols=250 Identities=29% Similarity=0.496 Sum_probs=203.4
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHH-HHHhcCCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.||+|+||+||+|.+..+|+.||||++.+... .......+..|.. +++.++||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----TEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-----CCEEEEEE
Confidence 469999999999999999999999999864321 2233455666665 4678999999999988843 35689999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
||+. ++|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~ 152 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---T 152 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---C
Confidence 9998 58888888888999999999999999999999999999999999999999999999999999875322221 1
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~-------------------- 210 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH-------------------- 210 (325)
T ss_pred cccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245689999999999877 6789999999999999999999999987764333222111
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH----HHHhcCCCccCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYFHGL 409 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta----~elL~Hp~f~~~ 409 (595)
. .. ...+..+..+.+||.+||..||.+||++ .++++||||...
T Consensus 211 ------~--~~---~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 211 ------K--PL---VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred ------C--Cc---cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 0 00 1123567889999999999999999976 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=361.47 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=207.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
.|++.+.||+|+||.||++.+..+++.||||++.... ........+.+|+.+++.++||||+.+++++... ..+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-----CeE
Confidence 3889999999999999999999999999999986422 1222234567899999999999999999988443 468
Q ss_pred EEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 193 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
|+||||+. ++|..++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999998 5787777543 46899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.........+...
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~------------- 216 (285)
T cd05605 156 ET----IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR------------- 216 (285)
T ss_pred Cc----cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-------------
Confidence 21 234579999999999876 67899999999999999999999999876543222211110
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 409 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~ 409 (595)
+ ... +. .....+++.+.+||.+||..||.+|| +++++++||||...
T Consensus 217 -------~---~~~-~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 217 -------V---KED-QE---EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred -------h---hhc-cc---ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 0 000 00 11234678899999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=378.99 Aligned_cols=258 Identities=30% Similarity=0.443 Sum_probs=223.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.+.|.++++||+|+||.+++++++..+..|++|+|.-.............|+.+++++.|||||.+++.|... ...
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~----~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED----GQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC----Cce
Confidence 4679999999999999999999999999999999975444445556788999999999999999999998533 234
Q ss_pred EEEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+||||+||+ |+|.+.|...+ .|+++.+..|+.||+.||.|||+++|+|||||+.|||++.++.|||+|||+|+....
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999 58999997654 689999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... ...+++|||.||+||++.+ .+|+.|+|||||||++|||++-+++|.+.+.......|......|-
T Consensus 159 ~~~---~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl------- 226 (426)
T KOG0589|consen 159 EDS---LASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL------- 226 (426)
T ss_pred chh---hhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC-------
Confidence 542 2467899999999999998 7999999999999999999999999999887666555544332221
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
-...+.++..||+.||..+|..||++.++|.+|.+..
T Consensus 227 -----------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 227 -----------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred -----------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 1345778999999999999999999999999988763
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=377.52 Aligned_cols=277 Identities=26% Similarity=0.354 Sum_probs=207.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
..|++++.||+|+||.||+|.+..++..||+|+.... ....|+.+|+.++||||+++++++... ...
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 132 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSG-----AIT 132 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeC-----Cee
Confidence 4799999999999999999999999999999975321 235699999999999999999988543 458
Q ss_pred EEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+|||++.++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 133 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 133 CMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred EEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 99999999999988865 4579999999999999999999999999999999999999999999999999997532221
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCC-CCCCCCCh---------HHHHHHHHhhcCCCC
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNV---------VHQLDLMTDLLGTPS 341 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~-~pF~~~~~---------~~~l~~i~~~lg~p~ 341 (595)
......||+.|+|||++.+ ..|+.++|||||||++|||+++. ++|..... ..++..+...++..+
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 212 ---AFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred ---ccccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 1234679999999999977 67999999999999999999865 45543221 122333333344322
Q ss_pred hhHHHHHhhHHHHHHhhhcccCCCCCCCC----CCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 342 TESISRIRNEKARRYLGSMRKKQPVPFSH----KFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 342 ~~~i~~i~~~~~~~~l~~~~~~~~~~~~~----~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..............++.. ......++.. ....++..+.+||.+||++||.+|||+.|+|+||||+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEY-ASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred hhcCCCCccHHHHHHHhh-cccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 221100000011111110 0000011110 112456778899999999999999999999999999863
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=361.05 Aligned_cols=285 Identities=36% Similarity=0.661 Sum_probs=220.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+|+.++||||+++++++. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR-----RKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc-----cCCeE
Confidence 3699999999999999999999989999999988653333334456788999999999999999999984 34568
Q ss_pred EEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+||||+++ .|..+......+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999999996 4555555556799999999999999999999999999999999999999999999999999976533221
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
..+...++.+|+|||++.+. ..++.++|||||||++|||++|++||.+....+.+..+....+.............
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 156 ---VYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred ---ccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 23456789999999988652 45788999999999999999999999988877777776666665433221111100
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
...............+....++.++..+.+|+.+||..||.+||++.++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000000000001111222345778899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=360.59 Aligned_cols=281 Identities=38% Similarity=0.688 Sum_probs=226.6
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++.+.||.|++|.||+|.+..+|..||||+++.... ......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEE
Confidence 48999999999999999999999999999999864322 2234567789999999999999999999854 34689
Q ss_pred EEEecccccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 194 VVFELMESDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 194 lV~E~~~g~L~~~i~~~---~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+||||++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 99999999999888754 358999999999999999999999999999999999999999999999999997543221
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. ......+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.|....+..+..
T Consensus 155 ~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 N---TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred c---ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1 12345688999999987652 4578899999999999999999999999988888888888888887766554431
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
. ..+................+..++.+.++|.+||+.||.+||++.++++||||
T Consensus 231 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 L--PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred C--chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1 11111111111112222334567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=363.25 Aligned_cols=286 Identities=40% Similarity=0.659 Sum_probs=229.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||.|+||.||+|.+..+++.||||.++...........+.+|+.+++.++||||+++++++.... ...+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence 5799999999999999999999999999999999643333233345678999999999999999999885432 2579
Q ss_pred EEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+||||+.++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 82 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 9999999999998887644 589999999999999999999999999999999999999999999999999986543321
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
......+++.|+|||++.+. ..++.++|||||||++|+|++|.+||.+......+..+...++.|....+..+..-
T Consensus 162 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 162 ---PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred ---ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 12345688999999988652 34688999999999999999999999999888888888888888877665443211
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCC--CHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNA--DPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~--~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
..... ..........+...++.. ++.+.+||++||..||++|||+.|+|+||||
T Consensus 238 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 238 PGAKK-KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred chhcc-cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00000 011111122233445544 8889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=362.71 Aligned_cols=254 Identities=25% Similarity=0.377 Sum_probs=202.0
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEecc
Q 007629 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 199 (595)
Q Consensus 121 LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~ 199 (595)
||+|+||+||+|.+..+|+.||+|++..... .......+..|+.+|+.++||||+++.+++.. ...+|+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-----KTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-----CCeEEEEEeCC
Confidence 7999999999999999999999999864221 22234567789999999999999999988843 34689999999
Q ss_pred c-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcc
Q 007629 200 E-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274 (595)
Q Consensus 200 ~-g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 274 (595)
+ ++|...+.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-- 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence 8 578776642 346899999999999999999999999999999999999999999999999999765332221
Q ss_pred cccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHH
Q 007629 275 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354 (595)
Q Consensus 275 ~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~ 354 (595)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.
T Consensus 154 -~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~-------------------- 210 (280)
T cd05608 154 -TKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-------------------- 210 (280)
T ss_pred -ccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH--------------------
Confidence 234579999999999987 688999999999999999999999997654211110000
Q ss_pred HHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCCCC
Q 007629 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLAN 411 (595)
Q Consensus 355 ~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~~~ 411 (595)
. ... ..+. .....+++.+.+|+.+||..||.+|| +++++++||||+++.+
T Consensus 211 ~---~~~-~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~ 265 (280)
T cd05608 211 Q---RIL-NDSV---TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW 265 (280)
T ss_pred H---hhc-ccCC---CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence 0 000 0011 11234678899999999999999999 8999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=385.76 Aligned_cols=281 Identities=26% Similarity=0.320 Sum_probs=209.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
...|.+.+.||+|+||.||+|.+..++..||||... ...+.+|+.+|+.|+|||||++++++.. ...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVV-----GGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCE
Confidence 457999999999999999999999999999999642 1235689999999999999999998743 345
Q ss_pred EEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.|+|||++.++|..++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 235 ~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 235 TCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 8999999999999888764 469999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCC-CCCCC------hHHHHHHHHhhcCCCChh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGKN------VVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~p-F~~~~------~~~~l~~i~~~lg~p~~~ 343 (595)
.. ......+||+.|+|||++.+ ..++.++|||||||+||||++|..+ |.... ...++..+....+....+
T Consensus 315 ~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 315 ST-PFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cc-ccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 21 11234679999999999977 6799999999999999999998754 43321 123344443333221111
Q ss_pred H----HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 344 S----ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 344 ~----i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
. ..++..................+....+...++.+.+||.+||++||.+|||+.|+|+||||+.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 0011000000000001111111111222356778999999999999999999999999999974
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=361.73 Aligned_cols=287 Identities=39% Similarity=0.675 Sum_probs=225.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||+|++|.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-----CCeE
Confidence 57999999999999999999999999999999986433322334567889999999999999999999843 3568
Q ss_pred EEEEecccccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC-CCcEEEcccCcceeccCC
Q 007629 193 YVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFND 269 (595)
Q Consensus 193 ylV~E~~~g~L~~~i~~~~~--l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~-~~~vKL~DFGla~~~~~~ 269 (595)
|+||||++++|.+.+..... +++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99999999999888876543 578888999999999999999999999999999999985 567999999999754322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. ..+...+++.|+|||++.+. ..++.++|||||||++|+|++|.+||.+....+.+..+...++.|....+....
T Consensus 157 ~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR---TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred cc---ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 11 12345788999999988652 457889999999999999999999999888877777777777877665443211
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
. ...+........+.......+..++.+.+||.+||..||++||++.++|+||||..+.
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 233 S--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred c--chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 1 0111111111111112223456788899999999999999999999999999998754
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=373.49 Aligned_cols=250 Identities=26% Similarity=0.415 Sum_probs=201.0
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhc---CCCceeeeeeeecCCCccCcccEEEEE
Q 007629 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 121 LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
||+|+||+||+|++..+|+.||||++.+.. ...........|..++..+ .||+|+.+++++.. ...+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-----~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-----DSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-----CCeEEEEE
Confidence 799999999999999999999999985421 1222344556777777665 69999999998843 35689999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
||+. ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~ 152 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---T 152 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---C
Confidence 9998 58999998888999999999999999999999999999999999999999999999999999875332221 1
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~-------------------- 211 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF-------------------- 211 (330)
T ss_pred ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc--------------------
Confidence 2456899999999998652 4588999999999999999999999987664332222210
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC----CHHHHhcCCCccCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP----TAEEALADPYFHGL 409 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp----ta~elL~Hp~f~~~ 409 (595)
.....+ ...+++.+.+||.+||..||.+|| ++.++++||||...
T Consensus 212 ------~~~~~~----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 212 ------GKVRFP----KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred ------CCCCCC----CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 000000 123578899999999999999998 79999999999764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=358.84 Aligned_cols=281 Identities=41% Similarity=0.695 Sum_probs=228.0
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lyl 194 (595)
|++.+.||.|++|.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++... ...|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-----~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-----NKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-----CeEEE
Confidence 6788999999999999999999999999999864433333345678899999999999999999998543 56899
Q ss_pred EEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 195 VFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 195 V~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
||||++++|.+++.... .+++..+..++.||++||.|||+.+++||||+|+|||++.++.++|+|||++........
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 99999989999987765 789999999999999999999999999999999999999999999999999975422211
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHH
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~ 352 (595)
......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+.+.+++|....+..+..
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 229 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS-- 229 (283)
T ss_pred --ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh--
Confidence 12334678999999987652 4578899999999999999999999999888888888888888887765443321
Q ss_pred HHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 353 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
...+...+............+..+..+.+||.+||+.||.+|||++|+++||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 112222222222223333456678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=369.24 Aligned_cols=250 Identities=27% Similarity=0.438 Sum_probs=202.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHH-HHHhcCCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
++||+|+||.||+|++..+|+.||+|++.+... .......+.+|+. +++.++||||+++++++.. ...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-----AEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCEEEEEE
Confidence 469999999999999999999999999864321 2223345566665 5788999999999988843 35689999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
|||+ ++|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---T 152 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---c
Confidence 9998 58888888888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-------------------- 210 (321)
T ss_pred cccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--------------------
Confidence 245689999999999876 6789999999999999999999999988764333222210
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH----HHHhcCCCccCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYFHGL 409 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta----~elL~Hp~f~~~ 409 (595)
.+.. ..+..+..+.+||.+||+.||.+|+++ .++++||||..+
T Consensus 211 --------~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 211 --------KPLQ---LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred --------CCCC---CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 0111 113457789999999999999999875 599999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=358.41 Aligned_cols=280 Identities=39% Similarity=0.726 Sum_probs=221.9
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcccEE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
|++.+.||+|+||.||+|.+..++..||+|+++....... .....+|+.+++.+. ||||+++++++... ....+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEE
Confidence 6789999999999999999999999999999875433322 234467999999885 99999999998543 224689
Q ss_pred EEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 194 VVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 194 lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
+||||++++|.+.+... ..+++..+..++.||+.||.|||+.||+||||||+||+++. +.+||+|||++........
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99999999998888764 57899999999999999999999999999999999999999 9999999999986543322
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHH
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~ 352 (595)
.....+++.|+|||++... ..++.++|||||||++|||++|.+||++.+..+.+..+...++.+............
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 2345789999999976542 457889999999999999999999999999888888888888887775533221111
Q ss_pred HHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 353 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
...+ .+.......+....+..+..+.+||.+||.+||.+||+++++|+||||
T Consensus 231 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccc--cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 000000111111224568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=369.43 Aligned_cols=250 Identities=28% Similarity=0.469 Sum_probs=203.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHH-HHHhcCCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.||+|+||+||+|++..+++.||+|++..... .......+..|.. +++.++||||+++++++.. ...+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----ADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-----CCeEEEEE
Confidence 469999999999999999999999999864221 1122334555554 4678999999999998843 35689999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~ 152 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---T 152 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---C
Confidence 9998 58999998888899999999999999999999999999999999999999999999999999975432221 1
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-------------------- 210 (325)
T ss_pred cccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--------------------
Confidence 245689999999999887 6789999999999999999999999988765443322211
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHH----HHhcCCCccCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE----EALADPYFHGL 409 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~----elL~Hp~f~~~ 409 (595)
.+. ...+.+++.+.+||.+||+.||.+|+++. ++++|+||..+
T Consensus 211 --------~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 211 --------KPL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred --------CCc---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 000 12245788899999999999999999875 89999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=367.43 Aligned_cols=258 Identities=22% Similarity=0.396 Sum_probs=204.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.||+|+||.||+|.+..+++.||||++++... .......+.+|+.++..+ .||+|+.+++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEEEEEE
Confidence 469999999999999999999999999975322 223456678899999888 59999999998843 35699999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---T 152 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---c
Confidence 9997 58988888888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....+||+.|+|||++.+ ..++.++|||||||++|||++|..||......... ...+.+. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~---------~~~~~~~--------~ 213 (327)
T cd05617 153 TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM---------NTEDYLF--------Q 213 (327)
T ss_pred eecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCccc---------ccHHHHH--------H
Confidence 245689999999999877 68899999999999999999999999643210000 0000000 0
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC------HHHHhcCCCccCCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT------AEEALADPYFHGLA 410 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt------a~elL~Hp~f~~~~ 410 (595)
.+. ..+..+ ...+++.+.+||.+||..||.+|++ ++++++||||..+.
T Consensus 214 ---~~~-~~~~~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 214 ---VIL-EKPIRI---PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred ---HHH-hCCCCC---CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 000 011111 1246788999999999999999998 57999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=371.01 Aligned_cols=283 Identities=23% Similarity=0.364 Sum_probs=214.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+++|+.++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCE
Confidence 368999999999999999999999999999999886432 22345678899999999999999999999854 346
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~-gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999997 58999998888899999999999999999999985 7999999999999999999999999998754322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHH-hhcCCCChhHHH--
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMT-DLLGTPSTESIS-- 346 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~-~~lg~p~~~~i~-- 346 (595)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+. ...+.+......
T Consensus 158 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred c-----cccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 1 234579999999999877 678999999999999999999999998765432222111 011111100000
Q ss_pred ---------HHhh-----HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 347 ---------RIRN-----EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 347 ---------~i~~-----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.... ..............+..+ .....+.++.+||.+||.+||.+|||++|++.||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000 000000000101111111 012357889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=359.52 Aligned_cols=286 Identities=38% Similarity=0.680 Sum_probs=223.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||.|+||.||+|.+..+++.||||+++...........+.+|+++|+.++|+||+++++++.. ...+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 37999999999999999999999999999999986543333445678899999999999999999999854 3468
Q ss_pred EEEEecccccHHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELMESDLHQV-IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~g~L~~~-i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+||||+++++... +.....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99999999765554 44456799999999999999999999999999999999999999999999999999976543322
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
.....+.++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.............
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred --ccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 123456889999999998762 37889999999999999999999999988887777777777666554332221100
Q ss_pred HHHHHhhhcccCCCCCCCCCCCC-CCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
....-........+..+...++. +++.+.+||++||..||++||+++++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00000000000001111112233 37889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=364.05 Aligned_cols=254 Identities=26% Similarity=0.441 Sum_probs=215.5
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
-|.++++||+|+||.||+|+++.+|..||||++.- ..+.+++.+||.||++++.|++|++|+.|+-. .++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-----sDLW 104 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-----SDLW 104 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccC-----CceE
Confidence 36778999999999999999999999999999853 46789999999999999999999999988543 4599
Q ss_pred EEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 194 VVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
||||||+ |+..++++. +++|+++++..+++..+.||+|||...-||||||..|||++.+|..||+|||.|..+.+...
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 9999999 788888874 56899999999999999999999999999999999999999999999999999976644333
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
+ ..+.+|||.|||||++.. -.|+.++||||||++..||.-|++||.+-.....+
T Consensus 185 K---RNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------------------- 238 (502)
T KOG0574|consen 185 K---RNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------------------- 238 (502)
T ss_pred h---hCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCccccccccee---------------------
Confidence 2 467899999999999987 68999999999999999999999999764432211
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..++.++| |-...-..++.++.|||++||.+.|++|.||-++++|||++.-
T Consensus 239 ------FMIPT~PP-PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 239 ------FMIPTKPP-PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred ------EeccCCCC-CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 11122222 2222334567889999999999999999999999999999864
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=361.90 Aligned_cols=287 Identities=40% Similarity=0.653 Sum_probs=218.2
Q ss_pred CeEEeeeeeecCceEEEEEEECC--CCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTH--TGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~--~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
+|++.+.||+|+||.||+|.+.. ++..||||.+.... ........+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 58999999999999999999988 89999999987532 1122345678899999999999999999998653 224
Q ss_pred cEEEEEecccccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC----CCcEEEcccC
Q 007629 191 DIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA----DCKLKICDFG 261 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~-----~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~----~~~vKL~DFG 261 (595)
.+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 69999999998888777532 26899999999999999999999999999999999999999 8999999999
Q ss_pred cceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChH---------HHHHH
Q 007629 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV---------HQLDL 332 (595)
Q Consensus 262 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~---------~~l~~ 332 (595)
++.................+|++|+|||++.+. ..++.++|||||||++|+|++|++||.+.... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 998653332212222345789999999987652 45789999999999999999999999866532 34555
Q ss_pred HHhhcCCCChhHHHHHhhHHHHHHhhhc--ccCCCCC------CCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCC
Q 007629 333 MTDLLGTPSTESISRIRNEKARRYLGSM--RKKQPVP------FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (595)
Q Consensus 333 i~~~lg~p~~~~i~~i~~~~~~~~l~~~--~~~~~~~------~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp 404 (595)
+...++.+........... ..+.... ......+ +...+...+..+.+||.+||..||++|||+.|+++||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~ 314 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKM--PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP 314 (316)
T ss_pred HHHHhCCCchhHHHHHhhc--ccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCC
Confidence 6666666655433222111 0111100 0000000 0011125678899999999999999999999999999
Q ss_pred Cc
Q 007629 405 YF 406 (595)
Q Consensus 405 ~f 406 (595)
||
T Consensus 315 ~f 316 (316)
T cd07842 315 YF 316 (316)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=350.35 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=209.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC---hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH---VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
+.|++.+.||+|+||.||+|.+..++..||+|.+...... ......+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-----D 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-----C
Confidence 4588999999999999999999999999999998643221 1234568889999999999999999999843 3
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||+++....
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 47999999998 58999998888899999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
............|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 221 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT------------- 221 (263)
T ss_pred cccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-------------
Confidence 2211111134578899999999987 5689999999999999999999999976543222111100
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
.... ......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 222 -------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 222 -------------QPTN---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -------------cCCC---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0000 01123467889999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=403.45 Aligned_cols=266 Identities=25% Similarity=0.396 Sum_probs=224.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|.|+++||+|+||.|.+++++.|++.||+|++++... ...+...|..|-.+|..-+.+-||.++-.| .+..
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence 5789999999999999999999999999999999976322 123456678888999999999999998777 5667
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
++|+|||||. |||..++...+.++++.+++|+..|+.||+-||+.|+|||||||+|||||..|+|||+|||.|-.+..+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 8999999998 699999998889999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccccccCCccccccccccc--C-CCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF--F-SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~--~-~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
. .+.....+|||.|.|||++... . +.|++.+|+||+||++||||.|..||..++..+..-.|..-
T Consensus 229 G--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h---------- 296 (1317)
T KOG0612|consen 229 G--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH---------- 296 (1317)
T ss_pred C--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch----------
Confidence 2 3345667999999999998532 2 56999999999999999999999999988876666555331
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC---HHHHhcCCCccCCCCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT---AEEALADPYFHGLANV 412 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt---a~elL~Hp~f~~~~~~ 412 (595)
+....|+ ....++..+++||+++|. +|..|.. ++++..||||.++.|.
T Consensus 297 ----------------k~~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 297 ----------------KESLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred ----------------hhhcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence 1112222 123489999999999998 8999998 9999999999998774
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=354.22 Aligned_cols=285 Identities=36% Similarity=0.628 Sum_probs=218.7
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 110 ~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
+...+|++.+.||+|+||.||+|.+..+|..||||.+..... ......+.+|+.+|+.++|+||+++++++.. .
T Consensus 2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~ 75 (291)
T cd07870 2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHT-----K 75 (291)
T ss_pred CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-----C
Confidence 345789999999999999999999999999999999864322 1223456789999999999999999998843 3
Q ss_pred ccEEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
...|+||||+.++|...+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 76 ETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred CeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 468999999998888777553 4688899999999999999999999999999999999999999999999999875322
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCC-hHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~-~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
... ......+++.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+ ..+++..+...+|.|.......
T Consensus 156 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 156 PSQ---TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CCC---CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence 111 12334679999999998652 457889999999999999999999998654 3456666667777776654333
Q ss_pred HhhHHHHHHhhh-cccCCCCCCCCCCC--CCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 348 IRNEKARRYLGS-MRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 348 i~~~~~~~~l~~-~~~~~~~~~~~~~~--~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
+.. ...+... .....+......+. ..++.+.+||.+||..||.+|||+.|++.||||
T Consensus 232 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 232 VSK--LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhh--cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 211 0011000 00111111111111 136789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=398.23 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=211.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
...+|++++.||+|+||+||+|.+..++..||+|++............+..|+.+|+.|+|||||+++++|.... ..
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~---~~ 87 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA---NQ 87 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC---CC
Confidence 456899999999999999999999999999999998754444455677899999999999999999999886432 34
Q ss_pred cEEEEEeccc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CeeecCCCCCceeeCC-------
Q 007629 191 DIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-------NVFHRDLKPKNILANA------- 251 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~-------gIiHrDLKP~NILl~~------- 251 (595)
.+||||||+. ++|.++|.. ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6899999998 589888865 35799999999999999999999985 4999999999999964
Q ss_pred ----------CCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCC
Q 007629 252 ----------DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321 (595)
Q Consensus 252 ----------~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF 321 (595)
.+.+||+|||++........ ....+||+.|+|||++.+....++.++||||||||||||++|..||
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccccc----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 23589999999976532211 2345799999999998653356889999999999999999999999
Q ss_pred CCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHh
Q 007629 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401 (595)
Q Consensus 322 ~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL 401 (595)
...+...++.... ...... .....++.+.+||.+||.++|.+||++.|+|
T Consensus 244 ~~~~~~~qli~~l--------------------------k~~p~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 244 HKANNFSQLISEL--------------------------KRGPDL----PIKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred CcCCcHHHHHHHH--------------------------hcCCCC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 7655433221110 000111 1234578899999999999999999999999
Q ss_pred cCCCccCC
Q 007629 402 ADPYFHGL 409 (595)
Q Consensus 402 ~Hp~f~~~ 409 (595)
.||||+.+
T Consensus 294 ~h~~ik~i 301 (1021)
T PTZ00266 294 GYQIIKNV 301 (1021)
T ss_pred ccHHHhhc
Confidence 99999754
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=353.04 Aligned_cols=282 Identities=48% Similarity=0.778 Sum_probs=231.9
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lyl 194 (595)
|++.+.||.|++|.||+|.+..+|+.||+|.+............+.+|+.+|+.++||||+++++++... ..+|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence 6778999999999999999999999999999875443334456788999999999999999999988543 56899
Q ss_pred EEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCc
Q 007629 195 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (595)
Q Consensus 195 V~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 273 (595)
||||++++|.+.+... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||.+.......
T Consensus 76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 9999999998888764 589999999999999999999999999999999999999999999999999997654332
Q ss_pred ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHH
Q 007629 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (595)
Q Consensus 274 ~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~ 353 (595)
.......++..|+|||.+.+. ..++.++|||||||++|+|++|++||++.+..+++..+...++.+..+.+..+..- .
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL-A 230 (283)
T ss_pred ccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh-h
Confidence 112345788999999998762 37889999999999999999999999999988888888888888776655443321 1
Q ss_pred HHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 354 ~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
......+............+.++..+.+||.+||.+||.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11111222222333334456678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=354.71 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=206.1
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
.|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++|++|+.+++.+.. ...+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-----CCEE
Confidence 37888999999999999999999999999999864322 22223457789999999999999999988843 3468
Q ss_pred EEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 193 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999997 5888887543 35899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+..........
T Consensus 156 ~~----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---------------- 213 (285)
T cd05630 156 QT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---------------- 213 (285)
T ss_pred cc----ccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH----------------
Confidence 21 133579999999999877 67899999999999999999999999764321100000
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGL 409 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~ 409 (595)
......... ......++.+.+||.+||+.||.+||| ++|+++||||+.+
T Consensus 214 ----~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 214 ----ERLVKEVQE-------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred ----Hhhhhhhhh-------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 000000000 112346788999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=380.88 Aligned_cols=257 Identities=23% Similarity=0.325 Sum_probs=209.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCC-CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHT-GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~-g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..|.+.+.||+|+||.||+|.+..+ +..||+|++.. ........+.+|+.+|+.++|||||++++++.. ...
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~ 139 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFKS-----DDK 139 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-----CCE
Confidence 3599999999999999999998877 78899997743 233445567889999999999999999999843 356
Q ss_pred EEEEEeccc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 192 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
+||||||+. ++|.+++.. ..++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999997 688877653 346899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
...... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 220 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~---------- 286 (478)
T PTZ00267 220 SDSVSL-DVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG---------- 286 (478)
T ss_pred CCcccc-ccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------
Confidence 432211 12345679999999999877 67999999999999999999999999876643333222110
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
...+ ....+++.+.+||.+||..||++||+++++|.|||++.+
T Consensus 287 ---------------~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 287 ---------------KYDP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred ---------------CCCC-----CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 0001 112467889999999999999999999999999999753
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=343.04 Aligned_cols=254 Identities=29% Similarity=0.468 Sum_probs=208.7
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
.|++++.||+|+||.||++.+..+++.||+|++............+.+|+.+++.++||||+++++.+... ...+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE----DGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC----CCEEE
Confidence 48999999999999999999999999999999865433444556788999999999999999998876322 23589
Q ss_pred EEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 194 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+||||+. ++|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999998 5888888753 468999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd08223 157 D---MASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--------------- 216 (257)
T ss_pred C---ccccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---------------
Confidence 1 1244578999999999877 6788999999999999999999999987654332221110
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
...+ ......++.+.+||.+||..||.+||++.++++||||
T Consensus 217 -----------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 217 -----------GKLP----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -----------cCCC----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 1113467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=366.45 Aligned_cols=262 Identities=28% Similarity=0.447 Sum_probs=206.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~ 190 (595)
...|+++++||+||.+.||++... ....||+|++.....+......+..||.+|.+|+ |.+||+|+++-+.. .
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d-----~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD-----G 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC-----c
Confidence 457999999999999999999754 4567888887665566677888999999999996 99999999988653 5
Q ss_pred cEEEEEecccccHHHHHHhcCCCCH-HHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTP-EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~-~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
++||||||-+.||..+|++.....+ -.+++|.+|||.|+.++|.+||||.||||.|+|+- +|.+||+|||+|.....+
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred eEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 6999999999999999987754333 48899999999999999999999999999999984 789999999999877655
Q ss_pred CCCcccccccccCCcccccccccccCC---------CCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCC
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFS---------KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~---------~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p 340 (595)
. +.+.....+||+.|||||.+..... +.+.++||||||||||+|+.|++||..- ..+++.+..+ ..|
T Consensus 513 T-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--~n~~aKl~aI-~~P 588 (677)
T KOG0596|consen 513 T-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--INQIAKLHAI-TDP 588 (677)
T ss_pred c-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--HHHHHHHHhh-cCC
Confidence 4 3444567799999999998754211 2567899999999999999999999531 1122221111 011
Q ss_pred ChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 341 ~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
...++|...-+ ..+++++++.||..||++||++.|+|+|||++.
T Consensus 589 ----------------------~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 589 ----------------------NHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ----------------------CccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 11112211111 123999999999999999999999999999975
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=356.28 Aligned_cols=283 Identities=24% Similarity=0.378 Sum_probs=213.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||+|+||.||+|.+..++..||+|.++... .......+.+|+++++.++||||+++++++.. ...+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEE
Confidence 36999999999999999999999999999999986432 22334568899999999999999999999844 3569
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999998 5899999888889999999999999999999998 699999999999999999999999999987543221
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhH------
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES------ 344 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~------ 344 (595)
....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+...........
T Consensus 155 -----~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred -----cccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence 234578999999999876 5788999999999999999999999987653332222211100000000
Q ss_pred ---HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 345 ---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 345 ---i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
....................+. ......+++.+.+||.+||.+||++|||+.++++||||....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPP--KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCc--cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 0000000000001111111110 111123678899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=362.89 Aligned_cols=286 Identities=23% Similarity=0.320 Sum_probs=205.9
Q ss_pred Eeeeeeec--CceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEE
Q 007629 117 IQEVIGKG--SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 117 i~~~LG~G--~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lyl 194 (595)
++++||+| +||+||++.++.+|+.||||++............+.+|+.+++.++||||+++++++... ..+|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence 56789999 788999999999999999999975433333455677899999999999999999998543 46899
Q ss_pred EEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 195 VFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 195 V~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
||||++ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999998 5888888653 4689999999999999999999999999999999999999999999999987643321111
Q ss_pred Cc----ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh-hHHH
Q 007629 272 SA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST-ESIS 346 (595)
Q Consensus 272 ~~----~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~-~~i~ 346 (595)
.. .......++..|+|||++.+....|+.++|||||||++|||++|+.||............ ..+..+. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--LNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH--hcCCcccccccc
Confidence 00 001123577889999998753346899999999999999999999999865543322211 1111110 0000
Q ss_pred HHhhHHHHHHh------hhccc----------CCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 347 RIRNEKARRYL------GSMRK----------KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 347 ~i~~~~~~~~l------~~~~~----------~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.+..+...... ..+.. ............+++.+.+||.+||+.||++|||++|+|+||||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00000000000 00000 00000011223457889999999999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=355.03 Aligned_cols=289 Identities=38% Similarity=0.647 Sum_probs=227.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC-----c
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-----R 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~ 186 (595)
.++|++.+.||+|+||.||+|.+..+|+.||||+++...........+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 46799999999999999999999999999999998643322233456778999999999999999999886543 1
Q ss_pred cCcccEEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 187 REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 187 ~~~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
.+...+|+||||+++++...+... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 123479999999999888877754 4689999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...... .......++..|+|||++.+. ..++.++|||||||++|+|++|++||...+....+..+....+.+....+
T Consensus 166 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 166 YNSEES--RPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred ccCCcc--cccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 543321 112234568889999987652 45788999999999999999999999998888888888888877765443
Q ss_pred HHHhhHHHHHHhhhcccC--CCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 346 SRIRNEKARRYLGSMRKK--QPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
..+.... +....... ....+...+..+++.+.+||.+||..||.+||++.+++.||||
T Consensus 243 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLP---YFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccc---cccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 3221100 00000000 0011222344568889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=361.82 Aligned_cols=290 Identities=39% Similarity=0.606 Sum_probs=228.5
Q ss_pred CCCeEE-eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChh------------hHHHHHHHHHHHHhcCCCceeeee
Q 007629 112 ASRYQI-QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS------------DATRILREIKLLRLLRHPDIVEIK 178 (595)
Q Consensus 112 ~~~Y~i-~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~------------~~~~~~~Ei~il~~l~HpnIv~l~ 178 (595)
.++|.. .+.||.|+||+||+|.+..+++.||||++........ ....+.+|+.+++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 457764 5779999999999999999999999999864322110 012467899999999999999999
Q ss_pred eeecCCCccCcccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEc
Q 007629 179 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258 (595)
Q Consensus 179 ~~~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~ 258 (595)
+++.. ...+|+||||+.++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 87 ~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 87 DVYVE-----GDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEEec-----CCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEEC
Confidence 99854 3468999999999999999888889999999999999999999999999999999999999999999999
Q ss_pred ccCcceeccCCC-----------CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChH
Q 007629 259 DFGLARVSFNDA-----------PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327 (595)
Q Consensus 259 DFGla~~~~~~~-----------~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~ 327 (595)
|||++....... ..........+++.|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999997654111 001112334678899999998653 45788999999999999999999999999988
Q ss_pred HHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 328 ~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
+++..+...++.|....+...... ..+ .......+..+...++..+..+.+||.+||..||.+|||++|+|.||||+
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKL--PLY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhc--ccc-cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 888888888888766543321100 000 00111112222333456688899999999999999999999999999998
Q ss_pred CCC
Q 007629 408 GLA 410 (595)
Q Consensus 408 ~~~ 410 (595)
...
T Consensus 318 ~~~ 320 (335)
T PTZ00024 318 SDP 320 (335)
T ss_pred CCC
Confidence 653
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=352.65 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=199.7
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEecc
Q 007629 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 199 (595)
Q Consensus 121 LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~ 199 (595)
||+|+||.||++.++.+|+.||+|++..... .......+..|+.+|+.++||||+++++++.. ...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-----KTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-----CCeEEEEEecC
Confidence 7999999999999999999999999864221 11223445679999999999999999998843 35689999999
Q ss_pred c-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccc
Q 007629 200 E-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (595)
Q Consensus 200 ~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 276 (595)
. ++|..++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++........ .
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~----~ 151 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT----I 151 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----e
Confidence 7 58887775543 588899999999999999999999999999999999999999999999999976533221 2
Q ss_pred cccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHH
Q 007629 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356 (595)
Q Consensus 277 ~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~ 356 (595)
....||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.........+. ...
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~-------------------~~~ 210 (277)
T cd05607 152 TQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK-------------------RRT 210 (277)
T ss_pred eccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH-------------------HHh
Confidence 34578999999999877 569999999999999999999999997643211100000 000
Q ss_pred hhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH----HHHhcCCCccCCCC
Q 007629 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYFHGLAN 411 (595)
Q Consensus 357 l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta----~elL~Hp~f~~~~~ 411 (595)
+ ... .......+++.+.+||.+||++||.+||++ ++++.||||+.+..
T Consensus 211 ~---~~~----~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 211 L---EDE----VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred h---ccc----cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 0 000 011123568889999999999999999999 77889999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=350.89 Aligned_cols=281 Identities=43% Similarity=0.736 Sum_probs=232.1
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lyl 194 (595)
|++.+.||+|+||.||+|.+..+++.||+|++............+..|+.+++.++|+||+++++++... ..+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence 6778999999999999999999999999999875433333456678899999999999999999988543 56899
Q ss_pred EEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCc
Q 007629 195 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (595)
Q Consensus 195 V~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 273 (595)
||||++++|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++........
T Consensus 76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 9999999999999876 5799999999999999999999999999999999999999999999999999976533221
Q ss_pred ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHH
Q 007629 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (595)
Q Consensus 274 ~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~ 353 (595)
......++..|+|||.+.+. ..++.++|||||||++|||++|.+||.+.+....+..+...++.+....+..+....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP- 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-
Confidence 12334678899999998662 478899999999999999999999999999888888888888888776655443221
Q ss_pred HHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 354 ~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
.+...+...........++..+..+.+||.+||..||++||++++++.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 -DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred -cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1111222222233334456678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=362.48 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=198.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~-----~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 185 (595)
.++|++.++||+|+||.||+|.+ ..++..||||+++.. ........+.+|+.+|+.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 35899999999999999999975 245678999998643 2233456788999999999 899999999987532
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhc------------------------------------------------------
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 210 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 210 (595)
...+|+||||++ |+|.+++...
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 235899999998 6898888642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccC
Q 007629 211 --------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282 (595)
Q Consensus 211 --------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT 282 (595)
..+++..+..++.||++||.|||+.||+||||||+|||++.++.+||+|||+++....... ........++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~ 239 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLP 239 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCC
Confidence 2477888899999999999999999999999999999999999999999999986533221 1111234567
Q ss_pred CcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcc
Q 007629 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMR 361 (595)
Q Consensus 283 ~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~ 361 (595)
+.|+|||++.+ ..++.++|||||||++|||++ |..||.+......+.... .
T Consensus 240 ~~y~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~--------------------------~ 291 (338)
T cd05102 240 LKWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL--------------------------K 291 (338)
T ss_pred ccccCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH--------------------------h
Confidence 88999999876 678999999999999999997 999998754322111100 0
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 362 KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..... ......++.+.+||.+||..||.+|||+.|+++
T Consensus 292 ~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 292 DGTRM---RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred cCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00000 011346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=350.42 Aligned_cols=283 Identities=40% Similarity=0.695 Sum_probs=225.7
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lyl 194 (595)
|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++.... ...+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 67899999999999999999999999999999754323334566789999999999999999999985431 256999
Q ss_pred EEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCc
Q 007629 195 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (595)
Q Consensus 195 V~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 273 (595)
||||++++|..++... ..+++..++.++.||+.||+|||+.|++|+||||+|||++.++.+||+|||++........
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9999999999888765 5799999999999999999999999999999999999999999999999999986544321
Q ss_pred ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHH
Q 007629 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (595)
Q Consensus 274 ~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~ 353 (595)
...+...++..|+|||.+.+. ..++.++|||||||++|||++|+.||...+....+..+.+..+.+....+..+....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP- 233 (287)
T ss_pred ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch-
Confidence 112344678899999987652 467899999999999999999999999999888888888887777655443221110
Q ss_pred HHHhhhcccCC--CCCCCCCCCC-CCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 354 RRYLGSMRKKQ--PVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 354 ~~~l~~~~~~~--~~~~~~~~~~-~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
+........ +..+...+.. .++.+.++|.+||..||.+||+++++++||||
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 --WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred --hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 000000000 0011122233 37889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=348.28 Aligned_cols=277 Identities=26% Similarity=0.398 Sum_probs=218.6
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcccEEEEE
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
.+.||+|+|+.|-.|....+|..||||+|.+.. .....++.+|++++..++ |+||+.++++| ++...+||||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYLVf 155 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYLVF 155 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEEEE
Confidence 368999999999999999999999999997642 234678999999999986 99999999999 5556799999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc---EEEcccCcceeccCCC--
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVSFNDA-- 270 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~---vKL~DFGla~~~~~~~-- 270 (595)
|-|. |.|+..|.+...|++.++..++..|+.||+|||.+||.||||||+|||-....+ ||||||.|+.......
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9998 589999999999999999999999999999999999999999999999766544 8999999875432111
Q ss_pred --CCcccccccccCCcccccccc---cccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 271 --PSAIFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 271 --~~~~~~~~~~gT~~Y~APE~l---~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
.....+.+.+|+..|||||+. .+....|+.++|.||||||+|-||.|.+||.|....+- -+--|.+..
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC----GWdrGe~Cr--- 308 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC----GWDRGEVCR--- 308 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC----CccCCCccH---
Confidence 122234567899999999975 33345699999999999999999999999988653110 000111111
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~ 413 (595)
.... .++..+....-......|..++.+++|||..+|..|+.+|.++.++|+|||++......
T Consensus 309 --~CQ~---~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek 371 (463)
T KOG0607|consen 309 --VCQN---KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK 371 (463)
T ss_pred --HHHH---HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence 1111 12233333333344566788899999999999999999999999999999998766543
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=350.14 Aligned_cols=258 Identities=26% Similarity=0.387 Sum_probs=207.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
.|++.+.||+|+||+||+|.+..+++.||+|.+..... .......+.+|+.+|+.++|++|+.+++++.. ...+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-----CCEE
Confidence 37888999999999999999999999999999864321 12233457789999999999999999988844 3468
Q ss_pred EEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 193 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
|+||||+. ++|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999998 5787777543 36999999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
. ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+....
T Consensus 156 ~----~~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~------------ 217 (285)
T cd05632 156 E----SIRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV------------ 217 (285)
T ss_pred C----cccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh------------
Confidence 1 1234579999999999876 678999999999999999999999998765433222221100
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGL 409 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~ 409 (595)
.... ....+..++.+.+|+.+||..||++||+ +.+++.|+||+..
T Consensus 218 -----------~~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 218 -----------LETE----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred -----------hccc----cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 0000 0112346778999999999999999999 8999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=348.25 Aligned_cols=282 Identities=39% Similarity=0.649 Sum_probs=221.9
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc---CCCceeeeeeeecCCCccCccc
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
|++.+.||.|+||.||+|.+..++..||||+++...........+.+|+.+++.+ .||||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6889999999999999999988999999999964333333344566788877766 5999999999987654334445
Q ss_pred EEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|++|||+.++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 89999999999988887643 5899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. .....++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....+....
T Consensus 161 ~~----~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 161 MA----LTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred cc----cccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 21 233468899999999877 678899999999999999999999999988888777777666554432221110
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
... ........+..+....+..++.+.+||.+||..||.+||++.+++.||||
T Consensus 235 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLP----RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccc----hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000 00111122222333345567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=364.64 Aligned_cols=256 Identities=28% Similarity=0.418 Sum_probs=212.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
-..|.-++.||.|+||.||-|++..+.+.||||++...... ......+++||.+|+.|+|||+|.+.++|+-..
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~----- 99 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH----- 99 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-----
Confidence 34577789999999999999999999999999999754332 334578999999999999999999999997543
Q ss_pred cEEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
..|+|||||-|+-.+++.-. +++-+.++..|..+.+.||.|||+.+.||||||..|||+.+.|.|||+|||.|.....
T Consensus 100 TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 100 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred hHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 47999999988655555432 5799999999999999999999999999999999999999999999999999976432
Q ss_pred CCCcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
..+++|||+|||||+++.. .+.|+-++|||||||+..||.-.+||+-..+....+.-|..
T Consensus 179 ------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ------------- 239 (948)
T KOG0577|consen 179 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------- 239 (948)
T ss_pred ------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh-------------
Confidence 2568999999999998653 25799999999999999999999999877665554443321
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
...|.-- -+.++..++.|+..||++-|.+|||++++|+|+|+..
T Consensus 240 -------------NesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 240 -------------NESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred -------------cCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 1111111 2456778999999999999999999999999999863
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=339.74 Aligned_cols=253 Identities=27% Similarity=0.433 Sum_probs=209.7
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|.+.+.||+|+||.||+|.+..++..||+|.+............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEE
Confidence 48899999999999999999999999999999864433445667788999999999999999999988543 4689
Q ss_pred EEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 194 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999997 5899988764 578999999999999999999999999999999999999999999999999988654322
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08529 156 N---FANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--------------- 215 (256)
T ss_pred c---hhhccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 1234578999999999877 5788999999999999999999999987664332221111
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
....+ ....+++.+.++|.+||+.+|++||++.++++|||+
T Consensus 216 ------------~~~~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 216 ------------GVFPP---VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ------------CCCCC---CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 00001 111457789999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=365.37 Aligned_cols=261 Identities=27% Similarity=0.474 Sum_probs=222.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
...-|.+.+.||+|.|++|.+|++..++..||||.|.+..-+......+.+|+++|+.|+|||||+++.++.. ..
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-----~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-----EA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-----cc
Confidence 3567999999999999999999999999999999998876666666778999999999999999999999944 35
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||+. |++++++.+++...+..++.++.|+++|++|||+++|||||||++|||++.+.++||+|||++..+...
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 6999999987 799999999999999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
....++||++.|.|||++.+. ..-++.+|+||+|++||.|+.|..||.|.+....-..
T Consensus 209 ----~~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r----------------- 266 (596)
T KOG0586|consen 209 ----LMLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR----------------- 266 (596)
T ss_pred ----ccccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccch-----------------
Confidence 235778999999999999884 3456899999999999999999999998763221100
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~ 412 (595)
.+..+..+++ .++.++.+||+++|.++|.+|++.+++..|.|.......
T Consensus 267 ---------vl~gk~rIp~-----~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 267 ---------VLRGKYRIPF-----YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred ---------heeeeecccc-----eeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 0111122222 245678999999999999999999999999999765544
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=346.68 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=206.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.+++.++||||+++++++.. ...
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~ 80 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDK 80 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCE
Confidence 35799999999999999999999999999999998643 22344567889999999999999999998843 356
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 899999998 5899999888899999999999999999999999999999999999999999999999999987553222
Q ss_pred CCcccccccccCCcccccccccc-cCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~-~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
. ......||+.|+|||++.. ....++.++|||||||++|+|++|.+||........+..+..
T Consensus 161 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~-------------- 223 (267)
T cd06645 161 A---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-------------- 223 (267)
T ss_pred c---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc--------------
Confidence 1 1234579999999998742 124588899999999999999999999865443221111100
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~ 405 (595)
....+..+ .....++..+.+||.+||..||++||+++++++|||
T Consensus 224 -----------~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 224 -----------SNFQPPKL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -----------cCCCCCcc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00001011 111235678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=348.81 Aligned_cols=254 Identities=27% Similarity=0.467 Sum_probs=212.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+++|+.+.||||+++++++.. ...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-----DSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCe
Confidence 36999999999999999999999999999999986422 122345678899999999999999999999843 356
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++......
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 899999995 789999988889999999999999999999999999999999999999999999999999999865433
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
.....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 212 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--------------- 212 (290)
T ss_pred -----CCCCCCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------
Confidence 134578999999999876 5788899999999999999999999987663322222110
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~~ 410 (595)
... .+ ....++.+.++|.+||..||.+|+ +++|+++||||..+.
T Consensus 213 -----------~~~--~~---~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 213 -----------GKV--RF---PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -----------CCc--cC---CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 000 11 123478899999999999999999 999999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=343.84 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=205.1
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC---ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++... ...
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CCC
Confidence 58899999999999999999999999999999864322 123345688999999999999999999987432 224
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|++|||+. ++|.+++...+.+++..++.++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 6899999998 589999988788999999999999999999999999999999999999999999999999998754321
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
...........++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+. .
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~---~----------- 223 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA---T----------- 223 (266)
T ss_pred cccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh---c-----------
Confidence 111111233568899999999876 678899999999999999999999997643222111110 0
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
.... + ..-...++.+.+|| +||..||++||+++|+++||||+
T Consensus 224 ----------~~~~-~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 224 ----------QPTN-P----QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ----------CCCC-C----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0000 0 01123567788999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=334.31 Aligned_cols=289 Identities=30% Similarity=0.608 Sum_probs=235.5
Q ss_pred ccccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCC
Q 007629 106 FTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPP 184 (595)
Q Consensus 106 ~~~~~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 184 (595)
..++|..++|++.+++|+|-|+.||.|++..+++.++||+++. -..+.+.+||+||..|. ||||++++++..++
T Consensus 31 ~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp 105 (338)
T KOG0668|consen 31 VIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDP 105 (338)
T ss_pred eeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCc
Confidence 3467889999999999999999999999999999999999864 23567899999999998 99999999998765
Q ss_pred CccCcccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC-CcEEEcccCc
Q 007629 185 SRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGL 262 (595)
Q Consensus 185 ~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~-~~vKL~DFGl 262 (595)
.. ....+|+||.+. +...+. ..|+.-.++++++||+.||.|||++||+|||+||.|++||.. -.++|+|||+
T Consensus 106 ~S---ktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 106 ES---KTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred cc---cCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecch
Confidence 43 457899999985 555444 358899999999999999999999999999999999999975 4699999999
Q ss_pred ceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCC-CCCCCCChHHHHHHHHhhcCCCC
Q 007629 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPS 341 (595)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~-~pF~~~~~~~~l~~i~~~lg~p~ 341 (595)
|.++.....- .-.+.++.|--||++... ..|+..-|+|||||+|+.|+..+ |.|.|.+..+|+..|.+.+|+..
T Consensus 180 AEFYHp~~eY----nVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e 254 (338)
T KOG0668|consen 180 AEFYHPGKEY----NVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE 254 (338)
T ss_pred HhhcCCCcee----eeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence 9987665442 345789999999998874 78999999999999999999987 45678999999999999999854
Q ss_pred hh-HHHHHhhHHHHHHhhhcccCCCCCCCCCCC-----CCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 342 TE-SISRIRNEKARRYLGSMRKKQPVPFSHKFP-----NADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 342 ~~-~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~-----~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
.. .+.+..-.-.++|-..+......+|....+ -++|+++|||.++|..|-.+|+||.|++.||||..+.
T Consensus 255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 32 223322222233333344444444443322 3579999999999999999999999999999997543
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=344.70 Aligned_cols=260 Identities=24% Similarity=0.416 Sum_probs=206.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCcc-Cc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRR-EF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~-~~ 189 (595)
.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ +||||+++++++...... ..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 457899999999999999999999999999999986432 2345678899999998 699999999998654321 13
Q ss_pred ccEEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 190 KDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
..+|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999998 5888888763 36899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCCccccccccccc---CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
..... ......|++.|+|||++.+. ...|+.++|||||||++|||++|..||...........+.
T Consensus 162 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~--------- 229 (272)
T cd06637 162 DRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------- 229 (272)
T ss_pred ccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh---------
Confidence 32221 12446799999999998531 1458889999999999999999999996543221111100
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
..... ......++..+.+||.+||..||.+|||+.++++||||
T Consensus 230 ------------------~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 230 ------------------RNPAP--RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ------------------cCCCC--CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00000 01122457789999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=372.23 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=212.6
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..+-|+|+..||.|+||.||+|..+.++-..|.|+|.- ....+...++-||.||..+.||+||+|++.|+.. +
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----n 102 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----N 102 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----C
Confidence 34567889999999999999999999999999999853 3345678889999999999999999999998654 4
Q ss_pred cEEEEEecccccHHHHH-Hh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 191 DIYVVFELMESDLHQVI-KA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i-~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.+||+.|||+|+--+.| .. ...|++.+++.+++|++.||.|||+++|||||||..|||++-+|.|+|+|||.+.....
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh
Confidence 59999999997644433 33 45799999999999999999999999999999999999999999999999998864322
Q ss_pred CCCCcccccccccCCccccccccccc---CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
. ......++|||+|||||+.... ..+|++++||||||++|.||..+.||-..-+....+-.|.+-
T Consensus 183 t---~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--------- 250 (1187)
T KOG0579|consen 183 T---RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--------- 250 (1187)
T ss_pred H---HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---------
Confidence 1 1223568999999999986432 367999999999999999999999998777765554444321
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.|..+ -....++..+.|||.+||.+||..||++.++|+||||+..
T Consensus 251 ------------------ePPTL-lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 251 ------------------EPPTL-LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred ------------------CCCcc-cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 11111 0112346679999999999999999999999999999864
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=350.47 Aligned_cols=263 Identities=27% Similarity=0.433 Sum_probs=212.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.+|++.+.||+|+||.||+|.+..+++.||||.+...... ......+..|+.+++.++||||+++++.+. ....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ-----TETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee-----cCCE
Confidence 3699999999999999999999999999999998653222 234567889999999999999999999884 3456
Q ss_pred EEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 899999997 5898888754 4689999999999999999999999999999999999999999999999999875422
Q ss_pred CCCC--------------------------cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCC
Q 007629 269 DAPS--------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP 322 (595)
Q Consensus 269 ~~~~--------------------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~ 322 (595)
.... .......+||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 1110 001123578999999999877 578899999999999999999999998
Q ss_pred CCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC----HH
Q 007629 323 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT----AE 398 (595)
Q Consensus 323 ~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt----a~ 398 (595)
+.+....+..+.. .. ..+. .....++.+.+||.+||..||++||+ ++
T Consensus 234 ~~~~~~~~~~~~~--------------------------~~--~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 234 GSNRDETFSNILK--------------------------KE--VTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCchHHHHHHHhc--------------------------CC--ccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 7764333222110 00 0111 11226788999999999999999999 99
Q ss_pred HHhcCCCccCCCC
Q 007629 399 EALADPYFHGLAN 411 (595)
Q Consensus 399 elL~Hp~f~~~~~ 411 (595)
|+|.||||++..+
T Consensus 285 ~ll~~~~~~~~~~ 297 (316)
T cd05574 285 EIKQHPFFRGVNW 297 (316)
T ss_pred HHHcCchhhcCCh
Confidence 9999999988654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=345.51 Aligned_cols=262 Identities=24% Similarity=0.396 Sum_probs=209.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.+.|++++.||.|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 83 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GK 83 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----Ce
Confidence 46799999999999999999999999999999998642 334566788999999999999999999988433 46
Q ss_pred EEEEEecccc-cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~g-~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||+++ +|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 8999999985 56666644 457899999999999999999999999999999999999999999999999998753222
Q ss_pred CCCcccccccccCCccccccccccc---CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~---~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
.. ......+++.|+|||++.+. ...++.++|||||||++|+|++|.+||...+.......+..
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~----------- 229 (292)
T cd06644 164 LQ---RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK----------- 229 (292)
T ss_pred cc---ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc-----------
Confidence 11 12345788999999987531 14578899999999999999999999976553222111110
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
... +.......++..+.+||.+||..||++||+++++++||||..+..
T Consensus 230 ---------------~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 230 ---------------SEP--PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred ---------------CCC--ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 000 001112345778999999999999999999999999999986543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=344.21 Aligned_cols=280 Identities=41% Similarity=0.721 Sum_probs=224.9
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcccEE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
|++.+.||.|+||+||+|....+++.||||++...... .......+|+..++.++ ||||+++++++.. ....|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEE
Confidence 67899999999999999999989999999998654332 22334567999999999 9999999998854 45689
Q ss_pred EEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 194 VVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 194 lV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
+||||++++|.+.+.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 999999999999887764 789999999999999999999999999999999999999999999999999986533221
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
.....++..|+|||++.+. ..++.++|+||||+++++|++|++||++....+++..+...++.+....+......
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 ----YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ----cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 2446789999999987542 56789999999999999999999999999988888888888888876543321100
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
....-..+....+......++..++.+.+||.+||..||.+|||+.|++.||||
T Consensus 230 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 -ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred -hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000000111111112223344557889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=338.77 Aligned_cols=262 Identities=26% Similarity=0.431 Sum_probs=210.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||.|+||+||+|....++..||+|++...... .....+.+|+.+|+.++|+||+++++.+.. ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ-TSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc-hHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEE
Confidence 3699999999999999999999889999999998643222 256778999999999999999999998843 3568
Q ss_pred EEEEeccc-ccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 193 YVVFELME-SDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~---~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
|+|||++. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999998 5888888764 3589999999999999999999999999999999999999999999999999976544
Q ss_pred CCCCc-ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
..... ......+|+..|+|||++... ..++.++|+|||||++|+|++|+.||...+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~------------ 221 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ------------ 221 (267)
T ss_pred CccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc------------
Confidence 32211 112345789999999998763 3688999999999999999999999976543221111110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
. ..........+...++.+.+||.+||..||.+||++.++++||||
T Consensus 222 -----------~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 222 -----------N--DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -----------C--CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0 000111111234677889999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=347.47 Aligned_cols=259 Identities=29% Similarity=0.510 Sum_probs=211.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
...+|++.+.||.|+||.||+|.+..+|+.||||.+... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 89 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GD 89 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----Cc
Confidence 346799999999999999999999999999999998642 22345678899999999999999999998853 34
Q ss_pred cEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||+.+ +|..++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 68999999984 77777754 46999999999999999999999999999999999999999999999999998754332
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
... .....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+... +
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~----------- 231 (296)
T cd06655 169 QSK---RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-G----------- 231 (296)
T ss_pred ccc---CCCcCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-C-----------
Confidence 211 234578999999999876 57889999999999999999999999877654333222110 0
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
.+.......+++.+.+||.+||..||.+||++.+++.||||+...
T Consensus 232 ----------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 232 ----------------TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred ----------------CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 000112235678899999999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=342.77 Aligned_cols=258 Identities=26% Similarity=0.394 Sum_probs=205.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|++.+.||+|+||.||+|.+..++..||+|++... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~ 80 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REK 80 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCE
Confidence 45799999999999999999999999999999998642 22334567889999999999999999998843 346
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 899999998 5898888877889999999999999999999999999999999999999999999999999998653222
Q ss_pred CCcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. .....|++.|+|||.+.+. ...++.++|||||||++|||++|+.||...........+..
T Consensus 161 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~-------------- 223 (267)
T cd06646 161 AK---RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK-------------- 223 (267)
T ss_pred cc---cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec--------------
Confidence 11 2345789999999987431 24578899999999999999999999865432111110000
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~ 405 (595)
.....+.......++..+.+||.+||..||.+|||++++|+|+|
T Consensus 224 ------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 ------------SNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ------------CCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00000001112346788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=340.60 Aligned_cols=256 Identities=29% Similarity=0.491 Sum_probs=206.8
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh-------hhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-------SDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
+|.+...||.|+||.||+|.+..++..||+|.+....... ...+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 4788899999999999999999899999999886432221 123567889999999999999999998843
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 187 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
....|+||||++ ++|..++...+.+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||+++.
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 356899999997 58999998888899999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCc---ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 266 SFNDAPSA---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 266 ~~~~~~~~---~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
........ .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-------
Confidence 54221111 11123468899999999876 5788999999999999999999999986543222111100
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
.. . .......+..+.+||++||+.||.+||++.++++||||
T Consensus 227 ----------------~~---~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 227 ----------------NA---S----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ----------------cC---C----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 00 0 01113457789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=378.47 Aligned_cols=287 Identities=24% Similarity=0.286 Sum_probs=203.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC-CcEEEEEEe--------------cC-ccCChhhHHHHHHHHHHHHhcCCCcee
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHT-GERVAIKKI--------------ND-VFEHVSDATRILREIKLLRLLRHPDIV 175 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~-g~~vAIK~i--------------~~-~~~~~~~~~~~~~Ei~il~~l~HpnIv 175 (595)
..+|++++.||+|+||+||+|..+.. +..+++|.+ .+ ..........+.+|+.+|+.++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 46899999999999999999876432 222222211 11 111122345678999999999999999
Q ss_pred eeeeeecCCCccCcccEEEEEecccccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC
Q 007629 176 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (595)
Q Consensus 176 ~l~~~~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~-----~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~ 250 (595)
++++++.. ....|+|+|++.++|..++.... ......++.|+.||+.||.|||++|||||||||+|||++
T Consensus 227 ~l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 99999843 34689999999998888775432 234567888999999999999999999999999999999
Q ss_pred CCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCC-CCCC--ChH
Q 007629 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGK--NVV 327 (595)
Q Consensus 251 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~p-F~~~--~~~ 327 (595)
.++.+||+|||+++....... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|..+ |.+. ...
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999986543221 11234689999999999987 6799999999999999999998854 4322 344
Q ss_pred HHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcc-cCCCCCCCCC--CCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCC
Q 007629 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMR-KKQPVPFSHK--FPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (595)
Q Consensus 328 ~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~-~~~~~~~~~~--~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp 404 (595)
.++..+...++.+..+.... ..+...++.... ...+..+... ....+..+.++|.+||.+||.+|||+.|+|+||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDP--PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHhcccChhhcCCc--HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 55555555554433221110 011111211110 0011111111 113566789999999999999999999999999
Q ss_pred CccCC
Q 007629 405 YFHGL 409 (595)
Q Consensus 405 ~f~~~ 409 (595)
||...
T Consensus 456 ~f~~~ 460 (501)
T PHA03210 456 LFSAE 460 (501)
T ss_pred hhhcC
Confidence 99753
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=338.46 Aligned_cols=260 Identities=27% Similarity=0.456 Sum_probs=206.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC---ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
..|++.+.||+|+||.||+|.+..+|..||||++..... .......+.+|+.+++.+.||||+++++++.... .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence 469999999999999999999999999999998853221 1234567888999999999999999999874321 2
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+|+||||++ ++|.+++.....+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++.....
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 45889999998 58999988877899999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
............|+..|+|||++.+ ..++.++|||||||++|+|++|+.||........+..+ ...+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~-------- 225 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI---ATQP-------- 225 (265)
T ss_pred ccccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH---hcCC--------
Confidence 2111111234568999999999876 57889999999999999999999999764432221111 0000
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
..+ ...+..+..+.++|.+||. +|++||+++|+++|||+.
T Consensus 226 --------------~~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 226 --------------TNP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred --------------CCC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 000 1112456778999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.36 Aligned_cols=253 Identities=28% Similarity=0.483 Sum_probs=211.2
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++++.||.|+||.||.+.+..++..|++|++............+.+|+.+|+.++|+||+++++++.. ...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence 5999999999999999999999999999999986544344556678899999999999999999999854 35689
Q ss_pred EEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 194 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999998 5899988765 468999999999999999999999999999999999999999999999999998653332
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.. +
T Consensus 156 ~---~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~------------ 216 (256)
T cd08221 156 S---MAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--G------------ 216 (256)
T ss_pred c---cccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--C------------
Confidence 1 1244678999999999877 5688899999999999999999999987664333322211 0
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
. .. .....++..+.+||.+||..||.+||++.++|+|||+
T Consensus 217 ------------~-~~---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 217 ------------N-YT---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ------------C-CC---CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0 00 1114567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=341.93 Aligned_cols=258 Identities=24% Similarity=0.441 Sum_probs=202.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHH-HHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKL-LRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++.+.||+|+||.||+|.+..+|+.||||+++...... ....+..|+.+ ++.+.||||+++++++.. ...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCc
Confidence 36899999999999999999999999999999987543322 33456667765 677789999999999853 345
Q ss_pred EEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 192 IYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~-gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 899999999988777754 24689999999999999999999997 9999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCCccccccccccc--CCCCCCcceeechhHHHHHHHcCCCCCCCCC-hHHHHHHHHhhcCCCChh
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~--~~~~~~k~DIWSlG~il~eLltG~~pF~~~~-~~~~l~~i~~~lg~p~~~ 343 (595)
..... .+...|+..|+|||++.+. ...++.++|+|||||++|+|++|+.||.... ....+..+
T Consensus 155 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---------- 220 (283)
T cd06617 155 VDSVA----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV---------- 220 (283)
T ss_pred ccccc----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH----------
Confidence 32211 1234688999999987542 1357889999999999999999999996422 11111110
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
....... .....++..+.+||.+||..||.+||++.++++||||...
T Consensus 221 -------------~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 221 -------------VEEPSPQ------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred -------------HhcCCCC------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 0000000 0012357889999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=346.64 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=210.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
...+|++.+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.+.||||+++++.+.. ..
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~ 90 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLV-----GD 90 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CC
Confidence 3468999999999999999999999999999999986432 2345678899999999999999999998854 34
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 6899999998 578888754 46899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. ......|++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+....+..+..
T Consensus 170 ~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-------------- 230 (296)
T cd06654 170 QS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-------------- 230 (296)
T ss_pred cc---ccCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc--------------
Confidence 21 1234578999999999876 5788999999999999999999999987654322211110
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
... +.......+++.+.+||.+||..||.+|||+.++++||||...
T Consensus 231 -----------~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 231 -----------NGT---PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred -----------CCC---CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 000 0011123467789999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=342.40 Aligned_cols=262 Identities=24% Similarity=0.412 Sum_probs=207.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|.+.+.||.|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.+ +||||+++++++.........
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 467999999999999999999999999999999986421 2235677899999998 799999999998655433345
Q ss_pred cEEEEEeccc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 191 DIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
.+|+||||++ ++|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 6899999997 588887753 35789999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCcccccccccCCcccccccccccC---CCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~---~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
....... .....|+..|+|||++.... ..++.++|||||||++|||++|++||...+....+..+..
T Consensus 178 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~------- 247 (291)
T cd06639 178 LTSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR------- 247 (291)
T ss_pred ccccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc-------
Confidence 4322111 12357899999999875421 2368899999999999999999999976554332221110
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
..+..+ .........+.+||.+||..||.+||++.|+++||||+
T Consensus 248 --------------------~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 248 --------------------NPPPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred --------------------CCCCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 000000 01123566799999999999999999999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=344.96 Aligned_cols=258 Identities=24% Similarity=0.396 Sum_probs=202.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++++.||+|+||.||+|.+..++..||||.+.... .......+.+|+.+++.++||||+++++.+.. ....+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 75 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRIS 75 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEE
Confidence 6889999999999999999999999999999986432 22344568899999999999999999999854 34589
Q ss_pred EEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCc
Q 007629 194 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (595)
Q Consensus 194 lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 273 (595)
+||||+++...... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 76 lv~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 76 ICTEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred EEEecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 99999996433322 357889999999999999999999999999999999999999999999999997653221
Q ss_pred ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHH
Q 007629 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (595)
Q Consensus 274 ~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~ 353 (595)
....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.......... ........
T Consensus 150 --~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~--------~~~~~~~~------ 211 (279)
T cd06619 150 --AKTYVGTNAYMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL--------MPLQLLQC------ 211 (279)
T ss_pred --ccCCCCChhhcCceeecC--CCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc--------chHHHHHH------
Confidence 234689999999999877 678999999999999999999999996532111000 00000000
Q ss_pred HHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 354 ~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.....+. .......++.+.+||.+||..||.+||+++|+++||||...
T Consensus 212 ------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 212 ------IVDEDPP--VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred ------HhccCCC--CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 0000000 11123467889999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=338.86 Aligned_cols=257 Identities=25% Similarity=0.416 Sum_probs=206.3
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC----hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH----VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
+|++.+.||.|+||.||+|.+ .+|..||||.+...... ......+.+|+.+|+.++|+||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----D 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----C
Confidence 588899999999999999986 57899999988642211 2234568899999999999999999999843 3
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.+|+|+||||+||+++.++.+||+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 56899999998 58999998878899999999999999999999999999999999999999999999999999875421
Q ss_pred CC---CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 269 DA---PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 269 ~~---~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
.. ..........|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 224 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR-------- 224 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc--------
Confidence 11 11112234578999999999877 678899999999999999999999997654322211111000
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
.........++..+.+||.+||..||.+||++.++|+||||
T Consensus 225 --------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 225 --------------------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred --------------------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00011123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=342.89 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=205.3
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lyl 194 (595)
|++.+.||.|+||.||+|.+..++..+|+|.+... .......+.+|+.+++.++||||+++++++... ...|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEE
Confidence 78889999999999999999999999999998542 234456788999999999999999999988543 46899
Q ss_pred EEecccc-cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 195 VFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 195 V~E~~~g-~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
||||+.+ +|..++.. ..++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 9999985 67666654 45799999999999999999999999999999999999999999999999999875432211
Q ss_pred cccccccccCCcccccccccc---cCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 273 AIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~---~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
......||+.|+|||++.. ....++.++|||||||++|+|++|++||...+.......+...
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~------------- 223 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------------- 223 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc-------------
Confidence 1234578999999998742 1245788999999999999999999999876543322221110
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
..+ .......++..+.+||.+||..||.+||+++++++||||..
T Consensus 224 -------------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 224 -------------EPP--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred -------------CCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 000 00111235678999999999999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=345.07 Aligned_cols=261 Identities=25% Similarity=0.440 Sum_probs=208.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++++.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeE
Confidence 36899999999999999999999999999999986432 23345678899999999999999999998854 3568
Q ss_pred EEEEecccc-cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 193 YVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 193 ylV~E~~~g-~L~~~i~~~---~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
|+||||+++ +|..++... ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999985 787777653 379999999999999999999997 599999999999999999999999999987543
Q ss_pred CCCCCcccccccccCCcccccccccccC----CCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~----~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
... .....+++.|+|||++.+.. ..++.++|||||||++|+|++|..||...........+...
T Consensus 155 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~------- 222 (286)
T cd06622 155 ASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI------- 222 (286)
T ss_pred CCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH-------
Confidence 221 13346888999999875421 23678999999999999999999999765432221111110
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
....+ ....+.+++.+.+||.+||..||.+||++.+++.||||.....
T Consensus 223 -----------------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 223 -----------------VDGDP---PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred -----------------hhcCC---CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 00011 1122347888999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=355.93 Aligned_cols=263 Identities=28% Similarity=0.439 Sum_probs=215.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
...|..-++||+|+||.||.|+.+.||+.||.|++.+.. .........+.|-.||.++..+.||.+--.| +...
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCCC
Confidence 356788899999999999999999999999999985321 1222344578899999999999999997777 4445
Q ss_pred cEEEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 191 DIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
.+|+||..|+ |||..+|...+ .|++..+.+++.+|+.||++||..+||+|||||+|||+|+.|+++|+|+|||..+.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 6999999998 68988887766 89999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
...+ .+..+||.+|||||++.. ..|+...|+|||||+||||+.|+.||...-..
T Consensus 339 ~g~~----~~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-------------------- 392 (591)
T KOG0986|consen 339 EGKP----IRGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-------------------- 392 (591)
T ss_pred CCCc----cccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhh--------------------
Confidence 4443 345599999999999988 57999999999999999999999999654321
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCCCCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLANV 412 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~~~~ 412 (595)
.+.+...+.. ...+..++ ...++++++|.+.+|++||.+|.. +.++.+||||+.+.+.
T Consensus 393 vk~eEvdrr~----~~~~~ey~---~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 393 VKREEVDRRT----LEDPEEYS---DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred hhHHHHHHHH----hcchhhcc---cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 1111111111 12222222 356889999999999999999975 6799999999987653
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=336.32 Aligned_cols=255 Identities=31% Similarity=0.511 Sum_probs=209.8
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++++.||.|+||.||+|.+..++..||+|.+............+..|+.+++.++||||+++++++... ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 58999999999999999999999999999999865444445567788999999999999999999987543 234689
Q ss_pred EEEeccc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCeeecCCCCCceeeCCCCcEEEcccCcc
Q 007629 194 VVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIH-----TANVFHRDLKPKNILANADCKLKICDFGLA 263 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLH-----s~gIiHrDLKP~NILl~~~~~vKL~DFGla 263 (595)
++|||++ ++|.+++.. ...+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999998 588888865 357899999999999999999999 899999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
........ ......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+..
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------- 224 (265)
T cd08217 158 KILGHDSS---FAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-------- 224 (265)
T ss_pred ccccCCcc---cccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc--------
Confidence 86543321 1234578999999999877 5688999999999999999999999987653222211110
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
... ...-...+..+.+|+.+||..+|.+||++.++|+|||+
T Consensus 225 -------------------~~~---~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 225 -------------------GKF---RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -------------------CCC---CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 000 11113457789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=336.61 Aligned_cols=258 Identities=29% Similarity=0.457 Sum_probs=208.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||.|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCE
Confidence 367999999999999999999999999999999986432 2356778899999999999999999998843 346
Q ss_pred EEEEEecccc-cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~g-~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|++|||+++ +|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 8999999985 788888766 68999999999999999999999999999999999999999999999999998754332
Q ss_pred CCCcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.. ......++..|+|||++.+. ...++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 155 ~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~------------ 219 (262)
T cd06613 155 IA---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS------------ 219 (262)
T ss_pred hh---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------
Confidence 11 12345789999999998651 126888999999999999999999999876543332221110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~ 405 (595)
.+ .+ +........+..+.+||.+||..||.+|||+.+++.|+|
T Consensus 220 ----------~~---~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 220 ----------NF---PP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ----------cC---CC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00 00 000111234667999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=347.52 Aligned_cols=259 Identities=29% Similarity=0.481 Sum_probs=210.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|++.+.||.|+||.||+|.+..++..||||.+... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 90 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDE 90 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC--ccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCE
Confidence 46899999999999999999999999999999998642 22344667899999999999999999999854 346
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred EEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 899999998 578887754 468999999999999999999999999999999999999999999999999987643322
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. ......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.. .+.
T Consensus 170 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~----------- 232 (297)
T cd06656 170 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT----------- 232 (297)
T ss_pred c---CcCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCC-----------
Confidence 1 1234578999999999876 6788999999999999999999999977553222111100 000
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
+........++.+.+||.+||..||.+||+++++|+||||.....
T Consensus 233 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 233 ----------------PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred ----------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 001112345778999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=367.44 Aligned_cols=253 Identities=33% Similarity=0.546 Sum_probs=210.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEec
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~ 198 (595)
-+||+|.||+||.|+|..|...+|||.|.. .+....+.+..||.+.+.|+|.|||++++.+ .+.+++-|.||-
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEq 653 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQ 653 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeec
Confidence 479999999999999999999999999964 3345567788999999999999999999987 344578899999
Q ss_pred cc-ccHHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC-CCcEEEcccCcceeccCCCCCc
Q 007629 199 ME-SDLHQVIKA-NDDL--TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPSA 273 (595)
Q Consensus 199 ~~-g~L~~~i~~-~~~l--~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~-~~~vKL~DFGla~~~~~~~~~~ 273 (595)
++ |+|..++.. .+++ .|..+-++.+||++||+|||++.|||||||-+|+||+. .|.+||+|||-++....-.+-
T Consensus 654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~- 732 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC- 732 (1226)
T ss_pred CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcc-
Confidence 98 578888875 4677 78889999999999999999999999999999999986 689999999999876444332
Q ss_pred ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHH
Q 007629 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (595)
Q Consensus 274 ~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~ 353 (595)
..++.||..|||||++......|+.++|||||||++.||.||+|||..- |.|....+.
T Consensus 733 --TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El-------------gspqAAMFk------- 790 (1226)
T KOG4279|consen 733 --TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL-------------GSPQAAMFK------- 790 (1226)
T ss_pred --ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec-------------CChhHhhhh-------
Confidence 3567899999999999776678999999999999999999999999642 333222211
Q ss_pred HHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 354 ~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.+.++..+++| ..++.+++.||.+|+.+||.+||+|.++|++||++.-
T Consensus 791 ---VGmyKvHP~iP-----eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 791 ---VGMYKVHPPIP-----EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ---hcceecCCCCc-----HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 22233334433 3467889999999999999999999999999999754
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=340.48 Aligned_cols=261 Identities=26% Similarity=0.446 Sum_probs=207.6
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC----hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH----VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
+|+..+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+++++.++||||+++++++. +.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence 478889999999999999999999999999998643211 123567889999999999999999999984 33
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC-cEEEcccCcceecc
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSF 267 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~-~vKL~DFGla~~~~ 267 (595)
..+++||||+. ++|.+++...+++++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++....
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 56899999998 58999998888899999999999999999999999999999999999998876 59999999987654
Q ss_pred CCCCC-cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 268 NDAPS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 268 ~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
..... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||...........+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 224 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA--------- 224 (268)
T ss_pred cccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh---------
Confidence 32211 111123568899999999876 578899999999999999999999997544322222111100
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
..... .......++.+.+|+.+||..||.+||++.++++||||+
T Consensus 225 --------------~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 225 --------------SATTA---PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred --------------ccCCC---CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00000 011134678899999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=359.83 Aligned_cols=252 Identities=29% Similarity=0.564 Sum_probs=212.7
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEe
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E 197 (595)
.++||.|-||+||-|+++++|+.||||+|.+..-.......+..|+.||+.+.||.||.+--.|.++ ..+++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~-----ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP-----ERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC-----ceEEEEeh
Confidence 4789999999999999999999999999976544445567889999999999999999998777444 45999999
Q ss_pred cccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC---CcEEEcccCcceeccCCCCC
Q 007629 198 LMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 198 ~~~g~L~~~i~~--~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~---~~vKL~DFGla~~~~~~~~~ 272 (595)
-+.||+.+.|.. .+.|++...++++.||+.||.|||-++|+|+||||+|||+.+. -++||||||+|+.....
T Consensus 644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--- 720 (888)
T KOG4236|consen 644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--- 720 (888)
T ss_pred hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh---
Confidence 999998888864 3689999999999999999999999999999999999999764 36999999999986443
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHH
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~ 352 (595)
.+....+|||.|+|||++.. ..|+..-|+||+|||+|--|.|..||....+.. ++|+..
T Consensus 721 -sFRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNA---------------- 779 (888)
T KOG4236|consen 721 -SFRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNA---------------- 779 (888)
T ss_pred -hhhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccchh--HHhhcc----------------
Confidence 24567899999999999987 789999999999999999999999997654322 122111
Q ss_pred HHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 353 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.| -.++ ..|..++++++|||..+|+..-.+|.+.+..|.|||+++.
T Consensus 780 --aF-----MyPp----~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 780 --AF-----MYPP----NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred --cc-----ccCC----CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 00 0122 2356789999999999999999999999999999999864
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=335.25 Aligned_cols=253 Identities=27% Similarity=0.471 Sum_probs=208.1
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++.+.||+|+||.||++.+..+|..||||.+............+.+|+.+++.++||||+++++++. .....|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE-----ENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec-----CCCeEE
Confidence 589999999999999999999999999999998643333345567889999999999999999999884 345689
Q ss_pred EEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 194 VVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+||||+. ++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999997 58988887543 57899999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
.. .....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.. +
T Consensus 156 ~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~------------ 216 (256)
T cd08218 156 EL---ARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--G------------ 216 (256)
T ss_pred hh---hhhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--C------------
Confidence 11 123468899999999877 5788899999999999999999999976654333222210 0
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
..+ ......+..+.++|.+||..+|.+||++.++|+||||
T Consensus 217 ------------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 217 ------------SYP----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ------------CCC----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 000 0113457789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=349.50 Aligned_cols=287 Identities=29% Similarity=0.478 Sum_probs=226.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-----C---CceeeeeeeecC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-----H---PDIVEIKHIMLP 183 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-----H---pnIv~l~~~~~~ 183 (595)
..||.++++||.|.|++||+|.|..+.++||+|+++.. . ...+..+.||++|++++ | ..||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-q--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-Q--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-h--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 47999999999999999999999999999999998642 1 22455689999999984 3 359999999976
Q ss_pred CCccCcccEEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeC----------
Q 007629 184 PSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILAN---------- 250 (595)
Q Consensus 184 ~~~~~~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~---------- 250 (595)
.. ....++|||+|+++..|+.+|... +.++...++.|++|||.||.|||. +||||.||||+|||+.
T Consensus 154 sG-pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 154 SG-PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred cC-CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence 54 567899999999999999999875 479999999999999999999996 7999999999999964
Q ss_pred --------------------------------------------------------------------------------
Q 007629 251 -------------------------------------------------------------------------------- 250 (595)
Q Consensus 251 -------------------------------------------------------------------------------- 250 (595)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------C----------------------------------------------------CCc
Q 007629 251 ------------------------A----------------------------------------------------DCK 254 (595)
Q Consensus 251 ------------------------~----------------------------------------------------~~~ 254 (595)
. +.+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 0 012
Q ss_pred EEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCC------hHH
Q 007629 255 LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN------VVH 328 (595)
Q Consensus 255 vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~------~~~ 328 (595)
|||+|||-|...... ++.-+.|+.|+|||++.| ..|++.+||||++|++|||+||..+|..++ +.+
T Consensus 393 vKIaDlGNACW~~kh------FT~DIQTRQYRapEVllG--sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 393 VKIADLGNACWVHKH------FTEDIQTRQYRAPEVLLG--SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred EEEeeccchhhhhhh------hchhhhhhhccCcceeec--CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 577777777654322 355678999999999999 899999999999999999999999996442 578
Q ss_pred HHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCC------------C-CCHHHHHHHHhhCcCCCCCCC
Q 007629 329 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP------------N-ADPLALHLLERLLAFDPKDRP 395 (595)
Q Consensus 329 ~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~------------~-~~~~~~dLl~~~L~~DP~~Rp 395 (595)
++++|.+++|..+....-.-+. .+.|+.....-..+.--..|+ . ...++.+||.-||+++|++||
T Consensus 465 HiA~i~ELLG~iPr~ia~~Gk~--SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~ 542 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGGKY--SRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP 542 (590)
T ss_pred HHHHHHHHHhhccHHHHhcCcc--hHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc
Confidence 8999999999988765443222 234443322222111111122 1 124578999999999999999
Q ss_pred CHHHHhcCCCccCCCCC
Q 007629 396 TAEEALADPYFHGLANV 412 (595)
Q Consensus 396 ta~elL~Hp~f~~~~~~ 412 (595)
||.++|+|||+..+...
T Consensus 543 tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 543 TAAQCLKHPWLNPVAGP 559 (590)
T ss_pred cHHHHhcCccccCCCCC
Confidence 99999999999876654
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=343.73 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=209.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||.|+||.||+|.+..++..||+|.+.. ........+.+|+.+++.++||||+++++.+... ..
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-----NK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-----Ce
Confidence 4579999999999999999999988999999999853 2334556788999999999999999999998543 46
Q ss_pred EEEEEecccc-cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~g-~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||+++ +|..++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 8999999985 788887664 57999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCCccccccccccc---CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~---~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
... .....||+.|+|||++... ...++.++|||||||++|+|++|++||.+.+....+..+..
T Consensus 157 ~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------- 222 (280)
T cd06611 157 LQK---RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK----------- 222 (280)
T ss_pred ccc---cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc-----------
Confidence 211 2345789999999987521 14577899999999999999999999977654322221110
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..+ +.......++..+.+||.+||..||.+||++.++|+||||...
T Consensus 223 ----------------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 223 ----------------SEP-PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ----------------CCC-CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 000 0001113457789999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=345.55 Aligned_cols=262 Identities=24% Similarity=0.439 Sum_probs=204.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|+..+.||+|+||.||++.+..++..||||++...... .....+.+|+.++.++. ||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GD 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----Cc
Confidence 4567788999999999999999999999999998643222 34567889999999986 99999999988543 45
Q ss_pred EEEEEecccccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 192 IYVVFELMESDLHQVIK-----ANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~-----~~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
.|++|||+..++..+.. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 79999999876544332 23579999999999999999999997 4999999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCCcccccccccccC-CCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~-~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
...... .....|++.|+|||++.+.. ..++.++|||||||++|+|++|++||..... ....+...
T Consensus 158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~-------- 223 (288)
T cd06616 158 LVDSIA----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQV-------- 223 (288)
T ss_pred hccCCc----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhh--------
Confidence 433221 13346899999999987621 2688999999999999999999999975431 11111111
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.....+.........+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 224 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 224 ---------------VKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ---------------cCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 00111111111224578899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=341.44 Aligned_cols=256 Identities=28% Similarity=0.453 Sum_probs=209.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeE
Confidence 37899999999999999999999999999999986432 233456688999999999999999999988533 568
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+|+||+. ++|.+++... .+++..++.++.||+.||.|||+.+|+||||+|+||+++.++.++|+|||+++.......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999998 5888888765 899999999999999999999999999999999999999999999999999986643321
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
. .....|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+..
T Consensus 154 ~---~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---------------- 212 (274)
T cd06609 154 K---RNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK---------------- 212 (274)
T ss_pred c---cccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh----------------
Confidence 1 234578999999999887 5689999999999999999999999976553222111110
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..+..+. ...+++.+.++|.+||..||.+|||++++++||||...
T Consensus 213 -----------~~~~~~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 213 -----------NNPPSLE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred -----------cCCCCCc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 0000000 11267789999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=337.82 Aligned_cols=261 Identities=27% Similarity=0.452 Sum_probs=207.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCc-cCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR-REF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~-~~~ 189 (595)
.++|++.+.||.|+||.||+|.+..++..||+|++.... .....+.+|+.+++.+ .||||+++++++..... ...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 478999999999999999999999999999999986422 2345688999999998 69999999999866543 334
Q ss_pred ccEEEEEecccc-cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 190 KDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 190 ~~lylV~E~~~g-~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
..+|+||||+++ +|.+++.. ...+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 568999999984 78777754 3579999999999999999999999999999999999999999999999999987
Q ss_pred eccCCCCCcccccccccCCccccccccccc---CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCC
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~ 341 (595)
....... ......|+..|+|||++... ...++.++|||||||++|+|++|.+||........+..+..
T Consensus 162 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------ 232 (275)
T cd06608 162 QLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR------ 232 (275)
T ss_pred ecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc------
Confidence 6433221 12345789999999987531 23578899999999999999999999976543322221110
Q ss_pred hhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 342 ~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
..+..+ ......+..+.+||.+||..||.+|||+.++++|||+
T Consensus 233 ---------------------~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 233 ---------------------NPPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ---------------------cCCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 000000 0112356789999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.18 Aligned_cols=262 Identities=24% Similarity=0.416 Sum_probs=206.2
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 189 (595)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++........
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 3578999999999999999999999999999999875321 2234577899999999 69999999998865443445
Q ss_pred ccEEEEEeccc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 190 KDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
..+|+||||++ ++|.+++.. ...+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 67999999998 578777642 3468899999999999999999999999999999999999999999999999997
Q ss_pred eccCCCCCcccccccccCCccccccccccc---CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCC
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~ 341 (595)
....... ......|++.|+|||++... ...++.++|||||||++|||++|+.||........+..+.
T Consensus 173 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~------- 242 (286)
T cd06638 173 QLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP------- 242 (286)
T ss_pred ecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc-------
Confidence 6532211 12345799999999987531 1457889999999999999999999997654322211110
Q ss_pred hhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 342 ~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
...+... ..-...+..+.+||.+||..||.+|||+.|+|+|+||
T Consensus 243 --------------------~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 243 --------------------RNPPPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred --------------------ccCCCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0000000 0011246679999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.79 Aligned_cols=260 Identities=25% Similarity=0.426 Sum_probs=206.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCc-cCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR-REF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~-~~~ 189 (595)
.+.|++.+.||.|+||.||+|.+..+++.||+|.+... ......+..|+.+++.+ +||||+++++++..... ...
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 46799999999999999999999999999999988532 23345678899999988 69999999999864321 234
Q ss_pred ccEEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 190 KDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
..+|++|||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 57899999998 4888888653 35888889999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCCccccccccccc---CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
..... ......|++.|+|||++... ...++.++|||||||++|||++|.+||........+..+.
T Consensus 172 ~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~--------- 239 (282)
T cd06636 172 DRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------- 239 (282)
T ss_pred hcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh---------
Confidence 22111 12345789999999987521 2468889999999999999999999997544322111100
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
.. .........++..+.+||.+||..||.+|||+.|+|+||||
T Consensus 240 ------------------~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 240 ------------------RN--PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ------------------hC--CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00 01111123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=343.86 Aligned_cols=261 Identities=25% Similarity=0.403 Sum_probs=209.4
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
+|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++.+.. ...+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-----KRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-----CCEE
Confidence 68999999999999999999999999999999864321 22345677899999999999999999988843 3568
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999998 58999998888899999999999999999999999999999999999999999999999999874211110
Q ss_pred C------------cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCC
Q 007629 272 S------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339 (595)
Q Consensus 272 ~------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~ 339 (595)
. ........|+..|+|||.+.+ ..++.++|||||||++|||++|..||.+......+..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~---- 230 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS---- 230 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----
Confidence 0 001123467889999999876 6789999999999999999999999987654322221110
Q ss_pred CChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC---HHHHhcCCCccCC
Q 007629 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT---AEEALADPYFHGL 409 (595)
Q Consensus 340 p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt---a~elL~Hp~f~~~ 409 (595)
.. ..+.......++.+.+||.+||..||.+||+ +.++|+||||...
T Consensus 231 ----------------------~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 231 ----------------------DD--IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ----------------------cc--cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 00 0011111246788999999999999999998 7999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=337.15 Aligned_cols=262 Identities=28% Similarity=0.478 Sum_probs=207.3
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC--------hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH--------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 185 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~--------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 185 (595)
+|.+.+.||.|+||.||+|.+..+|+.||||.++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 588999999999999999999999999999987532111 1123457789999999999999999998843
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
...+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.+++||||||+||+++.++.++|+|||++.
T Consensus 80 ---~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 80 ---EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ---CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 356899999997 5899999888889999999999999999999999999999999999999999999999999997
Q ss_pred eccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
....... ........|+..|+|||++......++.++|+|||||++|+|++|..||........+..+.
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---------- 225 (272)
T cd06629 157 KSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG---------- 225 (272)
T ss_pred ccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh----------
Confidence 5432211 11123456889999999987632347899999999999999999999996544321111100
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
.. ...+.......+.++..+.+||.+||..||.+||+++++|+||||
T Consensus 226 --------------~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 226 --------------NK-RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred --------------cc-ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00 001111112334568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=328.91 Aligned_cols=257 Identities=23% Similarity=0.410 Sum_probs=210.5
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcccEE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
.+++..||.|+.|+|++++.+.+|...|||.+.+. .+..+.++++..+.++.... +|.||+.+++|.... +++
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----dV~ 167 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----DVF 167 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----hHH
Confidence 45677899999999999999999999999999764 45567889999999876654 999999999997654 479
Q ss_pred EEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 194 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 194 lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|.||.|...+..+++. .++++|..+-++...++.||.||.+ +||||||+||+|||+|..|++||||||++..+.+...
T Consensus 168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 9999999776666654 3579999999999999999999986 5899999999999999999999999999977655443
Q ss_pred CcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCCh-HHHHHHHHhhcCCCChhHHHHHh
Q 007629 272 SAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
. +...|.+.|||||.+.-. ...|+.++||||||+.++||.||+.||.+.+. .+.+-.+.+
T Consensus 248 h----trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-------------- 309 (391)
T KOG0983|consen 248 H----TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-------------- 309 (391)
T ss_pred c----ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh--------------
Confidence 2 456899999999987543 46799999999999999999999999998652 222222221
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..| |.-..-...++.+++|+..||++|+.+||...++|+|||+...
T Consensus 310 -------------~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 310 -------------EEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred -------------cCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 111 1111112378999999999999999999999999999999754
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=333.28 Aligned_cols=261 Identities=31% Similarity=0.468 Sum_probs=210.2
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
||++.+.||+|+||.||+|.+..++..||+|.++...........+..|+.+++.++|+||+++++++.. ...++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-----REKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-----CCEEE
Confidence 6999999999999999999999899999999987543333467788999999999999999999998743 34689
Q ss_pred EEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 194 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
+|+||+. ++|.+++.....+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999998 689999988777999999999999999999999999999999999999999999999999999865433322
Q ss_pred ccc-ccccccCCcccccccccccC-CCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 273 AIF-WTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 273 ~~~-~~~~~gT~~Y~APE~l~~~~-~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
... .....+++.|+|||++.+.. ..++.++|||||||++|+|++|+.||..............
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~--------------- 220 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG--------------- 220 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh---------------
Confidence 111 22457889999999987632 2378899999999999999999999975432111110000
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
..... ....+..+++.+.+||.+||..||.+|||+.+++.|||+
T Consensus 221 ---------~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 221 ---------AGHKP---PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ---------cCCCC---CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000 111223457889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=331.98 Aligned_cols=252 Identities=28% Similarity=0.451 Sum_probs=206.7
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++.+.||+|+||.||+|.+..++..||||.+............+.+|+.+|+.++||||+++++.+.. ...+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-----DKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-----CCEEE
Confidence 5899999999999999999999999999999986543344456778899999999999999999988743 34689
Q ss_pred EEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC-cEEEcccCcceeccCC
Q 007629 194 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSFND 269 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~-~vKL~DFGla~~~~~~ 269 (595)
+||||++ ++|.+++... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++ .+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999998 5899988764 3589999999999999999999999999999999999998654 5899999999865433
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-------------- 215 (256)
T cd08220 156 SK----AYTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-------------- 215 (256)
T ss_pred cc----ccccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh--------------
Confidence 22 123578999999999876 5688999999999999999999999987654332221110
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
. ... .....+++.+.+|+.+||..||.+|||+.|+++||||
T Consensus 216 ---------~----~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 216 ---------G----TFA---PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ---------c----CCC---CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0 000 1112467789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=336.77 Aligned_cols=254 Identities=27% Similarity=0.447 Sum_probs=208.6
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
+|++.+.||.|+||.||+|.+..++..||+|++.+... .......+.+|+.+++.++||||+++++++. +...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ-----DEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc-----CCCeE
Confidence 48999999999999999999999999999999864322 2244677899999999999999999998873 34569
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+||||+. ++|.+.+.....+++..+..++.||++||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 99999998 58999988777899999999999999999999999999999999999999999999999999876533221
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
.....|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...+........ .
T Consensus 156 ----~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~---------------- 212 (258)
T cd05578 156 ----TTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-A---------------- 212 (258)
T ss_pred ----ccccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-H----------------
Confidence 234568899999999876 56899999999999999999999999876531100000 0
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH--HHHhcCCCc
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA--EEALADPYF 406 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta--~elL~Hp~f 406 (595)
.... ... ...+..++.+.++|.+||..||.+||++ .|+++||||
T Consensus 213 -------~~~~-~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 213 -------KQET-ADV---LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -------Hhcc-ccc---cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0000 000 1113456889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=343.30 Aligned_cols=259 Identities=21% Similarity=0.335 Sum_probs=197.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC----------------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCcee
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTH----------------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~----------------~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 175 (595)
.++|++.+.||+|+||.||+|.+.. ++..||||.+.... .......+.+|+.+|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4689999999999999999997532 34579999986432 233456788999999999999999
Q ss_pred eeeeeecCCCccCcccEEEEEeccc-ccHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhC
Q 007629 176 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-------------------DLTPEHYQFFLYQLLRGLKYIHTA 235 (595)
Q Consensus 176 ~l~~~~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~-------------------~l~~~~~~~i~~qil~aL~yLHs~ 235 (595)
++++++... ..+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 83 RLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred EEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 999998543 45899999997 58988886432 367788899999999999999999
Q ss_pred CeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHH
Q 007629 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML 315 (595)
Q Consensus 236 gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLl 315 (595)
||+||||||+|||++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|||+
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR-IQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCceeE-ecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHH
Confidence 99999999999999999999999999997653322111 1123456788999999876 67999999999999999998
Q ss_pred c--CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCC
Q 007629 316 T--GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD 393 (595)
Q Consensus 316 t--G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~ 393 (595)
+ +..||.+.+....+..+... +... .........+.++..+.+|+.+||..||.+
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~--------------------~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEF--------------------FRDQ---GRQVYLFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHH--------------------hhhc---cccccccCCCCCCHHHHHHHHHHccCCchh
Confidence 6 56788765543322221111 0000 000011122356788999999999999999
Q ss_pred CCCHHHHhc
Q 007629 394 RPTAEEALA 402 (595)
Q Consensus 394 Rpta~elL~ 402 (595)
|||+.++.+
T Consensus 292 RPs~~~i~~ 300 (304)
T cd05096 292 RPSFSDIHA 300 (304)
T ss_pred CcCHHHHHH
Confidence 999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=383.34 Aligned_cols=264 Identities=33% Similarity=0.468 Sum_probs=202.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecC---------
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP--------- 183 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--------- 183 (595)
.+|+.++.||+||||.||+++++-+|..||||+|.-.. .......+.+|+++|.+|+|||||+++..|..
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 45688999999999999999999999999999997654 45567789999999999999999999876610
Q ss_pred ---------------------------------------------CC-------c-------------------------
Q 007629 184 ---------------------------------------------PS-------R------------------------- 186 (595)
Q Consensus 184 ---------------------------------------------~~-------~------------------------- 186 (595)
.+ .
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 00 0
Q ss_pred ---------------------c-------CcccEEEEEecccccHHHHHHhcCCC--CHHHHHHHHHHHHHHHHHHHhCC
Q 007629 187 ---------------------R-------EFKDIYVVFELMESDLHQVIKANDDL--TPEHYQFFLYQLLRGLKYIHTAN 236 (595)
Q Consensus 187 ---------------------~-------~~~~lylV~E~~~g~L~~~i~~~~~l--~~~~~~~i~~qil~aL~yLHs~g 236 (595)
. ....+||-||||+.++.+.+-..+.+ ....++.+|+||++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 00348999999997655555444444 37889999999999999999999
Q ss_pred eeecCCCCCceeeCCCCcEEEcccCcceecc------C---------CCCCcccccccccCCcccccccccccCC-CCCC
Q 007629 237 VFHRDLKPKNILANADCKLKICDFGLARVSF------N---------DAPSAIFWTDYVATRWYRAPELCGSFFS-KYTP 300 (595)
Q Consensus 237 IiHrDLKP~NILl~~~~~vKL~DFGla~~~~------~---------~~~~~~~~~~~~gT~~Y~APE~l~~~~~-~~~~ 300 (595)
||||||||.||++++++.|||+|||+|.... . ........|..+||..|+|||++.+... .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998621 0 0011113467899999999999987422 6999
Q ss_pred cceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcc-cCCCCCCCCCCCCCCHHH
Q 007629 301 AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMR-KKQPVPFSHKFPNADPLA 379 (595)
Q Consensus 301 k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~~~ 379 (595)
|+|||||||||+||+. ||...-. ... .+..++ ...|.+ ...+.+.-+..
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsME--Ra~------------------------iL~~LR~g~iP~~-~~f~~~~~~~e 847 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSME--RAS------------------------ILTNLRKGSIPEP-ADFFDPEHPEE 847 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchHH--HHH------------------------HHHhcccCCCCCC-cccccccchHH
Confidence 9999999999999995 5754221 111 111222 112222 22233445667
Q ss_pred HHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 380 LHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 380 ~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
..+|++||+.||.+||||.|+|++.||.
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 8999999999999999999999999985
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=333.84 Aligned_cols=252 Identities=31% Similarity=0.529 Sum_probs=206.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||.|+||.||+|.+..++..||+|.+... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcE
Confidence 5799999999999999999999988999999998642 2266788999999999999999999988543 568
Q ss_pred EEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 193 YVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
|+++||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+|+||||+|+||+++.++.+||+|||++.......
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 99999998 588888865 4578999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. ......|+..|+|||++.+ ..++.++|||||||++|+|++|++||...........+.
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~---------------- 212 (256)
T cd06612 154 A---KRNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP---------------- 212 (256)
T ss_pred c---ccccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc----------------
Confidence 1 1233468899999999877 578999999999999999999999997654322111110
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
...+ +.......++..+.+||.+||..||.+|||+.|+|+||||
T Consensus 213 -----------~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 213 -----------NKPP-PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -----------cCCC-CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0000 0011112456789999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.11 Aligned_cols=246 Identities=20% Similarity=0.252 Sum_probs=198.7
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChh-hHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEe
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS-DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E 197 (595)
..||+|++|.||+|.. +|+.||||+++....... ..+.+.+|+.+|++++||||+++++++.... .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5699999999999976 689999999875433222 2466779999999999999999999885411 22346899999
Q ss_pred ccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 198 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 198 ~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
|+. |+|.+++...+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----
Confidence 999 5899999888889999999999999999999998 599999999999999999999999999997543221
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
...+||..|+|||++.+....|+.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~------------------- 237 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK------------------- 237 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-------------------
Confidence 234789999999998764457899999999999999999999999876644333222111
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
....++ ....++.+.+||.+||+.||.+|||+.|+++
T Consensus 238 -------~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 238 -------NNSLKL---PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -------CCCCCC---CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 000111 1246788999999999999999999999986
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=339.59 Aligned_cols=257 Identities=28% Similarity=0.484 Sum_probs=208.6
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++.+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+.+++.+.||||+++++++... ..+|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 75 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDIS 75 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEE
Confidence 68889999999999999999999999999999865332 23456788999999999999999999988543 5689
Q ss_pred EEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 194 VVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+||+. ++|.+++... ..+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999 6899998876 789999999999999999999999 999999999999999999999999999987543221
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCCh--HHHHHHHHhhcCCCChhHHHHH
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV--VHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~--~~~l~~i~~~lg~p~~~~i~~i 348 (595)
. ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+. ......+..
T Consensus 156 ~-----~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 215 (265)
T cd06605 156 A-----KTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY------------- 215 (265)
T ss_pred h-----hcccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH-------------
Confidence 1 12578899999999877 5789999999999999999999999976431 000111100
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.+ ...+.... ...+++.+.+||.+||..||.+|||+.+++.||||+.+
T Consensus 216 -------~~----~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 216 -------IV----NEPPPRLP--SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred -------Hh----cCCCCCCC--hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 00 00000000 01167889999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=345.19 Aligned_cols=257 Identities=26% Similarity=0.491 Sum_probs=206.4
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
.|.....||.|+||.||++.+..++..||||++... .......+.+|+.+++.++||||+++++.+.. ....|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~ 95 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDELW 95 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCeEE
Confidence 345567799999999999999999999999998542 22345668899999999999999999998743 34689
Q ss_pred EEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 194 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 194 lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
+||||+++ +|.+++. .+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 96 lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 96 VVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred EEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 99999985 6777664 457999999999999999999999999999999999999999999999999998754322211
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHH
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~ 352 (595)
.....|++.|+|||.+.+ ..++.++|||||||++|||++|..||.+.+....+..+...
T Consensus 175 ---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---------------- 233 (292)
T cd06658 175 ---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN---------------- 233 (292)
T ss_pred ---CceeecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------------
Confidence 234578999999999876 57889999999999999999999999876543322221110
Q ss_pred HHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 353 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
+.. ........+..+.+||.+||..||.+|||++++|+||||.....
T Consensus 234 -------~~~-----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 234 -------LPP-----RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred -------CCC-----ccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 000 00112245778999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=331.62 Aligned_cols=254 Identities=29% Similarity=0.490 Sum_probs=207.1
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC---ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
+|+..+.||+|+||.||+|.+..++..||+|.+..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-----ED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-----CC
Confidence 57888999999999999999988999999999854221 12345678899999999999999999998743 34
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||++ ++|.+++.....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 6899999998 589999988878999999999999999999999999999999999999999999999999998765333
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
. ......|+..|+|||.+... ..++.++|+|||||++|+|++|+.||...........+...
T Consensus 156 ~----~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------------- 217 (258)
T cd06632 156 S----FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS------------- 217 (258)
T ss_pred c----cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc-------------
Confidence 2 12345789999999988652 23889999999999999999999999765422211111000
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
. ......+.+++.+.+|+.+||..||.+||++.++|.|||+
T Consensus 218 --------------~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 218 --------------K--ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred --------------c--cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 0 0011123467889999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=363.50 Aligned_cols=263 Identities=29% Similarity=0.483 Sum_probs=219.1
Q ss_pred ccccCCCCCe-EEeeeeeecCceEEEEEEECCCCcEEEEEEe--cCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 007629 106 FTEYGEASRY-QIQEVIGKGSYGVVGSAVDTHTGERVAIKKI--NDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIML 182 (595)
Q Consensus 106 ~~~~~~~~~Y-~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i--~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 182 (595)
+.+....+|| +...+||+|+|-+||+|.|..+|..||.-.+ .+........+++..|+.+|+.|+|||||++|+.|.
T Consensus 32 ~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~ 111 (632)
T KOG0584|consen 32 FVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV 111 (632)
T ss_pred ccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehee
Confidence 3344455666 5567899999999999999999999996544 445556667789999999999999999999999997
Q ss_pred CCCccCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCceeeCCC-CcEEEc
Q 007629 183 PPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANAD-CKLKIC 258 (595)
Q Consensus 183 ~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~g--IiHrDLKP~NILl~~~-~~vKL~ 258 (595)
+... ..+-+|.|+|. |+|..++++.+.+....++.|++|||+||.|||++. |||||||.+||+|+.+ |.|||+
T Consensus 112 d~~n---~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIG 188 (632)
T KOG0584|consen 112 DTDN---KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIG 188 (632)
T ss_pred cCCC---ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeec
Confidence 6543 66899999998 899999999999999999999999999999999986 9999999999999875 899999
Q ss_pred ccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcC
Q 007629 259 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338 (595)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg 338 (595)
|+|||....... ....+|||.|||||++.. .|+..+||||||+.++||+|+..||.......|+.+-+
T Consensus 189 DLGLAtl~r~s~-----aksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV---- 256 (632)
T KOG0584|consen 189 DLGLATLLRKSH-----AKSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV---- 256 (632)
T ss_pred chhHHHHhhccc-----cceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH----
Confidence 999998764332 244799999999999864 89999999999999999999999998776655544321
Q ss_pred CCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 339 ~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
.....|..+.. --+|++++||.+||.. .++|+|+.|+|+||||..
T Consensus 257 ---------------------~SGiKP~sl~k---V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 257 ---------------------TSGIKPAALSK---VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred ---------------------HcCCCHHHhhc---cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 11222222221 2378999999999999 999999999999999975
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=344.53 Aligned_cols=261 Identities=25% Similarity=0.410 Sum_probs=218.9
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccC
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 188 (595)
...+|..+.+||+|+||.|.+|..+.+.+.||||++++.. ....+.+--..|-++|.... -|.++.++.+|.+
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT----- 421 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT----- 421 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh-----
Confidence 4568999999999999999999999999999999997532 23344555567888887774 6788888888844
Q ss_pred cccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
...+|+||||+. |+|...|++-+.|.|..+.+++.+|+-||-|||++|||+||||.+|||++.+|++||+|||+++...
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 455999999998 6999999999999999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
-+..+ ..++||||.|+|||++.- .+|+.++|+||+||+|||||.|++||.|++..+.+..|.+-.
T Consensus 502 ~~~~T---TkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn---------- 566 (683)
T KOG0696|consen 502 FDGVT---TKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN---------- 566 (683)
T ss_pred cCCcc---eeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc----------
Confidence 32222 356899999999999875 799999999999999999999999999999877665554311
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH-----HHHhcCCCccCCCCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-----EEALADPYFHGLANV 412 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta-----~elL~Hp~f~~~~~~ 412 (595)
+ ..-...+.++.++.+.+|.+.|.+|..+ .++-.||||+.+.+.
T Consensus 567 ------------------v---syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 567 ------------------V---SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWE 615 (683)
T ss_pred ------------------C---cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHH
Confidence 0 1113467889999999999999999764 689999999977653
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=333.04 Aligned_cols=250 Identities=24% Similarity=0.419 Sum_probs=204.3
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEecc
Q 007629 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 199 (595)
Q Consensus 121 LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~ 199 (595)
||.|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++.++||||+++++.+.. ...+|+||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-----KKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-----CCccEEEEecC
Confidence 7999999999999999999999999864322 22345678899999999999999999998743 35689999999
Q ss_pred c-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccccc
Q 007629 200 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 278 (595)
Q Consensus 200 ~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 278 (595)
+ ++|.+++.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~----~~~ 151 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK----TWT 151 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc----ccc
Confidence 7 68999998888899999999999999999999999999999999999999999999999999986543321 133
Q ss_pred cccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCCh--HHHHHHHHhhcCCCChhHHHHHhhHHHHHH
Q 007629 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV--VHQLDLMTDLLGTPSTESISRIRNEKARRY 356 (595)
Q Consensus 279 ~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~--~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~ 356 (595)
..|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||..... ......+..
T Consensus 152 ~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------- 208 (262)
T cd05572 152 FCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--------------------- 208 (262)
T ss_pred ccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc---------------------
Confidence 578999999999876 5789999999999999999999999976552 111111100
Q ss_pred hhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCCC
Q 007629 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 410 (595)
Q Consensus 357 l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~~ 410 (595)
......+ ....++.+.+||.+||..||.+||+ ++|+++||||+.+.
T Consensus 209 -----~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 209 -----GNGKLEF---PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred -----cCCCCCC---CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 0001111 1223678999999999999999999 99999999998764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=330.83 Aligned_cols=258 Identities=31% Similarity=0.469 Sum_probs=212.2
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++.+.||.|+||.||+|.+..+++.||||++...... .....+.+|+.++..++||||+++++++... ..+|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEIS 75 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEE
Confidence 689999999999999999999999999999998653222 4457788999999999999999999998544 5689
Q ss_pred EEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 194 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
+||||++ ++|.+++.....+++..+..++.||++||.|||+ .|++||||+|+||+++.++.++|+|||++........
T Consensus 76 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999 6899999887889999999999999999999999 9999999999999999999999999999986543322
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
. .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.........+.+...
T Consensus 156 ~---~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--------------- 215 (264)
T cd06623 156 Q---CNTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI--------------- 215 (264)
T ss_pred c---ccceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH---------------
Confidence 1 134578899999999877 57889999999999999999999999766421111111100
Q ss_pred HHHHHhhhcccCCCCCCCCCCCC-CCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
....... .... ++..+.+||.+||..+|++||++.++++||||+..
T Consensus 216 ---------~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 216 ---------CDGPPPS---LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ---------hcCCCCC---CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 0001111 1122 67889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=334.32 Aligned_cols=251 Identities=20% Similarity=0.282 Sum_probs=199.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~---~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
..+|++.+.||+|+||.||+|... ..+..||+|.++.... ......+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITR----- 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----
Confidence 357999999999999999999765 4567899999875322 2334568899999999999999999999854
Q ss_pred cccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 189 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
...+|+||||++ ++|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||.+...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 346899999998 5788888764 47899999999999999999999999999999999999999999999999987643
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+....+..+.+.
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~--------- 224 (266)
T cd05064 158 KSEAIY--TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG--------- 224 (266)
T ss_pred cccchh--cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC---------
Confidence 221110 0112245678999999876 688999999999999999775 99999876654433322111
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
...+ ....++..+.+|+.+||..+|.+||+++++++
T Consensus 225 ------------------~~~~---~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 225 ------------------FRLP---APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ------------------CCCC---CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 0011 12346778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=337.70 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=196.0
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCccCCh-hhHHHHHHHHHHHH---hcCCCceeeeeeeecCCCccCcccEEEE
Q 007629 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-SDATRILREIKLLR---LLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (595)
Q Consensus 120 ~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~-~~~~~~~~Ei~il~---~l~HpnIv~l~~~~~~~~~~~~~~lylV 195 (595)
.||+|+||.||+|.+..++..||||.+....... .......+|..+++ ...||+|+.+++.+... ..+|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEE
Confidence 4899999999999999999999999986433221 12233445554444 34799999999888443 458999
Q ss_pred Eeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcc
Q 007629 196 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274 (595)
Q Consensus 196 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 274 (595)
|||+. ++|.+++...+.+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 99998 5898888888889999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHH
Q 007629 275 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354 (595)
Q Consensus 275 ~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~ 354 (595)
.....||+.|+|||.+.+. ..++.++|||||||++|+|++|..||.+....... .+...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------------~~~~~------ 210 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-------------EIDRM------ 210 (279)
T ss_pred -ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-------------HHHHH------
Confidence 1234799999999987641 46889999999999999999999999764321110 00000
Q ss_pred HHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCCC
Q 007629 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (595)
Q Consensus 355 ~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~~ 410 (595)
.... +. ...+.+++.+.+||.+||..||.+|| ++.|+++||||+++.
T Consensus 211 --~~~~----~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 211 --TLTV----NV---ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred --hhcC----Cc---CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 0000 00 11234678899999999999999999 699999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=352.78 Aligned_cols=245 Identities=29% Similarity=0.451 Sum_probs=201.4
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
.+.+++.||+|-||.||.|.... ...||+|.++.. ....+.+++|+++|++|+|++||++++++... .-+|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piy 277 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIY 277 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceE
Confidence 45678899999999999997642 348999999743 23456788999999999999999999999543 2499
Q ss_pred EEEeccc-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 194 VVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
||||||. |+|.++++. ...+.......|+.||++|++||+++++|||||-..||||+++..+||+|||||+...++.
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 9999998 899999987 4578899999999999999999999999999999999999999999999999999544433
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.... ...--..-|.|||.+.. ..++.|+|||||||+|+||+| |+.||++.+..+.+..+.+..-
T Consensus 358 Y~~~--~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR----------- 422 (468)
T KOG0197|consen 358 YTAS--EGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR----------- 422 (468)
T ss_pred eeec--CCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc-----------
Confidence 2211 11122335899999976 789999999999999999998 8999999888777766644321
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHh
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL 401 (595)
.|.| +.+++.+-+++..||..+|++|||++.+.
T Consensus 423 --------------lp~P-----~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 423 --------------LPRP-----EGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred --------------CCCC-----CCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 2222 45788999999999999999999998654
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=353.71 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=196.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~-----g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 185 (595)
.++|++.+.||+|+||.||+|++..+ +..||||+++... .......+.+|+.+|+.+ +|||||++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~- 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHG- 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-
Confidence 45799999999999999999986544 3579999996432 223456788999999999 899999999988443
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhc------------------------------------------------------
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 210 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 210 (595)
..+|+|||||. ++|.+++...
T Consensus 115 ----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 115 ----GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ----CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 45899999998 6888887532
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcc
Q 007629 211 ----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274 (595)
Q Consensus 211 ----------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 274 (595)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-~ 269 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-V 269 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-e
Confidence 24778889999999999999999999999999999999999999999999999765332211 1
Q ss_pred cccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHH
Q 007629 275 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (595)
Q Consensus 275 ~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~ 353 (595)
......++..|||||++.+ ..++.++|||||||++|||++ |+.||........+..+..
T Consensus 270 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~------------------ 329 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK------------------ 329 (374)
T ss_pred eccCCCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH------------------
Confidence 1122345678999999876 679999999999999999997 9999976543221111100
Q ss_pred HHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 354 ~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
... .... ....++.+.+||.+||..||.+|||+.++++
T Consensus 330 ----~~~--~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 330 ----RGY--QMSR-----PDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ----ccc--CccC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 0000 1234788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=336.02 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=201.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCC-----cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTG-----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g-----~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
.+|++.+.||+|+||.||+|.+...+ ..||+|.++... .......+.+|+.+|+.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--- 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--- 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC---
Confidence 47899999999999999999876555 689999986432 223345688999999999999999999988533
Q ss_pred CcccEEEEEeccc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~ 250 (595)
...|++|||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 81 --~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 --QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 45899999998 6899988764 4578889999999999999999999999999999999999
Q ss_pred CCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHH
Q 007629 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 329 (595)
Q Consensus 251 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 329 (595)
.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYY-RVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEECCCcceeeccccccc-cccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999765332211 11234467889999999876 678999999999999999998 9999987664332
Q ss_pred HHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 330 l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
...+.. ....+ ....+++.+.+|+.+||+.||.+||++.|++++
T Consensus 236 ~~~i~~---------------------------~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRS---------------------------RQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHc---------------------------CCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 221111 01111 113567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=342.42 Aligned_cols=254 Identities=28% Similarity=0.525 Sum_probs=206.0
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lyl 194 (595)
|.....||.|+||.||+|.+..++..||||++.... ......+.+|+.+++.+.||||+++++++.. ...+|+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~i 95 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWV 95 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEE
Confidence 445567999999999999999999999999985422 2334568899999999999999999998844 356899
Q ss_pred EEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCc
Q 007629 195 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (595)
Q Consensus 195 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 273 (595)
||||+++ +|..++. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 96 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~- 173 (297)
T cd06659 96 LMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK- 173 (297)
T ss_pred EEecCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-
Confidence 9999984 6777664 457899999999999999999999999999999999999999999999999998754332211
Q ss_pred ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHH
Q 007629 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (595)
Q Consensus 274 ~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~ 353 (595)
.....|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+....+..+..
T Consensus 174 --~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------------ 231 (297)
T cd06659 174 --RKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD------------------ 231 (297)
T ss_pred --ccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Confidence 234679999999999876 5789999999999999999999999977654433322210
Q ss_pred HHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 354 ~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.+.+.......+++.+.+||.+||..||.+||+++++++||||...
T Consensus 232 ----------~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 232 ----------SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred ----------cCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 0011112234567889999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=338.98 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=207.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..+|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----H 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----C
Confidence 3569999999999999999999999999999999864322 233456788999999999999999999998543 4
Q ss_pred cEEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
..|+||||+.+++.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++......
T Consensus 89 ~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 89 TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred eEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 5899999999988887764 457999999999999999999999999999999999999999999999999998754221
Q ss_pred CCCcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
....+++.|+|||++.+. ...++.++|||||||++|||++|.+||.+.+....+..+..
T Consensus 169 -------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~------------- 228 (307)
T cd06607 169 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------- 228 (307)
T ss_pred -------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-------------
Confidence 235788999999987531 24688899999999999999999999977654332221110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
...+. .....++..+.+||.+||..||.+||++.+++.||||..
T Consensus 229 -------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 229 -------------NDSPT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred -------------CCCCC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 00000 001234677999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=329.00 Aligned_cols=253 Identities=29% Similarity=0.490 Sum_probs=205.6
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|.+.+.||+|+||.||+|.++.+|..||+|.+............+.+|+.+++.++|+||+++++.+.. ...+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-----NGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-----CCeEE
Confidence 5899999999999999999999999999999986432223345677899999999999999999998843 34689
Q ss_pred EEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc-EEEcccCcceeccCC
Q 007629 194 VVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVSFND 269 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~-vKL~DFGla~~~~~~ 269 (595)
+|+||+. ++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+|||++.++. +||+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999997 58988887643 4789999999999999999999999999999999999998864 699999999765432
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
... .....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 156 ~~~---~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 216 (257)
T cd08225 156 MEL---AYTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-------------- 216 (257)
T ss_pred ccc---ccccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--------------
Confidence 211 123468999999999876 5788999999999999999999999976553322211100
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
. .+....+..+..+.++|.+||..+|++|||+.++++||||
T Consensus 217 ------------~----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 217 ------------G----YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ------------c----cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0 0111224567789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.45 Aligned_cols=257 Identities=28% Similarity=0.515 Sum_probs=208.3
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
.|...+.||.|++|.||++.+..++..||||++... .......+.+|+.+++.+.||||+++++++... ...|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~~ 92 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DELW 92 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeEE
Confidence 455568999999999999999999999999998532 223345678999999999999999999988543 4589
Q ss_pred EEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 194 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
+|+||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.........
T Consensus 93 ~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 93 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred EEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence 9999997 588888876 67999999999999999999999999999999999999999999999999988754332221
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHH
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~ 352 (595)
.....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 172 ---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~---------------- 230 (285)
T cd06648 172 ---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN---------------- 230 (285)
T ss_pred ---cccccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc----------------
Confidence 133578999999999876 57899999999999999999999999776543332222110
Q ss_pred HHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 353 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
. .+.......++..+.+||.+||..||++|||+.++++||||+...+
T Consensus 231 -----------~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 231 -----------L-PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred -----------C-CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 0 0111112236788999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=330.04 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=199.4
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHH-HhcCCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLL-RLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.||.|+||.||+|.+..+|+.||||.+.+... .......+..|..++ ..+.||||+++++++.. ...+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-----KDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-----CCeEEEEE
Confidence 579999999999999999999999999864221 112233445565554 45589999999999843 34689999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
||++ ++|.+++...+.+++..+..++.||+.||.|||+.+|+||||+|+|||++.++.+||+|||++.....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 9998 58999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
.....|+..|+|||.+.+ ..++.++||||||+++|+|++|.+||...+.......+..
T Consensus 150 ~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 207 (260)
T cd05611 150 NKKFVGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-------------------- 207 (260)
T ss_pred cccCCCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------------------
Confidence 123468899999999877 4588999999999999999999999987654332221110
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC---HHHHhcCCCccCCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT---AEEALADPYFHGLA 410 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt---a~elL~Hp~f~~~~ 410 (595)
.....+ ......+++.+.+||.+||..||.+||+ ++|+|.||||..+.
T Consensus 208 ----~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 208 ----RRINWP---EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred ----cccCCC---CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 000000 1122356788999999999999999995 58999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=337.28 Aligned_cols=265 Identities=26% Similarity=0.400 Sum_probs=209.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++++.||+|+||+||+|.+..+|..||+|++.... .......+.+|+.+++.++||||+++++.+... ..+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 78 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNI 78 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEE
Confidence 57899999999999999999999999999999886432 223456788999999999999999999998543 568
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
|+||||++ ++|..++...+.+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999998 5788888887889999999999999999999997 699999999999999999999999999986542221
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
....+|+..|+|||++.+ ..++.++|||||||++|+|++|..||.......... .....
T Consensus 159 -----~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~--------~~~~~------ 217 (284)
T cd06620 159 -----ADTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ--------DDPMG------ 217 (284)
T ss_pred -----cCccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh--------hhhhH------
Confidence 123578999999999876 578899999999999999999999998654321100 00000
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
....+..+....+..+. ....+..+.+||.+||..||.+|||+.|+++||||..
T Consensus 218 --~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 218 --ILDLLQQIVQEPPPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred --HHHHHHHHhhccCCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 00011111111111110 1125678999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=330.18 Aligned_cols=256 Identities=21% Similarity=0.360 Sum_probs=200.9
Q ss_pred eEEeeeeeecCceEEEEEEECC---CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCcc
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~---~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~~ 190 (595)
|.+++.||+|+||.||+|.... ++..||||+++...........+.+|+.+|+.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5688999999999999998764 34789999987544444556778999999999999999999998865432 3334
Q ss_pred cEEEEEeccc-ccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcc
Q 007629 191 DIYVVFELME-SDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla 263 (595)
..++||||+. ++|..++... ..+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 5899999998 6888777432 35899999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
+......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+......++.+..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05035 161 KKIYSGDYYR-QGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH------- 230 (273)
T ss_pred eecccccccc-ccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------
Confidence 8654332111 1112245678999999866 678999999999999999999 8899987654332221111
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.... .....+++.+.+++.+||..||.+|||+.|++++
T Consensus 231 --------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 231 --------------------GNRL---KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred --------------------CCCC---CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 1123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=328.11 Aligned_cols=259 Identities=27% Similarity=0.445 Sum_probs=207.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc---CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF---EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence 46999999999999999999999999999999874321 1223456788999999999999999999987443 22
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+++||||+. ++|.+.+...+.+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 45899999997 58999998877899999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
........+...|+..|+|||++.+ ..++.++|||||||++|+|++|++||........+. .....+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~------- 226 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF---KIATQPT------- 226 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH---HHHcCCC-------
Confidence 2111111234578999999999877 568899999999999999999999997654322211 1111000
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
.......+++.+.++|.+||. +|..||++.+++.|||.
T Consensus 227 -------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 -------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 011123567889999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=328.05 Aligned_cols=249 Identities=28% Similarity=0.449 Sum_probs=203.6
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++.+.||.|+||.||++.+..++..||+|.++... .....+.+.+|+.+++.++||||+++++.+. ....+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEE
Confidence 5899999999999999999999999999999986432 2344567889999999999999999999884 345699
Q ss_pred EEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 194 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999998 5888887643 458999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. ......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+..
T Consensus 155 ~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--------------- 214 (255)
T cd08219 155 A---YACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--------------- 214 (255)
T ss_pred c---ccccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc---------------
Confidence 1 1234679999999999877 5789999999999999999999999987654332221110
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
....+ ....++..+.+||.+||..||.+||++.+++.-
T Consensus 215 ------------~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 ------------GSYKP---LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------------CCCCC---CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00001 112356789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=329.02 Aligned_cols=251 Identities=31% Similarity=0.468 Sum_probs=198.5
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEe
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E 197 (595)
...||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++|+||+++++++... ..+|+|||
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e 85 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-----GFFKIFME 85 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-----CEEEEEEe
Confidence 46899999999999999999999999988642 234566788999999999999999999988543 46899999
Q ss_pred ccc-ccHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC-CCcEEEcccCcceeccCCCCC
Q 007629 198 LME-SDLHQVIKAN-DDL--TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 198 ~~~-g~L~~~i~~~-~~l--~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~-~~~vKL~DFGla~~~~~~~~~ 272 (595)
|+. ++|.+++... ..+ ++..+..++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~- 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP- 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-
Confidence 998 5898888754 455 78889999999999999999999999999999999976 67999999999875432221
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHH
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~ 352 (595)
......|++.|+|||++.+....++.++|||||||++|+|++|++||........... .
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~--------------~----- 223 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF--------------K----- 223 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh--------------h-----
Confidence 1233468999999999865334588899999999999999999999965321110000 0
Q ss_pred HHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 353 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
.......+ .....+++.+.+|+.+||..+|.+|||+.|++.||||
T Consensus 224 -----~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 224 -----VGMFKIHP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----hhhhccCC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00000000 1113467889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=332.28 Aligned_cols=256 Identities=32% Similarity=0.536 Sum_probs=209.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~ 190 (595)
++|.+.+.||.|+||.||+|.+..+|..||||++.... ........+.+|+.+++.+. ||||+++++++.. ..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-----EE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-----Cc
Confidence 36999999999999999999999999999999986422 22233467889999999998 9999999998843 34
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 6899999995 799999998889999999999999999999999999999999999999999999999999999765432
Q ss_pred CCC-----------------cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHH
Q 007629 270 APS-----------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332 (595)
Q Consensus 270 ~~~-----------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~ 332 (595)
... ........|+..|+|||++.+ ..++.++|||||||++++|++|+.||...+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 211 011233568899999999876 5688899999999999999999999987653222211
Q ss_pred HHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH----HHHhcCCCc
Q 007629 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYF 406 (595)
Q Consensus 333 i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta----~elL~Hp~f 406 (595)
+.. ... .....+++.+.+||.+||..||.+||++ +++|+||||
T Consensus 234 ~~~--------------------------~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILK--------------------------LEY-----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHh--------------------------cCC-----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 110 000 0113447889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=332.82 Aligned_cols=265 Identities=25% Similarity=0.398 Sum_probs=205.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+++++.++||||+++++++... ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeE
Confidence 368999999999999999999999999999999864322 23456788999999999999999999988543 23468
Q ss_pred EEEEeccc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 193 YVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999998 578776543 3468999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCCh--HHHHHHHHhhcCCCChhHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV--VHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~--~~~l~~i~~~lg~p~~~~i 345 (595)
.... ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... ....+...
T Consensus 157 ~~~~-----~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------- 218 (287)
T cd06621 157 NSLA-----GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS----------- 218 (287)
T ss_pred cccc-----ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH-----------
Confidence 2221 23467889999999876 6789999999999999999999999976531 00011110
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
++..............-...++.+.+||.+||..||.+|||+.|+++||||+..
T Consensus 219 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 219 ----------YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred ----------HHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 000000000000000001245779999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=333.01 Aligned_cols=252 Identities=27% Similarity=0.381 Sum_probs=195.8
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCccCCh-hhHHHHHHHH---HHHHhcCCCceeeeeeeecCCCccCcccEEEE
Q 007629 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-SDATRILREI---KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (595)
Q Consensus 120 ~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~-~~~~~~~~Ei---~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV 195 (595)
.||+|+||.||+|.+..+++.||||.+....... ........|. .+++...||+|+.+++++.. ...+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----PDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCEEEEE
Confidence 4899999999999999999999999986432221 1112233343 44555679999999988843 3468999
Q ss_pred Eeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcc
Q 007629 196 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274 (595)
Q Consensus 196 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 274 (595)
|||+. ++|.+++...+.+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99998 5888888888889999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHH
Q 007629 275 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354 (595)
Q Consensus 275 ~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~ 354 (595)
....+|+..|+|||++.+. ..++.++||||+||++|+|++|+.||.+..........
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~--------------------- 208 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------------- 208 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---------------------
Confidence 1235799999999998642 46889999999999999999999999765321111000
Q ss_pred HHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCCC
Q 007629 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (595)
Q Consensus 355 ~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~~ 410 (595)
.... ..... .....++.+.+||.+||..||.+|| ++.++++||||+...
T Consensus 209 ~~~~----~~~~~---~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 209 RMTL----TMAVE---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HHhh----ccCCC---CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 0000 00111 1123578899999999999999999 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=350.57 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=196.9
Q ss_pred CCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~-----~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 186 (595)
++|++.+.||+|+||.||+|.. ..++..||||+++... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-- 111 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVG-- 111 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence 4799999999999999999964 3467789999986432 233456788999999999 899999999998443
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcC------------------------------------------------------
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 211 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~------------------------------------------------------ 211 (595)
...|+|||||+ |+|.+++....
T Consensus 112 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 112 ---GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ---CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 45899999998 68888886421
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 212 ---------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 212 ---------------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 46788899999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+......+..+..
T Consensus 269 ~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~-------------- 331 (375)
T cd05104 269 NYV-VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK-------------- 331 (375)
T ss_pred ccc-ccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH--------------
Confidence 111 1122345677999999877 679999999999999999998 8899976543221111100
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
...... .....+.++.+||.+||..||++||++.|+++.
T Consensus 332 --------~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 332 --------EGYRML-------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred --------hCccCC-------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 000000 012346789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=372.26 Aligned_cols=148 Identities=23% Similarity=0.412 Sum_probs=132.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|.+++.||+|+||.||+|.+..+++.||||+++... ........+.+|+.+++.++||||+++++++. ...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-----SAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-----ECC
Confidence 368999999999999999999999999999999986422 22334567889999999999999999998873 345
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
.+||||||+. ++|..++...+.+++..++.|+.||+.||.|||.+||+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 6999999997 6899999888889999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=323.54 Aligned_cols=253 Identities=30% Similarity=0.517 Sum_probs=210.1
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|.+.+.||.|+||.||+|.+..++..||+|++............+.+|+++++.++|||++++++.+... ..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 58999999999999999999999999999999875444445667788999999999999999999988543 5689
Q ss_pred EEEecccc-cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 194 VVFELMES-DLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 194 lV~E~~~g-~L~~~i~~~----~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+||||+++ +|.+.+... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999984 898888763 6799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... ......|++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.......+..
T Consensus 156 ~~~---~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 217 (258)
T cd08215 156 TVD---LAKTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK------------- 217 (258)
T ss_pred Ccc---eecceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-------------
Confidence 321 1234578999999999876 5688999999999999999999999976653222211110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
....+ .....+..+.+++.+||..+|.+|||+.++|+||||
T Consensus 218 --------------~~~~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 218 --------------GQYPP---IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred --------------CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 00111 112457789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=333.96 Aligned_cols=253 Identities=27% Similarity=0.377 Sum_probs=202.1
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEecc
Q 007629 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 199 (595)
Q Consensus 121 LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~ 199 (595)
||+|+||+||+|.+..+|+.||+|.+..... .......+..|+.+|+.++||||+++++++.. ...+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-----KDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-----CCeEEEEEecC
Confidence 6999999999999999999999999864322 12234456789999999999999999988843 35689999999
Q ss_pred c-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccc
Q 007629 200 E-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (595)
Q Consensus 200 ~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 276 (595)
+ ++|.+++.... .+++..+..++.|++.||.|||+.||+||||+|+|||++.++.+||+|||++........ .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----~ 151 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK----I 151 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc----c
Confidence 8 58988887665 799999999999999999999999999999999999999999999999999875432111 2
Q ss_pred cccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHH
Q 007629 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356 (595)
Q Consensus 277 ~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~ 356 (595)
....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...
T Consensus 152 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------------- 209 (277)
T cd05577 152 KGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR-------------------- 209 (277)
T ss_pred ccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--------------------
Confidence 34568889999999876 56889999999999999999999999765431111111000
Q ss_pred hhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCCCC
Q 007629 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLAN 411 (595)
Q Consensus 357 l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~~~ 411 (595)
. ...+. ...+..++.+.+||.+||..||.+|| ++.+++.||||..+..
T Consensus 210 ---~-~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 210 ---T-LEMAV---EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred ---c-ccccc---cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 0 00011 11234588899999999999999999 9999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=345.06 Aligned_cols=286 Identities=21% Similarity=0.269 Sum_probs=202.9
Q ss_pred eeeeec--CceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKG--SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G--~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
..||+| +||+||+|.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEE
Confidence 456766 99999999999999999999986543334445778899999999999999999999854 34589999
Q ss_pred eccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCc
Q 007629 197 ELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (595)
Q Consensus 197 E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 273 (595)
||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++|||.+..........
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9998 5888888764 358999999999999999999999999999999999999999999999998654322111110
Q ss_pred -cc---ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhH-----
Q 007629 274 -IF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES----- 344 (595)
Q Consensus 274 -~~---~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~----- 344 (595)
.. .....++..|+|||++.+....++.++|||||||++|+|++|.+||.+......+..+.......+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 00 011235667999999876434588999999999999999999999987664433322222111000000
Q ss_pred -HHHHhhHHHHHHh----hhccc-----CCC-CCC-CCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 345 -ISRIRNEKARRYL----GSMRK-----KQP-VPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 345 -i~~i~~~~~~~~l----~~~~~-----~~~-~~~-~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
........ ..+. ..... ... ..+ .......++.+.+||.+||..||.+|||+.|+|+||||..+.
T Consensus 239 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 239 EESRMKNSQ-SGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhhhhccch-hhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 00000000 0000 00000 000 000 001123567899999999999999999999999999997653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.16 Aligned_cols=258 Identities=29% Similarity=0.487 Sum_probs=209.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||.|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDE 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCc
Confidence 46899999999999999999999889999999998532 22345678899999999999999999998844 345
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.|+|+||++ ++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 899999998 588888765 468899999999999999999999999999999999999999999999999987543322
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+...++..+..
T Consensus 170 ~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--------------- 229 (293)
T cd06647 170 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--------------- 229 (293)
T ss_pred c---ccccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc---------------
Confidence 1 1234578999999999876 5788999999999999999999999987654332211100
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
. ..+.......++..+.+||.+||..||.+||++.+++.||||+...
T Consensus 230 ------------~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 230 ------------N-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ------------C-CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 0 0000111223567899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=327.83 Aligned_cols=248 Identities=22% Similarity=0.441 Sum_probs=200.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
.+|.+.+.||+|+||.||+|.+..++..||+|++... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF 77 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCCc
Confidence 4689999999999999999999999999999998642 2345678899999999999999999998843 3458
Q ss_pred EEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 193 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
|+||||++ ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999997 6899888754 35889999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||++.+..+....+..
T Consensus 158 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~------------- 220 (263)
T cd05052 158 TYTA--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------- 220 (263)
T ss_pred eeec--cCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-------------
Confidence 2111 112234567999999876 678999999999999999998 9999987664332222111
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.. .. .....+++.+.+||.+||..||++||++.++++
T Consensus 221 ----------~~----~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 221 ----------GY----RM---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ----------CC----CC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00 00 111346788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.71 Aligned_cols=257 Identities=31% Similarity=0.498 Sum_probs=207.1
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC---CCceeeeeeeecCCCccCcc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~~~ 190 (595)
.|++.+.||.|+||.||+|.+..++..||||.++... .......+.+|+.+++.+. ||||+++++++.. ..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CC
Confidence 4788899999999999999999999999999986432 2234567889999999997 9999999998843 34
Q ss_pred cEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
..|+||||+.+ +|.+++.. +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 68999999974 78888765 47999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
... .....|+..|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.........+
T Consensus 155 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---------------- 214 (277)
T cd06917 155 SSK---RSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI---------------- 214 (277)
T ss_pred ccc---cccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc----------------
Confidence 321 2345799999999987652 45788999999999999999999999765432211110
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
....+..+ .....+..+.+|+.+||..||.+||++.+++.||||+...
T Consensus 215 -----------~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 215 -----------PKSKPPRL--EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred -----------ccCCCCCC--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 00011111 1112577899999999999999999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=329.45 Aligned_cols=256 Identities=21% Similarity=0.376 Sum_probs=199.5
Q ss_pred eEEeeeeeecCceEEEEEEECCCCc--EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCccc
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGE--RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFKD 191 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~--~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~~~ 191 (595)
|.+.+.||+|+||.||+|....++. .||+|.++...........+.+|+.+|+.++||||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467899999999999999877765 69999887544445566788899999999999999999998754322 22345
Q ss_pred EEEEEeccc-ccHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 192 IYVVFELME-SDLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~------~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
.+++|||+. ++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 799999998 688877642 1347899999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
......... ......+++.|+|||.+.+ ..++.++|||||||++|||++ |++||.+.........+..
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-------- 229 (272)
T cd05075 161 KIYNGDYYR-QGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-------- 229 (272)
T ss_pred ccCccccee-cCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--------
Confidence 653322110 1122346778999999877 678999999999999999999 8899987554322221110
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.... ...+.++..+.+||.+||..||.+|||+.+++++
T Consensus 230 -------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 230 -------------------GNRL---KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -------------------CCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0000 1123456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=322.40 Aligned_cols=253 Identities=33% Similarity=0.540 Sum_probs=210.6
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++.+.||+|++|.||+|.+..++..||+|.+............+.+|+++++.++|||++++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence 5889999999999999999999999999999997654433456788999999999999999999998843 35689
Q ss_pred EEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 194 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 194 lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
+||||+++ +|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999984 89999988888999999999999999999999999999999999999999999999999999865433321
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHH
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~ 352 (595)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.
T Consensus 156 ---~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------------------ 212 (254)
T cd06627 156 ---DASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------------------ 212 (254)
T ss_pred ---ccccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------------------
Confidence 234578999999999876 458899999999999999999999997654322111110
Q ss_pred HHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 353 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
.... ......++..+.+||.+||..+|++|||+.+++.||||
T Consensus 213 --------~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 213 --------QDDH----PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred --------ccCC----CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0000 01123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=331.33 Aligned_cols=260 Identities=22% Similarity=0.362 Sum_probs=202.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~-----~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
.++|++.+.||+|+||.||+|..+. .+..||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-- 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 4689999999999999999997542 35589999886432 223345678899999999999999999988443
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcE
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAND----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 255 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~----------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~v 255 (595)
...|+||||+. ++|.+++.... .++...+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 82 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 ---QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred ---CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 45899999998 68999986532 34567788999999999999999999999999999999999999
Q ss_pred EEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 007629 256 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 334 (595)
Q Consensus 256 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~ 334 (595)
||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 159 KIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred EECcCCcccccccccccc-ccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999997543322111 1122345678999999876 678999999999999999998 788997755433222111
Q ss_pred hhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc------CCCccC
Q 007629 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA------DPYFHG 408 (595)
Q Consensus 335 ~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~------Hp~f~~ 408 (595)
.. ... ......++.+.+|+.+||..||++|||+.++++ ||||.+
T Consensus 236 ~~-------------------------~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 236 DG-------------------------GYL-----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred cC-------------------------CCC-----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 00 000 011234678999999999999999999999987 999987
Q ss_pred CC
Q 007629 409 LA 410 (595)
Q Consensus 409 ~~ 410 (595)
+.
T Consensus 286 ~~ 287 (288)
T cd05061 286 VS 287 (288)
T ss_pred CC
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.75 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=207.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
..|+.++.||.|+||.||+|.+..++..||||.+... ........+.+|+.+++.+.||||+++++++.. ...+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCEE
Confidence 3588889999999999999999999999999988642 223445678899999999999999999999843 3569
Q ss_pred EEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+||||+++ +|.+++.. +++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999984 78888764 5789999999999999999999999999999999999999999999999999976533221
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
......++..|+|||++.+ ..++.++|+|||||++|||++|.+||.+.+.......+.
T Consensus 157 ---~~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------------- 214 (277)
T cd06640 157 ---KRNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP----------------- 214 (277)
T ss_pred ---ccccccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-----------------
Confidence 1233468899999999876 578899999999999999999999997655332221110
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
...+ ......++..+.+||.+||..||.+||++.++++||||...
T Consensus 215 ----------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 215 ----------KNNP---PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ----------cCCC---CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 0000 11123456779999999999999999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=337.73 Aligned_cols=252 Identities=22% Similarity=0.374 Sum_probs=199.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcE----EEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~----vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
..+|++.+.||+|+||.||+|.+..++.. ||||+++.. ........+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---
Confidence 35799999999999999999987666654 899988642 2233456788999999999999999999998643
Q ss_pred CcccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
..++|+||+. |+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred ---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 3689999998 6899988764 3688999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
....... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+.
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~---------- 225 (316)
T cd05108 159 LGADEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---------- 225 (316)
T ss_pred ccCCCcc-eeccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh----------
Confidence 5432221 11122345678999999876 678999999999999999997 999997754322111110
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.....+. .+.++..+.+++.+||..||.+||++.+++.+
T Consensus 226 ---------------~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 226 ---------------KGERLPQ-----PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ---------------CCCCCCC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0001111 13456789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=329.98 Aligned_cols=253 Identities=21% Similarity=0.374 Sum_probs=198.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~-----~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
.++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~---- 79 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 79 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 467999999999999999999864 24568999998542 22334567889999999999999999999884
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcE
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAND----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 255 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~----------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~v 255 (595)
.....|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.++.+
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 80 -QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred -CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 3346899999998 68998886532 35677888999999999999999999999999999999999999
Q ss_pred EEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 007629 256 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 334 (595)
Q Consensus 256 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~ 334 (595)
||+|||+++......... ......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+....+..+.
T Consensus 159 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 159 KIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred EECCCCCccccCCcceee-cCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999987543222111 1122356788999999876 678999999999999999999 789998766433332221
Q ss_pred hhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 335 ~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.. ... ......++.+.+|+.+||+.||.+|||+.|++++
T Consensus 236 ~~---------------------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 EG---------------------------GLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cC---------------------------CcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 000 0112456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=331.42 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=201.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~-----~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
..+|.+.+.||+|+||.||+|.+.. ++..||||+++.... ......+.+|+++|+.++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG-- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC--
Confidence 3568899999999999999998743 467899999865322 22456788999999999999999999998543
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAND--------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~--------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~ 251 (595)
...|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 81 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 81 ---DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ---CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 46899999998 68999887543 4788899999999999999999999999999999999999
Q ss_pred CCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHH
Q 007629 252 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQL 330 (595)
Q Consensus 252 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l 330 (595)
++.+||+|||++......... .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+....+
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~ 234 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234 (280)
T ss_pred CCeEEECCcccceecccCcce-ecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999754332211 11123456788999999877 679999999999999999998 99999876644333
Q ss_pred HHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 331 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 331 ~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+.. ... ......++..+.+|+.+||..||.+||++.|+++
T Consensus 235 ~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 235 ECITQ---------------------------GRL---LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHc---------------------------CCc---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 22211 000 0111346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=326.65 Aligned_cols=245 Identities=23% Similarity=0.347 Sum_probs=195.6
Q ss_pred eeeecCceEEEEEEE--CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEe
Q 007629 120 VIGKGSYGVVGSAVD--THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (595)
Q Consensus 120 ~LG~G~fG~V~~a~~--~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E 197 (595)
.||+|+||.||+|.. ..++..||+|+++...........+.+|+.+++.+.||||+++++++.. ...++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 589999999999964 4578899999986544444456778899999999999999999998732 34699999
Q ss_pred ccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccc
Q 007629 198 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (595)
Q Consensus 198 ~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 276 (595)
|+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||+++............
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 998 5799999887889999999999999999999999999999999999999999999999999997654332211111
Q ss_pred cccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 277 ~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....++..|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+.......+..
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-------------------- 213 (257)
T cd05116 156 THGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-------------------- 213 (257)
T ss_pred CCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC--------------------
Confidence 22344678999998865 578889999999999999998 9999987654333222211
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
....+ ....+++.+.+||.+||+.||.+||++.+|.+
T Consensus 214 -------~~~~~---~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 214 -------GERME---CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -------CCCCC---CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 00001 11346788999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=340.33 Aligned_cols=281 Identities=23% Similarity=0.300 Sum_probs=201.2
Q ss_pred EeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEE
Q 007629 117 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 117 i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.+.+|. +|.||.+++..+++.||||+++...........+.+|+.+++.++||||+++++++... ..+|++|
T Consensus 6 i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~ 78 (314)
T cd08216 6 IGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVVS 78 (314)
T ss_pred hhHhhcC--CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEEE
Confidence 3444444 45566666677999999999975433445667899999999999999999999988543 4589999
Q ss_pred eccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC-
Q 007629 197 ELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS- 272 (595)
Q Consensus 197 E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~- 272 (595)
||+. ++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||.+.........
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 79 PLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred eccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 9998 6788888753 46899999999999999999999999999999999999999999999999998754322211
Q ss_pred ---cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 273 ---AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 273 ---~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
........++..|+|||++.+....|+.++|||||||++|||++|..||........+. ....+..... +...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~-~~~~- 234 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL--EKVRGTVPCL-LDKS- 234 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccCccc-cccC-
Confidence 01113346788999999987633468899999999999999999999998765433221 1111111100 0000
Q ss_pred hHHHHHHhhhccc--------CCCCC-CCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 350 NEKARRYLGSMRK--------KQPVP-FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 350 ~~~~~~~l~~~~~--------~~~~~-~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
........+.. ..... ........++.+.+|+.+||.+||.+|||+.++|+||||+++.
T Consensus 235 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 235 --TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred --chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00000000000 00000 0011123456789999999999999999999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=319.91 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=211.2
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|.+.+.||+|++|.||+|.+..++..|++|++............+.+|+.+++.++||||+++++.+.... ...+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 488899999999999999999999999999998654433345678899999999999999999999885432 25689
Q ss_pred EEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 194 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
+||||+. ++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999996 689999988778999999999999999999999999999999999999999999999999999876443321
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHH
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~ 352 (595)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... ....+..+.
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~--------------- 217 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIG--------------- 217 (260)
T ss_pred -ccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhcc---------------
Confidence 01234578899999999876 4588999999999999999999999977651 111111100
Q ss_pred HHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 353 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
. ...........+..+.+||.+||..||.+||++.+++.||||
T Consensus 218 ---------~--~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 218 ---------S--SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ---------c--cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 0 000111123347889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=363.33 Aligned_cols=257 Identities=24% Similarity=0.417 Sum_probs=203.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeee-ecCCCccC-c
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHI-MLPPSRRE-F 189 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~-~~~~~~~~-~ 189 (595)
-+++|.+.|.+|||+.||+|.+...|..||+|++-.. +......+.+||.+|++|+ |+|||.+++. ........ .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 4689999999999999999999888899999998543 5566778899999999998 9999999993 33332222 3
Q ss_pred ccEEEEEeccc-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 190 KDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~aL~yLHs~g--IiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
-.++|.||||. |.|.+++.. ...|++.++..||+|+++||.+||... |||||||-|||||..+|+.||||||.|.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 46889999999 699999874 346999999999999999999999998 9999999999999999999999999997
Q ss_pred eccCCCCCcccc---c---ccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhc
Q 007629 265 VSFNDAPSAIFW---T---DYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337 (595)
Q Consensus 265 ~~~~~~~~~~~~---~---~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~l 337 (595)
............ . ...-|+.|+|||.+.-+ ....++|+|||+|||+||-|+....||.+......
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI-------- 266 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI-------- 266 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE--------
Confidence 543332111000 0 12469999999976321 15689999999999999999999999976521110
Q ss_pred CCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCC
Q 007629 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (595)
Q Consensus 338 g~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp 404 (595)
+..+...| .++.++..+.+||..||+.||.+||++.+++.+-
T Consensus 267 ----------------------lng~Y~~P---~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 267 ----------------------LNGNYSFP---PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred ----------------------EeccccCC---CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 01111111 2367788899999999999999999999998753
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=335.26 Aligned_cols=254 Identities=28% Similarity=0.406 Sum_probs=205.5
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
.|++.+.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 78 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTKLW 78 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCceE
Confidence 47778899999999999999999999999999864322 2345678899999999999999999998854 34589
Q ss_pred EEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 194 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
+||||++ ++|.+++.. +.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 79 IIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred EEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999998 578777754 5789999999999999999999999999999999999999999999999999975432211
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHH
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~ 352 (595)
......|+..|+|||++.+ ..++.++|||||||++|||++|..||...........+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------------------- 213 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI------------------- 213 (277)
T ss_pred --hhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh-------------------
Confidence 1233468899999999877 57889999999999999999999999754432211110
Q ss_pred HHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 353 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
....+. ......+..+.+||.+||..+|.+||++.++++||||..+
T Consensus 214 --------~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 214 --------PKNSPP---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred --------hcCCCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 000000 1112456789999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.00 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=199.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~-----~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 185 (595)
.++|++.+.||.|+||.||+|.+. .+++.||+|+++... .......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 358999999999999999999743 345789999986432 233456778999999999 799999999987543
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhc------------------------------------------------------
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 210 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 210 (595)
...+|++|||+. ++|.+++...
T Consensus 84 ---~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 84 ---GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ---CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 246899999998 5788877532
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCC
Q 007629 211 -------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283 (595)
Q Consensus 211 -------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~ 283 (595)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ........++.
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~~~~~~~~ 239 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPL 239 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhccCCCCCc
Confidence 2578899999999999999999999999999999999999999999999999986533221 11123345677
Q ss_pred cccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhccc
Q 007629 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRK 362 (595)
Q Consensus 284 ~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~ 362 (595)
.|+|||++.+ ..++.++|||||||++|||++ |..||.+......+.... ..
T Consensus 240 ~y~aPE~~~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~--------------------------~~ 291 (337)
T cd05054 240 KWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL--------------------------KE 291 (337)
T ss_pred cccCcHHhcC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH--------------------------hc
Confidence 8999999877 689999999999999999997 999998754322111100 00
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 363 KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.... ......++.+.+++.+||+.+|.+||++.|+++|
T Consensus 292 ~~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 292 GTRM---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred cCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0000 0012356789999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=325.96 Aligned_cols=253 Identities=30% Similarity=0.507 Sum_probs=204.2
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEecc
Q 007629 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 199 (595)
Q Consensus 121 LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~ 199 (595)
||.|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++.+. ....+|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-----GKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-----cCcEEEEEEecC
Confidence 6899999999999999999999999864321 2234567889999999999999999988874 345689999999
Q ss_pred c-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC-----c
Q 007629 200 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS-----A 273 (595)
Q Consensus 200 ~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~-----~ 273 (595)
. ++|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+|||++.++.++|+|||++......... .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 7 589999988778999999999999999999999999999999999999999999999999998754332110 1
Q ss_pred ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHH
Q 007629 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (595)
Q Consensus 274 ~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~ 353 (595)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------------ 215 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------------------ 215 (265)
T ss_pred ccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Confidence 11234568899999999876 5688899999999999999999999977654332222111
Q ss_pred HHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH---HHHhcCCCccCC
Q 007629 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA---EEALADPYFHGL 409 (595)
Q Consensus 354 ~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta---~elL~Hp~f~~~ 409 (595)
.. ..+... ...++.+.+||.+||+.+|.+|||+ .++|+||||+.+
T Consensus 216 --------~~--~~~~~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 216 --------GK--IEWPED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred --------CC--cCCCcc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 00 011111 1247889999999999999999999 999999999865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=331.20 Aligned_cols=263 Identities=22% Similarity=0.389 Sum_probs=207.0
Q ss_pred CeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccC--ChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCcc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFE--HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~---~~g~~vAIK~i~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 187 (595)
.|++.+.||.|+||.||+|.+. .+|..||+|+++.... .....+.+.+|+.+|+.+ +|++|+.+++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---- 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence 3889999999999999999874 4789999999864221 222345678899999999 59999999988743
Q ss_pred CcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
...+|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++...
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 77 -DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 356899999998 589999988888999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
...... ......|+..|+|||.+.+....++.++|||||||++|+|++|..||...........+.+
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------- 222 (290)
T cd05613 156 HEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR----------- 222 (290)
T ss_pred cccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-----------
Confidence 332211 1234578999999999865334578899999999999999999999964332111111100
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~~ 410 (595)
.. +....+. ...+++.+.+|+.+||..||.+|| ++++++.||||..+.
T Consensus 223 --------~~---~~~~~~~-----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 223 --------RI---LKSEPPY-----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred --------Hh---hccCCCC-----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 00 0011111 124678899999999999999997 899999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=328.92 Aligned_cols=252 Identities=21% Similarity=0.376 Sum_probs=199.6
Q ss_pred CCeEEeeeeeecCceEEEEEEE----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVD----THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~----~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
.+|++.+.||+|+||+||+|.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE---- 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC----
Confidence 5789999999999999999985 3456789999986432 233446788999999999999999999988443
Q ss_pred cccEEEEEeccc-ccHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC
Q 007629 189 FKDIYVVFELME-SDLHQVIKAN-----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~-----------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~ 250 (595)
...|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 80 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 80 -QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred -CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 45899999998 5898888532 2478888999999999999999999999999999999999
Q ss_pred CCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHH
Q 007629 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 329 (595)
Q Consensus 251 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 329 (595)
.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYR-VQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEeccccccccccCCccee-cccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999997653322111 1233456778999999876 578999999999999999998 9999987654332
Q ss_pred HHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 330 l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
...+.. .... .....+++.+.+|+.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRK---------------------------RQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 222211 0001 1123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=330.73 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=200.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~-----~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
...|.+.+.||+|+||.||++.+. .++..||+|.+... .......+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--- 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---
Confidence 457999999999999999999752 34567999988642 23345678899999999999999999999853
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAND-------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 252 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~-------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~ 252 (595)
...+|+||||+. ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 79 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 79 --GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred --CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 346899999998 68988887543 48999999999999999999999999999999999999999
Q ss_pred CcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHH
Q 007629 253 CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLD 331 (595)
Q Consensus 253 ~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~ 331 (595)
+.+||+|||+++....... ........++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+....+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~ 233 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233 (288)
T ss_pred CcEEeccCCccccccCCce-eecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999975533221 111233456788999999876 678999999999999999998 899998766433322
Q ss_pred HHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 332 ~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.+.. ..... .....++.+.+|+.+||+.||.+|||+.++++
T Consensus 234 ~i~~---------------------------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 234 CITQ---------------------------GRVLQ---RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHc---------------------------CCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2211 00001 11245678999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=325.62 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=200.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++.+.||+|+||.||+|++..++..||||+++... ........+.+|+.+++.++||||+++++++.. ...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 57999999999999999999999999999999885422 233345568899999999999999999998843 346
Q ss_pred EEEEEeccc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 192 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
+|+||||++ ++|..++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 899999999 578877753 345889999999999999999999999999999999999999999999999998865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChH-HHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV-HQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~-~~l~~i~~~lg~p~~~~i 345 (595)
..... ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+.......+
T Consensus 157 ~~~~~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------- 224 (267)
T cd08228 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD------- 224 (267)
T ss_pred cchhH---HHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC-------
Confidence 33221 1234578899999999876 57889999999999999999999999654321 11110000000
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+. .....+..+.+||.+||..||.+||++.++++
T Consensus 225 -----------------~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 225 -----------------YPPL----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred -----------------CCCC----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 0011 11235677999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=328.19 Aligned_cols=253 Identities=27% Similarity=0.418 Sum_probs=205.4
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lyl 194 (595)
|++.+.||.|+||.||+|.+..++..||||.+.... .......+.+|+.+++.++||||+++++.+.. ...+|+
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 79 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLWI 79 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-----CCeEEE
Confidence 778899999999999999999999999999875321 22345678899999999999999999999843 356899
Q ss_pred EEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCc
Q 007629 195 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (595)
Q Consensus 195 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 273 (595)
||||+++ +|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 80 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 9999984 78777754 5789999999999999999999999999999999999999999999999999876533211
Q ss_pred ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHH
Q 007629 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (595)
Q Consensus 274 ~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~ 353 (595)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------------ 215 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK------------------ 215 (277)
T ss_pred -hhccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc------------------
Confidence 1234578999999999876 5778899999999999999999999976543222211100
Q ss_pred HHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 354 ~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..+ ......++..+.++|.+||..||.+||++.++++||||...
T Consensus 216 ---------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 216 ---------NNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ---------CCC---CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 000 01123467889999999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=334.47 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=206.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..|...+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++|||++++++++... ..
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HT 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----Ce
Confidence 348889999999999999999999999999999864322 223456788999999999999999999998543 45
Q ss_pred EEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.|+||||+.++|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++.....
T Consensus 100 ~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 100 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred EEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 899999999988887754 45789999999999999999999999999999999999999999999999999864322
Q ss_pred CCcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.....|++.|+|||++... ...++.++|||||||++|+|++|.+||...+....+..+...
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~------------- 239 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------- 239 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc-------------
Confidence 1234789999999987431 246888999999999999999999999765433322222110
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
..+. .....+++.+.+||.+||..+|.+||++.++++|+|+..
T Consensus 240 -------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 240 -------------ESPT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -------------cCCC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0000 011245678999999999999999999999999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=315.75 Aligned_cols=264 Identities=25% Similarity=0.405 Sum_probs=206.9
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
...||+|.+.||+|||+.||++.+..++..||+|+|... ...+.+..++|+...++++|||++++++..+........
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 457999999999999999999999999999999999653 356778899999999999999999999988766555566
Q ss_pred cEEEEEeccc-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCceeeCCCCcEEEcccCcc
Q 007629 191 DIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLA 263 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~qil~aL~yLHs~g--IiHrDLKP~NILl~~~~~vKL~DFGla 263 (595)
..||++.|.. |+|.+.|... ..+++.++..|+.+|++||++||+.. .+||||||.|||+.+.+.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 7999999987 7898888642 36999999999999999999999998 999999999999999999999999998
Q ss_pred eeccCCCCC------cccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhh
Q 007629 264 RVSFNDAPS------AIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 336 (595)
Q Consensus 264 ~~~~~~~~~------~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~ 336 (595)
....-.... ...|.....|..|+|||++.-. ....+.++|||||||+||+|+.|..||... ...
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~ 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQ 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhc
Confidence 753211111 1113344578899999987431 245788999999999999999999999421 110
Q ss_pred cCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 337 lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.|.-.. +. ......+... +..+..+.+||+.||+.||.+||++.+++.+
T Consensus 248 GgSlaL----------------Av-~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 248 GGSLAL----------------AV-QNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCeEEE----------------ee-eccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 000000 00 0001111111 2267889999999999999999999999874
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=317.45 Aligned_cols=251 Identities=31% Similarity=0.521 Sum_probs=206.7
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|.+.+.||.|++|.||++.+..++..|++|++..... .....+.+|+.+++.++||+|+++++++... ...|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence 48889999999999999999998999999999865322 3567788999999999999999999988543 4589
Q ss_pred EEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 194 VVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
+++||++ ++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+........
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999 6899888776 5899999999999999999999999999999999999999999999999999976543321
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+....+..+..
T Consensus 154 ----~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 211 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---------------- 211 (253)
T ss_pred ----ccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----------------
Confidence 234578899999999876 4688999999999999999999999987653332221111
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCC
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~ 405 (595)
...+ .......++..+.+||.+||..||++|||+.++|+|||
T Consensus 212 ----------~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 ----------NGPP--GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ----------cCCC--CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0000 00001123678999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=323.29 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=198.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|+++++||+|+||.||+|... ++..||+|.+... ....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK-----EEP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCC
Confidence 457999999999999999999864 5678999987532 2235678899999999999999999988743 345
Q ss_pred EEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 899999997 6899988653 4688899999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 156 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----------- 220 (261)
T cd05072 156 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG----------- 220 (261)
T ss_pred Ccee--ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----------
Confidence 2211 1123346678999999876 578899999999999999998 99999876543322222110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
... .....++..+.+|+.+||..||++||+++++++
T Consensus 221 ----------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 221 ----------------YRM---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ----------------CCC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 001 112346778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=322.71 Aligned_cols=247 Identities=25% Similarity=0.390 Sum_probs=197.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||+|+||.||+|..+ .+..||+|.+... ......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 74 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG---AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-----QKPL 74 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC---CccHHHHHHHHHHHHHCCCCCceeEEEEEcc-----CCCE
Confidence 56899999999999999999875 4568999987532 1224567889999999999999999998843 3458
Q ss_pred EEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 193 YVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
|+||||++ ++|.+++... +.+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 99999997 6899888753 468999999999999999999999999999999999999999999999999987543222
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. ......++..|+|||++.+ ..++.++|||||||++|||++ |++||...+..+.+..+....
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~------------ 218 (256)
T cd05114 155 YT--SSSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF------------ 218 (256)
T ss_pred ee--ccCCCCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC------------
Confidence 11 1122345668999999876 578999999999999999999 899998776544433332110
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.... ....+..+.+|+.+||..||.+||++.++++
T Consensus 219 ---------------~~~~---~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 219 ---------------RLYR---PKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ---------------CCCC---CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0000 0124567999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=382.59 Aligned_cols=262 Identities=30% Similarity=0.409 Sum_probs=214.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+++-.-.||.|.||.||.|.+..+|+..|+|-|+-..........+.+|.++|..|+|||+|++|++-.+. ..+|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-----ekv~ 1310 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-----EKVY 1310 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-----HHHH
Confidence 56667899999999999999999999999998864323334456778999999999999999999987654 3489
Q ss_pred EEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC-C
Q 007629 194 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA-P 271 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~-~ 271 (595)
|.||||+ |+|.+++...+-..+...+.+..|++.||.|||+.|||||||||.|||++.+|-+|++|||.|..+.+.. .
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999998 6899888877778888888999999999999999999999999999999999999999999998775543 1
Q ss_pred CcccccccccCCcccccccccccC-CCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~-~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
-......++||+.|||||++.+.. .....+.||||||||+.||+||+.||..-+..-+
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a--------------------- 1449 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA--------------------- 1449 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH---------------------
Confidence 122346789999999999997743 3466789999999999999999999965442211
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
--|--.+..+++.| ..++++..|||.+||..||++|.++.|+|+|-|-+.-
T Consensus 1450 ---IMy~V~~gh~Pq~P-----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1450 ---IMYHVAAGHKPQIP-----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred ---HHhHHhccCCCCCc-----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 11222333444433 2378999999999999999999999999999987643
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=327.64 Aligned_cols=247 Identities=22% Similarity=0.364 Sum_probs=194.9
Q ss_pred CCeEEeeee--eecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCc
Q 007629 113 SRYQIQEVI--GKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 113 ~~Y~i~~~L--G~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 189 (595)
+.|++.+.+ |.|+||.||++.++.++..+|+|.+...... . .|+.+...+ +||||+++++.+...
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--~-----~e~~~~~~~~~h~~iv~~~~~~~~~----- 81 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--A-----IEPMVHQLMKDNPNFIKLYYSVTTL----- 81 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--h-----hhHHHHHHhhcCCCEEEEEEEEecC-----
Confidence 356666665 9999999999999999999999998642111 1 133333323 699999999998543
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC-cEEEcccCcceecc
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSF 267 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~-~vKL~DFGla~~~~ 267 (595)
..+|+||||++ ++|.+++.....+++..++.++.||++||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 46899999997 69999998888999999999999999999999999999999999999999998 99999999987543
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.. ....|+..|+|||++.+ ..++.++|||||||++|+|++|..||....... +. .
T Consensus 162 ~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~-------------~-- 216 (267)
T PHA03390 162 TP-------SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LD-------------L-- 216 (267)
T ss_pred CC-------ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hh-------------H--
Confidence 21 23468999999999977 678999999999999999999999997543211 00 0
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-HHHHhcCCCcc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-AEEALADPYFH 407 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-a~elL~Hp~f~ 407 (595)
.... .... .+ ....+..++.+.+||.+||+.||.+||+ ++++|+||||.
T Consensus 217 ---~~~~---~~~~--~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 217 ---ESLL---KRQQ--KK---LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ---HHHH---Hhhc--cc---CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 0000 0000 00 1122357889999999999999999996 59999999996
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=329.34 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=201.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCC----------------cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCcee
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG----------------ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g----------------~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 175 (595)
..+|++++.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 468999999999999999999876544 468999986432 224466788999999999999999
Q ss_pred eeeeeecCCCccCcccEEEEEeccc-ccHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Q 007629 176 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 243 (595)
Q Consensus 176 ~l~~~~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~-----------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLK 243 (595)
++++++... ..+++||||+. ++|.+++.... .+++..+..++.|++.||.|||+.||+|||||
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 83 RLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred EEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 999988543 46899999998 58998887665 68999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc--CCCCC
Q 007629 244 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLF 321 (595)
Q Consensus 244 P~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt--G~~pF 321 (595)
|+|||++.++.++|+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 99999999999999999999764332211 11233456788999999876 578999999999999999998 67888
Q ss_pred CCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHh
Q 007629 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401 (595)
Q Consensus 322 ~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL 401 (595)
...+....+..+.... ............+.++.++.+|+.+||+.||.+|||+.|++
T Consensus 235 ~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 235 EHLTDQQVIENAGHFF-----------------------RDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred CCcChHHHHHHHHhcc-----------------------ccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 7655433322221110 00000001111234568899999999999999999999997
Q ss_pred c
Q 007629 402 A 402 (595)
Q Consensus 402 ~ 402 (595)
+
T Consensus 292 ~ 292 (296)
T cd05051 292 L 292 (296)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=321.16 Aligned_cols=246 Identities=26% Similarity=0.434 Sum_probs=201.0
Q ss_pred eeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~---g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV 195 (595)
+.||+|+||.||+|.+... +..||+|.++...... ....+.+|+.+++.++|+||+++++++.. ...+|+|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEE
Confidence 4699999999999998866 8999999987543322 46778899999999999999999998854 3568999
Q ss_pred Eeccc-ccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 196 FELME-SDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 196 ~E~~~-g~L~~~i~~~---------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
|||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+..
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99995 7899999875 7899999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
...... ........++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------- 222 (262)
T cd00192 155 VYDDDY-YRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--------- 222 (262)
T ss_pred cccccc-cccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------
Confidence 544321 111234567889999999876 578999999999999999999 6999987654333222211
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.... .....+++.+.+++.+||..||.+|||+.+++++
T Consensus 223 ------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 223 ------------------GYRL---PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ------------------CCCC---CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0000 1123457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=321.44 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=207.5
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|++.+.||.|+||.||++.+..+++.||+|++............+.+|+.+++.++||||+++++++... ...|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence 58999999999999999999999999999999875443444566778999999999999999999888543 5689
Q ss_pred EEEeccc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 194 VVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+||||++ ++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999997 588888765 35689999999999999999999999999999999999999999999999999986544
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.. .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 156 ~~-----~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 215 (256)
T cd08530 156 NM-----AKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------------- 215 (256)
T ss_pred CC-----cccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 31 223568899999999876 6788899999999999999999999987654322111100
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
... .......+..+.++|.+||..+|.+||++.++++||++
T Consensus 216 --------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 216 --------------GKY---PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred --------------CCC---CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 000 01112456789999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.28 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=206.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
+.|...+.||+|+||.||+|.+..+|..||||++..... .......+.+|+.+++.++|||++++++++.. ...
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 95 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHT 95 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCE
Confidence 347778889999999999999999999999999864322 22344678899999999999999999999844 346
Q ss_pred EEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.|+||||+.++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 96 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 899999999988888765 45789999999999999999999999999999999999999999999999999864211
Q ss_pred CCcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.....|+..|+|||++... ...++.++|||||||++|+|++|.+||...+....+..+..
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------------- 234 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------- 234 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--------------
Confidence 1345789999999997431 24588899999999999999999999987654333322211
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
...+ ....+.++..+.+||.+||+.+|.+||++.+++.||||..
T Consensus 235 ------------~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 235 ------------NDSP---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred ------------cCCC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 0000 0112345677999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=330.84 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=196.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCc--EEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGE--RVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~--~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 189 (595)
++|++.+.||+|+||.||+|....++. .+|+|.++.. ........+.+|+.++.++ +||||+++++++.. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~ 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-----R 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----C
Confidence 579999999999999999999877765 4788887632 2333456788999999999 79999999998843 3
Q ss_pred ccEEEEEeccc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC
Q 007629 190 KDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 252 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~ 252 (595)
..+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 45899999998 68999886542 47888999999999999999999999999999999999999
Q ss_pred CcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHH
Q 007629 253 CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLD 331 (595)
Q Consensus 253 ~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~ 331 (595)
+.+||+|||++........ ......+..|+|||++.+ ..++.++|||||||++|||++ |..||.+........
T Consensus 156 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CeEEECCcCCCccccceec----cCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999863211111 111223457999999876 678999999999999999997 999998766433222
Q ss_pred HHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 332 ~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.+.. .... .....+++.+.+||.+||..||.+||+++++++.
T Consensus 230 ~~~~---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 230 KLPQ---------------------------GYRM---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHhc---------------------------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2110 0000 0113467889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=327.15 Aligned_cols=252 Identities=21% Similarity=0.370 Sum_probs=198.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~-----~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
+.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 81 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--- 81 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence 569999999999999999999877 77899999886432 223345688999999999999999999988543
Q ss_pred CcccEEEEEeccc-ccHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC---cEE
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLK 256 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~~-------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~---~vK 256 (595)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+++||||||+|||++.++ .+|
T Consensus 82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 34799999997 68999887653 488899999999999999999999999999999999998765 599
Q ss_pred EcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 007629 257 ICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTD 335 (595)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~ 335 (595)
|+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+..
T Consensus 160 l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 160 IADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred eccCccccccCCccce-ecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999865322111 00112234567999999876 679999999999999999997 9999987664333222111
Q ss_pred hcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 336 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 336 ~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
. .... ....+++.+.+|+.+||+.||++||++.++|+|
T Consensus 237 ~---------------------------~~~~---~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 G---------------------------GRLD---PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C---------------------------CcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0000 113457789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=328.40 Aligned_cols=253 Identities=27% Similarity=0.447 Sum_probs=199.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~-----g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 185 (595)
.++|++.+.||+|+||.||++..... ...||+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 35799999999999999999987643 3789999986432 233456788999999999 79999999998843
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcee
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKA----------------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 248 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~----------------~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NIL 248 (595)
...+|++|||+. ++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||
T Consensus 88 ---~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 88 ---EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred ---CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 345899999997 689888854 236889999999999999999999999999999999999
Q ss_pred eCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChH
Q 007629 249 ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVV 327 (595)
Q Consensus 249 l~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~ 327 (595)
++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EcCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999998654322111 1122335677999999876 678999999999999999997 99999876643
Q ss_pred HHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 328 ~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.....+.. .... ......+..+.+|+.+||..||++|||+.|++++
T Consensus 242 ~~~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLKE---------------------------GYRM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 32221110 0000 0112457789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=321.70 Aligned_cols=245 Identities=23% Similarity=0.393 Sum_probs=192.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEec
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~ 198 (595)
+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++... ..+|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEee
Confidence 46999999999999999999999999876432 223446788999999999999999999998543 458999999
Q ss_pred cc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccc
Q 007629 199 ME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (595)
Q Consensus 199 ~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 276 (595)
+. ++|.+++...+ .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......... ...
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~ 153 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-STG 153 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccc-ccC
Confidence 97 58998887544 6899999999999999999999999999999999999999999999999998754321110 001
Q ss_pred cccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 277 ~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...........+..
T Consensus 154 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-------------------- 211 (252)
T cd05084 154 GMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-------------------- 211 (252)
T ss_pred CCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc--------------------
Confidence 11123456999999876 578999999999999999997 8899865443221111110
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+.+ .....+..+.+|+.+||..||.+|||+.++++
T Consensus 212 -------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 212 -------GVRLP---CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCCCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00111 11245778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=332.27 Aligned_cols=255 Identities=28% Similarity=0.511 Sum_probs=206.0
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lyl 194 (595)
|.....||+|+||.||++....+|..||||++... .......+.+|+.+++.++||||+++++++.. ....|+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 94 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV 94 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEE
Confidence 33347899999999999999999999999998532 22345668899999999999999999998843 356899
Q ss_pred EEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCc
Q 007629 195 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (595)
Q Consensus 195 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 273 (595)
||||+++ +|.+++. ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 95 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~- 172 (292)
T cd06657 95 VMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 172 (292)
T ss_pred EEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc-
Confidence 9999985 6777654 457899999999999999999999999999999999999999999999999998754332211
Q ss_pred ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHH
Q 007629 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (595)
Q Consensus 274 ~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~ 353 (595)
.....|++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+......+..+...
T Consensus 173 --~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~----------------- 231 (292)
T cd06657 173 --RKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN----------------- 231 (292)
T ss_pred --ccccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-----------------
Confidence 234578999999999876 57889999999999999999999999876654333222110
Q ss_pred HHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 354 ~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
.+..+ .....+++.+.+|+.+||..||.+||++.++|+||||....
T Consensus 232 ----------~~~~~-~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 232 ----------LPPKL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ----------CCccc-CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 01111 11234678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.59 Aligned_cols=245 Identities=22% Similarity=0.327 Sum_probs=194.4
Q ss_pred eeeeecCceEEEEEEECCCC---cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTG---ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g---~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV 195 (595)
++||+|+||.||+|....++ ..||+|.+...... .....+.+|+.+|+.+.||||+++++++.. ..+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEE
Confidence 46999999999999876554 78999998653322 345678899999999999999999998632 347999
Q ss_pred Eeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcc
Q 007629 196 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274 (595)
Q Consensus 196 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 274 (595)
|||+. ++|.+++.....+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++..........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99997 68999998888899999999999999999999999999999999999999999999999999986543222111
Q ss_pred cccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHH
Q 007629 275 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353 (595)
Q Consensus 275 ~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~ 353 (595)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~----------------- 214 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG----------------- 214 (257)
T ss_pred cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-----------------
Confidence 1111223467999999876 678999999999999999998 99999766543322222110
Q ss_pred HHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 354 ~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.+. .....+++.+.+||.+||..||++||++.++++
T Consensus 215 ----------~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 215 ----------ERL---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ----------CcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000 111345778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=328.18 Aligned_cols=258 Identities=33% Similarity=0.532 Sum_probs=211.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
....|++.+.||.|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||+++++++... .
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 88 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG-----D 88 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----C
Confidence 45568899999999999999999998999999999864322 456788999999999999999999998543 4
Q ss_pred cEEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 191 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.+|+|+||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 6899999999 68999998876 899999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+..
T Consensus 169 ~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~------------- 230 (286)
T cd06614 169 EKS---KRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT------------- 230 (286)
T ss_pred chh---hhccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------
Confidence 221 1133468889999999876 5789999999999999999999999976654332221110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
... +.......++..+.+||.+||+.+|.+||++.++|+||||...
T Consensus 231 --------------~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 231 --------------KGI-PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred --------------cCC-CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 000 0011122367789999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=332.26 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=196.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcE--EEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~--vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 188 (595)
.++|++.+.||+|+||.||+|.+..++.. +|+|.++.. ........+.+|+.++..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~----- 79 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----- 79 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-----
Confidence 45799999999999999999998877764 577776532 2233456788999999999 89999999999843
Q ss_pred cccEEEEEeccc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC
Q 007629 189 FKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~ 251 (595)
...+|+||||+. ++|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 346899999997 68999887542 4788999999999999999999999999999999999999
Q ss_pred CCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHH
Q 007629 252 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQL 330 (595)
Q Consensus 252 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l 330 (595)
++.+||+|||++........ .....++..|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 233 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 233 (303)
T ss_pred CCcEEeCccccCcccchhhh----cccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 99999999999863211110 111234567999998876 568899999999999999998 99999766543222
Q ss_pred HHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 331 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 331 ~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
..+. ..... ......++.+.+||.+||..||.+||+++++|++
T Consensus 234 ~~~~---------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 234 EKLP---------------------------QGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHh---------------------------cCCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1110 00000 0112357789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=322.44 Aligned_cols=253 Identities=24% Similarity=0.367 Sum_probs=200.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~---g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
.++|++.+.||+|+||+||+|....+ ...||||.++... .......+.+|+.+++.++||||+++++.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK----- 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----
Confidence 35799999999999999999988654 4589999886432 22345678899999999999999999998843
Q ss_pred cccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 189 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
...+|+||||+. ++|.+++... +.+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 345899999998 5899888764 46899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+....
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-------- 225 (266)
T cd05033 157 EDSEAT-YTTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-------- 225 (266)
T ss_pred cccccc-eeccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC--------
Confidence 422211 11112345678999999876 678999999999999999998 999997654332222221100
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
..+. ....++.+.+|+.+||+.||.+||++.+++++
T Consensus 226 -----------------~~~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 226 -----------------RLPP-----PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -----------------CCCC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0011 12457789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=325.37 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=199.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCc----EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~----~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
..+|++++.||.|+||+||+|.+..++. .||+|+++... .......+.+|+.+++.+.||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---
Confidence 4679999999999999999999877776 48999886432 233456788999999999999999999988543
Q ss_pred CcccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
..+++|||++ |+|.+++... +.+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 82 ---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred ---CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 3689999998 6899888764 4689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
....... .......+++.|+|||.+.+ ..++.++|||||||++|||++ |.+||...........+.
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---------- 225 (279)
T cd05109 159 LDIDETE-YHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE---------- 225 (279)
T ss_pred cccccce-eecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----------
Confidence 5432211 11122345678999999876 678999999999999999998 899997654322111111
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
. ....+ .....++.+.+|+.+||..||.+||++.+++.
T Consensus 226 --------------~---~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 226 --------------K---GERLP---QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred --------------C---CCcCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 00011 12346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=321.36 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=197.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
.+|++.+.||+|+||.||+|.+. ++..||||.++... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 76 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-----EEPI 76 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEec-----CCCe
Confidence 57999999999999999999875 45789999986422 234568899999999999999999998743 3458
Q ss_pred EEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 193 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999995 78999987654 6899999999999999999999999999999999999999999999999999876422
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.... ......+..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+....+..+...
T Consensus 157 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~------------ 220 (261)
T cd05068 157 IYEA--REGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG------------ 220 (261)
T ss_pred cccc--cCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC------------
Confidence 2111 111223457999999876 678999999999999999999 99999876643333222110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
...+ .....+..+.+|+.+||..||.+||++.++++
T Consensus 221 ---------------~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 221 ---------------YRMP---CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ---------------CCCC---CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0001 11345678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=343.57 Aligned_cols=255 Identities=25% Similarity=0.333 Sum_probs=203.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++..+++.||+|+||+||+|++- | .||||+++.........+.|..|+.+|++-+|.||+-+.+++..+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~------ 461 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP------ 461 (678)
T ss_pred HHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc------
Confidence 456788999999999999999653 4 5999999877667778899999999999999999999999997664
Q ss_pred EEEEEecccc-cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~g-~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+.||.-+|+| +|+.++.-. ..|.......|+.||++|+.|||.++|||||||..|||+.++++|||+||||+.....-
T Consensus 462 ~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 462 LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 4899999997 788888643 46888899999999999999999999999999999999999999999999999753221
Q ss_pred CCCcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.....+....|...|||||++... ..+|++.+|||||||++|||++|..||...+ .+|+- ...|.-.
T Consensus 542 -~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~dqIi---fmVGrG~------- 609 (678)
T KOG0193|consen 542 -SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RDQII---FMVGRGY------- 609 (678)
T ss_pred -ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hhheE---EEecccc-------
Confidence 111123345678889999998642 3579999999999999999999999998444 33322 1111110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..........+++.++++|+..||.+++++||.+.+||.
T Consensus 610 ---------------l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 610 ---------------LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ---------------cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 001112233456678999999999999999999999887
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=339.44 Aligned_cols=282 Identities=31% Similarity=0.522 Sum_probs=226.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC------CceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH------PDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~~~ 185 (595)
.++|.+....|+|-|++|..|.+...|..||||+|... ..-.+.=++|+.||++|.. -++++++..|..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-- 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-- 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--
Confidence 57999999999999999999999999999999999642 1223445789999999963 467888777743
Q ss_pred ccCcccEEEEEecccccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC-CcEEEcccC
Q 007629 186 RREFKDIYVVFELMESDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFG 261 (595)
Q Consensus 186 ~~~~~~lylV~E~~~g~L~~~i~~~~---~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~-~~vKL~DFG 261 (595)
.+++|||||-+.-+|.+++++-+ .|....++.|+.||..||..|..+||+|.||||+||||++. ..+||||||
T Consensus 506 ---knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 506 ---KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ---cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 46799999999999999998755 68889999999999999999999999999999999999975 458999999
Q ss_pred cceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCC
Q 007629 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (595)
Q Consensus 262 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~ 341 (595)
.|....... .+.|..++.|+|||+++| -.|+...|+||+||+||||.||+.+|+|...-++|.++.++-|..+
T Consensus 583 SA~~~~ene-----itPYLVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 583 SASFASENE-----ITPYLVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred ccccccccc-----ccHHHHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 997654333 477889999999999999 6899999999999999999999999999999999999999999988
Q ss_pred hhHHHHHhhHHH--HHHhh----------------hcccCCC-CCCC------CCCCC----CCHHHHHHHHhhCcCCCC
Q 007629 342 TESISRIRNEKA--RRYLG----------------SMRKKQP-VPFS------HKFPN----ADPLALHLLERLLAFDPK 392 (595)
Q Consensus 342 ~~~i~~i~~~~~--~~~l~----------------~~~~~~~-~~~~------~~~~~----~~~~~~dLl~~~L~~DP~ 392 (595)
...+.+-..... ...++ .|....| ..+. +.++. .-..+.+||.+||..||.
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 877655321110 00000 0000111 0000 11111 123478999999999999
Q ss_pred CCCCHHHHhcCCCccC
Q 007629 393 DRPTAEEALADPYFHG 408 (595)
Q Consensus 393 ~Rpta~elL~Hp~f~~ 408 (595)
+|.|..++|+||||..
T Consensus 736 KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 736 KRITVNQALKHPFITE 751 (752)
T ss_pred hcCCHHHHhcCCcccC
Confidence 9999999999999964
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.05 Aligned_cols=260 Identities=24% Similarity=0.389 Sum_probs=203.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++.+.||.|+||.||+|.+..++..||||.++.... ......+.+|+.++..+. ||||+++++++.. ..
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~ 87 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DS 87 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CC
Confidence 4679999999999999999999998999999999864322 223456777888776665 9999999999844 34
Q ss_pred cEEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 191 DIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.+|+||||+.+.|..++.. ...+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+||+|||++.....
T Consensus 88 ~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 88 DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 6899999999888777765 4578999999999999999999997 6999999999999999999999999999875432
Q ss_pred CCCCcccccccccCCcccccccccccC--CCCCCcceeechhHHHHHHHcCCCCCCCCChH-HHHHHHHhhcCCCChhHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV-HQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~--~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~-~~l~~i~~~lg~p~~~~i 345 (595)
... .....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||...... +.+..+
T Consensus 168 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~------------ 231 (296)
T cd06618 168 SKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI------------ 231 (296)
T ss_pred CCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH------------
Confidence 221 12345788999999986531 34788999999999999999999999653211 111110
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
+. ...+. + .....++..+.+||.+||..||.+||+++++++||||...
T Consensus 232 -----------~~---~~~~~-~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 232 -----------LQ---EEPPS-L-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred -----------hc---CCCCC-C-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 00 00000 0 0111357789999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.59 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=199.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCc---EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~---~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
.+|+..+.||+|+||.||+|.+..++. .||||++.... .......+..|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 78 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-----F 78 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-----C
Confidence 468889999999999999999876665 79999886432 23345678899999999999999999999843 3
Q ss_pred ccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 190 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
..+|+||||++ ++|.+++... +.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 45899999998 5788888654 578999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
..............+..|+|||++.+ ..++.++|||||||++|||++ |..||...+..+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~--------- 227 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF--------- 227 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC---------
Confidence 33221111111223457999999876 578999999999999999997 999997765443333222110
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+. ....+..+.+|+.+||..||.+||++.++++
T Consensus 228 ------------------~~~~---~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 228 ------------------RLPA---PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ------------------CCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1111 1235678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=344.11 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=196.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~-----g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 185 (595)
.++|+++++||+|+||.||+|.+... +..||||+++... .....+.+.+|+.+|+.+. ||||+++++++..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-- 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-- 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 46899999999999999999987433 3579999986432 2334567899999999996 9999999999843
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhc------------------------------------------------------
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 210 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 210 (595)
...+|||||||. |+|.+++..+
T Consensus 113 ---~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 113 ---SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred ---CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 346899999998 6888877542
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcee
Q 007629 211 ------------------------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 248 (595)
Q Consensus 211 ------------------------------------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NIL 248 (595)
..+++..+..++.||+.||+|||+.+|+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 24778888999999999999999999999999999999
Q ss_pred eCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChH
Q 007629 249 ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVV 327 (595)
Q Consensus 249 l~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~ 327 (595)
++.++.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 999999999999999865332211 11223457788999999876 678999999999999999997 99999764322
Q ss_pred HHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 328 ~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+... + ......+ ....+++.+.+|+.+||..||++||++.++.+
T Consensus 347 ~~~~~~--------------~------------~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNK--------------I------------KSGYRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHH--------------H------------hcCCCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 111100 0 0000000 11346788999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=328.79 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=206.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..+|...+.||+|+||.||+|++..++..||||.+.... ........+.+|+.+++.++|+|++++++++... .
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----H 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----C
Confidence 345788899999999999999999999999999986422 2223445678999999999999999999988543 4
Q ss_pred cEEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
..|+||||+.++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||++......
T Consensus 89 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred eeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 5899999999988887754 456899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
....|++.|+|||++.+. ...++.++|||||||++|+|++|..||...+....+..+..
T Consensus 169 -------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 228 (308)
T cd06634 169 -------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------- 228 (308)
T ss_pred -------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh-------------
Confidence 235788999999987531 14578899999999999999999999876543222211110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
...+. ......+..+.+||.+||.++|.+||+++++++|||+...
T Consensus 229 -------------~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 229 -------------NESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred -------------cCCCC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00000 0112456779999999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.66 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=200.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCc---EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~---~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
..+|++.+.||+|+||.||+|.+..++. .||+|.++.... ......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----- 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 3579999999999999999998865543 799998864322 2345678899999999999999999998843
Q ss_pred cccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 189 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
...+|+||||++ ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 346899999998 5899888765 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
..............++..|+|||.+.+ ..++.++|+|||||++|||++ |..||.+....+....+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-------- 226 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-------- 226 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC--------
Confidence 433221111122234568999999876 578999999999999999886 999997765433322221110
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+ ....+++.+.+|+.+||+.+|.+||++.++++
T Consensus 227 -------------------~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 227 -------------------RLP---APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -------------------cCC---CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 011 11345778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=364.96 Aligned_cols=256 Identities=28% Similarity=0.376 Sum_probs=200.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++.++||+|+||.||+|.+..+|+.||||++...... .....++.+|+.+++.++||||+++++++.. ...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-----~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-----GDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-----CCE
Confidence 5899999999999999999999999999999999753322 2335678999999999999999999998843 356
Q ss_pred EEEEEeccc-ccHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcc
Q 007629 192 IYVVFELME-SDLHQVIKAN-----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 259 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~-----------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~D 259 (595)
+|+||||++ ++|.+++... ..++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 899999998 5888887641 2345667788999999999999999999999999999999999999999
Q ss_pred cCcceeccCCCCC---------------cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCC
Q 007629 260 FGLARVSFNDAPS---------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK 324 (595)
Q Consensus 260 FGla~~~~~~~~~---------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~ 324 (595)
||+++........ .......+||+.|||||++.+ ..++.++|||||||++|||++|..||.+.
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999865211100 001123579999999999877 67899999999999999999999999764
Q ss_pred ChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 325 NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 325 ~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
........ ... ..+... ..+..+++.+.+++.+||..||++|++..+.|.+
T Consensus 235 ~~~ki~~~--~~i-------------------------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYR--DVI-------------------------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhh--hhc-------------------------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43211100 000 000000 1124567889999999999999999887766654
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=322.58 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=199.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~-----g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+|+.+.||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--
Confidence 35799999999999999999987644 3789999986432 223456788999999999999999999998543
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcE
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAND----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 255 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~----------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~v 255 (595)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+
T Consensus 82 ---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 ---QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred ---CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 45899999997 68998886432 36778899999999999999999999999999999999999999
Q ss_pred EEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 007629 256 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 334 (595)
Q Consensus 256 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~ 334 (595)
||+|||+++........ .......+|..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+.......+.
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 159 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred EECCcccchhhccCccc-ccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 99999999765332211 11123457788999999876 578999999999999999998 999998766433222111
Q ss_pred hhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 335 ~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
...... .....+..+.+||.+||..+|++|||+.++++
T Consensus 236 ---------------------------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 ---------------------------DGGHLD---LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ---------------------------cCCCCC---CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000000 11234778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=320.28 Aligned_cols=249 Identities=21% Similarity=0.336 Sum_probs=197.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|++.+.||+|+||+||+|.... +..||||.+.... .....+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CC
Confidence 3579999999999999999997653 4569999886422 2235688999999999999999999998433 35
Q ss_pred EEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 799999997 5799888764 46899999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+.......+...
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~------------ 217 (256)
T cd05113 154 EYT--SSVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG------------ 217 (256)
T ss_pred cee--ecCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC------------
Confidence 211 1112345677999999876 578999999999999999998 99999765543322222110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.... .....+..+.+|+.+||..||.+||++.+++++
T Consensus 218 ---------------~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 218 ---------------LRLY---RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---------------CCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0000 012346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=327.91 Aligned_cols=252 Identities=22% Similarity=0.355 Sum_probs=198.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~-----g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
.+|++.+.||+|+||.||+|.+..+ +..||||+++.... ......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--- 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--- 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC---
Confidence 4688899999999999999987543 57899999874322 22345678999999999999999999998543
Q ss_pred CcccEEEEEeccc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~ 250 (595)
..+++++||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 81 --~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 81 --QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred --CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 35899999998 5788887532 2478888999999999999999999999999999999999
Q ss_pred CCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHH
Q 007629 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 329 (595)
Q Consensus 251 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 329 (595)
.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |.+||.+....+.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred CCCceEecccccccccccchhe-eeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999998754322211 11233456789999999876 578999999999999999998 8889987665433
Q ss_pred HHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 330 l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
+..+... ...+ .-..++..+.+|+.+||+.||.+||++.++++.
T Consensus 236 ~~~i~~~---------------------------~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 236 IEMIRNR---------------------------QVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHcC---------------------------CcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 3322211 0001 113467789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=319.17 Aligned_cols=253 Identities=28% Similarity=0.472 Sum_probs=201.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++.+.||.|+||.||+|.+..+|+.||+|.++.. .........+.+|+++++.++|++|+++++++... ..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence 5799999999999999999999999999999988632 22233456788999999999999999999998543 45
Q ss_pred EEEEEeccc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 192 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
.|+||||++ ++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 899999998 588888754 245899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...... ... + ..
T Consensus 157 ~~~~~~---~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~-~-----------~~ 218 (267)
T cd08224 157 SSKTTA---AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYS-L-----------CK 218 (267)
T ss_pred cCCCcc---cceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHH-H-----------Hh
Confidence 332211 234578999999999876 67899999999999999999999999654310 000 0 00
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.+ .. ....+.+ ....+..+.++|.+||..+|.+|||+.++++
T Consensus 219 ~~--------~~--~~~~~~~----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 219 KI--------EK--CDYPPLP----ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred hh--------hc--CCCCCCC----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 00 0001111 1245678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=321.17 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=196.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
.+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|+.+++.++||||+++++++... ..+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 74 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----RPI 74 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----Cce
Confidence 46889999999999999999875 567899998864222 234678899999999999999999988433 458
Q ss_pred EEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 193 YVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
|+||||++ ++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 99999997 5899988764 468999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
... .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+...
T Consensus 155 ~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------------- 217 (256)
T cd05059 155 YTS--SQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG------------- 217 (256)
T ss_pred ccc--cCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-------------
Confidence 111 111233457999999876 678999999999999999999 89999776543322221110
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
. .. ......++.+.+|+.+||..+|++|||+.|+++.
T Consensus 218 ----------~----~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 218 ----------Y----RL---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ----------C----cC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0 00 1113467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=320.54 Aligned_cols=247 Identities=27% Similarity=0.395 Sum_probs=197.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+. .+..||+|.+..... ....+.+|+.+++.++||+|+++++++.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~ 74 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EP 74 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECC------CC
Confidence 457999999999999999999765 567799999864322 23568899999999999999999987732 24
Q ss_pred EEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 799999998 5899988753 3589999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+...
T Consensus 155 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~----------- 219 (260)
T cd05070 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG----------- 219 (260)
T ss_pred ccccc--ccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 22111 122345678999999876 678999999999999999999 89999876654433332211
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.+.+ .....+..+.+|+.+||..||.+|||+.++++
T Consensus 220 ----------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 220 ----------------YRMP---CPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ----------------CCCC---CCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0001 11345778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=321.15 Aligned_cols=247 Identities=27% Similarity=0.396 Sum_probs=196.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.++||+|+||.||+|.+..+ ..||+|+++.... ....+.+|+.+++.++||||+++++.+.. ..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC------CC
Confidence 46799999999999999999988655 4699999864222 23567899999999999999999987632 24
Q ss_pred EEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 799999998 5899998763 3588999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+..+...
T Consensus 155 ~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~----------- 219 (262)
T cd05071 155 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG----------- 219 (262)
T ss_pred cccc--cccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-----------
Confidence 2211 1123356778999998876 678999999999999999999 88999876543322221110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.+.+ .....+..+.+||.+||+.||.+||++.++++
T Consensus 220 ----------------~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 220 ----------------YRMP---CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ----------------CCCC---CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0001 11346778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=322.88 Aligned_cols=248 Identities=26% Similarity=0.418 Sum_probs=201.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|++.+.||.|+||.||+|.+.. +..||+|++... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 76 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-----GEP 76 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEec-----CCC
Confidence 3469999999999999999999877 889999998643 22345678899999999999999999998843 345
Q ss_pred EEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 899999998 5899998753 4689999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+....
T Consensus 157 ~~~~---~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---------- 221 (261)
T cd05148 157 DVYL---SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY---------- 221 (261)
T ss_pred cccc---ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC----------
Confidence 2211 123356778999999876 678899999999999999998 899998766433333222100
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+ .....++.+.+++.+||..||.+|||+.++++
T Consensus 222 ---------------~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 222 ---------------RMP-----CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ---------------cCC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 001 11356788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=325.71 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=198.8
Q ss_pred CCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~-----~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
.+|.+.+.||+|+||.||+|.+. .++..||+|.+.. ........+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG--- 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC---
Confidence 46999999999999999999753 3456799998853 2223446788999999999999999999998543
Q ss_pred CcccEEEEEeccc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~ 250 (595)
...++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 80 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 80 --DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 45899999997 68999886543 378899999999999999999999999999999999999
Q ss_pred CCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHH
Q 007629 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 329 (595)
Q Consensus 251 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 329 (595)
.++.+||+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+....
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred cCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999975433221 111234567889999999877 678999999999999999998 9999977654332
Q ss_pred HHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 330 l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
+..+.. ... .......+..+.+|+.+||..||.+||++.++++
T Consensus 235 ~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 235 IECITQ---------------------------GRV---LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHhC---------------------------CCC---CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 222110 000 0111235678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.42 Aligned_cols=243 Identities=31% Similarity=0.501 Sum_probs=199.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 190 (595)
...|.+...+|.|+|++|..+.+..+++.+|+|++.+.. ....+|+.++... .||||+++.+++ .+..
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~ 389 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVY-----EDGK 389 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeeccee-----cCCc
Confidence 457889999999999999999999999999999997541 2234577666554 699999999998 4556
Q ss_pred cEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee-CCCCcEEEcccCcceeccC
Q 007629 191 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA-NADCKLKICDFGLARVSFN 268 (595)
Q Consensus 191 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl-~~~~~vKL~DFGla~~~~~ 268 (595)
++|+|||++.| .+.+.+.....+. .++..|+.||+.|+.|||++|||||||||+|||+ +..++++|+|||.++....
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 79999999995 5666666655454 7888899999999999999999999999999999 6999999999999986544
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
+ +.+.+-|..|.|||++.. ..|++++||||||++||+||+|+.||....... + |...++.+
T Consensus 469 ~------~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--e-i~~~i~~~-------- 529 (612)
T KOG0603|consen 469 S------CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--E-IHTRIQMP-------- 529 (612)
T ss_pred h------hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCchH--H-HHHhhcCC--------
Confidence 3 233467889999999986 799999999999999999999999997765431 1 11111111
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
+++ ..+|..+++||++||++||.+|+++.+++.||||
T Consensus 530 ------------------~~s---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 530 ------------------KFS---ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ------------------ccc---cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 111 4578999999999999999999999999999999
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=324.34 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=198.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~-----~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
..+|.+.++||+|+||.||+|.. ..++..||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG-- 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--
Confidence 35788999999999999999964 235678999988642 234456789999999999999999999988543
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAND---------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~---------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~ 250 (595)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 80 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 ---RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred ---CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 45899999998 68988887643 478899999999999999999999999999999999999
Q ss_pred CCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHH
Q 007629 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 329 (595)
Q Consensus 251 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 329 (595)
.++.+||+|||++......... .......+++.|+|||.+.+ ..++.++|||||||++|||++ |.+||......+.
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCcee-ecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence 9999999999999755332211 11123345788999999876 678999999999999999998 8999976554333
Q ss_pred HHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 330 l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
+..+... .+. .....+++.+.+||.+||+.||.+||++.++++
T Consensus 234 ~~~~~~~---------------------------~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 234 IECITQG---------------------------REL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHcC---------------------------ccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2222110 000 111346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=322.69 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=197.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCc----EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~----~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
.+|++.+.||+|+||+||+|....++. .||+|.+... ........+..|+.+++.+.||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~----- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG----- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----
Confidence 578999999999999999999877776 4677766432 122334567788889999999999999998732
Q ss_pred cccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 189 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
...++++||+. ++|.+++... +.+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++..
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 23688999998 7999999764 57899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
..... ........++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.......+.+..
T Consensus 160 ~~~~~-~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~---------- 226 (279)
T cd05111 160 YPDDK-KYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK---------- 226 (279)
T ss_pred cCCCc-ccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC----------
Confidence 43321 112234567788999999876 578999999999999999998 9999987654322221110
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
....+. ....+..+.+++.+||..||.+|||+.|+++
T Consensus 227 -----------------~~~~~~---~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 227 -----------------GERLAQ---PQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----------------CCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000010 1124567899999999999999999999977
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=321.77 Aligned_cols=267 Identities=24% Similarity=0.418 Sum_probs=199.2
Q ss_pred CCeEEeeeeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 113 SRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~----~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
.+|++.+.||+|+||.||+|. +..++..||||++... .......+.+|+.+|+.++||||+++++++....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--- 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---
Confidence 479999999999999999997 4567889999998642 2344567889999999999999999999875432
Q ss_pred cccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 189 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 245899999997 6899988764 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh--hH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST--ES 344 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~--~~ 344 (595)
..............++..|+|||++.+ ..++.++|||||||++|||++|..++..... ... ...+.... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~----~~~~~~~~~~~~ 231 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFM----RMMGNDKQGQMI 231 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhh----hhcccccccccc
Confidence 332221111112234456999999876 6789999999999999999999877643321 111 11111100 00
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.. .....+......+ ....++..+.+||.+||..+|++|||+.|+++
T Consensus 232 ~~--------~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 232 VY--------HLIELLKNNGRLP---APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hH--------HHHHHHhcCCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00 0001111111111 12456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=319.06 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=199.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCc---EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~---~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
.+|++.+.||+|+||.||+|.++.++. .||||.+.... .......+..|+.+++.+.||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----S 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-----C
Confidence 468999999999999999999887665 69999986432 23445678999999999999999999998843 3
Q ss_pred ccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 190 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
..+|+||||++ ++|.+++... +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 45899999998 4788888753 568999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCcccccccc--cCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 268 NDAPSAIFWTDYV--ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 268 ~~~~~~~~~~~~~--gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
............. .+..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-------- 227 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-------- 227 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC--------
Confidence 3222111111111 2457999999876 678999999999999999886 99999776543322222110
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.+.+. ...+++.+.+++.+||..+|.+||++.+++.
T Consensus 228 -------------------~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 228 -------------------YRLPP---PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -------------------CcCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01111 1345778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=317.64 Aligned_cols=247 Identities=26% Similarity=0.401 Sum_probs=198.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|+++++||+|+||.||+|... ++..||+|.+.... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 74 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EP 74 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CC
Confidence 357999999999999999999864 57889999986432 234578899999999999999999987632 34
Q ss_pred EEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+|+||||+. ++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 799999997 6899888653 3688999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
..... .....++..|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+....+....
T Consensus 155 ~~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------- 220 (260)
T cd05067 155 NEYTA--REGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY---------- 220 (260)
T ss_pred CCccc--ccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC----------
Confidence 22111 123346678999999876 578899999999999999999 999998766443332221110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+ .....+..+.+||.+||..||++||++++++.
T Consensus 221 -----------------~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 221 -----------------RMP---RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----------------CCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 001 11335678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=325.89 Aligned_cols=259 Identities=23% Similarity=0.372 Sum_probs=197.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCC--------------cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeee
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG--------------ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 177 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g--------------~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 177 (595)
..+|++.+.||+|+||.||+|.+..++ ..||||+++... .......+.+|+++|+.++||||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 358999999999999999999875432 359999986432 23344568899999999999999999
Q ss_pred eeeecCCCccCcccEEEEEeccc-ccHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCC
Q 007629 178 KHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 244 (595)
Q Consensus 178 ~~~~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP 244 (595)
++++... ..+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||
T Consensus 83 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 157 (295)
T cd05097 83 LGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157 (295)
T ss_pred EEEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence 9998543 45899999998 58888885432 367888999999999999999999999999999
Q ss_pred CceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc--CCCCCC
Q 007629 245 KNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLFP 322 (595)
Q Consensus 245 ~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt--G~~pF~ 322 (595)
+|||++.++.+||+|||++......... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcce-eccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 9999999999999999999754332211 11123355778999999876 678999999999999999988 667887
Q ss_pred CCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 323 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 323 ~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+....+..+... ...... ..+....+..++.+.+|+.+||..||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~--------------------~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 235 LLSDEQVIENTGEF--------------------FRNQGR---QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ccChHHHHHHHHHh--------------------hhhccc---cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 65543332222111 000000 0001122345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.91 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=197.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCC
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPP 184 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~-------~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 184 (595)
++|.+.+.||+|+||.||+|.+.. ++..||+|.++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 579999999999999999998643 23579999986432 233456788999999999 79999999999843
Q ss_pred CccCcccEEEEEeccc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCce
Q 007629 185 SRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 247 (595)
Q Consensus 185 ~~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NI 247 (595)
...+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.|++||||||+||
T Consensus 96 ----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 96 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 345899999998 68999997542 478889999999999999999999999999999999
Q ss_pred eeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCCh
Q 007629 248 LANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNV 326 (595)
Q Consensus 248 Ll~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~ 326 (595)
|++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+...
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhh-ccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99999999999999987543211110 0112234568999999876 678999999999999999998 8899976553
Q ss_pred HHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 327 ~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.+....+.. .... ......+..+.+||.+||..+|.+||++.+++++
T Consensus 249 ~~~~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 249 EELFKLLKE---------------------------GHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHc---------------------------CCCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 222221110 0000 1123457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=321.45 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=200.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++.+.||.|+||.||+|.+..++..||||.+.... ........+.+|+.+++.+.||||+++++++.. ...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence 46889999999999999999999999999999885422 223345678899999999999999999998853 346
Q ss_pred EEEEEeccc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 192 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
+|++|||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 899999998 478887763 346899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
..... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+...... .. ..
T Consensus 157 ~~~~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~------------~~ 218 (267)
T cd08229 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SL------------CK 218 (267)
T ss_pred ccCCc---ccccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HH------------hh
Confidence 33221 1234578999999999876 5788999999999999999999999976432110 00 00
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
. +... ...+. .....++.+.+||.+||..||.+|||+.++++
T Consensus 219 ~---------~~~~-~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 219 K---------IEQC-DYPPL----PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred h---------hhcC-CCCCC----CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0 0000 00011 11246778999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=322.98 Aligned_cols=268 Identities=24% Similarity=0.343 Sum_probs=197.1
Q ss_pred CCe-EEeeeeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 113 SRY-QIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 113 ~~Y-~i~~~LG~G~fG~V~~a~----~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
+|| ++++.||+|+||+||++. ...++..||+|.++... .......+.+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ--- 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 355 999999999999998764 34578899999986432 122456678999999999999999999987432
Q ss_pred CcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
....+|+||||+. ++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 2345899999998 5788888654 6999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
..............++..|+|||.+.+ ..++.++|||||||++|||++|..||...... ....+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~---- 230 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTV---- 230 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccch----
Confidence 432221111122345677999999876 57899999999999999999999998653311 00001000000000
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
......+. .....+ .....+..+.+|+.+||..||++|||+.++++
T Consensus 231 ----~~~~~~~~---~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 231 ----VRLIELLE---RGMRLP---CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ----hhhhhhhh---cCCCCC---CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000000 000011 12346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=343.19 Aligned_cols=265 Identities=25% Similarity=0.382 Sum_probs=212.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
+-|..++.||-|+||.|+++....|...||+|.+.+.. .....+..+..|-.||.....+-||+||-.| .+...
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCc
Confidence 45888999999999999999999999999999986421 2223456677899999999999999998877 45567
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC--
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN-- 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~-- 268 (595)
+|+||||+. ||+..+|.+.+-|.|+.+++++.++..|+++.|.+|+|||||||+|||||.+|+|||+|||||.-+..
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999998 69999999999999999999999999999999999999999999999999999999999999963210
Q ss_pred ------CCCCc-------------------------------ccccccccCCcccccccccccCCCCCCcceeechhHHH
Q 007629 269 ------DAPSA-------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 311 (595)
Q Consensus 269 ------~~~~~-------------------------------~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il 311 (595)
..... +.....+||+.|+|||++.. ..|+..+|+||.||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhHHH
Confidence 00000 00123589999999999987 7899999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCC
Q 007629 312 AEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP 391 (595)
Q Consensus 312 ~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP 391 (595)
|||+.|++||-.....+....+. .++.++. + ....++++++.+||.++.. ++
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~-----------------nw~~~l~-------~---~~~~~ls~e~~~li~kLc~-sa 913 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVI-----------------NWRNFLH-------I---PYQGNLSKEALDLIQKLCC-SA 913 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeee-----------------ehhhccc-------c---ccccccCHHHHHHHHHHhc-Ch
Confidence 99999999997765433211111 1111111 1 1234678999999998765 88
Q ss_pred CCCCC---HHHHhcCCCccCCCCC
Q 007629 392 KDRPT---AEEALADPYFHGLANV 412 (595)
Q Consensus 392 ~~Rpt---a~elL~Hp~f~~~~~~ 412 (595)
+.|.. ++++..||||+++...
T Consensus 914 d~RLGkng~d~vKaHpfFkgIDfs 937 (1034)
T KOG0608|consen 914 DSRLGKNGADQVKAHPFFKGIDFS 937 (1034)
T ss_pred hhhhcccchhhhhcCccccccchH
Confidence 88875 7789999999987653
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=319.33 Aligned_cols=252 Identities=29% Similarity=0.482 Sum_probs=200.4
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC---ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
||.+.+.||+|+||.||++.+..++..+++|.++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----D 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----C
Confidence 69999999999999999999988888788877654221 222344577899999999999999999988543 4
Q ss_pred cEEEEEeccc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 191 DIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
..|+||||+. ++|..++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++. +.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 5899999998 478777653 357999999999999999999999999999999999999975 6799999999976
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
....... .....|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.........+..
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---------- 219 (260)
T cd08222 155 LMGSCDL---ATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---------- 219 (260)
T ss_pred cCCCccc---ccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc----------
Confidence 5433221 234568899999998866 5788899999999999999999999976553322211110
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
... ......++..+.+||.+||..||.+||++.++++||||
T Consensus 220 ----------------~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 220 ----------------GPT----PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ----------------CCC----CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 000 01113456789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.60 Aligned_cols=264 Identities=27% Similarity=0.432 Sum_probs=194.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
+.|.-...||+|+||.||+|.-. +|..||||++....... ..+|.+|+.+|.+++|||+|+|+++|..... ..
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~ 147 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR 147 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence 45666789999999999999864 45899999886432221 4559999999999999999999999965431 48
Q ss_pred EEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 193 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~g---IiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
+||+|||. |+|.+.+.... +++|.....|+.++++||+|||+.. ||||||||+|||+|++++.||+|||+|+..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 99999998 79999997665 8999999999999999999999853 999999999999999999999999999654
Q ss_pred cCCCCCccccccc-ccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDY-VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~-~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
... ... .... .||.+|+|||++.. +..+.|+|||||||+|+||+||+.+..............+. .
T Consensus 228 ~~~-~~~--~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~--------~ 294 (361)
T KOG1187|consen 228 PEG-DTS--VSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA--------K 294 (361)
T ss_pred Ccc-ccc--eeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH--------H
Confidence 321 111 1222 89999999999876 68899999999999999999999887653311111111100 0
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCC--CCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~--~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+........++. .... ..++ ..-..+..+..+|++.+|.+||++.|+++
T Consensus 295 ~~~~~~~~~eiiD~---~l~~---~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 295 PLLEEGKLREIVDP---RLKE---GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHCcchhheeCC---CccC---CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 00111111111111 0000 1111 11223678899999999999999999755
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.05 Aligned_cols=236 Identities=29% Similarity=0.442 Sum_probs=195.6
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEe
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E 197 (595)
++-||.|+-|.||+|+. .++.||||+++.. -..+|+-|++|+||||+.+.++|... ..+|||||
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiME 192 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIME 192 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCC-----ceeEEeee
Confidence 46699999999999964 4789999998532 13578899999999999999999543 45899999
Q ss_pred ccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccc
Q 007629 198 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (595)
Q Consensus 198 ~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 276 (595)
||. |-|..+++....++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++...... + .
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-T---k 268 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-T---K 268 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh-h---h
Confidence 998 7899999999999999999999999999999999999999999999999999999999999998654331 1 2
Q ss_pred cccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHH
Q 007629 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356 (595)
Q Consensus 277 ~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~ 356 (595)
-.++||..|||||++.. .+.+.|+|||||||||||||||..||.+-+. .+ |.+..|....
T Consensus 269 MSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVds---sA-IIwGVGsNsL-------------- 328 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS---SA-IIWGVGSNSL-------------- 328 (904)
T ss_pred hhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccch---he-eEEeccCCcc--------------
Confidence 35799999999999988 7899999999999999999999999976432 11 1122222111
Q ss_pred hhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCC
Q 007629 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (595)
Q Consensus 357 l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp 404 (595)
..|+| ..++..++=||+.||.-.|..||++.++|.|-
T Consensus 329 ------~LpvP-----stcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 329 ------HLPVP-----STCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred ------cccCc-----ccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 11111 34566789999999999999999999999993
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=316.99 Aligned_cols=244 Identities=22% Similarity=0.334 Sum_probs=190.6
Q ss_pred eeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEe
Q 007629 120 VIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (595)
Q Consensus 120 ~LG~G~fG~V~~a~~~--~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E 197 (595)
.||+|+||.||+|... ..+..||+|++.... .......+.+|+.+++.++||||+++++++.. ..+|+|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEE
Confidence 3899999999999765 445679999886432 23344668899999999999999999998732 24799999
Q ss_pred ccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 198 LME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 198 ~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
|++ ++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++............
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 998 588888875 457899999999999999999999999999999999999999999999999999754332221111
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~ 354 (595)
.+...++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+...
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------------------ 214 (257)
T cd05115 155 RSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG------------------ 214 (257)
T ss_pred cCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC------------------
Confidence 122234578999999876 578899999999999999996 99999876543322222110
Q ss_pred HHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 355 ~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.... ..+..++++.+||.+||..||++||++.++++
T Consensus 215 ---------~~~~---~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 215 ---------KRLD---CPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------CCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0001 11345788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=315.61 Aligned_cols=242 Identities=22% Similarity=0.402 Sum_probs=195.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
.+|++.+.||+|+||.||++.. .|..||+|.++.. ...+.+.+|+.+++.++|+||+++++++... ...+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~ 75 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGL 75 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCce
Confidence 5799999999999999999975 4788999988532 2345688999999999999999999876432 2458
Q ss_pred EEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 193 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999998 58999987654 4789999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
. ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+.......+..
T Consensus 156 ~------~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~------------- 214 (256)
T cd05082 156 Q------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------- 214 (256)
T ss_pred C------CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-------------
Confidence 1 22345668999999876 678999999999999999997 9999976553222211110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+. ...+.+++.+.+||.+||..||++|||+.++++
T Consensus 215 --------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 215 --------------GYKM---DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred --------------CCCC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0000 112356788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=316.17 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=199.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+. .+..||||.+.... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EEP 75 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CCc
Confidence 468999999999999999999875 45789999986422 234668899999999999999999998743 345
Q ss_pred EEEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 899999998 58999987643 689999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+.....
T Consensus 156 ~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------- 222 (261)
T cd05034 156 DEYTA--REGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR--------- 222 (261)
T ss_pred hhhhh--hhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 21110 112234568999999876 678999999999999999998 9999987765444433321110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.+. ....+..+.+++.+||..||.+||++.++++
T Consensus 223 ----------------~~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 223 ----------------MPR-----PPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ----------------CCC-----CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 011 1234678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=334.05 Aligned_cols=255 Identities=25% Similarity=0.429 Sum_probs=196.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~-----~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 185 (595)
.++|++.+.||+|+||+||+|.+ ..+++.||||+++... .......+.+|+.+|..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 46899999999999999999984 3567899999986432 223456788999999999 689999999987432
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhc------------------------------------------------------
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 210 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 210 (595)
...+|+|||||+ ++|.+++...
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 84 ---GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ---CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 245899999998 6888887642
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccccc
Q 007629 211 -------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 277 (595)
Q Consensus 211 -------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 277 (595)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 239 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKG 239 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-hhcC
Confidence 13677788889999999999999999999999999999999999999999999764322211 1112
Q ss_pred ccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHH
Q 007629 278 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356 (595)
Q Consensus 278 ~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~ 356 (595)
...++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+... +
T Consensus 240 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------------~-------- 295 (343)
T cd05103 240 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--------------L-------- 295 (343)
T ss_pred CCCCCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH--------------H--------
Confidence 2345678999999876 678999999999999999996 99999764321111100 0
Q ss_pred hhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 357 LGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 357 l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.... ..+.+ ...++.+.+++.+||..||.+|||+.|+++|
T Consensus 296 ~~~~--~~~~~-----~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 296 KEGT--RMRAP-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred hccC--CCCCC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0000 00111 1256789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=325.41 Aligned_cols=252 Identities=26% Similarity=0.421 Sum_probs=197.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 183 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~-------~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 183 (595)
.++|.+.+.||+|+||.||+|.+.. ....||+|.++... .......+.+|+.+++.+ .||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3579999999999999999997632 34579999886432 233456788999999999 59999999998843
Q ss_pred CCccCcccEEEEEeccc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCc
Q 007629 184 PSRREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (595)
Q Consensus 184 ~~~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~N 246 (595)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 90 -----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 90 -----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 345899999998 6899988653 247888999999999999999999999999999999
Q ss_pred eeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCC
Q 007629 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325 (595)
Q Consensus 247 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~ 325 (595)
||++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EEEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999997553221111 0112234567999999876 678999999999999999999 889998765
Q ss_pred hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 326 ~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
....+..+.. .... .....++..+.+||.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~~---------------------------~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 242 VEELFKLLRE---------------------------GHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHHc---------------------------CCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 4333222211 0000 112345778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=315.37 Aligned_cols=246 Identities=27% Similarity=0.390 Sum_probs=196.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||+|+||.||+|.+..+ ..||+|.+.... .....+.+|+.+++.+.||||+++++++.. ...
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~ 75 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EPI 75 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CCc
Confidence 5799999999999999999987654 469999875321 224567889999999999999999988732 247
Q ss_pred EEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 193 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999998 58999987643 4789999999999999999999999999999999999999999999999999765322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 156 ~~~--~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~------------ 219 (260)
T cd05069 156 EYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG------------ 219 (260)
T ss_pred ccc--ccCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence 211 1123346778999998876 678999999999999999999 89999876543333222110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
...+ .....+..+.+|+.+||.+||.+||+++++++
T Consensus 220 ---------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 220 ---------------YRMP---CPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ---------------CCCC---CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0001 11345678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=323.49 Aligned_cols=265 Identities=16% Similarity=0.189 Sum_probs=192.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhH---------HHHHHHHHHHHhcCCCceeeeee
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDA---------TRILREIKLLRLLRHPDIVEIKH 179 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~---g~~vAIK~i~~~~~~~~~~---------~~~~~Ei~il~~l~HpnIv~l~~ 179 (595)
..+|++.++||+|+||+||+|.+..+ +..+|+|+........... .....++..+..+.|++|+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35899999999999999999998777 6677777643211111000 11223344556678999999998
Q ss_pred eecCCCccCcccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcc
Q 007629 180 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 259 (595)
Q Consensus 180 ~~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~D 259 (595)
+...... .....|+++|++...+.+++.....+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|
T Consensus 91 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRC-RMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecC-CceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 7643321 122457889988888877777666678899999999999999999999999999999999999999999999
Q ss_pred cCcceeccCCCCCc----ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHh
Q 007629 260 FGLARVSFNDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD 335 (595)
Q Consensus 260 FGla~~~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~ 335 (595)
||+|+......... .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+......+.....
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 99998653322110 11123479999999999887 6799999999999999999999999987632221111100
Q ss_pred hcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 336 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 336 ~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
. .++..+.... ...+..++.+.++++.|+..+|.+||++.++++
T Consensus 248 --------------~----~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 248 --------------C----DFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred --------------H----HHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 0111111100 112445788999999999999999999999875
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=324.42 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=198.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT-------HTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 183 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~-------~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 183 (595)
..+|.+.+.||+|+||.||+|++. ..+..||+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 457999999999999999999753 234579999886432 234456788999999999 79999999998843
Q ss_pred CCccCcccEEEEEeccc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCc
Q 007629 184 PSRREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (595)
Q Consensus 184 ~~~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~N 246 (595)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 93 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 93 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 346899999998 5899888753 246778889999999999999999999999999999
Q ss_pred eeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCC
Q 007629 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325 (595)
Q Consensus 247 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~ 325 (595)
||++.++.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999865332211 11123356778999999876 678999999999999999998 789997765
Q ss_pred hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 326 ~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.......+.. .... .....++..+.+||.+||..+|.+||++.|+++.
T Consensus 245 ~~~~~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKE---------------------------GHRM---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 4333222210 0000 0113467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=324.78 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=198.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~-----~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 185 (595)
.++|.+.+.||+|+||.||+|.+ ..++..||||+++... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG- 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-
Confidence 35799999999999999999975 3355689999886432 233456788999999999 799999999988433
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCc
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGl 262 (595)
..+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||+
T Consensus 112 ----~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 ----GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ----CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 45899999998 68999987543 389999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCC
Q 007629 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPS 341 (595)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~ 341 (595)
++........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+......+.....
T Consensus 188 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~------ 258 (302)
T cd05055 188 ARDIMNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK------ 258 (302)
T ss_pred cccccCCCce-eecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH------
Confidence 9754332211 11123356788999999876 578999999999999999998 9999977553221111100
Q ss_pred hhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 342 ~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
... .. ......++.+.+|+.+||.++|++|||+.|+++
T Consensus 259 ----------------~~~----~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 259 ----------------EGY----RM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ----------------cCC----cC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 000 00 011245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=322.45 Aligned_cols=250 Identities=23% Similarity=0.388 Sum_probs=195.4
Q ss_pred CeEEeeeeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~-----~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ----- 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----
Confidence 47889999999999999998753 23578898876432 22345678899999999999999999998843
Q ss_pred cccEEEEEeccc-ccHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Q 007629 189 FKDIYVVFELME-SDLHQVIKAN------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 243 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~------------------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLK 243 (595)
....|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+|+|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 345899999998 6888887542 247888999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCC
Q 007629 244 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFP 322 (595)
Q Consensus 244 P~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~ 322 (595)
|+|||++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999765332211 11122345678999998876 678999999999999999998 999998
Q ss_pred CCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 323 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 323 ~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
+.........+... . ..+ ....++..+.+|+.+||+.||.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~-----------------------~--~~~-----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 232 GIAPERLFNLLKTG-----------------------Y--RME-----RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCHHHHHHHHhCC-----------------------C--CCC-----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 76543322211100 0 000 11245678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=315.12 Aligned_cols=246 Identities=23% Similarity=0.367 Sum_probs=196.0
Q ss_pred eeeeecCceEEEEEEECC-CCc--EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTH-TGE--RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~-~g~--~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV 195 (595)
+.||+|+||+||+|.+.. .+. .||||.+...... ...+.+.+|+.+++.++||||+++++++.. ..+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEE
Confidence 468999999999998765 333 6999998754332 456788899999999999999999998854 468999
Q ss_pred Eeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 196 FELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 196 ~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
|||++ ++|.+.+.... .+++..++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99997 68999987764 6899999999999999999999999999999999999999999999999999865432221
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+.+..+..
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---------------- 215 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK---------------- 215 (257)
T ss_pred eecccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----------------
Confidence 111123457788999999876 678999999999999999998 9999976654433322211
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.....+ .....+..+.+|+.+||..+|++||++.++++
T Consensus 216 --------~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 216 --------EGERLE-----RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred --------cCCcCC-----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 000000 11235678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=319.82 Aligned_cols=248 Identities=27% Similarity=0.441 Sum_probs=193.1
Q ss_pred EEeeeeeecCceEEEEEEEC----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 116 QIQEVIGKGSYGVVGSAVDT----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 116 ~i~~~LG~G~fG~V~~a~~~----~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.+.+.||.|+||.||+|... ..+..|+||.++. .........+.+|+++|+.++||||+++++++... ..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccc-----cc
Confidence 46789999999999999877 4567899999954 23344578899999999999999999999999632 34
Q ss_pred EEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+++|||||. ++|.+++... ..+++..+..|+.||++||.|||+.+|+|+||+++|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 899999998 6899999887 6899999999999999999999999999999999999999999999999999987522
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.... .......+...|+|||.+.. ..++.++||||||+++|||++ |+.||...+.......+.+..
T Consensus 156 ~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~---------- 222 (259)
T PF07714_consen 156 KSKY-KNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ---------- 222 (259)
T ss_dssp SSSE-EESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE----------
T ss_pred cccc-cccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccc----------
Confidence 2111 11223456778999999877 568999999999999999999 689998766544333221110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+ ....++..+.+||.+||..||.+||++.++++
T Consensus 223 ---------------~~~-----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 223 ---------------RLP-----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---------------ETT-----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---------------cce-----eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 000 11245778999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=322.47 Aligned_cols=264 Identities=23% Similarity=0.389 Sum_probs=204.6
Q ss_pred CeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccC--ChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCcc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFE--HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~---~~g~~vAIK~i~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 187 (595)
+|++.+.||+|+||.||+|.+. .++..||||.+++... .......+.+|+.++..+ .||||+.+++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~---- 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT---- 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence 4889999999999999999864 4678999999864211 122345678899999999 59999999988743
Q ss_pred CcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
...+|+||||+. ++|.+.+.....+++..++.++.|+++||.|||+.+++||||||+|||++.++.++|+|||+++..
T Consensus 77 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 77 -DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred -CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 346899999998 589998887778999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
...... ......|+..|+|||.+.+....++.++||||||+++|+|++|..||...........+
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------------- 220 (288)
T cd05583 156 LAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI------------- 220 (288)
T ss_pred cccccc--ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH-------------
Confidence 333211 11234689999999998663234788999999999999999999999643321111100
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC---HHHHhcCCCccCCCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT---AEEALADPYFHGLAN 411 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt---a~elL~Hp~f~~~~~ 411 (595)
...... ...+. ....++.+.+||.+||+.||++||| +.++|+||||+.+.+
T Consensus 221 ------~~~~~~---~~~~~-----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 221 ------SRRILK---SKPPF-----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred ------HHHHHc---cCCCC-----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 000110 01111 1235778999999999999999998 577899999987644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=313.46 Aligned_cols=245 Identities=30% Similarity=0.478 Sum_probs=201.6
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEecc
Q 007629 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 199 (595)
Q Consensus 121 LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~ 199 (595)
||.|+||.||++.+..+++.||+|.+..... .......+..|+.+++.++||||+++++.+. ....+|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-----TEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-----cCCeeEEEEecC
Confidence 6999999999999998999999999864322 2234567889999999999999999998873 345689999999
Q ss_pred c-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccccc
Q 007629 200 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 278 (595)
Q Consensus 200 ~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 278 (595)
. ++|.+++.....+++..+..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++........ ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNT 152 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---cccC
Confidence 5 78999998888899999999999999999999999999999999999999999999999999976543321 1234
Q ss_pred cccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhh
Q 007629 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLG 358 (595)
Q Consensus 279 ~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~ 358 (595)
..++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 153 ~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----------------------- 207 (250)
T cd05123 153 FCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----------------------- 207 (250)
T ss_pred CcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----------------------
Confidence 578899999999876 5678899999999999999999999976654221111110
Q ss_pred hcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH---HHHhcCCCc
Q 007629 359 SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA---EEALADPYF 406 (595)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta---~elL~Hp~f 406 (595)
... + .....+..+.+||++||..||.+||++ +++++||||
T Consensus 208 ---~~~--~---~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 208 ---DPL--R---FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---CCC--C---CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 000 1 112236789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=313.76 Aligned_cols=243 Identities=25% Similarity=0.429 Sum_probs=198.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|++.+.||.|+||.||+|... |+.||||++..... ..+++.+|+.+++.++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCC
Confidence 357899999999999999999764 88999999965322 46778999999999999999999999854 345
Q ss_pred EEEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.|+||||++ ++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 899999998 69999987765 699999999999999999999999999999999999999999999999999986522
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.. ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+..
T Consensus 155 ~~------~~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------------ 214 (256)
T cd05039 155 GQ------DSGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK------------ 214 (256)
T ss_pred cc------ccCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc------------
Confidence 21 12234567999999876 578899999999999999997 9999976553322111100
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.... ......++.+.+||.+||..+|.+||++.++++
T Consensus 215 ---------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 215 ---------------GYRM---EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---------------CCCC---CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0000 011245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=320.08 Aligned_cols=269 Identities=24% Similarity=0.371 Sum_probs=200.9
Q ss_pred CeEEeeeeeecCceEEEEEEE----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVD----THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~----~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
-|++++.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+++.+.||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG 80 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence 478899999999999999973 4678899999986432 233456788999999999999999999988543 12
Q ss_pred ccEEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 190 KDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
..+|+||||++ ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 45899999997 68999886653 58999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.............++..|+|||++.+ ..++.++|||||||++|||+++..|+.... ....+..+....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~-----~~~~~~~~~~~~~~~-- 231 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPM-----TLFLKMIGPTHGQMT-- 231 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCcccc-----chhhhhccccccccc--
Confidence 33221111234567778999999876 578999999999999999999887653321 111122221111100
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
....... +...... .....++..+.+||.+||+.||.+||++.+++++
T Consensus 232 --~~~~~~~---~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 232 --VTRLVRV---LEEGKRL---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred --HHHHHHH---HHcCccC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0000011 1111111 1234578899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.33 Aligned_cols=253 Identities=21% Similarity=0.356 Sum_probs=200.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTH----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~----~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
.++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.+.||||+++++++...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--- 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED--- 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence 4689999999999999999999876 3578999988643 2344567788999999999999999999987543
Q ss_pred CcccEEEEEeccc-ccHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEc
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAN--------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~--------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~ 258 (595)
....++++||+. ++|..++... ..+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+
T Consensus 81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred -CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence 235799999998 6888888653 358899999999999999999999999999999999999999999999
Q ss_pred ccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhc
Q 007629 259 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLL 337 (595)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~l 337 (595)
|||+++......... ......++..|+|||++.+ ..++.++|||||||++|||++ |++||...+.......+..
T Consensus 160 d~g~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-- 234 (280)
T cd05043 160 DNALSRDLFPMDYHC-LGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-- 234 (280)
T ss_pred CCCCcccccCCceEE-eCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc--
Confidence 999998654322111 1122346678999999876 578999999999999999998 9999977654221111110
Q ss_pred CCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 338 g~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..... ....+++.+.+++.+||..||++|||+.++++
T Consensus 235 -------------------------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 -------------------------GYRLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -------------------------CCCCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00001 11235778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=341.34 Aligned_cols=261 Identities=22% Similarity=0.395 Sum_probs=224.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++.+++..||-|+||.|-++.-......+|+|++++. .......+.+..|-.||..++.|.||++|..| ++.+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccch
Confidence 45678888999999999999876655556999998753 33445567788999999999999999999988 6677
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
++||+||-|- |+|+.++...+.|.+..+++++..+++|++|||++|||+|||||+|+|++.+|-+||.|||+|+.....
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 8999999986 789999999999999999999999999999999999999999999999999999999999999987655
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
..+ .++||||.|.|||+++. ...+.++|.||||+++||||+|.|||.+.+......+|.+.+. .+
T Consensus 574 ~KT----wTFcGTpEYVAPEIILn--KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid--------~i- 638 (732)
T KOG0614|consen 574 RKT----WTFCGTPEYVAPEIILN--KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID--------KI- 638 (732)
T ss_pred Cce----eeecCCcccccchhhhc--cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh--------hh-
Confidence 432 46899999999999987 6889999999999999999999999999998888887765421 11
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCCCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLANV 412 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~~~~ 412 (595)
.++ ..++..+.+||+++...+|.+|.. +.+|-+|.||.++.+.
T Consensus 639 ---------~~P-----------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 639 ---------EFP-----------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred ---------hcc-----------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 011 234566999999999999999987 8999999999987664
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.46 Aligned_cols=252 Identities=26% Similarity=0.420 Sum_probs=197.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCC-------CcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCC
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHT-------GERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPP 184 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~-------g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 184 (595)
.+|++++.||+|+||.||+|.+... +..||+|.++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 4799999999999999999986432 237999988643 2233456788999999999 79999999999843
Q ss_pred CccCcccEEEEEeccc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCce
Q 007629 185 SRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 247 (595)
Q Consensus 185 ~~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NI 247 (595)
...+|++|||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 90 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 90 ----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 345899999998 58999887532 367788889999999999999999999999999999
Q ss_pred eeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCCh
Q 007629 248 LANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNV 326 (595)
Q Consensus 248 Ll~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~ 326 (595)
|++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999765332111 11122344567999999876 678999999999999999998 8899987664
Q ss_pred HHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 327 ~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
......+.. .... ......+..+.+||.+||..+|.+||++.|++++
T Consensus 243 ~~~~~~~~~---------------------------~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKE---------------------------GHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHc---------------------------CCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 333222211 0000 0113456789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.81 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=197.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~-----~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
.++|++.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.+.||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~-- 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG-- 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--
Confidence 457999999999999999999874 367899999986432 223345688999999999999999999988543
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAND----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 243 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~----------------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLK 243 (595)
..+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+++|||||
T Consensus 81 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 81 ---KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred ---CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 45899999998 58998886432 36788889999999999999999999999999
Q ss_pred CCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCC
Q 007629 244 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFP 322 (595)
Q Consensus 244 P~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~ 322 (595)
|+|||++.++.+||+|||++.......... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred HhheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999987543222111 0122345667999999876 678999999999999999997 888987
Q ss_pred CCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 323 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 323 ~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
+.+..+.+..+.. ....+ .....+..+.+||.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~---------------------------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 235 GMAHEEVIYYVRD---------------------------GNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCHHHHHHHHhc---------------------------CCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6554332221110 00000 11245788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=311.45 Aligned_cols=247 Identities=29% Similarity=0.475 Sum_probs=199.1
Q ss_pred EEeeeeeecCceEEEEEEECCCC----cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 116 QIQEVIGKGSYGVVGSAVDTHTG----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 116 ~i~~~LG~G~fG~V~~a~~~~~g----~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++.+.||.|+||.||+|.+..++ ..||+|+++.. ........+..|+.+++.+.|+||+++++++... ..
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 75 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED-ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EP 75 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC-CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Ce
Confidence 56789999999999999998766 89999998643 2222567888999999999999999999998543 46
Q ss_pred EEEEEeccc-ccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~--l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.|++|||+. ++|.+++..... +++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 899999998 589988876554 99999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
..... .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+.......+...
T Consensus 156 ~~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~----------- 220 (258)
T smart00219 156 DDYYK--KKGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG----------- 220 (258)
T ss_pred ccccc--cccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----------
Confidence 32111 112236789999999865 678999999999999999998 88999875543333222110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
... ......+..+.+++.+||..||.+|||+.++++
T Consensus 221 ----------------~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 221 ----------------YRL---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ----------------CCC---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 000 011236788999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.34 Aligned_cols=258 Identities=22% Similarity=0.376 Sum_probs=195.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECC----------------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceee
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTH----------------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 176 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~----------------~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 176 (595)
++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999986432 3457999998643 22334567889999999999999999
Q ss_pred eeeeecCCCccCcccEEEEEeccc-ccHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCC
Q 007629 177 IKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 244 (595)
Q Consensus 177 l~~~~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~-----------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP 244 (595)
+++++... ..+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 84 LLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred EEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 99988543 35899999998 68998887543 366778999999999999999999999999999
Q ss_pred CceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc--CCCCCC
Q 007629 245 KNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLFP 322 (595)
Q Consensus 245 ~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt--G~~pF~ 322 (595)
+|||++.++.++|+|||+++......... ......++..|+|||+..+ ..++.++|||||||++|||++ |..||.
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCccee-ccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999997553322111 1122345678999998766 578999999999999999998 678887
Q ss_pred CCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 323 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 323 ~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+....+..... ++....... .......+++.+.+|+.+||..||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~--------------------~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 236 QLSDEQVIENTGE--------------------FFRDQGRQV---YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccChHHHHHHHHH--------------------HHhhccccc---cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6554322211100 000000000 00111345688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=313.91 Aligned_cols=249 Identities=25% Similarity=0.415 Sum_probs=198.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~---g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
.+|.+.+.||+|+||.||+|.+... ...||||...... .....+.+.+|+.+++.+.||||+++++++..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------ 78 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------ 78 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------
Confidence 4689999999999999999987544 3478999875432 23445678899999999999999999998743
Q ss_pred ccEEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 190 KDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
...|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.|++||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 23689999998 68999987644 58999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
..... ..+...++..|+|||.+.. ..++.++|||||||++|||++ |..||.+.+..+.+..+..
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~----------- 223 (270)
T cd05056 159 DESYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN----------- 223 (270)
T ss_pred cccce--ecCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-----------
Confidence 33211 1122344568999998866 578999999999999999986 9999987765433322211
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.... ...+.+++.+.+||.+||..+|.+|||+.+++.
T Consensus 224 ----------------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 224 ----------------GERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred ----------------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 112456788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=315.62 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=199.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCc----EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~----~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
..+|++.+.||+|+||+||+|.++.+|. .||+|.+.... .......+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS---- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 3679999999999999999999876665 58999876432 23345678899999999999999999998854
Q ss_pred CcccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
...++||||+. ++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 35899999997 6899888764 4689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
....... .......++..|+|||.+.. ..++.++|||||||++|||++ |..||.+....+....+..
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 226 (279)
T cd05057 159 LDVDEKE-YHAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK--------- 226 (279)
T ss_pred ccCcccc-eecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC---------
Confidence 5432211 11112234567999998865 678899999999999999998 9999987654322221111
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
....+. ....+..+.+++.+||..||.+||++.++++
T Consensus 227 ------------------~~~~~~---~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 227 ------------------GERLPQ---PPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------------------CCCCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111111 1235678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=310.47 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=197.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|++.+.||.|+||.||+|.+. .+..+|+|.+.... .....+.+|+++++.+.||+|+++++++... ..
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 73 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SP 73 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEccC-----Cc
Confidence 357999999999999999999875 47789999886422 2235678899999999999999999988433 45
Q ss_pred EEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||+. ++|.+++... +.++++.++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||++......
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 899999998 5788888754 46899999999999999999999999999999999999999999999999999755332
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||........+..+..
T Consensus 154 ~~~~--~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 216 (256)
T cd05112 154 QYTS--STGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA------------- 216 (256)
T ss_pred cccc--cCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-------------
Confidence 2111 112345678999999876 578899999999999999998 9999977654333222211
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
...... ....+..+.+|+.+||..+|++|||+.+++++
T Consensus 217 --------------~~~~~~---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 217 --------------GFRLYK---PRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred --------------CCCCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 000000 01246789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.43 Aligned_cols=242 Identities=25% Similarity=0.389 Sum_probs=189.0
Q ss_pred eeeeecCceEEEEEEECCCCc--EEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcccEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGE--RVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVV 195 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~--~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~lylV 195 (595)
+.||+|+||.||+|.+..++. .+|+|.++.. ........+.+|+.++..+ .||||+++++++... ..+|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEE
Confidence 368999999999999988776 4688887632 2233456788999999999 799999999998443 458999
Q ss_pred Eeccc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEc
Q 007629 196 FELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258 (595)
Q Consensus 196 ~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~ 258 (595)
|||+. ++|.+++.... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 99997 68999987543 47889999999999999999999999999999999999999999999
Q ss_pred ccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhc
Q 007629 259 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLL 337 (595)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~l 337 (595)
|||++........ ......+..|+|||++.. ..++.++|||||||++|||++ |..||.+.+.......+.
T Consensus 155 dfgl~~~~~~~~~----~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~--- 225 (270)
T cd05047 155 DFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--- 225 (270)
T ss_pred CCCCccccchhhh----ccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh---
Confidence 9999863211110 111234567999999876 678999999999999999997 999997755332222110
Q ss_pred CCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 338 g~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..... ......+..+.+|+.+||..||.+|||+.++++
T Consensus 226 ------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 226 ------------------------QGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ------------------------CCCCC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00000 011245678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=314.61 Aligned_cols=256 Identities=21% Similarity=0.369 Sum_probs=197.7
Q ss_pred eEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC-cc
Q 007629 115 YQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE-FK 190 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~---~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~-~~ 190 (595)
|.+.+.||+|+||.||+|... .++..||||++............+.+|+++|+.++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677899999999999999864 35789999998765445555677889999999999999999999886543221 22
Q ss_pred cEEEEEeccc-ccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcc
Q 007629 191 DIYVVFELME-SDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla 263 (595)
..++++||+. ++|..++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3578999997 6787776432 14788999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
+......... ......+++.|++||.+.. ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05074 161 KKIYSGDYYR-QGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK------- 230 (273)
T ss_pred ccccCCccee-cCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-------
Confidence 8653222110 1122345678999999876 578899999999999999999 8899976654222211110
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.... ..-+..++.+.+|+.+||..+|.+||++.+++++
T Consensus 231 --------------------~~~~---~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 231 --------------------GNRL---KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred --------------------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 0113456789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=309.79 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=196.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+. .+..||+|.+... ......+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~ 74 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP 74 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CC
Confidence 468999999999999999999754 4567999988632 2234678899999999999999999988743 34
Q ss_pred EEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.|++|||++ ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 799999997 6899998763 3578888999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 155 ~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----------- 219 (260)
T cd05073 155 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG----------- 219 (260)
T ss_pred CCcc--cccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-----------
Confidence 2111 1122345677999999876 678999999999999999998 99999876543332222110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
... ......+..+.+++.+||..||.+||++.++++
T Consensus 220 ----------------~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 220 ----------------YRM---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ----------------CCC---CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 000 112346778999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=313.78 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=186.3
Q ss_pred eeeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~--~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.||+|+||.||+|... .....+|+|.+... ........+.+|+.+++.++||||+++++.+... ..+|+||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~ 74 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVL 74 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEE
Confidence 35999999999999643 24457888877532 2233345678999999999999999999988543 4589999
Q ss_pred eccc-ccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 197 ELME-SDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~-----~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 9998 58999887643 24677888999999999999999999999999999999999999999999986532221
Q ss_pred CCcccccccccCCccccccccccc-----CCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~-----~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
.. .......++..|+|||++... ...++.++|||||||++|||++ |.+||......+.+..+...
T Consensus 155 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-------- 225 (269)
T cd05042 155 YY-ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE-------- 225 (269)
T ss_pred he-eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc--------
Confidence 11 011233567789999987431 1356889999999999999999 78899766543322222110
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
. ....+........++.+.+++..|+ .||.+|||++++++
T Consensus 226 ---------------~--~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 226 ---------------Q--DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ---------------c--CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0 0011111222356778899999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=313.83 Aligned_cols=252 Identities=22% Similarity=0.362 Sum_probs=198.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~-----~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
++|++++.||+|+||.||+|+.+. ....||+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE---- 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECC----
Confidence 578999999999999999998654 3467999987532 222245678899999999999999999998843
Q ss_pred CcccEEEEEeccc-ccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEE
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAND---------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 257 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~~---------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL 257 (595)
....|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|
T Consensus 80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 80 -AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred -CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 345899999998 68999998665 6899999999999999999999999999999999999999999999
Q ss_pred cccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhh
Q 007629 258 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDL 336 (595)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~ 336 (595)
+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..+.
T Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~-- 232 (275)
T cd05046 159 SLLSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ-- 232 (275)
T ss_pred cccccccccCcccc--cccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH--
Confidence 99999875432211 11233466788999998876 567889999999999999998 788996544322111110
Q ss_pred cCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 337 lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.. ...+. .....+..+.+++.+||..||.+||++.|++.+
T Consensus 233 -------------------------~~-~~~~~-~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 233 -------------------------AG-KLELP-VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -------------------------cC-CcCCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00 00010 113467789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=309.41 Aligned_cols=244 Identities=26% Similarity=0.419 Sum_probs=192.5
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEec
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~ 198 (595)
++||.|+||.||+|.+.. ++.||+|++...... .....+.+|+.+++.+.||||+++++++.. ....|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEc
Confidence 469999999999999877 999999998653322 345678899999999999999999998843 3468999999
Q ss_pred cc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccc
Q 007629 199 ME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (595)
Q Consensus 199 ~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 276 (595)
+. ++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++......... ...
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~ 152 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT-VSD 152 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce-ecc
Confidence 97 5788888653 46889999999999999999999999999999999999999999999999999754321110 000
Q ss_pred cccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 277 ~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 153 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~------------------- 211 (251)
T cd05041 153 GLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG------------------- 211 (251)
T ss_pred ccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-------------------
Confidence 11234567999999876 678999999999999999999 88999776543222211100
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
...+ .....+..+.+|+.+||..+|.+|||+.|+|+
T Consensus 212 --------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 212 --------YRMP---APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred --------CCCC---CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0000 11245678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=345.58 Aligned_cols=279 Identities=20% Similarity=0.254 Sum_probs=184.4
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCC----CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC-
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHT----GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS- 185 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~----g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~- 185 (595)
..++|++.+.||+|+||.||+|.+..+ +..||||++..... .+....| .++...+.+++.++..+....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 356899999999999999999999988 99999999853211 1111111 122222333433333332211
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCC
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKANDD--------------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 244 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~~~--------------------l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP 244 (595)
......+|+||||++ ++|.+++..... ..+..+..++.||+.||.|||+.+|+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 134456899999998 578888764321 12344678999999999999999999999999
Q ss_pred CceeeCC-CCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccC--------------------CCCCCcce
Q 007629 245 KNILANA-DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF--------------------SKYTPAID 303 (595)
Q Consensus 245 ~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~--------------------~~~~~k~D 303 (595)
+|||++. ++.+||+|||+|+....... .....+++|+.|||||.+.... ..++.++|
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999986 58999999999975432221 1224578999999999653211 12445679
Q ss_pred eechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCC---CCCCCCCHHHH
Q 007629 304 IWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFS---HKFPNADPLAL 380 (595)
Q Consensus 304 IWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~---~~~~~~~~~~~ 380 (595)
|||||||||||+++..++ .+...++..+....+.....+.. .+. ........ ..+...+..+.
T Consensus 362 VwSlGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~---------~~~---~~~~~~~~~~~~~~d~~~~~~~ 427 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRK---------LVE---PRASPDLRRGFEVLDLDGGAGW 427 (566)
T ss_pred cHHHHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHH---------hhc---cccchhhhhhhhhccccchHHH
Confidence 999999999999866543 34434444333333322111111 000 00000001 11122344577
Q ss_pred HHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 381 HLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 381 dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
+||.+||++||.+|||+.++|+||||++...
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 9999999999999999999999999987543
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=307.55 Aligned_cols=243 Identities=24% Similarity=0.416 Sum_probs=191.5
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEec
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~ 198 (595)
++||.|+||.||+|... ++..||+|.++.... ......+.+|+.+++.++||||+++++++... ...|+||||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEEC
Confidence 36999999999999864 688999999865332 22345688999999999999999999988433 458999999
Q ss_pred cc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccc
Q 007629 199 ME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276 (595)
Q Consensus 199 ~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 276 (595)
+. ++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......... .
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~ 151 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--S 151 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--C
Confidence 98 6888887653 468899999999999999999999999999999999999999999999999997543221111 1
Q ss_pred cccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 277 ~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-------------------- 209 (250)
T cd05085 152 GLKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-------------------- 209 (250)
T ss_pred CCCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc--------------------
Confidence 12234567999999876 678899999999999999998 9999987654322211110
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.... .....++..+.+|+.+||..+|++||++.|+++
T Consensus 210 -------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 210 -------GYRM---SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -------CCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0000 112346788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=334.08 Aligned_cols=254 Identities=25% Similarity=0.371 Sum_probs=197.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~-----~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 185 (595)
.++|.+.+.||+|+||.||+|++. .++..||||+++.... ......+.+|+.+|..+. |||||++++++...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~- 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG- 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-
Confidence 356889999999999999999853 4567899999975322 233456889999999997 99999999998543
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhcC-----------------------------------------------------
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKAND----------------------------------------------------- 211 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~~----------------------------------------------------- 211 (595)
..+|+|||||. |+|.+++...+
T Consensus 114 ----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 114 ----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred ----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 45899999998 68998886532
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCc
Q 007629 212 ---------------------------------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (595)
Q Consensus 212 ---------------------------------------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~N 246 (595)
.+++..+..|+.||+.||.|||+.+|+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 25667788899999999999999999999999999
Q ss_pred eeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCC
Q 007629 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325 (595)
Q Consensus 247 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~ 325 (595)
||++.++.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||....
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999864322211 11123467889999999876 578999999999999999998 889997654
Q ss_pred hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 326 ~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
..+.+..... ...+ .+ ....++..+.+||.+||..||.+||++.++++.
T Consensus 347 ~~~~~~~~~~----------------------~~~~--~~-----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 347 MNEQFYNAIK----------------------RGYR--MA-----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred chHHHHHHHH----------------------cCCC--CC-----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3222111100 0000 00 113467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=311.10 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=186.8
Q ss_pred eeeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~--~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEE
Confidence 35999999999999754 4567899998864322 2334568889999999999999999998843 34589999
Q ss_pred eccc-ccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 197 ELME-SDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~-----~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
||++ ++|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9998 68988886432 35667788899999999999999999999999999999999999999999997543221
Q ss_pred CCcccccccccCCcccccccccccC-----CCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~-----~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
. ........|+..|+|||++.+.. ..++.++|||||||++|||++ |..||......+.......
T Consensus 155 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 224 (269)
T cd05087 155 Y-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR--------- 224 (269)
T ss_pred e-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh---------
Confidence 1 11112346788899999885421 236789999999999999996 9999976543222111100
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
......+. .......++.+.+++++|+ .+|.+|||++|++.
T Consensus 225 --------------~~~~~~~~--~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 225 --------------EQQLKLPK--PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --------------cccCCCCC--CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00000111 1111235677899999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=310.61 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=188.5
Q ss_pred eeeeecCceEEEEEEECC---CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~---~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV 195 (595)
+.||+|+||.||+|.+.. .+..||||.+... ........+.+|+.+++.++||||+++++++.... ...|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEE
Confidence 368999999999998653 3457999988532 22344567889999999999999999999775332 347899
Q ss_pred Eeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCc
Q 007629 196 FELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273 (595)
Q Consensus 196 ~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 273 (595)
|||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99998 6899988764 346778888899999999999999999999999999999999999999999997543321111
Q ss_pred -ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 274 -IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 274 -~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
.......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~---------------- 217 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ---------------- 217 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc----------------
Confidence 11123356778999999876 678999999999999999999 4677876543322211100
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+.+.. ...++.+.+|+.+||..+|++||++.++++
T Consensus 218 -----------~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 218 -----------GRRLLQP---EYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred -----------CCCCCCC---CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0001111 124677999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=319.42 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=198.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCc----EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~----~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
..+|++.+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.+.||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence 3578899999999999999999887776 46888775422 223344678999999999999999999988543
Q ss_pred CcccEEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
..++++||+. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 ---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred ---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 2578999998 68998887654 689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
....... .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.........+..
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~--------- 226 (303)
T cd05110 159 LEGDEKE-YNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK--------- 226 (303)
T ss_pred ccCcccc-cccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC---------
Confidence 5332211 11223456778999999876 678999999999999999997 8999977543222111110
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.... + ..+..+..+.+++.+||..||.+||++.++++.
T Consensus 227 ----------------~~~~--~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 227 ----------------GERL--P---QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ----------------CCCC--C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 1 113356789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.81 Aligned_cols=228 Identities=25% Similarity=0.349 Sum_probs=184.8
Q ss_pred cCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEeccc-cc
Q 007629 124 GSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SD 202 (595)
Q Consensus 124 G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~~-g~ 202 (595)
|.||.||+|++..+++.||+|++.... ...+|...+....||||+++++++.. ...+|+||||+. ++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS-----EDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec-----CCeEEEEEecCCCCC
Confidence 899999999999999999999986421 22345555556679999999998843 356899999998 58
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccC
Q 007629 203 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282 (595)
Q Consensus 203 L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT 282 (595)
|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... .....++
T Consensus 72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~ 145 (237)
T cd05576 72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDGEAVE 145 (237)
T ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc------cccCCcC
Confidence 9999988778999999999999999999999999999999999999999999999999987654322 1234567
Q ss_pred CcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhccc
Q 007629 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRK 362 (595)
Q Consensus 283 ~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~ 362 (595)
..|+|||.+.+ ..++.++||||+||++|||++|..||...... +. .
T Consensus 146 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------------~~---------------~ 191 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG-----------------IN---------------T 191 (237)
T ss_pred ccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------------cc---------------c
Confidence 88999999866 57889999999999999999999887532110 00 0
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH-----HHHhcCCCc
Q 007629 363 KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-----EEALADPYF 406 (595)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta-----~elL~Hp~f 406 (595)
..... .-+.+++.+.+||.+||+.||.+||++ +++++||||
T Consensus 192 ~~~~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 HTTLN---IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccccC---CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 00000 112357889999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=312.70 Aligned_cols=238 Identities=20% Similarity=0.279 Sum_probs=182.6
Q ss_pred eeeeecCceEEEEEEECC------------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 119 EVIGKGSYGVVGSAVDTH------------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~------------~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
+.||+|+||.||+|+... ....||+|.+... .......+..|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 368999999999997432 2336888887542 223345678899999999999999999998543
Q ss_pred cCcccEEEEEecccc-cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc-------EEE
Q 007629 187 REFKDIYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-------LKI 257 (595)
Q Consensus 187 ~~~~~lylV~E~~~g-~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~-------vKL 257 (595)
...++||||+++ .|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++. +|+
T Consensus 77 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 77 ---VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred ---CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 347999999995 66666654 356899999999999999999999999999999999999987664 899
Q ss_pred cccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHH-cCCCCCCCCChHHHHHHHHhh
Q 007629 258 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML-TGKPLFPGKNVVHQLDLMTDL 336 (595)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLl-tG~~pF~~~~~~~~l~~i~~~ 336 (595)
+|||++...... ....++..|+|||++... ..++.++|||||||++|||+ +|..||......+....
T Consensus 154 ~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~---- 221 (262)
T cd05077 154 SDPGIPITVLSR-------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF---- 221 (262)
T ss_pred CCCCCCccccCc-------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH----
Confidence 999998654221 234688899999987632 56889999999999999998 58888876543211100
Q ss_pred cCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 337 lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
... .. ......++.+.+||.+||..||.+||++.+++++
T Consensus 222 --------------------~~~---~~-----~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 222 --------------------YEG---QC-----MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --------------------Hhc---Cc-----cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 000 00 0011234678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=308.53 Aligned_cols=240 Identities=25% Similarity=0.446 Sum_probs=194.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
.+|++.+.||+|+||.||++. .+++.||+|+++.. .....+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN------GL 73 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------Cc
Confidence 469999999999999999985 57889999998642 2345688999999999999999999987432 36
Q ss_pred EEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 193 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999998 58999987653 5789999999999999999999999999999999999999999999999999754321
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
. .....+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+.......+..
T Consensus 154 ~------~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 212 (254)
T cd05083 154 V------DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK------------- 212 (254)
T ss_pred C------CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-------------
Confidence 1 22234567999999876 678899999999999999997 9999987654332221110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.. .+. ....+++.+.+|+.+||..+|.+||++.+++.
T Consensus 213 ----------~~---~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 213 ----------GY---RME----PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ----------CC---CCC----CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 000 11346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.05 Aligned_cols=238 Identities=17% Similarity=0.273 Sum_probs=184.9
Q ss_pred eeeeecCceEEEEEEECCCCc-------EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 119 EVIGKGSYGVVGSAVDTHTGE-------RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~-------~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
+.||+|+||.||+|.+...+. .||+|.+... .......+..|+.+|+.+.||||+++++++... ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CC
Confidence 369999999999998866554 3888877532 223445678899999999999999999998543 35
Q ss_pred EEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc--------EEEcccC
Q 007629 192 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--------LKICDFG 261 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~--------vKL~DFG 261 (595)
.++||||+. ++|..++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 799999998 57888887654 5899999999999999999999999999999999999987765 6999999
Q ss_pred cceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCC-CCCCCCChHHHHHHHHhhcCCC
Q 007629 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTP 340 (595)
Q Consensus 262 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~-~pF~~~~~~~~l~~i~~~lg~p 340 (595)
++..... .....+++.|+|||++.+. ..++.++|||||||++|||++|. +||...+........
T Consensus 154 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~------- 218 (258)
T cd05078 154 ISITVLP-------KEILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY------- 218 (258)
T ss_pred cccccCC-------chhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------
Confidence 8864422 1235688899999998752 45788999999999999999994 666544322211100
Q ss_pred ChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 341 ~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
. ..... ....+..+.+||.+||+.||++|||++++++.
T Consensus 219 -----------------~---~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 219 -----------------E---DRHQL-----PAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -----------------H---ccccC-----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0 00001 11234678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=312.82 Aligned_cols=260 Identities=24% Similarity=0.404 Sum_probs=207.8
Q ss_pred EEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHH-HHhcCCCceeeeeeeecCCCccCcccEEE
Q 007629 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKL-LRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 116 ~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~~~~lyl 194 (595)
+-+..||.|+||+|++..++.+|+..|||+|+.... ..+.++++.|... ++.-+.||||++|++.+.. ++.||
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E-----GdcWi 140 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-----GDCWI 140 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----Cceee
Confidence 345779999999999999999999999999975433 3456788899976 5556799999999998643 45899
Q ss_pred EEecccccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 195 VFELMESDLHQVIK-----ANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 195 V~E~~~g~L~~~i~-----~~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.||+|+-+|..+.+ ....++|..+-.|....+.||.||.. .+|||||+||+|||++..|.|||||||++..+.+
T Consensus 141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99999976654443 23479999999999999999999986 6899999999999999999999999999976544
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCCh-HHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~lg~p~~~~i~~ 347 (595)
... -+.-.|.+.|||||.+......|+.++||||||++|||+.||..||.+-+. .+|+.++. .|.|+.
T Consensus 221 SiA----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~----- 289 (361)
T KOG1006|consen 221 SIA----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPI----- 289 (361)
T ss_pred HHH----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCe-----
Confidence 433 244589999999999877655699999999999999999999999977542 23333222 233321
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
..+....-..+..+..||..||.+|-.+||...+++++||++-..
T Consensus 290 ------------------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 290 ------------------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred ------------------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 112222334678899999999999999999999999999998653
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=313.97 Aligned_cols=237 Identities=20% Similarity=0.278 Sum_probs=182.3
Q ss_pred eeeecCceEEEEEEECCC------------------------CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCcee
Q 007629 120 VIGKGSYGVVGSAVDTHT------------------------GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175 (595)
Q Consensus 120 ~LG~G~fG~V~~a~~~~~------------------------g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 175 (595)
.||+|+||.||+|....+ ...||+|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 599999999999974321 245889988532 223345678899999999999999
Q ss_pred eeeeeecCCCccCcccEEEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC
Q 007629 176 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC 253 (595)
Q Consensus 176 ~l~~~~~~~~~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~ 253 (595)
++++++... ...|+||||++ ++|..++.. .+.+++..+..++.||++||+|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 999998543 35799999998 567777765 45789999999999999999999999999999999999997654
Q ss_pred -------cEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHH-cCCCCCCCCC
Q 007629 254 -------KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML-TGKPLFPGKN 325 (595)
Q Consensus 254 -------~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLl-tG~~pF~~~~ 325 (595)
.+||+|||++...... ....++..|+|||.+.+. ..++.++|||||||++|||+ +|..||.+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3899999988643221 223578889999988653 56899999999999999995 7899997654
Q ss_pred hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 326 ~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
....... +. .....+ ....+.+.+||.+||..+|.+|||+.++|++
T Consensus 227 ~~~~~~~------------------------~~---~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 227 PSEKERF------------------------YE---KKHRLP-----EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHHH------------------------HH---hccCCC-----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 3221110 00 000000 1234678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.04 Aligned_cols=267 Identities=27% Similarity=0.432 Sum_probs=210.2
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChh------hHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS------DATRILREIKLLRLLRHPDIVEIKHIMLPP 184 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 184 (595)
..+||-++.+||+|||+.||+|.|....++||+|+-.- ..++. ..+...+|..|.+.|.||.||++|++|...
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHql-NK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQL-NKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehh-ccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 35689999999999999999999999999999997421 12222 235577999999999999999999999543
Q ss_pred CccCcccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCceeeCC---CCcEEEc
Q 007629 185 SRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANA---DCKLKIC 258 (595)
Q Consensus 185 ~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~g--IiHrDLKP~NILl~~---~~~vKL~ 258 (595)
. ..+|-|+|||+| ||.-+++.+.-+++.+++.|+.||+.||.||.+.. |||-||||.|||+.. -|.+||+
T Consensus 540 t----dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 T----DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred c----ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 2 357999999996 89999999999999999999999999999999864 999999999999853 4789999
Q ss_pred ccCcceeccCCCCCcc---c-ccccccCCcccccccccc--cCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHH
Q 007629 259 DFGLARVSFNDAPSAI---F-WTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332 (595)
Q Consensus 259 DFGla~~~~~~~~~~~---~-~~~~~gT~~Y~APE~l~~--~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~ 332 (595)
||||++.+.++..... . .....||.||++||.+.- ...+.+.++||||+|||||.+|.|+.||..... +.+.
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHH
Confidence 9999998766544321 1 234689999999997532 235688899999999999999999999964321 1111
Q ss_pred HHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 333 i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
+.. ..+.+...+.|.. -|.+++++++||++||++.-++|....++-.||||.
T Consensus 694 Lqe----------------------NTIlkAtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 694 LQE----------------------NTILKATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred Hhh----------------------hchhcceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 100 0000111111111 256789999999999999999999999999999995
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=311.78 Aligned_cols=268 Identities=25% Similarity=0.417 Sum_probs=200.7
Q ss_pred CCeEEeeeeeecCceEEEEEEEC----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDT----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~----~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
.+|++.+.||+|+||.||+|... .++..||||++...... .....+.+|+++++.+.||||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~--- 79 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPG--- 79 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCC---
Confidence 46888999999999999999854 35889999998754332 34667899999999999999999999875422
Q ss_pred cccEEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 189 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
....|+||||++ ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 346899999997 58999887654 5899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh-hHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST-ESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~-~~i 345 (595)
..............++..|+|||.+.+ ..++.++|||||||++|||++|..||....... ....+.... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~ 232 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQGQMIV 232 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchh-----ccccccccccccH
Confidence 432221111122345667999998876 578899999999999999999999986532211 111111100 000
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
. .....+ ......+. ....+..+.+|+.+||..||.+|||+.|+++
T Consensus 233 ~-----~~~~~~---~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 233 T-----RLLELL---KEGERLPR---PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred H-----HHHHHH---HcCCcCCC---CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 011111 11111111 1245678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=310.28 Aligned_cols=245 Identities=28% Similarity=0.411 Sum_probs=191.5
Q ss_pred eeeeecCceEEEEEEECCCC------cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 119 EVIGKGSYGVVGSAVDTHTG------ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g------~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
+.||+|+||.||+|.+.... ..||||.+.... .......+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCe
Confidence 36999999999999876543 689999885432 123456788999999999999999999988543 358
Q ss_pred EEEEeccc-ccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC-----cEEEcc
Q 007629 193 YVVFELME-SDLHQVIKAN-------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-----KLKICD 259 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~-------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~-----~vKL~D 259 (595)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+|||++.++ .+||+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999998 6898888642 3478899999999999999999999999999999999999887 899999
Q ss_pred cCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcC
Q 007629 260 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLG 338 (595)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg 338 (595)
||++.......... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||...+.......+..
T Consensus 155 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--- 228 (269)
T cd05044 155 FGLARDIYKSDYYR-KEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA--- 228 (269)
T ss_pred cccccccccccccc-cCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc---
Confidence 99997553322111 1122355778999999876 678999999999999999998 9999987664333222210
Q ss_pred CCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 339 ~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.... ......+..+.+||.+||..+|.+||++.++++
T Consensus 229 ------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 229 ------------------------GGRL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ------------------------CCcc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0000 112345678999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=311.66 Aligned_cols=268 Identities=23% Similarity=0.406 Sum_probs=211.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 189 (595)
..+|.++++||+|+|++|.+++.+.|.+.||+|++++...+ ..+..=+..|-.+.... +||.+|.++.+|.+.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes---- 324 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES---- 324 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc----
Confidence 46899999999999999999999999999999999764433 33445556777777665 6999999999985554
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.+++|.||++ |+|.-.+++...+++++++++..+|+.||.|||+.|||+||||.+|+|++..|++||+|+|+++....
T Consensus 325 -rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 325 -RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred -eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 4999999998 58888888888999999999999999999999999999999999999999999999999999986443
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.... .+++||||.|.|||++.+ ..|+..+|+|+|||+++||+.|+.||.--.. ..|....
T Consensus 404 ~gd~---tstfcgtpnyiapeilrg--eeygfsvdwwalgvlmfemmagrspfdivgm-----------~n~d~nt---- 463 (593)
T KOG0695|consen 404 PGDT---TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIVGM-----------DNPDMNT---- 463 (593)
T ss_pred CCcc---cccccCCCcccchhhhcc--cccCceehHHHHHHHHHHHHcCCCCcceecC-----------CCcccch----
Confidence 3332 367899999999999998 7899999999999999999999999952100 0000000
Q ss_pred hhHHHHHHhhh-cccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC------HHHHhcCCCccCCCCCC
Q 007629 349 RNEKARRYLGS-MRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT------AEEALADPYFHGLANVD 413 (595)
Q Consensus 349 ~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt------a~elL~Hp~f~~~~~~~ 413 (595)
..|+.. +..++ +- .-..++-.+..+|+..|.+||++|.. ..++..|+||+.+.+..
T Consensus 464 -----edylfqvilekq-ir---iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~ 526 (593)
T KOG0695|consen 464 -----EDYLFQVILEKQ-IR---IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL 526 (593)
T ss_pred -----hHHHHHHHhhhc-cc---ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence 001100 00010 00 01234556788999999999999964 68999999999776543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=336.89 Aligned_cols=262 Identities=26% Similarity=0.442 Sum_probs=215.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.+.|+|.+.||.|.||.||+++++.+++.+|||+..... ...+++..|..+|+.+ .|||++.++++|.........
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 456899999999999999999999999999999875432 2335567788999887 499999999999766556667
Q ss_pred cEEEEEeccc-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 191 DIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
.+|||||||+ |+.-++++. ...+.|+.+.+|++.++.||.+||...++|||||-.|||++.++.|||+|||++....
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 8999999998 567777654 3579999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccCCccccccccccc---CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
.... ...+.+|||.|||||++... ...|+..+|+||||++..||--|.||+-+......|-+
T Consensus 175 sT~g---rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~------------ 239 (953)
T KOG0587|consen 175 STVG---RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------------ 239 (953)
T ss_pred cccc---cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc------------
Confidence 3222 24567999999999998543 23578899999999999999999999976543222211
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
++ +.|.|-...+..++..+.+||..||.+|-.+||+..++|+|||+.
T Consensus 240 ---------------Ip-RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 240 ---------------IP-RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred ---------------CC-CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 11 122233344566788899999999999999999999999999997
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.30 Aligned_cols=250 Identities=28% Similarity=0.468 Sum_probs=197.7
Q ss_pred CeEEeeeeeecCceEEEEEEECC-CCcEEEEEEecCcc--------CChhhHHHHHHHHHHHHh-cCCCceeeeeeeecC
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVF--------EHVSDATRILREIKLLRL-LRHPDIVEIKHIMLP 183 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~-~g~~vAIK~i~~~~--------~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~ 183 (595)
.|++.+.||+|+||.||+|.+.. ++..||+|.+.... ........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37889999999999999999887 78899999875321 122334567789998865 799999999998844
Q ss_pred CCccCcccEEEEEecccc-cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCCcEEE
Q 007629 184 PSRREFKDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKI 257 (595)
Q Consensus 184 ~~~~~~~~lylV~E~~~g-~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~vKL 257 (595)
....|+||||+++ +|.+++.. ...+++..++.++.|++.||.|||+ .+|+|+||||+|||++.++.+||
T Consensus 81 -----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 81 -----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred -----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence 3568999999984 77776632 3468999999999999999999996 78999999999999999999999
Q ss_pred cccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhc
Q 007629 258 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337 (595)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~l 337 (595)
+|||++....... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|++||...+.......+....
T Consensus 156 ~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 229 (269)
T cd08528 156 TDFGLAKQKQPES----KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229 (269)
T ss_pred ecccceeeccccc----ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence 9999998654322 2345678999999999876 578999999999999999999999997655433222211100
Q ss_pred CCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 338 g~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
..+. .....++.+.+||.+||..||.+||++.|+.++
T Consensus 230 -------------------------~~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 230 -------------------------YEPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -------------------------CCcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0011 112356789999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=306.71 Aligned_cols=236 Identities=19% Similarity=0.289 Sum_probs=185.5
Q ss_pred eeeeecCceEEEEEEECCCC----------cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 119 EVIGKGSYGVVGSAVDTHTG----------ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g----------~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
+.||+|+||.||+|.+..++ ..|++|.+.... .....+.+|+.+|+.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence 46999999999999998776 357888765321 115678899999999999999999998854
Q ss_pred cccEEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC-------cEEEcc
Q 007629 189 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-------KLKICD 259 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~-------~vKL~D 259 (595)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 23699999998 68888887765 789999999999999999999999999999999999999888 799999
Q ss_pred cCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcC
Q 007629 260 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLG 338 (595)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg 338 (595)
||++...... ....++..|+|||++.+....++.++|||||||++|+|++ |..||...+.......
T Consensus 152 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~------ 218 (259)
T cd05037 152 PGIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF------ 218 (259)
T ss_pred CCcccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH------
Confidence 9999764321 2345677899999987632378899999999999999999 5777865432111100
Q ss_pred CCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 339 ~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
+. .....+. .....+.+||.+||..||.+|||+.++++
T Consensus 219 -----------------~~--~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 219 -----------------YQ--DQHRLPM-------PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -----------------Hh--cCCCCCC-------CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 0000011 11267899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=304.72 Aligned_cols=250 Identities=21% Similarity=0.293 Sum_probs=184.2
Q ss_pred eeeecCceEEEEEEECCC--CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEe
Q 007629 120 VIGKGSYGVVGSAVDTHT--GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197 (595)
Q Consensus 120 ~LG~G~fG~V~~a~~~~~--g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E 197 (595)
.||+|+||.||+|..... ...+++|.+... ........+.+|+.+++.++||||+++++.+... ..+|+|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEEe
Confidence 599999999999975432 345667766532 2223456789999999999999999999988543 45899999
Q ss_pred ccc-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 198 LME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 198 ~~~-g~L~~~i~~~----~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
|+. ++|.+++... ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~- 154 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY- 154 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh-
Confidence 998 6899888754 2456677889999999999999999999999999999999999999999999864221111
Q ss_pred cccccccccCCccccccccccc-----CCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 273 AIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~-----~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
.......+++..|+|||++... ...++.++|||||||++|||++ |.+||...+..+.+..+..-
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~---------- 224 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD---------- 224 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh----------
Confidence 0111345788999999987531 1246789999999999999997 57788765543333222110
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.... ..-.......++.+.+++..|| .+|.+||+++++++
T Consensus 225 -------------~~~~--~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 225 -------------QQVK--LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -------------cccc--cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0000 0001112346778999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=340.70 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=204.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~-----~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
..+-+..+.||+|+||+||+|+-. .....||||.+++.. .....++|.||+.+|..|+|||||+|+|+|...
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~-- 561 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREG-- 561 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC--
Confidence 345677899999999999999743 234689999997642 233567899999999999999999999999544
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcC----------C----CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAND----------D----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~----------~----l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~ 251 (595)
+-+|||||||. |||.+++.... + |+..+...|+.||+.|+.||-++.+|||||-..|+||.+
T Consensus 562 ---~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 ---DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE 638 (774)
T ss_pred ---CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence 45899999998 89999997532 2 788899999999999999999999999999999999999
Q ss_pred CCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHH
Q 007629 252 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQL 330 (595)
Q Consensus 252 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l 330 (595)
+..|||+||||++.....+..... ....-...|||||.+.- .+|+.++||||+||+|||+++ |+.||.+-...+.+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~-~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVR-GNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred ceEEEecccccchhhhhhhhhccc-CCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 999999999999976544432211 11233567999998876 799999999999999999997 89999988876666
Q ss_pred HHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHh
Q 007629 331 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401 (595)
Q Consensus 331 ~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL 401 (595)
+.|...- -. ..-.++++++.+|+..||+..|++||++.||-
T Consensus 716 e~i~~g~-------------------------lL-----~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 716 ECIRAGQ-------------------------LL-----SCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHHcCC-------------------------cc-----cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 5553310 01 11246788999999999999999999999873
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=326.92 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=199.6
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCc---E-EEEEEecC-ccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGE---R-VAIKKIND-VFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~---~-vAIK~i~~-~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
+-.+.++||+|+||.||+|.-+..+. . ||||..+. .........++.+|+++|+.++|||||++||+.....
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--- 234 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--- 234 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC---
Confidence 34567899999999999998665322 3 89999874 2244566788999999999999999999999986554
Q ss_pred cccEEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 189 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
-+|||||+|. |+|.+++++++ .++..+...++++.+.||+|||++++|||||-..|+|+..++.+||+|||+++..
T Consensus 235 --Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 235 --PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred --ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 3899999998 59999999887 4999999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
....... ...--...|+|||.+.. ..|+.++|||||||++||+.+ |..||++....+....|..-
T Consensus 313 ~~~~~~~---~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~--------- 378 (474)
T KOG0194|consen 313 SQYVMKK---FLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN--------- 378 (474)
T ss_pred cceeecc---ccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc---------
Confidence 2111100 01123457999999987 589999999999999999998 78899998865444433110
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.++. +.+ ...+..+..++.+|+..||++||++.++.+
T Consensus 379 -------------~~r~--~~~-----~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 379 -------------GYRM--PIP-----SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred -------------CccC--CCC-----CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 0110 111 134567888999999999999999999876
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=341.50 Aligned_cols=252 Identities=23% Similarity=0.411 Sum_probs=204.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC-C----cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHT-G----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~-g----~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
...-++.+.||+|+||.||.|.-... | ..||||.+++. ....+...|++|..+|+.++|||||+++++++...
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~- 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG- 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC-
Confidence 34567889999999999999976543 2 34999999754 34566788999999999999999999999998743
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEc
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAN-------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~-------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~ 258 (595)
..+|++|||+ |||..+|+.. ..++..+...|+.||++|+.||+++++|||||-..|+|++....|||+
T Consensus 769 ----~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 769 ----PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred ----CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence 3799999998 6999999876 258999999999999999999999999999999999999999999999
Q ss_pred ccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhc
Q 007629 259 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLL 337 (595)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~l 337 (595)
|||+|+........... ....-...|||||.+.. ..++.|+|||||||++||++| |..||++.+..+.+......-
T Consensus 845 DFGlArDiy~~~yyr~~-~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKH-GEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG 921 (1025)
T ss_pred ccchhHhhhhchheecc-CccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence 99999954333321111 11122346999999987 689999999999999999998 789999988766554332210
Q ss_pred CCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 338 g~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
+.+. -+.++..+.+|+..||+.+|++||++..|++
T Consensus 922 -------------------------RL~~-----P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 -------------------------RLDP-----PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -------------------------ccCC-----CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 0111 1346677889999999999999999999988
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=324.54 Aligned_cols=206 Identities=31% Similarity=0.468 Sum_probs=173.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC-ccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~~~~ 191 (595)
.-+...+.||+|+||.||+++++.+|+.||||.++... +....++.-+|+++|++|+|||||+++++-.+.. .--...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 34566789999999999999999999999999987543 4566788899999999999999999988753321 001234
Q ss_pred EEEEEeccc-ccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee--CCCCc--EEEcccCcc
Q 007629 192 IYVVFELME-SDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA--NADCK--LKICDFGLA 263 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~---~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl--~~~~~--vKL~DFGla 263 (595)
-.+|||||. |+|..++..- .+|++.++..++..+..||.|||++|||||||||.||++ ..+|+ -||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 689999998 6899998653 479999999999999999999999999999999999986 34454 699999999
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCC
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK 324 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~ 324 (595)
+...++. .++..+||+.|.+||++.. ...|+..+|.|||||++|+++||..||-..
T Consensus 172 rel~d~s----~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 172 RELDDNS----LFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccCCCCC----eeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9765443 4678999999999999874 267899999999999999999999999543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=284.22 Aligned_cols=242 Identities=39% Similarity=0.652 Sum_probs=196.5
Q ss_pred CceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEecccc-cH
Q 007629 125 SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DL 203 (595)
Q Consensus 125 ~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~~g-~L 203 (595)
+||.||+|.+..+|+.||+|++........ ...+.+|+.+++.++|+||+++++.+... ...+++|||+++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCH
Confidence 689999999998999999999864322211 57788999999999999999999988543 458999999996 99
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCC
Q 007629 204 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283 (595)
Q Consensus 204 ~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~ 283 (595)
..++.....+++..+..++.+++.+|.|||+.+|+|+||+|.||+++.++.++|+|||++....... ......++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTP 150 (244)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCc
Confidence 9998877668999999999999999999999999999999999999999999999999998754432 123457889
Q ss_pred cccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCC-ChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhccc
Q 007629 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRK 362 (595)
Q Consensus 284 ~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~-~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~ 362 (595)
.|+|||.+.+ ..++.++||||||+++++|++|..||... +....+..+..
T Consensus 151 ~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~--------------------------- 201 (244)
T smart00220 151 EYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK--------------------------- 201 (244)
T ss_pred CCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc---------------------------
Confidence 9999999875 57888999999999999999999999763 22111111110
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 363 KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
...........++..+.+++.+||..||.+||++.++++||||
T Consensus 202 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 202 -PKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -cCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 0011111111266789999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.77 Aligned_cols=277 Identities=20% Similarity=0.269 Sum_probs=187.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC----------------CCCcEEEEEEecCccCChh------------hHHHHHHHH
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT----------------HTGERVAIKKINDVFEHVS------------DATRILREI 163 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~----------------~~g~~vAIK~i~~~~~~~~------------~~~~~~~Ei 163 (595)
.++|++.++||+|+||+||+|... ..++.||||+++....... ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999752 3456899999863211100 112234577
Q ss_pred HHHHhcCCCce-----eeeeeeecCCC---ccCcccEEEEEeccc-ccHHHHHHhc------------------------
Q 007629 164 KLLRLLRHPDI-----VEIKHIMLPPS---RREFKDIYVVFELME-SDLHQVIKAN------------------------ 210 (595)
Q Consensus 164 ~il~~l~HpnI-----v~l~~~~~~~~---~~~~~~lylV~E~~~-g~L~~~i~~~------------------------ 210 (595)
.++..++|.++ +++++++.... .......|+||||++ ++|.+++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776654 56666664321 112345899999998 5788777532
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCccccccc
Q 007629 211 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290 (595)
Q Consensus 211 ~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~ 290 (595)
..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++.......... .....+|+.|+|||+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYSPPEE 381 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcceeChhh
Confidence 123567788999999999999999999999999999999999999999999997543221111 112245899999998
Q ss_pred ccccCC------------------CCC--CcceeechhHHHHHHHcCCC-CCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 291 CGSFFS------------------KYT--PAIDIWSIGCIFAEMLTGKP-LFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 291 l~~~~~------------------~~~--~k~DIWSlG~il~eLltG~~-pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
+..... .|+ .+.||||+|||+|+|++|.. ||.+........ +. ....+..+
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~---~~----~~~~~~~~- 453 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL---RQ----YDNDLNRW- 453 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH---hh----ccchHHHH-
Confidence 753110 022 24799999999999999974 775432111000 00 00000000
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCC---CCCCCHHHHhcCCCccC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP---KDRPTAEEALADPYFHG 408 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP---~~Rpta~elL~Hp~f~~ 408 (595)
+. . ......++ .+...++.++|||.+||..+| .+|+|++|+|+||||..
T Consensus 454 ----r~----~-~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 454 ----RM----Y-KGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ----Hh----h-cccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 0 11111222 356678999999999999876 68999999999999953
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=299.94 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=202.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++..+.++||+|-||.|.+|.- ..+..||||+++.. ........+.+||++|.+|+|||||+++++|.... -
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----P 609 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----P 609 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----c
Confidence 35678899999999999999974 34689999999743 23334578999999999999999999999997654 3
Q ss_pred EEEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+++|+|||+ |+|.+++.++. .+.......|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++-+..
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccccc
Confidence 899999999 89999999874 334455566999999999999999999999999999999999999999999996654
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHH--cCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML--TGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLl--tG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
....... ...+-...|||||.+.- ++++.++|+|+||+++||++ +...||..-......+....++..+..
T Consensus 690 g~yy~vq-gr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~---- 762 (807)
T KOG1094|consen 690 GDYYRVQ-GRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR---- 762 (807)
T ss_pred CCceeee-cceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc----
Confidence 4432221 23455678999997765 68999999999999999976 467898766554444433333322221
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
......-+-++..+.+|+.+||..|-++||+++++..
T Consensus 763 -------------------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 763 -------------------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred -------------------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 1111222445677899999999999999999999865
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=318.25 Aligned_cols=246 Identities=33% Similarity=0.472 Sum_probs=188.8
Q ss_pred eeeeeecCce-EEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcccEEEE
Q 007629 118 QEVIGKGSYG-VVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVV 195 (595)
Q Consensus 118 ~~~LG~G~fG-~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~lylV 195 (595)
.+++|.|+-| .||+|.- .|+.||||.+-. .....+.+||..|+.-+ |||||++++.- .+...+||.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIa 581 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIA 581 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEE
Confidence 4679999988 5799964 588999998742 23446789999999885 99999998765 344569999
Q ss_pred EecccccHHHHHHhcC-C---CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC---C--CcEEEcccCcceec
Q 007629 196 FELMESDLHQVIKAND-D---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---D--CKLKICDFGLARVS 266 (595)
Q Consensus 196 ~E~~~g~L~~~i~~~~-~---l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~---~--~~vKL~DFGla~~~ 266 (595)
.|+|..+|.+++.... . ........++.|+++||++||+.+||||||||.||||.. + ..++|+|||+++..
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9999999999998741 1 111445778999999999999999999999999999976 3 46899999999987
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcC-CCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
..+...-....+..||-+|+|||++.. ..-+.++||||||||+|+.++| ..||...- ..+. .|.. |..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvfyYvltgG~HpFGd~~-~R~~-NIl~--~~~----- 730 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL-ERQA-NILT--GNY----- 730 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceEEEEecCCccCCCchH-Hhhh-hhhc--Ccc-----
Confidence 666554444567789999999999987 4556799999999999999997 78995422 1111 1110 000
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
.+...-+..+.++.|||.+||.+||..||+|.++|.||+|=
T Consensus 731 ---------------------~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 731 ---------------------TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred ---------------------ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 00111112222799999999999999999999999999993
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=270.67 Aligned_cols=212 Identities=26% Similarity=0.471 Sum_probs=174.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHH-HhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL-RLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
+...-+..||+|+||+|-+.++..+|...|+|.+..... ....++.++|+.+. +...+|.+|.+|+.+.. ..+
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-----egd 119 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-----EGD 119 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-----ccc
Confidence 445567789999999999999999999999999975444 34567788999875 45579999999998743 356
Q ss_pred EEEEEecccccHHH----HHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 192 IYVVFELMESDLHQ----VIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 192 lylV~E~~~g~L~~----~i~~~~~l~~~~~~~i~~qil~aL~yLHs~-gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
+||.||.|..+|.. .++..+.++|..+-.|+..++.||.|||++ .|||||+||+|||||.+|+|||||||.+..+
T Consensus 120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 99999999977644 445667899999999999999999999985 8999999999999999999999999999877
Q ss_pred cCCCCCcccccccccCCccccccccccc--CCCCCCcceeechhHHHHHHHcCCCCCCC-CChHHHHHHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEMLTGKPLFPG-KNVVHQLDLMT 334 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~--~~~~~~k~DIWSlG~il~eLltG~~pF~~-~~~~~~l~~i~ 334 (595)
.+.... +-..|...|||||.+... ...|+.++||||||++++||.+++.||+. .....|+.+++
T Consensus 200 ~dSiAk----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 200 VDSIAK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred hhhhHH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 555433 224688899999987543 24699999999999999999999999975 34555555543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.58 Aligned_cols=283 Identities=29% Similarity=0.464 Sum_probs=207.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECC---CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccC
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~---~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 188 (595)
..|.++.+||.|+|++||+|.+.. ..++||+|.|... ....++..|+.+|..+. +.||+++.+++ ..
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rn 106 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCF-----RN 106 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhh-----cc
Confidence 458899999999999999999887 7889999998542 34567899999999986 99999999988 44
Q ss_pred cccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC-CcEEEcccCcceec
Q 007629 189 FKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~-~~vKL~DFGla~~~ 266 (595)
...+.+||||++. +..+++. .++-.+++.+++.++.||.++|.+|||||||||.|+|.+.. +.-.|+|||+|...
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 4568999999996 4555543 36788999999999999999999999999999999999764 66889999999721
Q ss_pred cCCC--------------C-----------------Cc----------ccccccccCCcccccccccccCCCCCCcceee
Q 007629 267 FNDA--------------P-----------------SA----------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 305 (595)
Q Consensus 267 ~~~~--------------~-----------------~~----------~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIW 305 (595)
.... + .. .......||++|+|||++... ..-++++|||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiw 262 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIW 262 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCcccee
Confidence 1000 0 00 001124799999999998874 6778999999
Q ss_pred chhHHHHHHHcCCCCC-CCCChHHHHHHHHhhcCCCChhHHHHHh--------------hHHHHHHh----hhccc-CCC
Q 007629 306 SIGCIFAEMLTGKPLF-PGKNVVHQLDLMTDLLGTPSTESISRIR--------------NEKARRYL----GSMRK-KQP 365 (595)
Q Consensus 306 SlG~il~eLltG~~pF-~~~~~~~~l~~i~~~lg~p~~~~i~~i~--------------~~~~~~~l----~~~~~-~~~ 365 (595)
|.|||+.-+++++.|| ...++.+.+..|..++|...-......- .+....|. ....+ .++
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 9999999999999776 4456666666666666643322111100 00001111 11111 111
Q ss_pred CCCCCCCCC-CCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 366 VPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 366 ~~~~~~~~~-~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
......+.+ .+..+.||+.+||..||.+|+||+++|+||||..
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 011222223 3458999999999999999999999999999984
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=304.86 Aligned_cols=245 Identities=27% Similarity=0.486 Sum_probs=194.9
Q ss_pred EEeeeeeecCceEEEEEEECC----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 116 QIQEVIGKGSYGVVGSAVDTH----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 116 ~i~~~LG~G~fG~V~~a~~~~----~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.+.++||.|-||.||+|.-.. ..-.||||..+.... ..+.+.|+.|..+|+.++|||||+++|++... -
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P 464 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------P 464 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeecc------c
Confidence 345689999999999997532 233689998765433 34577899999999999999999999999543 3
Q ss_pred EEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|||||++. |.|..+++.+. .|+......+.+||+.||.|||+.+.|||||-..|||+.....|||+|||+++...++
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 899999999 89999998775 6888889999999999999999999999999999999999999999999999987554
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
..... +...-..-|||||-+.- ..++.++|||.|||.+||++. |..||.|-...+.+-.|.+
T Consensus 545 ~yYka--S~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn------------- 607 (974)
T KOG4257|consen 545 AYYKA--SRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN------------- 607 (974)
T ss_pred chhhc--cccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC-------------
Confidence 43211 11122345999998864 789999999999999999875 8999987543222111110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHh
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL 401 (595)
..+.|.| ++++|.+..|+.+||++||.+||++.++.
T Consensus 608 ------------GeRlP~P-----~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 608 ------------GERLPCP-----PNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ------------CCCCCCC-----CCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 1222332 67889999999999999999999986653
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=305.25 Aligned_cols=255 Identities=25% Similarity=0.392 Sum_probs=205.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-CC--cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTH-TG--ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~-~g--~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
.++..+.++||+|+||+|++|..+. +| ..||||.++...... ....|++|+.+|.+|+|||+++||++.++.
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~q---- 183 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQ---- 183 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccc----
Confidence 4566778999999999999997654 33 368999997543332 567899999999999999999999999763
Q ss_pred cccEEEEEeccc-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 189 FKDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
-+.||||++. |+|++.+.+ ...|.......|+.||+.|+.||.++++|||||-..|||+-..-.||||||||.+.
T Consensus 184 --p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 184 --PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred --hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence 2789999999 789998876 34678888999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
+......-.+....--...|.|||.+.. ..++.++|||++||+||||++ |+.||.|......|.+|.+.
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~-------- 331 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG-------- 331 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc--------
Confidence 7655433222222233456999999987 789999999999999999998 67999999876666554311
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCC
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~ 405 (595)
+..+. -+.++..+.+++..||..+|.+|||+..|.+.-+
T Consensus 332 -----------------erLpR-----Pk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 332 -----------------ERLPR-----PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred -----------------ccCCC-----CCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 11111 1346778999999999999999999998865433
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=310.88 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=210.0
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCc---EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 110 ~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~---~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
...+...|.++||.|.||.||+|+.+..|+ .||||.++.- ........|+.|+.||-++.||||++|.++...
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk--- 701 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK--- 701 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec---
Confidence 345667899999999999999999887764 7999999753 233456779999999999999999999999843
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
.+-+.||.|||+ |.|..+|+.+ +.|+..+...+++.|+.|++||-++|.|||||-..|||||.+-.+|++||||++
T Consensus 702 --s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 702 --SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred --CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccccee
Confidence 344899999999 7899999876 479999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCCccccccccc--CCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCC
Q 007629 265 VSFNDAPSAIFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPS 341 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~g--T~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~ 341 (595)
+..++.+.. +++.-| ...|.|||.+.- .+++.++||||+||+|||.++ |..||..-+.-+.+..|.+-...|+
T Consensus 780 vledd~~~~--ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp 855 (996)
T KOG0196|consen 780 VLEDDPEAA--YTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP 855 (996)
T ss_pred ecccCCCcc--ccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC
Confidence 776655322 222222 357999999875 789999999999999999775 9999988776666655544333322
Q ss_pred hhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 342 ~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
+ .+++..+-+|+..||++|-.+||.+.+|+.+
T Consensus 856 P------------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 856 P------------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred C------------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 1 2567789999999999999999999998864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.05 Aligned_cols=245 Identities=22% Similarity=0.440 Sum_probs=203.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
.+..+..+||-|-||.||.+..+.-.-.||||.++ ++.....+|+.|+.+|+.++|||+|+|+++|.... -+
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-----PF 338 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-----PF 338 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhh---hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-----Ce
Confidence 45667789999999999999999888899999986 45567889999999999999999999999996543 38
Q ss_pred EEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 193 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
|||.|||. |+|+++++... .++.-...+++.||..|++||..+++|||||-..|+||.++..|||+||||++++..+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99999998 89999998654 4677777889999999999999999999999999999999999999999999988665
Q ss_pred CCCccccccccc---CCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 270 APSAIFWTDYVA---TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 270 ~~~~~~~~~~~g---T~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
..+ ...| ..-|.|||-+.- ..++.|+|||+|||+|||+.| |-.||+|-+......++.+.
T Consensus 419 TYT-----AHAGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg--------- 482 (1157)
T KOG4278|consen 419 TYT-----AHAGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG--------- 482 (1157)
T ss_pred cee-----cccCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc---------
Confidence 533 2233 345999998754 678899999999999999987 88999998754444433221
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
++-.. -..+++....|+..||++.|.+||++.|+-+
T Consensus 483 --------------yRM~~-------PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 483 --------------YRMDG-------PEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred --------------ccccC-------CCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 11111 1357888999999999999999999988743
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=310.33 Aligned_cols=261 Identities=28% Similarity=0.426 Sum_probs=214.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|+++..+|.|+||.||+|+++.+++..|+|+++- ....+..-+..||-+++..+|||||.+++-++... .
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkL--ep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----k 86 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKL--EPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----K 86 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeec--cCCccccccccceeeeecCCCcChHHHHhhhhhhc-----C
Confidence 5689999999999999999999999999999999974 33345677889999999999999999999886543 4
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+||+||||+ |+|.+...-.+++++.++.++.+..++||+|||++|=+|||||-.|||+++.|.+|++|||.+-.+....
T Consensus 87 lwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 899999999 5777777778899999999999999999999999999999999999999999999999999986543222
Q ss_pred CCcccccccccCCcccccccc-cccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 271 PSAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l-~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.....+.||++|||||+. .+....|...+|||++|+...|+---++|-........+.++.+-.-.|+.
T Consensus 167 ---~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~------- 236 (829)
T KOG0576|consen 167 ---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT------- 236 (829)
T ss_pred ---hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc-------
Confidence 224568999999999974 222367999999999999999998888776555544445444443322221
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
...-...++.+-+|++.+|.++|++||+++.+|.|||..+
T Consensus 237 -------------------lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 237 -------------------LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred -------------------ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 0111345677899999999999999999999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=331.79 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=183.8
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
.|...+.||+|+||.||+|.+..++..||||++..... ....|+.+|+.++|||||++++++... ...|
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~ 759 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAY 759 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCE
Confidence 35566789999999999999999999999999864221 113468899999999999999999543 4579
Q ss_pred EEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 194 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLH---s~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|||||+ ++|.+++. .+++..+..++.||++||+||| +.+|+||||||+|||++.++..++. ||.+......
T Consensus 760 lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~ 835 (968)
T PLN00113 760 LIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835 (968)
T ss_pred EEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence 9999998 68998885 3889999999999999999999 6699999999999999999888876 6665432111
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChH-HHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV-HQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~-~~l~~i~~~lg~p~~~~i~~i 348 (595)
....||+.|||||++.+ ..|+.++|||||||++|||+||+.||...... ..+....+..-.
T Consensus 836 -------~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------- 897 (968)
T PLN00113 836 -------TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS--------- 897 (968)
T ss_pred -------CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC---------
Confidence 23478999999999876 67999999999999999999999999543210 000000000000
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.......+.. ...... .........+.+++.+||+.||++|||+.|+++.
T Consensus 898 -~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 898 -DCHLDMWIDP---SIRGDV-SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred -ccchhheeCc---cccCCC-CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000000000 000000 0001112356789999999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=284.77 Aligned_cols=267 Identities=25% Similarity=0.324 Sum_probs=200.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHh--cCCCceeeeeeeecCCCccCcc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL--LRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.-.++.++||+|.||.||+|. -+++.||||++.. .+.+.+..|-.|.+. ++|+||++++++-...... ..
T Consensus 210 ~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhh--ccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-cc
Confidence 345678899999999999995 4579999999852 456677888887765 5799999998765433322 45
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CeeecCCCCCceeeCCCCcEEEccc
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---------NVFHRDLKPKNILANADCKLKICDF 260 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~---------gIiHrDLKP~NILl~~~~~vKL~DF 260 (595)
.++||+||.+ |+|.++++.+ .+++.....++..|++||+|||+. .|+|||||..||||..|++.-|+||
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 6899999998 8999999875 799999999999999999999963 4999999999999999999999999
Q ss_pred CcceeccCCCCCcccccccccCCcccccccccccCCCCC-----CcceeechhHHHHHHHcCCCCCC-CCChHHHHHHHH
Q 007629 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYT-----PAIDIWSIGCIFAEMLTGKPLFP-GKNVVHQLDLMT 334 (595)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~-----~k~DIWSlG~il~eLltG~~pF~-~~~~~~~l~~i~ 334 (595)
|||..+....+.... ...+||+.|||||++.+. -.+. .++||||+|.|||||++.-..+. +.-..-|+..-.
T Consensus 361 GLAl~~~p~~~~~d~-~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDT-HGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ceeEEecCCCCCcch-hhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 999887655543332 336999999999999763 2222 35899999999999999764443 444444555555
Q ss_pred hhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCC--CCCHHHHHHHHhhCcCCCCCCCCHHHH
Q 007629 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEA 400 (595)
Q Consensus 335 ~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~--~~~~~~~dLl~~~L~~DP~~Rpta~el 400 (595)
++...|+.+.+.... ++++....+...|. ..-..+.+.++.||..||+.|.||.=+
T Consensus 439 evG~hPt~e~mq~~V----------V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELV----------VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HhcCCCCHHHHHHHH----------HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 555667766554332 11222222222222 223457899999999999999998543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-33 Score=291.81 Aligned_cols=204 Identities=25% Similarity=0.419 Sum_probs=174.5
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC----Ch--hhHHHHHHHHHHHHhcC---CCceeeee
Q 007629 108 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE----HV--SDATRILREIKLLRLLR---HPDIVEIK 178 (595)
Q Consensus 108 ~~~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~----~~--~~~~~~~~Ei~il~~l~---HpnIv~l~ 178 (595)
++....+|..++.+|.|+||.|++|.++.+...|+||.|.+... .. ...-.+-.||.||..|+ |+||++++
T Consensus 556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence 34445679999999999999999999999999999999864211 00 11223457999999997 99999999
Q ss_pred eeecCCCccCcccEEEEEeccc-c-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEE
Q 007629 179 HIMLPPSRREFKDIYVVFELME-S-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 256 (595)
Q Consensus 179 ~~~~~~~~~~~~~lylV~E~~~-g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vK 256 (595)
++| ++..++||+||--+ | ||+++|.....++|.+++.|++|++.|+++||+.||||||||-+|+.++.+|-+|
T Consensus 636 dfF-----Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 636 DFF-----EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred hee-----ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEE
Confidence 999 56677999999987 3 8999999999999999999999999999999999999999999999999999999
Q ss_pred EcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCC
Q 007629 257 ICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP 322 (595)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~ 322 (595)
|+|||.|...... .+..++||..|.|||++.|. ...+..-|||+||++||.++....||.
T Consensus 711 lidfgsaa~~ksg-----pfd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 711 LIDFGSAAYTKSG-----PFDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EeeccchhhhcCC-----CcceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999754332 24567999999999999983 334567899999999999999998885
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=273.65 Aligned_cols=262 Identities=25% Similarity=0.352 Sum_probs=192.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHH--hcCCCceeeeeeeecCCCcc
Q 007629 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR--LLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 110 ~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~--~l~HpnIv~l~~~~~~~~~~ 187 (595)
....+..+.+.||+|.||.||+|. ..|+.||||++.. .+...+.+|.+|.+ .|+|+||+.+++.-.... .
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-g 279 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKDN-G 279 (513)
T ss_pred hhhheeEEEEEecCccccceeecc--ccCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccCC-C
Confidence 345688999999999999999995 5699999999863 34556777777765 479999999988765443 4
Q ss_pred CcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeecCCCCCceeeCCCCcEEEc
Q 007629 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADCKLKIC 258 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~--------gIiHrDLKP~NILl~~~~~vKL~ 258 (595)
....+|||.+|.+ |+|++++.. ..++.+.+..++..++.||++||.. .|.|||||..||||..+|..-|+
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 5577999999999 899999987 5799999999999999999999963 39999999999999999999999
Q ss_pred ccCcceeccCCC-CCcccccccccCCcccccccccccC-----CCCCCcceeechhHHHHHHHcC----------CCCCC
Q 007629 259 DFGLARVSFNDA-PSAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEMLTG----------KPLFP 322 (595)
Q Consensus 259 DFGla~~~~~~~-~~~~~~~~~~gT~~Y~APE~l~~~~-----~~~~~k~DIWSlG~il~eLltG----------~~pF~ 322 (595)
|+|||.....+. .-.+.....+||..|||||++.... ..| ..+||||||.|+||+... ++||.
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesy-k~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESY-KRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhh-hHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999997654432 2223345679999999999986521 112 358999999999998762 35665
Q ss_pred CCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCC--HHHHHHHHhhCcCCCCCCCCHHHH
Q 007629 323 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD--PLALHLLERLLAFDPKDRPTAEEA 400 (595)
Q Consensus 323 ~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~--~~~~dLl~~~L~~DP~~Rpta~el 400 (595)
+--. ..|+.+.+.++ +.. ++...++...|...+ ..+..|++.||..+|.-|.||--+
T Consensus 438 d~Vp-----------~DPs~eeMrkV--------VCv--~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 438 DVVP-----------SDPSFEEMRKV--------VCV--QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred cCCC-----------CCCCHHHHhcc--------eee--cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 4221 12333322221 110 111122223333322 124578999999999999998665
Q ss_pred hc
Q 007629 401 LA 402 (595)
Q Consensus 401 L~ 402 (595)
-+
T Consensus 497 KK 498 (513)
T KOG2052|consen 497 KK 498 (513)
T ss_pred HH
Confidence 44
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=290.39 Aligned_cols=247 Identities=28% Similarity=0.478 Sum_probs=194.4
Q ss_pred EEeeeeeecCceEEEEEEEC----C---CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCcc
Q 007629 116 QIQEVIGKGSYGVVGSAVDT----H---TGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 116 ~i~~~LG~G~fG~V~~a~~~----~---~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 187 (595)
.+.+.||+|+||.|++|.-. . ....||||.++..... .+.+.+..|+++|+.+. ||||+.+++++..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 56779999999999999632 1 1457999998765444 67788999999999985 9999999999955
Q ss_pred CcccEEEEEeccc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~ 250 (595)
...+++|+||+. |+|..+++... .++..+...+++||+.|++||++.++|||||-..|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 356899999998 89999998765 388899999999999999999999999999999999999
Q ss_pred CCCcEEEcccCcceeccCCCCCccccccccc--CCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCC-h
Q 007629 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN-V 326 (595)
Q Consensus 251 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~g--T~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~-~ 326 (595)
.+..+||+|||+|+.......... ....| ...|||||.+.. ..|+.++||||+||+||||++ |..||++-. .
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999986544332211 11122 234999999987 789999999999999999998 779998733 1
Q ss_pred HHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 327 ~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.+.+.. ++ ...+-.+| ..+++++.++++.||..+|++||+..++.+
T Consensus 529 ~~l~~~---------------l~--------~G~r~~~P-------~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEF---------------LK--------EGNRMEQP-------EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHH---------------Hh--------cCCCCCCC-------CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 111111 10 00111111 245788999999999999999999998876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=242.38 Aligned_cols=212 Identities=37% Similarity=0.634 Sum_probs=181.1
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEeccc
Q 007629 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME 200 (595)
Q Consensus 121 LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~~ 200 (595)
||.|++|.||++.+..+++.+++|++....... ....+.+|+.+++.+.|++|+++++++... ...+++||++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCC
Confidence 689999999999998889999999986432211 346788999999999999999999998543 45899999999
Q ss_pred -ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC-CCcEEEcccCcceeccCCCCCccccc
Q 007629 201 -SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPSAIFWT 277 (595)
Q Consensus 201 -g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~ 277 (595)
++|.+++... ..+++..+..++.+++++|.|||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhh
Confidence 6899998765 47899999999999999999999999999999999999999 89999999999986543321 123
Q ss_pred ccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHh
Q 007629 278 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYL 357 (595)
Q Consensus 278 ~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l 357 (595)
...+...|++||.+... ..++.+.|+|+||+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 35678899999998762 3778899999999999999
Q ss_pred hhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCC
Q 007629 358 GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (595)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp 404 (595)
..+.+++.+||..||.+||++.++++|+
T Consensus 188 -------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1267899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=281.23 Aligned_cols=247 Identities=25% Similarity=0.404 Sum_probs=196.6
Q ss_pred EEeeeeeecCceEEEEEEECCCCc----EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 116 QIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 116 ~i~~~LG~G~fG~V~~a~~~~~g~----~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
+..++||.|+||+||+|...-.|+ +||||++.. +.......+++.|+-+|.+|+|||+++|+++++...
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 446799999999999998755454 688888753 334445678999999999999999999999997653
Q ss_pred EEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+.||++||+ |.|.++++.+ +.+-......|.+||++|+.|||.++++||||-..||||.+-.++||.|||+|+....+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 689999999 7899999865 47888999999999999999999999999999999999999999999999999987655
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
...-. .....-.+-|||=|.+.. ..|+.++|||||||++|||+| |..|+.+....+.-+.+.+
T Consensus 852 ~~ey~-~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~------------- 915 (1177)
T KOG1025|consen 852 EKEYS-APGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK------------- 915 (1177)
T ss_pred ccccc-ccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-------------
Confidence 43211 111122345888888766 789999999999999999998 8899988765333222211
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+.+. -+..+-++.-++.+||-.|+..||+++++..
T Consensus 916 ------------geRLsq-----PpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 916 ------------GERLSQ-----PPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ------------cccCCC-----CCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 111111 1456677889999999999999999988754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=256.58 Aligned_cols=246 Identities=26% Similarity=0.431 Sum_probs=186.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.+.|.|.+.||+|.||.+.+|+|+.++..+++|.+.+. ....+.+.+|..---.| .|.||+.-|++.+.. ..
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt----~d 95 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT----SD 95 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhc----Cc
Confidence 46799999999999999999999999999999998753 23466788888765555 499999988877543 34
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC--CCcEEEcccCcceecc
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVSF 267 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~--~~~vKL~DFGla~~~~ 267 (595)
.+++++||++ |+|..-+... ++-|...+.++.|+++||.|||++++||||||.+||||-. ..+|||||||+.+...
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 6788999999 8998887664 5889999999999999999999999999999999999843 3479999999987542
Q ss_pred CCCCCcccccccccCCccccccccccc---CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
.... ..--+-.|.+||++... .-...+.+|||.||+|+|.+|||.+||......++ +
T Consensus 175 ~tV~------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-----------~--- 234 (378)
T KOG1345|consen 175 TTVK------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-----------P--- 234 (378)
T ss_pred ceeh------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-----------h---
Confidence 2111 11234458999987532 12356789999999999999999999974332111 1
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCC
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 394 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~R 394 (595)
..+++.-...+. ......|...++.+..+.++-|..+|++|
T Consensus 235 --------Y~~~~~w~~rk~-~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 235 --------YWEWEQWLKRKN-PALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred --------HHHHHHHhcccC-ccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 111111111111 13445677889999999999999999999
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=308.01 Aligned_cols=208 Identities=16% Similarity=0.203 Sum_probs=148.7
Q ss_pred hcCC-CceeeeeeeecCCCc--cCcccEEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Q 007629 168 LLRH-PDIVEIKHIMLPPSR--REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 243 (595)
Q Consensus 168 ~l~H-pnIv~l~~~~~~~~~--~~~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLK 243 (595)
.+.| +||+++++.|..... .....++++||+++++|.+++... ..+++.+++.|++||++||.|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 4455 577777777622211 122457889999999999999753 469999999999999999999999999999999
Q ss_pred CCceeeCC-------------------CCcEEEcccCcceeccCCC-------------CCcccccccccCCcccccccc
Q 007629 244 PKNILANA-------------------DCKLKICDFGLARVSFNDA-------------PSAIFWTDYVATRWYRAPELC 291 (595)
Q Consensus 244 P~NILl~~-------------------~~~vKL~DFGla~~~~~~~-------------~~~~~~~~~~gT~~Y~APE~l 291 (595)
|+||||+. ++.+||+|||+++...... +........+||++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999954 4456666666665321100 000011225789999999998
Q ss_pred cccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCC
Q 007629 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHK 371 (595)
Q Consensus 292 ~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~ 371 (595)
.+ ..|+.++|||||||+||||++|.+||..... .+..+.. .. + +. .
T Consensus 188 ~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~-------------------~~---~----~~----~ 233 (793)
T PLN00181 188 NG--SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRH-------------------RV---L----PP----Q 233 (793)
T ss_pred cc--CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHH-------------------hh---c----Ch----h
Confidence 87 6799999999999999999999888753211 1100000 00 0 00 0
Q ss_pred CCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 372 FPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 372 ~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
+....+.+.+++.+||.+||.+||++.|+|+||||...
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 01123457789999999999999999999999999764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=243.57 Aligned_cols=200 Identities=38% Similarity=0.652 Sum_probs=171.6
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lyl 194 (595)
|.+.+.||.|++|.||++.+..+++.||||.+...... .....+.+|+..++.++|+|++++++.+... ...|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEE
Confidence 56789999999999999999988999999998653222 2467788999999999999999999987443 45899
Q ss_pred EEecccc-cHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 195 VFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 195 V~E~~~g-~L~~~i~~~~~-l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
++|++.+ +|.+++..... +++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999996 99999987766 899999999999999999999999999999999999999999999999999876543211
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCC
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~ 323 (595)
......++..|++||.+. ....++.++|||+||+++++|++|+.||..
T Consensus 155 --~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 --LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 123457888999999983 226788899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=284.00 Aligned_cols=267 Identities=28% Similarity=0.353 Sum_probs=202.1
Q ss_pred EEeeeeeecCceEEEEEEECCCCcEEEEEEecC---ccCChhh-HHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKIND---VFEHVSD-ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 116 ~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~---~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.....+|.|+||.|+.+......+.++.|.... ....... ...+..|+.+-..|.|||++..+..++... .
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-----~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-----G 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-----c
Confidence 356789999999999888877777777776541 1111111 223667888888899999988877764332 2
Q ss_pred EEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
++-+||||++||+.++...+.++..++..++.||+.||+|||++||.||||||+|+|+..+|.+||+|||.+........
T Consensus 396 ~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred chhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 34459999999999999888899999999999999999999999999999999999999999999999999986544333
Q ss_pred C-cccccccccCCcccccccccccCCCCCC-cceeechhHHHHHHHcCCCCCCCCChHHHHH-HHHhhcCCCChhHHHHH
Q 007629 272 S-AIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEMLTGKPLFPGKNVVHQLD-LMTDLLGTPSTESISRI 348 (595)
Q Consensus 272 ~-~~~~~~~~gT~~Y~APE~l~~~~~~~~~-k~DIWSlG~il~eLltG~~pF~~~~~~~~l~-~i~~~lg~p~~~~i~~i 348 (595)
. .......+|+..|+|||++.+ ..|++ .+||||.|+|++.|++|+.||.-....++.. .+.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~-------------- 539 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN-------------- 539 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccchhhhc--------------
Confidence 2 234567899999999999987 67776 4899999999999999999996543221110 000
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~ 412 (595)
..............+..++...+.+|.+||++||.+|.|+++|++.+||+.+...
T Consensus 540 ---------~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 540 ---------YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred ---------cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 0000111111122233455668899999999999999999999999999987543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=228.55 Aligned_cols=165 Identities=21% Similarity=0.268 Sum_probs=126.5
Q ss_pred ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccccccc
Q 007629 201 SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 279 (595)
Q Consensus 201 g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 279 (595)
|+|.+++... ..+++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||++...... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------QS 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------cC
Confidence 5788888764 46999999999999999999999998 999999999999999 9999865332 22
Q ss_pred ccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHH-HHHHHHhhcCCCChhHHHHHhhHHHHHHhh
Q 007629 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH-QLDLMTDLLGTPSTESISRIRNEKARRYLG 358 (595)
Q Consensus 280 ~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~-~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~ 358 (595)
.||+.|||||++.+ ..|+.++|||||||++|||++|+.||....... .+..+..
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~----------------------- 119 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN----------------------- 119 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH-----------------------
Confidence 68999999999987 689999999999999999999999997644321 1111111
Q ss_pred hcccCCCCCCCCCCCCCC--HHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 359 SMRKKQPVPFSHKFPNAD--PLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~--~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
.+....+.. ......++ ..+.+||.+||..||.+||++.|+++|+|+.
T Consensus 120 ~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 120 GMPADDPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HhccCCccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 011000000 00001122 2589999999999999999999999999974
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-25 Score=226.34 Aligned_cols=265 Identities=34% Similarity=0.520 Sum_probs=202.8
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChh-hHHHHHHHHHHHHhcCCC-ceeeeeeeecCCCccCcccE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS-DATRILREIKLLRLLRHP-DIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~-~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~~~~l 192 (595)
|.+.+.||.|+||.||++.+. ..+|+|.+........ ....+.+|+.++..+.|+ +|+++++++... ...
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEE
Confidence 788999999999999999887 7899999876544433 467789999999999988 799999998333 237
Q ss_pred EEEEecccc-cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC-cEEEcccCcceecc
Q 007629 193 YVVFELMES-DLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSF 267 (595)
Q Consensus 193 ylV~E~~~g-~L~~~i~~~~---~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~-~vKL~DFGla~~~~ 267 (595)
+++++++.+ .+.+++.... .+++..+..++.|++.++.|+|+.+++||||||+|||++..+ .++++|||++....
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999984 6776776654 799999999999999999999999999999999999999988 79999999998554
Q ss_pred CCCCCc---ccccccccCCcccccccccccC-CCCCCcceeechhHHHHHHHcCCCCCCCCCh---HHHHHHHHhhcCCC
Q 007629 268 NDAPSA---IFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---VHQLDLMTDLLGTP 340 (595)
Q Consensus 268 ~~~~~~---~~~~~~~gT~~Y~APE~l~~~~-~~~~~k~DIWSlG~il~eLltG~~pF~~~~~---~~~l~~i~~~lg~p 340 (595)
...... ......+||.+|+|||.+.+.. ..+....|+||+|++++++++|..||..... .............+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 333221 1246679999999999987621 3678899999999999999999999877653 11111111111111
Q ss_pred ChhHHHHHhhHHHHHHhhhcccCCCCCCCCCC-CCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 341 ~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.......... ......+.+++.+++..+|..|.+..+...++|....
T Consensus 234 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 234 ----------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ----------------------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0000000000 1123568999999999999999999999998776543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=231.07 Aligned_cols=253 Identities=19% Similarity=0.337 Sum_probs=197.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCC-----cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG-----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g-----~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
..|+++...+-+|.||.||.|+.+... +.|-+|.++.. ...-+...++.|-.+|..+.|||+..+.++...
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie--- 358 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE--- 358 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee---
Confidence 467888999999999999999765432 34667766542 233456678899999999999999999998864
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEE
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAN--------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 257 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~--------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL 257 (595)
+....++++.+++ |+|..++... +.++..+...++.|++.|++|||+.||||.||-..|.+|++.-++||
T Consensus 359 -~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 359 -DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred -ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 3345788899998 8898888721 24666777888999999999999999999999999999999999999
Q ss_pred cccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhh
Q 007629 258 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDL 336 (595)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~ 336 (595)
+|=.+++..+..+....- ...-....|||||.+.. ..|+.++|+|||||++|||+| |+.||..-+..+....+.+
T Consensus 438 tDsaLSRDLFP~DYhcLG-DnEnRPvkWMslEal~n--~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd- 513 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLG-DNENRPVKWMSLEALQN--SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD- 513 (563)
T ss_pred ccchhccccCcccccccC-CCCCCcccccCHHHHhh--hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc-
Confidence 999999987665433211 11123446999999987 789999999999999999998 8899977665444333322
Q ss_pred cCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 337 lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+-.+| -++++++..++..||+.+|++||+.+++..
T Consensus 514 ----------------------GyRlaQP-------~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 514 ----------------------GYRLAQP-------FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ----------------------cceecCC-------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 1111222 257889999999999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-26 Score=238.72 Aligned_cols=166 Identities=20% Similarity=0.233 Sum_probs=128.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-CCcEEEEEEecCccC---ChhhHHHHHHHHHHHHhcCCCceee-eeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVE-IKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~-~g~~vAIK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~~~~~ 186 (595)
.++|.+.+.||+|+||+||+|++.. ++..||||++..... .......+.+|+.+|+.++|+||+. +++.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~------ 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT------ 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc------
Confidence 4579999999999999999998876 788889998753211 2223556889999999999999985 4331
Q ss_pred cCcccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCC-CCCceeeCCCCcEEEcccCcce
Q 007629 187 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL-KPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 187 ~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDL-KP~NILl~~~~~vKL~DFGla~ 264 (595)
...|||||||+| +|. .+.. .. ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||+|+
T Consensus 91 ---~~~~LVmE~~~G~~L~-~~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLH-LARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred ---CCcEEEEEccCCCCHH-HhCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 236999999986 564 3211 11 2467899999999999999999999 9999999999999999999998
Q ss_pred eccCCCCCcc-----cccccccCCcccccccccc
Q 007629 265 VSFNDAPSAI-----FWTDYVATRWYRAPELCGS 293 (595)
Q Consensus 265 ~~~~~~~~~~-----~~~~~~gT~~Y~APE~l~~ 293 (595)
.......... ..+...+++.|+|||.+..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 7644322111 1245678999999998754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-24 Score=223.99 Aligned_cols=255 Identities=20% Similarity=0.217 Sum_probs=187.0
Q ss_pred CeEEeeeeeecCceEEEEEEECCCC-cEEEEEEecCccCChhhHHHHHHHHHHHHhcCC----CceeeeeeeecCCCccC
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLRH----PDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g-~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~~~~~~~~~~~ 188 (595)
+|.+.+.||+|+||.||+|.+..++ ..+|+|.......... ..+..|+.+|..+.. +++..+++... ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----ST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEecc----CC
Confidence 8999999999999999999988775 6788887754221111 156778999888863 57888877763 12
Q ss_pred cccEEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC-----CcEEEcccC
Q 007629 189 FKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-----CKLKICDFG 261 (595)
Q Consensus 189 ~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~-----~~vKL~DFG 261 (595)
...-||||++++.+|.++.... +.|+...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 3457999999999999988654 479999999999999999999999999999999999999865 369999999
Q ss_pred cce--eccCCCCCc-c---c-ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHH
Q 007629 262 LAR--VSFNDAPSA-I---F-WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMT 334 (595)
Q Consensus 262 la~--~~~~~~~~~-~---~-~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~ 334 (595)
+|+ ......... . . .....||..|.++....+ ...+.+.|+||++.++.+|+.|..||.+.........+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 998 432222111 0 1 123569999999999887 678999999999999999999999997655322211111
Q ss_pred hhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 335 ~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.. ....... . .....+..+..+...+-..+...+|....+..
T Consensus 251 ~~---------------~~~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 251 KD---------------PRKLLTD--------R---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HH---------------hhhhccc--------c---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 10 0000000 0 11223455667777776788888888776655
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-26 Score=245.28 Aligned_cols=241 Identities=25% Similarity=0.405 Sum_probs=195.0
Q ss_pred eeeecCceEEEEEEE---CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcccEEEE
Q 007629 120 VIGKGSYGVVGSAVD---THTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVV 195 (595)
Q Consensus 120 ~LG~G~fG~V~~a~~---~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~lylV 195 (595)
.+|.|+||.|++++. ...|..||+|+.++.............|-.++..++ ||.+|++...+.. ...+|++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-----~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-----DGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-----ccchhHh
Confidence 379999999988753 346788999998764333333335556888888887 9999999888744 3568999
Q ss_pred Eecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcc
Q 007629 196 FELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274 (595)
Q Consensus 196 ~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 274 (595)
+++..+ +|+..+.....+++...+.+...++.|++++|+.+|+|||+|++||+++.+|++|+.|||+++.......
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 999984 8999988888999999999999999999999999999999999999999999999999999986543322
Q ss_pred cccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHh-hcCCCChhHHHHHhhHHH
Q 007629 275 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD-LLGTPSTESISRIRNEKA 353 (595)
Q Consensus 275 ~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~-~lg~p~~~~i~~i~~~~~ 353 (595)
.|||..|||||++.+ +..++|+||||++++||+||..||.+ +....|.+ -++.|
T Consensus 153 ----~cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p------------- 207 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP------------- 207 (612)
T ss_pred ----cccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc-------------
Confidence 299999999999863 57789999999999999999999977 22222222 11111
Q ss_pred HHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCCCCC
Q 007629 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLANV 412 (595)
Q Consensus 354 ~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~~~~ 412 (595)
...+..+.+++..|+..+|..|.- +.|+++|+||+.+.+.
T Consensus 208 -------------------~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 208 -------------------RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred -------------------hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 234667999999999999999976 4899999999987664
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=206.11 Aligned_cols=209 Identities=25% Similarity=0.355 Sum_probs=169.0
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC-CceeeeeeeecCCCcc
Q 007629 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH-PDIVEIKHIMLPPSRR 187 (595)
Q Consensus 109 ~~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~ 187 (595)
....+.|.++++||.|+||.+|.|....+|+.||||.-+....+ ..+..|.++.+.|++ ..|..+..+..
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~----- 81 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGT----- 81 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhcc-----
Confidence 34567899999999999999999999999999999987543333 356789999999985 66777766653
Q ss_pred CcccEEEEEecccccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC---CcEEEcccCcc
Q 007629 188 EFKDIYVVFELMESDLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLA 263 (595)
Q Consensus 188 ~~~~lylV~E~~~g~L~~~i~-~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~---~~vKL~DFGla 263 (595)
+..+-.+|||+++.+|.+++. ....|+...+..++-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||+|
T Consensus 82 e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 82 EKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred ccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 334568999999998888886 34579999999999999999999999999999999999997543 45899999999
Q ss_pred eeccCCCCC-ccc---ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHH
Q 007629 264 RVSFNDAPS-AIF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH 328 (595)
Q Consensus 264 ~~~~~~~~~-~~~---~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~ 328 (595)
+.+.+.... .+. -....||..|.+--...+ ..-+.+.|+-|+|.+|..+..|..||.|-....
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 876443322 111 234689999999877665 456778999999999999999999999865433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=212.64 Aligned_cols=236 Identities=21% Similarity=0.301 Sum_probs=181.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcccE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~l 192 (595)
.|+++++||+|+||+.+.|.+.-++++||||.-.. .+++.++..|....+.|. .+.|..+|-+- .+..+-
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr----kS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~N 99 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYN 99 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc----cCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchh
Confidence 59999999999999999999999999999997543 245667788999988886 68888775443 344556
Q ss_pred EEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC-----cEEEcccCcceec
Q 007629 193 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-----KLKICDFGLARVS 266 (595)
Q Consensus 193 ylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~-----~vKL~DFGla~~~ 266 (595)
.||||+++.+|.+++.- ...|+...+..++.|++.-++|+|++.+|+|||||+|+||..-+ .|.|+|||+|+.+
T Consensus 100 iLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 100 ILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 89999999888887764 45799999999999999999999999999999999999997543 4899999999976
Q ss_pred cCCCCC-ccc---ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCC---hHHHHHHHHhhcCC
Q 007629 267 FNDAPS-AIF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN---VVHQLDLMTDLLGT 339 (595)
Q Consensus 267 ~~~~~~-~~~---~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~---~~~~l~~i~~~lg~ 339 (595)
.+...+ .+. .....||..||+=.-.+| ..-+.+.|+-|||-+|++.|-|..||.|-. ..+..+.|-+.-..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred cCccccccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 544332 222 234679999999887777 577889999999999999999999998754 33444455443333
Q ss_pred CChhHHHHHhhHHHHHHhhhc
Q 007629 340 PSTESISRIRNEKARRYLGSM 360 (595)
Q Consensus 340 p~~~~i~~i~~~~~~~~l~~~ 360 (595)
.+.+.++.--++....|+...
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yv 278 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYV 278 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHH
Confidence 344444443344444444433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-25 Score=246.53 Aligned_cols=228 Identities=28% Similarity=0.423 Sum_probs=171.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|..++.|-.|+||.||.++|+.+.+.+|+ +|++. .-++|- +|.....|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq-------~lilRn--ilt~a~np------------------- 132 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQ-------NLILRN--ILTFAGNP------------------- 132 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-ccccc-------chhhhc--cccccCCc-------------------
Confidence 35799999999999999999999999999999 45431 111111 22222222
Q ss_pred EEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
++| ||-..+++..++++.+. +.+++|||+.||+|||+||+|+||+.-|++|++|||+++.......
T Consensus 133 -fvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 133 -FVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred -cee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 233 55566666666666554 7789999999999999999999999999999999999875321111
Q ss_pred Cc------------ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCC
Q 007629 272 SA------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339 (595)
Q Consensus 272 ~~------------~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~ 339 (595)
.. ..-...||||.|+|||++.. ..|+..+|+|++|+|+||.+-|..||.|+...+.+..+....
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~-- 274 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-- 274 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh--
Confidence 11 11134699999999999877 689999999999999999999999999988765554432211
Q ss_pred CChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC---CHHHHhcCCCccCCCCC
Q 007629 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP---TAEEALADPYFHGLANV 412 (595)
Q Consensus 340 p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp---ta~elL~Hp~f~~~~~~ 412 (595)
+.|.+......++++++|.++|+.+|..|. .+.++.+|+||+.+.+.
T Consensus 275 --------------------------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 275 --------------------------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred --------------------------ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 122233345678999999999999999994 57899999999988765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-23 Score=234.57 Aligned_cols=252 Identities=27% Similarity=0.393 Sum_probs=183.5
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc--CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.|...+.||.+.|=+|.+|++. .|. |+||++-+.. .......+.+.|++ ...++|||.+.+..+. ...+.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 6888999999999999999875 344 9999974432 23344566677777 7778999999887664 33345
Q ss_pred EEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC--C
Q 007629 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN--D 269 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~--~ 269 (595)
-|||-+|...+|++.+....-+..-+.+.|+.||+.||.-+|..||+|+|||.+||||+.=+.+.|+||..-+..+- +
T Consensus 96 AylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 79999999999999999888888999999999999999999999999999999999999988999999987654322 2
Q ss_pred CCC--cccccccccCCcccccccccccC--------C-CCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhc
Q 007629 270 APS--AIFWTDYVATRWYRAPELCGSFF--------S-KYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLL 337 (595)
Q Consensus 270 ~~~--~~~~~~~~gT~~Y~APE~l~~~~--------~-~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~l 337 (595)
.+. ..++.+...--+|.|||.+.... . ..+++.||||+||+++||++ |+|||.- .|+-.-.. .
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~-~ 250 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRS-G 250 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhc-c
Confidence 111 11222222334699999764311 1 26788999999999999987 6899942 11110000 0
Q ss_pred CCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 338 g~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
+.-..+ ..+..+ .+..++.||..|++.||.+|.+|++.|+-
T Consensus 251 ~~~~~e-----------~~Le~I--------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPE-----------QLLEKI--------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHH-----------HHHHhC--------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 000000 011111 12348899999999999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.6e-23 Score=197.63 Aligned_cols=140 Identities=23% Similarity=0.250 Sum_probs=108.0
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhh------------------------HHHHHHHHHHHHhcCCCc
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD------------------------ATRILREIKLLRLLRHPD 173 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~------------------------~~~~~~Ei~il~~l~Hpn 173 (595)
...||+|+||.||+|.+. +|+.||||+++........ .....+|+++|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 8999999998643211111 112345999999998877
Q ss_pred eeeeeeeecCCCccCcccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCeeecCCCCCceeeCC
Q 007629 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNILANA 251 (595)
Q Consensus 174 Iv~l~~~~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yL-Hs~gIiHrDLKP~NILl~~ 251 (595)
+.....+.. ...||||||++| ++...+.....+++..+..++.||+.+|.|| |+.||+||||||+|||++
T Consensus 81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 643322211 123899999996 4444444456899999999999999999999 799999999999999998
Q ss_pred CCcEEEcccCcceec
Q 007629 252 DCKLKICDFGLARVS 266 (595)
Q Consensus 252 ~~~vKL~DFGla~~~ 266 (595)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 578999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=199.55 Aligned_cols=176 Identities=11% Similarity=0.120 Sum_probs=132.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhh-HHH------HHHHHHHHHhcCCCceeeeeeeecCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD-ATR------ILREIKLLRLLRHPDIVEIKHIMLPP 184 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~-~~~------~~~Ei~il~~l~HpnIv~l~~~~~~~ 184 (595)
.++|+++++||.|+||.||++.+ ++..||||.+......... ... +.+|+..+.++.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 57999999999999999999754 4668999999654332222 222 57899999999999999998886543
Q ss_pred Ccc---CcccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEccc
Q 007629 185 SRR---EFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260 (595)
Q Consensus 185 ~~~---~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DF 260 (595)
... .....||||||++| +|.++. .+++ ..+.+|+.+|..||..|++|||+||+|||++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 211 12457999999997 676653 2333 2466999999999999999999999999999998 999999
Q ss_pred CcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHH
Q 007629 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML 315 (595)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLl 315 (595)
|.......+... ..++.. ..|+.++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a~---------------d~~vle--r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK---------------DRIDLE--RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH---------------HHHHHH--hHhcccccccceeEeehHHH
Confidence 988654221110 013333 45778999999999998765
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-22 Score=191.43 Aligned_cols=140 Identities=23% Similarity=0.205 Sum_probs=110.3
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhh------------------------HHHHHHHHHHHHhcCCCc
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD------------------------ATRILREIKLLRLLRHPD 173 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~------------------------~~~~~~Ei~il~~l~Hpn 173 (595)
.+.||+|+||.||+|.+. +|+.||||+++........ ...+.+|+..+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 8999999998643211000 122357899999999998
Q ss_pred eeeeeeeecCCCccCcccEEEEEeccccc-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCC
Q 007629 174 IVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANA 251 (595)
Q Consensus 174 Iv~l~~~~~~~~~~~~~~lylV~E~~~g~-L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~ 251 (595)
|.....+... ..||||||++|. +.........+++..+..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 81 i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~- 152 (190)
T cd05145 81 VPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence 7544433321 138999999974 43333344578889999999999999999999 9999999999999998
Q ss_pred CCcEEEcccCcceec
Q 007629 252 DCKLKICDFGLARVS 266 (595)
Q Consensus 252 ~~~vKL~DFGla~~~ 266 (595)
++.++|+|||+|...
T Consensus 153 ~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 DGKPYIIDVSQAVEL 167 (190)
T ss_pred CCCEEEEEcccceec
Confidence 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-22 Score=203.10 Aligned_cols=260 Identities=28% Similarity=0.388 Sum_probs=174.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCC-----------------------------------cEEEEEEecCccCChhhH
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG-----------------------------------ERVAIKKINDVFEHVSDA 156 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g-----------------------------------~~vAIK~i~~~~~~~~~~ 156 (595)
.++|+|++.||+|..+.||.|.-...| -+.|||.+-.. ...+..
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~-~~~s~~ 234 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNF-EHDSGD 234 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccc-ccCCch
Confidence 467999999999999999998754321 13566765321 222222
Q ss_pred HHHH----HHH------HH--------HHh--------cCCCceeeeeeeecCC----------------------CccC
Q 007629 157 TRIL----REI------KL--------LRL--------LRHPDIVEIKHIMLPP----------------------SRRE 188 (595)
Q Consensus 157 ~~~~----~Ei------~i--------l~~--------l~HpnIv~l~~~~~~~----------------------~~~~ 188 (595)
..++ +|+ .. .+. -+|||||++..+|.+. ...+
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 2222 221 01 111 3599999999888431 1133
Q ss_pred cccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC--CCC--cEEEcccCcce
Q 007629 189 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADC--KLKICDFGLAR 264 (595)
Q Consensus 189 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~--~~~--~vKL~DFGla~ 264 (595)
...+|+||..+..+|.+++-.+ ..+......++.|+++|+.|||.+||.|||||.+|||+. +|+ .+.|+|||++-
T Consensus 315 ~~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred CceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 4569999999999999999765 466777888999999999999999999999999999974 333 48999999885
Q ss_pred eccCCCCCccccc---ccccCCcccccccccccCCC----CCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhc
Q 007629 265 VSFNDAPSAIFWT---DYVATRWYRAPELCGSFFSK----YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337 (595)
Q Consensus 265 ~~~~~~~~~~~~~---~~~gT~~Y~APE~l~~~~~~----~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~l 337 (595)
......-.-.+.+ +.-|...-||||+.....++ --.++|.|+.|.+.||+++...||.+.-... +
T Consensus 394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L------- 465 (598)
T KOG4158|consen 394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-L------- 465 (598)
T ss_pred eccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-e-------
Confidence 3222111111111 23477789999997543221 1137899999999999999999998743211 0
Q ss_pred CCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH---HHHhc
Q 007629 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA---EEALA 402 (595)
Q Consensus 338 g~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta---~elL~ 402 (595)
+ .+.| ++.+ +...-..+++.+++|+..+|+.||++|+++ ..+|+
T Consensus 466 -----~---------~r~Y----qe~q---LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 466 -----D---------TRTY----QESQ---LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred -----c---------hhhh----hhhh---CCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 0 0001 1111 111224577889999999999999999984 45554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=199.46 Aligned_cols=240 Identities=20% Similarity=0.271 Sum_probs=148.3
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhhHHHHHHHHHHHHhcCC----------Cceeeeeeeec
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRH----------PDIVEIKHIML 182 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~-~~~~~~~~~~~~Ei~il~~l~H----------pnIv~l~~~~~ 182 (595)
.+...+.||.|+++.||.+.|..||+.+|+|++.-. .......+.+.+|.-....+.+ -.++--+++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 467788999999999999999999999999987422 2223345566666544333222 11111111111
Q ss_pred -CCC---c---cCc-----ccEEEEEecccccHHHHHHh---cCCC----CHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Q 007629 183 -PPS---R---REF-----KDIYVVFELMESDLHQVIKA---NDDL----TPEHYQFFLYQLLRGLKYIHTANVFHRDLK 243 (595)
Q Consensus 183 -~~~---~---~~~-----~~lylV~E~~~g~L~~~i~~---~~~l----~~~~~~~i~~qil~aL~yLHs~gIiHrDLK 243 (595)
... . ... -..+++|+-+.++|.+++.. .... .......+..|+++.+++||+.||+|+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 100 0 000 13478888888888777642 2222 112223455899999999999999999999
Q ss_pred CCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCccccccccccc------CCCCCCcceeechhHHHHHHHcC
Q 007629 244 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEMLTG 317 (595)
Q Consensus 244 P~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~------~~~~~~k~DIWSlG~il~eLltG 317 (595)
|+|+|++.+|.++|+||+........ ......+..|.+||+.... ...++.+.|.|+||+++|.|++|
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTR------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEE------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCce------eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999987643221 1113455779999976431 13578899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCC
Q 007629 318 KPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 394 (595)
Q Consensus 318 ~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~R 394 (595)
..||........ + ...|.. +.+++...++||..||++||.+|
T Consensus 247 ~lPf~~~~~~~~----------~------------------------~~~f~~-C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEAD----------P------------------------EWDFSR-CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGST----------S------------------------GGGGTT-SS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccc----------c------------------------cccchh-cCCcCHHHHHHHHHHccCCcccC
Confidence 999975432100 0 001222 22667889999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.1e-21 Score=184.24 Aligned_cols=190 Identities=16% Similarity=0.071 Sum_probs=137.4
Q ss_pred EeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChh--hHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcccEE
Q 007629 117 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS--DATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 117 i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+...|++|+||+|+.+.. .+..++.+.+........ ....+.+|+++|++|. |++|++++++. ..|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~~ 74 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GRH 74 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CEE
Confidence 457899999999998754 677888777754322111 1235789999999996 58899887752 269
Q ss_pred EEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCC-CCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 194 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL-KPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 194 lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDL-KP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
++|||+.| +|.+.+.. . ...++.|++.+|.+||++||+|||| ||+|||++.++.++|+|||+|........
T Consensus 75 lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred EEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99999987 45443211 1 2357889999999999999999999 79999999999999999999985433221
Q ss_pred Ccc--ccc--------ccccCCcccccccccccCCCCC-CcceeechhHHHHHHHcCCCCCCCCC
Q 007629 272 SAI--FWT--------DYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKN 325 (595)
Q Consensus 272 ~~~--~~~--------~~~gT~~Y~APE~l~~~~~~~~-~k~DIWSlG~il~eLltG~~pF~~~~ 325 (595)
... ... -...++.|++|+.-.-. ...+ .+.++++.|+.+|.++|+..|+.+++
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 000 000 01367889999853221 1222 56799999999999999998876654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.9e-20 Score=180.99 Aligned_cols=136 Identities=21% Similarity=0.259 Sum_probs=106.2
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-----CCCceeeeeeeecCCCccCcccE
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-----RHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
.+.||+|+||.||. +..++.. +||++... .......+.+|+.+++.+ .||||+++++++.+.. ....+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~--~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHR--GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecc--ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 47899999999995 7777766 69988542 122456789999999999 5799999999996542 12343
Q ss_pred E-EEEeccc---ccHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCeeecCCCCCceeeCC----CCcEEEcccCcc
Q 007629 193 Y-VVFELME---SDLHQVIKANDDLTPEHYQFFLYQLLRGL-KYIHTANVFHRDLKPKNILANA----DCKLKICDFGLA 263 (595)
Q Consensus 193 y-lV~E~~~---g~L~~~i~~~~~l~~~~~~~i~~qil~aL-~yLHs~gIiHrDLKP~NILl~~----~~~vKL~DFGla 263 (595)
+ +||||++ ++|.+++... .+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 7899955 5999999764 56666 46688888888 9999999999999999999974 347999995544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-21 Score=202.83 Aligned_cols=255 Identities=24% Similarity=0.372 Sum_probs=166.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeee-------eec
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH-------IML 182 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~---g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-------~~~ 182 (595)
..+.+.+..+..++|.+....-... .+.++-|..+ ..+........+++-.+....|-+..-+.+ .+.
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~--~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRAD--VDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhh--ccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 3455666677777776665543322 2233333221 111123344556666665555444333322 111
Q ss_pred CCCccCcccEEEEEeccc-ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEc
Q 007629 183 PPSRREFKDIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258 (595)
Q Consensus 183 ~~~~~~~~~lylV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~ 258 (595)
........++||.|++|. ..|.++|.... ..+....+.++.|+..|++| +|.+|||+||.||+...++.+||.
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh
Confidence 111122346899999998 68999997543 46777889999999999999 999999999999999999999999
Q ss_pred ccCcceeccCCC---CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHh
Q 007629 259 DFGLARVSFNDA---PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD 335 (595)
Q Consensus 259 DFGla~~~~~~~---~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~ 335 (595)
|||+........ ......+..+||++||+||.+.+ ..|+.++||||||+||+||+. +|.... +...
T Consensus 399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~---~f~T~~--er~~---- 467 (516)
T KOG1033|consen 399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLI---QFSTQF--ERIA---- 467 (516)
T ss_pred hhhheeecccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHH---HhccHH--HHHH----
Confidence 999987654433 11223466799999999999998 789999999999999999997 221110 0000
Q ss_pred hcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 336 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 336 ~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
.+..+ +. ..+...+..-.|...+||.+||.+.|.+||++.+.--|+|.
T Consensus 468 --------t~~d~------------r~---g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 468 --------TLTDI------------RD---GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred --------hhhhh------------hc---CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 00001 10 01111112224557899999999999999988887777775
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=181.02 Aligned_cols=142 Identities=18% Similarity=0.135 Sum_probs=110.2
Q ss_pred CeEEeeeeeecCceEEEEEE-ECCCCcEEEEEEecCccCCh--------------------h--hHHHHHHHHHHHHhcC
Q 007629 114 RYQIQEVIGKGSYGVVGSAV-DTHTGERVAIKKINDVFEHV--------------------S--DATRILREIKLLRLLR 170 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~-~~~~g~~vAIK~i~~~~~~~--------------------~--~~~~~~~Ei~il~~l~ 170 (595)
-|.+.+.||+|+||.||+|. +..+|+.||||+++...... . ....+.+|+.+++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 67799999999986422100 0 0123568999999997
Q ss_pred CCc--eeeeeeeecCCCccCcccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCCCCc
Q 007629 171 HPD--IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN-VFHRDLKPKN 246 (595)
Q Consensus 171 Hpn--Iv~l~~~~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~g-IiHrDLKP~N 246 (595)
+.. +.++++. ...|+||||+++ +|.........+....+..++.||+.+|.+||+.| |+||||||+|
T Consensus 109 ~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe---------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence 532 3333321 124899999997 45444434455667778899999999999999999 9999999999
Q ss_pred eeeCCCCcEEEcccCccee
Q 007629 247 ILANADCKLKICDFGLARV 265 (595)
Q Consensus 247 ILl~~~~~vKL~DFGla~~ 265 (595)
||++ ++.++|+|||+|..
T Consensus 180 Ili~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEEE-CCCEEEEEChhhhc
Confidence 9999 88999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.9e-21 Score=212.67 Aligned_cols=264 Identities=26% Similarity=0.369 Sum_probs=204.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECC-CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~-~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~ 190 (595)
..|.+.+.||+|+|+.|-.+.... +...+|+|.+............+..|+.+-+.+. |+|++.+++....+ .
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~-----~ 94 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP-----R 94 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC-----c
Confidence 357788889999999998887643 4456788877644333344556667888888887 99999999887544 4
Q ss_pred cEEEEEeccc-ccHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCCCceeeCCCC-cEEEcccCccee
Q 007629 191 DIYVVFELME-SDLHQVI-KAND-DLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADC-KLKICDFGLARV 265 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i-~~~~-~l~~~~~~~i~~qil~aL~yLH-s~gIiHrDLKP~NILl~~~~-~vKL~DFGla~~ 265 (595)
..+++++|.. ++++..+ .... ..+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .+|++|||+|..
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 4799999977 4788877 4444 6788889999999999999999 99999999999999999999 999999999987
Q ss_pred ccCCCCCccccccccc-CCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 266 SFNDAPSAIFWTDYVA-TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~g-T~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
+.............+| ++.|+|||...+. ....+..|+||+|+++.-|++|..||........
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--------------- 238 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--------------- 238 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccc---------------
Confidence 7652333334566788 9999999998763 3456789999999999999999999865432110
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
.|...+ ......-...|...+..+.+++.++|..+|..|.+.+++-.+||+..
T Consensus 239 ----------~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 239 ----------RYSSWK-SNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ----------cceeec-ccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 001111 11111112345677888999999999999999999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.1e-19 Score=205.95 Aligned_cols=193 Identities=24% Similarity=0.326 Sum_probs=151.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC---CCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~ 188 (595)
...|.|.+.||+|+||.||+|.+.. |+.||+|+-+..... ++.--.+++.+|+ -+.|..+..+++...
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~--- 767 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQN--- 767 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccCC---
Confidence 3579999999999999999999876 999999986432111 1111223444444 234444444443322
Q ss_pred cccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC-------CcEEEccc
Q 007629 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-------CKLKICDF 260 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~-------~~vKL~DF 260 (595)
.-++|+||.+ |+|.+++..++.+++..+.+|..||+.-|+.||.++|||+||||+|+||... --++|+||
T Consensus 768 --~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 768 --ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred --cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 2589999999 8999999988899999999999999999999999999999999999997532 24899999
Q ss_pred CcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCC
Q 007629 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK 318 (595)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~ 318 (595)
|.+..+.--... ..+...++|-.+-.+|...| ..|++.+|.|.|..+++-||.|+
T Consensus 846 G~siDm~lfp~~-~~F~~~~~td~f~C~EM~~g--rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREG--RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEcCCC-cEEeeeeccccchhHHHhcC--CCCchhhhhHHHHHHHHHHHHHH
Confidence 999654322222 33567789999999999988 78999999999999999999997
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-18 Score=168.70 Aligned_cols=135 Identities=21% Similarity=0.282 Sum_probs=108.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChh------hHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS------DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
+.||+|++|.||+|.. .|..|+||+......... ....+.+|+.++..+.|++|.....++... ...
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence 5799999999999976 678899998653221111 124577899999999999887665554322 346
Q ss_pred EEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 193 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 193 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
++||||++| +|.+++.... + ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 899999985 7888876532 2 7788999999999999999999999999999999 78999999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-17 Score=162.60 Aligned_cols=136 Identities=23% Similarity=0.205 Sum_probs=104.1
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChh--------------------hHHHHHHHHHHHHhcCCCc-
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS--------------------DATRILREIKLLRLLRHPD- 173 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~--------------------~~~~~~~Ei~il~~l~Hpn- 173 (595)
|.+.+.||.|+||.||+|... +|+.||||++........ ......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 778899999999999999874 799999998753211000 1123567899999998774
Q ss_pred -eeeeeeeecCCCccCcccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC
Q 007629 174 -IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251 (595)
Q Consensus 174 -Iv~l~~~~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~ 251 (595)
+...++. ...++||||++| +|..+.. ......++.+|+.++.++|+.||+||||||+|||++.
T Consensus 96 ~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 96 PVPKPIDW---------NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCCceeec---------CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC
Confidence 3333321 235899999996 4544322 1345678899999999999999999999999999999
Q ss_pred CCcEEEcccCcceec
Q 007629 252 DCKLKICDFGLARVS 266 (595)
Q Consensus 252 ~~~vKL~DFGla~~~ 266 (595)
++.++|+|||++...
T Consensus 161 ~~~~~liDfg~~~~~ 175 (198)
T cd05144 161 DEKIYIIDWPQMVST 175 (198)
T ss_pred CCcEEEEECCccccC
Confidence 999999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=162.50 Aligned_cols=131 Identities=27% Similarity=0.391 Sum_probs=100.9
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCc-cCCh-----hhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 120 VIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHV-----SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 120 ~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~-~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
.||+|+||.||+|. .+|..|++|+.... .... ....++.+|+.+++.+.|+++....-++... ...+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence 48999999999997 46788999986432 1111 1235677899999999987654433333221 2368
Q ss_pred EEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 194 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 194 lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
+||||++| +|.+++..... .++.|++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999985 77777654321 7899999999999999999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4e-17 Score=176.12 Aligned_cols=211 Identities=25% Similarity=0.339 Sum_probs=151.4
Q ss_pred HHhcCCCceeeeeeeecCCCccCcccEEEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCe-eecCC
Q 007629 166 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANV-FHRDL 242 (595)
Q Consensus 166 l~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gI-iHrDL 242 (595)
|+.+.|.|+.++++.++.. ..+++|.+||. |+|.+.+.. ...+++.....+++.|+.||.|||...| .|+-|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 4678999999999999765 45899999998 899999987 3467788888899999999999998766 99999
Q ss_pred CCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccC--C---CCCCcceeechhHHHHHHHcC
Q 007629 243 KPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF--S---KYTPAIDIWSIGCIFAEMLTG 317 (595)
Q Consensus 243 KP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~--~---~~~~k~DIWSlG~il~eLltG 317 (595)
+..|.+++....+||+|||+........... ......-...|.|||++.+.. . ..+.+.||||+|+|++|+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~-~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPE-AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccccceeeeeEEEEechhhhccccccccccc-ccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999987653210000 001112334589999987631 1 146789999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH
Q 007629 318 KPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA 397 (595)
Q Consensus 318 ~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta 397 (595)
..||......... .+.+..+ .........|.-.......+.+..++..||.-+|..||++
T Consensus 155 ~~~~~~~~~~~~~-----------~eii~~~---------~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 155 SGPFDLRNLVEDP-----------DEIILRV---------KKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred cCccccccccCCh-----------HHHHHHH---------HhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence 9999864321110 1111111 0011111112111112455679999999999999999999
Q ss_pred HHHhc
Q 007629 398 EEALA 402 (595)
Q Consensus 398 ~elL~ 402 (595)
+++-.
T Consensus 215 ~~i~~ 219 (484)
T KOG1023|consen 215 EQIRS 219 (484)
T ss_pred HHHHh
Confidence 88754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.2e-17 Score=180.73 Aligned_cols=139 Identities=24% Similarity=0.331 Sum_probs=107.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEe-cCccCC-----hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEH-----VSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i-~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 185 (595)
...|...+.||+|+||+||++... +..+++|+. .+.... .....++.+|+.+++.++|++|+..+.++...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~- 408 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP- 408 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-
Confidence 344567899999999999999764 344555543 221111 11235678999999999999998776555432
Q ss_pred ccCcccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 186 RREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 186 ~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
...++||||+++ +|.+++. ....++.|++.+|.|||+.||+||||||+|||+ .++.++|+|||+++
T Consensus 409 ----~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 409 ----EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred ----CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 236899999985 7877774 356789999999999999999999999999999 67899999999998
Q ss_pred ec
Q 007629 265 VS 266 (595)
Q Consensus 265 ~~ 266 (595)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 54
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.9e-17 Score=154.90 Aligned_cols=136 Identities=25% Similarity=0.254 Sum_probs=96.3
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHH----------------------HHHHHHHHHhcCCCc--
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR----------------------ILREIKLLRLLRHPD-- 173 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~----------------------~~~Ei~il~~l~Hpn-- 173 (595)
.+.||+|+||.||+|.+. +|+.||||+++........... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 8999999988643221111111 134666666664433
Q ss_pred eeeeeeeecCCCccCcccEEEEEecccc-cHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeC
Q 007629 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLH-QVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILAN 250 (595)
Q Consensus 174 Iv~l~~~~~~~~~~~~~~lylV~E~~~g-~L~-~~i~~~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~ 250 (595)
+.+.+.+ ...++||||+++ .+. ..+... .. ...++.++.+++.++.++|. .||+||||||+|||++
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 3333322 125899999997 211 111111 11 16778899999999999999 9999999999999999
Q ss_pred CCCcEEEcccCcceec
Q 007629 251 ADCKLKICDFGLARVS 266 (595)
Q Consensus 251 ~~~~vKL~DFGla~~~ 266 (595)
++.++|+|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-17 Score=161.82 Aligned_cols=241 Identities=17% Similarity=0.250 Sum_probs=174.4
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+..++-+|.+...|..|+++ ..|..+++|+++-..-...-...+..|.-.|+.+.||||+.+++.|..+ .++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgr--wqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGR--WQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLV 263 (448)
T ss_pred hhhhhhhhccCCCccccccc--ccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCce
Confidence 44567789999999999995 5577788888753322333345677888899999999999999999554 4589
Q ss_pred EEEeccc-ccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC-eee-cCCCCCceeeCCCCcEEEc--ccCcceec
Q 007629 194 VVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTAN-VFH-RDLKPKNILANADCKLKIC--DFGLARVS 266 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~~~--l~~~~~~~i~~qil~aL~yLHs~g-IiH-rDLKP~NILl~~~~~vKL~--DFGla~~~ 266 (595)
++..||+ |+|+.++..... ....++..++..|++|++|||+.. ++- --|....++||++.+.+|. |--++.
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-- 341 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-- 341 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--
Confidence 9999999 899999986543 566788899999999999999964 333 3577888999998876653 433322
Q ss_pred cCCCCCcccccccccCCcccccccccccCCC-CCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~-~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
... ...-.|.||+||.+...... --.++|+|||.+++|||.|...||..-...+---+|
T Consensus 342 -qe~-------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki------------ 401 (448)
T KOG0195|consen 342 -QEV-------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI------------ 401 (448)
T ss_pred -ecc-------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh------------
Confidence 111 12346789999988663111 224789999999999999999999765542211100
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHH
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~el 400 (595)
-+..++. ..-|.+++-...|+.-|+.-||.+||.+..+
T Consensus 402 ----------aleglrv-------~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 402 ----------ALEGLRV-------HIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred ----------hhccccc-------cCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 1111111 2235678889999999999999999987654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=2e-15 Score=151.72 Aligned_cols=139 Identities=22% Similarity=0.280 Sum_probs=102.2
Q ss_pred eeee-ecCceEEEEEEECCCCcEEEEEEecCc------cC-----ChhhHHHHHHHHHHHHhcCCCce--eeeeeeecCC
Q 007629 119 EVIG-KGSYGVVGSAVDTHTGERVAIKKINDV------FE-----HVSDATRILREIKLLRLLRHPDI--VEIKHIMLPP 184 (595)
Q Consensus 119 ~~LG-~G~fG~V~~a~~~~~g~~vAIK~i~~~------~~-----~~~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~~ 184 (595)
..|| .|+.|+||.+.. .+..++||.+... .. ......++.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 777888888865 3778999977421 01 11233567899999999998875 5565553322
Q ss_pred CccCcccEEEEEecccc--cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCc
Q 007629 185 SRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262 (595)
Q Consensus 185 ~~~~~~~lylV~E~~~g--~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGl 262 (595)
. ......++|||+++| +|.+++.. ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 1 111123699999985 78887754 4555543 57899999999999999999999999999999999999998
Q ss_pred cee
Q 007629 263 ARV 265 (595)
Q Consensus 263 a~~ 265 (595)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2e-16 Score=170.87 Aligned_cols=257 Identities=25% Similarity=0.251 Sum_probs=198.1
Q ss_pred CCeEEeeeeee--cCceEEEEEEE--CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCcc
Q 007629 113 SRYQIQEVIGK--GSYGVVGSAVD--THTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 113 ~~Y~i~~~LG~--G~fG~V~~a~~--~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 187 (595)
..+.+.+.+|. |.+|.||.+.. ..++..+|+|+-+..........+-.+|+.-.+.+. |++.++.+..+ +
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e 188 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----E 188 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----c
Confidence 35677889999 99999999988 889999999985444443344445567887777775 99999977666 4
Q ss_pred CcccEEEEEecccccHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCeeecCCCCCceeeCCC-CcEEEcccC
Q 007629 188 EFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLR----GLKYIHTANVFHRDLKPKNILANAD-CKLKICDFG 261 (595)
Q Consensus 188 ~~~~lylV~E~~~g~L~~~i~~~~~-l~~~~~~~i~~qil~----aL~yLHs~gIiHrDLKP~NILl~~~-~~vKL~DFG 261 (595)
+...+|+-+|+|+.+|..+...... +++..++.++.+..+ ||.++|+.+|+|-|+||+||++..+ ...+++|||
T Consensus 189 ~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 189 GSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 4556899999999988888776554 888999999999999 9999999999999999999999999 889999999
Q ss_pred cceeccCCCCCcccc--cccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCC--ChHHHHHHHHhhc
Q 007629 262 LARVSFNDAPSAIFW--TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK--NVVHQLDLMTDLL 337 (595)
Q Consensus 262 la~~~~~~~~~~~~~--~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~--~~~~~l~~i~~~l 337 (595)
+...+....-..... ....|...|++||+..+ -++.+.||++||.++++..+|.-++... +.+.++..+.
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--- 342 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--- 342 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---
Confidence 998765443222111 12256778999999876 6888999999999999999987665444 3333322211
Q ss_pred CCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 338 g~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
+ ....+...+..+...+..|+..||..|+++..++.|+++...
T Consensus 343 ----------------------------i-p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 343 ----------------------------I-PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred ----------------------------C-chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 0 011122334456669999999999999999999999999754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.6e-16 Score=175.65 Aligned_cols=267 Identities=23% Similarity=0.253 Sum_probs=198.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.+.+.+.+-+-+|+++.++.+.-..+|...++|...... ....+.+.+.++-.++-...+|-+++..--+ ....
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rs 877 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRS 877 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCC
Confidence 456788889999999999999888888878877653211 1112233344444555555667777654332 2223
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
..+||++|++ ++|...+...+..+++-++.++..+..+++|||+..+.|||+||.|+|+..+|+.++.|||.......-
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence 4899999997 589998888888999999999999999999999999999999999999999999999999844321100
Q ss_pred --------CCC--------------------cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCC
Q 007629 270 --------APS--------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321 (595)
Q Consensus 270 --------~~~--------------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF 321 (595)
..+ .......+||+.|.+||.+.+ .....++|+|++|++++|.++|.+||
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 000 011123579999999999988 67788999999999999999999999
Q ss_pred CCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHH---
Q 007629 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE--- 398 (595)
Q Consensus 322 ~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~--- 398 (595)
........++.| . ....+|...-...++.+.+++.++|..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni---------------------------~-~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~ 1087 (1205)
T KOG0606|consen 1036 NAETPQQIFENI---------------------------L-NRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAA 1087 (1205)
T ss_pred CCcchhhhhhcc---------------------------c-cCCCCCCCCccccChhhhhhhhhhhccCchhccCccccc
Confidence 876542222111 1 112334444455688899999999999999999887
Q ss_pred HHhcCCCccCCCCCC
Q 007629 399 EALADPYFHGLANVD 413 (595)
Q Consensus 399 elL~Hp~f~~~~~~~ 413 (595)
++-.||||+...+..
T Consensus 1088 e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1088 EVKGHPFFQDVDWEN 1102 (1205)
T ss_pred ccccCCccCCCCccc
Confidence 999999999876543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.5e-15 Score=134.46 Aligned_cols=131 Identities=23% Similarity=0.213 Sum_probs=105.7
Q ss_pred EeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC--CceeeeeeeecCCCccCcccEEE
Q 007629 117 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH--PDIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 117 i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~~~~lyl 194 (595)
+.+.||.|.++.||++... +..++||.+..... ...+.+|+.+++.+.| ..+++++...... ...|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD-----GWSYL 70 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEE
Confidence 4578999999999999874 37899998864322 4567889999999976 5888887766332 45899
Q ss_pred EEeccccc-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 195 VFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 195 V~E~~~g~-L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~---gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
+|||+.+. +..+ +......++.+++.+|++||.. +++|+||+|.|||++..+.++++|||.+..
T Consensus 71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99999864 3322 4566677899999999999985 699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.8e-14 Score=140.68 Aligned_cols=246 Identities=19% Similarity=0.204 Sum_probs=160.1
Q ss_pred EEEEEEECCCCcEEEEEEecCccC-Chh-hHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEeccc-ccHH
Q 007629 128 VVGSAVDTHTGERVAIKKINDVFE-HVS-DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLH 204 (595)
Q Consensus 128 ~V~~a~~~~~g~~vAIK~i~~~~~-~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~~-g~L~ 204 (595)
.||++.+...|..|..-.+..... +.. .......=..-|-.+.|.|||+++.++.+...++...+.++.|||. |.|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 467777777776665443321000 000 0011111123345567999999999998777667778899999998 7888
Q ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc--c
Q 007629 205 QVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF--W 276 (595)
Q Consensus 205 ~~i~~~----~~l~~~~~~~i~~qil~aL~yLHs~g--IiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~--~ 276 (595)
+.+++. ..+.....++|+-||+.||.|||+.. |+|+.+..+-|++..+|-+||.---.... ......... .
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~-h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDST-HPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCcccc-chhhhhhhHhhh
Confidence 887643 35788888999999999999999985 99999999999999998888753221110 000000000 1
Q ss_pred cccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCC-CCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHH
Q 007629 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP-LFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355 (595)
Q Consensus 277 ~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~-pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~ 355 (595)
....+-++|.|||.-.. ...+.++|||+||....+|..|.. |-.+.+....-..+ . +
T Consensus 240 ~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~i------------a--------~ 297 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENI------------A--------N 297 (458)
T ss_pred hccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhh------------h--------h
Confidence 11246688999997433 556778999999999999988763 22222211100000 0 0
Q ss_pred HhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 356 ~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
. .+....+.-.+++.+||.-.|..||++.++|.||.+-.++
T Consensus 298 ~--------------i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 298 V--------------IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred h--------------eeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 0 0111123346799999999999999999999999876544
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=5.5e-12 Score=137.93 Aligned_cols=169 Identities=22% Similarity=0.357 Sum_probs=125.7
Q ss_pred EEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEecccccHHHHHHhc
Q 007629 131 SAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 210 (595)
Q Consensus 131 ~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~~g~L~~~i~~~ 210 (595)
.|..+.++.+|.|.+.+.... .....+.+-++-|+.|+||+|+++++.+ +....+|||+|-+.. |..+++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvTErV~P-l~~~lk~- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVTERVRP-LETVLKE- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEeecccc-HHHHHHH-
Confidence 455677888999988764322 3345567788999999999999999887 444579999998863 2333333
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccc
Q 007629 211 DDLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289 (595)
Q Consensus 211 ~~l~~~~~~~i~~qil~aL~yLH-s~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE 289 (595)
++...+..-++||+.||.||| +++++|++|.-+-|+|+..|+.||++|-++.....-.. ....+.---.|..|+
T Consensus 101 --l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 101 --LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPE 175 (690)
T ss_pred --hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChh
Confidence 337788889999999999997 68899999999999999999999999998864322211 001112222367777
Q ss_pred cccccCCCCCCcceeechhHHHHHHHcC
Q 007629 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTG 317 (595)
Q Consensus 290 ~l~~~~~~~~~k~DIWSlG~il~eLltG 317 (595)
.+.. . +-..|.|-|||+++|++.|
T Consensus 176 ~~~~--s--~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDP--S--EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCc--c--ccchhhhhHHHHHHHHhCc
Confidence 6543 1 2457999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.8e-13 Score=148.71 Aligned_cols=141 Identities=22% Similarity=0.308 Sum_probs=92.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh--------------------------------hhHHHHH-
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV--------------------------------SDATRIL- 160 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~--------------------------------~~~~~~~- 160 (595)
.|.. +.||.|++|.||+|+.+.+|+.||||+++...... .-.+.+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3554 78999999999999998889999999986321100 0011223
Q ss_pred -----HHHHHHHhcC----CCceeeeeeeecCCCccCcccEEEEEecccc-cHHHH--HHhcC----CCCHHHHHHHHHH
Q 007629 161 -----REIKLLRLLR----HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQV--IKAND----DLTPEHYQFFLYQ 224 (595)
Q Consensus 161 -----~Ei~il~~l~----HpnIv~l~~~~~~~~~~~~~~lylV~E~~~g-~L~~~--i~~~~----~l~~~~~~~i~~q 224 (595)
+|+..+.++. +...+.+-.++.+- ...-+|||||++| .+.++ +...+ .+.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 3443333332 33333333333211 1235899999996 56543 33333 2555556666666
Q ss_pred HHHHHHHHHhCCeeecCCCCCceeeCCCC----cEEEcccCcceec
Q 007629 225 LLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVS 266 (595)
Q Consensus 225 il~aL~yLHs~gIiHrDLKP~NILl~~~~----~vKL~DFGla~~~ 266 (595)
++ ..|++|+|+||.||+++.+| +++++|||++...
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 65 48999999999999999988 9999999998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4e-13 Score=145.46 Aligned_cols=250 Identities=22% Similarity=0.205 Sum_probs=178.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT-HTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~-~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~ 189 (595)
..+|..+..||.|.|+.|+.+... .++..|++|.+.+......+...-+.|+.+...+. |.++++.+..|.. .
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-----~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-----L 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-----c
Confidence 357888999999999999998755 67889999988665444444445567888877764 9999988777743 3
Q ss_pred ccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC-CcEEEcccCcceecc
Q 007629 190 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSF 267 (595)
Q Consensus 190 ~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~-~~vKL~DFGla~~~~ 267 (595)
...|+-.|||++ ++...+.....+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||+...+.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 457899999974 433333333468889999999999999999999999999999999999886 788999999886321
Q ss_pred CCCCCcccccccccCCccc-ccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 268 NDAPSAIFWTDYVATRWYR-APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~-APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
-. ......+-++. ..|++... ..+..+.|++|||.-+.+.++|.+.-........
T Consensus 419 ~~------~~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~----------------- 474 (524)
T KOG0601|consen 419 FS------SGVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT----------------- 474 (524)
T ss_pred ee------cccccccccccccchhhccc-cccccccccccccccccccccCcccCccccccee-----------------
Confidence 11 11122333344 35555442 5778899999999999999999854322111000
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
+ +....+ ..+.....+..+.+.++..|+..|+.+.++..|.=|.
T Consensus 475 -i-----------~~~~~p-----~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 475 -I-----------RSGDTP-----NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -e-----------eccccc-----CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0 000000 1122335678899999999999999999998887654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.7e-12 Score=137.40 Aligned_cols=140 Identities=22% Similarity=0.269 Sum_probs=92.4
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChh--h----------------------H--------------HHHH
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS--D----------------------A--------------TRIL 160 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~--~----------------------~--------------~~~~ 160 (595)
+.||.|++|.||+|+. .+|+.||||+.+......- + . -.+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999986 4799999999753210000 0 0 0133
Q ss_pred HHHHHHHhc----CCCceeeeeeeecCCCccCcccEEEEEecccc-cHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHH
Q 007629 161 REIKLLRLL----RHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLR-GLKYIH 233 (595)
Q Consensus 161 ~Ei~il~~l----~HpnIv~l~~~~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~-~~l~~~~~~~i~~qil~-aL~yLH 233 (595)
+|+..+..+ +|.+-+.+-.++...+ ..-+|||||++| +|.++.... ..+ ....++.+++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH
Confidence 455555444 2333333333332211 235899999986 565554321 122 23345566665 468899
Q ss_pred hCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 234 TANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 234 s~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
..|++|+|+||.||+++.+++++|+|||++...
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999999998754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=7e-12 Score=121.54 Aligned_cols=139 Identities=21% Similarity=0.244 Sum_probs=98.6
Q ss_pred eeeeeecCceEEEEEEECC------CCcEEEEEEecCc---cCC-----------------hhhHHH----HHHHHHHHH
Q 007629 118 QEVIGKGSYGVVGSAVDTH------TGERVAIKKINDV---FEH-----------------VSDATR----ILREIKLLR 167 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~------~g~~vAIK~i~~~---~~~-----------------~~~~~~----~~~Ei~il~ 167 (595)
...||.|--+.||.|.... .+..+|||+.+-. +.. ..-... ..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3569999999999997643 3579999986311 000 001112 237999999
Q ss_pred hcCC--CceeeeeeeecCCCccCcccEEEEEeccccc-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCeeecCCC
Q 007629 168 LLRH--PDIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLK 243 (595)
Q Consensus 168 ~l~H--pnIv~l~~~~~~~~~~~~~~lylV~E~~~g~-L~~~i~~~~~l~~~~~~~i~~qil~aL~yL-Hs~gIiHrDLK 243 (595)
++.. -++..++.+. .-+|||||++++ +..-..+...+++..+..++.|++.+|..| |..||||+||+
T Consensus 82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 8853 4555555432 248999999863 322112233466667778889999999999 89999999999
Q ss_pred CCceeeCCCCcEEEcccCcceec
Q 007629 244 PKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 244 P~NILl~~~~~vKL~DFGla~~~ 266 (595)
+.|||+. ++.+.|+|||.|...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999996 578999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.3e-12 Score=119.67 Aligned_cols=126 Identities=17% Similarity=0.128 Sum_probs=91.9
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCcee-eeeeeecCCCccCcccEEEEE
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV-EIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~~~~lylV~ 196 (595)
++.|+.|.++.||++... +..|++|....... ....+.+|+.+++.+.+.+++ +++.... ..-++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-------~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP-------ETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC-------CCCeEEE
Confidence 467899999999999754 78899998753211 122356899999988654443 4444321 1237999
Q ss_pred ecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe-----eecCCCCCceeeCCCCcEEEcccCcce
Q 007629 197 ELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV-----FHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 197 E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gI-----iHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
||++| .+... ......++.+++++|..||..++ +|+|++|.||+++ ++.++|+|||.+.
T Consensus 71 e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 71 EFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99997 33321 11123467899999999999885 9999999999998 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.8e-09 Score=101.70 Aligned_cols=142 Identities=23% Similarity=0.309 Sum_probs=102.1
Q ss_pred EeeeeeecCceEEEEEEECCCCcEEEEEEe-cCccCChh-----hHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 117 IQEVIGKGSYGVVGSAVDTHTGERVAIKKI-NDVFEHVS-----DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 117 i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i-~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.+..|-+|+-+.|+++. ..|+.+.||.- .+...++. ...+..+|+++|.++.--.|.-..-++.+..
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~----- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY----- 83 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----
Confidence 56789999999999995 56888888863 33333332 3456788999998875333322111222221
Q ss_pred cEEEEEecccc--cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc---EEEcccCcc
Q 007629 191 DIYVVFELMES--DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLA 263 (595)
Q Consensus 191 ~lylV~E~~~g--~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~---vKL~DFGla 263 (595)
.-.|+|||++| .+.+.+.... .........++.+|-+.|.-||..+|||+||..+||++..++. +.|+|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 23799999998 7888776542 2333333788999999999999999999999999999987653 589999998
Q ss_pred ee
Q 007629 264 RV 265 (595)
Q Consensus 264 ~~ 265 (595)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 64
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.2e-09 Score=112.44 Aligned_cols=215 Identities=17% Similarity=0.198 Sum_probs=154.1
Q ss_pred CceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEecccc--c
Q 007629 125 SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES--D 202 (595)
Q Consensus 125 ~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~~g--~ 202 (595)
--.+.|+|....+|..|++|+++..... .......-+++++++.|+|||.+.+++....+ ....+++|++|.++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCch
Confidence 3447899999999999999999421111 11112344678999999999999999985543 23458999999984 6
Q ss_pred HHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 203 LHQVIKAN---------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 203 L~~~i~~~---------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
|.++...+ ...+|+.+|.|+.||..||.+||+.|+.-+-|.|.+||++.+.+++|.-.|...+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 77766432 246789999999999999999999999999999999999999999999888877654
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCC-CCCCChHHH-HHHHHhhcCCCChhHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGKNVVHQ-LDLMTDLLGTPSTESI 345 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~p-F~~~~~~~~-l~~i~~~lg~p~~~~i 345 (595)
.+.. |.+.+ -.+-|.=.||.+++.|.||..- +........ +..
T Consensus 445 ~d~~-----------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~------------- 489 (655)
T KOG3741|consen 445 EDPT-----------------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR------------- 489 (655)
T ss_pred CCCC-----------------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH-------------
Confidence 4431 11222 1256888999999999999532 111111000 111
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
..+.++.++.++|.-+...++.+ -++.+++.|
T Consensus 490 -------------------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 490 -------------------------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred -------------------------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 11335666788888888888876 678888776
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.4e-09 Score=101.25 Aligned_cols=130 Identities=22% Similarity=0.347 Sum_probs=92.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEE-ecCccCChhh-----HHHHHHHHHHHHhcCC--CceeeeeeeecCCCccCcc
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKK-INDVFEHVSD-----ATRILREIKLLRLLRH--PDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~-i~~~~~~~~~-----~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~~~ 190 (595)
..+++|+-+.++.+.. -|..+.+|. +++...+..- ..+..+|+.+|..+.- -+...++++. + .
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~-----~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--P-----D 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--C-----C
Confidence 4578999999999843 355566775 3443333332 3456789999988863 3333444443 2 2
Q ss_pred cEEEEEeccccc-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 191 DIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 191 ~lylV~E~~~g~-L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
...|+|||.+|. |.+.+... ...++..+-.-+.-||..||+|+||.++||++..++ +.++||||+..
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 258999999985 45566554 144667777778889999999999999999997654 99999999974
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.7e-09 Score=106.13 Aligned_cols=142 Identities=19% Similarity=0.281 Sum_probs=98.3
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC--CceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH--PDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
+.||.|.++.||++... .|..|++|........ .....+.+|+.+++.+.+ ..+.+++.+..... .....|+||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEE
Confidence 67899999999999764 3688999987532211 124467899999999975 33555655543211 123468999
Q ss_pred eccccc-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 007629 197 ELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT----------------------------------------- 234 (595)
Q Consensus 197 E~~~g~-L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs----------------------------------------- 234 (595)
||++|. +...+.. ..+++.....++.+++++|..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 999863 4333211 345666666666677777766663
Q ss_pred ---------------CCeeecCCCCCceeeCC--CCcEEEcccCccee
Q 007629 235 ---------------ANVFHRDLKPKNILANA--DCKLKICDFGLARV 265 (595)
Q Consensus 235 ---------------~gIiHrDLKP~NILl~~--~~~vKL~DFGla~~ 265 (595)
..++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.6e-10 Score=121.84 Aligned_cols=154 Identities=23% Similarity=0.346 Sum_probs=111.5
Q ss_pred HHHHHHHHHHh-CCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccccc--------cccCCccccccccccc
Q 007629 224 QLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD--------YVATRWYRAPELCGSF 294 (595)
Q Consensus 224 qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~--------~~gT~~Y~APE~l~~~ 294 (595)
+++.||.|+|. .++||+.|.|++|.++..+.+||+.|+++........ ..+.. ..-...|.|||++.+
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--~p~~~yd~~lp~~~~~~~~f~apE~~~~- 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--YPFSEYDPPLPLLLQPHLNFLAPEYLLG- 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--cccccCCCCCChhhccCcccccchhhcc-
Confidence 44499999996 6899999999999999999999999998864332111 11111 134557999999987
Q ss_pred CCCCCCcceeechhHHHHHHH-cCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCC
Q 007629 295 FSKYTPAIDIWSIGCIFAEML-TGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP 373 (595)
Q Consensus 295 ~~~~~~k~DIWSlG~il~eLl-tG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~ 373 (595)
...+.++|+|||||++|.+. .|+..|.+.........-.. .... .....-.
T Consensus 184 -~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~---------------------~~~~------~~~~~s~ 235 (700)
T KOG2137|consen 184 -TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN---------------------LLNA------GAFGYSN 235 (700)
T ss_pred -ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc---------------------cccc------ccccccc
Confidence 67789999999999999999 66776655432111111000 0000 0011115
Q ss_pred CCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 374 NADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 374 ~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
++++++++=|.++|..|+..||++.+++.-|||.+
T Consensus 236 ~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D 270 (700)
T KOG2137|consen 236 NLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSD 270 (700)
T ss_pred cCcHHHHHHHHHHhcCCcccCcchhhhhcccccCC
Confidence 67889999999999999999999999999999974
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.7e-08 Score=102.94 Aligned_cols=134 Identities=15% Similarity=0.097 Sum_probs=90.3
Q ss_pred EEEEEECCCCcEEEEEEecCccCCh---------hhHHHHHHHHHHHHhcCCCcee--eeeeeecCCCccCcccEEEEEe
Q 007629 129 VGSAVDTHTGERVAIKKINDVFEHV---------SDATRILREIKLLRLLRHPDIV--EIKHIMLPPSRREFKDIYVVFE 197 (595)
Q Consensus 129 V~~a~~~~~g~~vAIK~i~~~~~~~---------~~~~~~~~Ei~il~~l~HpnIv--~l~~~~~~~~~~~~~~lylV~E 197 (595)
|.++. ..|+.|.||......... .-...+.+|...+..|..-+|. .++.+...........-+||||
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 55553 357789999653211000 0011367888888777433322 2222322111111234689999
Q ss_pred cccc--cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC-------CCcEEEcccCcce
Q 007629 198 LMES--DLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-------DCKLKICDFGLAR 264 (595)
Q Consensus 198 ~~~g--~L~~~i~~--~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~-------~~~vKL~DFGla~ 264 (595)
++++ +|.+++.. ....+......++.+++..+.-||..||+|+||++.|||++. ++.+.|+||+.++
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9996 68888754 245566778899999999999999999999999999999975 4679999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.1e-08 Score=96.79 Aligned_cols=127 Identities=28% Similarity=0.309 Sum_probs=82.5
Q ss_pred EEEEEEECCCCcEEEEEEecCc--------------cC--------Chh--hHHHHHHHHHHHHhcCCC--ceeeeeeee
Q 007629 128 VVGSAVDTHTGERVAIKKINDV--------------FE--------HVS--DATRILREIKLLRLLRHP--DIVEIKHIM 181 (595)
Q Consensus 128 ~V~~a~~~~~g~~vAIK~i~~~--------------~~--------~~~--~~~~~~~Ei~il~~l~Hp--nIv~l~~~~ 181 (595)
.||.|.. ..|..+|||+.+.. .. ... ......+|...|..+..- ++.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888976 46789999986311 00 000 123457899999999755 456665543
Q ss_pred cCCCccCcccEEEEEeccc--ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCeeecCCCCCceeeCCCCcEEEc
Q 007629 182 LPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY-IHTANVFHRDLKPKNILANADCKLKIC 258 (595)
Q Consensus 182 ~~~~~~~~~~lylV~E~~~--g~L~~~i~~~~~l~~~~~~~i~~qil~aL~y-LHs~gIiHrDLKP~NILl~~~~~vKL~ 258 (595)
.-+|||||++ |.....+... .++.+....++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---------CCEEEEEecCCCccchhhHHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence 1389999999 6333333322 23356677888899986665 579999999999999999877 99999
Q ss_pred ccCcceec
Q 007629 259 DFGLARVS 266 (595)
Q Consensus 259 DFGla~~~ 266 (595)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.1e-08 Score=98.49 Aligned_cols=129 Identities=24% Similarity=0.323 Sum_probs=91.3
Q ss_pred CCCcEEEEEEecCc-----cCChhhHHHHHHHHHHHHhcCCCc--eeeeeeeecCCCccCcccEEEEEecccc--cHHHH
Q 007629 136 HTGERVAIKKINDV-----FEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPSRREFKDIYVVFELMES--DLHQV 206 (595)
Q Consensus 136 ~~g~~vAIK~i~~~-----~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~~~~lylV~E~~~g--~L~~~ 206 (595)
..++.|-+|..... ....-...+..+|...+..|..-. ..+.+.+....... ....|+|+|++++ +|.++
T Consensus 30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~-~~~s~lite~l~~~~~L~~~ 108 (206)
T PF06293_consen 30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGG-GYRSYLITEALPGAQDLRDL 108 (206)
T ss_pred ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC-ceeEEEEEEeCCCcccHHHH
Confidence 34556666653211 111123456778888877775322 23333333222111 1346899999986 78998
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC---cEEEcccCccee
Q 007629 207 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARV 265 (595)
Q Consensus 207 i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~---~vKL~DFGla~~ 265 (595)
+.....++......++.+++..+.-||..||+|+|++|.|||++.++ .+.|+||+.++.
T Consensus 109 ~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 109 LQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 88755577788889999999999999999999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.2e-07 Score=97.29 Aligned_cols=257 Identities=17% Similarity=0.181 Sum_probs=156.3
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHh-cCCCceeeeeeee----cCCCccCcccE
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL-LRHPDIVEIKHIM----LPPSRREFKDI 192 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~----~~~~~~~~~~l 192 (595)
.+.||+|+-+.+|-.-. -+..| .|+.+..-. ....+ -+..|.. -.||.+..-+ +| +... +....+
T Consensus 16 gr~LgqGgea~ly~l~e--~~d~V-AKIYh~Ppp--a~~aq---k~a~la~~p~~p~~~~rv-aWPqa~L~G~-~~~~~i 85 (637)
T COG4248 16 GRPLGQGGEADLYTLGE--VRDQV-AKIYHAPPP--AAQAQ---KVAELAATPDAPLLNYRV-AWPQATLHGG-RRGKVI 85 (637)
T ss_pred CccccCCccceeeecch--hhchh-heeecCCCc--hHHHH---HHHHhccCCCCcchhhhh-cccHHHhhCC-Ccccee
Confidence 46799999999997632 22333 466643211 11111 1222222 2466544311 11 1111 222337
Q ss_pred EEEEecccc--cHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 193 YVVFELMES--DLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 193 ylV~E~~~g--~L~~~i~~------~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
-++|..+.| .+..++.. ...+.|+......+.|+.+.+-||..|.+-+|+.++|+|+.+++.|.|.|=..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 778888775 34444421 2347788899999999999999999999999999999999999999999854333
Q ss_pred eccCCCCCcccccccccCCccccccccc-ccC--CCCCCcceeechhHHHHHHHcC-CCCCCCCChHHHHHHHHhhcCCC
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCG-SFF--SKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTDLLGTP 340 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~-~~~--~~~~~k~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~lg~p 340 (595)
+..+ .+.....+|.+.|.+||+-. +.+ ..-+...|.|.||+++++||.| +.||.|-... .. -+.|
T Consensus 166 i~~n----g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~------~~-ap~p 234 (637)
T COG4248 166 INAN----GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI------SD-APNP 234 (637)
T ss_pred eccC----CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc------CC-CCCc
Confidence 2211 12234568999999999743 111 2345678999999999999987 8999874310 00 0111
Q ss_pred ChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcC--CCCCCCCHH
Q 007629 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAF--DPKDRPTAE 398 (595)
Q Consensus 341 ~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~--DP~~Rpta~ 398 (595)
.+..|......... +.-+...+.|.+-.|.-.++.+..|..+|+.. .+.-|||++
T Consensus 235 ~E~~Ia~g~f~ya~---~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 235 LETDIAHGRFAYAS---DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred chhhhhcceeeech---hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 11122211110000 11122334445555667789999999999975 356899974
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.4e-07 Score=94.26 Aligned_cols=135 Identities=27% Similarity=0.287 Sum_probs=97.5
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEec-------Ccc---------CChh----hHHHHHHHHHHHHhcCCC--
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-------DVF---------EHVS----DATRILREIKLLRLLRHP-- 172 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~-------~~~---------~~~~----~~~~~~~Ei~il~~l~Hp-- 172 (595)
+.++.+||-|--+.||.|.+. .|..+|||.=+ +.. .+.+ ......+|.++|..|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 467789999999999999875 68999999531 100 0000 123457899999998643
Q ss_pred ceeeeeeeecCCCccCcccEEEEEeccccc-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC
Q 007629 173 DIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251 (595)
Q Consensus 173 nIv~l~~~~~~~~~~~~~~lylV~E~~~g~-L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~ 251 (595)
.+.+.++ .+.-.+||||.+|- |..+ +++.+....++..|++-+.-+-..||||+|+.+-|||+++
T Consensus 172 ~VP~P~~---------~nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIA---------WNRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCccc---------cccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 4544433 23458999999983 3322 2245556667777777777666999999999999999999
Q ss_pred CCcEEEcccCcce
Q 007629 252 DCKLKICDFGLAR 264 (595)
Q Consensus 252 ~~~vKL~DFGla~ 264 (595)
+|.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999997664
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.2e-06 Score=85.60 Aligned_cols=142 Identities=15% Similarity=0.151 Sum_probs=100.5
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecC----ccCChhhHHHHHHHHHHHHhcCCCc--eeeeeeeecCCCccCcccEEE
Q 007629 121 IGKGSYGVVGSAVDTHTGERVAIKKIND----VFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 121 LG~G~fG~V~~a~~~~~g~~vAIK~i~~----~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~~~~lyl 194 (595)
-|+||-+-|+.... .|..|-+|.-.. ..........+.+|+..|..|..-+ +.++. ++-.......-.-+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 36688888888753 344688887541 1111234567889999999886433 33333 111111111234689
Q ss_pred EEeccc--ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc--EEEcccCccee
Q 007629 195 VFELME--SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARV 265 (595)
Q Consensus 195 V~E~~~--g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~--vKL~DFGla~~ 265 (595)
|+|-++ .+|.+++... .+.++.....++.+++..|.-||+.|+.|+|+-+.|||++.++. ++++||--++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999888 4898887653 34577777899999999999999999999999999999987777 99999987653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.6e-06 Score=83.55 Aligned_cols=143 Identities=17% Similarity=0.219 Sum_probs=88.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChh-hHH------HHHHHHHHHHhcCCCc---eeeeeeee
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS-DAT------RILREIKLLRLLRHPD---IVEIKHIM 181 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~-~~~------~~~~Ei~il~~l~Hpn---Iv~l~~~~ 181 (595)
..+|.+.+++-......|.+.. -.|..+.+|..+....... ... ...+++..+..+.... ++.++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4678999999888888787664 4678899998753221110 011 1234444444443222 22222222
Q ss_pred cCCCccCcccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEccc
Q 007629 182 LPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260 (595)
Q Consensus 182 ~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DF 260 (595)
.-....-....+|||||++| .|.+.. .+++ .+...|.+++.-||..|++|+|..|.|+++..+ .++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 11111222345689999997 444332 1233 244567788999999999999999999999854 5999999
Q ss_pred Cccee
Q 007629 261 GLARV 265 (595)
Q Consensus 261 Gla~~ 265 (595)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 87653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.1e-07 Score=104.03 Aligned_cols=241 Identities=16% Similarity=0.138 Sum_probs=160.0
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCc-eeeeeeeecCCCccCcccEE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~~~~ly 193 (595)
|....-+++|+++.+++.+...+...+ .+.+... ....-++++|.+++||| .+..++ +.+...+.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~~~ 310 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDYLW 310 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccc-----cCCcccccc
Confidence 444566899999999999887776666 7766432 33445889999999999 333222 234456789
Q ss_pred EEEeccccc--HHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 194 VVFELMESD--LHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 194 lV~E~~~g~--L~~~i-~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
++|+++.+. ..... ...-.+..-....+.+.-+++|+|||+.-=+||| |||..+ +..|..||+....+....
T Consensus 311 i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc
Confidence 999999843 11111 1111233344455667778899999998778999 887654 789999999887654332
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
......+|+.++|||+... ..+....|.|++|+-..+|--|.+|-...- ..+. ..|..+.
T Consensus 386 ----~~~t~~~~~~~~~pev~~~--~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~----~~g~~p~-------- 445 (829)
T KOG0576|consen 386 ----KPRTAIGTPEPLAPEVIQE--NTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLP----MIGNGPN-------- 445 (829)
T ss_pred ----ccccCCCCCCCCCchhhcc--cccccCCCccCCCcchhhcCCCCCCCCCCc--cccC----CCCCCCC--------
Confidence 2355689999999998876 688899999999998888888877754310 0000 0011000
Q ss_pred HHHHHHhhhcccCCCCCCC-CCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 351 EKARRYLGSMRKKQPVPFS-HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
.+.-.. ..|... .-.++...||..-|..|+....++.|.+|.+
T Consensus 446 -------------s~~L~~~~aw~~~--~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 446 -------------SPMLTDKSAWSPV--FHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred -------------ccccchhhhcCcc--cccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 000000 011111 0125778899999999999999999999975
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1e-06 Score=102.25 Aligned_cols=207 Identities=18% Similarity=0.229 Sum_probs=143.5
Q ss_pred HHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 007629 156 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234 (595)
Q Consensus 156 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs 234 (595)
......|+..+..+.|+|++.++.+-+..-... -.+.+..++|.+ ++...+..-+..+.+..+.+..++++||.|+|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 344456777788899999999988876543221 123455567774 788888888899999999999999999999999
Q ss_pred CCeeecCCCCC---ceeeCCCCcEEEc--ccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhH
Q 007629 235 ANVFHRDLKPK---NILANADCKLKIC--DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 309 (595)
Q Consensus 235 ~gIiHrDLKP~---NILl~~~~~vKL~--DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~ 309 (595)
....|.-|-.+ +-.++.++.+.++ ||+.+....+.... ....-+..+.+||.............|+|.+|.
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 97666655555 4455667777777 99988765433321 122445567888887652223333469999999
Q ss_pred HHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCC-HHHHHHHHhhCc
Q 007629 310 IFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD-PLALHLLERLLA 388 (595)
Q Consensus 310 il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~-~~~~dLl~~~L~ 388 (595)
.+..+..|..+-.-. ..+.. + .+... ....+++.+|+.
T Consensus 381 l~~~~~~~~~i~~~~------~~~~~--------------------~---------------l~~~~~~~~~d~~~~~~~ 419 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKS------AVPVS--------------------L---------------LDVLSTSELLDALPKCLD 419 (1351)
T ss_pred HHhhhhhcCcccccc------cchhh--------------------h---------------hccccchhhhhhhhhhcc
Confidence 999999876432110 00000 0 01111 147889999999
Q ss_pred CCCCCCCCHHHHhcCCCccC
Q 007629 389 FDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 389 ~DP~~Rpta~elL~Hp~f~~ 408 (595)
-|+++|+++.+++.|+|.+.
T Consensus 420 ~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 420 EDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hhhhhccchhhhhhchhccc
Confidence 99999999999999999863
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.23 E-value=8.1e-06 Score=81.08 Aligned_cols=136 Identities=21% Similarity=0.180 Sum_probs=91.5
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChh-----------------hHHH-----HHHHHHHHHhcC--CCce
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS-----------------DATR-----ILREIKLLRLLR--HPDI 174 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~-----------------~~~~-----~~~Ei~il~~l~--HpnI 174 (595)
..|..|--+.||+|.. ..+..||||+.+.....-. +... ..+|..-|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3566777778999964 5688999999752111000 0011 236777777764 3334
Q ss_pred eeeeeeecCCCccCcccEEEEEecccccH--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCC
Q 007629 175 VEIKHIMLPPSRREFKDIYVVFELMESDL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANA 251 (595)
Q Consensus 175 v~l~~~~~~~~~~~~~~lylV~E~~~g~L--~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~ 251 (595)
.+-+.+. .-.|||||++.+. .-.++ .-++..+++..+..++++.+.-|-. .++||+||..-|||+.
T Consensus 133 P~Pi~~~---------~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~- 201 (268)
T COG1718 133 PEPIAFR---------NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH- 201 (268)
T ss_pred CCceeec---------CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-
Confidence 4444333 2489999998431 11111 1134444788888999999988876 9999999999999998
Q ss_pred CCcEEEcccCcceec
Q 007629 252 DCKLKICDFGLARVS 266 (595)
Q Consensus 252 ~~~vKL~DFGla~~~ 266 (595)
++.+.|+|||-|...
T Consensus 202 ~~~p~iID~~QaV~~ 216 (268)
T COG1718 202 DGEPYIIDVSQAVTI 216 (268)
T ss_pred CCeEEEEECcccccc
Confidence 889999999988643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.6e-05 Score=77.74 Aligned_cols=132 Identities=15% Similarity=0.142 Sum_probs=77.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCc--eeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~~~~lylV~ 196 (595)
..||.|..+.||+. .|..+++|..... .....+.+|.++|+.+..-. +.+.+++... ....++||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-----~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG----FDKETIKREFDASRKVFSLGIPTPHPFDLVED-----GGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEec-----CCeeeeee
Confidence 67899999999984 2556778876531 12345688999998886332 3455555422 23367899
Q ss_pred eccccc--HH--------------HHHH-------hc--CCCCHHH-HHHHHHH----------HHH-HHHHHHh----C
Q 007629 197 ELMESD--LH--------------QVIK-------AN--DDLTPEH-YQFFLYQ----------LLR-GLKYIHT----A 235 (595)
Q Consensus 197 E~~~g~--L~--------------~~i~-------~~--~~l~~~~-~~~i~~q----------il~-aL~yLHs----~ 235 (595)
|+++|. +. ..+. .- ....... ...+..+ +.. ...+|.. .
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 999873 11 1110 00 0111000 0111111 111 1222221 2
Q ss_pred CeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 236 NVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 236 gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
.++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 479999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.4e-05 Score=75.04 Aligned_cols=139 Identities=21% Similarity=0.227 Sum_probs=79.2
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCC--ceeeeeeeecCCCccCcccEEEE
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP--DIVEIKHIMLPPSRREFKDIYVV 195 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~~~~~~~~lylV 195 (595)
++.|+.|..+.||++.... ..+++|..... .....+.+|+.+++.|... .+.+++...... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence 4779999999999998654 48999987532 3456778899998888533 244555433211 222347999
Q ss_pred Eeccccc-HHH----------------HHH---hc----CCCCHHH------HHHH---------------HHHHHH-HH
Q 007629 196 FELMESD-LHQ----------------VIK---AN----DDLTPEH------YQFF---------------LYQLLR-GL 229 (595)
Q Consensus 196 ~E~~~g~-L~~----------------~i~---~~----~~l~~~~------~~~i---------------~~qil~-aL 229 (595)
|++++|. +.. .+. .. .++.... ...+ +..+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 9999863 333 111 11 0111100 0000 111222 33
Q ss_pred HHHHh-------CCeeecCCCCCceeeC-CCCcEEEcccCcce
Q 007629 230 KYIHT-------ANVFHRDLKPKNILAN-ADCKLKICDFGLAR 264 (595)
Q Consensus 230 ~yLHs-------~gIiHrDLKP~NILl~-~~~~vKL~DFGla~ 264 (595)
..++. ..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 33332 3599999999999999 66777899999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.7e-05 Score=87.90 Aligned_cols=139 Identities=22% Similarity=0.302 Sum_probs=84.2
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----------------------------hhH----H------HHH
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----------------------------SDA----T------RIL 160 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~----------------------------~~~----~------~~~ 160 (595)
+.|+.++-|.||+|+-+ +|+.||||+.+...... ... + .+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67999999999999864 59999999975211000 000 0 123
Q ss_pred HHHHHHHhcC----CCceeeeeeeecCCCccCcccEEEEEecccc-cHHHH--HHhcCCCCHHHHHHHHHHHHHH-HHHH
Q 007629 161 REIKLLRLLR----HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQV--IKANDDLTPEHYQFFLYQLLRG-LKYI 232 (595)
Q Consensus 161 ~Ei~il~~l~----HpnIv~l~~~~~~~~~~~~~~lylV~E~~~g-~L~~~--i~~~~~l~~~~~~~i~~qil~a-L~yL 232 (595)
+|..-+.+++ ...-+.+=.++..-+ ..-.|+|||++| .+.+. ++. ..++...+ +..++++ +.-+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t----~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~~~~f~~q~ 281 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYT----TRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELLVRAFLRQL 281 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhcc----CCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHHHHHHHHHH
Confidence 4554444442 222223333332211 224899999997 34443 333 33443222 2222221 2223
Q ss_pred HhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 233 Hs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
=..|++|.|..|.||+++.+|++.+.|||+....
T Consensus 282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 3489999999999999999999999999998654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.92 E-value=8.1e-05 Score=72.35 Aligned_cols=132 Identities=25% Similarity=0.279 Sum_probs=91.3
Q ss_pred CCeEEeeeeeecCc-eEEEEEEECCCCcEEEEEEecCc-----------cCC-h-------hhHHHHHHHHHHHHhc---
Q 007629 113 SRYQIQEVIGKGSY-GVVGSAVDTHTGERVAIKKINDV-----------FEH-V-------SDATRILREIKLLRLL--- 169 (595)
Q Consensus 113 ~~Y~i~~~LG~G~f-G~V~~a~~~~~g~~vAIK~i~~~-----------~~~-~-------~~~~~~~~Ei~il~~l--- 169 (595)
.+++.++.||.|.- |.||++.. .|..||+|.++.. ... . .....+..|.....+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67999999999999 99999964 5889999994210 000 0 1123466777765555
Q ss_pred CCCce--eeeeeeecCCCc-------------cCcccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 007629 170 RHPDI--VEIKHIMLPPSR-------------REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234 (595)
Q Consensus 170 ~HpnI--v~l~~~~~~~~~-------------~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs 234 (595)
.+.++ |+.+++++-... .......||.||....- .++.. -+.+|++-|..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~----~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIR----DIPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchh----HHHHHHHHHHHHHH
Confidence 45666 899888854311 11122467888876432 23333 34677788889999
Q ss_pred CCeeecCCCCCceeeCCCCcEEEcccCcc
Q 007629 235 ANVFHRDLKPKNILANADCKLKICDFGLA 263 (595)
Q Consensus 235 ~gIiHrDLKP~NILl~~~~~vKL~DFGla 263 (595)
.||+=+|+|+.|.. .-||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999997 3489999964
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.90 E-value=4e-05 Score=72.39 Aligned_cols=128 Identities=20% Similarity=0.262 Sum_probs=87.6
Q ss_pred EEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceee-eeeeecCCCccCcccEEE
Q 007629 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE-IKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 116 ~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~~~~~~~~~~lyl 194 (595)
++.+.||+|.+|+||++. ..|..+|+|+-+. .+-...+..|+++|..+.-.++.. +|.+- ..++
T Consensus 25 ~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~yg---------~~~i 89 (201)
T COG2112 25 RVEKELAKGTTSVVYLGE--WRGGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFYG---------EDFI 89 (201)
T ss_pred hhhhhhhcccccEEEEee--ccCceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEec---------hhhh
Confidence 456889999999999996 4577999997643 233566789999999998665543 32221 2356
Q ss_pred EEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC-CCceeeCCCCcEEEcccCccee
Q 007629 195 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK-PKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 195 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLK-P~NILl~~~~~vKL~DFGla~~ 265 (595)
.|||..| .|..+.... + +.-+..++++-.-|-..||-|..|. |.-++|-.++.+.|+||..|+.
T Consensus 90 ~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 90 RMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7999998 555543211 2 2233455666555677899999985 5444444555999999998873
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00021 Score=71.71 Aligned_cols=69 Identities=13% Similarity=0.075 Sum_probs=43.9
Q ss_pred eeecCc-eEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcccEEEEEec
Q 007629 121 IGKGSY-GVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVFEL 198 (595)
Q Consensus 121 LG~G~f-G~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~lylV~E~ 198 (595)
|-.|.. ..||++... +..+.||...... ...+.+|+.+++.+. +--+.+++++.... ..-++|||+
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~e~ 73 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD-----GRAWLLTSA 73 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC-----CccEEEEEe
Confidence 444555 789999543 4678888764321 334678999988885 33344556554321 236899999
Q ss_pred ccc
Q 007629 199 MES 201 (595)
Q Consensus 199 ~~g 201 (595)
++|
T Consensus 74 i~G 76 (244)
T cd05150 74 VPG 76 (244)
T ss_pred eCC
Confidence 986
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00016 Score=78.23 Aligned_cols=176 Identities=26% Similarity=0.372 Sum_probs=118.6
Q ss_pred hHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 007629 155 DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234 (595)
Q Consensus 155 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs 234 (595)
...+++-...+++.+.|+|....+++..... ....+|||+++.+|.+.+.... +.... ++ .
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s-------~~-------~ 85 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDES-------LL-------A 85 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhh-------hc-------c
Confidence 4556777889999999999999887764322 3389999999999999887654 22111 11 1
Q ss_pred CCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHH
Q 007629 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM 314 (595)
Q Consensus 235 ~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eL 314 (595)
.++.|- | .++++| -++ +. | | ...++|+||||+|.|+.++
T Consensus 86 ~~~~~~-----~-------~~~~td-~~~-------------t~------~--~-------~~~~pKsdVwsl~~i~~el 124 (725)
T KOG1093|consen 86 HGVLHL-----N-------IIYITD-HFL-------------TK------Y--P-------SPIGPKSDVWSLGFIILEL 124 (725)
T ss_pred ccccee-----h-------hhhccc-ccc-------------cc------C--C-------CCCCcchhhhhHHHHHHHH
Confidence 222221 2 233344 000 00 1 1 1122599999999999999
Q ss_pred HcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCC
Q 007629 315 LTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 394 (595)
Q Consensus 315 ltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~R 394 (595)
.-|...|......+++..+.++...+.....-.. +.... -.++....+++.+|+...|..|
T Consensus 125 ~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~--e~~~~-----------------~~~d~~~~~~~~~c~~~~~~ir 185 (725)
T KOG1093|consen 125 YLGISLEAELTESEYLEILLKYYTDDQELLSTAM--EHLIQ-----------------LLADKKRLPLLKKCLWLEPIIR 185 (725)
T ss_pred HHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHH--HHHHH-----------------HhhhHhHHHHhccCCccccccc
Confidence 9999999988888888888877655443222111 11100 1245567899999999999999
Q ss_pred CCHHHHhcCCCccCC
Q 007629 395 PTAEEALADPYFHGL 409 (595)
Q Consensus 395 pta~elL~Hp~f~~~ 409 (595)
|...++.+|+-|...
T Consensus 186 ~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 186 PLPMELSKRCSFTEV 200 (725)
T ss_pred cchhHHhcCccHHHH
Confidence 999999999999754
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00034 Score=82.72 Aligned_cols=82 Identities=20% Similarity=0.241 Sum_probs=54.4
Q ss_pred eeeeeecCceEEEEEEECCCC--cEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCce--eeeeeeecCCCccCcccE
Q 007629 118 QEVIGKGSYGVVGSAVDTHTG--ERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDI--VEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g--~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnI--v~l~~~~~~~~~~~~~~l 192 (595)
++.|+.|.+..+|+......+ ..+++|+...... ......+.+|+.+|+.|. |++| .+++.++.+.. .....
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~--v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS--VIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC--cCCCc
Confidence 577899999999998654332 4677776542111 122346789999999996 6664 66666654321 12346
Q ss_pred EEEEeccccc
Q 007629 193 YVVFELMESD 202 (595)
Q Consensus 193 ylV~E~~~g~ 202 (595)
|+||||++|.
T Consensus 120 flVME~v~G~ 129 (822)
T PLN02876 120 FYIMEYLEGR 129 (822)
T ss_pred eEEEEecCCc
Confidence 8999999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.001 Score=64.98 Aligned_cols=131 Identities=21% Similarity=0.254 Sum_probs=90.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCcc--------------CChhhHHHHHHHHHHHHhcC------CCceeeee
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVF--------------EHVSDATRILREIKLLRLLR------HPDIVEIK 178 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~--------------~~~~~~~~~~~Ei~il~~l~------HpnIv~l~ 178 (595)
..||.|+.=.||.-- ......||++.... ..........+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 569999999998752 34457889886432 11123456677887766665 78899999
Q ss_pred eeecCCCccCcccEEEEEeccc---c----cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC
Q 007629 179 HIMLPPSRREFKDIYVVFELME---S----DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251 (595)
Q Consensus 179 ~~~~~~~~~~~~~lylV~E~~~---g----~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~ 251 (595)
|+..+. ..+-+|+|... | +|.+++.. +.+++ . +...+-+-..||-+.+|+.+||+|.||++..
T Consensus 84 G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVETN-----LGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEEecC-----CceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 998544 34688888764 2 68888854 45665 2 2333344567889999999999999999864
Q ss_pred CC----cEEEcc-cCc
Q 007629 252 DC----KLKICD-FGL 262 (595)
Q Consensus 252 ~~----~vKL~D-FGl 262 (595)
.. .+.|+| ||.
T Consensus 154 ~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGE 169 (199)
T ss_pred cCCCceEEEEEeCCCC
Confidence 32 577777 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00072 Score=74.96 Aligned_cols=138 Identities=26% Similarity=0.345 Sum_probs=83.4
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChh--h---------------------------HHH------HHHHH
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS--D---------------------------ATR------ILREI 163 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~--~---------------------------~~~------~~~Ei 163 (595)
+.||.-+.|.||+|+-+. |+.||||+-+....... + .+. +.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999998764 99999998643211110 0 011 22344
Q ss_pred HHH----HhcCCCc---eeeeeeeecCCCccCcccEEEEEecccc----cHHHHHHhcCCCCHHHHHHHHHHHHHHH-HH
Q 007629 164 KLL----RLLRHPD---IVEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGL-KY 231 (595)
Q Consensus 164 ~il----~~l~Hpn---Iv~l~~~~~~~~~~~~~~lylV~E~~~g----~L~~~i~~~~~l~~~~~~~i~~qil~aL-~y 231 (595)
+-. +.+.|-+ -|.+=.++..-+ ..-.|+||||+| |+ +.|.+. .++...+. ..+.++. .-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl-~~i~~~-gi~~~~i~---~~l~~~~~~q 316 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDL-DAIDKR-GISPHDIL---NKLVEAYLEQ 316 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCH-HHHHHc-CCCHHHHH---HHHHHHHHHH
Confidence 322 2234444 122222332211 124899999996 45 444444 35554333 3333322 22
Q ss_pred HHhCCeeecCCCCCceeeCC----CCcEEEcccCcceec
Q 007629 232 IHTANVFHRDLKPKNILANA----DCKLKICDFGLARVS 266 (595)
Q Consensus 232 LHs~gIiHrDLKP~NILl~~----~~~vKL~DFGla~~~ 266 (595)
|=..|++|.|=.|.|||+.. ++.+.+-|||+....
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 33578999999999999984 678999999998754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.46 E-value=3.2e-05 Score=91.91 Aligned_cols=155 Identities=17% Similarity=0.126 Sum_probs=116.4
Q ss_pred HHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEeccc-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH
Q 007629 159 ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIH 233 (595)
Q Consensus 159 ~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~qil~aL~yLH 233 (595)
.+.|...++...|+++...+.-..+. +....|.+++|+. |+++..|.+. .++....+.....+.+.+..-+|
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps---~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPS---ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCC---CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 44555566677899998765554332 3345689999998 6888888654 23444445555555577888888
Q ss_pred hCC-----eeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechh
Q 007629 234 TAN-----VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 308 (595)
Q Consensus 234 s~g-----IiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG 308 (595)
+.. .+|++||+-|.+|..+..+|+.++|+.+.... ...+....++++.|++|++... -.++.++|+|..|
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp---~~sf~Gl~l~sp~~v~qli~N~--ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP---VLSFFGLELCSPIYVLQLIKNE--IKFTKRSDILRRS 1427 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCc---hHhhhhhhhCCHHHHHHHHHHH--HhhhhHHHHHHHH
Confidence 642 69999999999999999999999999984322 2223456688999999999876 5788889999999
Q ss_pred HHHHHHHcCCCCC
Q 007629 309 CIFAEMLTGKPLF 321 (595)
Q Consensus 309 ~il~eLltG~~pF 321 (595)
+-+|++..|..+|
T Consensus 1428 ~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHhcccHHH
Confidence 9999999988776
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00077 Score=67.35 Aligned_cols=30 Identities=33% Similarity=0.482 Sum_probs=25.3
Q ss_pred CCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 235 ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 235 ~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
.+++|+|+.|.|||++.++..-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 358999999999999866555799999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0017 Score=64.52 Aligned_cols=72 Identities=11% Similarity=0.155 Sum_probs=44.2
Q ss_pred eeeeeecCceEEEEEEECC-CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCc-eeeeeeeecCCCccCcccEEEE
Q 007629 118 QEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPPSRREFKDIYVV 195 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~-~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~~~~lylV 195 (595)
++.|..|-...||++.... .+..|++|+...... ......+|+.+++.+.... ..+++... . -.+|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~----~~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATF-----Q----NGLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEe-----C----CcEE
Confidence 4668888899999996432 356888997643211 1122347898988885333 33443332 1 1479
Q ss_pred Eecccc
Q 007629 196 FELMES 201 (595)
Q Consensus 196 ~E~~~g 201 (595)
|||++|
T Consensus 71 ~e~i~G 76 (235)
T cd05157 71 YEFIPG 76 (235)
T ss_pred EEeeCC
Confidence 999875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00061 Score=65.95 Aligned_cols=97 Identities=23% Similarity=0.193 Sum_probs=76.9
Q ss_pred HHHHHHHHhcCC-CceeeeeeeecCCCccCcccEEEEEecccc-cHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 007629 160 LREIKLLRLLRH-PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQV---IKANDDLTPEHYQFFLYQLLRGLKYIHT 234 (595)
Q Consensus 160 ~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~~~~lylV~E~~~g-~L~~~---i~~~~~l~~~~~~~i~~qil~aL~yLHs 234 (595)
..|.-+|+.+.+ +++.+++|.|- -++|.||... .+... +..--..+|.....|+.++++.+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 358888999986 69999999981 2668899883 44311 1111246899999999999999999987
Q ss_pred ---CCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 235 ---ANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 235 ---~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
..+.-.|++|+|+-++++|++|++|...+..
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 4588899999999999999999999997754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0076 Score=65.05 Aligned_cols=77 Identities=21% Similarity=0.190 Sum_probs=52.2
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCcc----CC-hhhHHHHHHHHHHHHhcC---CCceeeeeeeecCCCccCc
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF----EH-VSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~----~~-~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~~ 189 (595)
.+.||.|.+..||++.....++.|+||.-.... .. .....+...|...|+.+. -..+.+++.+..
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~------- 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE------- 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-------
Confidence 367999999999999886443589999853111 11 224566778888888763 245667766531
Q ss_pred ccEEEEEecccc
Q 007629 190 KDIYVVFELMES 201 (595)
Q Consensus 190 ~~lylV~E~~~g 201 (595)
..-++|||++++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 235899999874
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0028 Score=66.48 Aligned_cols=139 Identities=24% Similarity=0.329 Sum_probs=93.4
Q ss_pred EEeeeeeecCceEEEEEEECCCCcEEEEEEecCc----------------cCC------hhhHHH--HHHHHHHHHhcCC
Q 007629 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV----------------FEH------VSDATR--ILREIKLLRLLRH 171 (595)
Q Consensus 116 ~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~----------------~~~------~~~~~~--~~~Ei~il~~l~H 171 (595)
.|-..|..|--+.||.|.. .+|..+|||+.+-. +.+ ....-. ...|+.-|++|..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 4556788899999999974 57888999986421 111 111111 2357777888765
Q ss_pred CceeeeeeeecCCCccCcccEEEEEeccccc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCeeecCCCCCcee
Q 007629 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNIL 248 (595)
Q Consensus 172 pnIv~l~~~~~~~~~~~~~~lylV~E~~~g~--L~~~i~~~~~l~~~~~~~i~~qil~aL~yL-Hs~gIiHrDLKP~NIL 248 (595)
..|.-.--+.+ ..-.|||++++.+ -.-.| +.-.++...+..+-.|++.-+.-| |.+++||.||.=-|+|
T Consensus 226 aGIP~PePIlL-------k~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~L 297 (520)
T KOG2270|consen 226 AGIPCPEPILL-------KNHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLL 297 (520)
T ss_pred cCCCCCCceee-------ecceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhhe
Confidence 55432222221 1247999999842 22222 233577778888878888877777 5689999999999999
Q ss_pred eCCCCcEEEcccCcce
Q 007629 249 ANADCKLKICDFGLAR 264 (595)
Q Consensus 249 l~~~~~vKL~DFGla~ 264 (595)
+ .+|.+.|+|-+-+.
T Consensus 298 y-hdG~lyiIDVSQSV 312 (520)
T KOG2270|consen 298 Y-HDGKLYIIDVSQSV 312 (520)
T ss_pred E-ECCEEEEEEccccc
Confidence 8 57899999998764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0034 Score=64.81 Aligned_cols=139 Identities=15% Similarity=0.065 Sum_probs=80.2
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCc--eeeeeeeecCCC--ccCcccEE
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPS--RREFKDIY 193 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~--~~~~~~ly 193 (595)
.+.|..|....+|+... .+..+++|+... .....+..|+.++..|.+.. +.+++... ... ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~-~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADR-DGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCC-CCcEeeeeCCceE
Confidence 56788888889999853 345788898753 22345677888888885433 34433221 000 01123468
Q ss_pred EEEecccccH---------H---HHHH---h-cCCCCH--------HHHH------------HHHHHHHHHHHHHHh---
Q 007629 194 VVFELMESDL---------H---QVIK---A-NDDLTP--------EHYQ------------FFLYQLLRGLKYIHT--- 234 (595)
Q Consensus 194 lV~E~~~g~L---------~---~~i~---~-~~~l~~--------~~~~------------~i~~qil~aL~yLHs--- 234 (595)
+|+++++|.. . ..+. . ...+.. .... .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999997521 0 1110 0 001100 0000 011122334455443
Q ss_pred ----CCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 235 ----ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 235 ----~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
.++||+|+.|.|||++.++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 469999999999999988777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0036 Score=63.37 Aligned_cols=130 Identities=17% Similarity=0.255 Sum_probs=72.6
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCce-eeeeeeecCCCccCcccEEEEEecc
Q 007629 121 IGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI-VEIKHIMLPPSRREFKDIYVVFELM 199 (595)
Q Consensus 121 LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~~~~lylV~E~~ 199 (595)
+..|-.+.+|+.. .++..+++|......... .....+|..+++.+..-.+ .+++... . -++||||+
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~--~-------~~~v~e~i 70 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN--E-------HWLLVEWL 70 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe--C-------CEEEEEec
Confidence 5568888899886 456778888654221111 0124678888888864323 2333322 1 26899999
Q ss_pred ccc-H--------------HHHHHh---cC----CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCeee
Q 007629 200 ESD-L--------------HQVIKA---ND----DLTP-EHYQFFLYQL---------LRGLKYIHT--------ANVFH 239 (595)
Q Consensus 200 ~g~-L--------------~~~i~~---~~----~l~~-~~~~~i~~qi---------l~aL~yLHs--------~gIiH 239 (595)
+|. + .+.+.+ .. ++.. ..+..+..++ ...+..+-. ..++|
T Consensus 71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H 150 (256)
T TIGR02721 71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH 150 (256)
T ss_pred cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence 862 1 111111 11 1111 1222222222 111222211 24899
Q ss_pred cCCCCCceeeCCCCcEEEcccCcce
Q 007629 240 RDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 240 rDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
+|+.|.|||++.++ +.|+||..|.
T Consensus 151 ~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 151 MDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CCCCcCcEEEeCCC-CEEEeccccC
Confidence 99999999999877 8899999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.018 Score=59.92 Aligned_cols=76 Identities=14% Similarity=0.117 Sum_probs=50.9
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC---CceeeeeeeecCCCccCcccEEE
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH---PDIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~~~~~~~~~lyl 194 (595)
.+.||.|..+.||+.... .+ .+.+|..+. ......+.+|...|+.|.- ..+.++++++.... ....-+|
T Consensus 19 ~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~L 90 (297)
T PRK10593 19 VECISEQPYAALWALYDS-QG-NPMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVL 90 (297)
T ss_pred eeecCCccceeEEEEEcC-CC-CEEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEE
Confidence 577999999999998532 23 466776432 1123467889999988853 35677777664321 1234799
Q ss_pred EEecccc
Q 007629 195 VFELMES 201 (595)
Q Consensus 195 V~E~~~g 201 (595)
|||+++|
T Consensus 91 VmE~i~G 97 (297)
T PRK10593 91 LLERLRG 97 (297)
T ss_pred EEeccCC
Confidence 9999885
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.01 Score=61.98 Aligned_cols=30 Identities=33% Similarity=0.352 Sum_probs=25.8
Q ss_pred CCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 235 ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 235 ~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999866555899999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.012 Score=61.34 Aligned_cols=144 Identities=17% Similarity=0.115 Sum_probs=80.7
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCc--eeeeeeeecCC-CccCccc
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPP-SRREFKD 191 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~-~~~~~~~ 191 (595)
...++.++.|....||++.. .+| .+++|+.... .....+..|+.++..|.... +.+++...... .....+.
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKR----VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCC----CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 44467788888889999853 344 5778876431 11334566778887775322 33433321000 0011245
Q ss_pred EEEEEeccccc------HH------HHH---H-hcCCCCH-------HHHH----------------HHHHHHHHHHHHH
Q 007629 192 IYVVFELMESD------LH------QVI---K-ANDDLTP-------EHYQ----------------FFLYQLLRGLKYI 232 (595)
Q Consensus 192 lylV~E~~~g~------L~------~~i---~-~~~~l~~-------~~~~----------------~i~~qil~aL~yL 232 (595)
.+++|||++|. .. ..+ . ....++. ...+ .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999998761 10 111 0 0011100 0000 0011233345555
Q ss_pred Hh-------CCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 233 HT-------ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 233 Hs-------~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
.. .++||+|+.+.||+++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 42 579999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.0085 Score=62.12 Aligned_cols=29 Identities=38% Similarity=0.416 Sum_probs=26.1
Q ss_pred CeeecCCCCCceeeCCC----CcEEEcccCcce
Q 007629 236 NVFHRDLKPKNILANAD----CKLKICDFGLAR 264 (595)
Q Consensus 236 gIiHrDLKP~NILl~~~----~~vKL~DFGla~ 264 (595)
.++|+|+.|.|||++.+ +.+.|+||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999985 889999999774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.0024 Score=65.95 Aligned_cols=135 Identities=19% Similarity=0.201 Sum_probs=90.2
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecC---ccC---------------Chhh--HHHHHHHHHHHHhcC-CC
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIND---VFE---------------HVSD--ATRILREIKLLRLLR-HP 172 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~---~~~---------------~~~~--~~~~~~Ei~il~~l~-Hp 172 (595)
-|.++..||-|--+-||.+-+ ..|...++|.=+- .+. .+.. .-...+|...|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 356788999999999999986 4688888885210 000 0111 122457999998885 32
Q ss_pred c-eeeeeeeecCCCccCcccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC
Q 007629 173 D-IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (595)
Q Consensus 173 n-Iv~l~~~~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~ 250 (595)
. +.+.+++ ..-++|||++.| .|.++-.- ..+..+...+..-+.-|-..|+||+|..--||+|+
T Consensus 172 fpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 172 FPVPKPIDH---------NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCCcccc---------cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEe
Confidence 2 2233322 346899999986 44433211 12233444555556678899999999999999999
Q ss_pred CCCcEEEcccCcce
Q 007629 251 ADCKLKICDFGLAR 264 (595)
Q Consensus 251 ~~~~vKL~DFGla~ 264 (595)
+++.++++||--+.
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999997553
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.023 Score=58.38 Aligned_cols=30 Identities=33% Similarity=0.604 Sum_probs=25.4
Q ss_pred CeeecCCCCCceeeCCCCcE-EEcccCccee
Q 007629 236 NVFHRDLKPKNILANADCKL-KICDFGLARV 265 (595)
Q Consensus 236 gIiHrDLKP~NILl~~~~~v-KL~DFGla~~ 265 (595)
.++|+|+.|.|||++.++.+ -|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 48999999999999975664 6999998863
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.043 Score=58.27 Aligned_cols=74 Identities=19% Similarity=0.095 Sum_probs=49.1
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEec----Ccc-CChhhHHHHHHHHHHHHhcC--CC-ceeeeeeeecCCCccCccc
Q 007629 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN----DVF-EHVSDATRILREIKLLRLLR--HP-DIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 120 ~LG~G~fG~V~~a~~~~~g~~vAIK~i~----~~~-~~~~~~~~~~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~~~~ 191 (595)
.||.|....||++.+...++.|+||.-. ... .......+...|...|+... -| .+.+++.+- + ..
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~-----e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--T-----EM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--c-----cc
Confidence 5899999999999975444689999742 111 12345567778888887764 34 455565543 1 22
Q ss_pred EEEEEeccc
Q 007629 192 IYVVFELME 200 (595)
Q Consensus 192 lylV~E~~~ 200 (595)
..+|||+++
T Consensus 75 ~~~vMEdL~ 83 (370)
T TIGR01767 75 AVTVMEDLS 83 (370)
T ss_pred ceehHhhCc
Confidence 468999986
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.12 Score=53.98 Aligned_cols=143 Identities=17% Similarity=0.195 Sum_probs=79.5
Q ss_pred EeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC--CceeeeeeeecCCCccCcccEEE
Q 007629 117 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH--PDIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 117 i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~~~~lyl 194 (595)
+.+.+-.|.--.+|...+. ++.+++. ...............+|..+|+.+.- .-+...++++.... ....|.
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~pf~ 102 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGTPFY 102 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCCceE
Confidence 3444433433345555433 7778877 33222233345566788888887753 22233444443322 245799
Q ss_pred EEeccccc-------------------HHHHHHh---c-----------CCCCHHHHHHHHHH--------------HHH
Q 007629 195 VFELMESD-------------------LHQVIKA---N-----------DDLTPEHYQFFLYQ--------------LLR 227 (595)
Q Consensus 195 V~E~~~g~-------------------L~~~i~~---~-----------~~l~~~~~~~i~~q--------------il~ 227 (595)
||++++|. |.+.+.. - +.+...++..+..+ +..
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 99999871 1111111 0 00111112222222 223
Q ss_pred HHHHHHhC--------CeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 228 GLKYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 228 aL~yLHs~--------gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
-..||+.. .++|+|+.+.||+++.++-+=|.||+++..
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 34566543 489999999999999998899999999875
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.11 Score=55.87 Aligned_cols=76 Identities=22% Similarity=0.197 Sum_probs=51.4
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecC---cc-CChhhHHHHHHHHHHHHhcC--CC-ceeeeeeeecCCCccCcc
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKIND---VF-EHVSDATRILREIKLLRLLR--HP-DIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~---~~-~~~~~~~~~~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~~~ 190 (595)
.+.||.|.-..||++.+...+..|+||.-.. .. .......+..-|..+|+.+. -| .+.+++.+- ..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D-------~e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD-------SV 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC-------cH
Confidence 5779999999999998744456799997421 11 22345677888998888764 34 455565532 12
Q ss_pred cEEEEEeccc
Q 007629 191 DIYVVFELME 200 (595)
Q Consensus 191 ~lylV~E~~~ 200 (595)
...+|||+++
T Consensus 107 ~~~~vMEdL~ 116 (409)
T PRK12396 107 MNCCVMEDLS 116 (409)
T ss_pred HhhHHHHhCc
Confidence 3478899886
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.25 Score=53.44 Aligned_cols=75 Identities=17% Similarity=0.157 Sum_probs=49.6
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccC-----ChhhHHHHHHHHHHHHhcC---CCceeeeeeeecCCCccCc
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-----HVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-----~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~~ 189 (595)
.+.||.|.-..||+..+. +..|+||.-..... ......+...|...|+.+. ...+.+++.++..
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded------ 108 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT------ 108 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC------
Confidence 577999999999999763 45688997531111 0123455566777777664 2467777777632
Q ss_pred ccEEEEEecccc
Q 007629 190 KDIYVVFELMES 201 (595)
Q Consensus 190 ~~lylV~E~~~g 201 (595)
.-+++||++++
T Consensus 109 -~~vlvME~L~~ 119 (418)
T PLN02756 109 -MALIGMRYLEP 119 (418)
T ss_pred -CCEEEEeecCC
Confidence 24788999975
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.15 Score=54.23 Aligned_cols=29 Identities=28% Similarity=0.442 Sum_probs=25.6
Q ss_pred CeeecCCCCCceeeCC-CCcEEEcccCcce
Q 007629 236 NVFHRDLKPKNILANA-DCKLKICDFGLAR 264 (595)
Q Consensus 236 gIiHrDLKP~NILl~~-~~~vKL~DFGla~ 264 (595)
.++|+|+++.|||++. ++.+.|+||..|.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5899999999999976 4689999998775
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.15 Score=53.17 Aligned_cols=30 Identities=17% Similarity=0.135 Sum_probs=27.6
Q ss_pred CeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 236 NVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 236 gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
++||+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.18 Score=53.21 Aligned_cols=28 Identities=32% Similarity=0.464 Sum_probs=24.8
Q ss_pred eeecCCCCCceeeCC-CCcEEEcccCcce
Q 007629 237 VFHRDLKPKNILANA-DCKLKICDFGLAR 264 (595)
Q Consensus 237 IiHrDLKP~NILl~~-~~~vKL~DFGla~ 264 (595)
++|.||-+.|||++. ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 5789999999764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.05 Score=57.27 Aligned_cols=74 Identities=23% Similarity=0.347 Sum_probs=56.6
Q ss_pred CcccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 188 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 188 ~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~-gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
+..+.|++|++-++.+.-. ..-..+++..|+.+.+..++-+..+ ..-||||...||||+ +|+|-|+||-+++..
T Consensus 297 e~~y~yl~~kdhgt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 297 ETLYLYLHFKDHGTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred CceEEEEEEecCCceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 4457889999887755422 1234677778888877766666543 589999999999999 999999999999954
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.19 E-value=1 Score=48.53 Aligned_cols=29 Identities=31% Similarity=0.287 Sum_probs=23.7
Q ss_pred CCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 235 ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 235 ~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
...+|.||-+.|||.+. +.+.++||-.|.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 35799999999999754 469999997653
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.93 E-value=1.3 Score=46.56 Aligned_cols=28 Identities=36% Similarity=0.387 Sum_probs=23.9
Q ss_pred CCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 235 ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 235 ~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4689999999999995 4 57899999775
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.92 E-value=0.16 Score=52.67 Aligned_cols=29 Identities=24% Similarity=0.377 Sum_probs=25.6
Q ss_pred CCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 235 ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 235 ~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=92.74 E-value=1.3 Score=45.89 Aligned_cols=73 Identities=15% Similarity=0.112 Sum_probs=43.0
Q ss_pred EEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC---CCceeeeeeeecCCCccCcccE
Q 007629 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 116 ~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~~~~l 192 (595)
+-.+.|+-|....+|+.. .++..|.||+-.. .....+..|..-|+.|. --.+.+++.+.... ..-
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-----~~~ 87 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD-----DDA 87 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S-----SCC
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec-----CCc
Confidence 345779999999999986 6788899997642 22345667888888873 33355666655322 223
Q ss_pred EEEEeccc
Q 007629 193 YVVFELME 200 (595)
Q Consensus 193 ylV~E~~~ 200 (595)
||||||++
T Consensus 88 fLlle~l~ 95 (288)
T PF03881_consen 88 FLLLEFLE 95 (288)
T ss_dssp EEEEE---
T ss_pred eEEEEeec
Confidence 99999986
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=92.04 E-value=0.034 Score=60.59 Aligned_cols=73 Identities=29% Similarity=0.462 Sum_probs=59.6
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 184 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 184 (595)
+...++.+..+|.|+||+|+.+..+..+..+|||.|... .......+.++|+.-+..+.|++|+++.+.|...
T Consensus 47 ~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlk-n~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 47 EANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLK-NREESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred hhccccccccccccCccccCCccccccchhhHHHHhccc-chhhhhhhhhccccchhhhcccchhhheeceecC
Confidence 456788899999999999999999888889999998532 1223345678999999999999999998888543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=91.01 E-value=1.1 Score=44.52 Aligned_cols=100 Identities=18% Similarity=0.224 Sum_probs=63.6
Q ss_pred EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEecccc--cHHHHHHhcCCCCHHH
Q 007629 140 RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEH 217 (595)
Q Consensus 140 ~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~~g--~L~~~i~~~~~l~~~~ 217 (595)
...+|++....-.. ...-+..+..++.++. .|+++.. ...-.+-++.|+|.. .+.
T Consensus 87 ~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~~~i~~------------- 143 (308)
T PF07387_consen 87 PLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYKIKINF------------- 143 (308)
T ss_pred hhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccCcccch-------------
Confidence 45566664321111 2234466777777764 4666642 122346789999863 111
Q ss_pred HHHHHHHHHHHHHHHHh--CCeeecCCCCCceeeCCCCcEEEcccCcc
Q 007629 218 YQFFLYQLLRGLKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLA 263 (595)
Q Consensus 218 ~~~i~~qil~aL~yLHs--~gIiHrDLKP~NILl~~~~~vKL~DFGla 263 (595)
..++.-=+.+|.-.|+ .+.+|+|..|+||+-|..|.+||.|=+..
T Consensus 144 -~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 144 -SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred -hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 1122222566778895 47999999999999999999999998754
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=90.67 E-value=1.2 Score=44.34 Aligned_cols=67 Identities=16% Similarity=0.238 Sum_probs=38.7
Q ss_pred eEEEEEEECCCC-cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEEeccc
Q 007629 127 GVVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME 200 (595)
Q Consensus 127 G~V~~a~~~~~g-~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~~ 200 (595)
|.|..|....+| ..|-||+=. ......+..|+.-|+.|.-.|-|.+-.++... ....+.|+||||++
T Consensus 27 G~inea~~v~dg~~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G--~~~~~sylVle~L~ 94 (286)
T COG3001 27 GDINEAWRLRDGTDPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVG--ASRDHSYLVLEYLP 94 (286)
T ss_pred ccccceeEeecCCcceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEec--CCCCeeEEEEeecc
Confidence 345444444444 467788532 23445677888888777544433332222222 33467899999997
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.34 E-value=0.19 Score=48.57 Aligned_cols=28 Identities=25% Similarity=0.444 Sum_probs=25.0
Q ss_pred CeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 236 NVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 236 gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
-.+|+|+.|.||+++.++ ++|+||+.|.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 369999999999998777 9999999875
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=90.13 E-value=0.25 Score=51.84 Aligned_cols=52 Identities=31% Similarity=0.402 Sum_probs=34.9
Q ss_pred HHHHHHHHHHHHHHHHHHH----hCCeeecCCCCCceeeCCC------------------CcEEEcccCcceec
Q 007629 215 PEHYQFFLYQLLRGLKYIH----TANVFHRDLKPKNILANAD------------------CKLKICDFGLARVS 266 (595)
Q Consensus 215 ~~~~~~i~~qil~aL~yLH----s~gIiHrDLKP~NILl~~~------------------~~vKL~DFGla~~~ 266 (595)
.+-+++++.||+.-.--+- -.+.+|-||||+||||-+. -.++|.||.+|+..
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 3557788888865331122 2468999999999997432 23577888887653
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.67 E-value=2.8 Score=46.14 Aligned_cols=28 Identities=29% Similarity=0.495 Sum_probs=23.5
Q ss_pred CeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 236 NVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 236 gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
.++|.|+-+.|||.+.+ .++|+||-.|.
T Consensus 285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK-CLRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCC-CEEEEeecccc
Confidence 48999999999998655 49999998664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 595 | ||||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-81 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-81 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-75 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-75 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-75 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-75 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-75 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-75 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-75 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-75 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-75 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-75 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-75 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-75 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-75 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-75 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-74 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-74 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-74 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-74 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-74 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-74 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-73 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-73 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-73 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-72 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-69 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-69 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-69 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-69 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-69 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-69 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-69 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-69 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-69 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-69 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-69 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-69 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-69 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-69 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-69 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-69 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-69 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-69 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-69 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-69 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-68 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-68 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-68 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-68 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-68 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-68 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-68 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-68 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-68 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-68 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-68 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-68 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-68 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-68 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-68 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-68 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-68 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-68 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-68 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-68 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-68 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-68 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-68 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-68 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-68 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-68 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-68 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-67 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-67 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-67 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-67 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-67 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-67 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-67 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-67 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-67 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-67 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-66 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-66 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-66 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-66 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-65 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-61 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-60 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-60 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-60 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-60 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-59 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-58 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-54 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-51 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-49 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-49 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-49 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-49 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-49 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-49 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-49 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-49 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-48 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-48 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-48 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-48 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-48 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-48 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-48 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-48 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-48 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-48 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-48 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-48 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-48 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-47 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-47 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-47 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-47 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-47 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-47 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-47 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-46 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-46 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-46 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-46 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-46 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-46 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-45 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-44 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-43 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-43 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-38 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-38 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-38 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-38 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-38 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-38 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-38 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-38 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-38 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-38 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-38 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-38 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-38 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-38 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-38 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-38 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-38 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-38 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-38 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-38 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-38 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-38 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-38 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-38 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-38 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-38 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-38 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-38 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-37 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-37 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-37 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-37 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-37 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-37 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-37 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-37 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-37 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-37 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-37 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-36 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-35 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-35 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-35 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-35 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-35 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-34 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-34 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-34 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-34 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-34 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-34 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-34 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-34 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-34 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-34 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-34 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-34 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-33 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-33 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-33 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-33 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-33 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-33 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-33 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-33 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-33 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-33 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-33 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-33 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-33 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-33 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-33 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-33 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-32 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-32 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-32 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-32 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-30 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-30 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-30 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-30 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-25 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-25 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-25 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-24 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-23 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-22 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-21 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-20 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-20 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-20 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-20 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-20 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-20 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-20 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-20 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-20 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-20 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-20 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-20 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-20 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-20 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-20 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-20 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 8e-20 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-20 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-20 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-20 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-20 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-20 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-19 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-19 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-19 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-19 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-19 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-19 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-19 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-19 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-19 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-19 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-19 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-18 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-18 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-17 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-17 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-17 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-17 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-17 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-16 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-16 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-16 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-15 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-06 |
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 584 bits (1508), Expect = 0.0
Identities = 164/365 (44%), Positives = 226/365 (61%), Gaps = 5/365 (1%)
Query: 88 PTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN 147
M + E + RY IG+G+YG+V SA D RVAIKKI+
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS 61
Query: 148 DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI 207
FEH + R LREIK+L RH +I+ I I+ P+ + KD+Y+V +LME+DL++++
Sbjct: 62 -PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL 120
Query: 208 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267
K L+ +H +FLYQ+LRGLKYIH+ANV HRDLKP N+L N C LKICDFGLARV+
Sbjct: 121 KTQH-LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179
Query: 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
D F T+YVATRWYRAPE+ + YT +IDIWS+GCI AEML+ +P+FPGK+ +
Sbjct: 180 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238
Query: 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLL 387
QL+ + +LG+PS E ++ I N KAR YL S+ K VP++ FPNAD AL LL+++L
Sbjct: 239 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML 298
Query: 388 AFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREIL 447
F+P R E+ALA PY + EP + +F+ E L K+ ++E+I+ E
Sbjct: 299 TFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETA 356
Query: 448 EYHPQ 452
+ P
Sbjct: 357 RFQPG 361
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 580 bits (1497), Expect = 0.0
Identities = 145/351 (41%), Positives = 217/351 (61%), Gaps = 13/351 (3%)
Query: 107 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 166
Y +S +Q++ ++G+G+YGVV SA TGE VAIKKI F+ A R LREIK+L
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKIL 63
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL 226
+ +H +I+ I +I P S F ++Y++ ELM++DLH+VI L+ +H Q+F+YQ L
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFIYQTL 122
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI-------FWTDY 279
R +K +H +NV HRDLKP N+L N++C LK+CDFGLAR+ A ++
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339
VATRWYRAPE+ + +KY+ A+D+WS GCI AE+ +P+FPG++ HQL L+ ++GT
Sbjct: 183 VATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 340 PSTES-ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
P +++ + I + +AR Y+ S+ P FP +P + LL+R+L FDP R TA+
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 399 EALADPYFHGLANVDREPSTQPISKLEFEF--ERRKLAKDDVREMIYREIL 447
EAL PY + + EP +PI FEF + L D++++I+ EI
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 575 bits (1484), Expect = 0.0
Identities = 136/424 (32%), Positives = 213/424 (50%), Gaps = 52/424 (12%)
Query: 93 MDPHKKSALETEFFTEYGE---ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV 149
H S E +F Y I+ +IG+GSYG V A D +T + VAIKK+N +
Sbjct: 3 HHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM 62
Query: 150 FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA 209
FE + D RILREI +L L+ I+ + +++P +F ++Y+V E+ +SDL ++ K
Sbjct: 63 FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT 122
Query: 210 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269
LT EH + LY LL G +IH + + HRDLKP N L N DC +K+CDFGLAR ++
Sbjct: 123 PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182
Query: 270 APSAI-------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 310
+ I T +V TRWYRAPEL YT +IDIWS GCI
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTGCI 241
Query: 311 FAEMLTG-----------KPLFPG-----------------KNVVHQLDLMTDLLGTPST 342
FAE+L PLFPG K+ QL+++ +++GTP+
Sbjct: 242 FAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTE 301
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
+ + I + +Y+ ++P+ K+P+ ++LLE +L F+P R T ++AL
Sbjct: 302 DDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD 361
Query: 403 DPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGE 462
PY + E + L F+ + L++ +R + +E+ +HP+++ +
Sbjct: 362 HPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELVIPSVFTIH 420
Query: 463 QTSF 466
+ +F
Sbjct: 421 ENNF 424
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 559 bits (1442), Expect = 0.0
Identities = 140/378 (37%), Positives = 219/378 (57%), Gaps = 16/378 (4%)
Query: 87 APTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI 146
+P PA +++ +T + + Y+ + +G G+YG V SAVD TG +VAIKK+
Sbjct: 3 SPPPARSGFYRQEVTKTAWEVR----AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL 58
Query: 147 NDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP-PSRREFKDIYVVFELMESDLHQ 205
F+ A R RE++LL+ +RH +++ + + P + +F D Y+V M +DL +
Sbjct: 59 YRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK 118
Query: 206 VIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265
++K L + QF +YQ+L+GL+YIH A + HRDLKP N+ N DC+LKI DFGLAR
Sbjct: 119 LMKHEK-LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177
Query: 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
+ ++ T YV TRWYRAPE+ ++ +YT +DIWS+GCI AEM+TGK LF G +
Sbjct: 178 ADSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230
Query: 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLER 385
+ QL + + GTP E + R+++++A+ Y+ + + + F+ NA PLA++LLE+
Sbjct: 231 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 290
Query: 386 LLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYRE 445
+L D + R TA EALA PYF L + + EP Q + F+ D+ + + Y+E
Sbjct: 291 MLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKY---DDSFDDVDRTLDEWKRVTYKE 347
Query: 446 ILEYHPQMLQEYLRGGEQ 463
+L + P E
Sbjct: 348 VLSFKPPRQLGARVSKET 365
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 556 bits (1435), Expect = 0.0
Identities = 135/340 (39%), Positives = 199/340 (58%), Gaps = 12/340 (3%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
Y +G G+YG V SA+D +GE+VAIKK++ F+ A R RE+ LL+ ++H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 173 DIVEIKHIMLPPSR-REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+++ + + P S R F D Y+V M++DL +++ + E Q+ +YQ+L+GLKY
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKY 141
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
IH+A V HRDLKP N+ N DC+LKI DFGLAR + + T YV TRWYRAPE+
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVI 195
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
S+ Y +DIWS+GCI AEMLTGK LF GK+ + QL + + G P TE + ++ ++
Sbjct: 196 LSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411
A+ Y+ S+ + F+ FP A P A LLE++L D R TA +AL P+F +
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314
Query: 412 VDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
+ E Q + E KL D+ ++ IY+EI+ + P
Sbjct: 315 PEEETEAQQ--PFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 555 bits (1433), Expect = 0.0
Identities = 125/369 (33%), Positives = 186/369 (50%), Gaps = 20/369 (5%)
Query: 93 MDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIND---- 148
M ++A+ + S Y +Q I GSYG V + VD+ G VAIK++ +
Sbjct: 2 MQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSD 60
Query: 149 -----VFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDL 203
+ R+LREI+LL HP+I+ ++ I + +Y+V ELM +DL
Sbjct: 61 GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDL 120
Query: 204 HQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262
QVI ++P+H Q+F+Y +L GL +H A V HRDL P NIL + + ICDF L
Sbjct: 121 AQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180
Query: 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFP 322
AR DA T YV RWYRAPEL F +T +D+WS GC+ AEM K LF
Sbjct: 181 AREDTADA----NKTHYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFR 235
Query: 323 GKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYL-GSMRKKQPVPFSHKFPNADPLALH 381
G +QL+ + +++GTP E + + AR YL S+ ++ P ADP+AL
Sbjct: 236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALD 295
Query: 382 LLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREM 441
L+ ++L F+P+ R + E+AL PYF L + F F+ D+ ++
Sbjct: 296 LIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSE---RFHFDESVTDVYDMHKI 352
Query: 442 IYREILEYH 450
E+ ++
Sbjct: 353 FTAEVERFN 361
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 552 bits (1425), Expect = 0.0
Identities = 150/368 (40%), Positives = 220/368 (59%), Gaps = 18/368 (4%)
Query: 96 HKKSALETEFF------TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV 149
H S F+ T + RYQ +G G+YG V +A DT TG RVA+KK++
Sbjct: 6 HHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 65
Query: 150 FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE-FKDIYVVFELMESDLHQVIK 208
F+ + A R RE++LL+ ++H +++ + + P E F D+Y+V LM +DL+ ++K
Sbjct: 66 FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 209 ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
LT +H QF +YQ+LRGLKYIH+A++ HRDLKP N+ N DC+LKI DFGLAR + +
Sbjct: 126 CQK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184
Query: 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH 328
T YVATRWYRAPE+ ++ Y +DIWS+GCI AE+LTG+ LFPG + +
Sbjct: 185 ------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237
Query: 329 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLA 388
QL L+ L+GTP E + +I +E AR Y+ S+ + + F++ F A+PLA+ LLE++L
Sbjct: 238 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297
Query: 389 FDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILE 448
D R TA +ALA YF + D EP P + E R L D+ + + Y E++
Sbjct: 298 LDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQSLESRDLLIDEWKSLTYDEVIS 354
Query: 449 YHPQMLQE 456
+ P L +
Sbjct: 355 FVPPPLDQ 362
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 550 bits (1420), Expect = 0.0
Identities = 139/386 (36%), Positives = 221/386 (57%), Gaps = 43/386 (11%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-H 171
+Y++ + +GKG+YG+V ++D TGE VA+KKI D F++ +DA R REI +L L H
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+IV + +++ + +D+Y+VF+ ME+DLH VI+AN L P H Q+ +YQL++ +KY
Sbjct: 69 ENIVNLLNVLRADN---DRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIKY 124
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARV------------------SFNDAPSA 273
+H+ + HRD+KP NIL NA+C +K+ DFGL+R + N
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 274 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332
TDYVATRWYRAPE L GS +KYT ID+WS+GCI E+L GKP+FPG + ++QL+
Sbjct: 185 PILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF----------------PNAD 376
+ ++ PS E + I++ A+ + S+++K + S+K + +
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302
Query: 377 PLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKD 436
AL LL++LL F+P R +A +AL P+ N + EP+ I + + K + D
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSID 361
Query: 437 DVREMIYREILEYHPQMLQEYLRGGE 462
D R ++Y EI +++ + +
Sbjct: 362 DYRNLVYSEISRRKRELISNKHQNVQ 387
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 551 bits (1421), Expect = 0.0
Identities = 145/422 (34%), Positives = 208/422 (49%), Gaps = 57/422 (13%)
Query: 87 APTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI 146
K +A +++ RY+I+ +IG GSYG V A D VAIKKI
Sbjct: 27 GQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86
Query: 147 NDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQV 206
VFE + D RILREI +L L H +V++ I++P +F ++YVV E+ +SD ++
Sbjct: 87 LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKL 146
Query: 207 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV- 265
+ LT H + LY LL G+KY+H+A + HRDLKP N L N DC +K+CDFGLAR
Sbjct: 147 FRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206
Query: 266 -----------------------SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAI 302
+ T +V TRWYRAPEL YT AI
Sbjct: 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAI 265
Query: 303 DIWSIGCIFAEMLT-----------GKPLFPGKNVV--------------------HQLD 331
D+WSIGCIFAE+L PLFPG + QL+
Sbjct: 266 DVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLN 325
Query: 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP 391
++ ++LGTPS E I + E A+RY+ K++ + +FP + A+HLL+R+L F+P
Sbjct: 326 VIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNP 385
Query: 392 KDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
R T E LA P+F + + E + +L F + + + +R +EI YHP
Sbjct: 386 NKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHP 444
Query: 452 QM 453
++
Sbjct: 445 EI 446
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 542 bits (1398), Expect = 0.0
Identities = 127/447 (28%), Positives = 216/447 (48%), Gaps = 34/447 (7%)
Query: 83 QFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVA 142
+ ++ + + ++ F RYQ + IG G+ G+V +A D VA
Sbjct: 36 HYNMSKSKVDNQFYSVEVGDSTFTVL----KRYQNLKPIGSGAQGIVCAAYDAVLDRNVA 91
Query: 143 IKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP-PSRREFKDIYVVFELMES 201
IKK++ F++ + A R RE+ L++ + H +I+ + ++ P + EF+D+Y+V ELM++
Sbjct: 92 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 151
Query: 202 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 261
+L QVI+ +L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI DFG
Sbjct: 152 NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 209
Query: 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
LAR A ++ T YV TR+YRAPE+ Y +DIWS+GCI EM+ K LF
Sbjct: 210 LART----AGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILF 263
Query: 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA------ 375
PG++ + Q + + + LGTP E + ++ R Y+ + K + F FP++
Sbjct: 264 PGRDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADS 322
Query: 376 ------DPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE 429
A LL ++L DP R + ++AL PY + + P + + +
Sbjct: 323 EHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE-APPPQIYDKQLD 381
Query: 430 RRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKG 489
R+ ++ +E+IY+E++ + ++G S L
Sbjct: 382 EREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGAAV-------NSSESLPPSSSVN 434
Query: 490 ERSTPLQRQHASLPRERVPAPKDENAG 516
+ S+ Q + + G
Sbjct: 435 DISSMSTDQTLASDTDSSLEASAGPLG 461
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 532 bits (1373), Expect = 0.0
Identities = 122/382 (31%), Positives = 199/382 (52%), Gaps = 27/382 (7%)
Query: 87 APTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI 146
+ + + + ++ F RYQ + IG G+ G+V +A D VAIKK+
Sbjct: 3 SRSKRDNNFYSVEIGDSTFTVL----KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL 58
Query: 147 NDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP-SRREFKDIYVVFELMESDLHQ 205
+ F++ + A R RE+ L++ + H +I+ + ++ P S EF+D+Y+V ELM+++L Q
Sbjct: 59 SRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ 118
Query: 206 VIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265
VI+ +L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI DFGLAR
Sbjct: 119 VIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176
Query: 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
A ++ T YV TR+YRAPE+ Y +DIWS+GCI EM+ G LFPG +
Sbjct: 177 ----AGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTD 230
Query: 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA---------- 375
+ Q + + + LGTP E + ++ R Y+ + K F FP+
Sbjct: 231 HIDQWNKVIEQLGTPCPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 289
Query: 376 --DPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKL 433
A LL ++L D R + +EAL PY + + P + + + R+
Sbjct: 290 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE-APPPKIPDKQLDEREH 348
Query: 434 AKDDVREMIYREILEYHPQMLQ 455
++ +E+IY+E+++
Sbjct: 349 TIEEWKELIYKEVMDLEHHHHH 370
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 521 bits (1344), Expect = 0.0
Identities = 127/315 (40%), Positives = 173/315 (54%), Gaps = 15/315 (4%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
SRY + +G G G+V SAVD +RVAIKKI V LREIK++R L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDH 67
Query: 172 PDIVEIKHIMLPPSRR---------EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 222
+IV++ I+ P + E +Y+V E ME+DL V++ L EH + F+
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFM 126
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPSAIFWTDYVA 281
YQLLRGLKYIH+ANV HRDLKP N+ N D LKI DFGLAR+ ++ +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 282 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
T+WYR+P L S + YT AID+W+ GCIFAEMLTGK LF G + + Q+ L+ + +
Sbjct: 187 TKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
E + + Y+ + + P + P A+ LE++L F P DR TAEEAL
Sbjct: 246 EEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 402 ADPYFHGLANVDREP 416
+ PY + EP
Sbjct: 305 SHPYMSIYSFPMDEP 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 482 bits (1242), Expect = e-168
Identities = 114/351 (32%), Positives = 180/351 (51%), Gaps = 27/351 (7%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
E R+Q++ + G+G++G V + TG VAIKK+ + R L+ ++ L +L
Sbjct: 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLH 77
Query: 171 HPDIVEIKHIMLPPSRREFKDIY--VVFELMESDLHQVIK----ANDDLTPEHYQFFLYQ 224
HP+IV+++ R+ +DIY VV E + LH+ + P + FL+Q
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 225 LLRGLKYIH--TANVFHRDLKPKNILAN-ADCKLKICDFGLARVSFNDAPSAIFWTDYVA 281
L+R + +H + NV HRD+KP N+L N AD LK+CDFG A+ P+ Y+
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN----VAYIC 193
Query: 282 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
+R+YRAPEL YT A+DIWS+GCIFAEM+ G+P+F G N QL + +LG PS
Sbjct: 194 SRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKF----PNADPLALHLLERLLAFDPKDRPTA 397
E + ++ L + +P+S+ F A LL LL + P++R
Sbjct: 253 REVLRKLNPSHTDVDL---YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
Query: 398 EEALADPYFHGLAN-VDREPSTQPISKLEFEFERRKL--AKDDVREMIYRE 445
EAL PYF L + + P+ + + + F F ++ + + + R+
Sbjct: 310 YEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 450 bits (1159), Expect = e-155
Identities = 123/404 (30%), Positives = 202/404 (50%), Gaps = 31/404 (7%)
Query: 85 PIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIK 144
+ P L ++ T Y +VIG GS+GVV A + E VAIK
Sbjct: 12 GVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIK 70
Query: 145 KINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFKDIYVVFELMESDL 203
K+ + D RE++++R+++HP++V++K +++ + +V E + +
Sbjct: 71 KV------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV 124
Query: 204 HQVI----KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKIC 258
++ K + + ++YQLLR L YIH+ + HRD+KP+N+L + LK+
Sbjct: 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLI 184
Query: 259 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTG 317
DFG A++ P+ Y+ +R+YRAPEL G+ + YT IDIWS GC+ AE++ G
Sbjct: 185 DFGSAKILIAGEPN----VSYICSRYYRAPELIFGA--TNYTTNIDIWSTGCVMAELMQG 238
Query: 318 KPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNAD 376
+PLFPG++ + QL + +LGTPS E I + + +P PFS F P
Sbjct: 239 QPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKF---PQIRPHPFSKVFRPRTP 295
Query: 377 PLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD-REPSTQPISKLEFEFERRKLAK 435
P A+ L+ RLL + P R TA EAL P+F L + R P+ + + L F + + +L
Sbjct: 296 PDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPL-FNWTKEEL-- 352
Query: 436 DDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQF 479
VR + ++ H + + RG + +F P ++ K
Sbjct: 353 -SVRPDLISRLVPQHAEA-ELLSRGIDVHNFQ-PIPLESLKVTL 393
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 437 bits (1126), Expect = e-150
Identities = 105/392 (26%), Positives = 182/392 (46%), Gaps = 66/392 (16%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
+ +Y + + +G GS+G+V D +G+R A+KK+ D RE+ ++++L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 172 PDIVEIKHIM---------------------------------LPPSRREFKDIYVVFEL 198
+I+++ + + + K + V+ E
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 199 MESDLHQVI----KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DC 253
+ LH+V+ ++ + ++YQL R + +IH+ + HRD+KP+N+L N+ D
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 254 KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA 312
LK+CDFG A+ PS Y+ +R+YRAPEL G+ ++YTP+ID+WSIGC+F
Sbjct: 180 TLKLCDFGSAKKLIPSEPS----VAYICSRFYRAPELMLGA--TEYTPSIDLWSIGCVFG 233
Query: 313 EMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF 372
E++ GKPLF G+ + QL + ++GTP+ E + R+ + +
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFP---TLKAKDWRKIL 290
Query: 373 PNADP-LALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREP----------STQPI 421
P P LA+ LLE++L ++P R EA+A P+F L N Q I
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNI 350
Query: 422 SKL-EFEFERRKLAKDDVREMIYREILEYHPQ 452
+L F + +V I + + +
Sbjct: 351 PQLFNFSPYELSIIPGNVLNRILPKNFSPNYK 382
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 427 bits (1100), Expect = e-146
Identities = 110/355 (30%), Positives = 181/355 (50%), Gaps = 28/355 (7%)
Query: 107 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 166
+ + Y +VIG GS+GVV A +GE VAIKK+ D RE++++
Sbjct: 48 PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIM 101
Query: 167 RLLRHPDIVEIKHIMLPPS-RREFKDIYVVFELMESDLHQVIK----ANDDLTPEHYQFF 221
R L H +IV +++ +++ + +V + + +++V + A L + + +
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 161
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSFNDAPSAIFWTDYV 280
+YQL R L YIH+ + HRD+KP+N+L + D LK+CDFG A+ P+ Y+
Sbjct: 162 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN----VSYI 217
Query: 281 ATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339
+R+YRAPEL G+ + YT +ID+WS GC+ AE+L G+P+FPG + V QL + +LGT
Sbjct: 218 CSRYYRAPELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275
Query: 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAE 398
P+ E I + + + P++ F P P A+ L RLL + P R T
Sbjct: 276 PTREQIREMNPNYTEFKF---PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332
Query: 399 EALADPYFHGLANV-DREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQ 452
EA A +F L + + P+ + L F F ++L + ++ H +
Sbjct: 333 EACAHSFFDELRDPNVKLPNGRDTPAL-FNFTTQEL---SSNPPLATILIPPHAR 383
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 397 bits (1023), Expect = e-135
Identities = 89/316 (28%), Positives = 151/316 (47%), Gaps = 24/316 (7%)
Query: 105 FFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK 164
E+G YQ+ +G+G Y V A++ E+V +K + V +I REIK
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIK 82
Query: 165 LLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 223
+L LR P+I+ + I+ P V + +D Q+ + LT +F++Y
Sbjct: 83 ILENLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMY 137
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282
++L+ L Y H+ + HRD+KP N++ + KL++ D+GLA + VA+
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVAS 193
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPS 341
R+++ PEL + Y ++D+WS+GC+ A M+ K P F G + QL + +LGT
Sbjct: 194 RYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 342 TES-ISRIRNEKARRYLGSMRKKQPVPFSHKFPN-----ADPLALHLLERLLAFDPKDRP 395
I + E R+ + + + + P AL L++LL +D + R
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312
Query: 396 TAEEALADPYFHGLAN 411
TA EA+ PYF+ +
Sbjct: 313 TAREAMEHPYFYTVVK 328
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 362 bits (932), Expect = e-122
Identities = 104/309 (33%), Positives = 158/309 (51%), Gaps = 12/309 (3%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y+ IG+GSYGVV + TG+ VAIKK + + LREI++L+ L+HP+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 232
+V + + R + +++VFE + + + + + +Q L+ + +
Sbjct: 64 LVNLLEVF-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LC 291
H N HRD+KP+NIL +K+CDFG AR PS + D VATRWYR+PE L
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTG-PSDYY-DDEVATRWYRSPELLV 175
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
G ++Y P +D+W+IGC+FAE+L+G PL+PGK+ V QL L+ LG
Sbjct: 176 GD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411
+ + + P KFPN AL LL+ L DP +R T E+ L PYF +
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293
Query: 412 VDREPSTQP 420
++
Sbjct: 294 IEDLAKEHD 302
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-115
Identities = 97/296 (32%), Positives = 155/296 (52%), Gaps = 12/296 (4%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y+ ++G+GSYG+V + TG VAIKK + + +REIKLL+ LRH +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 232
+V + + ++ K Y+VFE ++ + ++ + L + Q +L+Q++ G+ +
Sbjct: 86 LVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC- 291
H+ N+ HRD+KP+NIL + +K+CDFG AR + P ++ D VATRWYRAPEL
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAA-PGEVY-DDEVATRWYRAPELLV 197
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
G KY A+D+W+IGC+ EM G+PLFPG + + QL + LG
Sbjct: 198 GD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
+ K+ P ++P + + L ++ L DP RP E L +F
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 322 bits (828), Expect = e-106
Identities = 115/321 (35%), Positives = 166/321 (51%), Gaps = 30/321 (9%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRI--LREIKLLRL 168
A RY+ + +G+G + V A D +T + VAIKKI D LREIKLL+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLR 227
L HP+I+ + S I +VF+ ME+DL +IK N LTP H + ++ L+
Sbjct: 69 LSHPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL+Y+H + HRDLKP N+L + + LK+ DFGLA+ SF P+ + T V TRWYRA
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGS-PNRAY-THQVVTRWYRA 180
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES-- 344
PE L G+ Y +D+W++GCI AE+L P PG + + QL + + LGTP+ E
Sbjct: 181 PELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238
Query: 345 -ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+ + + + + +P H F A L L++ L F+P R TA +AL
Sbjct: 239 DMCSLPDYV------TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292
Query: 404 PYFHGLANVDREPSTQPISKL 424
YF P P +L
Sbjct: 293 KYF------SNRPGPTPGCQL 307
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-106
Identities = 124/324 (38%), Positives = 174/324 (53%), Gaps = 24/324 (7%)
Query: 93 MDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH 152
M H + E G +YQ E +G+G+YGVV A D+ G VA+K+I +
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR--LDA 57
Query: 153 VSDATRI--LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA- 209
+ +REI LL+ L HP+IV + ++ + +VFE ME DL +V+
Sbjct: 58 EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDEN 112
Query: 210 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269
L + +LYQLLRG+ + H + HRDLKP+N+L N+D LK+ DFGLAR +F
Sbjct: 113 KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGI 171
Query: 270 APSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH 328
P + T V T WYRAP+ L GS KY+ ++DIWSIGCIFAEM+TGKPLFPG
Sbjct: 172 -PVRSY-THEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227
Query: 329 QLDLMTDLLGTPSTES---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLER 385
QL + +LGTP+ + + K R + + + P+S P + LL
Sbjct: 228 QLPKIFSILGTPNPREWPQVQELPLWKQRTF----QVFEKKPWSSIIPGFCQEGIDLLSN 283
Query: 386 LLAFDPKDRPTAEEALADPYFHGL 409
+L FDP R +A +A+ PYF L
Sbjct: 284 MLCFDPNKRISARDAMNHPYFKDL 307
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-105
Identities = 112/328 (34%), Positives = 169/328 (51%), Gaps = 23/328 (7%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
Y + +G+G+Y V T VA+K+I E + T I RE+ LL+ L+H +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHAN 61
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 232
IV + I+ + +VFE ++ DL Q + + + + + FL+QLLRGL Y
Sbjct: 62 IVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LC 291
H V HRDLKP+N+L N +LK+ DFGLAR + + P+ + + V T WYR P+ L
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSI-PTKTY-DNEVVTLWYRPPDILL 173
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES---ISRI 348
GS + Y+ ID+W +GCIF EM TG+PLFPG V QL + +LGTP+ E+ I
Sbjct: 174 GS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408
K Y K + P D LL +LL F+ ++R +AE+A+ P+F
Sbjct: 232 EEFKTYNY----PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL- 286
Query: 409 LANVDREPSTQPISKLEFEFERRKLAKD 436
++ P + F + +L K+
Sbjct: 287 --SLGERIHKLPDTTSIFALKEIQLQKE 312
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 319 bits (821), Expect = e-105
Identities = 101/309 (32%), Positives = 142/309 (45%), Gaps = 30/309 (9%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI-----LREIKLLR 167
SRY+ IG G+YG V A D H+G VA+K + + +RE+ LLR
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLR 66
Query: 168 LLR---HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFL 222
L HP++V + + + +VFE ++ DL + L E + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282
Q LRGL ++H + HRDLKP+NIL + +K+ DFGLAR ++ + T V T
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMA---LTPVVVT 182
Query: 283 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
WYRAPE L S Y +D+WS+GCIFAEM KPLF G + QL + DL+G P
Sbjct: 183 LWYRAPEVLLQS---TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239
Query: 342 TES---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
+ + P P P + LL +L F+P R +A
Sbjct: 240 EDDWPRDVSLPRGAFPPR-------GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292
Query: 399 EALADPYFH 407
AL Y H
Sbjct: 293 RALQHSYLH 301
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 314 bits (806), Expect = e-103
Identities = 113/300 (37%), Positives = 167/300 (55%), Gaps = 25/300 (8%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRH 171
+Y E IG+G+YGVV A + GE A+KKI E + +REI +L+ L+H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR--LEKEDEGIPSTTIREISILKELKH 59
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLK 230
+IV++ ++ R + +VFE ++ DL +++ L + FL QLL G+
Sbjct: 60 SNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 289
Y H V HRDLKP+N+L N + +LKI DFGLAR +F P + T + T WYRAP+
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGI-PVRKY-THEIVTLWYRAPDV 171
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES---IS 346
L GS KY+ IDIWS+GCIFAEM+ G PLFPG + QL + +LGTP++++ ++
Sbjct: 172 LMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ Y + +P+P+ D + LL ++L DP R TA++AL YF
Sbjct: 230 ELPK-----YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-103
Identities = 112/304 (36%), Positives = 168/304 (55%), Gaps = 25/304 (8%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRH 171
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKH 60
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLK 230
+IV + ++ + + +VFE + DL + + N DL PE + FL+QLL+GL
Sbjct: 61 KNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 289
+ H+ NV HRDLKP+N+L N + +LK+ +FGLAR +F P + + V T WYR P+
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGI-PVRCY-SAEVVTLWYRPPDV 172
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES---I 345
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG +V QL + LLGTP+ E +
Sbjct: 173 LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+++ + K + P + LL+ LL +P R +AEEAL PY
Sbjct: 231 TKLPDYKPYP-----MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
Query: 406 FHGL 409
F
Sbjct: 286 FSDF 289
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-103
Identities = 112/340 (32%), Positives = 162/340 (47%), Gaps = 28/340 (8%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRL 168
E S+Y+ IG+G++G V A TG++VA+KK+ E+ + I LREIK+L+L
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQL 72
Query: 169 LRHPDIVEIKHIM---LPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQ 224
L+H ++V + I P R IY+VF+ E DL ++ T + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY---VA 281
LL GL YIH + HRD+K N+L D LK+ DFGLAR +F+ Y V
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSL-AKNSQPNRYTNRVV 190
Query: 282 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
T WYR PE L G Y P ID+W GCI AEM T P+ G HQL L++ L G+
Sbjct: 191 TLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248
Query: 341 STES---ISRIRNEKARRYLGSMRKKQPVPFSHKFPN--ADPLALHLLERLLAFDPKDRP 395
+ E + + K Q + DP AL L+++LL DP R
Sbjct: 249 TPEVWPNVDNYELYEKLEL----VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 396 TAEEALADPYFHGL---ANVDREPSTQPISKLEFEFERRK 432
+++AL +F +++ ST S E+ R+
Sbjct: 305 DSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRR 344
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 312 bits (803), Expect = e-102
Identities = 105/329 (31%), Positives = 159/329 (48%), Gaps = 29/329 (8%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDT-HTGERVAIKKINDVFEHVSDATRI--LREIKLLRLL 169
+Y+ IG+G+YG V A D + G VA+K++ + + + +RE+ +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHL 68
Query: 170 R---HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQ 224
HP++V + + + +VFE ++ DL + + E + ++Q
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
LLRGL ++H+ V HRDLKP+NIL + ++K+ DFGLAR ++ + T V T W
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMA---LTSVVVTLW 184
Query: 285 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
YRAPE L S Y +D+WS+GCIFAEM KPLF G + V QL + D++G P E
Sbjct: 185 YRAPEVLLQS---SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 344 S---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
+ + P + D L LL + L F+P R +A A
Sbjct: 242 DWPRDVALPRQAFHSK-------SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 401 LADPYFHGL-ANVDREPSTQPISKLEFEF 428
L+ PYF L + S P S+ E
Sbjct: 295 LSHPYFQDLERCKENLDSHLPPSQNTSEL 323
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-102
Identities = 111/309 (35%), Positives = 165/309 (53%), Gaps = 29/309 (9%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLR 170
RY+ +G+G+YG V A+DT T E VAIK+I EH + +RE+ LL+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
H +I+E+K ++ R ++++FE E+DL + + N D++ + FLYQL+ G+
Sbjct: 92 HRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 231 YIHTANVFHRDLKPKNILANADCK-----LKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
+ H+ HRDLKP+N+L + LKI DFGLAR +F P F T + T WY
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGI-PIRQF-THEIITLWY 203
Query: 286 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
R PE L GS Y+ ++DIWSI CI+AEML PLFPG + + QL + ++LG P +
Sbjct: 204 RPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 345 ---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNA-DPLALHLLERLLAFDPKDRPTAEEA 400
++ + + + S K + D L LL +L DP R +A+ A
Sbjct: 262 WPGVTALPD-----WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA 316
Query: 401 LADPYFHGL 409
L PYF
Sbjct: 317 LEHPYFSHN 325
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 308 bits (792), Expect = e-101
Identities = 107/314 (34%), Positives = 171/314 (54%), Gaps = 31/314 (9%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
+S+++ E +G G+Y V ++ TG VA+K++ E + +T I REI L++ L+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKELK 61
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN------DDLTPEHYQFFLYQ 224
H +IV + ++ ++ + +VFE M++DL + + + L ++F +Q
Sbjct: 62 HENIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
LL+GL + H + HRDLKP+N+L N +LK+ DFGLAR +F P F + V T W
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGI-PVNTF-SSEVVTLW 173
Query: 285 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
YRAP+ L GS Y+ +IDIWS GCI AEM+TGKPLFPG N QL L+ D++GTP+
Sbjct: 174 YRAPDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231
Query: 344 S---ISRIRNEKARRYLGSMRKKQPVPFSHKFPNA-----DPLALHLLERLLAFDPKDRP 395
++++ Y +++++ P D + L LL +P R
Sbjct: 232 LWPSVTKLPK-----YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL 286
Query: 396 TAEEALADPYFHGL 409
+A++AL P+F
Sbjct: 287 SAKQALHHPWFAEY 300
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 277 bits (709), Expect = 1e-87
Identities = 107/366 (29%), Positives = 168/366 (45%), Gaps = 52/366 (14%)
Query: 112 ASRYQIQ-EVIGKGSYGVVGSAV--DTHTGERVAIKKINDVFEHVSDATRILREIKLLRL 168
++ + +G+G+YG V A D + A+K+I +S + REI LLR
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSA--CREIALLRE 74
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD---------LTPEHYQ 219
L+HP+++ ++ + L + + ++++F+ E DL +IK + L +
Sbjct: 75 LKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 220 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK----LKICDFGLARVSFNDAPSAIF 275
LYQ+L G+ Y+H V HRDLKP NIL + +KI D G AR FN P
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNS-PLKPL 189
Query: 276 --WTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN------- 325
V T WYRAPE L G+ YT AIDIW+IGCIFAE+LT +P+F +
Sbjct: 190 ADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 326 --VVHQLDLMTDLLGTPSTES---ISRIRNEKARRYLGSMRKKQPVPF----SHKFPNAD 376
QLD + +++G P+ + I ++ D
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307
Query: 377 PLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP-ISKLEFEFERRKLAK 435
A HLL++LL DP R T+E+A+ DPYF + T + + + +R+
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFL-----EDPLPTSDVFAGCQIPYPKREFLT 362
Query: 436 DDVREM 441
++ +
Sbjct: 363 EEEPDD 368
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 238 bits (608), Expect = 2e-72
Identities = 90/400 (22%), Positives = 152/400 (38%), Gaps = 67/400 (16%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR-LLRHP 172
+ ++V+G G+ G + VA+K+I +D RE++LLR HP
Sbjct: 25 SFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 231
+++ + ++ + Y+ EL + L + ++ D L Q GL +
Sbjct: 79 NVIRYFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 232 IHTANVFHRDLKPKNIL-----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
+H+ N+ HRDLKP NIL A+ K I DFGL + S + T +
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 287 APE-LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344
APE L T +DI+S GC+F +++ G F
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL------------------- 234
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+R + + H + D +A L+E+++A DP+ RP+A+ L P
Sbjct: 235 ---------QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285
Query: 405 YFHGLAN-----------VDREPSTQPISKLEFEFERRKLAKDDVREMIYREILE----- 448
+F L +++E PI K + E R + K D RE I +
Sbjct: 286 FFWSLEKQLQFFQDVSDRIEKESLDGPIVK-QLERGGRAVVKMDWRENITVPLQTDLRKF 344
Query: 449 --YHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHY 486
Y +++ LR Y + L + +
Sbjct: 345 RTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPDDF 384
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-65
Identities = 112/434 (25%), Positives = 184/434 (42%), Gaps = 64/434 (14%)
Query: 18 HSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQQLTIVEDFDFSGLKLIR 77
H ++S+ + N + + K + + Q++Q+LT E I
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMGKVKATPMTPEQAMK--QYMQKLTAFE------HHEIF 53
Query: 78 VPKRIQFPIAPTPATMDPHKKSALETEFFTEYGE---------ASRYQIQEVIGKGSYGV 128
I F + + + G A RY++ +VIGKGS+G
Sbjct: 54 SYPEIYF-LGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQ 112
Query: 129 VGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188
V A D + VA+K + + + EI++L LR D +++
Sbjct: 113 VVKAYDHKVHQHVALKMVRNE-KRFHRQAAE--EIRILEHLRKQDKDNTMNVIHMLENFT 169
Query: 189 FKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPK 245
F++ I + FEL+ +L+++IK N + + F + +L+ L +H + H DLKP+
Sbjct: 170 FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPE 229
Query: 246 NIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAI 302
NIL +K+ DFG + + Y+ +R+YRAPE + G+ +Y I
Sbjct: 230 NILLKQQGRSGIKVIDFGSS--CYEHQRV----YTYIQSRFYRAPEVILGA---RYGMPI 280
Query: 303 DIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN------------ 350
D+WS+GCI AE+LTG PL PG++ QL M +LLG PS + + +
Sbjct: 281 DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPR 340
Query: 351 -------EKARRYLGSMRKK----QPVPFSHKFPNA-----DPLALHLLERLLAFDPKDR 394
L R + + P S ++ NA DPL L L++ L +DP R
Sbjct: 341 YCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400
Query: 395 PTAEEALADPYFHG 408
T +AL P+
Sbjct: 401 MTPGQALRHPWLRR 414
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 6e-65
Identities = 75/321 (23%), Positives = 111/321 (34%), Gaps = 51/321 (15%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP- 172
Y I + IG G V ++ + AIK +N EI L L+
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 173 -DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
I+ + + + IY+V E DL+ +K + P + + +L +
Sbjct: 88 DKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL- 290
IH + H DLKP N L D LK+ DFG+A +++ V T Y PE
Sbjct: 143 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ-MQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 291 --------CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
G SK +P D+WS+GCI M GK F
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----------------I 243
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
IS++ + + F + +L+ L DPK R + E LA
Sbjct: 244 NQISKLHAI--------IDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
Query: 403 DPYFHGLANVDREPSTQPISK 423
PY + P Q
Sbjct: 293 HPYV----QIQTHPVNQMAKG 309
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 9e-64
Identities = 57/373 (15%), Positives = 98/373 (26%), Gaps = 60/373 (16%)
Query: 79 PKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASR-YQIQEVIGKGSYGVVGSAVDTHT 137
+ ++ P A A ET + + R ++ E + G VV D
Sbjct: 27 EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVER 86
Query: 138 GERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK---HIMLPP--------- 184
E A+K S+ R+ L E + ++LP
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 185 ---------SRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-------QFFLYQLLRG 228
+ ++ DL + D + QL+R
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
+ + + H P N+ D +L + D P+ Y
Sbjct: 207 AANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA------SSVPVTYAPR 260
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
E + + +T A++ W +G + F + L P T+
Sbjct: 261 EFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD----- 315
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408
+ F L+ R L FD + R EA+ P F
Sbjct: 316 ----------------SLAFGS-CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
Query: 409 LANV--DREPSTQ 419
L N + Q
Sbjct: 359 LQNEISSSLSTGQ 371
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-62
Identities = 95/346 (27%), Positives = 151/346 (43%), Gaps = 63/346 (18%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI--NDVFEHVSDATRILREIKLLRLL 169
RY+I +IGKGS+G V A D E VAIK I F + + E++LL L+
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----QIEVRLLELM 107
Query: 170 RHPDIVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLL 226
D +I+ F++ + +VFE++ +L+ +++ + ++ + F Q+
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 227 RGLKYIHT--ANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTD---- 278
L ++ T ++ H DLKP+NIL +KI DFG S+
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----------SSCQLGQRIYQ 217
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338
Y+ +R+YR+PE+ Y AID+WS+GCI EM TG+PLF G N V Q++ + ++LG
Sbjct: 218 YIQSRFYRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 339 TPS--------------------------TESISRIRNEKARRYLGSMRKKQPVPFSHKF 372
P T+ R R L ++ + +
Sbjct: 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRR 335
Query: 373 PN------ADPLAL-HLLERLLAFDPKDRPTAEEALADPYFHGLAN 411
AD L L+ R+L +DPK R AL +F A+
Sbjct: 336 AGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 4e-62
Identities = 87/339 (25%), Positives = 141/339 (41%), Gaps = 57/339 (16%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
++RY+I + +G+G++G V +D G VA+K + +V + +A R EI++L L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHLN 69
Query: 171 HPDIVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 227
D + E I +VFEL+ + IK N +H + YQ+ +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 228 GLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVSFN 268
+ ++H+ + H DLKP+NIL + +K+ DFG
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG------- 182
Query: 269 DAPSAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323
SA + + V+TR YRAPE + ++ D+WSIGCI E G +FP
Sbjct: 183 ---SATYDDEHHSTLVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPT 236
Query: 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLA---- 379
+ L +M +LG I + R K + + + PL
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296
Query: 380 ---------LHLLERLLAFDPKDRPTAEEALADPYFHGL 409
L++++L +DP R T EAL P+F L
Sbjct: 297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 5e-62
Identities = 73/330 (22%), Positives = 115/330 (34%), Gaps = 47/330 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP- 172
Y I + IG G V ++ + AIK +N EI L L+
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 173 -DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
I+ + + IY+V E DL+ +K + P + + +L +
Sbjct: 69 DKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL- 290
IH + H DLKP N L D LK+ DFG+A +++ V T Y PE
Sbjct: 124 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ-MQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 291 --------CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
G SK +P D+WS+GCI M GK F
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----------------I 224
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
IS++ + + F + +L+ L DPK R + E LA
Sbjct: 225 NQISKLHAI--------IDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
Query: 403 DPYFHGLANVDREPSTQPISKLEFEFERRK 432
PY + + + ++++ +
Sbjct: 274 HPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 303
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 6e-62
Identities = 68/343 (19%), Positives = 132/343 (38%), Gaps = 65/343 (18%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
+ + + +G G++G V + A+K + ++ + + + +I E +L+ +++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKI--EADILKKIQN 90
Query: 172 PDIVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRG 228
D + +I+ + + D + ++FE + L+++I N+ E + + ++L+
Sbjct: 91 DD-INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 229 LKYIHTANVFHRDLKPKNIL-------------------------ANADCKLKICDFGLA 263
L Y+ ++ H DLKP+NIL +K+ DFG
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-- 207
Query: 264 RVSFNDAPSAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGK 318
A F +D + TR YRAPE + + + D+WS GC+ AE+ TG
Sbjct: 208 --------CATFKSDYHGSIINTRQYRAPEVILNL---GWDVSSDMWSFGCVLAELYTGS 256
Query: 319 PLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYL-------------GSMRKKQP 365
LF + L +M ++ + +Y+ S+ +
Sbjct: 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKH 316
Query: 366 VPFSHKFPNA--DPLALHLLERLLAFDPKDRPTAEEALADPYF 406
V L L +L DP RP+ E L +
Sbjct: 317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-61
Identities = 92/350 (26%), Positives = 140/350 (40%), Gaps = 57/350 (16%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
RY+I +G+G++G V +D G +VA+K I +V +A R+ EI +L+ ++
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARL--EINVLKKIK 74
Query: 171 HPDIVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 227
D +L F + + FEL+ + + +K N+ H + YQL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 228 GLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVSFN 268
L+++H + H DLKP+NIL + + +++ DFG
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG------- 187
Query: 269 DAPSAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323
SA F + VATR YR PE + + D+WSIGCI E G LF
Sbjct: 188 ---SATFDHEHHTTIVATRHYRPPEVILEL---GWAQPCDVWSIGCILFEYYRGFTLFQT 241
Query: 324 KNVVHQLDLMTDLLGTPSTESISRIRNEK------ARRYLGSMRKKQPVPFSHKFPNA-- 375
L +M +LG + I R R +K S + +
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301
Query: 376 -----DPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP 420
L+ R+L FDP R T EAL P+F GL +R T
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSR 351
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 6e-61
Identities = 83/364 (22%), Positives = 123/364 (33%), Gaps = 53/364 (14%)
Query: 79 PKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTG 138
Q +P T D K S+ E + G Y I + IG G V ++
Sbjct: 24 KFERQHMDSPDLGTDDDDKASSSANECISVKGR--IYSILKQIGSGGSSKVFQVLNE-KK 80
Query: 139 ERVAIKKINDVFEHVSDATRILREIKLLRLLRHP--DIVEIKHIMLPPSRREFKDIYVVF 196
+ AIK +N EI L L+ I+ + + + IY+V
Sbjct: 81 QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVM 135
Query: 197 ELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 256
E DL+ +K + P + + +L + IH + H DLKP N L D LK
Sbjct: 136 ECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLK 194
Query: 257 ICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSI 307
+ DFG+A +++ V Y PE G SK +P D+WS+
Sbjct: 195 LIDFGIAN-QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 308 GCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVP 367
GCI M GK F IS++ + +
Sbjct: 254 GCILYYMTYGKTPFQQI-----------------INQISKLHAI--------IDPNHEIE 288
Query: 368 FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFE 427
F + +L+ L DPK R + E LA PY + P Q E
Sbjct: 289 FP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV----QIQTHPVNQMAKGTTEE 341
Query: 428 FERR 431
+
Sbjct: 342 MKYV 345
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 5e-60
Identities = 74/334 (22%), Positives = 127/334 (38%), Gaps = 49/334 (14%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
+RY + +G G + V A D VA+K + + ++A EIKLL+ +
Sbjct: 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAED--EIKLLQRVND 74
Query: 172 PDIVEIKHIMLPPSRR-----EFKDIYV-----VFELMESDLHQVIKANDD--LTPEHYQ 219
D + + + K VFE++ +L +IK + + + +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 134
Query: 220 FFLYQLLRGLKYIHT-ANVFHRDLKPKNILAN------ADCKLKICDFGLARVSFNDAPS 272
QLL GL Y+H + H D+KP+N+L ++KI D G A
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-- 192
Query: 273 AIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV----- 326
T+ + TR YR+PE L G+ + DIWS C+ E++TG LF
Sbjct: 193 ----TNSIQTREYRSPEVLLGA---PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 327 -VHQLDLMTDLLGTPSTESISRIR----------NEKARRYLGSMRKKQPVPFSHKFPNA 375
+ + +LLG + + + + L + + +KF
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 376 DPLAL-HLLERLLAFDPKDRPTAEEALADPYFHG 408
+ + L +L DP+ R A + P+
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-59
Identities = 75/317 (23%), Positives = 118/317 (37%), Gaps = 56/317 (17%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
AS ++ V+G+G++G V A + AIKKI + IL E+ LL L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNH 61
Query: 172 PDIVEIKH--------IMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPE-HYQFF 221
+V + + ++ +++ E E L+ +I + + Y
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW----- 276
Q+L L YIH+ + HRDLKP NI + +KI DFGLA+
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 277 ------TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQL 330
T + T Y A E+ Y ID++S+G IF EM+ P G V+
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVN-- 236
Query: 331 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAF 389
++ L + + F F N + ++ L+
Sbjct: 237 -ILKKL-------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDH 270
Query: 390 DPKDRPTAEEALADPYF 406
DP RP A L +
Sbjct: 271 DPNKRPGARTLLNSGWL 287
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-58
Identities = 80/371 (21%), Positives = 125/371 (33%), Gaps = 68/371 (18%)
Query: 38 NNKKSNNINTSSSSSSHEGQHLQQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHK 97
++ S+ ++ + + + H Q P+R+ F + P
Sbjct: 4 HHHHSSGVDLGTENLYFQSMHQLQ-----------------PRRVSFRGEASETLQSPGY 46
Query: 98 KSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT 157
+ FF + +Q +G GSYG V G A+K+ F D
Sbjct: 47 DPSRPESFFQQ-----SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA 101
Query: 158 RILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE 216
R L E+ ++ +HP V ++ + E +Y+ EL L Q +A PE
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQ-----AWEEGGILYLQTELCGPSLQQHCEAWGASLPE 156
Query: 217 HY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275
+L L L ++H+ + H D+KP NI + K+ DFGL +
Sbjct: 157 AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ 216
Query: 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTD 335
Y APEL Y A D++S+G E+ L G QL
Sbjct: 217 ----EGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL----- 264
Query: 336 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP 395
+ P F+ + +L +L DPK R
Sbjct: 265 ------------------------RQGYLPPEFTAGLSSE---LRSVLVMMLEPDPKLRA 297
Query: 396 TAEEALADPYF 406
TAE LA P
Sbjct: 298 TAEALLALPVL 308
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 5e-58
Identities = 80/351 (22%), Positives = 140/351 (39%), Gaps = 48/351 (13%)
Query: 96 HKKSALETEFFTEYGEA-SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS 154
H S ++ Y ++ +Y + IG+GS+G T G + IK+IN +S
Sbjct: 6 HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN--ISRMS 63
Query: 155 DATR--ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIK-AN 210
R RE+ +L ++HP+IV+ + S E +Y+V + E DL + I
Sbjct: 64 SKEREESRREVAVLANMKHPNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKRINAQK 118
Query: 211 DDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269
L E + Q+ LK++H + HRD+K +NI D +++ DFG+ARV +
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178
Query: 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQ 329
A + T +Y +PE+C + Y DIW++GC+ E+ T K F +
Sbjct: 179 VELA---RACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGS---- 229
Query: 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAF 389
M +L + +I + + +S+ + L+ +L
Sbjct: 230 ---MKNL--------VLKIISGSFPPV--------SLHYSYDLRS-------LVSQLFKR 263
Query: 390 DPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVRE 440
+P+DRP+ L + P F + +
Sbjct: 264 NPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKR 314
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-57
Identities = 62/308 (20%), Positives = 120/308 (38%), Gaps = 26/308 (8%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ + +++G+G+ V TG+ AIK N++ + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKN 68
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGL 229
IV++ I + R ++ E L+ V++ L + L ++ G+
Sbjct: 69 IVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 230 KYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
++ + HR++KP NI+ + K+ DFG AR +D + T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEY 181
Query: 286 RAPEL------CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF-PGKNVVHQLDLMTDLLG 338
P++ KY +D+WSIG F TG F P + ++M ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
+ +IS ++ + S S L +L +L D + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 399 EALADPYF 406
+ A+
Sbjct: 299 QFFAETSD 306
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-57
Identities = 69/327 (21%), Positives = 121/327 (37%), Gaps = 55/327 (16%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+ ++ + +G+G +GVV A + AIK+I + +++RE+K L L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 63
Query: 173 DIVEIKH-------IMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQF---F 221
IV + +Y+ +L +L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV---------SFNDAPS 272
Q+ ++++H+ + HRDLKP NI D +K+ DFGL P+
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332
T V T+ Y +PE + Y+ +DI+S+G I E+L P V
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY--PFSTQMERV----- 234
Query: 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPK 392
+++ +RN K F F P +++ +L+ P
Sbjct: 235 ----------RTLTDVRNLK---------------FPPLFTQKYPCEYVMVQDMLSPSPM 269
Query: 393 DRPTAEEALADPYFHGLANVDREPSTQ 419
+RP A + + F L + Q
Sbjct: 270 ERPEAINIIENAVFEDLDFPGKTVLRQ 296
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 3e-57
Identities = 87/305 (28%), Positives = 134/305 (43%), Gaps = 49/305 (16%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN------DVFEHVSDATRILREIKLLR 167
Y + + +G G+ G V A + T ++VAI+ I+ A + EI++L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 226
L HP I++IK+ + +D Y+V ELME +L + N L + + YQ+L
Sbjct: 196 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 227 RGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
++Y+H + HRDLKP+N+L DC +KI DFG +++ + T
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTP 305
Query: 284 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 354
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+ I + +Y F + AL L+++LL DPK R T EEAL
Sbjct: 355 DQI------TSGKY----------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398
Query: 402 ADPYF 406
P+
Sbjct: 399 RHPWL 403
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 2e-56
Identities = 83/308 (26%), Positives = 129/308 (41%), Gaps = 52/308 (16%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRL 168
A Y++ IG GSYG G+ + K+++ + +++A + ++ E+ LLR
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRE 61
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKA---NDDLTPEHY-QFFLY 223
L+HP+IV ++ R +Y+V E E DL VI E + +
Sbjct: 62 LKHPNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 224 QLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 278
QL LK H + V HRDLKP N+ + +K+ DFGLAR+ +D A
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KT 175
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338
+V T +Y +PE Y DIWS+GC+ E+ P F + +L
Sbjct: 176 FVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFS-------QKEL-- 224
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
+IR K RR P +S + ++ R+L RP+ E
Sbjct: 225 ------AGKIREGKFRRI--------PYRYSDELNE-------IITRMLNLKDYHRPSVE 263
Query: 399 EALADPYF 406
E L +P
Sbjct: 264 EILENPLI 271
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 4e-56
Identities = 91/341 (26%), Positives = 139/341 (40%), Gaps = 55/341 (16%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN------DVFEHVSDATRILREIKLLR 167
Y + + +G G+ G V A + T ++VAIK I+ A + EI++L+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 226
L HP I++IK+ + +D Y+V ELME +L + N L + + YQ+L
Sbjct: 71 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 227 RGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
++Y+H + HRDLKP+N+L DC +KI DFG +++ + T
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETS---LMRTLCGTP 180
Query: 284 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------------ 228
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+I + K F + AL L+++LL DPK R T EEAL
Sbjct: 229 --KDQITSGK-------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273
Query: 402 ADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMI 442
P+ E + L E + +
Sbjct: 274 RHPWLQD------EDMKRKFQDLLSEENESTALPQVLAQPS 308
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 4e-56
Identities = 71/310 (22%), Positives = 111/310 (35%), Gaps = 63/310 (20%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
++ E+IG G +G V A G+ IK++ + + RE+K L L H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDH 63
Query: 172 PDIVEIKH-----------IMLPPSRREFKDIYVVFELMES-DLHQVIK-ANDDLTPEHY 218
+IV SR + K +++ E + L Q I+ + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 219 -QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT 277
Q+ +G+ YIH+ + +RDLKP NI ++KI DFGL ND
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-- 181
Query: 278 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDL 336
T Y +PE S Y +D++++G I AE+L F
Sbjct: 182 --KGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSKF---------- 227
Query: 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
+ +R F K LL++LL+ P+DRP
Sbjct: 228 --------FTDLR-----------DGIISDIFDKKEKT-------LLQKLLSKKPEDRPN 261
Query: 397 AEEALADPYF 406
E L
Sbjct: 262 TSEILRTLTV 271
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 6e-55
Identities = 71/364 (19%), Positives = 138/364 (37%), Gaps = 29/364 (7%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ + +++G+G+ V TG+ AIK N++ + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKN 68
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGL 229
IV++ I + R ++ E L+ V++ L + L ++ G+
Sbjct: 69 IVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 230 KYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
++ + HR++KP NI+ + K+ DFG AR +D + T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEY 181
Query: 286 RAPEL------CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF-PGKNVVHQLDLMTDLLG 338
P++ KY +D+WSIG F TG F P + ++M ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE 398
+ +IS ++ + S S L +L +L D + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 399 EALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYL 458
+ A+ V S Q ++ + A E++Y++ + QE +
Sbjct: 299 QFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTAT-IFHELVYKQT-KIISSN-QELI 355
Query: 459 RGGE 462
G
Sbjct: 356 YEGR 359
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 3e-54
Identities = 80/328 (24%), Positives = 134/328 (40%), Gaps = 53/328 (16%)
Query: 88 PTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN 147
P + AL + Y + ++I++ IG+G + V A G VA+KK+
Sbjct: 9 QGPPVPQFQPQKALRPD--MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ 66
Query: 148 DVFEHVSDATR--ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLH 204
+F+ + R ++EI LL+ L HP++++ S E ++ +V EL ++ DL
Sbjct: 67 -IFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA-----SFIEDNELNIVLELADAGDLS 120
Query: 205 QVIKA---NDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260
++IK L PE + QL L+++H+ V HRD+KP N+ A +K+ D
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDL 180
Query: 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 320
GL R + +A V T +Y +PE + Y DIWS+GC+ EM +
Sbjct: 181 GLGRFFSSKTTAA---HSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSP 235
Query: 321 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVP---FSHKFPNADP 377
F G ++ L +I P+P +S +
Sbjct: 236 FYGDK-MNLYSLC------------KKIEQCDY----------PPLPSDHYSEELRQ--- 269
Query: 378 LALHLLERLLAFDPKDRPTAEEALADPY 405
L+ + DP+ RP
Sbjct: 270 ----LVNMCINPDPEKRPDVTYVYDVAK 293
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-53
Identities = 89/374 (23%), Positives = 139/374 (37%), Gaps = 61/374 (16%)
Query: 79 PKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTG 138
P + P P + E + RY +GKG + D T
Sbjct: 7 PGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTK 66
Query: 139 ERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 197
E A K + + ++ EI + R L H +V ++VV E
Sbjct: 67 EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-----VFVVLE 121
Query: 198 LMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 256
L L ++ K LT +++L Q++ G +Y+H V HRDLK N+ N D ++K
Sbjct: 122 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVK 181
Query: 257 ICDFGLARVSFNDAPSAIFWT-----DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 311
I DFGLA + + +Y+ APE+ ++ +D+WSIGCI
Sbjct: 182 IGDFGLA--TKVEYDGERKKVLCGTPNYI------APEVLSK--KGHSFEVDVWSIGCIM 231
Query: 312 AEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHK 371
+L GKP F + E+ RI+ Y P +
Sbjct: 232 YTLLVGKPPFETSCL---------------KETYLRIKK---NEY------SIPKHIN-- 265
Query: 372 FPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLE----FE 427
P+A L++++L DP RPT E L D +F P+ PI+ L F
Sbjct: 266 -----PVAASLIQKMLQTDPTARPTINELLNDEFF----TSGYIPARLPITCLTIPPRFS 316
Query: 428 FERRKLAKDDVREM 441
L + + +
Sbjct: 317 IAPSSLDPSNRKPL 330
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-52
Identities = 83/319 (26%), Positives = 127/319 (39%), Gaps = 57/319 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
RY +GKG + D T E A K + + ++ EI + R L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+V ++VV EL L ++ K LT +++L Q++ G +Y
Sbjct: 76 HVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-----DYVATRWYR 286
+H V HRDLK N+ N D ++KI DFGLA + + +Y+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKVLCGTPNYI------ 182
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
APE+ ++ +D+WSIGCI +L GKP F + E+
Sbjct: 183 APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------------KETYL 225
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
RI+ Y P + P+A L++++L DP RPT E L D +F
Sbjct: 226 RIKK---NEY------SIPKHIN-------PVAASLIQKMLQTDPTARPTINELLNDEFF 269
Query: 407 HGLANVDREPSTQPISKLE 425
P+ PI+ L
Sbjct: 270 ----TSGYIPARLPITCLT 284
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-51
Identities = 83/365 (22%), Positives = 134/365 (36%), Gaps = 84/365 (23%)
Query: 93 MDPHKKSALETEFFTEYGEA---SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-- 147
H S E +F +Y ++ IG+GSYGVV A++ T AIK +N
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 148 -DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQ 205
+ D RI E++L++ L HP+I + + + + I +V EL L
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----EDEQYICLVMELCHGGHLLD 117
Query: 206 VIKANDDLTPEHYQF----------------------------------------FLYQL 225
+ D + + Q+
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177
Query: 226 LRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIF-WTDYVAT 282
L Y+H + HRD+KP+N L N ++K+ DFGL++ + + T T
Sbjct: 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
++ APE+ + Y P D WS G + +L G FPG N
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVN---------------DA 282
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEAL 401
++IS++ + + F + + PLA LL LL + +R A AL
Sbjct: 283 DTISQV-------------LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329
Query: 402 ADPYF 406
P+
Sbjct: 330 QHPWI 334
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-51
Identities = 65/303 (21%), Positives = 110/303 (36%), Gaps = 43/303 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
Y + +G+G + V H G A+K+I D RE + RL HP+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNHPN 87
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRG 228
I+ + L + + +++ + L I+ + LT + + L + RG
Sbjct: 88 ILRLVAYCLRERGAKHE-AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA------IFWTDYVAT 282
L+ IH HRDLKP NIL + + + D G + + W T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 283 RWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
YRAPEL D+WS+GC+ M+ G+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF--------------QK 252
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+S++ ++ + +P S + +A LL ++ DP RP L
Sbjct: 253 GDSVALA-----------VQNQLSIPQSPRHSSA---LWQLLNSMMTVDPHQRPHIPLLL 298
Query: 402 ADP 404
+
Sbjct: 299 SQL 301
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 3e-51
Identities = 91/320 (28%), Positives = 136/320 (42%), Gaps = 53/320 (16%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
RY I ++GKGS+G V D T + A+K IN D + ILRE++LL+ L HP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 173 DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 228
+I+++ I +D Y+V EL +L I + + Q+ G
Sbjct: 82 NIMKLFEI--------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 229 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
+ Y+H N+ HRDLKP+NIL DC +KI DFGL+ + D + T +Y
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK----MKDRIGTAYY 189
Query: 286 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
APE L G Y D+WS G I +L+G P F GKN +
Sbjct: 190 IAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN---------------EYDI 230
Query: 345 ISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+ R+ + F ++ A L+ ++L F P R TA + L
Sbjct: 231 LKRV-------------ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277
Query: 404 PYFHGLANVDREPSTQPISK 423
P+ ++ S P +
Sbjct: 278 PWIQKYSSETPTISDLPSLE 297
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-51
Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 42/299 (14%)
Query: 113 SRY-QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
R+ + IG+GS+ V +DT T VA ++ D S+ R E ++L+ L+H
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH 84
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
P+IV + + K I +V ELM S L +K + + + + Q+L+GL+
Sbjct: 85 PNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 231 YIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
++HT + HRDLK NI +KI D GLA + A+ T + A
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE----FM-A 198
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
PE+ KY ++D+++ G EM T + + Q+
Sbjct: 199 PEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------------- 238
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
Y +P F A P ++E + + +R + ++ L +F
Sbjct: 239 --------YRRVTSGVKPASFDK---VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 6e-51
Identities = 90/336 (26%), Positives = 141/336 (41%), Gaps = 56/336 (16%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
YQ + +G G+YG V D T AIK I S +++L E+ +L+LL HP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 173 DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 228
+I+++ F+D Y+V E + +L I + Q+L G
Sbjct: 97 NIMKLYDF--------FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 229 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
+ Y+H N+ HRDLKP+N+L D +KI DFGL+ V N + + T +Y
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK----MKERLGTAYY 204
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ KY D+WSIG I +L G P F G+ E +
Sbjct: 205 IAPEV---LRKKYDEKCDVWSIGVILFILLAGYPPFGGQT---------------DQEIL 246
Query: 346 SRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
++ K F S ++ N A L++++L FD + R +A++AL P
Sbjct: 247 RKVEKGK-------------YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293
Query: 405 YFHGLANVDREPSTQPISKLEFE-----FERRKLAK 435
+ + + P E +KLA+
Sbjct: 294 WIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQ 329
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 6e-51
Identities = 80/321 (24%), Positives = 134/321 (41%), Gaps = 52/321 (16%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRH 171
RY+ Q V+GKGS+G V D TG+ A+K I+ + +D +LRE++LL+ L H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 172 PDIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR 227
P+I+++ F+D Y+V E+ +L I + + + Q+L
Sbjct: 86 PNIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 228 GLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
G+ Y+H + HRDLKP+N+L + D ++I DFGL+ D + T +
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK----MKDKIGTAY 193
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
Y APE+ Y D+WS G I +L+G P F G N +
Sbjct: 194 YIAPEV---LHGTYDEKCDVWSTGVILYILLSGCPPFNGAN---------------EYDI 235
Query: 345 ISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+ ++ +K F ++ A L+ ++L + P R +A +AL
Sbjct: 236 LKKV-------------EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282
Query: 404 PYFHGLANVDREPSTQPISKL 424
+ +
Sbjct: 283 EWIQTYTKEQISVDVPSLDNA 303
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-50
Identities = 80/399 (20%), Positives = 140/399 (35%), Gaps = 93/399 (23%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR-LLRH 171
+ ++++G GS G V + G VA+K++ + L EIKLL H
Sbjct: 15 NLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRML-----IDFCDIALMEIKLLTESDDH 68
Query: 172 PDIVEIKHIMLPPSRREFKD---IYVVFELMESDLHQVIKANDDLTPEHYQF-------F 221
P+++ +Y+ EL +L ++++ +
Sbjct: 69 PNVIRYYCS--------ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNIL-------------ANADCKLKICDFGLAR-VSF 267
L Q+ G+ ++H+ + HRDLKP+NIL + ++ I DFGL + +
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 268 NDAPSAIFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLF 321
+ + T +RAPEL + T +IDI+S+GC+F +L+ GK F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH 381
K S I + A
Sbjct: 241 GDKY-----------------SRESNIIRGI---------FSLDEMKCLHDRSLIAEATD 274
Query: 382 LLERLLAFDPKDRPTAEEALADPYFHGLA--------------NVDREPSTQPISKLEFE 427
L+ +++ DP RPTA + L P F + +R+P + + K +
Sbjct: 275 LISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFD-A 333
Query: 428 FERRKLAKDDVREMIYREILE-------YHPQMLQEYLR 459
+ D + ++ YH L + LR
Sbjct: 334 GSDFVIPSGDWTVKFDKTFMDNLERYRKYHSSKLMDLLR 372
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 8e-50
Identities = 73/367 (19%), Positives = 127/367 (34%), Gaps = 104/367 (28%)
Query: 112 ASR----YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR 167
ASR ++ + +G+G +GVV A + AIK+I + +++RE+K L
Sbjct: 1 ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIR-LPNRELAREKVMREVKALA 59
Query: 168 LLRHPDIVEIKH------------------------------------------------ 179
L HP IV +
Sbjct: 60 KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119
Query: 180 ----IMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQ---FFLYQLLRGLKY 231
+ +Y+ +L +L + L + Q+ +++
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND---------APSAIFWTDYVAT 282
+H+ + HRDLKP NI D +K+ DFGL D P+ T V T
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
+ Y +PE + Y+ +DI+S+G I E+L V +
Sbjct: 240 KLYMSPEQIHG--NNYSHKVDIFSLGLILFELLY--SFSTQMERVRII------------ 283
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
+ +RN K P+ F+ K+P +++ +L+ P +RP A + +
Sbjct: 284 ---TDVRNLKF-----------PLLFTQKYPQ----EHMMVQDMLSPSPTERPEATDIIE 325
Query: 403 DPYFHGL 409
+ F L
Sbjct: 326 NAIFENL 332
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-49
Identities = 87/332 (26%), Positives = 129/332 (38%), Gaps = 64/332 (19%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-----------DVFEHVSDATRILR 161
Y +G G+YG V + + AIK I D I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 162 EIKLLRLLRHPDIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEH 217
EI LL+ L HP+I+++ + F+D Y+V E E +L + I
Sbjct: 96 EISLLKSLDHPNIIKLFDV--------FEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 218 YQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAI 274
+ Q+L G+ Y+H N+ HRD+KP+NIL N+ +KI DFGL+ D
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--- 204
Query: 275 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 333
D + T +Y APE L KY D+WS G I +L G P F G+N
Sbjct: 205 -LRDRLGTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPPFGGQND------- 252
Query: 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPK 392
+ I ++ K F + + N A L++ +L +D
Sbjct: 253 --------QDIIKKVEKGK-------------YYFDFNDWKNISDEAKELIKLMLTYDYN 291
Query: 393 DRPTAEEALADPYFHGLANVDREPSTQPISKL 424
R TAEEAL + AN + + +
Sbjct: 292 KRCTAEEALNSRWIKKYANNINKSDQKTLCGA 323
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-49
Identities = 95/358 (26%), Positives = 151/358 (42%), Gaps = 49/358 (13%)
Query: 87 APTPATMDPHKKSALETEFFTEYGE--ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIK 144
P A+M ++ +EF + Y ++E +GKG++ VV V TG A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 145 KINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDL 203
IN D ++ RE ++ R L+HP+IV + + +E Y+VF+L+ +L
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGEL 115
Query: 204 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDF 260
+ I A + + + Q+L + Y H+ + HR+LKP+N+L +K+ DF
Sbjct: 116 FEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 175
Query: 261 GLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 319
GLA ND+ W + T Y +PE L Y+ +DIW+ G I +L G P
Sbjct: 176 GLAIE-VNDSE---AWHGFAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYP 228
Query: 320 LFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPL 378
F ++ Q L I K + S ++ P
Sbjct: 229 PFWDED---QHRLY---------AQI----------------KAGAYDYPSPEWDTVTPE 260
Query: 379 ALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE-RRKLAK 435
A L++ +L +PK R TA++AL P+ V Q +F RRKL
Sbjct: 261 AKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKG 318
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-48
Identities = 86/319 (26%), Positives = 139/319 (43%), Gaps = 51/319 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
Y ++E +GKG++ VV V TG A K IN D ++ RE ++ R L+HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+IV + + +E Y+VF+L+ +L + I A + + + Q+L + Y
Sbjct: 66 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 232 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
H+ + HR+LKP+N+L +K+ DFGLA ND+ W + T Y +P
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWHGFAGTPGYLSP 176
Query: 289 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
E L Y+ +DIW+ G I +L G P F ++ Q L I
Sbjct: 177 EVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLY---------AQI-- 219
Query: 348 IRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
K + S ++ P A L++ +L +PK R TA++AL P+
Sbjct: 220 --------------KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
Query: 407 HGLANVDREPSTQPISKLE 425
+RE I + +
Sbjct: 266 -----CNRERVASAIHRQD 279
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-48
Identities = 86/302 (28%), Positives = 123/302 (40%), Gaps = 49/302 (16%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
Y ++ IG+GS+G V AV T R A KKI V D R +EI++++ L HP
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHP 66
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+I+ + + DIY+V EL +L + + + +L + Y
Sbjct: 67 NIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 232 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
H NV HRDLKP+N L + D LK+ DFGLA F V T +Y +P
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR-FKPGK---MMRTKVGTPYYVSP 177
Query: 289 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
+ L G Y P D WS G + +L G P F ++M I
Sbjct: 178 QVLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVM---------LKI-- 219
Query: 348 IRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
++ F + N P A L+ RLL PK R T+ +AL +F
Sbjct: 220 --------------REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265
Query: 407 HG 408
Sbjct: 266 EK 267
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-48
Identities = 74/317 (23%), Positives = 127/317 (40%), Gaps = 59/317 (18%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRH 171
++I +GKG +G V A + + +A+K + E ++ RE+++ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
P+I+ + +R +Y++ E +++ ++ + ++ +L L
Sbjct: 69 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-----DYVATRWY 285
Y H+ V HRD+KP+N+L + +LKI DFG + APS+ DY+
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYL----- 174
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
PE+ + +D+WS+G + E L GKP F E+
Sbjct: 175 -PPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---------------ETY 216
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADP 404
RI + FP+ A L+ RLL +P RP E L P
Sbjct: 217 KRISRVE-----------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259
Query: 405 YFHGLANVDREPSTQPI 421
+ AN + + Q
Sbjct: 260 WI--TANSSKPSNCQNK 274
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-48
Identities = 78/360 (21%), Positives = 142/360 (39%), Gaps = 70/360 (19%)
Query: 93 MDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----D 148
M+P K+ +E Y I E +G G + +V + TG A K I
Sbjct: 2 MEPFKQQKVE----------DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSR 51
Query: 149 VFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLH 204
I RE+ +LR + H +++ + + +++ + ++ EL+ +L
Sbjct: 52 ASRRGVSREEIEREVSILRQVLHHNVITLHDV--------YENRTDVVLILELVSGGELF 103
Query: 205 QVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDF 260
+ + L+ E F+ Q+L G+ Y+HT + H DLKP+NI+ +K+ DF
Sbjct: 104 DFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163
Query: 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 320
GLA + + + T + APE+ + D+WSIG I +L+G
Sbjct: 164 GLAHEIEDGVE----FKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASP 217
Query: 321 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLA 379
F G + + + +I+ + + F + F + LA
Sbjct: 218 FLGDT---KQETL---------ANITSVSYD----------------FDEEFFSHTSELA 249
Query: 380 LHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLE----FEFERRKLAK 435
+ +LL + + R T +EAL P+ + N + + LE + RR+
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQ-YVRRRWKL 308
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-48
Identities = 91/324 (28%), Positives = 141/324 (43%), Gaps = 47/324 (14%)
Query: 96 HKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD 155
H S+ + + A RY I ++GKGS+G V D T + A+K IN D
Sbjct: 5 HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64
Query: 156 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLT 214
+ ILRE++LL+ L HP+I+++ I+ + Y+V EL +L I +
Sbjct: 65 TSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFS 119
Query: 215 PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAP 271
+ Q+ G+ Y+H N+ HRDLKP+NIL DC +KI DFGL+ +
Sbjct: 120 EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178
Query: 272 SAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQL 330
D + T +Y APE L G Y D+WS G I +L+G P F GKN +
Sbjct: 179 ---KMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN---EY 228
Query: 331 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAF 389
D++ + + + F + A L+ ++L F
Sbjct: 229 DIL---------KRV----------------ETGKYAFDLPQWRTISDDAKDLIRKMLTF 263
Query: 390 DPKDRPTAEEALADPYFHGLANVD 413
P R TA + L P+ ++ +
Sbjct: 264 HPSLRITATQCLEHPWIQKYSSEE 287
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-48
Identities = 71/343 (20%), Positives = 130/343 (37%), Gaps = 22/343 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
++++E +G G +G V + TGE+VAIK+ + R EI++++ L HP+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPN 73
Query: 174 IVEIKHIMLPPSRREFKD-IYVVFELMES-DLHQVIKANDD---LTPEHYQFFLYQLLRG 228
+V + + + D + E E DL + + ++ L + L +
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 229 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
L+Y+H + HRDLKP+NI+ KI D G A+ T++V T Y
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----LCTEFVGTLQY 189
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APEL KYT +D WS G + E +TG F Q + +
Sbjct: 190 LAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR-EKSNEHIVV 246
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+ P P +H L+ +L + + R T +
Sbjct: 247 YDDLTGAVKF-----SSVLPTP-NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
Query: 406 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILE 448
F L ++ ++ + + +++ + + + +
Sbjct: 301 FQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQ 343
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 4e-48
Identities = 77/318 (24%), Positives = 129/318 (40%), Gaps = 51/318 (16%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-------DVFEHVSDATRILREIKL 165
Y+ +E++G+G VV + T + A+K I+ E L+E+ +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 166 LRLL-RHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLY 223
LR + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 77 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
LL + +H N+ HRDLKP+NIL + D +K+ DFG + + + T
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGE---KLREVCGTP 187
Query: 284 WYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339
Y APE + S Y +D+WS G I +L G P F + Q+ ++
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLML------ 238
Query: 340 PSTESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAE 398
I F S ++ + L+ R L P+ R TAE
Sbjct: 239 ---RMI----------------MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 279
Query: 399 EALADPYFHGLANVDREP 416
EALA P+F +
Sbjct: 280 EALAHPFFQQYVVEEVRH 297
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 9e-48
Identities = 80/349 (22%), Positives = 142/349 (40%), Gaps = 61/349 (17%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRL 168
Y E +G G + VV + TG + A K I I RE+ +L+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 169 LRHPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 224
++HP+++ + + +++ + ++ EL+ +L + + LT E FL Q
Sbjct: 71 IQHPNVITLHEV--------YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 225 LLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
+L G+ Y+H+ + H DLKP+NI+ ++KI DFGLA + +
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIF 178
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
T + APE+ + D+WSIG I +L+G F G + + +
Sbjct: 179 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL------- 226
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEE 399
++S + E F + F N LA + RLL DPK R T ++
Sbjct: 227 --ANVSAVNYE----------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268
Query: 400 ALADPYFHGL---ANVDREPSTQPISKLEFEFERRK---LAKDDVREMI 442
+L P+ + R+ S + K + R+K + + ++
Sbjct: 269 SLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGSGGGLNDIF 317
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-47
Identities = 72/302 (23%), Positives = 133/302 (44%), Gaps = 56/302 (18%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
+++ ++GKGS+ V A HTG VAIK I+ R+ E+K+ L+HP
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLK 230
I+E+ + + +Y+V E+ + ++++ +K + + F++Q++ G+
Sbjct: 72 SILELYNYFEDSNY-----VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-----DYVATRWY 285
Y+H+ + HRDL N+L + +KI DFGLA + P +T +Y+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYTLCGTPNYI----- 179
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
+PE+ S + D+WS+GC+F +L G+P F V ++
Sbjct: 180 -SPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTV---------------KNTL 221
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADP 404
+++ Y + P+ A L+ +LL +P DR + L P
Sbjct: 222 NKV---VLADY--------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264
Query: 405 YF 406
+
Sbjct: 265 FM 266
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-47
Identities = 72/317 (22%), Positives = 120/317 (37%), Gaps = 57/317 (17%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRH 171
+ I +GKG +G V A + +A+K + E ++ REI++ LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
P+I+ + + R IY++ E +L++ ++ + + F+ +L L
Sbjct: 74 PNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-----DYVATRWY 285
Y H V HRD+KP+N+L +LKI DFG + APS T DY+
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRTMCGTLDYL----- 179
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
PE+ + +D+W G + E L G P F + E+
Sbjct: 180 -PPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---------------ETH 221
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPN-ADPLALHLLERLLAFDPKDRPTAEEALADP 404
RI N + FP + L+ +LL + P R + + P
Sbjct: 222 RRIVNVDLK-----------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264
Query: 405 YFHGLANVDREPSTQPI 421
+ + P Q
Sbjct: 265 WVKANSRRVLPPVYQST 281
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-47
Identities = 78/385 (20%), Positives = 146/385 (37%), Gaps = 59/385 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRL 168
Y I E +G G + +V + TG A K I I RE+ +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 227
+ HP+I+ + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 228 GLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
G+ Y+HT + H DLKP+NI+ +K+ DFGLA + + + T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIFGTP 182
Query: 284 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
+ APE+ + D+WSIG I +L+G F G + + +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL---------A 228
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALA 402
+I+ + + F + F LA + +LL + + R T +EAL
Sbjct: 229 NITAVSYD----------------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 403 DPYFHGL---ANVDREPSTQPISKLEFEFERRKLAK-----DDVREMIYREILEYHPQML 454
P+ + + R S + + ++ RR+ + + + H +
Sbjct: 273 HPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHLTRSLMKKVHLRTS 332
Query: 455 QEYLRG--GEQTSFMYPSGVDRFKR 477
++ + + + +R
Sbjct: 333 EDLRNCESDTEENIARRKALHPRRR 357
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 4e-47
Identities = 75/318 (23%), Positives = 131/318 (41%), Gaps = 55/318 (17%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRL 168
Y++ E +G G + +V TG+ A K I I RE+ +LR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 169 LRHPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 224
+RHP+I+ + I F++ + ++ EL+ +L + + LT + FL Q
Sbjct: 65 IRHPNIITLHDI--------FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ 116
Query: 225 LLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
+L G+ Y+H+ + H DLKP+NI+ + ++K+ DFG+A + +
Sbjct: 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIF 172
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
T + APE+ + D+WSIG I +L+G F G+ + + +
Sbjct: 173 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGET---KQETL------- 220
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEE 399
+IS + + F + F N LA + RLL DPK R T +
Sbjct: 221 --TNISAVNYD----------------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQ 262
Query: 400 ALADPYFHGLANVDREPS 417
+L + + +
Sbjct: 263 SLEHSWIKAIRRRNVRGE 280
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 70/319 (21%), Positives = 134/319 (42%), Gaps = 62/319 (19%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN------------------------DV 149
+Y +++ IGKGSYGVV A + + A+K ++
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 150 FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIK 208
+ ++ +EI +L+ L HP++V++ ++ P+ +Y+VFEL+ + +V
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVMEVPT 130
Query: 209 ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
L+ + +F+ L++G++Y+H + HRD+KP N+L D +KI DFG++
Sbjct: 131 -LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF-- 187
Query: 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVV 327
A+ V T + APE ++ A+D+W++G + G+ F +
Sbjct: 188 KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-- 244
Query: 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLL 387
+ L S+I+++ P P+ L+ R+L
Sbjct: 245 -----IMCLH--------SKIKSQALE-----------FP---DQPDIAEDLKDLITRML 277
Query: 388 AFDPKDRPTAEEALADPYF 406
+P+ R E P+
Sbjct: 278 DKNPESRIVVPEIKLHPWV 296
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-46
Identities = 59/319 (18%), Positives = 99/319 (31%), Gaps = 71/319 (22%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL-RLLR 170
+ + E IG G +G V V G AIK+ D LRE+ L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLT---PEHY-QFFLYQL 225
H +V + E + + E L I N + E + L Q+
Sbjct: 70 HSHVVRYFS-----AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 226 LRGLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVS 266
RGL+YIH+ ++ H D+KP NI A+ KI D G
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-R 183
Query: 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV 326
+ + A E+ ++ + P DI+++ +PL +
Sbjct: 184 ISSPQV------EEGDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQ 236
Query: 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 386
H++ R+ + LL+ +
Sbjct: 237 WHEI------------------------------RQGRLPRIPQVLS---QEFTELLKVM 263
Query: 387 LAFDPKDRPTAEEALADPY 405
+ DP+ RP+A +
Sbjct: 264 IHPDPERRPSAMALVKHSV 282
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-46
Identities = 76/321 (23%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 96 HKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD 155
H S+ + + + + +G G++G V + +G IK IN
Sbjct: 5 HHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD-RSQVP 63
Query: 156 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLT 214
+I EI++L+ L HP+I++I + ++ ++Y+V E E +L + I +
Sbjct: 64 MEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQA-R 117
Query: 215 PEHY-----QFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVS 266
+ + Q++ L Y H+ +V H+DLKP+NIL + +KI DFGLA +
Sbjct: 118 GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177
Query: 267 FNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
+D T+ T Y APE T DIWS G + +LTG F G +
Sbjct: 178 KSDE----HSTNAAGTALYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229
Query: 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLER 385
++ + + ++ + P A+ LL++
Sbjct: 230 ---LEEVQ---------QKA----------------TYKEPNYAVECRPLTPQAVDLLKQ 261
Query: 386 LLAFDPKDRPTAEEALADPYF 406
+L DP+ RP+A + L +F
Sbjct: 262 MLTKDPERRPSAAQVLHHEWF 282
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-46
Identities = 88/351 (25%), Positives = 139/351 (39%), Gaps = 46/351 (13%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
YQ+ E +GKG++ VV V G+ A IN D ++ RE ++ RLL+HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+IV + + E Y++F+L+ +L + I A + + + Q+L + +
Sbjct: 71 NIVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 232 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
H V HR+LKP+N+L +K+ DFGLA + W + T Y +P
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQA-WFGFAGTPGYLSP 182
Query: 289 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
E L Y +D+W+ G I +L G P F ++ Q L + I
Sbjct: 183 EVLRK---DPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLY---------QQI-- 225
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
K F P A L+ ++L +P R TA EAL P+
Sbjct: 226 --------------KAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271
Query: 407 HGLANVDREPSTQPISKLEFEFE-RRKLAKDDVREMIYREILEYHPQMLQE 456
+ V Q +F RRKL + M+ Q + +
Sbjct: 272 SHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLATRNFSVRKQEIIK 322
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-46
Identities = 56/343 (16%), Positives = 115/343 (33%), Gaps = 64/343 (18%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN---------------DVFEHVSDATR 158
Y+I + +G + + + A+KK D S
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 159 ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEH 217
E++++ +++ + + I+ ++Y+++E ME+ + + + L +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 218 YQ--------FFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
+ +L YIH N+ HRD+KP NIL + + ++K+ DFG +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES----E 200
Query: 269 DAPSAIFWT-----DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323
+++ PE + S +DIWS+G M F
Sbjct: 201 YMVDKKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
Query: 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKAR---RYLGSMRKKQPVPFSHKFPNADPLAL 380
K + +L + IR + + + +
Sbjct: 255 KISLVEL--------------FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI 300
Query: 381 HLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISK 423
L+ L +P +R T+E+AL + D ++ + K
Sbjct: 301 DFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 89/363 (24%), Positives = 156/363 (42%), Gaps = 68/363 (18%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
Y++ + IGKG++ V A TG VAIK I+ + + ++ RE++++++L HP+
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
IV++ ++ K +Y++ E ++ + A+ + + + Q++ ++Y
Sbjct: 76 IVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW-----YRA 287
H + HRDLK +N+L +AD +KI DFG S F + Y A
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGF---------SNEFTVGGKLDAFCGAPPYAA 181
Query: 288 PELCGSFFS--KYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
PEL F KY P +D+WS+G I +++G F G+N + +L
Sbjct: 182 PEL----FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------LKELR------- 223
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
R+ +R K +PF + + D +LL+R L +P R T E+ + D
Sbjct: 224 -ERV-----------LRGKYRIPF---YMSTD--CENLLKRFLVLNPIKRGTLEQIMKDR 266
Query: 405 YFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQT 464
+ N E +L+ E D R I + Y + +QE L +
Sbjct: 267 WI----NAGHEE-----DELKPFVEPELDISDQKRIDIMVG-MGYSQEEIQESLSKMKYD 316
Query: 465 SFM 467
Sbjct: 317 EIT 319
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-45
Identities = 84/339 (24%), Positives = 130/339 (38%), Gaps = 51/339 (15%)
Query: 87 APTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI 146
+ + LE ++ E + V+GKG+YG+V + D R+AIK+I
Sbjct: 1 SMRSTEEGDCESDLLEYDY-----EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI 55
Query: 147 NDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQ 205
+ + EI L + L+H +IV+ S E I + E + L
Sbjct: 56 P--ERDSRYSQPLHEEIALHKHLKHKNIVQYLG-----SFSENGFIKIFMEQVPGGSLSA 108
Query: 206 VIKANDDLTPE---HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFG 261
++++ + F+ Q+L GLKY+H + HRD+K N+L N LKI DFG
Sbjct: 109 LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFG 168
Query: 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321
++ P + T Y APE+ Y A DIWS+GC EM TGKP
Sbjct: 169 TSKRLAGINPCT---ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP-- 223
Query: 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH 381
P + M +G + +P + A
Sbjct: 224 PFYELGEPQAAM---------------------FKVGMFKVHPEIP-----ESMSAEAKA 257
Query: 382 LLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQP 420
+ + DP R A + L D + L ++ TQP
Sbjct: 258 FILKCFEPDPDKRACANDLLVDEF---LKVSSKKKKTQP 293
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-45
Identities = 80/341 (23%), Positives = 128/341 (37%), Gaps = 62/341 (18%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN---DVFEHVSDATRILREIKLLRLL 169
Y++ EVIGKG + VV ++ TG++ A+K ++ + RE + +L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 170 RHPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVI----KANDDLTPEHYQFF 221
+HP IVE+ + +Y+VFE M+ +DL I A + +
Sbjct: 84 KHPHIVELLET--------YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTD 278
+ Q+L L+Y H N+ HRD+KP +L +K+ FG+A
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL---VAGG 192
Query: 279 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337
V T + APE + Y +D+W G I +L+G F G
Sbjct: 193 RVGTPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYGTK------------ 237
Query: 338 GTPSTESI-SRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRP 395
E + I K ++ + A L+ R+L DP +R
Sbjct: 238 -----ERLFEGIIKGK-------------YKMNPRQWSHISESAKDLVRRMLMLDPAERI 279
Query: 396 TAEEALADPYFHGLANVDREPSTQPISKLEFEFE-RRKLAK 435
T EAL P+ + + +F RRKL
Sbjct: 280 TVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKG 320
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-45
Identities = 70/295 (23%), Positives = 121/295 (41%), Gaps = 39/295 (13%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ + + +G+G+YG V AV+ T E VA+K ++ V I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHEN 66
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+V+ + Y+ E +L I+ + + Q F +QL+ G+ Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLK 180
Query: 293 SFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
++ +D+WS G + ML G+ + + D + +
Sbjct: 181 R--REFHAEPVDVWSCGIVLTAMLAGELPWDQPS-----DSCQEYS--------DWKEKK 225
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
P+ D L LL ++L +P R T + D ++
Sbjct: 226 TYL-----------NPWKK----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-45
Identities = 83/402 (20%), Positives = 158/402 (39%), Gaps = 57/402 (14%)
Query: 22 NNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQQLTIVEDFDFSGLKLIRVPKR 81
++ +++++ +N F+ +++ + + ++ I D + +
Sbjct: 2 HHHHHHSSGVDNKFNKERRRARR---EIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEA 58
Query: 82 IQFPIAPTPATMDPHKKSALETEFFTEYGEAS----RYQIQEVIGKGSYGVVGSAVDTHT 137
+ A T + + +S + ++ A +Y ++VIG+G VV V T
Sbjct: 59 KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118
Query: 138 GERVAIKKIN------DVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 190
G A+K + + RE +LR + HP I+ +
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-----ESSS 173
Query: 191 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 249
+++VF+LM +L + L+ + + + LL + ++H N+ HRDLKP+NIL
Sbjct: 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL 233
Query: 250 NADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFS---KYTPAIDIW 305
+ + ++++ DFG + + T Y APE L S Y +D+W
Sbjct: 234 DDNMQIRLSDFGFSCH-LEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLW 289
Query: 306 SIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQP 365
+ G I +L G P F + Q+ ++ I +
Sbjct: 290 ACGVILFTLLAGSPPFWHRR---QILML---------RMI----------------MEGQ 321
Query: 366 VPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
F S ++ + L+ RLL DP+ R TAE+AL P+F
Sbjct: 322 YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-45
Identities = 76/318 (23%), Positives = 125/318 (39%), Gaps = 48/318 (15%)
Query: 114 RYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-H 171
YQ+Q +V+G+G++ V + ++ T + A+K I + +R+ RE+++L + H
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGH 70
Query: 172 PDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 227
+++E+ F++ Y+VFE M + I + +
Sbjct: 71 RNVLELIEF--------FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122
Query: 228 GLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARV----SFNDAPSAIFWTDYV 280
L ++H + HRDLKP+NIL N +KICDF L S
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 281 ATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337
+ Y APE+ S Y D+WS+G I +L+G P F G+ +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD-----PLALHLLERLLAFDPK 392
I+ K + FP+ D A L+ +LL D K
Sbjct: 243 PACQNMLFESIQEGK---------------YE--FPDKDWAHISCAAKDLISKLLVRDAK 285
Query: 393 DRPTAEEALADPYFHGLA 410
R +A + L P+ G A
Sbjct: 286 QRLSAAQVLQHPWVQGCA 303
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 6e-45
Identities = 78/304 (25%), Positives = 116/304 (38%), Gaps = 49/304 (16%)
Query: 108 EYGEASR-YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 166
EY E Q +G+GS+G V D TG + A+KK+ E E+
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRV-----EELVAC 104
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQ 224
L P IV + + RE + + EL+E S L Q+IK L + ++L Q
Sbjct: 105 AGLSSPRIVPLYG-----AVREGPWVNIFMELLEGGS-LGQLIKQMGCLPEDRALYYLGQ 158
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDY--VA 281
L GL+Y+HT + H D+K N+L ++D + +CDFG A D T
Sbjct: 159 ALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 282 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
T + APE+ +DIWS C+ ML G + Q L
Sbjct: 219 TETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPW------TQYFRGPLCL---- 266
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+I +E +P P+ PL ++ L +P R +A E
Sbjct: 267 -----KIASEPPPIR--------EIP-----PSCAPLTAQAIQEGLRKEPVHRASAMELR 308
Query: 402 ADPY 405
Sbjct: 309 RKVG 312
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-45
Identities = 91/361 (25%), Positives = 148/361 (40%), Gaps = 64/361 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
Y I+E +G+GS+G V A T ++VA+K I+ + + R+ REI L+LLRHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
I+++ ++ P DI +V E +L I +T + + F Q++ ++Y
Sbjct: 70 HIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW-----YRA 287
H + HRDLKP+N+L + + +KI DFGL S I Y A
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGL---------SNIMTDGNFLKTSCGSPNYAA 175
Query: 288 PELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
PE+ Y P +D+WS G + ML G+ F + + +
Sbjct: 176 PEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------------- 218
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
++ + P S P A L+ R++ DP R T +E DP+F
Sbjct: 219 KVNSCVYV---------MPDFLS-------PGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
Query: 407 HGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSF 466
NV+ +P+ E + V ++ E + + + E LR E
Sbjct: 263 ----NVNLPDYLRPME----EVQGSYADSRIVSKLG--EAMGFSEDYIVEALRSDENNEV 312
Query: 467 M 467
Sbjct: 313 K 313
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 74/350 (21%), Positives = 130/350 (37%), Gaps = 53/350 (15%)
Query: 102 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR 161
++ F+ Y + +G+GS+ + V + + A+K I+ +
Sbjct: 3 DSPFYQHY---DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQK 54
Query: 162 EIKLLRLLR-HPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPE 216
EI L+L HP+IV++ + F D ++V EL+ +L + IK +
Sbjct: 55 EITALKLCEGHPNIVKLHEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFSET 106
Query: 217 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSA 273
+ + +L+ + ++H V HRDLKP+N+L N + ++KI DFG AR+ D
Sbjct: 107 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165
Query: 274 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332
T Y APE L + Y + D+WS+G I ML+G+ F +
Sbjct: 166 --LKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220
Query: 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDP 391
+++ +I+ F + N A L++ LL DP
Sbjct: 221 AVEIM--------KKIKKGD-------------FSFEGEAWKNVSQEAKDLIQGLLTVDP 259
Query: 392 KDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREM 441
R + + + + P P K
Sbjct: 260 NKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAF 309
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 64/303 (21%), Positives = 121/303 (39%), Gaps = 51/303 (16%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLRH 171
+Y + +++G+GSYG V +D+ T R A+K + + + + +EI+LLR LRH
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK--ANDDLTPEHYQFFLYQLLRGL 229
+++++ ++ + + +Y+V E + +++ + QL+ GL
Sbjct: 66 KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT-----DYVATRW 284
+Y+H+ + H+D+KP N+L LKI G+A A T +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ---- 178
Query: 285 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
PE+ + ++ +DIWS G + TG F G N+ L
Sbjct: 179 --PPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------KLF------ 222
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
I +P + P LL+ +L ++P R + +
Sbjct: 223 --ENIGKGSYA-----------IP-----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264
Query: 404 PYF 406
+F
Sbjct: 265 SWF 267
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 64/331 (19%), Positives = 117/331 (35%), Gaps = 58/331 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HP 172
R +++ V+ +G + V A D +G A+K++ I++E+ ++ L HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME---SDLHQVI---KANDDLTPEHYQFFLYQLL 226
+IV+ L E L + + ++ L+ + YQ
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 227 RGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA--- 281
R ++++H + HRDLK +N+L + +K+CDFG A + +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 282 ------TRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 333
T YR PE+ +S DIW++GCI + + F +
Sbjct: 207 EITRNTTPMYRTPEII-DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259
Query: 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD 393
RI N G F + L+ +L +P++
Sbjct: 260 -------------RIVN-------GKYSIPPHDTQYTVFHS-------LIRAMLQVNPEE 292
Query: 394 RPTAEEALADPYFHGLANVDREPSTQPISKL 424
R + E + +A PI++L
Sbjct: 293 RLSIAEVVHQL--QEIAAARNVNPKSPITEL 321
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 3e-44
Identities = 78/331 (23%), Positives = 128/331 (38%), Gaps = 52/331 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
Y I E +G G++GVV V+ TG K IN + D + EI ++ L HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 108
Query: 173 DIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHY-QFFLYQLLR 227
++ + F+D + ++ E + +L I A D E ++ Q
Sbjct: 109 KLINLHDA--------FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 228 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
GLK++H ++ H D+KP+NI+ +KI DFGLA N P I AT +
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK-LN--PDEIVKVT-TATAEF 216
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ D+W+IG + +L+G F G++ E++
Sbjct: 217 AAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGED---------------DLETL 259
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
++ F F + P A ++ LL +P+ R T +AL P
Sbjct: 260 QNVKRCD-------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306
Query: 405 YFHGLANVDREPSTQPISKLEFEFERRKLAK 435
+ G + + + K A
Sbjct: 307 WLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-44
Identities = 73/332 (21%), Positives = 134/332 (40%), Gaps = 58/332 (17%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+Y I E +G+G +G+V V+T + + K + +D + +EI +L + RH
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHR 61
Query: 173 DIVEIKHIMLPPSRREFKD---IYVVFELME-SDLH-QVIKANDDLTPEHYQFFLYQLLR 227
+I+ + F+ + ++FE + D+ ++ + +L +++Q+
Sbjct: 62 NILHLHES--------FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 228 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
L+++H+ N+ H D++P+NI+ +KI +FG AR + Y
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRLLFTAPEY 169
Query: 286 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
APE + A D+WS+G + +L+G F + + +
Sbjct: 170 YAPEVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAET---------------NQQI 211
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
I I N + F + F A+ ++RLL + K R TA EAL
Sbjct: 212 IENIMNAE-------------YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258
Query: 404 PYFHGLANVDREPSTQPISKLEFEFERRKLAK 435
P+ L ST+ I L+ L K
Sbjct: 259 PW---LKQKIERVSTKVIRTLKHRRYYHTLIK 287
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-44
Identities = 60/407 (14%), Positives = 108/407 (26%), Gaps = 93/407 (22%)
Query: 54 HEGQHLQQLTIVEDFDFSGLKLIR-VPKRIQFPIAPTPATMDPHKKSAL----------E 102
H H F G +I + RI T + +L
Sbjct: 2 HHHHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQP 61
Query: 103 TEFFTEYGEASR-YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV------------ 149
+E GE R V+G+ A D TGE +
Sbjct: 62 FRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMK 121
Query: 150 -----------FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198
++ A LR I L++ P ++ + L + ++
Sbjct: 122 EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPR 181
Query: 199 MESDLHQVIKANDDLTPEHYQF-------FLYQLLRGLKYIHTANVFHRDLKPKNILANA 251
M+S+L + + H Q++R L +H + H L+P +I+ +
Sbjct: 182 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ 241
Query: 252 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAI 302
+ + F +R + PEL + T +
Sbjct: 242 RGGVFLTGFEHLVRDGAR-------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSF 294
Query: 303 DIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRK 362
D W++G + + + I R
Sbjct: 295 DAWALGLVIYWIWCADLPITKDAAL---------------GGSEWI-----------FRS 328
Query: 363 KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409
+ +P LLE L + +DR +A+ P + L
Sbjct: 329 CKNIP---------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-44
Identities = 73/317 (23%), Positives = 125/317 (39%), Gaps = 44/317 (13%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ + + +G+G+YG V AV+ T E VA+K ++ V I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHEN 66
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+V+ + Y+ E +L I+ + + Q F +QL+ G+ Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPEL-- 178
Query: 293 SFFS--KYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
++ +D+WS G + ML G+ + + D +
Sbjct: 179 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-----DSCQEYS--------DWKE 223
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF-HG 408
+ P+ D L LL ++L +P R T + D ++
Sbjct: 224 KKTYL-----------NPWKK----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268
Query: 409 LANVDREPSTQPISKLE 425
L + P E
Sbjct: 269 LKKGAKRPRVTSGGVSE 285
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-44
Identities = 77/340 (22%), Positives = 134/340 (39%), Gaps = 62/340 (18%)
Query: 113 SRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
+ Y + + +G+G + VV + TG+ A K + IL EI +L L +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 172 -PDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHY-----QFF 221
P ++ + + +++ I ++ E ++ + E
Sbjct: 88 CPRVINLHEV--------YENTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRL 136
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTD 278
+ Q+L G+ Y+H N+ H DLKP+NIL +KI DFG++R A +
Sbjct: 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHAC---ELRE 192
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338
+ T Y APE+ + T A D+W+IG I +LT F G++ +
Sbjct: 193 IMGTPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETY----- 242
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTA 397
+IS++ V +S + F + LA ++ LL +P+ RPTA
Sbjct: 243 ----LNISQVN----------------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTA 282
Query: 398 EEALADPYF--HGLANVDREPSTQPISKLEFEFERRKLAK 435
E L+ + N+ T S+ + R K
Sbjct: 283 EICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDK 322
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 6e-44
Identities = 75/301 (24%), Positives = 118/301 (39%), Gaps = 55/301 (18%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
Y + + +G G++G V TG +VA+K +N + +I REI+ L+L RHP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
I+++ ++ P+ D ++V E + +L I + + + Q+L + Y
Sbjct: 72 HIIKLYQVISTPT-----DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW-----YR 286
H V HRDLKP+N+L +A KI DFGL S + Y
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGL---------SNMMSDGEFLRTSCGSPNYA 177
Query: 287 APELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ Y P +DIWS G I +L G F ++ + L
Sbjct: 178 APEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEH-------VPTLF-------- 220
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+IR P + LL +L DP R T ++ +
Sbjct: 221 KKIRGGVFY---------IPEYLN-------RSVATLLMHMLQVDPLKRATIKDIREHEW 264
Query: 406 F 406
F
Sbjct: 265 F 265
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 7e-44
Identities = 86/368 (23%), Positives = 142/368 (38%), Gaps = 56/368 (15%)
Query: 79 PKRIQFPIAPTPATMDPHKKSALETEFFTEYGEAS----RYQIQEVIGKGSYGVVGSAVD 134
+ + F + ++L +++ + ++++ +G+G+ +V
Sbjct: 15 TENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQ 74
Query: 135 THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD-IY 193
T + A+K + D + EI +L L HP+I+++K I E I
Sbjct: 75 KGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNIIKLKEIF------ETPTEIS 124
Query: 194 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---A 249
+V EL+ +L I + + Q+L + Y+H + HRDLKP+N+L
Sbjct: 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP 184
Query: 250 NADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIG 308
D LKI DFGL+++ + T Y APE L G Y P +D+WS+G
Sbjct: 185 APDAPLKIADFGLSKIVEHQV----LMKTVCGTPGYCAPEILRG---CAYGPEVDMWSVG 237
Query: 309 CIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPF 368
I +L G F + + RI N + F
Sbjct: 238 IITYILLCGFEPFYDERGDQFM--------------FRRILNCE-------------YYF 270
Query: 369 -SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFE 427
S + A L+ +L+ DPK R T +AL P+ G A + KL+
Sbjct: 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA-ANFVHMDTAQKKLQEF 329
Query: 428 FERRKLAK 435
RRKL
Sbjct: 330 NARRKLKA 337
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-44
Identities = 74/331 (22%), Positives = 130/331 (39%), Gaps = 48/331 (14%)
Query: 114 RYQI-QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL-RLLRH 171
YQ+ ++V+G G G V TG++ A+K + D + + +E+ +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-------SPKARQEVDHHWQASGG 81
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI--KANDDLTPEHYQFFLYQLLRG 228
P IV I + + + + ++ E ME +L I + + T + +
Sbjct: 82 PHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 229 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
++++H+ N+ HRD+KP+N+L D LK+ DFG A+ + +A T +Y
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-----LQTPCYTPYY 195
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ G KY + D+WS+G I +L G P F M
Sbjct: 196 VAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-----------K 242
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALADP 404
RIR + F + A L+ LL DP +R T + + P
Sbjct: 243 RRIRLGQ-------------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289
Query: 405 YFHGLANVDREPSTQPISKLEFEFERRKLAK 435
+ + V + P E + ++ +
Sbjct: 290 WINQSMVVPQTPLHTARVLQEDKDHWDEVKE 320
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 88/338 (26%), Positives = 136/338 (40%), Gaps = 49/338 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RY + IG G++GV D T E VA+K I + + REI R LRHP+
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE---RGAAIDENVQREIINHRSLRHPN 77
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
IV K ++L P+ + ++ E +L++ I + + +FF QLL G+ Y
Sbjct: 78 IVRFKEVILTPT-----HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 233 HTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
H+ + HRDLK +N L + +LKICDFG ++ S + V T Y APE+
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEV 188
Query: 291 CGSFFS--KYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
+Y D+WS G ML G F ++I R
Sbjct: 189 ----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-----------RKTIQR 233
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
I + K +P + P HL+ R+ DP R + E +F
Sbjct: 234 ILSVKYS-----------IPDDIRIS---PECCHLISRIFVADPATRISIPEIKTHSWF- 278
Query: 408 GLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYRE 445
L N+ + + + +F+ + + D I E
Sbjct: 279 -LKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISE 315
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 74/328 (22%), Positives = 118/328 (35%), Gaps = 62/328 (18%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRL 168
+ Y++ ++GKG +G V + +VAIK I + +SD+ E+ LL
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 169 LR----HPDIVEIKHIMLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFL 222
+ HP ++ + + +V E DL I L + F
Sbjct: 91 VGAGGGHPGVIRLLDWFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDYVA 281
Q++ +++ H+ V HRD+K +NIL + K+ DFG + TD+
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG----ALLHDEPY-TDFDG 200
Query: 282 TRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
TR Y PE +Y +WS+G + +M+ G F
Sbjct: 201 TRVYSPPEWIS--RHQYHALPATVWSLGILLYDMVCGDIPF------------------- 239
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
E I + P S P L+ R LA P RP+ EE
Sbjct: 240 --ERDQEILEAELH---------FPAHVS-------PDCCALIRRCLAPKPSSRPSLEEI 281
Query: 401 LADPYFH-GLANVDREPSTQPISKLEFE 427
L DP+ +V PS + L +
Sbjct: 282 LLDPWMQTPAEDVPLNPSKGGPAPLAWS 309
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 46/335 (13%), Positives = 88/335 (26%), Gaps = 70/335 (20%)
Query: 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE------------------ 151
V+G+ A D TGE +
Sbjct: 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 152 -----HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQV 206
+ A LR I L++ P ++ + L + ++ M+S+L
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 207 IKANDDLTPEHYQ-------FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 259
+ + H Q++R L +H + H L+P +I+ + + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 260 FGLARVSFNDAPSAIFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAEMLT 316
F A + A A + + T A D W++G +
Sbjct: 255 FEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 317 GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNAD 376
+ + + R + +P
Sbjct: 313 ADLPNTDDAALGGSEWI--------------------------FRSCKNIP--------- 337
Query: 377 PLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411
LLE L + +DR +A+ P + L
Sbjct: 338 QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 7e-43
Identities = 80/321 (24%), Positives = 125/321 (38%), Gaps = 56/321 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLLRHP 172
Y+++E IG GSY V + T A+K I+ EI+ LLR +HP
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHP 76
Query: 173 DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 228
+I+ +K + + D +YVV ELM+ +L I + L+ + +
Sbjct: 77 NIITLKDV--------YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 229 LKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
++Y+H V HRDLKP NIL + ++ICDFG A+ + T
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG---LLMTPCYTAN 185
Query: 285 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
+ APE L Y A DIWS+G + MLTG F +++
Sbjct: 186 FVAPEVLER---QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA--------- 233
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALA 402
RI + K S + + A L+ ++L DP R TA L
Sbjct: 234 ---RIGSGK-------------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277
Query: 403 DPYFHGLANVDREPSTQPISK 423
P+ + + + +
Sbjct: 278 HPWIVHWDQLPQYQLNRQDAP 298
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-42
Identities = 73/335 (21%), Positives = 128/335 (38%), Gaps = 59/335 (17%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 214
Query: 173 DIVEIKHIMLPPSRREFKD---IYVVFELME-SDL-HQVIKANDDLTPEHYQFFLYQLLR 227
+V + F+D + +++E M +L +V ++ ++ + ++ Q+ +
Sbjct: 215 TLVNLHDA--------FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 228 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
GL ++H N H DLKP+NI+ +LK+ DFGL T +
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS----VKVTTGTAEF 322
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ D+WS+G + +L+G F G+N E++
Sbjct: 323 AAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---------------DDETL 365
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+++ F + +LL DP R T +AL P
Sbjct: 366 RNVKSCD-------------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412
Query: 405 YFHGLANVDREPSTQPISKLEF----EFERRKLAK 435
+ L + I + + + K
Sbjct: 413 W---LTPGNAPGRDSQIPSSRYTKIRDSIKTKYDA 444
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-42
Identities = 70/305 (22%), Positives = 115/305 (37%), Gaps = 59/305 (19%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRLL 169
+YQ+ ++G G +G V S + VAIK + + + + TR+ E+ LL+ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 170 RH--PDIVEIKHIMLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQL 225
++ + P ++ E E DL I L E + F +Q+
Sbjct: 104 SSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 226 LRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
L +++ H V HRD+K +NIL + + +LK+ DFG ++ TD+ TR
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG----ALLKDTVY-TDFDGTRV 213
Query: 285 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
Y PE + +Y + +WS+G + +M+ G F E
Sbjct: 214 YSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPF---------------------E 250
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
I + S HL+ LA P DRPT EE
Sbjct: 251 HDEEIIRGQVFF---------RQRVS-------SECQHLIRWCLALRPSDRPTFEEIQNH 294
Query: 404 PYFHG 408
P+
Sbjct: 295 PWMQD 299
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-42
Identities = 77/367 (20%), Positives = 136/367 (37%), Gaps = 65/367 (17%)
Query: 102 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILR 161
+ +Y +V+G G G V + T E+ A+K + D + R
Sbjct: 56 KNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARR 103
Query: 162 EIKLL-RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQ 219
E++L R + P IV I + K + +V E ++ +L I+ D Q
Sbjct: 104 EVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGD------Q 156
Query: 220 FF--------LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFN 268
F + + ++Y+H+ N+ HRD+KP+N+L + LK+ DFG A+ + +
Sbjct: 157 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH 328
T T +Y APE+ G KY + D+WS+G I +L G P F +
Sbjct: 217 HNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNH--- 267
Query: 329 QLDLMTDLLGTPSTESI-SRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERL 386
G + + +RIR + F + L+ L
Sbjct: 268 ---------GLAISPGMKTRIRMGQ-------------YEFPNPEWSEVSEEVKMLIRNL 305
Query: 387 LAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREI 446
L +P R T E + P+ V + P E + + ++ + +
Sbjct: 306 LKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRV 365
Query: 447 LEYHPQM 453
++
Sbjct: 366 DYEQIKI 372
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 79/359 (22%), Positives = 135/359 (37%), Gaps = 63/359 (17%)
Query: 88 PTPATMDPHKKSALETEFFTEYGEASRYQI--QEVIGKGSYGVVGSAVDTHTGERVAIKK 145
P P H+ + + Y + E++G G +G V +T TG ++A K
Sbjct: 67 PAPPAPFDHRIVTAKQGAVNSF-----YTVSKTEILGGGRFGQVHKCEETATGLKLAAKI 121
Query: 146 INDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF---KDIYVVFELME-S 201
I + D + EI ++ L H +++++ F DI +V E ++
Sbjct: 122 IKT--RGMKDKEEVKNEISVMNQLDHANLIQLYDA--------FESKNDIVLVMEYVDGG 171
Query: 202 DLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKIC 258
+L I E F+ Q+ G++++H + H DLKP+NIL ++KI
Sbjct: 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKII 231
Query: 259 DFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTG 317
DFGLAR + P T + APE + F + D+WS+G I +L+G
Sbjct: 232 DFGLARR-YK--PREKL-KVNFGTPEFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSG 284
Query: 318 KPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHK-FPNAD 376
F G N E+++ I + + F +
Sbjct: 285 LSPFLGDN---------------DAETLNNILACR-------------WDLEDEEFQDIS 316
Query: 377 PLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAK 435
A + +LL + R +A EAL P+ + S Q + + + K
Sbjct: 317 EEAKEFISKLLIKEKSWRISASEALKHPWLSD-HKLHSRLSAQKKKNRGSDA-QDFVTK 373
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 75/383 (19%), Positives = 135/383 (35%), Gaps = 78/383 (20%)
Query: 85 PIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIK 144
+ P ++ +A E E+ +Y +G G++G V +AVD + V +K
Sbjct: 2 ALEEPPKAVELEGLAACEGEYS------QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVK 55
Query: 145 KIN------DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198
I D + ++ EI +L + H +I+++ I +V E
Sbjct: 56 FIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ-----GFFQLVMEK 110
Query: 199 MES--DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 256
S DL I + L + QL+ + Y+ ++ HRD+K +NI+ D +K
Sbjct: 111 HGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIK 170
Query: 257 ICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS--KYT-PAIDIWSIGCIFAE 313
+ DFG A F+T + T Y APE+ Y P +++WS+G
Sbjct: 171 LIDFGSAAYLERGKL---FYT-FCGTIEYCAPEV----LMGNPYRGPELEMWSLGVTLYT 222
Query: 314 MLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP 373
++ + F + P S
Sbjct: 223 LVFEENPF---------------------CELEET---VEAAI------HPPYLVS---- 248
Query: 374 NADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKL 433
+ L+ LL P+ R T E+ + DP+ TQP++ ++ +E
Sbjct: 249 ---KELMSLVSGLLQPVPERRTTLEKLVTDPWV-----------TQPVNLADYTWEEVFR 294
Query: 434 AKDDVREMIYREILEYHPQMLQE 456
++ LE + L +
Sbjct: 295 VNKPESGVLSAASLEMGNRSLSD 317
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 75/352 (21%), Positives = 124/352 (35%), Gaps = 75/352 (21%)
Query: 95 PHKKSALE---TEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE 151
PH KS L+ +Y +V+G G G V + T E+ A+K + D
Sbjct: 2 PHVKSGLQIKKNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-- 54
Query: 152 HVSDATRILREIKLL-RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI-- 207
+ RE++L R + P IV I + K + +V E ++ +L I
Sbjct: 55 -----PKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQD 108
Query: 208 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 264
+ + T + + ++Y+H+ N+ HRD+KP+N+L + LK+ DFG
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-- 166
Query: 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK 324
A E G KY + D+WS+G I +L G P F
Sbjct: 167 ----------------------AKETTG---EKYDKSCDMWSLGVIMYILLCGYPPFYSN 201
Query: 325 NVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLL 383
+ + M +RIR + F + L+
Sbjct: 202 HGLAISPGM-----------KTRIRMGQ-------------YEFPNPEWSEVSEEVKMLI 237
Query: 384 ERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAK 435
LL +P R T E + P+ V + P E + + +
Sbjct: 238 RNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKE 289
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-41
Identities = 74/384 (19%), Positives = 126/384 (32%), Gaps = 46/384 (11%)
Query: 91 ATMDPHKKSALETEFFTEYG-EASRYQIQEVIGKG--SYGVVGSAVDTHTGERVAIKKIN 147
A H L + + + E Y++ VIGKG V A TGE V +++IN
Sbjct: 2 AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61
Query: 148 DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQ 205
T + E+ + +L HP+IV + + + +++VV M S
Sbjct: 62 LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-----ELWVVTSFMAYGS-AKD 115
Query: 206 VIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG-- 261
+I D + + L +L+ L YIH HR +K +IL + D K+ +
Sbjct: 116 LICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175
Query: 262 --LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 319
+ F V + +PE+ Y DI+S+G E+ G
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
Query: 320 ----------LF----------PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGS 359
L + + +L + + +S R
Sbjct: 236 PFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNG 295
Query: 360 MRKKQPVP--FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPS 417
P FS F H +E+ L +P RP+A L +F + E
Sbjct: 296 DSPSHPYHRTFSPHF-------HHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEAL 348
Query: 418 TQPISKLEFEFERRKLAKDDVREM 441
+ + + D +
Sbjct: 349 PELLRPVTPITNFEGSQSQDHSGI 372
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-40
Identities = 94/450 (20%), Positives = 155/450 (34%), Gaps = 68/450 (15%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
Y + + +G G++G V TG +VA+K +N + +I REI+ L+L RHP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
I+++ ++ P DI++V E + +L I N L + + Q+L G+ Y
Sbjct: 77 HIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW-----YR 286
H V HRDLKP+N+L +A KI DFGL S + Y
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGL---------SNMMSDGEFLRTSCGSPNYA 182
Query: 287 APELCGSFFSKYT-PAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ Y P +DIWS G I +L G F +V
Sbjct: 183 APEVISG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK-------------- 226
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+I + P + P + LL+ +L DP R T ++ +
Sbjct: 227 -KICDGIFY---------TPQYLN-------PSVISLLKHMLQVDPMKRATIKDIREHEW 269
Query: 406 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTS 465
F D P + + + + ++E+ E E + + L
Sbjct: 270 F----KQDLPKYLFPE---DPSYSSTMIDDEALKEVC--EKFECSEEEVLSCLYNRNHQD 320
Query: 466 FM---YPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNNDYG 522
+ Y +D +R ++ Y H P +
Sbjct: 321 PLAVAYHLIIDN-RRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHT 379
Query: 523 RTADSVAATLQSPPTENANTEEQNGINRPN 552
+ + + +RPN
Sbjct: 380 LDELNPQKSKHQGVRKAKWHLGIRSQSRPN 409
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-39
Identities = 78/368 (21%), Positives = 142/368 (38%), Gaps = 79/368 (21%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
RY + +G G + V + D + VA+K + EH ++ EI+LL+ +R+
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--DEIRLLKSVRN 92
Query: 172 PDIVEIKHIMLPPSRREFKD-------IYVVFELMESDLHQVIKANDD--LTPEHYQFFL 222
D + M+ +FK I +VFE++ L + I ++ L + +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 223 YQLLRGLKYIHT-ANVFHRDLKPKNILANAD----------------------------- 252
Q+L+GL Y+HT + H D+KP+NIL + +
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 253 ----------CKLKICDFGLARVSFNDAPSAIF----WTDYVATRWYRAPELCGSFFSKY 298
L+ + +V D +A + +T+ + TR YR+ E+ S Y
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVL--IGSGY 270
Query: 299 TPAIDIWSIGCIFAEMLTGKPLFPGKN------VVHQLDLMTDLLGTPSTESISRIRNEK 352
DIWS C+ E+ TG LF + + L+ +LLG + I +
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV--AGKY 328
Query: 353 ARRYL---GSMRKKQPVPFS---------HKFPNAD-PLALHLLERLLAFDPKDRPTAEE 399
++ + G ++ + +++ + L +L P+ R TA E
Sbjct: 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388
Query: 400 ALADPYFH 407
L P+ +
Sbjct: 389 CLRHPWLN 396
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-39
Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLL 169
A + IG+G+YG V V +G+ +A+K+I + ++L ++ ++R
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSS 78
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELM----ESDLHQVIKANDDLTPEHY-QFFLYQ 224
P IV+ + D ++ ELM + V DD+ PE
Sbjct: 79 DCPYIVQFYGALFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 225 LLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
++ L ++ + HRD+KP NIL + +K+CDFG +S S I T R
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG---ISGQLVDS-IAKTRDAGCR 189
Query: 284 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
Y APE + Y D+WS+G E+ TG+ +P + + + D L
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP------KWNSVFDQL---- 239
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+++ + + + FS F ++ + L D RP +E L
Sbjct: 240 ----TQVVKGDPPQ----LSNSEEREFSPSF-------INFVNLCLTKDESKRPKYKELL 284
Query: 402 ADPYF 406
P+
Sbjct: 285 KHPFI 289
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 90/393 (22%), Positives = 151/393 (38%), Gaps = 71/393 (18%)
Query: 76 IRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGE---ASRYQIQEVIGKGSYGVVGSA 132
I + + F A P S + + + + + IG GS+G V A
Sbjct: 14 IPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFA 73
Query: 133 VDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191
D E VAIKK++ + I++E++ L+ LRHP+ ++ + L
Sbjct: 74 RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----T 128
Query: 192 IYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250
++V E +++ + E + L+GL Y+H+ N+ HRD+K NIL +
Sbjct: 129 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS 188
Query: 251 ADCKLKICDFGLA-----RVSFNDAPSAIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDI 304
+K+ DFG A SF P +W APE+ +Y +D+
Sbjct: 189 EPGLVKLGDFGSASIMAPANSFVGTP---YWM---------APEVILAMDEGQYDGKVDV 236
Query: 305 WSIGCIFA-EMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKK 363
WS+G I E+ KP N + L + +P +++
Sbjct: 237 WSLG-ITCIELAERKPPLFNMNAMSALYHIAQ-NESP------ALQSGH----------- 277
Query: 364 QPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISK 423
+S F N ++ L P+DRPT+E L + V RE I
Sbjct: 278 ----WSEYFRN-------FVDSCLQKIPQDRPTSEVLLKHRF------VLRERPPTVIMD 320
Query: 424 LEFEFERRKLAKDDVREMIYREILEYHPQMLQE 456
L +R K A ++ + YR++ + QE
Sbjct: 321 L---IQRTKDAVRELDNLQYRKM---KKILFQE 347
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-38
Identities = 66/298 (22%), Positives = 111/298 (37%), Gaps = 54/298 (18%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRIL-----REIKLLRLLR 170
+ ++ IGKG +G+V VAIK + RE+ ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI-KANDDLTPEHYQFFLYQLLRG 228
HP+IV++ +M P +V E + DL+ + + + + G
Sbjct: 82 HPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 229 LKYIHTAN--VFHRDLKPKNIL-----ANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 281
++Y+ N + HRDL+ NI NA K+ DFGL++ S + + +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV------SGLLG 188
Query: 282 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
+ APE G+ YT D +S I +LTG+ F +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------------- 235
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
+ I+ IR E R +P + P +++E + DPK RP
Sbjct: 236 IKFINMIREEGLR---------PTIP-----EDCPPRLRNVIELCWSGDPKKRPHFSY 279
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 44/310 (14%), Positives = 95/310 (30%), Gaps = 53/310 (17%)
Query: 80 KRIQFPIAPTPATMDPHKK-SALETEFFTEYGEASRYQIQEVIGKGSYGVV-----GSAV 133
+ P++ P T + K A++ + + G + ++G+G++ V G
Sbjct: 32 SGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGS-KLVYVHHLLGEGAFAQVYEATQGDLN 90
Query: 134 DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD-I 192
D ++ +K + + + ++ L+ ++ F++
Sbjct: 91 DAKNKQKFVLKVQKP--ANPWEFYIGTQLMERLKPSMQHMFMKFYSAH------LFQNGS 142
Query: 193 YVVFELME-SDLHQVIK-----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246
+V EL L I + F ++L ++ +H + H D+KP N
Sbjct: 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDN 202
Query: 247 IL-----------ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSF 294
+ + L + D G + IF T ++ E L
Sbjct: 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK-CETSGFQCVEMLSN-- 259
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH-----------QLDLMTD----LLGT 339
+ ID + + ML G + LD+ + +L
Sbjct: 260 -KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNI 318
Query: 340 PSTESISRIR 349
P + +
Sbjct: 319 PDCHHLPSLD 328
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 79/306 (25%), Positives = 129/306 (42%), Gaps = 39/306 (12%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
Y++QEVIG G+ VV +A E+VAIK+I ++ + + +L+EI+ + H
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHH 72
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTP-----EHYQFFL 222
P+IV + ++++V +L+ D+ + I A + L
Sbjct: 73 PNIVSYYTSFVVKD-----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYV 280
++L GL+Y+H HRD+K NIL D ++I DFG++ + D +V
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
T + APE+ Y DIWS G E+ TG + H+ M L+ T
Sbjct: 188 GTPCWMAPEVMEQ-VRGYDFKADIWSFGITAIELATGAAPY------HKYPPMKVLMLTL 240
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
+N+ G K+ + F ++ L DP+ RPTA E
Sbjct: 241 --------QNDPPSLETGVQDKEMLKKYGKSFRK-------MISLCLQKDPEKRPTAAEL 285
Query: 401 LADPYF 406
L +F
Sbjct: 286 LRHKFF 291
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 62/302 (20%), Positives = 111/302 (36%), Gaps = 43/302 (14%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLL 169
E + + +G G+ G V TG +A+K++ + + RIL ++ +L+
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSH 81
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRG 228
P IV+ + + D+++ ELM + ++ K PE +++
Sbjct: 82 DCPYIVQCFGTFITNT-----DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 229 LKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
L Y+ V HRD+KP NIL + ++K+CDFG +S Y A
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDD-KAKDRSAGCAAYMA 192
Query: 288 PE---LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
PE Y D+WS+G E+ TG+ + E
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK--------------TDFEV 238
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
++++ E+ + FS F ++ L D + RP + L
Sbjct: 239 LTKVLQEEPP------LLPGHMGFSGDF-------QSFVKDCLTKDHRKRPKYNKLLEHS 285
Query: 405 YF 406
+
Sbjct: 286 FI 287
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-37
Identities = 71/313 (22%), Positives = 124/313 (39%), Gaps = 32/313 (10%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
+ ++ +G G+ GVV +G +A K I + + +I+RE+++L
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECN 89
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGL 229
P IV +I + E M+ L QV+K + + +++GL
Sbjct: 90 SPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 230 KYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFND-APSAIFWTDYVATRWYRA 287
Y+ + HRD+KP NIL N+ ++K+CDFG++ + A S +V TR Y +
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTRSYMS 198
Query: 288 PE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPSTESI 345
PE L G + Y+ DIWS+G EM G+ P+ P +L + G +
Sbjct: 199 PERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255
Query: 346 SRIRNEKARRYLGSMRKKQPVPFS--HKFPNADPLAL----------HLLERLLAFDPKD 393
+ G + F N P L + + L +P +
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315
Query: 394 RPTAEEALADPYF 406
R ++ + +
Sbjct: 316 RADLKQLMVHAFI 328
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 64/297 (21%), Positives = 108/297 (36%), Gaps = 58/297 (19%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+ + IG GS+G V + G+ VA+K +N E+ +LR RH
Sbjct: 27 TVGQRIGSGSFGTV------YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLK 230
+I+ P + +V + E S L+ + A++ + Q RG+
Sbjct: 81 NILLFMGYSTAP------QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMD 134
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 289
Y+H ++ HRDLK NI + D +KI DFGLA + S F + + APE
Sbjct: 135 YLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF-EQLSGSILWMAPEV 193
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-------VVHQLDLMTDLLGTPST 342
+ + Y+ D+++ G + E++TG+ + N +V + L DL
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR-- 251
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
N L+ L +RP+
Sbjct: 252 ------------------------------SNCPKRMKRLMAECLKKKRDERPSFPR 278
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-37
Identities = 80/305 (26%), Positives = 129/305 (42%), Gaps = 62/305 (20%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+Y E IG+G+ G V +A+D TG+ VAI+++N + I+ EI ++R ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+IV S +++VV E + L V+ + + L+ L++
Sbjct: 78 NIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEF 131
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTDYVAT 282
+H+ V HRD+K NIL D +K+ DFG R + V T
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------------VGT 179
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
++ APE+ Y P +DIWS+G I A EM+ G+P + +N + L L+ GTP
Sbjct: 180 PYWMAPEVVTR--KAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIAT-NGTP- 234
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+ P S F + L R L D + R +A+E L
Sbjct: 235 -------------------ELQNPEKLSAIFRD-------FLNRCLEMDVEKRGSAKELL 268
Query: 402 ADPYF 406
+
Sbjct: 269 QHQFL 273
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-37
Identities = 67/304 (22%), Positives = 122/304 (40%), Gaps = 46/304 (15%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLL 169
+A + +G+G+YGVV +G+ +A+K+I + + R+L ++ +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTV 63
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELM----ESDLHQVIKANDDLTPEHYQFFLYQL 225
P V + D+++ ELM + QVI + + +
Sbjct: 64 DCPFTVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 226 LRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
++ L+++H+ +V HRD+KP N+L NA ++K+CDFG +S + +
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG---ISGYLVDD-VAKDIDAGCKP 174
Query: 285 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
Y APE Y+ DIWS+G E+ + FP + + ++ PS
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS- 231
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
P + KF + + L + K+RPT E +
Sbjct: 232 ----------------------PQLPADKFS---AEFVDFTSQCLKKNSKERPTYPELMQ 266
Query: 403 DPYF 406
P+F
Sbjct: 267 HPFF 270
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-37
Identities = 82/353 (23%), Positives = 143/353 (40%), Gaps = 70/353 (19%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR-LLR 170
A +++ E++G G+YG V TG+ AIK ++ + + I +EI +L+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE---IKQEINMLKKYSH 79
Query: 171 HPDIVEIKHIMLPPSRREFKD-IYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQL 225
H +I + + D +++V E +DL + K N L E + ++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREI 138
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFW 276
LRGL ++H V HRD+K +N+L + ++K+ DFG++ R +F
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--------- 189
Query: 277 TDYVATRWYRAPE--LCGSFF-SKYTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDL 332
+ T ++ APE C + Y D+WS+G I A EM G P +
Sbjct: 190 ---IGTPYWMAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPL------CDMHP 239
Query: 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPK 392
M L P R++++K +S KF + +E L +
Sbjct: 240 MRALFLIP-RNPAPRLKSKK---------------WSKKFQS-------FIESCLVKNHS 276
Query: 393 DRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYRE 445
RP E+ + P+ D+ Q +L+ +R K + + E Y
Sbjct: 277 QRPATEQLMKHPFIR-----DQPNERQVRIQLKDHIDRTKKKRGEKDETEYEY 324
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 75/305 (24%), Positives = 125/305 (40%), Gaps = 62/305 (20%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
IG+GS G+V A + H+G +VA+K ++ + E+ ++R +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHF 102
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
++VE+ S ++++V+ E ++ L ++ L E +L+ L Y
Sbjct: 103 NVVEMYK-----SYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAY 156
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTDYVAT 282
+H V HRD+K +IL D ++K+ DFG R S P +W
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP---YWM----- 208
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
APE+ S Y +DIWS+G I EM+ G+P + + V + + D P
Sbjct: 209 ----APEVISR--SLYATEVDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPP- 259
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+ K S + LER+L DP++R TA+E L
Sbjct: 260 -------------------KLKNSHKVSPVLRD-------FLERMLVRDPQERATAQELL 293
Query: 402 ADPYF 406
P+
Sbjct: 294 DHPFL 298
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 22/222 (9%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+I E+IGKG +G V GE VAI+ I+ ++ RE+ R RH ++V
Sbjct: 36 EIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 176 E-IKHIMLPPSRREFKDIYVVFELME-SDLHQVI-KANDDLTPEHYQFFLYQLLRGLKYI 232
+ M PP + ++ L + L+ V+ A L + ++++G+ Y+
Sbjct: 93 LFMGACMSPP------HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR--APEL 290
H + H+DLK KN+ + + K+ I DFGL +S + W APE+
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 291 -------CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN 325
++ D++++G I+ E+ + F +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 47/287 (16%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
I+E IG GS+G V A G VA+K + + H LRE+ +++ LRHP+IV
Sbjct: 40 NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 176 EIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGLKY 231
+ P + +V E + L++++ + L Y + +G+ Y
Sbjct: 98 LFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 232 IHTAN--VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+H N + HR+LK N+L + +K+CDFGL+R+ + S+ T + APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMAPE 209
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ D++S G I E+ T + + N + ++ +
Sbjct: 210 VLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLN---------------PAQVVAAVG 252
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
+ R +P N +P ++E +P RP+
Sbjct: 253 FKCKR---------LEIP-----RNLNPQVAAIIEGCWTNEPWKRPS 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 60/296 (20%), Positives = 105/296 (35%), Gaps = 48/296 (16%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
EV+GKG +G TGE + +K++ E L+E+K++R L HP+++
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT--FLKEVKVMRCLEHPNVL 70
Query: 176 E-IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 232
+ I + + + E ++ L +IK+ D F + G+ Y+
Sbjct: 71 KFIGVLYKDK------RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+ N+ HRDL N L + + + DFGLAR+ ++ + + G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 293 SF---------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343
+ Y +D++S G + E++ P P T
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD--------------YLPRTM 230
Query: 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
R P PN P + R DP+ RP+ +
Sbjct: 231 DFGLNVRGFLDR---------YCP-----PNCPPSFFPITVRCCDLDPEKRPSFVK 272
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 57/292 (19%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+++EV+G+G++GVV A + VAIK+I S+ + E++ L + HP+IV
Sbjct: 11 EVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIV 64
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEHYQFFLYQLLRGLKY 231
++ L P + +V E E L+ V+ + T H + Q +G+ Y
Sbjct: 65 KLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 232 IHTAN---VFHRDLKPKNILANADCK-LKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
+H+ + HRDLKP N+L A LKICDFG A T+ + + A
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM------TNNKGSAAWMA 171
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
PE+ S Y+ D++S G I E++T + F I
Sbjct: 172 PEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--------------RIMW 215
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
+ R P+ N L+ R + DP RP+ EE
Sbjct: 216 AVHNGTRP---------PLI-----KNLPKPIESLMTRCWSKDPSQRPSMEE 253
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 77/341 (22%), Positives = 134/341 (39%), Gaps = 73/341 (21%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
++I +G G++G V A + TG A K I + + + EI++L H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDH 75
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 227
P IV++ ++++ E + +++ + LT Q Q+L
Sbjct: 76 PYIVKLLGAYYHDG-----KLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQMLE 128
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTD 278
L ++H+ + HRDLK N+L + +++ DFG++ R SF P +W
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP---YWM- 184
Query: 279 YVATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDLMT 334
APE+ K Y DIWS+G I EM +P P H+L+ M
Sbjct: 185 --------APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP--P----HHELNPMR 229
Query: 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 394
LL +++ L P +S +F L+ L +P+ R
Sbjct: 230 VLLKIA--------KSDPPT--L-----LTPSKWSVEF-------RDFLKIALDKNPETR 267
Query: 395 PTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAK 435
P+A + L P+ V S + + +L E + + +
Sbjct: 268 PSAAQLLEHPF------VSSITSNKALRELVAEAKAEVMEE 302
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-35
Identities = 79/312 (25%), Positives = 120/312 (38%), Gaps = 75/312 (24%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
+ E IGKGS+G V +D T + VAIK I D+ E + I +EI +L
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDS 79
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 227
P + + L + ++++ E + DL + L L ++L+
Sbjct: 80 PYVTKYYGSYLKDT-----KLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILK 130
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFNDAPSAIFWTD 278
GL Y+H+ HRD+K N+L + ++K+ DFG+A R +F P FW
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP---FWM- 186
Query: 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDLMTDLL 337
APE+ S Y DIWS+G I A E+ G+P +L M L
Sbjct: 187 --------APEVIKQ--SAYDSKADIWSLG-ITAIELARGEPPH------SELHPMKVLF 229
Query: 338 GTPSTESISRIRNEKARRYLGSMRKKQPV---PFSHKFPNADPLALHLLERLLAFDPKDR 394
P + P +S +E L +P R
Sbjct: 230 LIP--------------------KNNPPTLEGNYSKPLKE-------FVEACLNKEPSFR 262
Query: 395 PTAEEALADPYF 406
PTA+E L +
Sbjct: 263 PTAKELLKHKFI 274
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 75/300 (25%), Positives = 109/300 (36%), Gaps = 34/300 (11%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
Q+ + IGKG YG V GE+VA+K E S EI L+RH +I+
Sbjct: 40 QMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTT-EEASWFRE--TEIYQTVLMRHENIL 94
Query: 176 E-IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
I + +Y++ + E+ L+ +K+ L + Y + GL ++H
Sbjct: 95 GFIAADIKGTGSW--TQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLH 151
Query: 234 TANVF--------HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY--VATR 283
T HRDLK KNIL + I D GLA F + + V T+
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK-FISDTNEVDIPPNTRVGTK 210
Query: 284 WYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339
Y PE L S + + D++S G I E+ G +QL +
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG-GIVEEYQLPYHDLVPSD 269
Query: 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
PS E + I K R P L+ A +P R TA
Sbjct: 270 PSYEDMREIVCIKKLR--------PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 80/333 (24%), Positives = 140/333 (42%), Gaps = 58/333 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ + E +G+GSYG V A+ TG+ VAIK++ V + + I++EI +++ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQE---IIKEISIMQQCDSPH 85
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGL 229
+V+ + D+++V E SD+ ++ N LT + L L+GL
Sbjct: 86 VVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGL 138
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGL-ARVSFNDAPSAIFWTDYVATRWYRAP 288
+Y+H HRD+K NIL N + K+ DFG+ +++ A + T ++ AP
Sbjct: 139 EYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV----IGTPFWMAP 194
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFA-EMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
E+ Y DIWS+G I A EM GKP + + + + ++ P
Sbjct: 195 EVIQE--IGYNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMIPT-NPPP------- 243
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
++P +S F +++ L P+ R TA + L P+
Sbjct: 244 -------------TFRKPELWSDNF-------TDFVKQCLVKSPEQRATATQLLQHPF-- 281
Query: 408 GLANVDREPSTQPISKLEFEFERRKLAKDDVRE 440
V + L E KL + + ++
Sbjct: 282 ----VRSAKGVSILRDLINEAMDVKLKRQESQQ 310
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 73/299 (24%), Positives = 119/299 (39%), Gaps = 60/299 (20%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATR-ILREIKLLRLLRHPD 173
++E+IG G +G V A G+ VA+K D E +S + +E KL +L+HP+
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 174 IVEIKHI-MLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
I+ ++ + + P ++ +V E L++V+ + P+ + Q+ RG+ Y
Sbjct: 68 IIALRGVCLKEP------NLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNY 120
Query: 232 IHTAN---VFHRDLKPKNIL--------ANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
+H + HRDLK NIL ++ LKI DFGLAR +
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA--- 177
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
W APE+ + S ++ D+WS G + E+LTG+ F G +
Sbjct: 178 -YAW-MAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGID--------------- 218
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
+ K P+P L+E DP RP+
Sbjct: 219 GLAVAYGVAMNKLA---------LPIP-----STCPEPFAKLMEDCWNPDPHSRPSFTN 263
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-34
Identities = 69/313 (22%), Positives = 117/313 (37%), Gaps = 61/313 (19%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLLR 170
A +Y+++ I G G + A+D + R V +K + + + E + L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVV 137
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGL 229
HP IV+I + + R Y+V E + L + L +L ++L L
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPAL 195
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
Y+H+ + + DLKP+NI+ + +LK+ D G ++ + T ++APE
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGYL-----YGTPGFQAPE 247
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ + T A DI+++G A + P G+ V
Sbjct: 248 IVR---TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------- 283
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALH-LLERLLAFDPKDRP-TAEEALADPYFH 407
+ + PV + LL R + DP+ R TAEE A
Sbjct: 284 ----------LPEDDPVL-------KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQ---- 322
Query: 408 GLANVDREPSTQP 420
L V RE Q
Sbjct: 323 -LTGVLREVVAQD 334
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 43/288 (14%), Positives = 90/288 (31%), Gaps = 50/288 (17%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+ + G + G + +K + + E LR+ HP+++
Sbjct: 13 NFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 176 EIKHIML-PPSRREFKDIYVVFELMES-DLHQVI--KANDDLTPEHYQFFLYQLLRGLKY 231
+ PP+ ++ M L+ V+ N + F + RG+ +
Sbjct: 71 PVLGACQSPPAPH----PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 232 IHTAN--VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+HT + L ++++ + D +I + + + + APE
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--------PGRMYAPAWVAPE 178
Query: 290 -LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
L + D+WS + E++T + F + + E ++
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---------------NMEIGMKV 223
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
E R +P P P L++ + DP RP
Sbjct: 224 ALEGLR---------PTIP-----PGISPHVSKLMKICMNEDPAKRPK 257
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 84/348 (24%), Positives = 136/348 (39%), Gaps = 60/348 (17%)
Query: 85 PIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIK 144
+ P + MD +S T+F Y+++ ++G+G G V A DT VA+K
Sbjct: 13 GLVPRGSHMDGTAESREGTQF-------GPYRLRRLVGRGGMGDVYEAEDTVRERIVALK 65
Query: 145 KINDVFEHVSDAT---RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI-YVVFELME 200
+++ SD R+ RE + L+ P +V I H E YV L+
Sbjct: 66 LMSE--TLSSDPVFRTRMQREARTAGRLQEPHVVPI-H-----DFGEIDGQLYVDMRLIN 117
Query: 201 -SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 259
DL +++ L P + Q+ L H A HRD+KP+NIL +AD + D
Sbjct: 118 GVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVD 177
Query: 260 FGLARVSFNDAP----SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEML 315
FG+A + D V T +Y APE S T DI+++ C+ E L
Sbjct: 178 FGIAS-ATTDEKLTQLGNT-----VGTLYYMAPERFSE--SHATYRADIYALTCVLYECL 229
Query: 316 TGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA 375
TG P + G + S+ ++ + S P
Sbjct: 230 TGSPPYQGDQL-----------------SV-------MGAHI----NQAIPRPSTVRPGI 261
Query: 376 DPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISK 423
++ R +A +P+DR L+ LA D++ +T + +
Sbjct: 262 PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRATDILRR 309
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 76/314 (24%), Positives = 127/314 (40%), Gaps = 69/314 (21%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK--------KINDVFEHVSDATRILREIKLL 166
++ +++G+GS+ V A + T AIK K N V +V RE ++
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKV-PYV------TRERDVM 84
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFL 222
L HP V++ F+D +Y ++ +L + I+ +F+
Sbjct: 85 SRLDHPFFVKLYF--------TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 136
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282
+++ L+Y+H + HRDLKP+NIL N D ++I DFG A+V ++ A + +V T
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGT 195
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
Y +PEL + D+W++GCI +++ G P F N L+
Sbjct: 196 AQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLI--------- 240
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDRPT----- 396
+I + FP P A L+E+LL D R
Sbjct: 241 --FQKIIKLEYD-----------------FPEKFFPKARDLVEKLLVLDATKRLGCEEME 281
Query: 397 -AEEALADPYFHGL 409
A P+F +
Sbjct: 282 GYGPLKAHPFFESV 295
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 78/305 (25%), Positives = 127/305 (41%), Gaps = 58/305 (19%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT---RILREIKLLRL 168
RY+I + +G G V A DT +VAIK I R RE+
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFI--PPREKEETLKRFEREVHNSSQ 67
Query: 169 LRHPDIVEIKHIMLPPSRREFKDI-------YVVFELME-SDLHQVIKANDDLTPEHYQF 220
L H +IV + D+ Y+V E +E L + I+++ L+ +
Sbjct: 68 LSHQNIVSMI------------DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN 115
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
F Q+L G+K+ H + HRD+KP+NIL +++ LKI DFG+A+ + +++ T++V
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL---SETSLTQTNHV 172
Query: 281 -ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339
T Y +PE DI+SIG + EML G+P F G+ V
Sbjct: 173 LGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAV------------ 218
Query: 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-TAE 398
SI+ + ++ P + + +++ R D +R T +
Sbjct: 219 ----SIA----------IKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQ 264
Query: 399 EALAD 403
E D
Sbjct: 265 EMKDD 269
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 72/303 (23%), Positives = 111/303 (36%), Gaps = 40/303 (13%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+QE IGKG +G V GE VA+K + R EI +LRH +I+
Sbjct: 45 VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS--REERSWFR-EAEIYQTVMLRHENIL 99
Query: 176 -----EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 229
+ K +++V + E L + +T E GL
Sbjct: 100 GFIAADNKDNGTWT------QLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGL 152
Query: 230 KYIHTANVF--------HRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYV 280
++H V HRDLK KNIL + I D GLA I V
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 281 ATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 336
T+ Y APE L S K+ + DI+++G +F E+ + G + +QL +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLV 271
Query: 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
PS E + ++ E+ R +P + A + ++ + R T
Sbjct: 272 PSDPSVEEMRKVVCEQKLR--------PNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323
Query: 397 AEE 399
A
Sbjct: 324 ALR 326
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 76/306 (24%), Positives = 129/306 (42%), Gaps = 55/306 (17%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT---RILREIKLLRL 168
+ RY++ E++G G V A D VA+K + + D + R RE +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAA 68
Query: 169 LRHPDIVEI--------KHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQ 219
L HP IV + LP Y+V E ++ L ++ +TP+
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLP---------YIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 220 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 279
+ + L + H + HRD+KP NI+ +A +K+ DFG+AR + D+ +++ T
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAA 178
Query: 280 V-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338
V T Y +PE D++S+GC+ E+LTG+P F G
Sbjct: 179 VIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGD-------------- 222
Query: 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-TA 397
+P + + +R + P+P S + ++ + LA +P++R TA
Sbjct: 223 SPVSVAYQHVRED-------------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTA 269
Query: 398 EEALAD 403
E AD
Sbjct: 270 AEMRAD 275
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 62/305 (20%), Positives = 107/305 (35%), Gaps = 40/305 (13%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+ E +GKG YG V + GE VA+K + R E+ +LRH +I+
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS--RDEKSWFR-ETELYNTVMLRHENIL 65
Query: 176 -----EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 229
++ ++++ E L+ ++ L + + GL
Sbjct: 66 GFIASDMTSRHSST------QLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGL 118
Query: 230 KYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARV-SFNDAPSAIFWTDYV 280
++H + HRDLK KNIL + + I D GLA + S + + V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 281 ATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 336
T+ Y APE L + +DIW+ G + E+ G ++ +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN-GIVEDYKPPFYDVV 237
Query: 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT 396
PS E + ++ +R +P L++ +P R T
Sbjct: 238 PNDPSFEDMRKVVCVDQQR--------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 397 AEEAL 401
A
Sbjct: 290 ALRIK 294
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 71/300 (23%), Positives = 116/300 (38%), Gaps = 34/300 (11%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
Q+ EV +G +G V A E VA+K + + E+ L ++H +I+
Sbjct: 27 QLLEVKARGRFGCVWKA--QLLNEYVAVKIF---PIQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 176 E-IKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
+ I S D++++ E L +KAN ++ + RGL Y+H
Sbjct: 82 QFIGAEKRGTSVD--VDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLH 138
Query: 234 TA----------NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATR 283
+ HRD+K KN+L + I DFGLA F SA V TR
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHGQVGTR 197
Query: 284 WYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
Y APE+ +F ID++++G + E+ + G + L ++ P
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLAL-HLLERLLAFDPKDRPTAEE 399
S E + + K +R PV + +A L +E D + R +A
Sbjct: 258 SLEDMQEVVVHKKKR---------PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-29
Identities = 65/303 (21%), Positives = 118/303 (38%), Gaps = 52/303 (17%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+G+G +G V + TG+ A KK+N + + E K+L + IV +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 179 HIMLPPSRREFKDIYVVFELMES-DL----HQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
+ + + +V +M D+ + V + N F+ Q++ GL+++H
Sbjct: 252 YAFETKTD-----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYVATRWYRAPELC 291
N+ +RDLKP+N+L + D ++I D GLA + Y T + APEL
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-----YAGTPGFMAPELL 361
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
+Y ++D +++G EM+ + F + + + R+ +
Sbjct: 362 LG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-----------RVLEQ 408
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYF 406
V + KF P + E LL DP+ R + + P F
Sbjct: 409 -------------AVTYPDKFS---PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452
Query: 407 HGL 409
+
Sbjct: 453 RDI 455
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 68/302 (22%), Positives = 125/302 (41%), Gaps = 49/302 (16%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDI 174
+I IGKGS+G V T + A+K +N ++ + +E+++++ L HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 175 VEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
V + + F+D +++V +L+ DL ++ N E + F+ +L+ L
Sbjct: 78 VNLWY--------SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 289
Y+ + HRD+KP NIL + + I DF +A + + T+ Y APE
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM----AGTKPYMAPEM 185
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ Y+ A+D WS+G E+L G+ + ++ T S E +
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS------------STSSKEIVHTFE 233
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNA-DPLALHLLERLLAFDPKDR-PTAEEALADPYFH 407
+P+A + LL++LL +P R + PY +
Sbjct: 234 TTVVT-----------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276
Query: 408 GL 409
+
Sbjct: 277 DI 278
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 102 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDAT 157
T+F E + + +GKG++G V +TGE VA+KK+
Sbjct: 4 PTQF-----EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLR 56
Query: 158 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTP 215
REI++L+ L+H +IV+ K + RR ++ ++ E + L ++ + + +
Sbjct: 57 DFEREIEILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDH 113
Query: 216 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275
+ Q+ +G++Y+ T HRDL +NIL + ++KI DFGL +V D
Sbjct: 114 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF--- 170
Query: 276 WTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+ WY APE SK++ A D+WS G + E+ T
Sbjct: 171 ---FKVKEPGESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 32/240 (13%)
Query: 90 PATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKK 145
M + T+F E + + +GKG++G V +TGE VA+KK
Sbjct: 23 QGAMGSAFEDRDPTQF-----EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK 77
Query: 146 INDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLH 204
+ REI++L+ L+H +IV+ K + RR ++ ++ E + L
Sbjct: 78 LQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLR 132
Query: 205 QVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263
++ + + + + Q+ +G++Y+ T HRDL +NIL + ++KI DFGL
Sbjct: 133 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
Query: 264 RVSFNDAPSAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
+V D Y WY APE SK++ A D+WS G + E+ T
Sbjct: 193 KVLPQDK------EYYKVKEPGESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT 243
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-29
Identities = 66/306 (21%), Positives = 113/306 (36%), Gaps = 55/306 (17%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
VIG+G++ V TG+ A+K +N + + E +L I ++
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 179 HIMLPPSRREFKD---IYVVFELMES-DL-HQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
F+D +Y+V E DL + K + + E +F+L +++ + +H
Sbjct: 128 F--------AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYVATRWYRAPEL- 290
HRD+KP NIL + +++ DFG + S + V T Y +PE+
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA----VGTPDYLSPEIL 235
Query: 291 ----CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
G Y P D W++G EM G+ F + E+
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---------------ETYG 280
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEALAD 403
+I + K+ + A ++RLL P+ R A +
Sbjct: 281 KI-----------VHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328
Query: 404 PYFHGL 409
P+F GL
Sbjct: 329 PFFFGL 334
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 69/299 (23%), Positives = 114/299 (38%), Gaps = 47/299 (15%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
V+GKG +G V + TG+ A KK+ + L E ++L + +V +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 179 HIMLPPSRREFKDIYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 235
+ + +V LM DL H F+ ++ GL+ +H
Sbjct: 251 YAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 236 NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF 295
+ +RDLKP+NIL + ++I D GLA V T Y APE+ +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKN-- 359
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355
+YT + D W++GC+ EM+ G+ F + + + + ++
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-----------LVKEV---- 404
Query: 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 409
P +S +F A L +LL DP +R +A E P F L
Sbjct: 405 ---------PEEYSERFSPQ---ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 69/307 (22%), Positives = 123/307 (40%), Gaps = 49/307 (15%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 173
++I +VIG+G++G V + + A+K +N ++ E +L
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 174 IVEIKHIMLPPSRREFKD---IYVVFELMES-DL-HQVIKANDDLTPEHYQFFLYQLLRG 228
I + + F+D +Y+V + DL + K D L E +F+L +++
Sbjct: 136 ITTLHY--------AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA 187
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
+ +H + HRD+KP NIL + + +++ DFG D + V T Y +P
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSV-AVGTPDYISP 245
Query: 289 EL---CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
E+ +Y P D WS+G EML G+ F +++V E+
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---------------ETY 290
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEALA 402
+I M K+ F + + A L+ RL+ + R E+
Sbjct: 291 GKI-----------MNHKERFQFPTQVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKK 338
Query: 403 DPYFHGL 409
P+F G+
Sbjct: 339 HPFFSGI 345
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 32/223 (14%)
Query: 111 EASRYQIQ--EVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATR--ILRE 162
+ ++ +G+G +G V +TGE+VA+K + + +E
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK---PESGGNHIADLKKE 73
Query: 163 IKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQF 220
I++LR L H +IV+ K I + I ++ E + S L + + N + + +
Sbjct: 74 IEILRNLYHENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
+ Q+ +G+ Y+ + HRDL +N+L ++ ++KI DFGL + D Y
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY------YT 184
Query: 281 AT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
WY APE SK+ A D+WS G E+LT
Sbjct: 185 VKDDRDSPVFWY-APE--CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 6e-28
Identities = 71/303 (23%), Positives = 112/303 (36%), Gaps = 55/303 (18%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHP 172
+IG+G +G V TG+ A+K + + +L + P
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD---CP 252
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
IV + + P + + + +LM DLH + + + +F+ +++ GL++
Sbjct: 253 FIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+H V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVL 362
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
Y + D +S+GC+ ++L G F R
Sbjct: 363 QK-GVAYDSSADWFSLGCMLFKLLRGHSPF-------------------------RQHKT 396
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYF 406
K + + M V F P LLE LL D R A+E P+F
Sbjct: 397 KDKHEIDRMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
Query: 407 HGL 409
L
Sbjct: 454 RSL 456
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 70/312 (22%), Positives = 123/312 (39%), Gaps = 49/312 (15%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
++ E+IG+G YG V + VA+K + + + + I + L+ H +I
Sbjct: 16 KLLELIGRGRYGAVYKG--SLDERPVAVKVFSF--ANRQNFIN-EKNIYRVPLMEHDNIA 70
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ + +V E + L + + + + + RGL Y+HT
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH-SVTRGLAYLHT 129
Query: 235 ANVF---------HRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY-----V 280
HRDL +N+L D I DFGL+ + D V
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 281 ATRWYRAPE-LCGSF----FSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVV-HQLDLM 333
T Y APE L G+ +D++++G I+ E+ LFPG++V +Q+
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA---DPLALHLLERLL--- 387
T++ P+ E + + + + +R P KFP A + LA+ L+ +
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQR---------P-----KFPEAWKENSLAVRSLKETIEDC 295
Query: 388 -AFDPKDRPTAE 398
D + R TA+
Sbjct: 296 WDQDAEARLTAQ 307
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 69/287 (24%), Positives = 114/287 (39%), Gaps = 46/287 (16%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 173
Y++ +VIG+G++G V T + A+K ++ SD+ E ++ P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 174 IVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGL 229
+V++ + F+D +Y+V E M DL ++ N D+ + +F+ +++ L
Sbjct: 131 VVQLFY--------AFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLAL 181
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
IH+ HRD+KP N+L + LK+ DFG N T V T Y +PE
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-KMNKEGMVRCDT-AVGTPDYISPE 239
Query: 290 --LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
Y D WS+G EML G F ++V + S+
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---------------GTYSK 284
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 394
I M K + F + A +L+ L D + R
Sbjct: 285 I-----------MNHKNSLTF-PDDNDISKEAKNLICAFLT-DREVR 318
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 74/312 (23%), Positives = 127/312 (40%), Gaps = 55/312 (17%)
Query: 102 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDAT 157
T F E + +GKG++G V +TG VA+K++
Sbjct: 17 PTIF-----EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQR 69
Query: 158 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTP 215
REI++L+ L IV+ + + P R + + +V E + S L ++ + L
Sbjct: 70 DFQREIQILKALHSDFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDA 126
Query: 216 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275
+ Q+ +G++Y+ + HRDL +NIL ++ +KI DFGLA++ D
Sbjct: 127 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD------ 180
Query: 276 WTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT--GKPLFPGKN 325
D YV WY APE + ++ D+WS G + E+ T K P
Sbjct: 181 -KDYYVVREPGQSPIFWY-APE--SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236
Query: 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH-LLE 384
+ + D + + + E+ +R + P A P +H L++
Sbjct: 237 FLRMMGCERD--VPALSRLLELL--EEGQR----LPA----------PPACPAEVHELMK 278
Query: 385 RLLAFDPKDRPT 396
A P+DRP+
Sbjct: 279 LCWAPSPQDRPS 290
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 53/235 (22%), Positives = 98/235 (41%), Gaps = 38/235 (16%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATR--ILREIKLLRLL 169
+ +V+G G++G V + GE+ VAIK++ E S IL E ++ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASV 74
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 227
+P + + I L + + ++ +LM L ++ + D + ++ + Q+ +
Sbjct: 75 DNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT----- 282
G+ Y+ + HRDL +N+L +KI DFGLA++ +
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEGGKV 181
Query: 283 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+W A E YT D+WS G E++T G + G + L+
Sbjct: 182 PIKWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 53/235 (22%), Positives = 101/235 (42%), Gaps = 40/235 (17%)
Query: 116 QIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRI--LREIKLLRLLR 170
+ ++G+G +G V G + + VA+K + + + + E +++ L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLD 71
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRG 228
HP IV++ I+ +++ EL +L ++ N + L + Q+ +
Sbjct: 72 HPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------ 282
+ Y+ + N HRD+ +NIL + +K+ DFGL+R ++ DY
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--------DYYKASVTRLP 177
Query: 283 -RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+W +PE S F ++T A D+W E+L+ GK F V+ L+
Sbjct: 178 IKWM-SPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 54/231 (23%), Positives = 98/231 (42%), Gaps = 37/231 (16%)
Query: 116 QIQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ + +G G +GVV G + VA+K I E +E + + L HP
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQY---DVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPK 64
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKY 231
+V+ + + IY+V E + + L ++++ L P Y + G+ +
Sbjct: 65 LVKFYGVCS-----KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RW 284
+ + HRDL +N L + D +K+ DFG+ R +D YV++ +W
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--------QYVSSVGTKFPVKW 171
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
APE + KY+ D+W+ G + E+ + GK + VV ++
Sbjct: 172 S-APE--VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 40/235 (17%)
Query: 116 QIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRI--LREIKLLRLLR 170
++ IG+G +G V G + VAIK SD+ R L+E +R
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFD 74
Query: 171 HPDIVEIKHIML-PPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 227
HP IV++ ++ P ++++ EL +L ++ L + YQL
Sbjct: 75 HPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT----- 282
L Y+ + HRD+ +N+L +++ +K+ DFGL+R + Y
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKASKGKL 179
Query: 283 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 180 PIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 55/235 (23%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+ ++ +G G YG V V VA+K + E + L+E +++ ++HP
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 69
Query: 173 DIVEIKHIML--PPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLR 227
++V++ + PP Y++ E M +L ++ + +++ + Q+
Sbjct: 70 NLVQLLGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-------IFWTDYV 280
++Y+ N HRDL +N L + +K+ DFGL+R+ D +A I WT
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT--- 179
Query: 281 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
APE ++K++ D+W+ G + E+ T G +PG + V L+
Sbjct: 180 ------APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 35/231 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLR 170
++ + IGKG +G V + G +VA+K I + DAT L E ++ LR
Sbjct: 21 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN------DATAQAFLAEASVMTQLR 72
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLR 227
H ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 73 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF---WTDYVATRW 284
++Y+ N HRDL +N+L + D K+ DFGL + + + + WT
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 181
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
APE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 182 --APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 57/234 (24%), Positives = 95/234 (40%), Gaps = 34/234 (14%)
Query: 116 QIQEVIGKGSYGVVGSAV---DTHTGERVAIKKI-NDVFEHVSDATRILREIKLLRLLRH 171
++ E +G GS+GVV + VA+K + DV +RE+ + L H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 229
+++ + ++L P + +V EL L ++ + + Q+ G+
Sbjct: 81 RNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 282
Y+ + HRDL +N+L +KI DFGL R + YV
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH------YVMQEHRKVPF 188
Query: 283 RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
W APE S ++ A D W G EM T G+ + G N ++H++D
Sbjct: 189 AWC-APE---SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 37/293 (12%), Positives = 68/293 (23%), Gaps = 69/293 (23%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT---RILREIKLLRL 168
RY++ G A+DT +VA+ ++ + V L L
Sbjct: 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVD--PQGVLPDDVLQETLSRTLRLSR 87
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 227
+ P + + ++ + VV E + L +V + +P + L
Sbjct: 88 IDKPGVARVLDVVHTRAG-----GLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAA 140
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
H A V P + + D + +
Sbjct: 141 AADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-----------------------TMP 177
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
P DI IG +L + P V L
Sbjct: 178 DA---------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ------- 221
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
P+ + + + R + D R +
Sbjct: 222 -----------------PIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 37/231 (16%)
Query: 116 QIQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ IG G +G+V G ++ +VAIK I E + E +++ L HP
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKD---KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPK 64
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKY 231
+V++ + L E I +V E ME L ++ E + G+ Y
Sbjct: 65 LVQLYGVCL-----EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RW 284
+ A V HRDL +N L + +K+ DFG+ R +D Y ++ +W
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--------QYTSSTGTKFPVKW 171
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+PE FS+Y+ D+WS G + E+ + GK + ++ VV +
Sbjct: 172 A-SPE--VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 50/236 (21%), Positives = 93/236 (39%), Gaps = 34/236 (14%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLLRL 168
+ + +V+G G +G V G + + V IK I D + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGS 71
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLL 226
L H IV + + S + +V + + L ++ + L P+ + Q+
Sbjct: 72 LDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT---- 282
+G+ Y+ + HR+L +N+L + ++++ DFG+A + D +
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-------DKQLLYSEAK 178
Query: 283 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+W A E F KYT D+WS G E++T G + G V L+
Sbjct: 179 TPIKWM-ALE--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 58/229 (25%), Positives = 87/229 (37%), Gaps = 35/229 (15%)
Query: 102 ETEFFTEYGEASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDAT 157
T F + +G+G +G V + TGE VA+K +
Sbjct: 25 PTVF-----HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---ADAGPQH 76
Query: 158 RI--LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLT 214
R +EI +LR L H I++ K + +V E + L + + +
Sbjct: 77 RSGWKQEIDILRTLYHEHIIKYKGCCEDAGA---ASLQLVMEYVPLGSLRDYLPRHS-IG 132
Query: 215 PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAI 274
F Q+ G+ Y+H + HRDL +N+L + D +KI DFGLA+
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---- 188
Query: 275 FWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
Y WY APE K+ A D+WS G E+LT
Sbjct: 189 --EYYRVREDGDSPVFWY-APE--CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 29/228 (12%)
Query: 118 QEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
+ +G G++G V G + VA+K + + + +L E +++ L +P IV
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ I S +V E+ E L++ ++ N + ++ ++Q+ G+KY+
Sbjct: 82 RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RWYRA 287
+N HRDL +N+L KI DFGL++ D Y A +WY A
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE------NYYKAQTHGKWPVKWY-A 188
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
PE + K++ D+WS G + E + G+ + G V L+
Sbjct: 189 PE--CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 68/259 (26%), Positives = 115/259 (44%), Gaps = 37/259 (14%)
Query: 93 MDPHKKSALET---EFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGER---VAIKKI 146
+DPH EF E +A+ I +V+G G +G V S ++ VAIK +
Sbjct: 23 VDPHTFEDPTQTVHEFAKEL-DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 147 NDVFEHVSDATRI--LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DL 203
++ R L E ++ HP+I+ ++ ++ + K + +V E ME+ L
Sbjct: 82 K---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KSKPVMIVTEYMENGSL 133
Query: 204 HQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262
++ +D T L + G+KY+ HRDL +NIL N++ K+ DFGL
Sbjct: 134 DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 263 ARVSFNDAPSAIFWTDYVAT------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
RV +D Y RW +PE + K+T A D+WS G + E+++
Sbjct: 194 GRVLEDDP-----EAAYTTRGGKIPIRWT-SPE--AIAYRKFTSASDVWSYGIVLWEVMS 245
Query: 317 -GKPLFPGKN---VVHQLD 331
G+ + + V+ +D
Sbjct: 246 YGERPYWEMSNQDVIKAVD 264
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 25/227 (11%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRI--LREIKLLRLLRHPD 173
+ E IG+G++G V S VA+K E + + L+E ++L+ HP+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPN 173
Query: 174 IVEIKHIML--PPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGL 229
IV + + P IY+V EL++ D ++ L + + G+
Sbjct: 174 IVRLIGVCTQKQP-------IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+Y+ + HRDL +N L LKI DFG++R + +A V +W APE
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APE 285
Query: 290 LCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+ + +Y+ D+WS G + E + G +P + ++
Sbjct: 286 ---ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 50/231 (21%), Positives = 92/231 (39%), Gaps = 37/231 (16%)
Query: 116 QIQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ +G G +GVV G + VAIK I E + E K++ L H
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQY---DVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEK 80
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKY 231
+V++ + + + I+++ E M + L ++ + + ++Y
Sbjct: 81 LVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RW 284
+ + HRDL +N L N +K+ DFGL+R +D +Y ++ RW
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--------EYTSSVGSKFPVRW 187
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
PE +SK++ DIW+ G + E+ + GK + +
Sbjct: 188 S-PPE--VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 64/313 (20%), Positives = 124/313 (39%), Gaps = 39/313 (12%)
Query: 38 NNKKSNNINTSSSSSSHEGQHLQQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHK 97
+ I S +G + + +G + + I + ++P
Sbjct: 18 RASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLS--ALNPEL 75
Query: 98 KSALETEFFTEYGEASRYQIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVS 154
A++ + EVIG+G +G V G+ +D + A+K +N + +
Sbjct: 76 VQAVQ-HVVIGP-SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-G 132
Query: 155 DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-D 212
+ ++ L E +++ HP+++ + I L VV M+ DL I+ +
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHN 188
Query: 213 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272
T + F Q+ +G+K++ + HRDL +N + + +K+ DFGLAR
Sbjct: 189 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD------- 241
Query: 273 AIFWTDYVAT----------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLF 321
++ ++ + +W A E K+T D+WS G + E++T G P +
Sbjct: 242 -MYDKEFDSVHNKTGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297
Query: 322 PGKN---VVHQLD 331
P N + L
Sbjct: 298 PDVNTFDITVYLL 310
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 61/261 (23%), Positives = 112/261 (42%), Gaps = 37/261 (14%)
Query: 90 PATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKI 146
+ ++P A++ + EVIG+G +G V G+ +D + A+K +
Sbjct: 4 LSALNPELVQAVQ-HVVIGP-SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 61
Query: 147 NDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQ 205
N + + + ++ L E +++ HP+++ + I L VV M+ DL
Sbjct: 62 NRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRN 116
Query: 206 VIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264
I+ + T + F Q+ +G+KY+ + HRDL +N + + +K+ DFGLAR
Sbjct: 117 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
Query: 265 VSFNDAPSAIFWTDYVAT----------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEM 314
++ +Y + +W A E K+T D+WS G + E+
Sbjct: 177 D--------MYDKEYYSVHNKTGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWEL 225
Query: 315 LT-GKPLFPGKN---VVHQLD 331
+T G P +P N + L
Sbjct: 226 MTRGAPPYPDVNTFDITVYLL 246
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 51/233 (21%), Positives = 101/233 (43%), Gaps = 33/233 (14%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+ ++ +G G YG V V VA+K + E + L+E +++ ++HP
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 276
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGL 229
++V++ + Y++ E M +L ++ + +++ + Q+ +
Sbjct: 277 NLVQLLGVCT-----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 282
+Y+ N HR+L +N L + +K+ DFGL+R+ D Y A
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--------YTAHAGAKFPI 383
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
+W APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 384 KWT-APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 33/233 (14%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATRI--LREIKLLRLLR 170
I+++IG G G V G+R VAIK + ++ R L E ++
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFD 108
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRG 228
HP+I+ ++ ++ + +V E ME+ L ++ +D T L + G
Sbjct: 109 HPNIIRLEGVVT-----RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------ 282
++Y+ HRDL +N+L +++ K+ DFGL+RV +D +A Y T
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA-----YTTTGGKIPI 218
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
RW APE F ++ A D+WS G + E+L G+ + V+ ++
Sbjct: 219 RWT-APE--AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 50/242 (20%), Positives = 95/242 (39%), Gaps = 35/242 (14%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRILREIKLLRLL 169
+ + +++G+G +G V G+ +VA+K + + L E ++
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN------DDLTPEHYQFFL 222
HP+++ + + + S + V+ M+ DLH + + + + F+
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD-YVA 281
+ G++Y+ N HRDL +N + D + + DFGL++ I+ D Y
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--------IYSGDYYRQ 205
Query: 282 T-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQ 329
+W A E S YT D+W+ G E+ T G +PG +
Sbjct: 206 GRIAKMPVKWI-AIE---SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261
Query: 330 LD 331
L
Sbjct: 262 LL 263
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 61/238 (25%), Positives = 111/238 (46%), Gaps = 36/238 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRI--LREIKLL 166
S Q+VIG G +G V + + + VAIK + ++ R+ L E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIM 100
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQ 224
H +I+ ++ ++ ++K + ++ E ME+ L + ++ D + L
Sbjct: 101 GQFSHHNIIRLEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-- 282
+ G+KY+ N HRDL +NIL N++ K+ DFGL+RV +D Y +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTSGG 210
Query: 283 ----RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
RW APE + + K+T A D+WS G + E++T G+ + + V+ ++
Sbjct: 211 KIPIRWT-APE---AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 51/233 (21%), Positives = 97/233 (41%), Gaps = 34/233 (14%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLRLLRH 171
+ +V+G G++G V + GE+ VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 229
P + + I L + + ++ +LM L ++ + D + ++ + Q+ +G+
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 282
Y+ + HRDL +N+L +KI DFGLA++ +
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEGGKVPI 183
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+W A E YT D+WS G E++T G + G + L+
Sbjct: 184 KWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+++ +G+G +G V T RVAIK + L+E ++++ LRH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 239
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGL 229
+V++ ++ + IY+V E M L +K L Q+ G+
Sbjct: 240 KLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 282
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ +Y A
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKFPI 345
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
+W APE + + ++T D+WS G + E+ T G+ +PG + V+ Q++
Sbjct: 346 KWT-APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATR--ILREIKLLRLLR 170
++ + IGKG +G V + G +VA+K I + DAT L E ++ LR
Sbjct: 193 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKN------DATAQAFLAEASVMTQLR 244
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLR 227
H ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 245 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
++Y+ N HRDL +N+L + D K+ DFGL + + + + +W A
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWT-A 354
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
PE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 355 PE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 54/242 (22%), Positives = 100/242 (41%), Gaps = 34/242 (14%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRILREIKLLRLL 169
++ + ++GKG +G V +VA+K + SD LRE ++
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 170 RHPDIVEIKHIMLPP-SRREFKDIYVVFELMES-DLHQVIKAN------DDLTPEHYQFF 221
HP + ++ + L ++ V+ M+ DLH + A+ +L + F
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 222 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY-- 279
+ + G++Y+ + N HRDL +N + D + + DFGL+R I+ DY
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--------IYSGDYYR 194
Query: 280 ------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQ 329
+ +W A E + YT D+W+ G E++T G+ + G + +
Sbjct: 195 QGCASKLPVKWL-ALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 330 LD 331
L
Sbjct: 252 LI 253
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 62/236 (26%), Positives = 101/236 (42%), Gaps = 41/236 (17%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
++ E +G G +G V G +VA+K + + L E L++ L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHT---KVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 171 HPDIVEIKHIML-PPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLL 226
H +V + ++ P IY++ E ME+ L +K LT Q+
Sbjct: 67 HQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT---- 282
G+ +I N HRDL+ NIL + KI DFGLAR+ ++ +Y A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN--------EYTAREGAK 171
Query: 283 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+W APE + +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 172 FPIKWT-APE--AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 76/308 (24%), Positives = 125/308 (40%), Gaps = 66/308 (21%)
Query: 120 VIGKGSYG---VVGSAVDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLRHPDI 174
V+GKG YG V +TG+ A+K + + + D E +L ++HP I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 175 VEIKHIMLPPSRREFKDIYVVF------ELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 228
V++ + + +Y++ EL + ++ + F+L ++
Sbjct: 84 VDLIYAFQTGGK-----LYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLAEISMA 133
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
L ++H + +RDLKP+NI+ N +K+ DFGL + S +D + T Y AP
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT---HTFCGTIEYMAP 190
Query: 289 E-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
E L S + A+D WS+G + +MLTG P F G+N ++I +
Sbjct: 191 EILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGENR---------------KKTIDK 232
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR----PT-AEEAL 401
I K P A LL++LL + R P A E
Sbjct: 233 ILKCKLN-----------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275
Query: 402 ADPYFHGL 409
A P+F +
Sbjct: 276 AHPFFRHI 283
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 67/243 (27%), Positives = 104/243 (42%), Gaps = 41/243 (16%)
Query: 111 EASRYQIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRILREIKLLR 167
E VIGKG +GVV G +D + AIK ++ + E LRE L+R
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-QQVEAFLREGLLMR 77
Query: 168 LLRHPDIVEIKHIML---PPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFL 222
L HP+++ + IML +V+ M DL Q I++ + T + F
Sbjct: 78 GLNHPNVLALIGIMLPPEGL-------PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG 130
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282
Q+ RG++Y+ HRDL +N + + +K+ DFGLAR I +Y +
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD--------ILDREYYSV 182
Query: 283 ----------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVH 328
+W A E ++T D+WS G + E+LT G P + + + H
Sbjct: 183 QQHRHARLPVKWT-ALE--SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH 239
Query: 329 QLD 331
L
Sbjct: 240 FLA 242
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 66/293 (22%), Positives = 116/293 (39%), Gaps = 68/293 (23%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK--------KINDVFEHVSDATRILREIKLL 166
+ + +G GS+G V +G A+K K+ + EH + RIL+ +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-EHTLNEKRILQAV--- 98
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFL 222
P +V+++ FKD +Y+V E + ++ ++ + H +F+
Sbjct: 99 ---NFPFLVKLEF--------SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA 147
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT 282
Q++ +Y+H+ ++ +RDLKP+N+L + +++ DFG A+ WT T
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WT-LCGT 201
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
APE+ S Y A+D W++G + EM G P F +
Sbjct: 202 PEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--------------- 244
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR 394
+ +I + K R FP + LL LL D R
Sbjct: 245 QIYEKIVSGKVR-----------------FPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 74/318 (23%), Positives = 128/318 (40%), Gaps = 83/318 (26%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIK--------KINDVFEHVSDATRILREIKLL 166
+QI +G GS+G V H G A+K ++ V EH +D +L +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQV-EHTNDERLMLSIV--- 63
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFL 222
HP I+ + F+D I+++ + +E +L +++ + +F+
Sbjct: 64 ---THPFIIRMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA 112
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWT----- 277
++ L+Y+H+ ++ +RDLKP+NIL + + +KI DFG A+ + +T
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTP 167
Query: 278 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337
DY+ APE+ + Y +ID WS G + EML G F N +
Sbjct: 168 DYI------APEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---------- 209
Query: 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-- 394
++ +I N + R FP + LL RL+ D R
Sbjct: 210 -----KTYEKILNAELR-----------------FPPFFNEDVKDLLSRLITRDLSQRLG 247
Query: 395 ---PTAEEALADPYFHGL 409
E+ P+F +
Sbjct: 248 NLQNGTEDVKNHPWFKEV 265
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 72/299 (24%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
++GKG++G V + TG A+K + +V + + E ++L+ RHP + +K
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 179 HIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 237
+ R + V E +L + T E +F+ +++ L+Y+H+ +V
Sbjct: 72 YAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 238 FHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFS 296
+RD+K +N++ + D +KI DFGL + +D + + T Y APE L +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED---N 180
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356
Y A+D W +G + EM+ G+ F ++ + + + I E+ R
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFE-----------LILMEEIR-- 223
Query: 357 LGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 409
FP P A LL LL DPK R A+E + +F +
Sbjct: 224 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+++ +G+G +G V T RVAIK + L+E ++++ LRH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 322
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGL 229
+V++ ++ + IY+V E M L +K L Q+ G+
Sbjct: 323 KLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 282
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ +Y A
Sbjct: 377 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKFPI 428
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
+W APE + + ++T D+WS G + E+ T G+ +PG + V+ Q++
Sbjct: 429 KWT-APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 37/233 (15%)
Query: 117 IQEVIGKGSYGVVGSAVDTHTGER--VAIK--KINDVFEHVSDATRILREIKLLRLLRHP 172
+G G++G V V ++ VAIK K + ++RE +++ L +P
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE---MMREAQIMHQLDNP 70
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLK 230
IV + + + + +V E+ LH+ + + + + L+Q+ G+K
Sbjct: 71 YIVRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 124
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------R 283
Y+ N HRDL +N+L KI DFGL++ D Y A +
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLK 178
Query: 284 WYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
WY APE F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 179 WY-APE---CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 74/299 (24%), Positives = 127/299 (42%), Gaps = 51/299 (17%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIK 178
++GKG++G V + TG A+K + +V + L E ++L+ RHP + +K
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 179 HIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-N 236
+ R + V E +L + + + +F+ +++ L Y+H+ N
Sbjct: 215 YSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 269
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
V +RDLK +N++ + D +KI DFGL + D + + T Y APE+ +
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED--N 324
Query: 297 KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRY 356
Y A+D W +G + EM+ G+ F ++ + + +L I E+ R
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFEL-----------ILMEEIR-- 367
Query: 357 LGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR----PT-AEEALADPYFHGL 409
FP P A LL LL DPK R A+E + +F G+
Sbjct: 368 ---------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 175
++++ +G G +G V A +VA+K + L E +++ L+H +V
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 176 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYI 232
++ ++ + IY++ E M L +K+++ F Q+ G+ +I
Sbjct: 247 KLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RWY 285
N HRDL+ NIL +A KI DFGLARV ++ +Y A +W
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN--------EYTAREGAKFPIKWT 352
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG---KNVVHQLD 331
APE F +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 353 -APE--AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 62/331 (18%), Positives = 122/331 (36%), Gaps = 35/331 (10%)
Query: 20 FTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQQLTIVEDFDFSGLK----L 75
++ +++ + + + + +H ++ + G
Sbjct: 239 LKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPAR 298
Query: 76 IRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDT 135
I P + + T P + + +G G++G V V
Sbjct: 299 ITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYR 358
Query: 136 HTGER--VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193
++ VAIK + E +D ++RE +++ L +P IV + + + +
Sbjct: 359 MRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA------LM 411
Query: 194 VVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251
+V E+ LH+ + + + + L+Q+ G+KY+ N HR+L +N+L
Sbjct: 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN 471
Query: 252 DCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDI 304
KI DFGL++ D Y A +WY APE F K++ D+
Sbjct: 472 RHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY-APE--CINFRKFSSRSDV 522
Query: 305 WSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
WS G E L+ G+ + V+ ++
Sbjct: 523 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 67/302 (22%), Positives = 118/302 (39%), Gaps = 61/302 (20%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHP 172
++GKGS+G V A T + AIK + +D E T + + + L HP
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----TMVEKRV-LSLAWEHP 78
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+ + ++ V E + DL I++ F+ +++ GL++
Sbjct: 79 FLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 133
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLAR--VSFNDAPSAIFWTDYVATRWYRAPE 289
+H+ + +RDLK NIL + D +KI DFG+ + + + + + T Y APE
Sbjct: 134 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-----FCGTPDYIAPE 188
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ KY ++D WS G + EML G+ F G++ + + IR
Sbjct: 189 ILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFH-----------SIR 231
Query: 350 NEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-PTAEEALADPYFH 407
+ +P + A LL +L +P+ R + P F
Sbjct: 232 MDNPF-----------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274
Query: 408 GL 409
+
Sbjct: 275 EI 276
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 40/235 (17%)
Query: 116 QIQEVIGKGSYGVV--GSAVDTHTGE-RVAIKKINDVFEHVSDATRI--LREIKLLRLLR 170
++ IG+G +G V G + VAIK SD+ R L+E +R
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALTMRQFD 449
Query: 171 HPDIVEIKHIML-PPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 227
HP IV++ ++ P ++++ EL +L ++ L + YQL
Sbjct: 450 HPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT----- 282
L Y+ + HRD+ +N+L +++ +K+ DFGL+R + Y
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKASKGKL 554
Query: 283 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 555 PIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 3e-23
Identities = 72/306 (23%), Positives = 117/306 (38%), Gaps = 64/306 (20%)
Query: 120 VIGKGSYG---VVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 176
V+G+GS+G +V + + A+K + V D R E +L + HP IV+
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 177 IKHIMLPPSRREFKDIYVVF------ELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
+ + + +Y++ +L + T E +F+L +L L
Sbjct: 91 LHYAFQTEGK-----LYLILDFLRGGDLF---TR--LSKEVMFTEEDVKFYLAELALALD 140
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 289
++H+ + +RDLKP+NIL + + +K+ DFGL++ S + A + T Y APE
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVEYMAPEV 197
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ +T + D WS G + EMLTG F GK+ I
Sbjct: 198 VNR---RGHTQSADWWSFGVLMFEMLTGTLPFQGKDR----KETMT-----------MIL 239
Query: 350 NEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR-----PTAEEALAD 403
K P P A LL L +P +R EE
Sbjct: 240 KAKLG-----------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282
Query: 404 PYFHGL 409
+F +
Sbjct: 283 SFFSTI 288
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 63/310 (20%), Positives = 114/310 (36%), Gaps = 73/310 (23%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHP 172
V+GKGS+G V + T E A+K + +D E T + + + L + P
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC----TMVEKRV-LALPGKPP 81
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFE------LMESDLHQVIKANDDLTPEHYQFFLYQLL 226
+ ++ R +Y V E LM H I+ H F+ ++
Sbjct: 82 FLTQLHSCFQTMDR-----LYFVMEYVNGGDLM---YH--IQQVGRFKEPHAVFYAAEIA 131
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
GL ++ + + +RDLK N++ +++ +KI DFG+ + + D + + T Y
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT---KTFCGTPDYI 188
Query: 287 APE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE + Y ++D W+ G + EML G+ F G++ E
Sbjct: 189 APEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---------------DELF 230
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR----PT-AEE 399
I +P + A+ + + L+ P R P +
Sbjct: 231 QSIMEHNVA-----------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 273
Query: 400 ALADPYFHGL 409
+F +
Sbjct: 274 IKEHAFFRYI 283
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 68/342 (19%), Positives = 125/342 (36%), Gaps = 68/342 (19%)
Query: 88 PTPATMDPHKKSALETEFFTEYGEASRYQIQE-----VIGKGSYGVVGSAVDTHTGERVA 142
T P +K+A F G R ++ + V+GKGS+G V + T E A
Sbjct: 311 IGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYA 370
Query: 143 IKKI-------NDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 195
+K + +D E T + + + L + P + ++ R +Y V
Sbjct: 371 VKILKKDVVIQDDDVEC----TMVEKRV-LALPGKPPFLTQLHSCFQTMDR-----LYFV 420
Query: 196 FELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 254
E + DL I+ H F+ ++ GL ++ + + +RDLK N++ +++
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH 480
Query: 255 LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAE 313
+KI DFG+ + + D + + T Y APE + Y ++D W+ G + E
Sbjct: 481 IKIADFGMCKENIWDGVTT---KTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYE 534
Query: 314 MLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP 373
ML G+ F G++ E I +P
Sbjct: 535 MLAGQAPFEGEDE---------------DELFQSIMEHNVA-----------------YP 562
Query: 374 -NADPLALHLLERLLAFDPKDR-----PTAEEALADPYFHGL 409
+ A+ + + L+ P R + +F +
Sbjct: 563 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 78/346 (22%), Positives = 123/346 (35%), Gaps = 65/346 (18%)
Query: 82 IQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQE-----VIGKGSYGVVGSAVDTH 136
I P P +P A + + + VIGKGS+G V A
Sbjct: 2 ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKA 61
Query: 137 TGERVAIKKIN-DVFEHVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194
A+K + + I+ E LL+ ++HP +V + + +Y
Sbjct: 62 EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK-----LYF 116
Query: 195 VF------ELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 248
V EL H ++ +F+ ++ L Y+H+ N+ +RDLKP+NIL
Sbjct: 117 VLDYINGGELF---YH--LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL 171
Query: 249 ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 308
++ + + DFGL + + + T + T Y APE+ Y +D W +G
Sbjct: 172 LDSQGHIVLTDFGLCKENIEHNSTT--ST-FCGTPEYLAPEVLHK--QPYDRTVDWWCLG 226
Query: 309 CIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPF 368
+ EML G P F +N M D I N+ +
Sbjct: 227 AVLYEMLYGLPPFYSRNT----AEMYD-----------NILNKPLQ-------------- 257
Query: 369 SHKFP-NADPLALHLLERLLAFDPKDR----PTAEEALADPYFHGL 409
N A HLLE LL D R E + +F +
Sbjct: 258 ---LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 38/239 (15%), Positives = 78/239 (32%), Gaps = 40/239 (16%)
Query: 116 QIQEVIGKGSYGVVGSAVDTHTGE-------RVAIKKINDVFEHVSDATRILREIKLLRL 168
E +G+G++ + V G+ V +K ++ + S++ ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES--FFEAASMMSK 68
Query: 169 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLL 226
L H +V + + + +V E ++ L +K N + + QL
Sbjct: 69 LSHKHLVLNYGVCV-----CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKL--------KICDFGLARVSFNDAPSAIFWTD 278
+ ++ + H ++ KNIL + K+ D G++ + D
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--------VLPKD 175
Query: 279 Y--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
W PE C A D WS G E+ + G + + +
Sbjct: 176 ILQERIPWV-PPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 56/255 (21%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 165
++ +G+G++G V + + VA+K + D + A R RE +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAEL 70
Query: 166 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN-------------- 210
L L+H IV+ + + + +VFE M+ DL++ ++A+
Sbjct: 71 LTNLQHEHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 211 --DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
+L Q+ G+ Y+ + + HRDL +N L A+ +KI DFG++R
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD--- 182
Query: 269 DAPSAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKP 319
++ TDY RW PE + K+T D+WS G I E+ T GK
Sbjct: 183 -----VYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 320 LFPGKN---VVHQLD 331
+ + V+ +
Sbjct: 235 PWFQLSNTEVIECIT 249
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 63/280 (22%), Positives = 109/280 (38%), Gaps = 39/280 (13%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIK-LLRLLRHPDIVEI 177
VIG+GSY V T A+K + ++ D + E + HP +V +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
SR ++ V E + DL ++ L EH +F+ ++ L Y+H
Sbjct: 76 HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFF 295
+ +RDLK N+L +++ +K+ D+G+ + + + + T Y APE L G
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--- 184
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355
Y ++D W++G + EM+ G+ F D I ++ R
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------QNTEDYLFQVILEKQIR- 237
Query: 356 YLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR 394
P + A +L+ L DPK+R
Sbjct: 238 ----------------IPRSLSVKAASVLKSFLNKDPKER 261
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 6e-22
Identities = 64/285 (22%), Positives = 110/285 (38%), Gaps = 58/285 (20%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKI-------NDVFEHVSDATRILREIKLLRLLRHP 172
V+GKGS+G V A TG+ A+K + +D E T + I L HP
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVEC----TMTEKRI-LSLARNHP 84
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+ ++ P R ++ V E + DL I+ + +F+ +++ L +
Sbjct: 85 FLTQLFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-L 290
+H + +RDLK N+L + + K+ DFG+ + + + + T Y APE L
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT---ATFCGTPDYIAPEIL 196
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
Y PA+D W++G + EML G F +N + I N
Sbjct: 197 QE---MLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---------------DDLFEAILN 238
Query: 351 EKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR 394
++ +P A +L+ + +P R
Sbjct: 239 DEVV-----------------YPTWLHEDATGILKSFMTKNPTMR 266
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 62/251 (24%), Positives = 99/251 (39%), Gaps = 62/251 (24%)
Query: 111 EASRYQIQ--EVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LR 161
E +R +I +G+GS+G+V G A E RVAIK +N E S RI L
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN 77
Query: 162 EIKLLRLLRHPDIVEIKHIML--PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 210
E +++ +V + ++ P V+ ELM DL +++
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQP-------TLVIMELMTRGDLKSYLRSLRPAMANNP 130
Query: 211 --DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
+ ++ G+ Y++ HRDL +N + D +KI DFG+ R
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--- 187
Query: 269 DAPSAIFWTDYVATRWYR------------APELCGS-FFSKYTPAIDIWSIGCIFAEML 315
I+ TDY YR +PE S +T D+WS G + E+
Sbjct: 188 -----IYETDY-----YRKGGKGLLPVRWMSPE---SLKDGVFTTYSDVWSFGVVLWEIA 234
Query: 316 T-GKPLFPGKN 325
T + + G +
Sbjct: 235 TLAEQPYQGLS 245
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 58/254 (22%), Positives = 102/254 (40%), Gaps = 55/254 (21%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 165
++ +G+G++G V + + VA+K + + S++ R RE +L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAEL 96
Query: 166 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD------------ 212
L +L+H IV + E + + +VFE M DL++ ++++
Sbjct: 97 LTMLQHQHIVRFFGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 213 ---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269
L Q+ G+ Y+ + HRDL +N L +KI DFG++R
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD---- 207
Query: 270 APSAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPL 320
I+ TDY RW PE + K+T D+WS G + E+ T GK
Sbjct: 208 ----IYSTDYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
Query: 321 FPGKN---VVHQLD 331
+ + + +
Sbjct: 261 WYQLSNTEAIDCIT 274
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 65/309 (21%), Positives = 127/309 (41%), Gaps = 60/309 (19%)
Query: 120 VIGKGSYG---VVGSAVDTHTGERVAIK---------KINDVFEHVSDATRILREIKLLR 167
V+G G+YG +V TG+ A+K K EH ++L I+
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT-EHTRTERQVLEHIR--- 116
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 226
+ P +V + + ++ ++++ + + +L + + T Q ++ +++
Sbjct: 117 --QSPFLVTLHYAFQTETK-----LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 169
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYR 286
L+++H + +RD+K +NIL +++ + + DFGL++ D + + + T Y
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYD-FCGTIEYM 227
Query: 287 APELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
AP++ S + A+D WS+G + E+LTG F + ++
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR----------- 276
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR----PT-AEEA 400
RI + +P LA L++RLL DPK R P A+E
Sbjct: 277 RILKSEPP-----------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 319
Query: 401 LADPYFHGL 409
+F +
Sbjct: 320 KEHLFFQKI 328
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 54/236 (22%), Positives = 93/236 (39%), Gaps = 51/236 (21%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 165
S + E +G+ +G V G GE VAIK + + R E L
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAML 65
Query: 166 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN-------------- 210
L+HP++V + ++ + + + ++F DLH+ +
Sbjct: 66 RARLQHPNVVCLLGVVT-----KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 211 --DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
L P + + Q+ G++Y+ + +V H+DL +N+L +KI D GL R
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE--- 177
Query: 269 DAPSAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316
++ DY RW APE + K++ DIWS G + E+ +
Sbjct: 178 -----VYAADYYKLLGNSLLPIRWM-APE--AIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 62/280 (22%), Positives = 109/280 (38%), Gaps = 39/280 (13%)
Query: 120 VIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIK-LLRLLRHPDIVEI 177
VIG+GSY V T A++ + ++ D + E + HP +V +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 178 KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
SR ++ V E + DL ++ L EH +F+ ++ L Y+H
Sbjct: 119 HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE-LCGSFF 295
+ +RDLK N+L +++ +K+ D+G+ + + + + T Y APE L G
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--- 227
Query: 296 SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355
Y ++D W++G + EM+ G+ F D I ++ R
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------QNTEDYLFQVILEKQIR- 280
Query: 356 YLGSMRKKQPVPFSHKFP-NADPLALHLLERLLAFDPKDR 394
P + A +L+ L DPK+R
Sbjct: 281 ----------------IPRSLSVKAASVLKSFLNKDPKER 304
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 58/270 (21%), Positives = 99/270 (36%), Gaps = 51/270 (18%)
Query: 94 DPHKKSALETEFFTEYGEASRYQIQ--EVIGKGSYGVV--GSAVDTHTGE---RVAIKKI 146
+P+ A +T ++ E R I +G G++G V G +VA+K +
Sbjct: 9 NPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 68
Query: 147 NDVFEHVSDATRI--LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DL 203
E S+ + L E ++ H +IV + L + +++ ELM DL
Sbjct: 69 P---EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-----QSLPRFILMELMAGGDL 120
Query: 204 HQVIKANDDLTPEHYQFFLYQLL-------RGLKYIHTANVFHRDLKPKNILANA---DC 253
++ + + LL G +Y+ + HRD+ +N L
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180
Query: 254 KLKICDFGLARVSFNDAPSAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIW 305
KI DFG+AR I+ Y +W PE +T D W
Sbjct: 181 VAKIGDFGMARD--------IYRASYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTW 229
Query: 306 SIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
S G + E+ + G +P K+ V+ +
Sbjct: 230 SFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 60/252 (23%), Positives = 107/252 (42%), Gaps = 52/252 (20%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 165
R ++ + +G+G++G V A VA+K + E + + + E+K+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 166 L-RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN------------- 210
L + H ++V +L + + V+ E + +L +++
Sbjct: 84 LIHIGHHLNVVN----LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 211 ---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267
D LT EH + +Q+ +G++++ + HRDL +NIL + +KICDFGLAR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD-- 197
Query: 268 NDAPSAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GK 318
I+ YV +W APE F YT D+WS G + E+ + G
Sbjct: 198 ------IYKDPDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLLWEIFSLGA 248
Query: 319 PLFPGKNVVHQL 330
+PG + +
Sbjct: 249 SPYPGVKIDEEF 260
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 58/276 (21%), Positives = 99/276 (35%), Gaps = 51/276 (18%)
Query: 88 PTPATMDPHKKSALETEFFTEYGEASRYQIQ--EVIGKGSYGVV--GSAVDTHTGE---R 140
+P+ A +T ++ E R I +G G++G V G +
Sbjct: 44 TIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 103
Query: 141 VAIKKINDVFEHVSDATRI--LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 198
VA+K + E S+ + L E ++ H +IV + L + +++ EL
Sbjct: 104 VAVKTLP---EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-----QSLPRFILLEL 155
Query: 199 MES-DLHQVIKANDDLTPEHYQFFLYQLL-------RGLKYIHTANVFHRDLKPKNILAN 250
M DL ++ + + LL G +Y+ + HRD+ +N L
Sbjct: 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 215
Query: 251 A---DCKLKICDFGLARVSFNDAPSAIFWTDYVAT--------RWYRAPELCGSFFSKYT 299
KI DFG+AR I+ Y +W PE +T
Sbjct: 216 CPGPGRVAKIGDFGMARD--------IYRAGYYRKGGCAMLPVKWM-PPE--AFMEGIFT 264
Query: 300 PAIDIWSIGCIFAEMLT-GKPLFPGKN---VVHQLD 331
D WS G + E+ + G +P K+ V+ +
Sbjct: 265 SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 66/289 (22%), Positives = 110/289 (38%), Gaps = 67/289 (23%)
Query: 80 KRIQFPIAPTPATMDPHKKSALET-EFFTEYGEASRYQIQEVIGKGSYGVV--GSAVDTH 136
K I+ + +DP + E EF + Q + +G G++G V +A
Sbjct: 17 KIIESYEGNSYTFIDPTQLPYNEKWEF-----PRNNLQFGKTLGAGAFGKVVEATAFGLG 71
Query: 137 TGE---RVAIKKINDVFEHVSDATRI--LREIKLL-RLLRHPDIVEIKHIML------PP 184
+ +VA+K + + + E+K++ L +H +IV +L P
Sbjct: 72 KEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQHENIVN----LLGACTHGGP 124
Query: 185 SRREFKDIYVVFELMES-DL--------------HQVIKANDDLTPEHYQFFLYQLLRGL 229
+ V+ E DL AN + F Q+ +G+
Sbjct: 125 -------VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGM 177
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT------- 282
++ + N HRD+ +N+L KI DFGLAR ND ++Y+
Sbjct: 178 AFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND-------SNYIVKGNARLPV 230
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQL 330
+W APE F YT D+WS G + E+ + G +PG V +
Sbjct: 231 KWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 79/270 (29%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 165
+ + +G+G +G V +A VA+K + E+ S + L E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNV 79
Query: 166 LRLLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 210
L+ + HP +++ + P + ++ E + L ++ +
Sbjct: 80 LKQVNHPHVIK----LYGACSQDGP-------LLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 211 ----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 254
LT F +Q+ +G++Y+ + HRDL +NIL K
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 255 LKICDFGLARVSFNDAPSAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIW 305
+KI DFGL+R ++ D YV +W A E S F YT D+W
Sbjct: 189 MKISDFGLSRD--------VYEEDSYVKRSQGRIPVKWM-AIE---SLFDHIYTTQSDVW 236
Query: 306 SIGCIFAEMLT--GKPLFPG---KNVVHQL 330
S G + E++T G P +PG + + + L
Sbjct: 237 SFGVLLWEIVTLGGNP-YPGIPPERLFNLL 265
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 55/251 (21%), Positives = 95/251 (37%), Gaps = 73/251 (29%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 165
+ + IG+G++G V A E VA+K + E S + RE L
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAAL 103
Query: 166 LRLLRHPDIVEIKHIML--PPSRREFKDIYVVFELMES-DLHQVIKANDD---------- 212
+ +P+IV++ + P + ++FE M DL++ +++
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKP-------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 213 --------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258
L+ Q+ G+ Y+ HRDL +N L + +KI
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216
Query: 259 DFGLARVSFNDAPSAIFWTDYVATRWYR------------APELCGS-FFSKYTPAIDIW 305
DFGL+R I+ DY Y+ PE S F+++YT D+W
Sbjct: 217 DFGLSRN--------IYSADY-----YKADGNDAIPIRWMPPE---SIFYNRYTTESDVW 260
Query: 306 SIGCIFAEMLT 316
+ G + E+ +
Sbjct: 261 AYGVVLWEIFS 271
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 9e-19
Identities = 61/264 (23%), Positives = 108/264 (40%), Gaps = 72/264 (27%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE-----RVAIKKINDVFEHVSDATRI--LREI 163
+ + + +G+G++G V AV + VA+K + + ++ + E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 164 KLL-RLLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES-DLHQVIKAN----- 210
+++ + +H +I+ +L P +YV+ E +L + ++A
Sbjct: 92 EMMKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGM 140
Query: 211 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 259
+ +T + YQL RG++Y+ + HRDL +N+L + +KI D
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 260 FGLARVSFNDAPSAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCI 310
FGLAR I D Y T +W APE + F YT D+WS G +
Sbjct: 201 FGLARD--------INNIDYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVL 248
Query: 311 FAEMLT-GK---PLFPGKNVVHQL 330
E+ T G P P + + L
Sbjct: 249 MWEIFTLGGSPYPGIPVEELFKLL 272
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 65/260 (25%), Positives = 95/260 (36%), Gaps = 67/260 (25%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKL 165
+R + +G G++G V +A + VA+K + R + E+K+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKV 79
Query: 166 L-RLLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES-DLHQVIKAN------- 210
L L H +IV +L P V+ E DL ++
Sbjct: 80 LSYLGNHMNIVN----LLGACTIGGP-------TLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 211 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 259
L E F YQ+ +G+ ++ + N HRDL +NIL KICD
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 260 FGLARVSFNDAPSAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 311
FGLAR I YV +W APE F YT D+WS G
Sbjct: 189 FGLARD--------IKNDSNYVVKGNARLPVKWM-APESI--FNCVYTFESDVWSYGIFL 237
Query: 312 AEMLT-GKPLFPGKNVVHQL 330
E+ + G +PG V +
Sbjct: 238 WELFSLGSSPYPGMPVDSKF 257
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 86.1 bits (212), Expect = 2e-18
Identities = 51/349 (14%), Positives = 92/349 (26%), Gaps = 75/349 (21%)
Query: 106 FTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI------NDVFEHVSDATRI 159
F+ + Q E IG+G +G V + HT VAIK I H I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 160 LREIKLLRLL---------RHPDIVEIKHIML-------------------------PPS 185
L EI + + L R + + + P
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 186 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF-HRDLKP 244
+ +++V E + + + L+QL L + F HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 245 KNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 304
N+L K+ + S + + + + YT +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSS------------TIPSCGLQVSII------DYTLSRLE 232
Query: 305 WSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK-------ARRYL 357
+F ++ + LF G +Q D + L+ + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDG-DYQFD-IYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM 290
Query: 358 GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ + +L F +A + L
Sbjct: 291 LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 61/261 (23%), Positives = 107/261 (40%), Gaps = 72/261 (27%)
Query: 116 QIQEVIGKGSYGVV--GSAVDTHTGE-----RVAIKKINDVFEHVSDATRI--LREIKLL 166
+ + +G+G +G V AV + VA+K + + ++ + E++++
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMM 140
Query: 167 -RLLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 210
+ +H +I+ +L P +YV+ E +L + ++A
Sbjct: 141 KMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 211 --------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262
+ +T + YQL RG++Y+ + HRDL +N+L + +KI DFGL
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 249
Query: 263 ARVSFNDAPSAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAE 313
AR I D Y T +W APE + F YT D+WS G + E
Sbjct: 250 ARD--------INNIDYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLMWE 297
Query: 314 MLT-GKPLFPG---KNVVHQL 330
+ T G +PG + + L
Sbjct: 298 IFTLGGSPYPGIPVEELFKLL 318
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 61/264 (23%), Positives = 108/264 (40%), Gaps = 72/264 (27%)
Query: 113 SRYQIQEVIGKGSYGVV--GSAVDTHTGE-----RVAIKKINDVFEHVSDATRI--LREI 163
R + + +G+G++G V A+ + +VA+K + ++ + E+
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEM 125
Query: 164 KLL-RLLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES-DLHQVIKAN----- 210
+++ + +H +I+ +L P +YV+ E +L + ++A
Sbjct: 126 EMMKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLQARRPPGL 174
Query: 211 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 259
+ L+ + YQ+ RG++Y+ + HRDL +N+L D +KI D
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234
Query: 260 FGLARVSFNDAPSAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCI 310
FGLAR I D Y T +W APE + F YT D+WS G +
Sbjct: 235 FGLARD--------IHHIDYYKKTTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVL 282
Query: 311 FAEMLT-GK---PLFPGKNVVHQL 330
E+ T G P P + + L
Sbjct: 283 LWEIFTLGGSPYPGVPVEELFKLL 306
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 56/250 (22%), Positives = 93/250 (37%), Gaps = 63/250 (25%)
Query: 94 DPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVV--GSAVDTHTGERVAIKKINDVFE 151
H K+ + + + + + Q+VIG+G++G V AIK++ E
Sbjct: 7 HHHGKNNPDPTIYPVL-DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---E 62
Query: 152 HVSDATRI--LREIKLL-RLLRHPDIVEIKHIML------PPSRREFKDIYVVFELMES- 201
+ S E+++L +L HP+I+ +L +Y+ E
Sbjct: 63 YASKDDHRDFAGELEVLCKLGHHPNIIN----LLGACEHRGY-------LYLAIEYAPHG 111
Query: 202 DLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPK 245
+L ++ + L+ + F + RG+ Y+ HRDL +
Sbjct: 112 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 171
Query: 246 NILANADCKLKICDFGLARVSFNDAPSAIFWTDYVAT-------RWYRAPELCGSFFSKY 298
NIL + KI DFGL+R + YV RW A E +S Y
Sbjct: 172 NILVGENYVAKIADFGLSR--GQEV--------YVKKTMGRLPVRWM-AIE--SLNYSVY 218
Query: 299 TPAIDIWSIG 308
T D+WS G
Sbjct: 219 TTNSDVWSYG 228
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 72/307 (23%), Positives = 118/307 (38%), Gaps = 77/307 (25%)
Query: 74 KLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQ--EVIGKGSYGVV-- 129
K R ++Q + + E E+ ++ E R ++ +V+G G++G V
Sbjct: 5 KQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKW-EFPRENLEFGKVLGSGAFGKVMN 63
Query: 130 GSAVDTHTGE---RVAIKKINDVFEHVSDATRI--LREIKLL-RLLRHPDIVEIKHIML- 182
+A +VA+K + E + R + E+K++ +L H +IV +L
Sbjct: 64 ATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHENIVN----LLG 116
Query: 183 -----PPSRREFKDIYVVFELME------------------------SDLHQVIKANDDL 213
P IY++FE + + + L
Sbjct: 117 ACTLSGP-------IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 214 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA 273
T E F YQ+ +G++++ + HRDL +N+L +KICDFGLAR
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD-------- 221
Query: 274 IFWTD-YVAT-------RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
I YV +W APE S F YT D+WS G + E+ + G +PG
Sbjct: 222 IMSDSNYVVRGNARLPVKWM-APE---SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277
Query: 324 KNVVHQL 330
V
Sbjct: 278 IPVDANF 284
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 39/167 (23%), Positives = 68/167 (40%), Gaps = 30/167 (17%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRIL-REIKLLRLLR 170
+++ + IG G++G + + +T E VAIK E + L E + + L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG 62
Query: 171 H-PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL------- 222
I ++ + K +V EL+ L + D F L
Sbjct: 63 SGDGIPQVYY-----FGPCGKYNAMVLELLGPSLEDLFDLCD------RTFSLKTVLMIA 111
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNIL-----ANADCKLKICDFGLAR 264
QL+ ++Y+H+ N+ +RD+KP+N L + I DF LA+
Sbjct: 112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 16/159 (10%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-SDATRILREIKLLRLLR 170
+RY++ IG GS+G + D GE VAIK E V + ++ E K+ ++++
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQ 62
Query: 171 H-PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRG 228
I I+ E +V EL+ L + + + Q++
Sbjct: 63 GGVGIPTIRW-----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 117
Query: 229 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 264
++YIH+ N HRD+KP N L + I DFGLA+
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 33/168 (19%), Positives = 71/168 (42%), Gaps = 21/168 (12%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
++ + + IG G +G++ A T+ E+ A + E+ + + E+K + + D
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK--VEY-QENGPLFSELKFYQRVAKKD 94
Query: 174 IVE-------IKHIMLP-------PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 219
++ + ++ +P + ++V E + DL ++ N
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVL 154
Query: 220 FFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 264
++L L+YIH H D+K N+L N D ++ + D+GL+
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 36/167 (21%), Positives = 68/167 (40%), Gaps = 30/167 (17%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRIL-REIKLLRLLR 170
Y++ IG+GS+GV+ + ++VAIK FE L E + +LL
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLA 63
Query: 171 H-PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL------- 222
I + + +E +V +L+ L ++ +F +
Sbjct: 64 GCTGIPNVYY-----FGQEGLHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAA 112
Query: 223 YQLLRGLKYIHTANVFHRDLKPKNIL-----ANADCKLKICDFGLAR 264
Q+L ++ IH ++ +RD+KP N L + + + DFG+ +
Sbjct: 113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 55/235 (23%), Positives = 90/235 (38%), Gaps = 76/235 (32%)
Query: 120 VIGKGSYGVV--GSAVDTHTGERVAIKKINDV-------FEHVSDATRILREIKLLRLLR 170
+IG G +G V G D G +VA+K+ F EI+ L R
Sbjct: 46 LIGHGVFGKVYKGVLRD---GAKVALKRRTPESSQGIEEF---------ETEIETLSFCR 93
Query: 171 HPDIV-------EIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHY 218
HP +V E ++L +++ M + L+ ++ E
Sbjct: 94 HPHLVSLIGFCDERNEMIL------------IYKYMENGNLKRHLYGSDLPTMSMSWE-- 139
Query: 219 QFFLYQLL-------RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271
Q L RGL Y+HT + HRD+K NIL + + KI DFG+++
Sbjct: 140 -----QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 272 SAIFWTDYVATRW-----YRAPELCGSFFS--KYTPAIDIWSIGCIFAEMLTGKP 319
+ +++T Y PE +F + T D++S G + E+L +
Sbjct: 195 T------HLSTVVKGTLGYIDPE----YFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-SDATRILREIKLLRLLR 170
+++++ IG GS+G + + T E VAIK E+V + ++L E K+ R+L+
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQ 60
Query: 171 -HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRG 228
I ++ E +V +L+ L + L+ + Q++
Sbjct: 61 GGTGIPNVRW-----FGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Query: 229 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 264
++++H+ + HRD+KP N L ++ I DFGLA+
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 18/140 (12%)
Query: 199 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258
+E + D LT EH + +Q+ +G++++ + HRDL +NIL + +KIC
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 259 DFGLARVSFNDAPSAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 311
DFGLAR + D DYV +W APE F YT D+WS G +
Sbjct: 236 DFGLARDIYKD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLL 285
Query: 312 AEMLT-GKPLFPGKNVVHQL 330
E+ + G +PG + +
Sbjct: 286 WEIFSLGASPYPGVKIDEEF 305
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 60/231 (25%), Positives = 94/231 (40%), Gaps = 67/231 (29%)
Query: 120 VIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSD--ATRILREIKLLRLLRHPDIV 175
+G+G +GVV G V+ VA+KK+ + + ++ + +EIK++ +H ++V
Sbjct: 38 KMGEGGFGVVYKGY-VN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 176 -------EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL-- 226
+ + L V+ M N L L L
Sbjct: 94 ELLGFSSDGDDLCL------------VYVYMP---------NGSL-----LDRLSCLDGT 127
Query: 227 ----------------RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270
G+ ++H + HRD+K NIL + KI DFGLAR S A
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 271 PSAIFWTDYVA-TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKP 319
+ + T + T Y APE L G + TP DI+S G + E++TG P
Sbjct: 188 QTVM--TSRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLP 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 36/174 (20%), Positives = 72/174 (41%), Gaps = 30/174 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+++ IG+G +G + A D ++ E V V SD + E+K + P+
Sbjct: 36 AWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 174 IVE-------IKHIMLPP-------SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 219
++ +K++ +P + +++ + SDL ++ +AN +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA------KR 148
Query: 220 FFL-------YQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLAR 264
F ++L L+YIH H D+K N+L ++ + D+GLA
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.7 bits (167), Expect = 4e-12
Identities = 62/416 (14%), Positives = 124/416 (29%), Gaps = 111/416 (26%)
Query: 133 VDTHTGE-RVAIKKINDVFE----------HVSDATR-ILREIKLLRLLRHPDIVEIKHI 180
+D TGE + K I VFE V D + IL + EI HI
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK------------EEIDHI 54
Query: 181 MLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQL--------LRGLK 230
++ +F + S ++++ + L Y+F + + +
Sbjct: 55 IMSKDAVS--GTLRLFWTLLSKQEEMVQKFVEEVLRIN-YKFLMSPIKTEQRQPSMMTRM 111
Query: 231 YIHTANVFHRD-----------LKPKNILANADCKLK----ICDFG--------LARVSF 267
YI + + D L+P L A +L+ + G +A
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVC 171
Query: 268 NDA------PSAIFWTDYVATRWYRAPE--------LCGSFFSKYTPAIDIWSIGCIFAE 313
IFW + + +PE L +T D S +
Sbjct: 172 LSYKVQCKMDFKIFW---LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 314 MLTGKP--LFPGKNVVHQLDLMTDLLGTPSTESI------SRI----RNEKARRYLGSMR 361
+ + L K + L ++ ++ + ++ +I R ++ +L +
Sbjct: 229 SIQAELRRLLKSKPYENCLLVLLNVQ---NAKAWNAFNLSCKILLTTRFKQVTDFLSAAT 285
Query: 362 KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA-DPYFHGL--ANVDREPST 418
H LL + L P+D P E L +P + ++ +T
Sbjct: 286 TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP--REVLTTNPRRLSIIAESIRDGLAT 343
Query: 419 QPISKLEFEFER-RKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVD 473
++ + + D + +I + P ++ ++P
Sbjct: 344 ---------WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF----DRLSVFPPSAH 386
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.6 bits (159), Expect = 3e-11
Identities = 81/562 (14%), Positives = 164/562 (29%), Gaps = 170/562 (30%)
Query: 60 QQLTIVEDF-------DFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEA 112
+Q +V+ F ++ L + + + P T ++ + + + F +Y
Sbjct: 74 KQEEMVQKFVEEVLRINYKFL-MSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKY-NV 131
Query: 113 SR-----------YQIQEVIGKGSYGVVGS-----AVDTHTGERVAIKKINDVF-----E 151
SR +++ GV+GS A+D +V K +F
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKN 191
Query: 152 HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQ----VI 207
S T + KLL + H R + L++S ++ V+
Sbjct: 192 CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR-RLLKSKPYENCLLVL 250
Query: 208 KANDDL-TPEHYQFFLYQ--------------LLRGLKYIHTANVFHRD-LKP---KNIL 248
++ + + F L H + H L P K++L
Sbjct: 251 ---LNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307
Query: 249 ANADCKLKICDFGLARVSFNDAPSAI--FWT---DYVATRW--YRAPELCGSFFSKYTPA 301
L L R P + D +A W ++ K T
Sbjct: 308 LKY---LDCRPQDLPREVLTTNPRRLSIIAESIRDGLA-TWDNWKHVN-----CDKLTTI 358
Query: 302 IDIWSIGCI--------FAEMLTGKPLFPGKNVVHQLDLMTDLLGT----PSTESISRIR 349
I+ S+ + F + L+ +FP + + T LL + +
Sbjct: 359 IES-SLNVLEPAEYRKMF-DRLS---VFP-PSA----HIPTILLSLIWFDVIKSDVMVVV 408
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL-------- 401
N+ + S+ +KQP + ++ + L ++ ++
Sbjct: 409 NKLHKY---SLVEKQPKESTI--------SIPSIYLELKVKLENEYALHRSIVDHYNIPK 457
Query: 402 -----------ADPYF------HGLANVDREPSTQPISK--LEFEFERRKLAKD------ 436
D YF H L N++ L+F F +K+ D
Sbjct: 458 TFDSDDLIPPYLDQYFYSHIGHH-LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA 516
Query: 437 ---------DVREMIYRE-ILEYHPQM------LQEYLRGGEQTSFMYPSGVDRFKR--Q 478
++ Y+ I + P+ + ++L E+ + +
Sbjct: 517 SGSILNTLQQLK--FYKPYICDNDPKYERLVNAILDFLPKIEENLICSK-----YTDLLR 569
Query: 479 FAHLEEH---YGKGERSTPLQR 497
A + E + + + +QR
Sbjct: 570 IALMAEDEAIFEEAHKQ--VQR 589
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 23/174 (13%), Positives = 62/174 (35%), Gaps = 30/174 (17%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTG--------ERVAIKKINDVFEHVSDATRILREIKL 165
+++++ + + G++ A T T ++ ++K + R+ E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKD--GRLFNEQNF 95
Query: 166 L-RLLRHPDIVEIKHIMLPPS----------RREFKDIYVVFELMESDLHQVIKANDDLT 214
R + + + K + P + K ++V + L + +
Sbjct: 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHV 155
Query: 215 -PEHYQFFL-YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI--CDFGLAR 264
E + +LL L+++H H ++ +NI + + + ++ +G A
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 49/219 (22%), Positives = 94/219 (42%), Gaps = 43/219 (19%)
Query: 120 VIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV-- 175
++G+G +G V G D G VA+K++ + + + E++++ + H +++
Sbjct: 37 ILGRGGFGKVYKGRLAD---GTLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRL 92
Query: 176 -----EIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLT-PEHYQFFLYQ 224
+L V+ M S L + ++ L P+ + L
Sbjct: 93 RGFCMTPTERLL------------VYPYMANGSVASCLRERPESQPPLDWPKRQRIAL-G 139
Query: 225 LLRGLKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 281
RGL Y+H + HRD+K NIL + + + + DFGLA++ + + + T
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVT-TAVRG 197
Query: 282 TRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEMLTGK 318
T + APE G K + D++ G + E++TG+
Sbjct: 198 TIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQ 232
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 595 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.72 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.43 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.25 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.17 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.15 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.08 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.0 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.6 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.45 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.32 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.97 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.93 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.84 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.83 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.72 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.6 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.59 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.56 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.33 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.02 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.86 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.46 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.81 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.78 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.92 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-68 Score=573.65 Aligned_cols=338 Identities=50% Similarity=0.887 Sum_probs=295.4
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCC-CccCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP-SRREF 189 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~~ 189 (595)
..++|++++.||+|+||+||+|+++.+|+.||||++++........+.+++|+.+|+.|+|||||++++++... .+.+.
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 35689999999999999999999999999999999987666666778899999999999999999999998654 23455
Q ss_pred ccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
..+|||||||+|+|.+++...+.+++.+++.|++||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 132 ~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 132 KSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 78999999999999999999899999999999999999999999999999999999999999999999999999865332
Q ss_pred C-CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 A-PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~-~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
. ......++++||++|||||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..|....|.|+...+..+
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred ccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 2 122234678999999999998763 46799999999999999999999999999999999999999999999888777
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHH
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEF 428 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~ 428 (595)
.......++..++...+.++...++.++++++|||.+||.+||.+||||+|+|+||||+.+.+++.+|...+ .+++.+
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~--~~~~~~ 368 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP--PFDFAF 368 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSS--CCCCHH
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCC--CCCCcc
Confidence 777777888888888888888888999999999999999999999999999999999999887776665443 567778
Q ss_pred HHhhhcHHHHHHHHHHHHHhhCh
Q 007629 429 ERRKLAKDDVREMIYREILEYHP 451 (595)
Q Consensus 429 e~~~~~~~~~~~~i~~ei~~~~~ 451 (595)
+...+..++++++|+.|+.++|.
T Consensus 369 ~~~~~~~~~~k~~i~~ei~~~~~ 391 (398)
T 4b99_A 369 DREALTRERIKEAIVAEIEDFHA 391 (398)
T ss_dssp HHSCCCHHHHHHHHHHHHHHHHH
T ss_pred chhhcCHHHHHHHHHHHHHHHHH
Confidence 88899999999999999998875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-62 Score=505.79 Aligned_cols=262 Identities=26% Similarity=0.455 Sum_probs=224.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+++|+.|+|||||++++++. +...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 47999999999999999999999999999999996432 12234567899999999999999999999994 4457
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|||||||+ |+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999998 5999999998999999999999999999999999999999999999999999999999999998764333
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
.. ....+.+||+.|||||++.+ ..|+.++||||||||+|||++|++||.+.+....+..|...
T Consensus 187 ~~-~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-------------- 249 (311)
T 4aw0_A 187 KQ-ARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL-------------- 249 (311)
T ss_dssp TC-CCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------------
T ss_pred Cc-ccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Confidence 22 22456799999999999987 68999999999999999999999999988866555444321
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHH------HhcCCCccCCCCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE------ALADPYFHGLANVD 413 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~e------lL~Hp~f~~~~~~~ 413 (595)
. ..+ ...+++++++||.+||.+||++|||++| +++||||+++.+..
T Consensus 250 ------------~--~~~---p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 250 ------------E--YDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp ------------C--CCC---CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred ------------C--CCC---CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 0 011 1357899999999999999999999987 58999999876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-61 Score=507.39 Aligned_cols=257 Identities=29% Similarity=0.496 Sum_probs=220.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|+++++||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+.+|+.|+|||||++++++.. ...
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~ 145 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDE 145 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 3579999999999999999999999999999999964322 234567899999999999999999999943 456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|||||||+ |+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999998 589988875 579999999999999999999999999999999999999999999999999998764433
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. ..++.+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+....+..|....
T Consensus 225 ~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------- 286 (346)
T 4fih_A 225 P---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------- 286 (346)
T ss_dssp C---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-------------
T ss_pred C---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-------------
Confidence 2 2356799999999999987 689999999999999999999999999988766655443211
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.+....+..+++++++||.+||.+||++|||++|+|+||||+..
T Consensus 287 ---------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 287 ---------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp ---------------CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 01112345678999999999999999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-61 Score=490.70 Aligned_cols=255 Identities=31% Similarity=0.525 Sum_probs=204.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++++.||+|+||+||+|+++.+|+.||||++++... .......+.+|+.+|+.++|||||++++++.. ..
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-----KD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CC
Confidence 4689999999999999999999999999999999965432 22335678999999999999999999999944 45
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|||||||+|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 87 ~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 69999999999999999999999999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCCcccccccccccCCCC-CCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~-~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
...+.+||+.|||||++.+ ..| +.++|||||||++|||++|++||.+.+....+..+...
T Consensus 167 ----~~~~~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~------------- 227 (275)
T 3hyh_A 167 ----FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG------------- 227 (275)
T ss_dssp ------------CTTSCHHHHSS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------
T ss_pred ----ccCCeeECcccCChhhhcC--CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-------------
Confidence 2356799999999999987 454 68999999999999999999999987754443333211
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
. .+ ....+++.+++||.+||++||++|||++|+|+||||+.
T Consensus 228 -------------~--~~---~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 228 -------------V--YT---LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -------------C--CC---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -------------C--CC---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 0 01 11347899999999999999999999999999999973
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-61 Score=507.49 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=216.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+.+|+.|+|||||++++++. +...
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCE
Confidence 46899999999999999999999999999999999765555566778999999999999999999999994 4456
Q ss_pred EEEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+|||||||+ |+|.++|...+ .+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 999999998 69999997653 578999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
. ....+..+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+....+..+...
T Consensus 178 ~---~~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------------ 240 (350)
T 4b9d_A 178 T---VELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG------------ 240 (350)
T ss_dssp H---HHHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT------------
T ss_pred C---cccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC------------
Confidence 1 112345789999999999987 68999999999999999999999999998876655444321
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
. +......+++++.+||.+||++||.+|||++|+|+||||+.
T Consensus 241 --------------~----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 241 --------------S----FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp --------------C----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred --------------C----CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 0 01123467899999999999999999999999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-60 Score=487.34 Aligned_cols=259 Identities=26% Similarity=0.374 Sum_probs=215.7
Q ss_pred CCe-EEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRY-QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y-~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++| ++.++||+|+||+||+|.++.++..||||++..........+.+.+|+.+|+.|+|||||++++++.... .....
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcE
Confidence 455 7888999999999999999999999999999765555566778999999999999999999999985421 22356
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCceeeCC-CCcEEEcccCcceecc
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLARVSF 267 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~g--IiHrDLKP~NILl~~-~~~vKL~DFGla~~~~ 267 (595)
+|||||||+ |+|.+++...+.+++..++.|+.||+.||+|||++| ||||||||+|||++. +|.+||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 899999998 699999999899999999999999999999999998 999999999999984 7999999999998532
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.. ...+.+||+.|||||++.+ .|+.++|||||||++|||+||++||.+.+...++......
T Consensus 184 ~~-----~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~----------- 244 (290)
T 3fpq_A 184 AS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS----------- 244 (290)
T ss_dssp TT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-----------
T ss_pred CC-----ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-----------
Confidence 21 2356799999999999864 6999999999999999999999999876544333221110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
...|.. .....++++.+||.+||.+||.+|||++|+|+||||++
T Consensus 245 --------------~~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 245 --------------GVKPAS---FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp --------------TCCCGG---GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred --------------CCCCCC---CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 001111 12346788999999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-60 Score=508.63 Aligned_cols=257 Identities=29% Similarity=0.492 Sum_probs=221.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|+.|+|||||+++++|.. ...
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~ 222 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDE 222 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCE
Confidence 357999999999999999999999999999999996432 2234568899999999999999999999954 456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|||||||+ |+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 223 ~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred EEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999998 589888865 579999999999999999999999999999999999999999999999999998764433
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. ..++.+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+....+..|....
T Consensus 302 ~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------- 363 (423)
T 4fie_A 302 P---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------- 363 (423)
T ss_dssp C---CBCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------
T ss_pred c---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-------------
Confidence 2 2356799999999999987 689999999999999999999999999888766555443211
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.+....+..+++.+++||.+||.+||.+|||++|+|+||||+..
T Consensus 364 ---------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 364 ---------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ---------------CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 11122345789999999999999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-60 Score=514.70 Aligned_cols=342 Identities=42% Similarity=0.740 Sum_probs=282.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..++|++++.||+|+||+||+|+++.+|+.||||++..........+++.+|+.+|+.++|||||++++++.........
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 45789999999999999999999999999999999987666667778899999999999999999999999877666677
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+||||++++|.+++.....+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 131 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 131 ELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp CEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred eEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 89999999999999999988899999999999999999999999999999999999999999999999999998654222
Q ss_pred CC------------------------cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc----------
Q 007629 271 PS------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT---------- 316 (595)
Q Consensus 271 ~~------------------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt---------- 316 (595)
.. ....+.++||++|+|||++... ..|+.++||||||||||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 11 0124567899999999986442 579999999999999999999
Q ss_pred -CCCCCCCCC--------------------hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCC
Q 007629 317 -GKPLFPGKN--------------------VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNA 375 (595)
Q Consensus 317 -G~~pF~~~~--------------------~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~ 375 (595)
|++||++.+ ..+++..|.+++|+|..+.+..+.......++..+.......+...++.+
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 888998865 36889999999999999999999888999999988888888888889999
Q ss_pred CHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHHHhhhcHHHHHHHHHHHHHhhChhhH
Q 007629 376 DPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQML 454 (595)
Q Consensus 376 ~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~ei~~~~~~~~ 454 (595)
++.+++||.+||.+||.+|||++|+|+||||+++.+...++.......+.+. +...+..++++++++.|+..++|+..
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~~ 447 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPEIQ 447 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSC-TTSCCCHHHHHHHHHHHHTTTCTTCC
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhCcccc
Confidence 9999999999999999999999999999999998876655543322222221 23567889999999999999998653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-61 Score=494.54 Aligned_cols=258 Identities=28% Similarity=0.435 Sum_probs=213.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~---~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
.++|++++.||+|+||+||+|++. .+++.||||++++......+..++.+|+.+|+.|+|||||++++++. +
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~ 97 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----T 97 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----E
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----E
Confidence 367999999999999999999874 46889999999754333333456789999999999999999999994 3
Q ss_pred cccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
...+|||||||+ |+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 456999999998 6999999999999999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.... ...+.+||+.|||||++.+ ..|+.++|||||||++|||+||++||.+.+..+.+..|...
T Consensus 178 ~~~~---~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~----------- 241 (304)
T 3ubd_A 178 DHEK---KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA----------- 241 (304)
T ss_dssp ---C---CCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred CCCc---cccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC-----------
Confidence 3322 2356799999999999987 68999999999999999999999999998876655544321
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 410 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~~ 410 (595)
.. + ....+++++.+||.+||++||++||| ++|+++||||+++.
T Consensus 242 ---------------~~--~---~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 242 ---------------KL--G---MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp ---------------CC--C---CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ---------------CC--C---CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 00 1 12357899999999999999999998 58999999998764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-59 Score=503.76 Aligned_cols=343 Identities=38% Similarity=0.698 Sum_probs=292.4
Q ss_pred cCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 109 YGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 109 ~~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
+...++|++++.||+|+||+||+|++..+|+.||||+++.........+++.+|+.+|+.++||||+++++++.......
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 34567999999999999999999999999999999999876666677788999999999999999999999998766555
Q ss_pred cccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 189 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 189 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
...+|+|||||+++|.+++.....+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 102 FDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 67899999999999999999888899999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCc-------------------ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-----------CC
Q 007629 269 DAPSA-------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-----------GK 318 (595)
Q Consensus 269 ~~~~~-------------------~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-----------G~ 318 (595)
..... ...+.++||++|+|||++... ..|+.++||||||||+|||++ |.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 32110 124678999999999986542 679999999999999999998 66
Q ss_pred CCCCCCC-----------------hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHH
Q 007629 319 PLFPGKN-----------------VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH 381 (595)
Q Consensus 319 ~pF~~~~-----------------~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~d 381 (595)
++|++.+ ..+++..|.+++|+|..+.+..+.......++..+....+.++...++.+++.+++
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 7777765 47899999999999999999999888899999888888888888888999999999
Q ss_pred HHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHHHhhhcHHHHHHHHHHHHHhhChhh
Q 007629 382 LLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQM 453 (595)
Q Consensus 382 Ll~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~ei~~~~~~~ 453 (595)
||.+||.+||.+|||++|+|+||||+++.+...++.......+.++ +...+..+++++++++|+..++|+.
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~ 411 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPEL 411 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSC-TTCCCCHHHHHHHHHHHHHHHCTTC
T ss_pred HHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChh-hcccCCHHHHHHHHHHHHHHhCccc
Confidence 9999999999999999999999999999887766543322222221 2256889999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-59 Score=488.84 Aligned_cols=258 Identities=27% Similarity=0.371 Sum_probs=214.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
...|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.|+|||||++++++. +...
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~-----~~~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVR-----EGPW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEE-----ETTE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence 4579999999999999999999999999999999964221 247999999999999999999984 3456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC-cEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~-~vKL~DFGla~~~~~~ 269 (595)
+|||||||+ |+|.+++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+....+
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999998 69999999989999999999999999999999999999999999999999998 6999999999876443
Q ss_pred CCCc--ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 270 APSA--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 270 ~~~~--~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.... ......+||+.|||||++.+ ..|+.++||||||||+|||++|++||.+.+....+..|..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------------ 270 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------------ 270 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------------
T ss_pred CcccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------------
Confidence 2211 11234689999999999987 6899999999999999999999999988764333332221
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHH-------------hcCCCccCCCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA-------------LADPYFHGLAN 411 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~el-------------L~Hp~f~~~~~ 411 (595)
.+.++....+.+++.+.+||.+||++||.+|||+.|+ |+|||+.....
T Consensus 271 ----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 271 ----------------EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp ----------------SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred ----------------CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 1112223456789999999999999999999999997 68999987643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=483.33 Aligned_cols=331 Identities=41% Similarity=0.770 Sum_probs=281.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC-ccCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREF 189 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~~ 189 (595)
..++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++.... ....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 457899999999999999999999999999999999765555566778999999999999999999999987653 2334
Q ss_pred ccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
..+|+||||++++|.+++.. ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (367)
T 1cm8_A 103 TDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181 (367)
T ss_dssp CCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred ceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc
Confidence 56899999998899999876 57999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.+.++||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..+...+|+|+.+.+..+.
T Consensus 182 ------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 182 ------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp ------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ------cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 3457899999999998763 578999999999999999999999999999999999999999999999999988
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHH
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE 429 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e 429 (595)
......++..++......+...++.+++.+.+||.+||.+||.+|||++|+|+||||+.+.+...++... .+++.++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~---~~~~~~~ 331 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYDDSFD 331 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCCCC--
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC---CCCCChh
Confidence 8888889888888777888888899999999999999999999999999999999999988877666544 3566777
Q ss_pred HhhhcHHHHHHHHHHHHHhhChh
Q 007629 430 RRKLAKDDVREMIYREILEYHPQ 452 (595)
Q Consensus 430 ~~~~~~~~~~~~i~~ei~~~~~~ 452 (595)
......++++++++.|++.++|.
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~ 354 (367)
T 1cm8_A 332 DVDRTLDEWKRVTYKEVLSFKPP 354 (367)
T ss_dssp ---CCHHHHHHHHHHHHHTCCC-
T ss_pred hhcCCHHHHHHHHHHHHHHhccc
Confidence 78889999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-58 Score=487.03 Aligned_cols=285 Identities=26% Similarity=0.433 Sum_probs=221.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~---~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 187 (595)
.++|++++.||+|+||+||+|+++ .+++.||||++... ....++.+|+++|+.+ .|||||++++++.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~----- 90 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFR----- 90 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----
Confidence 468999999999999999999875 46789999998642 2345688999999998 5999999999984
Q ss_pred CcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC-CcEEEcccCccee
Q 007629 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~-~~vKL~DFGla~~ 265 (595)
+..++|||||||+ ++|.+++ +.+++.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ECCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 4467999999998 6899888 359999999999999999999999999999999999999877 7999999999986
Q ss_pred ccCCCCC-------------------------cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCC
Q 007629 266 SFNDAPS-------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 320 (595)
Q Consensus 266 ~~~~~~~-------------------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~p 320 (595)
....... ....++.+||++|||||++.+. ..|+.++||||+|||+|||++|++|
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCC
Confidence 5332111 1123456899999999998763 4689999999999999999999988
Q ss_pred C-CCCChHHHHHHHHhhcCCCChhHHHHHhh--------------HHHHHHhhhcccCC---------CCCCCCCCCCCC
Q 007629 321 F-PGKNVVHQLDLMTDLLGTPSTESISRIRN--------------EKARRYLGSMRKKQ---------PVPFSHKFPNAD 376 (595)
Q Consensus 321 F-~~~~~~~~l~~i~~~lg~p~~~~i~~i~~--------------~~~~~~l~~~~~~~---------~~~~~~~~~~~~ 376 (595)
| .+.+..+++..|..++|++.......... ......+..+.... .......|..++
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 7 56778899999999988754332211100 00000000000000 011223467789
Q ss_pred HHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 377 PLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 377 ~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
++++|||.+||++||++||||+|+|+||||+++
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-57 Score=486.21 Aligned_cols=336 Identities=40% Similarity=0.740 Sum_probs=265.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++++.||+|+||+||+|.+..+|+.||||++...........++.+|+.+|+.+. ||||+++++++... +..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence 36899999999999999999999999999999999776666677888999999999997 99999999998643 234
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+|||||+++|..++.. +.+++..++.+++||+.||+|||+.||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 85 DVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp CEEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 6899999999999999976 579999999999999999999999999999999999999999999999999998653211
Q ss_pred ------------------CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHH
Q 007629 271 ------------------PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332 (595)
Q Consensus 271 ------------------~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~ 332 (595)
......+.++||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 011224567999999999998763 5789999999999999999999999999999999999
Q ss_pred HHhhcCCCChhHHHHHhhHHHHHHhhhcccCC---CCCCCCCCC-------------CCCHHHHHHHHhhCcCCCCCCCC
Q 007629 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQ---PVPFSHKFP-------------NADPLALHLLERLLAFDPKDRPT 396 (595)
Q Consensus 333 i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~---~~~~~~~~~-------------~~~~~~~dLl~~~L~~DP~~Rpt 396 (595)
+...+|.|..+.+..+.......++..+.... ...+...++ .+++.+.+||.+||.+||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 99999999998876655444444443333221 222222222 67899999999999999999999
Q ss_pred HHHHhcCCCccCCCCCCCCCCCCCCcccchHHH-HhhhcHHHHHHHHHHHHHhhChhhH
Q 007629 397 AEEALADPYFHGLANVDREPSTQPISKLEFEFE-RRKLAKDDVREMIYREILEYHPQML 454 (595)
Q Consensus 397 a~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e-~~~~~~~~~~~~i~~ei~~~~~~~~ 454 (595)
++|+|+||||+.+.+...++........ .++ ......+++++++|.|+.+++++..
T Consensus 323 ~~e~l~Hp~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (388)
T 3oz6_A 323 ANDALKHPFVSIFHNPNEEPNCDHIITI--PINDNVKHSIDDYRNLVYSEISRRKRELI 379 (388)
T ss_dssp HHHHTTSTTTTTTCCGGGCCCCSSCCCC--C------CCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhCCHHHHHhcCCccCCCCCCCCCC--CccccccCCHHHHHHHHHHHHHHhhhhhh
Confidence 9999999999998887766655443322 333 3567889999999999998887654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=482.42 Aligned_cols=333 Identities=44% Similarity=0.821 Sum_probs=276.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC-ccCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREF 189 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~~ 189 (595)
..++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++.... ....
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 357899999999999999999999999999999999766556666788999999999999999999999986542 2344
Q ss_pred ccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
..+|+||||++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185 (367)
T ss_dssp CCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred CeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence 67899999999999988875 57999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.+..+||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..+.+.+|.|..+.+..+.
T Consensus 186 ------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 186 ------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp -----------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred ------CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 3457899999999998763 578999999999999999999999999999999999999999999999999888
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHH
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE 429 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e 429 (595)
......++..+.......+...++.+++.+.+||.+||.+||.+|||++|+|+||||+.+.++..++...+ +++.++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~---~~~~~~ 335 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQSLE 335 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCC---CCGGGS
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCC---CCcchh
Confidence 88888888888777777777778889999999999999999999999999999999999887766655443 456667
Q ss_pred HhhhcHHHHHHHHHHHHHhhChhhH
Q 007629 430 RRKLAKDDVREMIYREILEYHPQML 454 (595)
Q Consensus 430 ~~~~~~~~~~~~i~~ei~~~~~~~~ 454 (595)
...+..+++++++|.|+..++|..+
T Consensus 336 ~~~~~~~~~~~~~~~e~~~~~~~~~ 360 (367)
T 2fst_X 336 SRDLLIDEWKSLTYDEVISFVPPPL 360 (367)
T ss_dssp SCCCCHHHHHHHHHHHHHHCCCCC-
T ss_pred hccCCHHHHHHHHHHHHHHhccCcc
Confidence 7788899999999999999998743
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=491.70 Aligned_cols=330 Identities=36% Similarity=0.677 Sum_probs=262.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~~ 190 (595)
.++|++++.||+|+||+||+|++..+|+.||||++...........++.+|+.+|+.++||||+++++++..... ++..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999999999999999998765566677889999999999999999999999976532 3456
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|||||||+++|.+.+.. .+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 141 ~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 218 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218 (464)
T ss_dssp EEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred eEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence 7999999999999888854 59999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
..+..+||++|+|||++.+ ..|+.++||||||||+|||++|++||.+.+..+++..|.+.+|+|..+.+..+.
T Consensus 219 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~- 291 (464)
T 3ttj_A 219 ----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ- 291 (464)
T ss_dssp ----CC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC-
T ss_pred ----ccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc-
Confidence 2356799999999999987 689999999999999999999999999999999999999999999998877664
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCC------------CHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNA------------DPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPST 418 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~------------~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~ 418 (595)
.....++...+......+...++.. ++.+++||.+||.+||.+|||++|+|+||||+.+.+...+...
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~ 371 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP 371 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSCC
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccCC
Confidence 3445555544433333333223222 5679999999999999999999999999999977654322211
Q ss_pred CCCcccchHHHHhhhcHHHHHHHHHHHHHhhCh
Q 007629 419 QPISKLEFEFERRKLAKDDVREMIYREILEYHP 451 (595)
Q Consensus 419 ~~~~~~~~~~e~~~~~~~~~~~~i~~ei~~~~~ 451 (595)
+....++.++......+++++++++|++....
T Consensus 372 -~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 403 (464)
T 3ttj_A 372 -PPQIYDKQLDEREHTIEEWKELIYKEVMNSEE 403 (464)
T ss_dssp -C-----------CCCHHHHHHHHHHHHHC---
T ss_pred -CCccCCcchhhccCCHHHHHHHHHHHHHHhhh
Confidence 12234555677778899999999999886654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-57 Score=465.31 Aligned_cols=264 Identities=25% Similarity=0.417 Sum_probs=199.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc------
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR------ 186 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~------ 186 (595)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ......+.+.+|+.+|+.|+|||||++++++.....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC-SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 3699999999999999999999999999999999643 233345678999999999999999999999864332
Q ss_pred -cCcccEEEEEeccc-ccHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccC
Q 007629 187 -REFKDIYVVFELME-SDLHQVIKANDDL---TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 261 (595)
Q Consensus 187 -~~~~~lylV~E~~~-g~L~~~i~~~~~l---~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFG 261 (595)
....++|||||||+ |+|.+++.....+ .+..++.|+.||++||+|||++|||||||||+|||++.+|.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 12345899999998 6899999876654 445688999999999999999999999999999999999999999999
Q ss_pred cceeccCCCCCc---------ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHH
Q 007629 262 LARVSFNDAPSA---------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDL 332 (595)
Q Consensus 262 la~~~~~~~~~~---------~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~ 332 (595)
+|+......... ...++.+||+.|||||++.+ ..|+.++||||||||+|||++ ||.+. .+....
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~ 236 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRT 236 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHH
Confidence 998764432211 12345689999999999987 689999999999999999996 77543 222222
Q ss_pred HHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 333 MTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 333 i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
+........+ ..++..++.+.+||.+||++||.+|||+.|+|+||||+++..
T Consensus 237 ~~~~~~~~~p---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 237 LTDVRNLKFP---------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHHTTCCC---------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHHHhcCCCC---------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 2221111111 111234567899999999999999999999999999987643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-55 Score=461.58 Aligned_cols=337 Identities=48% Similarity=0.839 Sum_probs=286.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
...+|++++.||+|+||.||+|.+..++..||||++... ........+.+|+.+|+.++||||+++++++.........
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 356899999999999999999999999999999999642 3334557789999999999999999999999776655567
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+||||++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 104 ~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 104 DVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp CEEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred eEEEEEcccCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 7999999999999999876 469999999999999999999999999999999999999999999999999998764433
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
.........+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...+|.|..+.+..+..
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 333234567899999999987652 5689999999999999999999999999999999999999999999998888777
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHHH
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e~ 430 (595)
.....+...+......++...++.+++.+.+||.+||.+||.+|||++|+|+||||+.......++.... .+.+..+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~--~~~~~~~~ 339 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMEL 339 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CCCCC---
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCC--cCCccccc
Confidence 7777777777777777777777889999999999999999999999999999999998765544443322 34445566
Q ss_pred hhhcHHHHHHHHHHHHHhhChh
Q 007629 431 RKLAKDDVREMIYREILEYHPQ 452 (595)
Q Consensus 431 ~~~~~~~~~~~i~~ei~~~~~~ 452 (595)
..+.++++++++++|+..++|.
T Consensus 340 ~~~~~~~~~~~~~~e~~~~~~~ 361 (364)
T 3qyz_A 340 DDLPKEKLKELIFEETARFQPG 361 (364)
T ss_dssp --CCHHHHHHHHHHHTGGGCC-
T ss_pred ccCCHHHHHHHHHHHHHHhhhh
Confidence 7788999999999998888775
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-55 Score=488.85 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=225.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||+||+|+++.+|+.||||++.. ....+...+.+|+.+|+.|+|||||+++++|. +...
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~~~ 228 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNE 228 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----CSSE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEec--cchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCE
Confidence 3689999999999999999999999999999999964 23445677899999999999999999999994 4457
Q ss_pred EEEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC--CcEEEcccCcceecc
Q 007629 192 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVSF 267 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~--~~vKL~DFGla~~~~ 267 (595)
+|||||||+ |+|+++|.. .+.+++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999998 599998864 4579999999999999999999999999999999999999865 899999999998764
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
... .....+||++|||||++.+ ..|+.++||||||||+|||++|.+||.+.+..+.+..|......+
T Consensus 309 ~~~----~~~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~------- 375 (573)
T 3uto_A 309 PKQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM------- 375 (573)
T ss_dssp TTS----EEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC-------
T ss_pred CCC----ceeeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCC-------
Confidence 332 2356799999999999988 689999999999999999999999999988776666554322111
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~ 413 (595)
....++.+++.+++||.+||.+||.+|||+.|+|+||||+......
T Consensus 376 --------------------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 376 --------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp --------------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred --------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 1223456889999999999999999999999999999998765443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-55 Score=490.48 Aligned_cols=261 Identities=26% Similarity=0.366 Sum_probs=212.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHH---HHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRIL---REIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~---~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
.++|+++++||+|+||+||+|+++.+|+.||||++++... .......+. .++.+++.++|||||+++++|.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~---- 263 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---- 263 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE----
Confidence 5689999999999999999999999999999999964211 111122233 34566777899999999999944
Q ss_pred CcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
...+|||||||. |+|.++|...+.|++..+++|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+..
T Consensus 264 -~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 264 -PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred -CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 456999999998 699999999999999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
.... ..+.+||+.|||||++.+. ..|+.++||||||||+|||++|++||.+.+..+....+...
T Consensus 343 ~~~~-----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---------- 406 (689)
T 3v5w_A 343 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---------- 406 (689)
T ss_dssp SSCC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH----------
T ss_pred CCCC-----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh----------
Confidence 4332 2457999999999998641 57999999999999999999999999765422211111000
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCCCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLAN 411 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~~~ 411 (595)
+ .. +. .....+++++++||.+||.+||.+|++ ++||++||||+++.+
T Consensus 407 ----------~---~~--~~---~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 407 ----------L---TM--AV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp ----------H---HC--CC---CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred ----------c---CC--CC---CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 0 00 01 122457899999999999999999998 899999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=449.01 Aligned_cols=256 Identities=24% Similarity=0.295 Sum_probs=205.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.++||+|+||+||+|+.. ..||||+++.........+.+.+|+.+|+.++|||||++++++.. ..
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence 468999999999999999999754 359999997655555667889999999999999999999998743 24
Q ss_pred EEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+.....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 799999998 6999999764 57999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... ...+..+||+.|||||++.+. ...|+.++|||||||+||||+||++||.+.+....+..+...
T Consensus 186 ~~~-~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~------------ 252 (307)
T 3omv_A 186 SGS-QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR------------ 252 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT------------
T ss_pred Ccc-eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc------------
Confidence 221 123557899999999998642 246899999999999999999999999887654443322211
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
...+.......+.+++.+.+||.+||+.||++|||+.|+++
T Consensus 253 -------------~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 253 -------------GYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp -------------TCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred -------------CCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 01111223345678899999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=446.46 Aligned_cols=256 Identities=23% Similarity=0.340 Sum_probs=209.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~-----~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
.++|.+.+.||+|+||+||+|++. .++..||||+++.. .....+.+.+|+.+|++|+|||||++++++...
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-- 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-- 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--
Confidence 467999999999999999999865 36889999999752 334567899999999999999999999999543
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAN-------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 252 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~-------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~ 252 (595)
..+|||||||+ |+|.+++... ..+++..+..|+.||++||.|||+++||||||||+|||++.+
T Consensus 88 ---~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 ---DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp ---SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred ---CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 45899999998 6999999764 369999999999999999999999999999999999999999
Q ss_pred CcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHH
Q 007629 253 CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLD 331 (595)
Q Consensus 253 ~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~ 331 (595)
+.+||+|||+|+........ ......+||+.|||||++.+ ..|+.++|||||||++|||+| |++||.+.+..+.+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 241 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CcEEECCcccceecCCCCce-eecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999865433221 11234579999999999987 689999999999999999998 899999877654443
Q ss_pred HHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 332 ~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.+... ...+ ....+++.+.+||.+||+.||++|||+.|++ +|++.+
T Consensus 242 ~i~~~-------------------------~~~~-----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~ 287 (299)
T 4asz_A 242 CITQG-------------------------RVLQ-----RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNL 287 (299)
T ss_dssp HHHHT-------------------------CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred HHHcC-------------------------CCCC-----CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHH
Confidence 33221 0011 1135788999999999999999999999994 477654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=447.54 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=201.6
Q ss_pred CCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~-----~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
.+|.+.++||+|+||+||+|+.. .++..||||+++. ......+.+.+|+.+|+.|+|||||++++++...
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--- 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCTEG--- 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC---
Confidence 46899999999999999999864 4688999999974 2344567899999999999999999999999543
Q ss_pred CcccEEEEEeccc-ccHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAN---------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~---------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~ 251 (595)
..+|||||||+ |+|.+++... +++++.++..|+.||++||.|||+++||||||||+||||+.
T Consensus 116 --~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 116 --RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp --SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred --CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 45899999998 6999998753 35899999999999999999999999999999999999999
Q ss_pred CCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHH
Q 007629 252 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQL 330 (595)
Q Consensus 252 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l 330 (595)
++.+||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+.+
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 270 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270 (329)
T ss_dssp TTEEEECCCC-----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred CCcEEEcccccceeccCCCcc-eecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999999999865433221 12245689999999999987 789999999999999999999 89999987765544
Q ss_pred HHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 331 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 331 ~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
..+... ...+ ....+++.+.+|+.+||+.||++|||+.|++++
T Consensus 271 ~~i~~g-------------------------~~~~-----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 271 DCITQG-------------------------RELE-----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHT-------------------------CCCC-----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHcC-------------------------CCCC-----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 433221 0111 113578899999999999999999999999873
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=450.28 Aligned_cols=330 Identities=41% Similarity=0.760 Sum_probs=275.5
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REF 189 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~ 189 (595)
...+|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++..... ...
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3578999999999999999999999999999999997655555556788999999999999999999999965432 122
Q ss_pred ccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
..+|+||||++++|.+++. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 3459999999999988874 45999999999999999999999999999999999999999999999999999854322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....|.+..+.+..+.
T Consensus 198 ------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 198 ------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred ------cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 2456899999999998763 578999999999999999999999999999999999999999999998887776
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHH
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE 429 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e 429 (595)
......+...+.......+...++.+++.+.+||.+||++||.+|||++|+|+||||+.+..+..+...+ ..+....+
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~--~~~~~~~~ 348 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQ--QPFDDSLE 348 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCS--SCCCCTTS
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccc--cCcCcchh
Confidence 6666667666665555555556678899999999999999999999999999999999876654333222 12222334
Q ss_pred HhhhcHHHHHHHHHHHHHhhCh
Q 007629 430 RRKLAKDDVREMIYREILEYHP 451 (595)
Q Consensus 430 ~~~~~~~~~~~~i~~ei~~~~~ 451 (595)
..++..+++++.|++|+.+++|
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T 4exu_A 349 HEKLTVDEWKQHIYKEIVNFSP 370 (371)
T ss_dssp SCCCCHHHHHHHHHHHHHHCCC
T ss_pred hcccchHHHHHHHHHHHHhccc
Confidence 5667889999999999998876
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=442.37 Aligned_cols=253 Identities=21% Similarity=0.347 Sum_probs=208.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~-----~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
.++++++++||+|+||+||+|... .+++.||||+++... .....+.+.+|+.+|++|+|||||++++++...
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-- 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD-- 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC--
Confidence 356899999999999999999853 467899999997532 223457799999999999999999999999543
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 249 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl 249 (595)
..+|||||||+ |+|.++|... ..+++..+..|+.||++||.|||+++||||||||+||||
T Consensus 102 ---~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 ---QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp ---SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ---CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 45899999998 6999999653 358999999999999999999999999999999999999
Q ss_pred CCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHH
Q 007629 250 NADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVH 328 (595)
Q Consensus 250 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~ 328 (595)
+.++++||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred CCCCCEEECCcccceeccCCCce-eEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999865433221 12345689999999999987 689999999999999999998 899999887655
Q ss_pred HHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 329 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 329 ~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.+..+... ...+. .+.+++.+.+|+.+||+.||.+|||+.||+++
T Consensus 256 ~~~~i~~~-------------------------~~~~~-----p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 256 VVEMIRNR-------------------------QVLPC-----PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHTT-------------------------CCCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcC-------------------------CCCCC-----cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44333211 01111 23578899999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=440.53 Aligned_cols=334 Identities=43% Similarity=0.797 Sum_probs=270.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+|+.++||||+++++++.........
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 357899999999999999999999999999999999642 3334456788999999999999999999998766555667
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+||||++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 88 EVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp CEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred eEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 8999999999999999876 579999999999999999999999999999999999999999999999999998654322
Q ss_pred CCc-------ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 271 PSA-------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 271 ~~~-------~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...+|.|...
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred ccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 111 012345899999999987542 578999999999999999999999999999999999999988887643
Q ss_pred -HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCc
Q 007629 344 -SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPIS 422 (595)
Q Consensus 344 -~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~ 422 (595)
....+.......++..+......++...++.+++.+.+||.+||..||.+|||+.|+|+||||+.+.....++..+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~ 325 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIP 325 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCCCCC
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccCCCC
Confidence 2222333344445444444444444455678899999999999999999999999999999999887766655555544
Q ss_pred c--cchHHHHhhhcHHHHHHHHHHHHH
Q 007629 423 K--LEFEFERRKLAKDDVREMIYREIL 447 (595)
Q Consensus 423 ~--~~~~~e~~~~~~~~~~~~i~~ei~ 447 (595)
. +++......++.++++++++.|+.
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 326 PSFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp GGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred cceeeecchhhcCCHHHHHHHHHHHhh
Confidence 3 344444566889999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=441.51 Aligned_cols=329 Identities=41% Similarity=0.762 Sum_probs=276.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~~ 190 (595)
.++|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999999999999999997655555556788999999999999999999999865432 2234
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+||||++++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 179 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179 (353)
T ss_dssp CCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred eEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence 579999999999888774 35999999999999999999999999999999999999999999999999999754321
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+++..+....|.+..+.+..+..
T Consensus 180 -----~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 180 -----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ---------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred -----ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 2456899999999998753 5789999999999999999999999999999999999999999999988887777
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHHH
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e~ 430 (595)
.....++..+.......+...++.+++.+.+||.+||..||.+|||++|+|+||||+.+.....++... ..+....+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~--~~~~~~~~~ 331 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQ--QPFDDSLEH 331 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCS--SCCCCTTTT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCC--CCCccchhh
Confidence 767777777766666667777788999999999999999999999999999999999876544333222 223344456
Q ss_pred hhhcHHHHHHHHHHHHHhhCh
Q 007629 431 RKLAKDDVREMIYREILEYHP 451 (595)
Q Consensus 431 ~~~~~~~~~~~i~~ei~~~~~ 451 (595)
..+..+++++.|++|+.++.|
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 3coi_A 332 EKLTVDEWKQHIYKEIVNFSP 352 (353)
T ss_dssp CCCCHHHHHHHHHHHHHTCCC
T ss_pred ccCCHHHHHHHHHHHHHhhcc
Confidence 678899999999999988764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-53 Score=447.17 Aligned_cols=329 Identities=36% Similarity=0.669 Sum_probs=251.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC-ccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~~~ 190 (595)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999999999999999999765555556678899999999999999999999986543 23345
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+|||||+++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 104 ~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp EEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred ceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence 789999999999999886 459999999999999999999999999999999999999999999999999998653221
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+...++..+...+|.|..+.+..+..
T Consensus 182 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 182 ----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp ------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred ----ccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 2345689999999999987 6799999999999999999999999999999999999999999998877665533
Q ss_pred HHHHHHhhhcccCCCCCCCCCC-----CC-------CCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKF-----PN-------ADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPST 418 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~-----~~-------~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~ 418 (595)
. ...++...+......+...+ +. .++.+++||.+||.+||.+|||++|+|+||||+.+.++......
T Consensus 256 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~ 334 (371)
T 2xrw_A 256 T-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 334 (371)
T ss_dssp H-HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTCC
T ss_pred H-HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCCC
Confidence 2 22333222211111111111 11 15678999999999999999999999999999876543211111
Q ss_pred CCCcccchHHHHhhhcHHHHHHHHHHHHHhhC
Q 007629 419 QPISKLEFEFERRKLAKDDVREMIYREILEYH 450 (595)
Q Consensus 419 ~~~~~~~~~~e~~~~~~~~~~~~i~~ei~~~~ 450 (595)
.+ .......+.+....++++++++.++..+.
T Consensus 335 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (371)
T 2xrw_A 335 PP-KIPDKQLDEREHTIEEWKELIYKEVMDLE 365 (371)
T ss_dssp CC-CCCTTTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred CC-CCCChhhccccCcHHHHHHHHHHHHHHHh
Confidence 11 01112223456678899999999987654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=431.61 Aligned_cols=290 Identities=40% Similarity=0.678 Sum_probs=234.7
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 110 ~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
+..++|++++.||+|+||+||+|.+. +|+.||||++............+.+|+.+|+.++||||+++++++.. .
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-----E 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-----S
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-----C
Confidence 44678999999999999999999985 59999999997544444445678899999999999999999999843 3
Q ss_pred ccEEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+|+|||||+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 92 RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 5689999999999999887654 599999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... .....+||+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+....+.+..+...++.+....+...
T Consensus 172 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 172 PVR---SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp CCC------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred Ccc---cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 222 13456899999999998652 56899999999999999999999999999999999999999998877655443
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
....... ..........++....+.+++++.+||.+||.+||.+|||++|+|+||||+++.
T Consensus 248 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 248 QELPLWK-QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp TTSHHHH-SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hccchhh-hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 2211100 001111112223334466789999999999999999999999999999998763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=424.51 Aligned_cols=287 Identities=37% Similarity=0.609 Sum_probs=235.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++. ....+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 5899999999999999999999999999999999765555555678889999999999999999999984 34569
Q ss_pred EEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+|||||+++|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 99999999988877765 56899999999999999999999999999999999999999999999999999986533222
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCC-CCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~p-F~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+..+++..+...++.+..+.+.....
T Consensus 157 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 13456899999999998762 4489999999999999999987655 788888889999999999887765443221
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
. ..+................+.+++.+.+||.+||++||.+|||++|+|+||||+++.
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 233 L--PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp S--TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred c--ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 0 000000000111123344567889999999999999999999999999999998753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=441.23 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=208.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC-CceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSDATRILREIKLLRLLRH-PDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~-----g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~ 185 (595)
.++|++++.||+|+||+||+|.+..+ ++.||||+++.. ......+.+.+|+.+|+.+.| ||||+++++|....
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 46899999999999999999987654 468999999753 233456779999999999975 99999999985432
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcee
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 248 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NIL 248 (595)
..+|||||||+ |+|.++|+.. ..+++.++..|+.||++||.|||+++||||||||+|||
T Consensus 142 ----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 142 ----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp ----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 35899999998 6999999753 34899999999999999999999999999999999999
Q ss_pred eCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChH
Q 007629 249 ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVV 327 (595)
Q Consensus 249 l~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~ 327 (595)
++.++.+||+|||+|+....+... ...+..+||+.|||||++.+ ..|+.++|||||||++|||+| |++||.+.+..
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eCCCCCEEECcchhhhhcccCCCc-eeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999876443322 22355689999999999987 789999999999999999998 99999886543
Q ss_pred HHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 328 ~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
..+..+.. ... ..+. ...+++++.+||.+||+.||.+|||+.|+++|
T Consensus 295 ~~~~~~i~----------------------~g~--~~~~-----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 295 EEFCRRLK----------------------EGT--RMRA-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHH----------------------HTC--CCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHH----------------------cCC--CCCC-----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 32221111 000 1111 13468899999999999999999999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=424.05 Aligned_cols=284 Identities=38% Similarity=0.657 Sum_probs=231.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++++.||+|+||+||+|.+ .+|+.||||++............+.+|+.+|+.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence 5899999999999999999998 679999999996543333334678899999999999999999999854 3468
Q ss_pred EEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+||||++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 999999999999998764 6799999999999999999999999999999999999999999999999999976532211
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...++.+....+..+..
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (288)
T 1ob3_A 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE- 230 (288)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG-
T ss_pred ---ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc-
Confidence 12455899999999998652 4689999999999999999999999999999889988888888876654432211
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
...+...+....+.++......+++.+.+||.+||..||.+|||++|+|+||||++
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 231 -LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp -STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred -ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 01111122223344455556778999999999999999999999999999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=428.40 Aligned_cols=259 Identities=27% Similarity=0.495 Sum_probs=222.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++.. ...
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~~ 88 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-----EKT 88 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCE
Confidence 468999999999999999999999999999999997655555667789999999999999999999999843 456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+|||||+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 999999997 6999999888899999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCCcccccccccccCCCC-CCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~-~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.....+||++|+|||++.+ ..+ +.++|||||||++|+|++|++||.+.+.......+...
T Consensus 169 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------- 229 (328)
T 3fe3_A 169 ----KLDAFCGAPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------------- 229 (328)
T ss_dssp ----GGGTTSSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred ----ccccccCCcceeCcccccC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 2356789999999999887 455 47999999999999999999999988765444333211
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~ 412 (595)
....+ ..+++.+.+||.+||.+||.+|||++|+|+||||+.....
T Consensus 230 -------------~~~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (328)
T 3fe3_A 230 -------------KYRIP-----FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274 (328)
T ss_dssp -------------CCCCC-----TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred -------------CCCCC-----CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence 11111 2368899999999999999999999999999999876543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-51 Score=428.76 Aligned_cols=331 Identities=37% Similarity=0.669 Sum_probs=259.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC---------ChhhHHHHHHHHHHHHhcCCCceeeeeeee
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE---------HVSDATRILREIKLLRLLRHPDIVEIKHIM 181 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~---------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 181 (595)
..++|++.+.||+|+||.||+|.+.. |..||||++..... .....+.+.+|+.+|+.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 35789999999999999999999864 99999999854222 122347789999999999999999999998
Q ss_pred cCCCccCcccEEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEccc
Q 007629 182 LPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260 (595)
Q Consensus 182 ~~~~~~~~~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DF 260 (595)
..........+|+||||++++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp EECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred EeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 665444556799999999999999887654 6999999999999999999999999999999999999999999999999
Q ss_pred CcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCC
Q 007629 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (595)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p 340 (595)
|++........ ....+||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....+.|
T Consensus 179 g~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 179 NLAREDTADAN----KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp TC-------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred Ccccccccccc----cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99975433222 2456899999999988753 568999999999999999999999999999999999999999999
Q ss_pred ChhHHHHHhhHHHHHHhhhcccC-CCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCC
Q 007629 341 STESISRIRNEKARRYLGSMRKK-QPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQ 419 (595)
Q Consensus 341 ~~~~i~~i~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~ 419 (595)
..+.+..........++...... ....+....+..++.+.+||.+||.+||.+|||+.|+|+||||+.+..+.......
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~ 333 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGL 333 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTTC
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcccccccc
Confidence 98877666555555554433322 22233344567789999999999999999999999999999999875533221111
Q ss_pred CCcccchHHHHhhhcHHHHHHHHHHHHHhhC
Q 007629 420 PISKLEFEFERRKLAKDDVREMIYREILEYH 450 (595)
Q Consensus 420 ~~~~~~~~~e~~~~~~~~~~~~i~~ei~~~~ 450 (595)
...+.++.......++++.++.|+.++.
T Consensus 334 ---~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 361 (362)
T 3pg1_A 334 ---SERFHFDESVTDVYDMHKIFTAEVERFN 361 (362)
T ss_dssp ---CCCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred ---ccccChhhhhhhHHHHHHHHHHHHHHhc
Confidence 1122334456677888999999988765
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=419.22 Aligned_cols=288 Identities=36% Similarity=0.663 Sum_probs=229.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++. ....+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence 6899999999999999999999999999999998765444445667889999999999999999999984 34568
Q ss_pred EEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+||||+++ +|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 999999996 5677777777899999999999999999999999999999999999999999999999999986543221
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.............
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 158 ---YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp -----------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred ---ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 13456899999999998653 56899999999999999999999999999999999999888888766543322111
Q ss_pred HHHHHhhhcccCCC---CCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCC
Q 007629 352 KARRYLGSMRKKQP---VPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (595)
Q Consensus 352 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~ 412 (595)
.+........+ .+....++.+++.+.+||.+||.+||.+|||++|+|+||||+++.+.
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 234 ---QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp ---GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred ---cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 11111111111 11122346788999999999999999999999999999999987654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=425.03 Aligned_cols=288 Identities=35% Similarity=0.592 Sum_probs=231.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC---ChhhHHHHHHHHHHHHhcC---CCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE---HVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~---~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~ 185 (595)
.++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+++.+. ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 4689999999999999999999999999999999863221 1112345667887777664 999999999986654
Q ss_pred ccCcccEEEEEecccccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcc
Q 007629 186 RREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263 (595)
Q Consensus 186 ~~~~~~lylV~E~~~g~L~~~i~~~~~--l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla 263 (595)
......+|+||||++++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 344446899999999999999987654 999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
+....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+++..+...++.+...
T Consensus 168 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 168 RIYSYQMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp TTSTTCCC----SGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccCCCcc----cCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 76533222 355689999999999877 679999999999999999999999999999999999999988887765
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.+....... ...+....+.++....+.+++.+.+||.+||++||.+|||+.|+|+||||+..
T Consensus 242 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 242 DWPRDVSLP----RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TSCSSCSSC----GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hccchhhcc----ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 432211000 01111222233333456788999999999999999999999999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=426.67 Aligned_cols=289 Identities=34% Similarity=0.615 Sum_probs=219.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||.||+|.++.+|+.||||+++... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHT-----ENK 77 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-----TTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-----CCe
Confidence 468999999999999999999999999999999986432 22234567899999999999999999999854 356
Q ss_pred EEEEEecccccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 192 IYVVFELMESDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~~------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 8999999999999988754 3589999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...... .....+||+.|+|||++.+. ..++.++|||||||++|||++|++||.+.+...++..+.+.+|.+....+
T Consensus 158 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 158 FGIPVN---TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp TTSCCC---CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cCCCcc---cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 543221 12456899999999998752 46899999999999999999999999999999999999999998876554
Q ss_pred HHHhhHHHHHHhhhcccCCCCCC-----CCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPF-----SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~ 412 (595)
..+... ..+...+....+..+ ......+++.+.+||.+||+.||.+|||+.|+|+||||+.+...
T Consensus 234 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 234 PSVTKL--PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GGGGGC--TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhhh--hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 332110 000000000001000 01123578899999999999999999999999999999986553
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=426.16 Aligned_cols=261 Identities=28% Similarity=0.454 Sum_probs=222.4
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
..++|++++.||+|+||+||+|.++.+|..||||+++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--- 86 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--- 86 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC---
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe---
Confidence 3467999999999999999999999999999999996533221 135678899999999999999999999843
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC----cEEEcccC
Q 007629 187 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFG 261 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~----~vKL~DFG 261 (595)
...+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 87 --~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 87 --RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp --SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 456999999997 69999998888999999999999999999999999999999999999998877 79999999
Q ss_pred cceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCC
Q 007629 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (595)
Q Consensus 262 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~ 341 (595)
++........ ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..+........
T Consensus 165 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~ 238 (361)
T 2yab_A 165 LAHEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD 238 (361)
T ss_dssp SCEECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred CceEcCCCCc----cccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 9987543321 345689999999999877 6899999999999999999999999999887666555543322211
Q ss_pred hhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 342 ~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
. ..++.+++.+++||.+||..||.+|||+.|+|+||||+..
T Consensus 239 ~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 239 E---------------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp H---------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred c---------------------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 1 1134578899999999999999999999999999999854
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=424.70 Aligned_cols=288 Identities=36% Similarity=0.577 Sum_probs=222.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||+||+|++..+++.||||+++...........+.+|+.+|+.++||||+++++++. ....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 107 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HNHR 107 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ETTE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cCCE
Confidence 46899999999999999999999999999999999754433344566789999999999999999999984 3456
Q ss_pred EEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC-----CCCcEEEcccCcceec
Q 007629 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-----ADCKLKICDFGLARVS 266 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~-----~~~~vKL~DFGla~~~ 266 (595)
+|+||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 108 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 108 LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99999999999999999988999999999999999999999999999999999999994 4556999999999865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
..... .....+||+.|+|||++.+. ..++.++|||||||++|||++|.+||.+.+..+++..+...++.|....+.
T Consensus 188 ~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 188 GIPIR---QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp C--------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred CCccc---ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 32221 13456789999999998762 458999999999999999999999999999999999998888887765443
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCC-CCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
..... ..+...+.......+... ...+++.+.+||.+||.+||.+|||++|+|+||||++..
T Consensus 264 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 264 GVTAL--PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp TGGGS--TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhh--hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 22110 000000000000000000 011678899999999999999999999999999998764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-51 Score=435.19 Aligned_cols=288 Identities=36% Similarity=0.647 Sum_probs=233.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~~ 190 (595)
..+|++.+.||+|+||+||+|++..++. ||+|++..... ...+|+.+|+.++||||+++++++..... .+..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3579999999999999999999987766 88888753221 12379999999999999999999865432 3345
Q ss_pred cEEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC-CCCcEEEcccCccee
Q 007629 191 DIYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARV 265 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~-~~~~vKL~DFGla~~ 265 (595)
.+|+|||||++++...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 5889999999887666542 56899999999999999999999999999999999999999 799999999999987
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...... ...++||++|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+++..+.+.+|+|..+.+
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP----NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCC----CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCCCC----CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 644332 2456899999999998662 46999999999999999999999999999999999999999999998876
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCC-CCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 414 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~ 414 (595)
........ ...++...+.++...+ +.+++.+.+||.+||.+||.+|||+.|+|+||||+.+.+...
T Consensus 267 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 267 KTMNPNYM---EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA 333 (394)
T ss_dssp HHHCGGGS---SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCC
T ss_pred HhhChhhh---hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccc
Confidence 55432110 0111122222232222 347899999999999999999999999999999998876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=425.06 Aligned_cols=289 Identities=35% Similarity=0.626 Sum_probs=229.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++++.||+|+||+||+|.+..+++.||||++...... .....+.+|+.+|+.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEE
Confidence 5799999999999999999999999999999998642211 111234579999999999999999999844 3568
Q ss_pred EEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+||||++++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 9999999999999988754 599999999999999999999999999999999999999999999999999975432221
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
.....+||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..+...+|.|....+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 ---TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ---ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 23456899999999998653 56899999999999999999999999999999999999999999887765543222
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCC
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~ 412 (595)
...... ..............+.+++.+.+||.+||++||.+|||++|+|+||||..+...
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 232 EEFKTY-NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHHHHT-CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hhhccc-ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 111110 111111112223345678999999999999999999999999999999987553
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=433.86 Aligned_cols=288 Identities=35% Similarity=0.622 Sum_probs=232.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~~~ 191 (595)
.+|++.+.||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++|||||++++++..... .+..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 469999999999999999999999999999999864211 22479999999999999999998854321 23345
Q ss_pred EEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC-CcEEEcccCcceec
Q 007629 192 IYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVS 266 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~-~~vKL~DFGla~~~ 266 (595)
+++||||++++|.+++.. ...+++..++.++.||++||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 789999999988776643 4679999999999999999999999999999999999999965 57899999999875
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
..... ...++||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..+.+.+|+|..+.+.
T Consensus 208 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 208 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CTTCC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCC----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43332 2456899999999998762 479999999999999999999999999999999999999999999987765
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCC-CCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHK-FPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 414 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~ 414 (595)
...... ..+ .++.....+|... .+.+++.+++||.+||.+||.+|||+.|+|+||||+.+.+...
T Consensus 283 ~~~~~~-~~~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 283 EMNPNY-TEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 348 (420)
T ss_dssp HHCSCC-CCC--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred hhChhh-hhh--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence 432100 000 0011111111111 1356899999999999999999999999999999998766543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=428.51 Aligned_cols=285 Identities=33% Similarity=0.670 Sum_probs=229.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-----
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR----- 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 186 (595)
..+|++++.||+|+||+||+|.+..+|+.||||++..... ...+|+.+|+.++||||+++++++.....
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4689999999999999999999999999999999864322 12379999999999999999999854322
Q ss_pred ----------------------------cCcccEEEEEecccccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh
Q 007629 187 ----------------------------REFKDIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHT 234 (595)
Q Consensus 187 ----------------------------~~~~~lylV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~qil~aL~yLHs 234 (595)
....++|+|||||+++|.+.+. ....+++..++.++.||+.||.|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 2345689999999998777665 35689999999999999999999999
Q ss_pred CCeeecCCCCCceeeC-CCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHH
Q 007629 235 ANVFHRDLKPKNILAN-ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 313 (595)
Q Consensus 235 ~gIiHrDLKP~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~e 313 (595)
+||+||||||+|||++ .++.+||+|||+|+....... ....+||+.|+|||++.+. ..|+.++|||||||++||
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHH
Confidence 9999999999999998 689999999999986543332 2456899999999998762 458999999999999999
Q ss_pred HHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCC-CCCCHHHHHHHHhhCcCCCC
Q 007629 314 MLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPK 392 (595)
Q Consensus 314 LltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~dLl~~~L~~DP~ 392 (595)
|++|++||.+.+..+++..+...+|+|..+.+......... ..++......+...+ ...++.+.+||.+||.+||.
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE---VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-----CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc---ccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 99999999999999999999999999998876554321000 000011111111112 34788999999999999999
Q ss_pred CCCCHHHHhcCCCccCCC
Q 007629 393 DRPTAEEALADPYFHGLA 410 (595)
Q Consensus 393 ~Rpta~elL~Hp~f~~~~ 410 (595)
+|||+.|+|+||||+.+.
T Consensus 312 ~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp GSCCHHHHHTSGGGHHHH
T ss_pred hCCCHHHHhcCHHHHHHH
Confidence 999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=419.17 Aligned_cols=258 Identities=25% Similarity=0.441 Sum_probs=218.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-----CC
Confidence 3589999999999999999999999999999999964211 22345678899999999999999999999854 34
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||++ ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 6999999998 589999988889999999999999999999999999999999999999999999999999999854322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.......+...
T Consensus 159 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------- 220 (337)
T 1o6l_A 159 GA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------- 220 (337)
T ss_dssp TC---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred CC---cccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence 21 2356789999999999987 68999999999999999999999999887754433332210
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~~ 410 (595)
. .. ....+++.+.+||.+||..||.+|| +++|+++||||.++.
T Consensus 221 -------------~--~~---~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 221 -------------E--IR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp -------------C--CC---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -------------C--CC---CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 0 00 1134688999999999999999999 999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=426.06 Aligned_cols=258 Identities=23% Similarity=0.413 Sum_probs=214.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.+ .||||+++++++.. .
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-----P 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-----C
Confidence 468999999999999999999999999999999996421 1223456678999999988 69999999999844 3
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+|+|||||. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 46999999998 59999999888999999999999999999999999999999999999999999999999999975332
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+....+..+...
T Consensus 177 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------ 239 (353)
T 3txo_A 177 NGV---TTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------------ 239 (353)
T ss_dssp ------------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CCc---cccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence 221 2345789999999999987 57999999999999999999999999988866555444321
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH------HHHhcCCCccCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA------EEALADPYFHGLA 410 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta------~elL~Hp~f~~~~ 410 (595)
.. .+ ...+++.+.+||.+||.+||.+||++ +|+++||||+++.
T Consensus 240 --------------~~--~~---p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 240 --------------EV--VY---PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp --------------CC--CC---CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred --------------CC--CC---CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 00 01 12368889999999999999999998 9999999998764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=421.75 Aligned_cols=274 Identities=23% Similarity=0.231 Sum_probs=193.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
.+|.+.++||+|+||+||+|++ +|+.||||+++.. ........+|+..+..++|||||++++++.... .....+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEE
Confidence 4699999999999999999986 5899999999642 112222345666677899999999999986432 122458
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeecCCCCCceeeCCCCcEEEcccCcc
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLA 263 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~--------gIiHrDLKP~NILl~~~~~vKL~DFGla 263 (595)
|||||||+ |+|.+++.. .+++++.+..++.|++.||+|||++ +||||||||+||||+.++++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999998 699999976 4699999999999999999999987 9999999999999999999999999999
Q ss_pred eeccCCCCC-cccccccccCCcccccccccccC----CCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcC
Q 007629 264 RVSFNDAPS-AIFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338 (595)
Q Consensus 264 ~~~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~~----~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg 338 (595)
+........ .......+||++|||||++.+.. ..|+.++|||||||+||||+||.+||.......... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~~~ 234 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVPS 234 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSCS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhcccc
Confidence 876443321 11223468999999999986521 136779999999999999999998875443211000 000000
Q ss_pred CCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 339 ~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.+..+.+ ...+..-...++.+...........+.+|+.+||..||++|||+.|+++
T Consensus 235 ~~~~~~~--------~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 235 DPSVEEM--------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCCHHHH--------HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchHHHH--------HHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1111111 1111000001111111011122346789999999999999999999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=432.58 Aligned_cols=260 Identities=28% Similarity=0.467 Sum_probs=220.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++++.||+|+||+||+|.++.+|+.||+|++........+...+.+|+.+|+.++||||+++++++. +...+
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~~~ 85 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EEGHH 85 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CSSEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----ECCEE
Confidence 5799999999999999999999999999999999765444455677899999999999999999999984 34568
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC---CCCcEEEcccCcceeccC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVSFN 268 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~---~~~~vKL~DFGla~~~~~ 268 (595)
|+|||||. ++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999998 58999999989999999999999999999999999999999999999998 467899999999976543
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+....+..+....
T Consensus 166 ~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~----------- 229 (444)
T 3soa_A 166 EQQ---AWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA----------- 229 (444)
T ss_dssp TCC---BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----------
T ss_pred CCc---eeecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-----------
Confidence 322 2355789999999999977 689999999999999999999999998877655444332211
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.......++.+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 230 ----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 230 ----------------YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp ----------------CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred ----------------CCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 111123456789999999999999999999999999999999753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=416.93 Aligned_cols=297 Identities=35% Similarity=0.557 Sum_probs=233.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc---c
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR---R 187 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---~ 187 (595)
..++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4578999999999999999999999999999999986544433445567899999999999999999999865321 1
Q ss_pred CcccEEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 188 EFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 188 ~~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
....+|+|||||+++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 13568999999999998888764 57999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCC-CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
..... ........+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+...++..+....+.+..+.+
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 42221 12223556899999999998752 46899999999999999999999999999999999999998888776554
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCC--CCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKF--PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..+........+..... ........+ ...++.+.+||.+||.+||.+|||++|+|+||||...
T Consensus 254 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKG-QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp TTGGGCGGGTSSCCCSS-CCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred cccccchhhcccccccc-cccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 43321100000000000 000000000 0136789999999999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=427.47 Aligned_cols=280 Identities=33% Similarity=0.552 Sum_probs=230.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc------CCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL------RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~~~~ 185 (595)
..+|++++.||+|+||.||+|.+..+++.||||+++.. ......+.+|+.+|+.+ .|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--
Confidence 56899999999999999999999999999999999642 23445677899888887 57799999999843
Q ss_pred ccCcccEEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc--EEEcccC
Q 007629 186 RREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFG 261 (595)
Q Consensus 186 ~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~--vKL~DFG 261 (595)
...+|+||||++++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 171 ---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 171 ---RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp ---TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred ---CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 35689999999999999998764 5999999999999999999999999999999999999999987 9999999
Q ss_pred cceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCC
Q 007629 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (595)
Q Consensus 262 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~ 341 (595)
+|...... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+++..+...+|.|+
T Consensus 248 ~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 248 SSCYEHQR------VYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp TCEETTCC------CCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cceecCCc------ccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99764322 245689999999999987 6799999999999999999999999999999999999999999999
Q ss_pred hhHHHHHhhHHHHHHhhhcccCCC-------------------------CCCCCC-----CCCCCHHHHHHHHhhCcCCC
Q 007629 342 TESISRIRNEKARRYLGSMRKKQP-------------------------VPFSHK-----FPNADPLALHLLERLLAFDP 391 (595)
Q Consensus 342 ~~~i~~i~~~~~~~~l~~~~~~~~-------------------------~~~~~~-----~~~~~~~~~dLl~~~L~~DP 391 (595)
.+.+...... ..++..-..... .+.... ....++.+.+||.+||++||
T Consensus 320 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP 397 (429)
T 3kvw_A 320 QKLLDASKRA--KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDP 397 (429)
T ss_dssp HHHHHTBTTH--HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSST
T ss_pred HHHHHhhhhh--hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCCh
Confidence 8876654322 222211100000 000000 11347889999999999999
Q ss_pred CCCCCHHHHhcCCCccCC
Q 007629 392 KDRPTAEEALADPYFHGL 409 (595)
Q Consensus 392 ~~Rpta~elL~Hp~f~~~ 409 (595)
.+|||++|+|+||||+..
T Consensus 398 ~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 398 AVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp TTSCCHHHHHTSTTTC--
T ss_pred hhCCCHHHHhCChhhccC
Confidence 999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=417.66 Aligned_cols=256 Identities=30% Similarity=0.519 Sum_probs=213.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+|+.++||||+++++++... .
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----T 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence 46899999999999999999999999999999998642211 11235688999999999999999999998543 4
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+||||++|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 83 DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 68999999999999999988899999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCCcccccccccccCCCC-CCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~-~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.....+||+.|+|||++.+ ..+ ++++|||||||++|+|++|+.||.+......
T Consensus 163 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------------- 216 (336)
T 3h4j_B 163 ----FLKTSCGSPNYAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------------- 216 (336)
T ss_dssp ----TTCCCTTSTTTSCGGGSCC--SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--------------------
T ss_pred ----ccccccCCcCcCCHHHHcC--CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--------------------
Confidence 2345689999999999876 444 7899999999999999999999977542110
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
...+. .........+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 217 -------~~~i~----~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 217 -------FKKVN----SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -------BCCCC----SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -------HHHHH----cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 00000 00111223478999999999999999999999999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=406.97 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=216.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|++.+.||+|+||+||+|.+..+|+.||||++..... .....+.+|+.+|+.++||||+++++++.. ...
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 91 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLV-----GDE 91 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCE
Confidence 4689999999999999999999999999999999864322 235668899999999999999999999854 346
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+|||||+ ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 899999997 6899988764 69999999999999999999999999999999999999999999999999998654333
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
.. ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+....+..+.... .+
T Consensus 171 ~~---~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~---------- 234 (297)
T 3fxz_A 171 SK---RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TP---------- 234 (297)
T ss_dssp CC---BCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SC----------
T ss_pred cc---cCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CC----------
Confidence 22 345689999999999987 689999999999999999999999998877655444332110 00
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.......+++.+.+||.+||..||.+|||++|+|+||||+..
T Consensus 235 -----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 235 -----------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp -----------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -----------------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 001123467889999999999999999999999999999854
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=410.30 Aligned_cols=258 Identities=29% Similarity=0.468 Sum_probs=219.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
++|++.+.||+|+||.||+|.+..+|..||||+++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----- 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence 57999999999999999999999999999999986532221 135678899999999999999999999844
Q ss_pred cccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC----cEEEcccCcc
Q 007629 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLA 263 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~----~vKL~DFGla 263 (595)
...+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 356899999997 69999998888899999999999999999999999999999999999999888 8999999999
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
+....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.........
T Consensus 166 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~- 238 (326)
T 2y0a_A 166 HKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED- 238 (326)
T ss_dssp EECCTTSC----CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH-
T ss_pred eECCCCCc----cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc-
Confidence 87543221 245689999999999876 67999999999999999999999999988766555544332211111
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
..++.+++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 239 --------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 239 --------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp --------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred --------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 112456888999999999999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=419.77 Aligned_cols=259 Identities=29% Similarity=0.481 Sum_probs=220.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||+|+||.||+|.++.+|..||||++............+.+|+.+|+.++||||+++++++.. ...+
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~ 103 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESFH 103 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCEE
Confidence 47999999999999999999999999999999997654455566788999999999999999999999844 4568
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC---cEEEcccCcceeccC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVSFN 268 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~---~vKL~DFGla~~~~~ 268 (595)
|+|||||. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 99999998 58999998888899999999999999999999999999999999999998654 599999999986543
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.. .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+....+..+.....
T Consensus 184 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~---------- 247 (362)
T 2bdw_A 184 SE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY---------- 247 (362)
T ss_dssp CC----SCCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----------
T ss_pred Cc----ccccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 22 1345689999999999977 6799999999999999999999999988776544443322110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
......+..+++.+.+||.+||..||.+|||+.|+|+||||...
T Consensus 248 -----------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 248 -----------------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp -----------------CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred -----------------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 01112345678999999999999999999999999999999753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=421.68 Aligned_cols=296 Identities=23% Similarity=0.312 Sum_probs=218.7
Q ss_pred CCCCeEEeeeeeec--CceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 111 EASRYQIQEVIGKG--SYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G--~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
..++|++++.||+| +||.||+|++..+|+.||||+++...........+.+|+.+|+.++|||||++++++..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 97 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----- 97 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-----
Confidence 45789999999999 99999999999999999999997654445556778899999999999999999999853
Q ss_pred cccEEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 189 FKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
...+|+|||||+ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 356999999998 6899999876 6799999999999999999999999999999999999999999999999999865
Q ss_pred ccCCCCC----cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhc----
Q 007629 266 SFNDAPS----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL---- 337 (595)
Q Consensus 266 ~~~~~~~----~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~l---- 337 (595)
....... .......+||+.|+|||++.+....|+.++|||||||++|||++|++||.+.+....+..+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 4322111 11122348999999999987643578999999999999999999999998876554443222110
Q ss_pred ----CCCChhHHHHHh----hHHHHHHhh---hcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 338 ----GTPSTESISRIR----NEKARRYLG---SMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 338 ----g~p~~~~i~~i~----~~~~~~~l~---~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
..+......... .......+. ........+.......+++.+.+||.+||++||.+|||++|+|+||||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 000000000000 000000000 000000111122345678999999999999999999999999999999
Q ss_pred cCCCC
Q 007629 407 HGLAN 411 (595)
Q Consensus 407 ~~~~~ 411 (595)
+.+..
T Consensus 338 ~~~~~ 342 (389)
T 3gni_B 338 KQIKR 342 (389)
T ss_dssp GGC--
T ss_pred HHHhh
Confidence 98754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=412.38 Aligned_cols=257 Identities=25% Similarity=0.431 Sum_probs=219.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||+||+|.+..+++.||+|++... ......+.+|+.+|+.++||||+++++++. +...
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~ 75 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFE-----SMEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCE
Confidence 46899999999999999999999999999999998632 234566889999999999999999999984 3456
Q ss_pred EEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC--CCcEEEcccCcceecc
Q 007629 192 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVSF 267 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~--~~~vKL~DFGla~~~~ 267 (595)
+|+|||||+ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 999999998 58999997654 7999999999999999999999999999999999999987 7899999999998754
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.........
T Consensus 156 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----- 224 (321)
T 1tki_A 156 PGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE----- 224 (321)
T ss_dssp TTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH-----
T ss_pred CCC----ccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh-----
Confidence 322 1345689999999999877 56899999999999999999999999988876655555433222211
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..++.+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 225 ----------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 225 ----------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ----------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ----------------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 1234678899999999999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=414.27 Aligned_cols=279 Identities=22% Similarity=0.427 Sum_probs=227.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-----CCceeeeeeeecCCC
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-----HPDIVEIKHIMLPPS 185 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~~~~~~~ 185 (595)
..++|++++.||+|+||+||+|++..+++.||||+++. .......+.+|+.+|+.+. ||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~-- 107 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-- 107 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE--
Confidence 35789999999999999999999999999999999963 2334556778999999997 9999999999854
Q ss_pred ccCcccEEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC------------
Q 007629 186 RREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA------------ 251 (595)
Q Consensus 186 ~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~------------ 251 (595)
...+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 108 ---~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 108 ---YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp ---TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred ---CCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence 34689999999889999998764 5999999999999999999999999999999999999975
Q ss_pred -------------CCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCC
Q 007629 252 -------------DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK 318 (595)
Q Consensus 252 -------------~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~ 318 (595)
++.+||+|||+|+..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILN--LGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcC--CCCCCccchHHHHHHHHHHHHCC
Confidence 789999999999864322 234689999999999987 68999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCC-----------------CCCCHHHHH
Q 007629 319 PLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF-----------------PNADPLALH 381 (595)
Q Consensus 319 ~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~-----------------~~~~~~~~d 381 (595)
+||.+.+..+.+..+....+.++...+..........++.... ....+.... ...++.+.+
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDE--LKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTT--TEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCccc--ceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 9999999999999999998888776554332111111110000 000000000 112477889
Q ss_pred HHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 382 LLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 382 Ll~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
||.+||++||.+|||+.|+|+||||+
T Consensus 335 li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHhcCChhhCCCHHHHhcCcccC
Confidence 99999999999999999999999995
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=410.91 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=217.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-----CC
Confidence 3579999999999999999999999999999999864221 12335667899999999999999999999843 35
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 6999999998 599999998889999999999999999999999999999999999999999999999999999865321
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+....+..+...
T Consensus 160 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------- 218 (318)
T 1fot_A 160 ------TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------- 218 (318)
T ss_dssp ------BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------------
T ss_pred ------cccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 234689999999999987 67999999999999999999999999887765444433221
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~~ 410 (595)
.. . ..+.+++.+.+||.+||..||.+|| +++|+++||||+++.
T Consensus 219 -------------~~--~---~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 219 -------------EL--R---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp -------------CC--C---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred -------------CC--C---CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 00 0 1134688999999999999999999 999999999998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=417.41 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=218.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|++.+.||+|+||.||+|+++.+|+.||||++++... .......+.+|..+|+.+ +||||+++++++.. .
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~-----~ 90 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----K 90 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----S
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-----C
Confidence 4689999999999999999999999999999999964311 122355678899999876 89999999999844 3
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 56999999997 69999999888999999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+....+..+...
T Consensus 171 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------ 233 (345)
T 1xjd_A 171 GDA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------------ 233 (345)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CCC---cccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC------------
Confidence 221 1356789999999999987 67999999999999999999999999987765444333210
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHH-HHhcCCCccCCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE-EALADPYFHGLAN 411 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~-elL~Hp~f~~~~~ 411 (595)
.. . ....+++.+.+||.+||..||.+||++. ++++||||+++.+
T Consensus 234 --------------~~--~---~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 234 --------------NP--F---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp --------------CC--C---CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred --------------CC--C---CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 00 0 1124688999999999999999999998 9999999997653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=432.23 Aligned_cols=269 Identities=23% Similarity=0.383 Sum_probs=221.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|+++++||+|+||+||+|+++.+++.||||++++... .......+.+|+.+|..++||||+++++++.. ..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-----~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-----DN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-----SS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CC
Confidence 4689999999999999999999999999999999864211 11122337789999999999999999999844 45
Q ss_pred cEEEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 191 DIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.+|||||||. |+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 6999999996 699999987 46899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcccccccccCCccccccccccc---CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
... ...+..+||++|+|||++... ...|+.++|||||||++|||++|++||.+.+..+.+..|.....
T Consensus 228 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------- 298 (437)
T 4aw2_A 228 DGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------- 298 (437)
T ss_dssp TSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-------
T ss_pred CCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc-------
Confidence 322 223456899999999998621 25689999999999999999999999999887666555432100
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCC--CCCHHHHhcCCCccCCCCCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGLANVD 413 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~--Rpta~elL~Hp~f~~~~~~~ 413 (595)
...+...+..+++.+++||++||..+|++ |++++|+++||||+++.+..
T Consensus 299 -------------------~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 299 -------------------RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp -------------------HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred -------------------cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 01122334568999999999999999998 99999999999999876543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=407.35 Aligned_cols=298 Identities=42% Similarity=0.646 Sum_probs=229.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC-----
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS----- 185 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 185 (595)
..++|++++.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec--CChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 35789999999999999999999999999999999864 23455677899999999999999999999885432
Q ss_pred ----ccCcccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC-CCCcEEEccc
Q 007629 186 ----RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDF 260 (595)
Q Consensus 186 ----~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~-~~~~vKL~DF 260 (595)
......+|+||||++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp ----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 133467899999999999998864 5799999999999999999999999999999999999997 5679999999
Q ss_pred CcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCC
Q 007629 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (595)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p 340 (595)
|+++................+|++|+|||++.+. ..++.++|||||||++|||++|+.||.+.+....+..+....+.+
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998654322222223455789999999987652 578999999999999999999999999999888888888777766
Q ss_pred ChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCC
Q 007629 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (595)
Q Consensus 341 ~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~ 413 (595)
..+....+... ...++.........++....+.+++.+.+||.+||..||.+|||++|+|+||||+.+..+.
T Consensus 245 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 245 HEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CHHHHHHHHTT-SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred chhhhhhhhhc-CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 65544332110 0011111111122233334467899999999999999999999999999999998765443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=414.49 Aligned_cols=285 Identities=34% Similarity=0.621 Sum_probs=227.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++. ....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCCE
Confidence 46899999999999999999999999999999998655444445567889999999999999999999984 3456
Q ss_pred EEEEEeccccc-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~g~-L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+||||++++ |..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 89999999965 55555666789999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. .....+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++............
T Consensus 179 ~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 179 E---VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp --------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred c---ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 1 12456899999999998762 4789999999999999999999999999999999888888888776654332211
Q ss_pred HHHHHHhhhccc---CCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 351 EKARRYLGSMRK---KQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 351 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
.. ....... ....+....++.+++.+.+||.+||.+||.+|||+.|+|+||||+.
T Consensus 255 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 255 NP---VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CG---GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cc---ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 00 0000000 0111122234567899999999999999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=415.74 Aligned_cols=288 Identities=37% Similarity=0.609 Sum_probs=227.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh---hhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV---SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
.++|++++.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH----- 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-----
Confidence 468999999999999999999999999999999986422211 112467899999999999999999999844
Q ss_pred cccEEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 189 FKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 189 ~~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
...+|+||||++++|..++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 84 KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred CCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 34689999999999998887653 69999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+++..+...++.+..+.+..
T Consensus 164 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 164 SPNR---AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp SCCC---CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred CCcc---cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 3221 23456899999999998652 4589999999999999999999999999999999999888888877654332
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
.... ..+ ..+......++...+..+++.+.+||.+||..||.+|||+.|+|+||||.....
T Consensus 240 ~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 240 MCSL--PDY-VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp TTSS--TTC-CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hccC--ccc-ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 2100 000 000111112222334667899999999999999999999999999999987543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=410.88 Aligned_cols=267 Identities=22% Similarity=0.390 Sum_probs=214.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|++++.||+|+||.||+|+++.+++.||||++++... .......+.+|+.+|+.+ +||||+++++++.. .
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----C
Confidence 3579999999999999999999999999999999975432 334566788999999987 89999999999844 3
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 56999999997 59999998888999999999999999999999999999999999999999999999999999985332
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.......... .....
T Consensus 163 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----------~~~~~-- 225 (345)
T 3a8x_A 163 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD----------QNTED-- 225 (345)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-----------------CHH--
T ss_pred CCC---cccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc----------cccHH--
Confidence 221 1355789999999999987 689999999999999999999999996532110000 00000
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH------HHHhcCCCccCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA------EEALADPYFHGLA 410 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta------~elL~Hp~f~~~~ 410 (595)
........ .. ..+ ...+++.+.+||.+||..||.+||++ +|+++||||+++.
T Consensus 226 --~~~~~i~~---~~--~~~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 226 --YLFQVILE---KQ--IRI---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp --HHHHHHHH---CC--CCC---CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred --HHHHHHHc---CC--CCC---CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 00000010 11 111 13578899999999999999999995 8999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=420.71 Aligned_cols=268 Identities=22% Similarity=0.391 Sum_probs=213.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|+++++||+|+||+||+|+++.+++.||||++++... .......+.+|+.+|+.+ +|||||++++++.. .
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-----S
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-----C
Confidence 4689999999999999999999999999999999975432 222345678899999877 89999999999854 3
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+|+|||||. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 56999999998 58999999888999999999999999999999999999999999999999999999999999985332
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+........ ......+
T Consensus 206 ~~~---~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~-------~~~~~~~--- 270 (396)
T 4dc2_A 206 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------QNTEDYL--- 270 (396)
T ss_dssp TTC---CBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCHHHH---
T ss_pred CCC---ccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc-------hhhHHHH---
Confidence 221 2356789999999999987 689999999999999999999999997543211000 0000000
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH------HHHhcCCCccCCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA------EEALADPYFHGLAN 411 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta------~elL~Hp~f~~~~~ 411 (595)
....+. .. .. ....+++.+.+||.+||+.||.+||++ +|+++||||+++.+
T Consensus 271 ----~~~i~~---~~--~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 271 ----FQVILE---KQ--IR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp ----HHHHHH---CC--CC---CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred ----HHHHhc---cc--cC---CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 000000 11 11 113578999999999999999999985 89999999997643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=414.67 Aligned_cols=259 Identities=22% Similarity=0.381 Sum_probs=218.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|+.+|..+ .||+|+++++++.. .
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----M 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-----S
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-----C
Confidence 4689999999999999999999999999999999964311 123456678999999887 79999999999844 3
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 56999999997 59999999888999999999999999999999999999999999999999999999999999985332
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+....+..+...
T Consensus 174 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------ 236 (353)
T 2i0e_A 174 DGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------ 236 (353)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CCc---ccccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC------------
Confidence 221 2345789999999999987 67999999999999999999999999987765544433221
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLAN 411 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~~~ 411 (595)
.. . ....+++.+.+||.+||..||.+||+ ++++++||||+++.+
T Consensus 237 --------------~~--~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 237 --------------NV--A---YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp --------------CC--C---CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred --------------CC--C---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 00 0 11357889999999999999999994 799999999987643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=413.07 Aligned_cols=255 Identities=22% Similarity=0.383 Sum_probs=218.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----CC
Confidence 468999999999999999999999999999999986421 112345678899999999999999999999844 35
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 6999999997 699999998889999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+....+..+...
T Consensus 195 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------- 253 (350)
T 1rdq_E 195 ------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------------- 253 (350)
T ss_dssp ------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred ------cccccCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-------------
Confidence 234689999999999987 67999999999999999999999999887765444333221
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 410 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~~ 410 (595)
.. .+ ...+++.+.+||.+||..||.+||+ ++|+++||||+++.
T Consensus 254 -------------~~--~~---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 254 -------------KV--RF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp -------------CC--CC---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred -------------CC--CC---CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 00 01 1346889999999999999999998 99999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=392.91 Aligned_cols=263 Identities=29% Similarity=0.488 Sum_probs=222.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-----CCE
Confidence 468999999999999999999999999999999997655555566788999999999999999999999843 356
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc---EEEcccCcceecc
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVSF 267 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~---vKL~DFGla~~~~ 267 (595)
.|+||||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 899999998 589999988889999999999999999999999999999999999999987665 9999999997654
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 160 ~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--------- 224 (284)
T 3kk8_A 160 DSEA----WHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY--------- 224 (284)
T ss_dssp SSCB----CCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---------
T ss_pred cCcc----ccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc---------
Confidence 3221 245689999999999887 6789999999999999999999999988775544433322110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~ 412 (595)
......+..+++.+.+||.+||..||.+|||++|+|+||||+.....
T Consensus 225 ------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 225 ------------------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV 271 (284)
T ss_dssp ------------------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred ------------------cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence 11122345678999999999999999999999999999999875443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=412.19 Aligned_cols=292 Identities=35% Similarity=0.615 Sum_probs=223.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc--cCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR--REF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--~~~ 189 (595)
.++|++.+.||+|+||.||+|.+..+|..||||++.... .......+|+..++.++||||+++++++..... ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 468999999999999999999999999999999985422 222345678888999999999999999865322 223
Q ss_pred ccEEEEEecccccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCCCceeeCC-CCcEEEcccCc
Q 007629 190 KDIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIH--TANVFHRDLKPKNILANA-DCKLKICDFGL 262 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~qil~aL~yLH--s~gIiHrDLKP~NILl~~-~~~vKL~DFGl 262 (595)
..+|+||||++++|...+. ....+++..++.++.||+.||.||| +.||+||||||+|||++. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 4488999999998776554 4567899999999999999999999 999999999999999997 89999999999
Q ss_pred ceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
++....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+...++.+..
T Consensus 179 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 179 AKKLSPSEP----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CBCCCTTSC----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ceecCCCCC----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 986543322 2456899999999998652 45899999999999999999999999999999999999999999988
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCC----CCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCC
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFS----HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 414 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~----~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~ 414 (595)
+.+..+....... ........++. ......++.+.+||.+||++||.+|||+.|+|+||||+.+.....
T Consensus 254 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 254 EVLRKLNPSHTDV---DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp HHHHHHCTTCCCG---GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred HHHHhcccchhhc---cccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 7766543211000 00011111111 122335788999999999999999999999999999998766543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=423.39 Aligned_cols=266 Identities=24% Similarity=0.338 Sum_probs=217.9
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
..++|++++.||+|+||+||+|+++.+++.||||++++... .......+.+|+.+|+.++|||||++++++.. .
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-----D 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----C
Confidence 35689999999999999999999999999999999864211 11122347789999999999999999999843 4
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+|||||||+ |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 56999999996 689998875 4799999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCCcccccccccccCC--CCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFS--KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~--~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
.. .......+||+.|+|||++.+... .|+.++|||||||++|||++|++||.+.+.......|.....
T Consensus 221 ~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-------- 290 (410)
T 3v8s_A 221 EG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN-------- 290 (410)
T ss_dssp TS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--------
T ss_pred CC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc--------
Confidence 22 112346789999999999876211 178999999999999999999999998887665554432100
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCC--CCCHHHHhcCCCccCCCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKD--RPTAEEALADPYFHGLAN 411 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~--Rpta~elL~Hp~f~~~~~ 411 (595)
. ... .....+++.+++||.+||..+|.+ |++++|+++||||+++.+
T Consensus 291 ------------~----~~~---p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 291 ------------S----LTF---PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp ------------H----CCC---CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred ------------c----ccC---CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence 0 000 112457899999999999999998 999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=404.78 Aligned_cols=258 Identities=28% Similarity=0.469 Sum_probs=207.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~---~~g~~vAIK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
.++|++++.||+|+||.||+|++. .+|+.||||++++... .......+.+|+.+|+.++||||+++++++..
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 92 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--- 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---
Confidence 357999999999999999999985 6899999999975321 22344567889999999999999999999844
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 187 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
...+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 93 --GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp --SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred --CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 356999999998 68999998888999999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 171 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--------- 236 (327)
T 3a62_A 171 SIHDGT---VTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--------- 236 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT---------
T ss_pred cccCCc---cccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC---------
Confidence 432221 1245689999999999877 67899999999999999999999999987765544433221
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~~ 410 (595)
.. ...+.+++.+.+||.+||..||.+|| +++|+++||||+++.
T Consensus 237 -----------------~~-----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 237 -----------------KL-----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp -----------------CC-----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred -----------------CC-----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 00 01134688999999999999999999 899999999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=401.46 Aligned_cols=259 Identities=27% Similarity=0.458 Sum_probs=219.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
++|++.+.||+|+||.||+|.+..+|+.||||+++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 86 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN----- 86 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 57999999999999999999999999999999986532221 135678899999999999999999999843
Q ss_pred cccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC----cEEEcccCcc
Q 007629 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLA 263 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~----~vKL~DFGla 263 (595)
...+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 356899999997 69999999888899999999999999999999999999999999999999888 7999999999
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+..........
T Consensus 167 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 240 (321)
T 2a2a_A 167 HEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE 240 (321)
T ss_dssp EECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred eecCcccc----ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChh
Confidence 86543322 245679999999999877 678999999999999999999999999887666555544332221111
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.+...++.+.+||.+||..||.+|||+.|+|+||||...
T Consensus 241 ---------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 241 ---------------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp ---------------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred ---------------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 123567889999999999999999999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=417.04 Aligned_cols=263 Identities=25% Similarity=0.420 Sum_probs=216.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+|+.++|||||++++++.. ..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-----EE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence 468999999999999999999999999999999986421 122345678899999999999999999999854 35
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+|||||. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 6999999997 689999998889999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.. ....+||+.|+|||++.+. ...|+.++|||||||++|||++|++||.+.........+..
T Consensus 169 ~~----~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------- 231 (384)
T 4fr4_A 169 TQ----ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT------------- 231 (384)
T ss_dssp CC----BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH-------------
T ss_pred Cc----eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH-------------
Confidence 22 3567899999999998642 14589999999999999999999999986543211111100
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-HHHHhcCCCccCCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-AEEALADPYFHGLAN 411 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-a~elL~Hp~f~~~~~ 411 (595)
... . .. .....+++.+.+||.+||..||.+||+ ++++++||||+++.+
T Consensus 232 -------~~~-~----~~---~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 232 -------FET-T----VV---TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp -------HHH-C----CC---CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred -------Hhh-c----cc---CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 000 0 00 112356889999999999999999998 999999999987653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=403.88 Aligned_cols=290 Identities=35% Similarity=0.592 Sum_probs=234.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc---CCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT-HTGERVAIKKINDVFEHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~-~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~ 187 (595)
.++|++.+.||+|+||.||+|.+. .+|+.||||+++...........+.+|+.+++.+ .||||+++++++......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 368999999999999999999995 6789999999864332222223456788777766 899999999998633323
Q ss_pred CcccEEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 188 EFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
....+|+||||++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 90 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 456799999999999999998754 499999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...++.+....+
T Consensus 170 ~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 170 YSFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CCGGG----GGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred ccCCC----CccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 43221 2345689999999999877 67999999999999999999999999999998889888888888766543
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
...... ....+......+.....+.+++.+.+||.+||..||.+|||+.|+|+||||+.+..
T Consensus 244 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 244 PRDVAL----PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CTTCSS----CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccc----chhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 221000 00011122223344456778999999999999999999999999999999987754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=422.47 Aligned_cols=270 Identities=22% Similarity=0.340 Sum_probs=218.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
..++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|+.+|..++||||+++++++.. .
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-----~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-----E 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-----S
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----C
Confidence 35789999999999999999999999999999999964211 11223457789999999999999999999844 4
Q ss_pred ccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 190 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
..+|||||||. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 56999999996 6999999875 479999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCCccccccccccc-----CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~-----~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
.... ......+||+.|+|||++... ...|+.++|||||||++|||++|++||.+.+....+..|.....
T Consensus 214 ~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---- 287 (412)
T 2vd5_A 214 ADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE---- 287 (412)
T ss_dssp TTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----
T ss_pred CCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----
Confidence 3322 112346899999999998631 14689999999999999999999999998876655554432100
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCC---CCHHHHhcCCCccCCCCCCC
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR---PTAEEALADPYFHGLANVDR 414 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~R---pta~elL~Hp~f~~~~~~~~ 414 (595)
. ..+......+++.+++||++||. +|.+| ++++|+++||||+++.+...
T Consensus 288 --------------------~--~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 288 --------------------H--LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp --------------------H--CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred --------------------C--cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 0 00111124578999999999999 99998 59999999999998866543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=424.87 Aligned_cols=290 Identities=34% Similarity=0.591 Sum_probs=212.4
Q ss_pred CCeEE-eeeeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 113 SRYQI-QEVIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 113 ~~Y~i-~~~LG~G~fG~V~~a~~~--~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
+.|++ .++||+|+||+||+|+++ .++..||||++.... ....+.+|+.+|+.++||||+++++++... ..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~ 92 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSH---AD 92 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CC
Confidence 35776 458999999999999965 578999999996432 224578999999999999999999998542 23
Q ss_pred ccEEEEEecccccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee----CCCCcEE
Q 007629 190 KDIYVVFELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLK 256 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~---------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl----~~~~~vK 256 (595)
..+||||||++++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.+|
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 93 RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp TEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred CeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 568999999999999888632 249999999999999999999999999999999999999 6778999
Q ss_pred EcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCCh---------H
Q 007629 257 ICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---------V 327 (595)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~---------~ 327 (595)
|+|||+|+...............+||++|+|||++.+. ..|+.++||||||||+|||++|++||.+... .
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 99999998654332222233557899999999998762 4589999999999999999999999987654 4
Q ss_pred HHHHHHHhhcCCCChhHHHHHhhHH-HHHHhhhcccCCCCC------CCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHH
Q 007629 328 HQLDLMTDLLGTPSTESISRIRNEK-ARRYLGSMRKKQPVP------FSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400 (595)
Q Consensus 328 ~~l~~i~~~lg~p~~~~i~~i~~~~-~~~~l~~~~~~~~~~------~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~el 400 (595)
+++..+...+|.|....+..+.... .......+....... +.......++.+.+||.+||.+||.+|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 7889999999998876655432110 011111111100000 001112346789999999999999999999999
Q ss_pred hcCCCccCCC
Q 007629 401 LADPYFHGLA 410 (595)
Q Consensus 401 L~Hp~f~~~~ 410 (595)
|+||||....
T Consensus 332 L~hp~f~~~~ 341 (405)
T 3rgf_A 332 MQDPYFLEDP 341 (405)
T ss_dssp HTSGGGTSSS
T ss_pred hcChhhccCC
Confidence 9999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=427.35 Aligned_cols=258 Identities=31% Similarity=0.498 Sum_probs=214.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++++.||+|+||+||+|+++.++..||||++............+.+|+.+|+.++||||+++++++.. ...+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-----KRNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCEE
Confidence 47999999999999999999999999999999997644333445678899999999999999999999943 4568
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC---CcEEEcccCcceeccC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVSFN 268 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~---~~vKL~DFGla~~~~~ 268 (595)
|+|||||. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++.....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999998 5899999888899999999999999999999999999999999999999764 4599999999987543
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+....+..+......
T Consensus 192 ~~~----~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------- 255 (494)
T 3lij_A 192 QKK----MKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT--------- 255 (494)
T ss_dssp TBC----BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------
T ss_pred Ccc----ccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 321 345689999999999864 6899999999999999999999999988765555444322111
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.....|..+++.+.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 256 ------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 256 ------------------FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp ------------------CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred ------------------CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 1122345788999999999999999999999999999999764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=410.12 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=210.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc---CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF---EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
++|++.+.||+|+||+||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++. ..
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~ 98 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----SD 98 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence 47999999999999999999999999999999985321 11123567889999999999999999999984 34
Q ss_pred ccEEEEEeccc-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc---EEEcccC
Q 007629 190 KDIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFG 261 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~---vKL~DFG 261 (595)
..+|+|||||+ ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 56999999998 6888777543 35899999999999999999999999999999999999987655 9999999
Q ss_pred cceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCC
Q 007629 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (595)
Q Consensus 262 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~ 341 (595)
++........ .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+... ..+..+.......
T Consensus 179 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~- 251 (351)
T 3c0i_A 179 VAIQLGESGL---VAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKM- 251 (351)
T ss_dssp TCEECCTTSC---BCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCC-
T ss_pred ceeEecCCCe---eecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCC-
Confidence 9987543221 2345689999999999987 6789999999999999999999999987532 2222221110000
Q ss_pred hhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 342 ~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
....++.+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 252 --------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 252 --------------------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp --------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred --------------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 011234578899999999999999999999999999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=405.59 Aligned_cols=263 Identities=27% Similarity=0.381 Sum_probs=212.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~ 79 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNI 79 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CCe
Confidence 4689999999999999999999999999999999854221 2223567899999999999999999999843 456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+|||||+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 899999997 5899999887789999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. .......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+...........
T Consensus 160 ~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---------------- 221 (323)
T 3tki_A 160 R-ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---------------- 221 (323)
T ss_dssp E-ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH----------------
T ss_pred c-ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH----------------
Confidence 1 1123456899999999998762 234778999999999999999999998765322111000
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
.. . ......+..+++.+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 222 ------~~---~---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 222 ------KE---K---KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp ------HT---T---CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ------hc---c---cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 00 0 001112345788999999999999999999999999999998643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=413.72 Aligned_cols=259 Identities=27% Similarity=0.444 Sum_probs=210.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHH-HHhcCCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKL-LRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|++++.||+|+||.||+|+++.++..||||++++... .......+.+|..+ ++.++||||+++++++.. .
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-----~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----A 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-----C
Confidence 4689999999999999999999999999999999965322 22334566778776 577899999999999844 3
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 56999999998 58999999888999999999999999999999999999999999999999999999999999985433
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+.......+...
T Consensus 192 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------ 254 (373)
T 2r5t_A 192 HNS---TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------------ 254 (373)
T ss_dssp CCC---CCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS------------
T ss_pred CCC---ccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc------------
Confidence 222 1345789999999999987 68999999999999999999999999987765544433210
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH----HHHhcCCCccCCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA----EEALADPYFHGLAN 411 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta----~elL~Hp~f~~~~~ 411 (595)
+. ...+.+++.+.+||.+||..||.+||++ .++++||||+++.+
T Consensus 255 ----------------~~---~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 255 ----------------PL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp ----------------CC---CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred ----------------cc---CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 00 1124578899999999999999999986 79999999997654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=398.98 Aligned_cols=260 Identities=25% Similarity=0.461 Sum_probs=206.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC------------------------hhhHHHHHHHHHHHH
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH------------------------VSDATRILREIKLLR 167 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~------------------------~~~~~~~~~Ei~il~ 167 (595)
.++|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999999999999999998643211 112356789999999
Q ss_pred hcCCCceeeeeeeecCCCccCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCc
Q 007629 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (595)
Q Consensus 168 ~l~HpnIv~l~~~~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~N 246 (595)
.++||||+++++++.... ...+|+||||++ ++|.+++ ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPN---EDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECSS---SSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcCC---CCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999986432 356899999998 4666543 34579999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCC-CCCcceeechhHHHHHHHcCCCCCCCCC
Q 007629 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLFPGKN 325 (595)
Q Consensus 247 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~-~~~k~DIWSlG~il~eLltG~~pF~~~~ 325 (595)
||++.++.+||+|||+++....... .....+||+.|+|||++.+.... ++.++|||||||++|+|++|+.||.+.+
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999986543221 23456899999999998763111 4778999999999999999999998766
Q ss_pred hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCC
Q 007629 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405 (595)
Q Consensus 326 ~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~ 405 (595)
.......+... .... ...+.+++.+.+||.+||..||.+|||+.|+|+|||
T Consensus 245 ~~~~~~~~~~~--------------------------~~~~---~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 245 IMCLHSKIKSQ--------------------------ALEF---PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HHHHHHHHHHC--------------------------CCCC---CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HHHHHHHHhcc--------------------------cCCC---CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 43322221110 0000 112467889999999999999999999999999999
Q ss_pred cc
Q 007629 406 FH 407 (595)
Q Consensus 406 f~ 407 (595)
|+
T Consensus 296 ~~ 297 (298)
T 2zv2_A 296 VT 297 (298)
T ss_dssp HH
T ss_pred cc
Confidence 95
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=400.59 Aligned_cols=252 Identities=27% Similarity=0.303 Sum_probs=206.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|+++++||+|+||+||+|++..+|+.||||++...............|+..+..+ .||||+++++++. +...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 479999999999999999999999999999999876555555566667777776655 8999999999984 4456
Q ss_pred EEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+|||||+++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 99999999999998887654 69999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+...... +.. +....
T Consensus 212 ~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~~~-------- 271 (311)
T 3p1a_A 212 A----GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYLPP-------- 271 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCCCH--------
T ss_pred C----CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCCCc--------
Confidence 2 234579999999999865 689999999999999999999877655332111 110 00000
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
.....+++.+.+||.+||..||.+|||++|+|+||||++
T Consensus 272 -------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 272 -------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 011346788999999999999999999999999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=424.06 Aligned_cols=258 Identities=26% Similarity=0.446 Sum_probs=209.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++++.||+|+||.||+|.+..+|+.||||+++... ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----TT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----CC
Confidence 468999999999999999999999999999999986422 222345667899999999999999999999843 35
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.+|||||||+ ++|..++...+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+|+....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 6899999998 5899999888899999999999999999999998 9999999999999999999999999999975332
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+.......+...
T Consensus 302 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------ 364 (446)
T 4ejn_A 302 DGA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------ 364 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CCc---ccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------------
Confidence 221 2355789999999999977 68999999999999999999999999887765444433211
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~~ 410 (595)
... ....+++.+.+||.+||.+||.+|| +++|+|+||||+++.
T Consensus 365 --------------~~~-----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 365 --------------EIR-----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp --------------CCC-----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred --------------CCC-----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 000 1134688999999999999999999 999999999999764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=411.99 Aligned_cols=258 Identities=27% Similarity=0.431 Sum_probs=217.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||.||+|.+..+|+.||+|++... ...+...+.+|+.+|+.++||||+++++++.. ...
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 122 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYE 122 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----CCE
Confidence 35799999999999999999999999999999998643 23345678899999999999999999999843 456
Q ss_pred EEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC--CCcEEEcccCcceecc
Q 007629 192 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVSF 267 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~--~~~vKL~DFGla~~~~ 267 (595)
+|+|||||. ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999998 58999887654 7999999999999999999999999999999999999974 4779999999998754
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.... ....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+....+..+....
T Consensus 203 ~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~---------- 266 (387)
T 1kob_A 203 PDEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD---------- 266 (387)
T ss_dssp TTSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC----------
T ss_pred CCcc----eeeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 3321 234589999999999987 678999999999999999999999999887655544332211
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.......+..+++.+.+||.+||..||.+|||+.|+|+||||++.
T Consensus 267 -----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 267 -----------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp -----------------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -----------------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 011123345788999999999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=407.79 Aligned_cols=261 Identities=31% Similarity=0.466 Sum_probs=201.7
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..++|++++.||+|+||+||+|++..+++.||||++..... ....+.+|+.+++.++||||+++++++... .
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 89 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTP-----T 89 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-----C
Confidence 35689999999999999999999999999999999964322 235578999999999999999999999543 4
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc--EEEcccCcceecc
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVSF 267 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~--vKL~DFGla~~~~ 267 (595)
.+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 6899999997 699999988889999999999999999999999999999999999999987765 9999999997432
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCc-ceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPA-IDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k-~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
.... ....+||+.|+|||++.+ ..++.+ +|||||||++|+|++|++||.+.........+..
T Consensus 170 ~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----------- 232 (361)
T 3uc3_A 170 LHSQ----PKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ----------- 232 (361)
T ss_dssp ---------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH-----------
T ss_pred ccCC----CCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH-----------
Confidence 2221 244689999999999876 455544 8999999999999999999987543221111100
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
..+. ..... .....+++.+.+||.+||..||.+|||+.|+|+||||....
T Consensus 233 --------~~~~---~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 233 --------RILS---VKYSI---PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp --------HHHT---TCCCC---CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred --------HHhc---CCCCC---CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 0000 00000 11234689999999999999999999999999999996543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=400.69 Aligned_cols=287 Identities=31% Similarity=0.591 Sum_probs=221.9
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCc
Q 007629 108 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSR 186 (595)
Q Consensus 108 ~~~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 186 (595)
+++..++|++++.||+|+||.||+|.+..+++.||||+++. .....+.+|+.+|+.+. ||||+++++++....
T Consensus 31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~- 104 (330)
T 3nsz_A 31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPV- 104 (330)
T ss_dssp CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT-
T ss_pred cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCC-
Confidence 34456799999999999999999999999999999999863 23467889999999997 999999999986432
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC-cEEEcccCcce
Q 007629 187 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLAR 264 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~-~vKL~DFGla~ 264 (595)
...+|+||||+. ++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 105 --~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 105 --SRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp --TCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred --CCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 356899999998 57777764 489999999999999999999999999999999999999777 89999999998
Q ss_pred eccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCC-CCCChHHHHHHHHhhcCCCChh
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF-PGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF-~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.|| .+.+..+++..+...++.+...
T Consensus 180 ~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 180 FYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 254 (330)
T ss_dssp ECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred EcCCCCc----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhh
Confidence 6543322 2446899999999998653 56899999999999999999999888 4556667777777766643221
Q ss_pred HH-HHHhhHHHHHHhhhcccCCCCCCC-----CCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 344 SI-SRIRNEKARRYLGSMRKKQPVPFS-----HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 344 ~i-~~i~~~~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
.. ..........+...........+. .....+++.+.+||.+||.+||.+|||++|+|+||||+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 11 000000000000001111111111 11123689999999999999999999999999999999764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=426.73 Aligned_cols=260 Identities=33% Similarity=0.530 Sum_probs=218.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.. ...+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~ 96 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSSF 96 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-----CCEE
Confidence 57999999999999999999999999999999986533333456778999999999999999999999844 4569
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC---CCCcEEEcccCcceeccC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVSFN 268 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~---~~~~vKL~DFGla~~~~~ 268 (595)
|+|||||. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999998 58999998888999999999999999999999999999999999999995 456799999999976533
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.. .....+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+......
T Consensus 177 ~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------- 240 (486)
T 3mwu_A 177 NT----KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA--------- 240 (486)
T ss_dssp C--------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------
T ss_pred CC----ccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 22 1345689999999999875 5899999999999999999999999988876655544322111
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
.....+..+++.+++||.+||.+||.+|||+.|+|+||||+....
T Consensus 241 ------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 241 ------------------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp ------------------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred ------------------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 011224567899999999999999999999999999999987643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=408.73 Aligned_cols=256 Identities=29% Similarity=0.447 Sum_probs=210.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++.+.||+|+||+||+|.++.+|+.||||++.+... ...+|+.+|..+ .||||+++++++. +...
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~ 90 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYD-----DGKY 90 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEE-----CSSE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEE-----cCCE
Confidence 579999999999999999999999999999999965322 234688888887 7999999999984 3456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC----CcEEEcccCcceec
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLARVS 266 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~----~~vKL~DFGla~~~ 266 (595)
+|+|||||. ++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++..
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999997 5999999988899999999999999999999999999999999999998443 35999999999865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCCh---HHHHHHHHhhcCCCChh
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV---VHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~---~~~l~~i~~~lg~p~~~ 343 (595)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+... ...+..+.
T Consensus 171 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~--------- 236 (342)
T 2qr7_A 171 RAENG---LLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG--------- 236 (342)
T ss_dssp BCTTC---CBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH---------
T ss_pred cCCCC---ceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc---------
Confidence 43322 1245689999999999876 5688999999999999999999999986431 11111111
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
..........++.+++.+.+||.+||..||.+|||+.++|+||||..+..
T Consensus 237 ------------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~ 286 (342)
T 2qr7_A 237 ------------------SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286 (342)
T ss_dssp ------------------HCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred ------------------cCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence 11111122345678999999999999999999999999999999976543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=409.47 Aligned_cols=283 Identities=27% Similarity=0.400 Sum_probs=224.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC--------CCceeeeeeeecC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR--------HPDIVEIKHIMLP 183 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~~~~~~ 183 (595)
.++|++.+.||+|+||+||+|++..+++.||||+++.. ......+.+|+.+|+.++ ||||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 46899999999999999999999999999999999632 334567889999999986 7889999998853
Q ss_pred CCccCcccEEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCceeeCCCC-------
Q 007629 184 PSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADC------- 253 (595)
Q Consensus 184 ~~~~~~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~-gIiHrDLKP~NILl~~~~------- 253 (595)
.. .....+|+||||++++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 113 ~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 21 134569999999999988888765 4699999999999999999999998 999999999999999876
Q ss_pred ------------------------------------------cEEEcccCcceeccCCCCCcccccccccCCcccccccc
Q 007629 254 ------------------------------------------KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291 (595)
Q Consensus 254 ------------------------------------------~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l 291 (595)
.+||+|||++...... ....+||+.|+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhh
Confidence 7999999999865432 2445899999999999
Q ss_pred cccCCCCCCcceeechhHHHHHHHcCCCCCCCCC------hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCC
Q 007629 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN------VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQP 365 (595)
Q Consensus 292 ~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~------~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~ 365 (595)
.+ ..|+.++|||||||++|||++|++||.+.+ ...++..+...+|.++...+...... ..++........
T Consensus 266 ~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~ 341 (397)
T 1wak_A 266 IG--SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS--KEFFTKKGDLKH 341 (397)
T ss_dssp HT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG--GGTBCTTSSBSS
T ss_pred cC--CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc--ccccCCcccccc
Confidence 87 679999999999999999999999998765 56778888899998887655332110 001100000000
Q ss_pred CCCC-------------CCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 366 VPFS-------------HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 366 ~~~~-------------~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
.... ......++.+.+||.+||.+||.+|||++|+|+||||++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0000 001123456889999999999999999999999999963
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=407.12 Aligned_cols=281 Identities=32% Similarity=0.521 Sum_probs=226.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CC-----ceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HP-----DIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~~~~~~~~ 185 (595)
.++|++.+.||+|+||+||+|.+..+++.||||+++.. ......+.+|+.+++.+. |+ +|+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 46899999999999999999999999999999999642 234566778999998885 55 48999888843
Q ss_pred ccCcccEEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCCCceeeC--CCCcEEEcc
Q 007629 186 RREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIH--TANVFHRDLKPKNILAN--ADCKLKICD 259 (595)
Q Consensus 186 ~~~~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLH--s~gIiHrDLKP~NILl~--~~~~vKL~D 259 (595)
...+|+||||++++|.+++... ..+++..++.++.||+.||.||| ..||+||||||+|||++ .++.+||+|
T Consensus 128 ---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 ---RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ---TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ---CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 3568999999999999999875 46999999999999999999999 57999999999999994 478899999
Q ss_pred cCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCC
Q 007629 260 FGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339 (595)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~ 339 (595)
||+|+..... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..+...++.
T Consensus 205 FG~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 205 FGSSCQLGQR------IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CTTCEETTCC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred ccCceecccc------cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999865322 245689999999999987 67999999999999999999999999999999999999999999
Q ss_pred CChhHHHHHhhHHHHHHhhhcccCCC---------CCCCC-CC------------------C-------CCCHHHHHHHH
Q 007629 340 PSTESISRIRNEKARRYLGSMRKKQP---------VPFSH-KF------------------P-------NADPLALHLLE 384 (595)
Q Consensus 340 p~~~~i~~i~~~~~~~~l~~~~~~~~---------~~~~~-~~------------------~-------~~~~~~~dLl~ 384 (595)
|+...+.... ..+.++..+..... ..+.. .. . ...+.+++||.
T Consensus 277 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 354 (382)
T 2vx3_A 277 PPAHILDQAP--KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354 (382)
T ss_dssp CCHHHHTTCT--THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred CCHHHHHhhH--HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence 8877654332 22333333221100 00000 00 0 00147899999
Q ss_pred hhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 385 RLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 385 ~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
+||++||.+|||++|+|+||||+...
T Consensus 355 ~mL~~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 355 RMLDYDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp HHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred HhcCCChhhCCCHHHHhcCcccccCC
Confidence 99999999999999999999998653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=386.41 Aligned_cols=256 Identities=32% Similarity=0.475 Sum_probs=217.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+|+.++||||+++++++.. ...+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 81 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFED-----NTDI 81 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCeE
Confidence 579999999999999999999999999999999865332 345678899999999999999999999843 3568
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee---CCCCcEEEcccCcceeccC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVSFN 268 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl---~~~~~vKL~DFGla~~~~~ 268 (595)
|+||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999997 5899999888899999999999999999999999999999999999999 7889999999999986543
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+.......+..
T Consensus 162 ~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 229 (277)
T 3f3z_A 162 GKM----MRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK----- 229 (277)
T ss_dssp TSC----BCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH-----
T ss_pred ccc----hhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch-----
Confidence 322 245689999999999865 48999999999999999999999999877655554443322222111
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.+..+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 230 ----------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 230 ----------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp ----------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred ----------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 123567889999999999999999999999999999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=405.72 Aligned_cols=263 Identities=26% Similarity=0.459 Sum_probs=192.3
Q ss_pred CeEEe---eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCc
Q 007629 114 RYQIQ---EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 114 ~Y~i~---~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~ 189 (595)
+|++. +.||+|+||+||+|.+..+|+.||||++.. .....+.+|+.+|+.+. ||||+++++++.. .
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-----~ 78 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHD-----Q 78 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-----C
Confidence 56665 789999999999999999999999999864 23456789999999997 9999999999843 4
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC---cEEEcccCccee
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARV 265 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~---~vKL~DFGla~~ 265 (595)
..+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 56899999998 59999999988999999999999999999999999999999999999998766 899999999986
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..... ....+.+
T Consensus 159 ~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--------~~~~~~~ 225 (325)
T 3kn6_A 159 KPPDNQ---PLKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC--------TSAVEIM 225 (325)
T ss_dssp CCC---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C--------CCHHHHH
T ss_pred cCCCCC---cccccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc--------ccHHHHH
Confidence 533222 2345689999999999977 67999999999999999999999999875431100 0000000
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
..+...........+..+++.+.+||.+||..||.+|||++|+|+||||++...
T Consensus 226 ------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 226 ------------KKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp ------------HHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred ------------HHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 111111111111223457899999999999999999999999999999987543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=397.06 Aligned_cols=282 Identities=31% Similarity=0.534 Sum_probs=227.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCc------eeeeeeeecCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVD-THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD------IVEIKHIMLPP 184 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~-~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~~~~ 184 (595)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ......+.+|+.+++.++|++ |+++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~-- 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE-- 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE--
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc--
Confidence 46899999999999999999998 568899999999642 234567889999999887654 899999884
Q ss_pred CccCcccEEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC-----------
Q 007629 185 SRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA----------- 251 (595)
Q Consensus 185 ~~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~----------- 251 (595)
....+|+||||++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 88 ---~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 88 ---HHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp ---ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred ---cCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 345699999999999999998765 6899999999999999999999999999999999999987
Q ss_pred --------CCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCC
Q 007629 252 --------DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323 (595)
Q Consensus 252 --------~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~ 323 (595)
++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 668999999999864322 234689999999999987 6799999999999999999999999999
Q ss_pred CChHHHHHHHHhhcCCCChhHHHHHhhHH--------------HHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcC
Q 007629 324 KNVVHQLDLMTDLLGTPSTESISRIRNEK--------------ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAF 389 (595)
Q Consensus 324 ~~~~~~l~~i~~~lg~p~~~~i~~i~~~~--------------~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~ 389 (595)
.+..+.+..+...++..+...+....... ...+...... ....+.......++.+.+||.+||..
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCc-chhhhcccchhhHHHHHHHHHHHhCc
Confidence 99999999999998887776654432110 0000000000 00001111123356789999999999
Q ss_pred CCCCCCCHHHHhcCCCccCCC
Q 007629 390 DPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 390 DP~~Rpta~elL~Hp~f~~~~ 410 (595)
||.+|||+.|+|+||||+.+.
T Consensus 316 dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 316 DPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp STTTSCCHHHHTTSGGGGGGG
T ss_pred CcccccCHHHHhcCHHHHHHh
Confidence 999999999999999998653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=422.14 Aligned_cols=261 Identities=31% Similarity=0.448 Sum_probs=217.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh-----------hhHHHHHHHHHHHHhcCCCceeeeeee
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-----------SDATRILREIKLLRLLRHPDIVEIKHI 180 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~l~~~ 180 (595)
.++|++++.||+|+||+||+|.++.++..||||++....... .....+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 468999999999999999999999999999999986532211 234678899999999999999999999
Q ss_pred ecCCCccCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC---cEE
Q 007629 181 MLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLK 256 (595)
Q Consensus 181 ~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~---~vK 256 (595)
+. +...+|+|||||+ ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~-----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 FE-----DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EE-----CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EE-----cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 84 3456999999998 58999998888999999999999999999999999999999999999998876 699
Q ss_pred EcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhh
Q 007629 257 ICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 336 (595)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~ 336 (595)
|+|||++........ ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+....+..+...
T Consensus 190 l~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK----LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp ECCCTTCEECCTTSC----BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred EEECCCCEEcCCCCc----cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 999999987543322 345689999999999864 6899999999999999999999999998876665555432
Q ss_pred cCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 337 lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
...... ..|..+++.+++||.+||.+||.+|||++|+|+||||+....
T Consensus 263 ~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 263 KYYFDF---------------------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCCCCH---------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCCCCc---------------------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 211111 123467889999999999999999999999999999987543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=404.33 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=200.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. ...+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~ 122 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PTE 122 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeEec-----CCe
Confidence 35799999999999999999999999999999998643 234567889999999999999999999854 346
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC---CCcEEEcccCcceecc
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVSF 267 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~---~~~vKL~DFGla~~~~ 267 (595)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 899999998 699999988888999999999999999999999999999999999999975 8899999999998653
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHH-HHHHHHhhcCCCChhHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH-QLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~-~l~~i~~~lg~p~~~~i~ 346 (595)
... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+..... .+..+..
T Consensus 203 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~----------- 265 (349)
T 2w4o_A 203 HQV----LMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN----------- 265 (349)
T ss_dssp --------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT-----------
T ss_pred ccc----ccccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh-----------
Confidence 322 1245689999999999987 679999999999999999999999997655332 1111111
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
.........++.+++.+.+||.+||..||.+|||+.|+|+||||.+..
T Consensus 266 ----------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 266 ----------------CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ----------------TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ----------------CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 111112234567889999999999999999999999999999998643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=388.78 Aligned_cols=255 Identities=30% Similarity=0.478 Sum_probs=206.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||+|+||.||+|.+..++..||+|++..... ......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~ 95 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-----YHNM 95 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheec-----CCeE
Confidence 579999999999999999999999999999999865332 2345778899999999999999999999843 4568
Q ss_pred EEEEeccc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee---CCCCcEEEcccCcce
Q 007629 193 YVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLAR 264 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl---~~~~~vKL~DFGla~ 264 (595)
|+||||++ ++|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 99999998 488888754 3679999999999999999999999999999999999999 456789999999997
Q ss_pred eccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 176 ~~~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~-------- 240 (285)
T 3is5_A 176 LFKSDEH----STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-------- 240 (285)
T ss_dssp C--------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred ecCCccc----CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC--------
Confidence 6533221 245679999999999754 6889999999999999999999999887643332221110
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
...+.......++.+.+||.+||..||.+|||+.|+|+||||++
T Consensus 241 --------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 241 --------------------EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp --------------------CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred --------------------CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 01111222346889999999999999999999999999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=419.91 Aligned_cols=256 Identities=30% Similarity=0.529 Sum_probs=216.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|.+++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++... .
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----S 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence 4689999999999999999999999999999999964211 112356788999999999999999999998543 4
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 6999999996 699999988889999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCCcccccccccccCCCC-CCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~-~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
. .....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 170 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------- 232 (476)
T 2y94_A 170 E----FLRTSCGSPNYAAPEVISG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI----------- 232 (476)
T ss_dssp C----CBCCCCSCSTTCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-----------
T ss_pred c----cccccCCCcCeEChhhccC--CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 2 2345689999999999877 344 689999999999999999999998876544433332110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
. .....+++.+.+||.+||..||.+|||+.|+++||||+..
T Consensus 233 ---------------~-----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 ---------------F-----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ---------------C-----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ---------------c-----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0 0112467899999999999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=420.74 Aligned_cols=260 Identities=30% Similarity=0.479 Sum_probs=220.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 100 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-----KGY 100 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CCE
Confidence 579999999999999999999999999999999864322 23456778999999999999999999999843 456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee---CCCCcEEEcccCcceecc
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVSF 267 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl---~~~~~vKL~DFGla~~~~ 267 (595)
+|+|||||. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999997 6899999988899999999999999999999999999999999999999 567899999999998653
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+....+..+.......
T Consensus 181 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------- 246 (484)
T 3nyv_A 181 ASK----KMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF------- 246 (484)
T ss_dssp CCC----SHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------
T ss_pred ccc----ccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 322 1345689999999999865 68999999999999999999999999988766555443321111
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
....+..+++.+.+||.+||.+||.+|||+.|+|+||||+....
T Consensus 247 --------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 247 --------------------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp --------------------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred --------------------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 11223467889999999999999999999999999999987543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=386.75 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=215.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
...|++.+.||+|+||.||+|.+..++..||+|++............+.+|+.+|+.++||||+++++++.... .....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCce
Confidence 45689999999999999999999999999999999765555566778899999999999999999999875432 23456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCceeeC-CCCcEEEcccCcceecc
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVSF 267 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~g--IiHrDLKP~NILl~-~~~~vKL~DFGla~~~~ 267 (595)
+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 899999997 599999998889999999999999999999999999 99999999999997 78999999999997543
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+......
T Consensus 184 ~~~-----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----------- 244 (290)
T 1t4h_A 184 ASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS----------- 244 (290)
T ss_dssp TTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-----------
T ss_pred ccc-----cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc-----------
Confidence 221 244679999999998864 5899999999999999999999999875543332211110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
...+. ......++.+.+||.+||..||.+|||++|+|+||||++
T Consensus 245 --------------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 245 --------------GVKPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp --------------TCCCG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred --------------cCCcc---ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 00011 111235678999999999999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=405.82 Aligned_cols=255 Identities=27% Similarity=0.402 Sum_probs=209.2
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEE
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lyl 194 (595)
|...+.||+|+||.||+|.+..+|..||||+++.. .......+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~l 163 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----KNDIVL 163 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEE
Confidence 33467899999999999999999999999999642 23456778999999999999999999999844 356899
Q ss_pred EEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee--CCCCcEEEcccCcceeccCCC
Q 007629 195 VFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA--NADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 195 V~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl--~~~~~vKL~DFGla~~~~~~~ 270 (595)
|||||+ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++......
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 999998 5888888654 469999999999999999999999999999999999999 667899999999998754332
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+....+..+.......
T Consensus 244 ~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~---------- 307 (373)
T 2x4f_A 244 K----LKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL---------- 307 (373)
T ss_dssp B----CCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCS----------
T ss_pred c----cccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC----------
Confidence 2 234579999999999876 678999999999999999999999999988766655544321111
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
....++.+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 308 -----------------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 308 -----------------EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp -----------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred -----------------ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 112345678999999999999999999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=394.53 Aligned_cols=262 Identities=25% Similarity=0.400 Sum_probs=204.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc------
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR------ 186 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~------ 186 (595)
++|++++.||+|+||.||+|+++.+|+.||||+++... .....+.+.+|+.+|+.++||||+++++++.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 47999999999999999999999999999999996432 33456778999999999999999999998854321
Q ss_pred ----------------------------------------------cCcccEEEEEeccc-ccHHHHHHhcCC---CCHH
Q 007629 187 ----------------------------------------------REFKDIYVVFELME-SDLHQVIKANDD---LTPE 216 (595)
Q Consensus 187 ----------------------------------------------~~~~~lylV~E~~~-g~L~~~i~~~~~---l~~~ 216 (595)
.....+|+|||||+ ++|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 11234899999998 589999987653 4555
Q ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCc---------ccccccccCCcccc
Q 007629 217 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA---------IFWTDYVATRWYRA 287 (595)
Q Consensus 217 ~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~---------~~~~~~~gT~~Y~A 287 (595)
.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......... ......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 689999999999999999999999999999999999999999999998764432111 11244689999999
Q ss_pred cccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCC
Q 007629 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVP 367 (595)
Q Consensus 288 PE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~ 367 (595)
||++.+ ..++.++|||||||++|||++|..|+.. ....+.........
T Consensus 245 PE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~------------------------- 292 (332)
T 3qd2_B 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFP------------------------- 292 (332)
T ss_dssp HHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCC-------------------------
T ss_pred hHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCC-------------------------
Confidence 999987 6899999999999999999998766521 11111111111000
Q ss_pred CCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 368 FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 368 ~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..+...++.+.+||.+||..||.+|||+.|+|+||||+++
T Consensus 293 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 293 --LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp --HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred --cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 0112235678999999999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=387.96 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=213.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++.+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----AT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-----CC
Confidence 4689999999999999999999999999999999854211 11224568899999999999999999999843 35
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||++ ++|.+.+.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 6899999998 589999988889999999999999999999999999999999999999999999999999998643322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 163 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 224 (279)
T 3fdn_A 163 R-----RTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----------- 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-----------
T ss_pred c-----ccccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-----------
Confidence 2 244689999999999877 6789999999999999999999999988775444433322100
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
.....+++.+.+||.+||..||.+|||+.|+|+||||+....
T Consensus 225 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 225 --------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred --------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 011236788999999999999999999999999999986543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=396.90 Aligned_cols=262 Identities=25% Similarity=0.421 Sum_probs=216.9
Q ss_pred CCeEEe-eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcc
Q 007629 113 SRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 113 ~~Y~i~-~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~ 190 (595)
++|.+. +.||+|+||+||+|.+..+|+.||||+++...........+.+|+.+++.+. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~-----~~ 102 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN-----TS 102 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe-----CC
Confidence 468887 8999999999999999999999999999765444455678899999999995 6999999999843 45
Q ss_pred cEEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC---CCcEEEcccCcce
Q 007629 191 DIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLAR 264 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~---~~~vKL~DFGla~ 264 (595)
.+|+|||||. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 6899999998 4888887543 57999999999999999999999999999999999999998 7899999999998
Q ss_pred eccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 183 ~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~----- 251 (327)
T 3lm5_A 183 KIGHACE----LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD----- 251 (327)
T ss_dssp EC-------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----
T ss_pred ccCCccc----cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc-----
Confidence 6543222 244689999999999977 68999999999999999999999999988765554443322111
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCC
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANV 412 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~ 412 (595)
.....+..+++.+.+||.+||..||.+|||++++|+||||+++...
T Consensus 252 ----------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 252 ----------------------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp ----------------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred ----------------------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 1122345678999999999999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=394.07 Aligned_cols=255 Identities=29% Similarity=0.501 Sum_probs=212.8
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
.|...+.||+|+||.||+|++..+|+.||||++.... ......+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-----GEELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEE
Confidence 4888899999999999999999999999999986432 2345678899999999999999999999854 34689
Q ss_pred EEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 194 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
+||||++ ++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 119 lv~e~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 119 VLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp EEECCCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EEEecCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence 9999998 57888765 457999999999999999999999999999999999999999999999999999865443222
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHH
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~ 352 (595)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 198 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~--------------- 257 (321)
T 2c30_A 198 ---RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP--------------- 257 (321)
T ss_dssp ---BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS---------------
T ss_pred ---cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------------
Confidence 245689999999999877 678999999999999999999999998876544433322110
Q ss_pred HHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 353 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.+.......+++.+.+||.+||..||.+|||+.|+|+||||...
T Consensus 258 -------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 258 -------------PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp -------------CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred -------------CCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 00111123467889999999999999999999999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=392.76 Aligned_cols=281 Identities=26% Similarity=0.387 Sum_probs=206.8
Q ss_pred CCCeEEe-eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~-~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|++. +.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+|+.+ +||||+++++++.. .
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~ 83 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----E 83 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----C
Confidence 4679995 78999999999999999999999999996532 23456788999999885 79999999999843 3
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc---EEEcccCccee
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARV 265 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~---vKL~DFGla~~ 265 (595)
..+|+|||||+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 56999999998 699999988889999999999999999999999999999999999999998876 99999999975
Q ss_pred ccCCCC----CcccccccccCCccccccccccc---CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcC
Q 007629 266 SFNDAP----SAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338 (595)
Q Consensus 266 ~~~~~~----~~~~~~~~~gT~~Y~APE~l~~~---~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg 338 (595)
...... ........+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+....+..... +
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~----~ 239 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR----G 239 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc----c
Confidence 432211 11112345799999999998641 134788999999999999999999999876421100000 0
Q ss_pred CCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 339 ~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
....... ......+...........+..+++.+.+||.+||..||.+|||++|+|+||||++...
T Consensus 240 ~~~~~~~--------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 240 EACPACQ--------NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp -CCHHHH--------HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred ccchhHH--------HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 0000000 0000011111111111123457889999999999999999999999999999987643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=435.34 Aligned_cols=260 Identities=22% Similarity=0.381 Sum_probs=220.4
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccC
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 188 (595)
..++|++++.||+|+||.||+|+++.+++.||||++++.. ........+..|+.+|..+ .||+|+.+++++..
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~----- 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----- 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-----
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-----
Confidence 3578999999999999999999999999999999996421 1223356678899999887 69999999999843
Q ss_pred cccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
...+||||||++ ++|..++...+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 456999999998 6999999988899999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|...
T Consensus 494 ~~~~---~~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----------- 557 (674)
T 3pfq_A 494 WDGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------- 557 (674)
T ss_dssp CTTC---CBCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-----------
T ss_pred cCCc---ccccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------
Confidence 3222 1356789999999999987 68999999999999999999999999998765555444321
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCH-----HHHhcCCCccCCCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA-----EEALADPYFHGLAN 411 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta-----~elL~Hp~f~~~~~ 411 (595)
.. . ....+++.+.+||.+||.+||.+||++ +||++||||+++.+
T Consensus 558 ---------------~~--~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 558 ---------------NV--A---YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp ---------------CC--C---CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred ---------------CC--C---CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 00 1 113578999999999999999999997 99999999998654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=400.11 Aligned_cols=267 Identities=28% Similarity=0.445 Sum_probs=212.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc---CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF---EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
++|++.+.||+|+||+||+|.+..++..||||++.... ........+.+|+.+|+.++||||+++++++.. .
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~ 100 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED-----E 100 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-----C
Confidence 57999999999999999999999999999999986421 123456788999999999999999999999843 4
Q ss_pred ccEEEEEeccc-ccHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHH
Q 007629 190 KDIYVVFELME-SDLHQVIKA----------------------------------------NDDLTPEHYQFFLYQLLRG 228 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~----------------------------------------~~~l~~~~~~~i~~qil~a 228 (595)
..+|+|||||+ ++|.+++.. ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 56899999997 689888741 1123677888999999999
Q ss_pred HHHHHhCCeeecCCCCCceeeCCCC--cEEEcccCcceeccCCCC-CcccccccccCCcccccccccccCCCCCCcceee
Q 007629 229 LKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVSFNDAP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 305 (595)
Q Consensus 229 L~yLHs~gIiHrDLKP~NILl~~~~--~vKL~DFGla~~~~~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIW 305 (595)
|.|||+.||+||||||+|||++.++ .+||+|||+++....... .........||+.|+|||++.+....++.++|||
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 9999999999999999999998776 899999999986543221 1112345689999999999875446789999999
Q ss_pred chhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHh
Q 007629 306 SIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLER 385 (595)
Q Consensus 306 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~ 385 (595)
||||++|||++|+.||.+.+..+.+..+...... .....+..+++.+.+||.+
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~ 313 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC---------------------------FENPNYNVLSPLARDLLSN 313 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------------------TTSGGGGGSCHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc---------------------------cCCcccccCCHHHHHHHHH
Confidence 9999999999999999988765554443321111 0111223468899999999
Q ss_pred hCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 386 LLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 386 ~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
||..||.+|||+.++|+||||+++.+
T Consensus 314 ~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 314 LLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HcCCChhHCCCHHHHhcChhhccChH
Confidence 99999999999999999999987654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=396.92 Aligned_cols=269 Identities=24% Similarity=0.352 Sum_probs=213.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++.+.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.+++.++||||+++++++.... ....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 4689999999999999999999999999999999975432 3334567889999999999999999999885432 1123
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 4699999997 699999998889999999999999999999999999999999999999999999999999999865443
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
..........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~----------- 236 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP----------- 236 (311)
T ss_dssp ------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-----------
T ss_pred ccccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-----------
Confidence 322222345679999999999987 6899999999999999999999999998776544333322111
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
.+.......+++.+.+||.+||..||.+||++.++|.|+|++...
T Consensus 237 ----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 237 ----------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp ----------------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred ----------------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 111112345788999999999999999999999999999997543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=396.02 Aligned_cols=282 Identities=31% Similarity=0.522 Sum_probs=226.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCC-cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCc------eeeeeeeecCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG-ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD------IVEIKHIMLPP 184 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g-~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~~~~ 184 (595)
.++|++.+.||+|+||+||+|.+..++ ..||||+++.. ......+.+|+.+|+.+.|++ ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~-- 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN-- 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE--
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee--
Confidence 468999999999999999999998877 68999999642 234567788999999998766 888888773
Q ss_pred CccCcccEEEEEecccccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee-------------
Q 007629 185 SRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA------------- 249 (595)
Q Consensus 185 ~~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl------------- 249 (595)
....+|+||||++++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 93 ---~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 93 ---FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp ---ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred ---eCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 345689999999999988887654 69999999999999999999999999999999999999
Q ss_pred ------CCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCC
Q 007629 250 ------NADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323 (595)
Q Consensus 250 ------~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~ 323 (595)
+.++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 56789999999999864322 234689999999999987 6899999999999999999999999999
Q ss_pred CChHHHHHHHHhhcCCCChhHHHHHhhHHH--------------HHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcC
Q 007629 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKA--------------RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAF 389 (595)
Q Consensus 324 ~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~--------------~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~ 389 (595)
.+....+..+...++.++...+........ ..++..... ............++.+.+||.+||..
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC-cccccccccchhHHHHHHHHHHHhcC
Confidence 999999999999999888766544321100 000000000 00000011122346789999999999
Q ss_pred CCCCCCCHHHHhcCCCccCCC
Q 007629 390 DPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 390 DP~~Rpta~elL~Hp~f~~~~ 410 (595)
||.+|||+.|+|+||||+++.
T Consensus 321 dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 321 DPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp STTTSCCHHHHTTSGGGGGCC
T ss_pred ChhhCcCHHHHhcChhhcCCC
Confidence 999999999999999999764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=406.72 Aligned_cols=262 Identities=27% Similarity=0.435 Sum_probs=203.6
Q ss_pred CCCeEEe-eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHH-HhcCCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL-RLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~-~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|.+. +.||+|+||+||+|.++.+|+.||||++.. ...+.+|+.++ +.++||||+++++++.... .+.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCC
Confidence 4578887 789999999999999999999999999853 23467899887 4568999999999874311 224
Q ss_pred ccEEEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC---CCcEEEcccCcc
Q 007629 190 KDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLA 263 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~---~~~vKL~DFGla 263 (595)
..+|||||||. ++|.+++...+ .+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 56899999998 59999998653 5999999999999999999999999999999999999998 789999999999
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
+...... .....+||+.|+|||++.+ ..|+.++||||||||+|||++|++||.+.+.... ...
T Consensus 212 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----------~~~ 274 (400)
T 1nxk_A 212 KETTSHN----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPG 274 (400)
T ss_dssp EECC---------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS-----------CCS
T ss_pred cccCCCC----ccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc-----------cHH
Confidence 8653322 1345689999999999977 6899999999999999999999999987653110 000
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
....+. ..........+..+++.+.+||.+||..||.+|||+.|+|+||||.+..
T Consensus 275 ~~~~i~------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 275 MKTRIR------------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp HHHHHH------------HTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred HHHHHH------------cCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 011110 0000111223567899999999999999999999999999999998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=397.80 Aligned_cols=260 Identities=28% Similarity=0.365 Sum_probs=206.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC--CceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH--PDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~~ 189 (595)
..+|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+|+.++| |||+++++++.. .
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-----~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----D 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-----C
Confidence 46799999999999999999987 468999999997554455556788999999999986 999999999854 3
Q ss_pred ccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
..+|||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++.....
T Consensus 82 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp SEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 4699999988899999999989999999999999999999999999999999999999997 688999999999865433
Q ss_pred CCCcccccccccCCccccccccccc---------CCCCCCcceeechhHHHHHHHcCCCCCCCCChH-HHHHHHHhhcCC
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV-HQLDLMTDLLGT 339 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~---------~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~-~~l~~i~~~lg~ 339 (595)
... ......+||+.|+|||++.+. ...|+.++|||||||++|||++|+.||.+.... ..+..+
T Consensus 161 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------ 233 (343)
T 3dbq_A 161 TTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI------ 233 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH------
T ss_pred ccc-ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH------
Confidence 221 123456899999999998531 146888999999999999999999999764321 111111
Q ss_pred CChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 340 p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
+ ...... ......++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 234 -----------------~---~~~~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 234 -----------------I---DPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp -----------------H---CTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred -----------------h---cCCccc---CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 0 001111 111234678999999999999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=382.59 Aligned_cols=260 Identities=28% Similarity=0.477 Sum_probs=215.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC----hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH----VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
++|++.+.||+|+||.||+|.+..+|+.||||+++..... ......+.+|+.+|+.++||||+++++++..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN----- 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence 4799999999999999999999999999999998643221 1235778999999999999999999999854
Q ss_pred cccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC----cEEEcccCcc
Q 007629 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLA 263 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~----~vKL~DFGla 263 (595)
...+|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 346899999997 69999998888899999999999999999999999999999999999999887 8999999999
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.........
T Consensus 160 ~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 232 (283)
T 3bhy_A 160 HKIEAGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE- 232 (283)
T ss_dssp EECC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-
T ss_pred eeccCCCc----ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-
Confidence 86533221 244579999999999876 67899999999999999999999999987765554444322111111
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
..++..++.+.+||.+||..||.+|||+.|+|+||||+.+.
T Consensus 233 --------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 233 --------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp --------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred --------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 11245678899999999999999999999999999998654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=386.23 Aligned_cols=259 Identities=23% Similarity=0.380 Sum_probs=196.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||.||+|.+..+|+.||||+++...........+..+...++.+.||||+++++++.. ...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cCC
Confidence 468999999999999999999999999999999997543333333334445556788899999999999854 346
Q ss_pred EEEEEecccccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 192 IYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~-gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 899999999988777653 46899999999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCCcccccccccc--cCCCCCCcceeechhHHHHHHHcCCCCCCCCC-hHHHHHHHHhhcCCCChh
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~--~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~-~~~~l~~i~~~lg~p~~~ 343 (595)
..... .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.... ....+..+..
T Consensus 161 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------- 228 (290)
T 3fme_A 161 VDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-------- 228 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH--------
T ss_pred ccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc--------
Confidence 43322 233479999999999631 11568899999999999999999999997633 2221111110
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
...+ ......+++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 229 ------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 229 ------------------EPSP---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ------------------SCCC---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ------------------cCCC---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 0011 0112356889999999999999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=392.17 Aligned_cols=263 Identities=29% Similarity=0.426 Sum_probs=220.9
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 108 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 108 ~~~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
......+|.+.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 112 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--- 112 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence 3445678999999999999999999999999999999986432 233456778899999999999999999999844
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 187 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
...+|+||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 113 --~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 113 --NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp --SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred --CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 356899999998 68999998888999999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+...
T Consensus 191 ~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 256 (335)
T 2owb_A 191 VEYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--------- 256 (335)
T ss_dssp CCSTTCC---BCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---------
T ss_pred cccCccc---ccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC---------
Confidence 5432221 244679999999999877 67899999999999999999999999887654333222110
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
.. .....+++.+.+||.+||..||.+|||++|+|+||||.....
T Consensus 257 -----------------~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 257 -----------------EY-----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp -----------------CC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred -----------------CC-----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 00 011346788999999999999999999999999999986543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=404.79 Aligned_cols=260 Identities=28% Similarity=0.377 Sum_probs=207.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC--CCceeeeeeeecCCCccCcc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR--HPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~~~ 190 (595)
.+|++++.||+|+||+||+|.+.. ++.||||++............+.+|+.+|+.+. ||||+++++++... .
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-----~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----Q 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----S
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----C
Confidence 469999999999999999999865 999999999754444556678899999999997 59999999998543 4
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 130 ~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 599999987889999999988999999999999999999999999999999999999995 6899999999998654332
Q ss_pred CCcccccccccCCccccccccccc---------CCCCCCcceeechhHHHHHHHcCCCCCCCCCh-HHHHHHHHhhcCCC
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQLDLMTDLLGTP 340 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~---------~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~lg~p 340 (595)
.. ......+||+.|+|||++.+. ...|+.++||||||||+|||++|++||.+... ...+..+.
T Consensus 209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~------ 281 (390)
T 2zmd_A 209 TS-VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------ 281 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH------
T ss_pred cc-ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh------
Confidence 21 123456899999999998641 13688999999999999999999999976432 11111111
Q ss_pred ChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 341 ~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.......+ ....++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 282 --------------------~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 282 --------------------DPNHEIEF---PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp --------------------CTTSCCCC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred --------------------CccccCCC---CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 00011111 12246789999999999999999999999999999853
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=387.29 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=214.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++.+.||+|+||.||+|.+..+|+.||||+++... ......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 81 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYES-----TTHY 81 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhccc-----CCEE
Confidence 57999999999999999999999999999999997432 2234567899999999999999999999843 3568
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee---CCCCcEEEcccCcceeccC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVSFN 268 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl---~~~~~vKL~DFGla~~~~~ 268 (595)
|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999997 5999999888899999999999999999999999999999999999999 7889999999999975422
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 162 ~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~----------- 223 (304)
T 2jam_A 162 G-----IMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY----------- 223 (304)
T ss_dssp B-----TTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC-----------
T ss_pred C-----ccccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 1 1234579999999999877 678999999999999999999999998877544443332211
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
.......+..+++.+.+||.+||..||.+|||++|+|+||||.+..
T Consensus 224 ----------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 224 ----------------YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp ----------------CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred ----------------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 0011123456789999999999999999999999999999998643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=396.65 Aligned_cols=256 Identities=26% Similarity=0.400 Sum_probs=213.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..+|++++.||+|+||.||+|++..+|+.||||++...... ......+.+|+.+|+.++||||+++++++.. ..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 127 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EH 127 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence 35699999999999999999999999999999998643222 2334678899999999999999999999854 34
Q ss_pred cEEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||+.|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 128 ~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 128 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred eEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 6899999999999888864 56799999999999999999999999999999999999999999999999999975432
Q ss_pred CCCcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
....+||+.|+|||++.+. ...++.++|||||||++|||++|++||.+.+....+..+...
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~------------ 268 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------ 268 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc------------
Confidence 1346899999999998531 257899999999999999999999999887754443322210
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
..+. .....+++.+.+||.+||..||.+|||++++|+||||..
T Consensus 269 --------------~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 269 --------------ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp --------------CCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------------CCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 0111 112356788999999999999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=425.91 Aligned_cols=262 Identities=26% Similarity=0.402 Sum_probs=215.2
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
..++|++.+.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++|||||++++++.. .
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~ 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----K 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----C
Confidence 3568999999999999999999999999999999986421 112234567899999999999999999999844 3
Q ss_pred ccEEEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 190 KDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
..+|+|||||+ ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 56999999997 69999988754 4999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
..... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.........+.
T Consensus 337 ~~~~~----~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~------------ 398 (576)
T 2acx_A 337 PEGQT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------------ 398 (576)
T ss_dssp CTTCC----EECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH------------
T ss_pred ccCcc----ccccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH------------
Confidence 43321 245689999999999987 679999999999999999999999998764211111110
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~~ 410 (595)
..+... +.. ....+++.+.+||.+||..||.+|| +++|+++||||+++.
T Consensus 399 --------~~i~~~----~~~---~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 399 --------RLVKEV----PEE---YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp --------HHHHHC----CCC---CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred --------HHhhcc----ccc---CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 001111 111 1245789999999999999999999 899999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=411.98 Aligned_cols=254 Identities=17% Similarity=0.195 Sum_probs=201.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhhHHHHHHHHH---HHHhcCCCceeeeeeeec-----
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIK---LLRLLRHPDIVEIKHIML----- 182 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~-~~~~~~~~~~~~Ei~---il~~l~HpnIv~l~~~~~----- 182 (595)
.++|++.+.||+|+||.||+|++..+|+.||||++... .......+.+.+|+. +|+.++|||||++++.+.
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46899999999999999999999999999999998643 223345677889995 555567999999984443
Q ss_pred --CCCc-------cCc-----ccEEEEEecccccHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCeeecC
Q 007629 183 --PPSR-------REF-----KDIYVVFELMESDLHQVIKANDDLTP-------EHYQFFLYQLLRGLKYIHTANVFHRD 241 (595)
Q Consensus 183 --~~~~-------~~~-----~~lylV~E~~~g~L~~~i~~~~~l~~-------~~~~~i~~qil~aL~yLHs~gIiHrD 241 (595)
.... .+. ...||||||++|+|.+++...+.+++ ..+..|+.||+.||+|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 2210 000 13799999999999999987665666 77888999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCC-----------CCCCcceeechhHH
Q 007629 242 LKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS-----------KYTPAIDIWSIGCI 310 (595)
Q Consensus 242 LKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~-----------~~~~k~DIWSlG~i 310 (595)
|||+|||++.++.+||+|||+|+.... .....+| +.|+|||++.+ . .|+.++|||||||+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~--~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEAR--RATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHH--HTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcc--cccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999985321 2345678 99999999876 4 68999999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCC
Q 007629 311 FAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFD 390 (595)
Q Consensus 311 l~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~D 390 (595)
+|||++|+.||.+.+....+. .....++.+++.+.+||.+||..|
T Consensus 303 l~elltg~~Pf~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~li~~~L~~d 347 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSE-----------------------------------WIFRSCKNIPQPVRALLEGFLRYP 347 (377)
T ss_dssp HHHHHHSSCCC------CCSG-----------------------------------GGGSSCCCCCHHHHHHHHHHTCSS
T ss_pred HHHHHHCCCCCcccccccchh-----------------------------------hhhhhccCCCHHHHHHHHHHcCCC
Confidence 999999999997654211100 001122567899999999999999
Q ss_pred CCCCCCHHHHhcCCCccCC
Q 007629 391 PKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 391 P~~Rpta~elL~Hp~f~~~ 409 (595)
|.+|||+.|+|+||||+.+
T Consensus 348 p~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 348 KEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp GGGCCCHHHHHTSHHHHHH
T ss_pred chhCCCHHHHhhChHHHHH
Confidence 9999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=383.32 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=216.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++.+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-----RK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----CC
Confidence 4689999999999999999999999999999999854211 11224568899999999999999999999844 35
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 6899999997 599999998888999999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 168 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------- 227 (284)
T 2vgo_A 168 R-----RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------------- 227 (284)
T ss_dssp C-----BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------
T ss_pred c-----cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-------------
Confidence 1 234679999999999887 67899999999999999999999999877654433222110
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
.. ...+.+++.+.+||.+||..||.+|||++++|+||||+....
T Consensus 228 -------------~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 228 -------------DL-----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp -------------CC-----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred -------------cc-----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 00 011346888999999999999999999999999999986543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=395.41 Aligned_cols=259 Identities=28% Similarity=0.492 Sum_probs=215.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh------hhHHHHHHHHHHHHhc-CCCceeeeeeeecCCC
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV------SDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~------~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 185 (595)
++|++.+.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+++.+ .||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 57999999999999999999999999999999986432211 1135678999999999 79999999999843
Q ss_pred ccCcccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 186 RREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 186 ~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
...+|+||||+++ +|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 172 ---~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 172 ---SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp ---SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ---CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 4568999999985 899999888889999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCcccccccccCCccccccccccc----CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCC
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p 340 (595)
....... ....+||+.|+|||++.+. ...|+.++|||||||++|+|++|..||.+.+....+..+......+
T Consensus 249 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 324 (365)
T 2y7j_A 249 HLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324 (365)
T ss_dssp ECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred ccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 6543322 2456899999999988642 1358889999999999999999999998877655444443221111
Q ss_pred ChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 341 ~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
.. ..+...++.+.+||.+||..||.+|||++|+|+||||+
T Consensus 325 ~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 325 SS---------------------------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp CH---------------------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CC---------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 10 11245678899999999999999999999999999996
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=381.60 Aligned_cols=261 Identities=29% Similarity=0.434 Sum_probs=219.6
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 110 GEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 110 ~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
...++|.+.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+.||||+++++++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 86 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----- 86 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-----
Confidence 45678999999999999999999999999999999986533 233456678899999999999999999999843
Q ss_pred cccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
...+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 356899999998 6899999888899999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+..
T Consensus 167 ~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------ 229 (294)
T 2rku_A 167 YDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------------ 229 (294)
T ss_dssp STTCC---BCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------------
T ss_pred cCccc---cccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh------------
Confidence 32221 244679999999999877 6789999999999999999999999988765433222211
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
... .....+++.+.+||.+||..||.+|||++|+|+||||.....
T Consensus 230 --------------~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 230 --------------NEY-----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp --------------TCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred --------------ccC-----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 000 011346788999999999999999999999999999986543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=379.70 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=206.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++.+.||+|+||.||+|.+..+++.||||+++...........+.+|+.++..+ +||||+++++++.. ...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~~~ 85 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----DDH 85 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----TTE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence 579999999999999999999999999999999976555555677889999999999 89999999999843 356
Q ss_pred EEEEEecccc-cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC--------------
Q 007629 192 IYVVFELMES-DLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-------------- 252 (595)
Q Consensus 192 lylV~E~~~g-~L~~~i~~~----~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~-------------- 252 (595)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 8999999974 999999765 679999999999999999999999999999999999999844
Q ss_pred -----CcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChH
Q 007629 253 -----CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV 327 (595)
Q Consensus 253 -----~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~ 327 (595)
..+||+|||++...... ....||+.|+|||++.+. ..++.++|||||||++|+|++|.+||......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred ccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 47999999999865332 224699999999998762 35678999999999999999999877543221
Q ss_pred HHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 328 ~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
. .+. . .. .......+++.+.+||.+||..||.+|||+.|+|+||||.
T Consensus 238 ~---~~~-----------------------~---~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 238 H---EIR-----------------------Q---GR----LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp H---HHH-----------------------T---TC----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred H---HHH-----------------------c---CC----CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 1 110 0 00 0112245788999999999999999999999999999997
Q ss_pred CC
Q 007629 408 GL 409 (595)
Q Consensus 408 ~~ 409 (595)
..
T Consensus 285 ~~ 286 (289)
T 1x8b_A 285 SA 286 (289)
T ss_dssp --
T ss_pred hh
Confidence 53
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=398.84 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=209.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh------hhHHHHHHHHHHHHhcCCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV------SDATRILREIKLLRLLRHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 185 (595)
.++|++++.||+|+||.||+|++..+++.||||+++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 358999999999999999999999999999999986532211 123456789999999999999999999843
Q ss_pred ccCcccEEEEEeccc-c-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcc
Q 007629 186 RREFKDIYVVFELME-S-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla 263 (595)
...+|+||||+. + +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 101 ---~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 101 ---QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp ---SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred ---CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 456899999986 4 89999998889999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCC-CCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~-~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
........ ....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||......
T Consensus 178 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 178 AYLERGKL----FYTFCGTIEYCAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp EECCTTCC----BCEECSCGGGCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred eECCCCCc----eeccCCCccccChhhhcC--CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 86543322 245689999999999876 444 78999999999999999999999652110
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
..... .....+++.+.+||.+||..||.+|||++++|+||||+.
T Consensus 237 -----------------~~~~~-----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 237 -----------------VEAAI-----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp -----------------TTTCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred -----------------Hhhcc-----CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 00000 011236889999999999999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=395.86 Aligned_cols=286 Identities=24% Similarity=0.363 Sum_probs=223.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-----------CCceeeeeee
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-----------HPDIVEIKHI 180 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~ 180 (595)
.++|++++.||+|+||+||+|.+..+++.||||++.. .......+.+|+.+++.+. ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 4689999999999999999999999999999999863 2234566789999999886 8999999999
Q ss_pred ecCCCccCcccEEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCceeeC------C
Q 007629 181 MLPPSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILAN------A 251 (595)
Q Consensus 181 ~~~~~~~~~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~-gIiHrDLKP~NILl~------~ 251 (595)
+.... .....+++||||++++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++ .
T Consensus 95 ~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 95 FNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred hhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 85432 123468999999988999999864 4599999999999999999999998 999999999999994 4
Q ss_pred CCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCC------
Q 007629 252 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN------ 325 (595)
Q Consensus 252 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~------ 325 (595)
.+.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+
T Consensus 174 ~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp EEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred cceEEEcccccccccCCC------CCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 458999999999865432 234589999999999987 679999999999999999999999998765
Q ss_pred hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCC-------------CCCCCCCHHHHHHHHhhCcCCCC
Q 007629 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFS-------------HKFPNADPLALHLLERLLAFDPK 392 (595)
Q Consensus 326 ~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~-------------~~~~~~~~~~~dLl~~~L~~DP~ 392 (595)
...++..+...+|.++...+...... ..++............ ......++.+.+||.+||..||.
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchh--hhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 55677888888898887665433221 1111110000000000 01123456789999999999999
Q ss_pred CCCCHHHHhcCCCccCCCC
Q 007629 393 DRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 393 ~Rpta~elL~Hp~f~~~~~ 411 (595)
+|||++|+|+||||++...
T Consensus 324 ~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 324 KRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp TCBCHHHHHTCGGGTTCTT
T ss_pred ccCCHHHHhhChhhhcccC
Confidence 9999999999999987644
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=385.28 Aligned_cols=267 Identities=23% Similarity=0.404 Sum_probs=215.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|++.+.||+|+||.||+|.+..++..||||+++.... .......+.+|+.+|+.++||||+++++++... +.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence 4689999999999999999999999999999999964321 123456789999999999999999999998542 23
Q ss_pred ccEEEEEecccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 190 KDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~--~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
..+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 46899999999888888876 3579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
..... .......||+.|+|||++.+....++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 161 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----------- 228 (305)
T 2wtk_C 161 PFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG----------- 228 (305)
T ss_dssp TTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----------
T ss_pred ccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-----------
Confidence 32221 123456799999999998763233477999999999999999999999887654433322110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~ 413 (595)
.. .....+++.+.+||.+||..||.+|||++|+++||||+......
T Consensus 229 ---------------~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 229 ---------------SY-----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp ---------------CC-----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred ---------------CC-----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 00 11235688899999999999999999999999999998765443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=408.45 Aligned_cols=260 Identities=32% Similarity=0.529 Sum_probs=202.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC------hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 185 (595)
.++|.+.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|+.++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 46899999999999999999999999999999998643211 1122347899999999999999999998732
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC---cEEEcccC
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFG 261 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~---~vKL~DFG 261 (595)
..+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 212 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp ----SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ----CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 34799999997 58999888888999999999999999999999999999999999999997654 59999999
Q ss_pred cceeccCCCCCcccccccccCCcccccccccc-cCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHH-HHHHhhcCC
Q 007629 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQL-DLMTDLLGT 339 (595)
Q Consensus 262 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l-~~i~~~lg~ 339 (595)
+|+...... .....+||+.|+|||++.+ ....|+.++|||||||++|+|++|.+||.+......+ ..+...
T Consensus 288 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~--- 360 (419)
T 3i6u_A 288 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG--- 360 (419)
T ss_dssp TTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT---
T ss_pred cceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC---
Confidence 998653321 2345689999999999853 1256888999999999999999999999865432111 111110
Q ss_pred CChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 340 p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
........+..+++.+.+||.+||.+||.+|||++|+|+||||++
T Consensus 361 ------------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 361 ------------------------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ------------------------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ------------------------CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 000111223457889999999999999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=379.86 Aligned_cols=263 Identities=28% Similarity=0.439 Sum_probs=217.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-------hhhHHHHHHHHHHHHhcC-CCceeeeeeeecC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-------VSDATRILREIKLLRLLR-HPDIVEIKHIMLP 183 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~-------~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 183 (595)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+|+.+. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46899999999999999999999999999999998643210 122456789999999996 9999999999843
Q ss_pred CCccCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCc
Q 007629 184 PSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262 (595)
Q Consensus 184 ~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGl 262 (595)
...+|+||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 -----NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp -----SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred -----CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence 356899999998 69999998888999999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCcccccccccCCccccccccccc----CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcC
Q 007629 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338 (595)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg 338 (595)
+........ .....||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 171 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~- 245 (298)
T 1phk_A 171 SCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN- 245 (298)
T ss_dssp CEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-
T ss_pred hhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC-
Confidence 986543322 2456899999999987521 2468899999999999999999999998876544433332211
Q ss_pred CCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 339 ~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
.......++.+++.+.+||.+||..||.+|||+.|+|+||||++..
T Consensus 246 --------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 246 --------------------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp --------------------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred --------------------------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 0011122345788999999999999999999999999999998754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=405.03 Aligned_cols=269 Identities=17% Similarity=0.146 Sum_probs=194.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc--CCCceeeeeeeec-------
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLL--RHPDIVEIKHIML------- 182 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~------- 182 (595)
.+|++.+.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+++.| +||||++++..++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 359999999999999999999999999999999976433 223455677886555555 6999888653332
Q ss_pred CCCc------------cCcccEEEEEecccccHHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHhCCeeecCCC
Q 007629 183 PPSR------------REFKDIYVVFELMESDLHQVIKAND-DLTPEHY------QFFLYQLLRGLKYIHTANVFHRDLK 243 (595)
Q Consensus 183 ~~~~------------~~~~~lylV~E~~~g~L~~~i~~~~-~l~~~~~------~~i~~qil~aL~yLHs~gIiHrDLK 243 (595)
.... .....+|||||||+++|.+++...+ .+.+... ..++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 1110 0114589999999999999998643 4444545 5777999999999999999999999
Q ss_pred CCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCC
Q 007629 244 PKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPG 323 (595)
Q Consensus 244 P~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~ 323 (595)
|+|||++.++.+||+|||+|+..... .....+|+.|+|||++.+....|+.++|||||||++|||++|+.||.+
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred HHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999865221 124567899999999865334689999999999999999999999987
Q ss_pred CChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 324 ~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
...... ..+.. . ..............++.+++.+.+||.+||..||.+|||+.++|+|
T Consensus 296 ~~~~~~-------------~~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 296 VTPGIK-------------GSWKR--------P-SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CCTTCT-------------TCCCB--------C-CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred cCcccc-------------cchhh--------h-hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 642100 00000 0 0000000111112235789999999999999999999999999999
Q ss_pred CCccCC
Q 007629 404 PYFHGL 409 (595)
Q Consensus 404 p~f~~~ 409 (595)
|||+.+
T Consensus 354 p~f~~~ 359 (371)
T 3q60_A 354 PEFLQL 359 (371)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=379.97 Aligned_cols=257 Identities=27% Similarity=0.470 Sum_probs=190.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----SN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----SS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----CC
Confidence 4679999999999999999999999999999999863211 11224678899999999999999999999844 35
Q ss_pred cEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 191 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 6899999997 5899988865 5799999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........+..+
T Consensus 165 ~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------------- 224 (278)
T 3cok_A 165 PHEK---HYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--------------- 224 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C---------------
T ss_pred CCCc---ceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH---------------
Confidence 2211 234579999999999877 67899999999999999999999999875532211100
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.... ......+++.+.+||.+||..||.+|||++++|+||||...
T Consensus 225 -----------~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 225 -----------VLAD-----YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp -----------CSSC-----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred -----------hhcc-----cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 0000 01123468899999999999999999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=416.35 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=214.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-----KT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----CC
Confidence 4689999999999999999999999999999999964221 11234678899999999999999999999844 35
Q ss_pred cEEEEEeccc-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 191 DIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
.+|+|||||+ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 6999999998 6899988764 3699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
....... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.......+ .
T Consensus 339 ~~~~~~~---~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~-----------~ 402 (543)
T 3c4z_A 339 LKAGQTK---TKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-----------K 402 (543)
T ss_dssp CCTTCCC---BCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH-----------H
T ss_pred ccCCCcc---cccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH-----------H
Confidence 5433221 244689999999999987 68999999999999999999999999875421100000 0
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCCCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLAN 411 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~~~ 411 (595)
. ..+. .. .. ....+++.+.+||.+||.+||.+||+ ++++++||||+++.+
T Consensus 403 ~--------~i~~---~~--~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 403 Q--------RVLE---QA--VT---YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp H--------HHHH---CC--CC---CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred H--------HHhh---cc--cC---CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 0 0000 00 11 11457899999999999999999996 589999999997643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=383.79 Aligned_cols=265 Identities=28% Similarity=0.343 Sum_probs=211.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++++.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++. ...
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-----EDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-----CSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-----eCC
Confidence 4689999999999999999999999999999999854322 3344577899999999999999999999984 345
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 6899999998 599999998889999999999999999999999999999999999999999999999999999765322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 165 ~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~-------------- 226 (294)
T 4eqm_A 165 SL--TQTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ-------------- 226 (294)
T ss_dssp ------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS--------------
T ss_pred cc--cccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh--------------
Confidence 21 11234679999999999887 6789999999999999999999999998775443221111
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
...+.......+.+++.+.++|.+||..||.+||+..+.+.+.|..-+..
T Consensus 227 ------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 227 ------------DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp ------------SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred ------------ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 01111111123457889999999999999999997777777777654443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=378.09 Aligned_cols=261 Identities=28% Similarity=0.409 Sum_probs=212.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++. +...+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 80 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence 579999999999999999999999999999999864322 234567889999999999999999999984 34568
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999998 58999887777899999999999999999999999999999999999999999999999999986533221
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
. ......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+........ ..
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------------~~---- 220 (276)
T 2yex_A 161 E-RLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--------------SD---- 220 (276)
T ss_dssp E-CCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH--------------HH----
T ss_pred h-hcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH--------------HH----
Confidence 1 113456899999999998762 224778999999999999999999998755321110 00
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
... . ......+..+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 221 ----~~~----~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 221 ----WKE----K--KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp ----HHT----T--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ----hhh----c--ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 000 0 00111234578899999999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=396.40 Aligned_cols=283 Identities=22% Similarity=0.348 Sum_probs=216.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+..++..||+|++.... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 105 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 105 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCE
Confidence 468999999999999999999999999999999986532 33445678999999999999999999999853 356
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~-gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 899999998 59999999888999999999999999999999996 9999999999999999999999999999754322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhc-CCCChhHHH--
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL-GTPSTESIS-- 346 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~l-g~p~~~~i~-- 346 (595)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.... +.+......
T Consensus 186 ~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 186 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp C---------CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred c-----ccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 1 234689999999999987 679999999999999999999999999877544333221111 110000000
Q ss_pred -------HHh-----hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 347 -------RIR-----NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 347 -------~i~-----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
... .......+.......+.. .....+++.+.+||.+||.+||.+|||++|+|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCC--CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 000 000000111111111111 1123468899999999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=380.42 Aligned_cols=260 Identities=33% Similarity=0.539 Sum_probs=217.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.. ...
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CCe
Confidence 358999999999999999999999999999999997544444556788999999999999999999999844 356
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC---CcEEEcccCcceecc
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVSF 267 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~---~~vKL~DFGla~~~~ 267 (595)
+|+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 899999997 5899988888889999999999999999999999999999999999999764 469999999997653
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 176 ~~~~----~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 238 (287)
T 2wei_A 176 QNTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK---------- 238 (287)
T ss_dssp CCSS----CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred CCCc----cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------
Confidence 3221 234578999999999865 58999999999999999999999998877554433332210
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
... ....+..+++.+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 239 ----------------~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 239 ----------------YAF-DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp ----------------CCC-CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred ----------------CCC-CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 000 0112346788999999999999999999999999999998653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=397.86 Aligned_cols=265 Identities=23% Similarity=0.379 Sum_probs=210.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccC--ChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFE--HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~---~~g~~vAIK~i~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 185 (595)
.++|++++.||+|+||.||+|++. .+|+.||||+++.... .......+.+|+.+|+.+ .||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 368999999999999999999984 5899999999864221 112234567899999999 69999999998843
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
...+|+|||||+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 131 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 131 ---ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp ---TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred ---CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 356899999998 5999999988899999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
....... ......+||+.|+|||++.+....++.++|||||||++|||++|+.||...........+.
T Consensus 208 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~---------- 275 (355)
T 1vzo_A 208 EFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS---------- 275 (355)
T ss_dssp ECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH----------
T ss_pred ecccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH----------
Confidence 6533221 1234568999999999987633458899999999999999999999997644211111110
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCCC
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~~ 410 (595)
...+. ... .....+++.+.+||.+||..||.+|| +++|+++||||+.+.
T Consensus 276 ---------~~~~~---~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 276 ---------RRILK---SEP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp ---------HHHHH---CCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ---------HHHhc---cCC-----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 00010 011 11245688899999999999999999 999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=384.93 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=207.5
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCc---EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~---~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
..++|++.+.||+|+||.||+|.+..++. .||||+++... .......+.+|+.+|+.++||||+++++++.
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 120 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVT----- 120 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 45789999999999999999999986665 49999997532 3345667899999999999999999999984
Q ss_pred CcccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
+...+|+||||++ ++|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 3456899999997 5999999755 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
...............+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+....
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~------- 271 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY------- 271 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-------
T ss_pred cccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-------
Confidence 6544333323344567889999999976 678999999999999999999 999998877554443332211
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+ ....+++.+.+||.+||..||.+|||+.++++
T Consensus 272 ------------------~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 272 ------------------RLP-----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ------------------CCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCC-----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 001 12356889999999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=375.25 Aligned_cols=257 Identities=27% Similarity=0.435 Sum_probs=205.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----PT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence 4689999999999999999999999999999999864211 12234578899999999999999999999854 34
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 6899999997 599999988888999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
. ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+......+..+...
T Consensus 165 ~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------- 226 (276)
T 2h6d_A 165 E----FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG------------- 226 (276)
T ss_dssp ----------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred c----ceecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-------------
Confidence 2 12345799999999998762 22368999999999999999999999876643333222110
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
... ....+++.+.+||.+||..||.+|||+.|+++||||+..
T Consensus 227 -------------~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 227 -------------VFY-----IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp -------------CCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -------------ccc-----CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 000 112457889999999999999999999999999999753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=385.44 Aligned_cols=259 Identities=33% Similarity=0.526 Sum_probs=206.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC------ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE------HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 87 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 87 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--
Confidence 579999999999999999999999999999999864321 112234578999999999999999999998432
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc---EEEcccCc
Q 007629 187 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGL 262 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~---vKL~DFGl 262 (595)
.+|+||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 88 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 ----DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp ----SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred ----ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 3799999997 589999988889999999999999999999999999999999999999987665 99999999
Q ss_pred ceeccCCCCCcccccccccCCcccccccccc-cCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHH-HHHHhhcCCC
Q 007629 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQL-DLMTDLLGTP 340 (595)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l-~~i~~~lg~p 340 (595)
+...... .......||+.|+|||++.+ ....++.++|||||||++|+|++|..||.+......+ ..+.....
T Consensus 164 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-- 237 (322)
T 2ycf_A 164 SKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY-- 237 (322)
T ss_dssp CEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC--
T ss_pred ceecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc--
Confidence 9865322 11244679999999998742 1256889999999999999999999999765432111 11111000
Q ss_pred ChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 341 ~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
......+..+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 238 -------------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 238 -------------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp -------------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred -------------------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 0011122456888999999999999999999999999999974
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=380.41 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=202.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||+||+|.+ +|..||||++............+.+|+.+|+.++||||+++++++... ..
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-----PN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-----TC
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Cc
Confidence 45899999999999999999976 588999999976555555667889999999999999999999998543 45
Q ss_pred EEEEEeccc-ccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 192 IYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~---l~~~~~~~i~~qil~aL~yLHs~g--IiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
+|+||||++ ++|.+++...+. +++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 899999998 589999987653 999999999999999999999999 99999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 189 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~-------- 255 (309)
T 3p86_A 189 KASTFL---SSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC-------- 255 (309)
T ss_dssp ----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC--------
T ss_pred cccccc---ccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------
Confidence 433221 1245689999999999987 678999999999999999999999998876544333221100
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc--CCCcc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA--DPYFH 407 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~--Hp~f~ 407 (595)
.. ......+++.+.+||.+||..||.+|||+.++++ .+|++
T Consensus 256 ----------------~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 256 ----------------KR-----LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp ----------------CC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ----------------CC-----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00 0112457889999999999999999999999998 44544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=378.90 Aligned_cols=262 Identities=23% Similarity=0.385 Sum_probs=208.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..++|++++.||+|+||.||+|.+..++..||+|++... .......+.+|+.+|+.++||||+++++++... .
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 89 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----G 89 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----C
Confidence 356899999999999999999999999999999998643 233467788999999999999999999998543 4
Q ss_pred cEEEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 191 DIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.+|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 6899999998 478887765 46799999999999999999999999999999999999999999999999999754221
Q ss_pred CCCCcccccccccCCcccccccccc---cCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~---~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
... ......||+.|+|||++.. ....++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 170 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------- 237 (302)
T 2j7t_A 170 TLQ---KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--------- 237 (302)
T ss_dssp HHH---C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---------
T ss_pred ccc---ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc---------
Confidence 110 1234579999999998741 1257889999999999999999999999887654433222111
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
..+ .......+++.+.+||.+||..||.+|||+.++++||||+.+.
T Consensus 238 -----------------~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 238 -----------------DPP--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp -----------------CCC--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred -----------------CCc--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 000 0011134578899999999999999999999999999998753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=376.02 Aligned_cols=259 Identities=29% Similarity=0.447 Sum_probs=212.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++... ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence 4689999999999999999999999999999999975444455667889999999999999999999987532 2356
Q ss_pred EEEEEeccc-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCCCceeeCCCCcEEEcccC
Q 007629 192 IYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFG 261 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~qil~aL~yLHs~g-----IiHrDLKP~NILl~~~~~vKL~DFG 261 (595)
+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 899999998 5899988753 34999999999999999999999999 9999999999999999999999999
Q ss_pred cceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCC
Q 007629 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (595)
Q Consensus 262 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~ 341 (595)
+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 162 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----- 231 (279)
T 2w5a_A 162 LARILNHDT---SFAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----- 231 (279)
T ss_dssp HHHHC---C---HHHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----
T ss_pred hheeecccc---ccccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc-----
Confidence 997643221 11234579999999999877 57899999999999999999999999887643332222110
Q ss_pred hhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 342 ~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
.. ......+++.+.+||.+||..||.+|||+.|+|+|+|+.+
T Consensus 232 ----------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 232 ----------------------KF---RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp ----------------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ----------------------cc---ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 00 0112356889999999999999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=380.50 Aligned_cols=264 Identities=24% Similarity=0.408 Sum_probs=208.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCc-cC
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSR-RE 188 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~-~~ 188 (595)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+++.+ .||||+++++++..... ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 3578999999999999999999999999999999986432 2345688999999998 79999999999865321 11
Q ss_pred cccEEEEEecccc-cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 189 FKDIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 189 ~~~lylV~E~~~g-~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
...+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 3568999999985 999999864 4799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCCccccccccccc---CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
...... ......||+.|+|||++... ...++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 179 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------ 249 (326)
T 2x7f_A 179 LDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN------ 249 (326)
T ss_dssp ---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------
T ss_pred cCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC------
Confidence 532221 12345799999999998621 156889999999999999999999999877654433222110
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..+ ......+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 250 --------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 250 --------------------PAP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp --------------------CCC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred --------------------ccc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 000 01124568899999999999999999999999999999853
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=378.04 Aligned_cols=256 Identities=28% Similarity=0.466 Sum_probs=208.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .....+.+|+.+|+.++||||+++++++.. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 98 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTD 98 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCE
Confidence 46899999999999999999999999999999998642 234568899999999999999999999843 346
Q ss_pred EEEEEecccc-cHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELMES-DLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~g-~L~~~i~-~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||+++ +|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 8999999985 8999886 4568999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 179 ~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------- 240 (314)
T 3com_A 179 MA---KRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN------------- 240 (314)
T ss_dssp BS---CBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------------
T ss_pred cc---ccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-------------
Confidence 22 1245679999999999877 67899999999999999999999999876654332221110
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.+ +.......+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 241 --------------~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 241 --------------PP-PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp --------------CC-CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred --------------CC-cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 00 0001123357889999999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=382.28 Aligned_cols=276 Identities=22% Similarity=0.367 Sum_probs=209.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||+||+|.+..+|+.||||+++.... ......+.+|+.+|+.++||||+++++++.... ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 83 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRH 83 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCC
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---Cce
Confidence 4689999999999999999999999999999999964322 233566789999999999999999999885432 246
Q ss_pred EEEEEeccc-ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee----CCCCcEEEcccCcc
Q 007629 192 IYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGLA 263 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl----~~~~~vKL~DFGla 263 (595)
+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 899999997 68999998654 39999999999999999999999999999999999999 88889999999999
Q ss_pred eeccCCCCCcccccccccCCccccccccccc------CCCCCCcceeechhHHHHHHHcCCCCCCCCCh-HHHHHHHHhh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQLDLMTDL 336 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~------~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~ 336 (595)
+....... ....+||+.|+|||++... ...++.++|||||||++|||++|+.||..... ......+..+
T Consensus 164 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 164 RELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp EECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred eecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 87644332 2456799999999987521 25789999999999999999999999975432 1112222222
Q ss_pred cCCCChhHHHHHhhHHHHHHhhhcccCCCCCCC-------CCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCC
Q 007629 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFS-------HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405 (595)
Q Consensus 337 lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~-------~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~ 405 (595)
+...+...+..+.. ....+..|. .....+++.+.+||.+||++||.+|||++|+|+||=
T Consensus 240 ~~~~p~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 240 ITGKPSGAISGVQK----------AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHCCTTCCEEEEC----------STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred hcCCCcccchhhhc----------ccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 11111110000000 000011111 111234567899999999999999999999999973
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=381.63 Aligned_cols=271 Identities=28% Similarity=0.421 Sum_probs=192.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 87 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----DE 87 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS-----SC
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----CC
Confidence 468999999999999999999999899999999886422 123356678999999999999999999998543 45
Q ss_pred EEEEEeccc-ccHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCc
Q 007629 192 IYVVFELME-SDLHQVIKA--------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~--------~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGl 262 (595)
+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 899999997 589888864 45699999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCC--CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCC
Q 007629 263 ARVSFNDAP--SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (595)
Q Consensus 263 a~~~~~~~~--~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p 340 (595)
+........ .........||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+...... .+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~ 244 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN--DP 244 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS--SC
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc--CC
Confidence 975432211 11112345799999999998652 46889999999999999999999999877654433222110 00
Q ss_pred ChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 341 ~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
.. .............+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 245 ~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 245 PS-------------------LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CC-------------------TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred Cc-------------------cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 00 0000111223456788999999999999999999999999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=373.66 Aligned_cols=254 Identities=27% Similarity=0.412 Sum_probs=213.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
.+|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.+.||||+++++++.. ...+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 95 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL 95 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeE
Confidence 579999999999999999999999999999999864322 2346778999999999999999999999853 3468
Q ss_pred EEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|+||||+++ +|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 999999985 88888754 6799999999999999999999999999999999999999999999999999986543321
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||........+..+..
T Consensus 175 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 233 (303)
T 3a7i_A 175 ---KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK---------------- 233 (303)
T ss_dssp ---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----------------
T ss_pred ---ccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc----------------
Confidence 1245689999999999877 6789999999999999999999999987664333222211
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
..+ ......+++.+.+||.+||..||.+|||+.++|+||||..
T Consensus 234 -----------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 234 -----------NNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp -----------SCC---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred -----------CCC---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 011 1122456888999999999999999999999999999965
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=381.52 Aligned_cols=266 Identities=22% Similarity=0.368 Sum_probs=193.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCc---EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc-
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR- 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~---~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~- 187 (595)
.++|++.+.||+|+||.||+|.+..++. .||||+++...........+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4689999999999999999999887765 899999976544455678899999999999999999999998654321
Q ss_pred CcccEEEEEecccc-cHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEccc
Q 007629 188 EFKDIYVVFELMES-DLHQVIKAND------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260 (595)
Q Consensus 188 ~~~~lylV~E~~~g-~L~~~i~~~~------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DF 260 (595)
.....|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence 12235999999984 8998886543 5999999999999999999999999999999999999999999999999
Q ss_pred CcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCC
Q 007629 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGT 339 (595)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~ 339 (595)
|+++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+....
T Consensus 182 g~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-- 256 (323)
T 3qup_A 182 GLSRKIYSGDYYR-QGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-- 256 (323)
T ss_dssp CC------------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--
T ss_pred ccccccccccccc-ccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC--
Confidence 9998654332211 1234467889999999887 679999999999999999999 999998876544433322110
Q ss_pred CChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-------HHHHhcCCCccCCC
Q 007629 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-------AEEALADPYFHGLA 410 (595)
Q Consensus 340 p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-------a~elL~Hp~f~~~~ 410 (595)
. ....+.+++.+.+||.+||..||.+||| ++++++|||+....
T Consensus 257 -------------------------~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 257 -------------------------R---LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp -------------------------C---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred -------------------------C---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 0 1112457789999999999999999999 78899999997643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=381.68 Aligned_cols=263 Identities=25% Similarity=0.424 Sum_probs=191.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHH-HHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++++.||+|+||.||+|.+..+|+.||||+++... .......+.+|+. +++.++||||+++++++... .
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~ 94 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----G 94 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----S
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----C
Confidence 468999999999999999999999999999999997532 2234455667776 67778999999999998543 4
Q ss_pred cEEEEEecccccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 191 DIYVVFELMESDLHQVIKA-----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~-----~~~l~~~~~~~i~~qil~aL~yLHs~-gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
.+|+||||++++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 6899999999998888763 56799999999999999999999998 99999999999999999999999999997
Q ss_pred eccCCCCCcccccccccCCcccccccccc--cCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
....... .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+..... ..+.
T Consensus 175 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~-------- 240 (327)
T 3aln_A 175 QLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLT-------- 240 (327)
T ss_dssp C----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------C--------
T ss_pred ecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHH--------
Confidence 6533221 234479999999999832 11568999999999999999999999997643210 0000
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.......+.........+++.+.+||.+||..||.+|||+.++++||||...
T Consensus 241 ---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 241 ---------------QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp ---------------CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ---------------HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 0011111111122335678999999999999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=385.73 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=206.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT-------HTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 183 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~-------~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 183 (595)
.++|++.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 468999999999999999999864 35568999999753 2334567789999999999 89999999999854
Q ss_pred CCccCcccEEEEEeccc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCc
Q 007629 184 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (595)
Q Consensus 184 ~~~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~N 246 (595)
...+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 159 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred -----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 345899999998 59999998653 47899999999999999999999999999999999
Q ss_pred eeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCC
Q 007629 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325 (595)
Q Consensus 247 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~ 325 (595)
||++.++.+||+|||+++......... ......+|+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+..
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYK-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTC-TTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCCCEEEccccCCcccCccccee-cccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999999999998654332211 1234567899999999877 679999999999999999999 999998866
Q ss_pred hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 326 ~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
....+..+... .. ......+++.+.+||.+||..||.+|||+.|++++
T Consensus 311 ~~~~~~~~~~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 311 VEELFKLLKEG---------------------------HR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGGHHHHHHTT---------------------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcC---------------------------CC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 44333222110 00 01123568899999999999999999999999873
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=388.44 Aligned_cols=257 Identities=21% Similarity=0.315 Sum_probs=208.3
Q ss_pred CCCeEEeeeeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAV-----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~-----~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
.++|++++.||+|+||+||+|. +..++..||||+++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-- 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 4689999999999999999999 5567889999998643 2334556788999999999999999999998543
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC---cE
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KL 255 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~-------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~---~v 255 (595)
...|+|||||. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 147 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 ---LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ---CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 45799999997 59999998653 489999999999999999999999999999999999999655 49
Q ss_pred EEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 007629 256 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 334 (595)
Q Consensus 256 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~ 334 (595)
||+|||+|+........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+....+..+.
T Consensus 224 kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp EECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EECCCcccccccccccc-ccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999754322211 11234578999999999877 689999999999999999998 999999877654443332
Q ss_pred hhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 335 ~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
... .. .....+++.+.+||.+||+.||.+|||+.++++|.|+.
T Consensus 301 ~~~---------------------------~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGG---------------------------RM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTC---------------------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC---------------------------CC---CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 210 00 11235678899999999999999999999999998864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=382.53 Aligned_cols=255 Identities=25% Similarity=0.430 Sum_probs=207.2
Q ss_pred CCCeEEeeeeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAV-----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~-----~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 185 (595)
.++|++.+.||+|+||.||+|. +..+++.||||+++.. ........+.+|+.+|+.+ +||||+++++++....
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 4689999999999999999998 5667899999999743 2334456789999999999 7999999999985432
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhcCC----------------------------------------------------
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKANDD---------------------------------------------------- 212 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~~~---------------------------------------------------- 212 (595)
..+|+|||||. ++|.+++.....
T Consensus 100 ----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 100 ----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp ----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 34899999998 599999976543
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCcccccc
Q 007629 213 --------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTD 278 (595)
Q Consensus 213 --------------l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 278 (595)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~ 254 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGD 254 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC--
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhccc
Confidence 89999999999999999999999999999999999999999999999999986543322 122345
Q ss_pred cccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHh
Q 007629 279 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYL 357 (595)
Q Consensus 279 ~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l 357 (595)
..||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+......+......
T Consensus 255 ~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--------------------- 311 (359)
T 3vhe_A 255 ARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--------------------- 311 (359)
T ss_dssp CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH---------------------
T ss_pred cCCCceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc---------------------
Confidence 678999999999877 689999999999999999998 99999876643322211110
Q ss_pred hhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 358 GSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.... .....+++.+.+||.+||..||.+|||+.|+++|
T Consensus 312 -----~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 312 -----GTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -----TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCCC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 0000 1123468899999999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=368.72 Aligned_cols=262 Identities=29% Similarity=0.427 Sum_probs=200.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC-------
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS------- 185 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------- 185 (595)
++|++++.||+|+||.||+|.+..+|+.||||++.. .......+.+|+.+++.++||||+++++++....
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 579999999999999999999999999999999853 2344567889999999999999999999875421
Q ss_pred -ccCcccEEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCc
Q 007629 186 -RREFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262 (595)
Q Consensus 186 -~~~~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGl 262 (595)
......+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 123467899999997 59999998654 678899999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCC-----------CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCC-hHHHH
Q 007629 263 ARVSFNDAP-----------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQL 330 (595)
Q Consensus 263 a~~~~~~~~-----------~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~-~~~~l 330 (595)
+........ .........||+.|+|||++.+. ..++.++|||||||++|+|++ ||.... ....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 976532210 01122456799999999998752 468999999999999999998 553211 11111
Q ss_pred HHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 331 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 331 ~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
..+ .......+ .......++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 239 ~~~------------------------~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 239 KKL------------------------RSVSIEFP---PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHH------------------------HSTTCCCC---TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred Hhc------------------------cccccccC---ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 111 00001111 1123456788999999999999999999999999999974
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=369.47 Aligned_cols=258 Identities=28% Similarity=0.405 Sum_probs=203.4
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
+|.....||+|+||.||+|.+..++..||||++... .......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 95 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIK 95 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEE
Confidence 344456899999999999999999999999998643 23345678899999999999999999999843 35689
Q ss_pred EEEeccc-ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC-CCcEEEcccCcceeccC
Q 007629 194 VVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVSFN 268 (595)
Q Consensus 194 lV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~-~~~vKL~DFGla~~~~~ 268 (595)
+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999997 68999887652 4678899999999999999999999999999999999987 89999999999986543
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... ......||+.|+|||++.+....++.++|||||||++|+|++|+.||.+..........
T Consensus 176 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--------------- 237 (295)
T 2clq_A 176 INP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK--------------- 237 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH---------------
T ss_pred CCC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh---------------
Confidence 221 12446799999999998663234889999999999999999999999654321110000
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
... . ... ......+++.+.+||.+||..||.+|||++++|+||||+..
T Consensus 238 ------~~~--~-~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 238 ------VGM--F-KVH----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp ------HHH--H-CCC----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred ------hcc--c-ccc----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 000 0 000 01224578899999999999999999999999999999854
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=372.57 Aligned_cols=261 Identities=21% Similarity=0.328 Sum_probs=192.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||.||+|.+..+|+.||||++............+..+..+++.++||||+++++++... ..
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-----TD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----Cc
Confidence 4689999999999999999999999999999999975432222233344445578888999999999998543 46
Q ss_pred EEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~-gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||+++.+..+... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 99 VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 899999997666666554 46799999999999999999999995 9999999999999999999999999999765332
Q ss_pred CCCcccccccccCCcccccccccc---cCCCCCCcceeechhHHHHHHHcCCCCCCCCC-hHHHHHHHHhhcCCCChhHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-VVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~---~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~-~~~~l~~i~~~lg~p~~~~i 345 (595)
.. .....||+.|+|||++.+ ....++.++|||||||++|+|++|+.||.... ....+..+..
T Consensus 179 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------- 244 (318)
T 2dyl_A 179 KA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---------- 244 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH----------
T ss_pred cc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc----------
Confidence 21 234579999999999852 12568899999999999999999999997643 2222211111
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
. . + +.......+++.+.+||.+||..||.+||+++++|+||||+.+
T Consensus 245 -------------~---~-~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 245 -------------E---E-P-PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp -------------S---C-C-CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred -------------c---C-C-CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 0 0 0 1111223578999999999999999999999999999999754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=378.50 Aligned_cols=262 Identities=26% Similarity=0.405 Sum_probs=184.2
Q ss_pred CCCCeEEee-eeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHH-HHHHhcCCCceeeeeeeecCCCccC
Q 007629 111 EASRYQIQE-VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREI-KLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 111 ~~~~Y~i~~-~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
..++|.+.+ .||+|+||+||+|.++.+|+.||||++... ....+|+ ..++.+.||||+++++++.... ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~ 97 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVYENMH-HG 97 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TT
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CC
Confidence 356899965 699999999999999999999999998531 1223344 3467789999999999985321 22
Q ss_pred cccEEEEEecccc-cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC---CcEEEcccCc
Q 007629 189 FKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGL 262 (595)
Q Consensus 189 ~~~lylV~E~~~g-~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~---~~vKL~DFGl 262 (595)
...+|+|||||++ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 3558999999985 9999998764 69999999999999999999999999999999999999864 5599999999
Q ss_pred ceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus 178 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------- 243 (336)
T 3fhr_A 178 AKETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR------- 243 (336)
T ss_dssp CEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ceeccccc-----cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH-------
Confidence 98653322 234578999999999876 6788999999999999999999999976543221110000
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
.+...........+..+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 244 ----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 244 ----------------RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp -----------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred ----------------hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 0000001111223456889999999999999999999999999999998643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=371.39 Aligned_cols=258 Identities=23% Similarity=0.403 Sum_probs=207.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||+||+|.+..+++.||+|++.. ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 81 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKR 81 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCe
Confidence 4689999999999999999999999999999999854 234556788999999999999999999999853 356
Q ss_pred EEEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 899999998 599999987 467999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCc-----------ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcC
Q 007629 270 APSA-----------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338 (595)
Q Consensus 270 ~~~~-----------~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg 338 (595)
.... ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~-------- 231 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD-------- 231 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT--------
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH--------
Confidence 2211 01124689999999999987 68999999999999999999999998754321000
Q ss_pred CCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 339 ~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
..... ...+.. . ..+.+++.+.+||.+||..||.+|||+.++++ |+..
T Consensus 232 --~~~~~--------~~~~~~---~-------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~ 279 (310)
T 3s95_A 232 --FGLNV--------RGFLDR---Y-------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET 279 (310)
T ss_dssp --SSBCH--------HHHHHH---T-------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred --Hhhhh--------hccccc---c-------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence 00000 000000 0 11345677999999999999999999999988 5543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=382.54 Aligned_cols=273 Identities=19% Similarity=0.320 Sum_probs=211.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh---------------hhHHHHHHHHHHHHhcCCCceee
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV---------------SDATRILREIKLLRLLRHPDIVE 176 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~---------------~~~~~~~~Ei~il~~l~HpnIv~ 176 (595)
.++|++.+.||+|+||.||+|.+ +|+.||||++....... .....+.+|+.+|+.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999998 89999999986422111 11277889999999999999999
Q ss_pred eeeeecCCCccCcccEEEEEecccc-cHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCc
Q 007629 177 IKHIMLPPSRREFKDIYVVFELMES-DLHQV------IKA--NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKN 246 (595)
Q Consensus 177 l~~~~~~~~~~~~~~lylV~E~~~g-~L~~~------i~~--~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~N 246 (595)
+++++.. ...+|+||||+++ +|.++ +.. ...+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus 108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999854 3568999999985 88887 655 5679999999999999999999999 999999999999
Q ss_pred eeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCC-cceeechhHHHHHHHcCCCCCCCCC
Q 007629 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEMLTGKPLFPGKN 325 (595)
Q Consensus 247 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~-k~DIWSlG~il~eLltG~~pF~~~~ 325 (595)
||++.++.+||+|||++...... ......||+.|+|||++.+. ..++. ++|||||||++|+|++|..||.+..
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999865332 23456899999999998762 25665 9999999999999999999998876
Q ss_pred h-HHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCC
Q 007629 326 V-VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (595)
Q Consensus 326 ~-~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp 404 (595)
. ...+..+.......+... .. + ...............+++.+.+||.+||..||.+|||+.|+|+||
T Consensus 257 ~~~~~~~~i~~~~~~~~~~~-~~--------~---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLDR-NH--------F---LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCSS-SS--------S---TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred cHHHHHHHHhccCcCCccch-hh--------h---hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 5 333333322111000000 00 0 000000001112256789999999999999999999999999999
Q ss_pred CccCC
Q 007629 405 YFHGL 409 (595)
Q Consensus 405 ~f~~~ 409 (595)
||++.
T Consensus 325 ~f~~~ 329 (348)
T 2pml_X 325 WLADT 329 (348)
T ss_dssp GGTTC
T ss_pred cccCC
Confidence 99864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=380.03 Aligned_cols=250 Identities=27% Similarity=0.440 Sum_probs=207.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hhHHHHHHHHHHHHhcC--CCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLLR--HPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~ 185 (595)
.++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.+. ||||+++++++..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~-- 119 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 119 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec--
Confidence 568999999999999999999999999999999986432211 12244668999999996 5999999999854
Q ss_pred ccCcccEEEEEeccc--ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC-CCCcEEEcccCc
Q 007629 186 RREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGL 262 (595)
Q Consensus 186 ~~~~~~lylV~E~~~--g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~-~~~~vKL~DFGl 262 (595)
...+|+|||++. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 120 ---~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 120 ---PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp ---SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ---CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 346899999997 68999999888999999999999999999999999999999999999999 789999999999
Q ss_pred ceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
++...... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||..... +.
T Consensus 197 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~-------- 256 (320)
T 3a99_A 197 GALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II-------- 256 (320)
T ss_dssp CEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH--------
T ss_pred cccccccc-----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh------hh--------
Confidence 98654322 2456799999999998762 2346789999999999999999999965321 00
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
. .. . .....+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 257 ---------------~---~~--~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 257 ---------------R---GQ--V---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp ---------------H---CC--C---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ---------------c---cc--c---cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 0 00 0 0123568899999999999999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=372.56 Aligned_cols=261 Identities=28% Similarity=0.360 Sum_probs=205.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC--CCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR--HPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~~ 189 (595)
..+|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+|+.+. ||||+++++++...
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~----- 100 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD----- 100 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS-----
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC-----
Confidence 457999999999999999999885 5899999999754444556678899999999997 59999999998543
Q ss_pred ccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
..+|+|||+..++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++......
T Consensus 101 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 101 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence 4589999988899999999988999999999999999999999999999999999999996 589999999999865433
Q ss_pred CCCcccccccccCCccccccccccc---------CCCCCCcceeechhHHHHHHHcCCCCCCCCChH-HHHHHHHhhcCC
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVV-HQLDLMTDLLGT 339 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~---------~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~-~~l~~i~~~lg~ 339 (595)
... ......+||+.|+|||++.+. ...++.++|||||||++|+|++|..||...... ..+..
T Consensus 180 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~------- 251 (313)
T 3cek_A 180 TTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA------- 251 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH-------
T ss_pred ccc-ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH-------
Confidence 221 122345799999999998641 136888999999999999999999999764321 11110
Q ss_pred CChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 340 p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.+ ...... ......++.+.+||.+||..||.+||++.|+|+||||+..
T Consensus 252 ----------------~~---~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 252 ----------------II---DPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp ----------------HH---CTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ----------------HH---hccccc---CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 00 000111 1112347789999999999999999999999999999854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=363.18 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=204.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+. ++..||||++..... ....+.+|+.+|+.++||||+++++++.. ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 79 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAP 79 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSS
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCc
Confidence 468999999999999999999986 577899999974322 34568899999999999999999999854 345
Q ss_pred EEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 899999998 5899998754 46899999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+....
T Consensus 160 ~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~----------- 224 (269)
T 4hcu_A 160 QY--TSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------- 224 (269)
T ss_dssp HH--HSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----------
T ss_pred cc--ccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-----------
Confidence 11 11234467889999999876 679999999999999999999 999998877544433332110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.. ......++.+.+||.+||..||.+|||+.++++|
T Consensus 225 ------------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 225 ------------RL-------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------------CC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------cC-------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00 0113357889999999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=375.69 Aligned_cols=256 Identities=20% Similarity=0.241 Sum_probs=203.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+|+.+ .||||+++++++.. ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~ 78 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GK 78 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TT
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CC
Confidence 4689999999999999999999999999999999864321 23477899999999 89999999998843 35
Q ss_pred cEEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc-----EEEcccCcce
Q 007629 191 DIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLAR 264 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~-----vKL~DFGla~ 264 (595)
.+|+||||++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++. +||+|||+++
T Consensus 79 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 79 YNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred ccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 68999999988999999864 68999999999999999999999999999999999999999987 9999999998
Q ss_pred eccCCCCCcc----cccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCC
Q 007629 265 VSFNDAPSAI----FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (595)
Q Consensus 265 ~~~~~~~~~~----~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p 340 (595)
.......... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i---- 232 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI---- 232 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH----
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH----
Confidence 7544332111 1245689999999999987 67999999999999999999999999875432222211111
Q ss_pred ChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 341 ~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
...... .+....... .|.+.+||.+||..||.+||+++++++
T Consensus 233 --------~~~~~~-----------~~~~~~~~~-~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 233 --------GDTKRA-----------TPIEVLCEN-FPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp --------HHHHHH-----------SCHHHHTTT-CHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred --------Hhhhcc-----------CCHHHHhcc-ChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 000000 000000112 237999999999999999999998876
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=360.59 Aligned_cols=249 Identities=21% Similarity=0.330 Sum_probs=204.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+. ++..||||+++... .....+.+|+.+|+.++||||+++++++.. ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 77 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-----EYP 77 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCc
Confidence 468999999999999999999875 57789999996432 234568899999999999999999999843 345
Q ss_pred EEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||++ ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 899999997 57999987654 5999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+....
T Consensus 158 ~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----------- 222 (268)
T 3sxs_A 158 QY--VSSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH----------- 222 (268)
T ss_dssp CE--EECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----------
T ss_pred hh--hcccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-----------
Confidence 22 11234467788999999877 578999999999999999999 999998776544333221110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.. ......++.+.+||.+||..||.+|||+.++++|
T Consensus 223 ----------------~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 223 ----------------RL---YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ----------------CC---CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------CC---CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 0112357889999999999999999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=365.37 Aligned_cols=257 Identities=18% Similarity=0.234 Sum_probs=206.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+++.+ .|++|+++++++. ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~ 79 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGL 79 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETT
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCc
Confidence 468999999999999999999999999999999986432 223467899999999 7999999999873 445
Q ss_pred cEEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc-----EEEcccCcce
Q 007629 191 DIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLAR 264 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~-----vKL~DFGla~ 264 (595)
..|+||||++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++
T Consensus 80 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 80 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 689999999889999998754 6999999999999999999999999999999999999988776 9999999998
Q ss_pred eccCCCCCc----ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCC
Q 007629 265 VSFNDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (595)
Q Consensus 265 ~~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p 340 (595)
......... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~----- 232 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER----- 232 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-----
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH-----
Confidence 765433211 11245689999999999877 6789999999999999999999999987543221111111
Q ss_pred ChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 341 ~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
+...... .+.....+.+++.+.+||.+||..||.+||++.++++
T Consensus 233 -------~~~~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 233 -------IGEKKQS-----------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp -------HHHHHHH-----------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -------HHhhccC-----------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 0000000 0111112456889999999999999999999999887
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=369.48 Aligned_cols=270 Identities=21% Similarity=0.365 Sum_probs=204.6
Q ss_pred CCCeEEeeeeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~----~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
..+|++++.||+|+||+||+|+ +..+++.||||++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--- 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 4689999999999999999998 667899999999864 2334557789999999999999999999988542
Q ss_pred CcccEEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
....+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 2245899999997 59999998754 599999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...............+|..|+|||++.+ ..++.++|||||||++|||++|..||..... ......+.......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQM 236 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH-----HHHHHHCTTCCTHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChH-----HHHhhhcCccccch
Confidence 5443322222234567888999999987 6799999999999999999999999865321 11122222221111
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.. ......+......+ ....+++.+.+||.+||..||.+|||+.|+++
T Consensus 237 ~~------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 237 IV------FHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HH------HHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hH------HHHHHHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 10 00111111111111 12457889999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=369.71 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=207.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~-----~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
..+|++.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 97 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--- 97 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence 468999999999999999999873 45689999998643 234456778999999999999999999999844
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCeeecC
Q 007629 187 REFKDIYVVFELME-SDLHQVIKANDD------------------------LTPEHYQFFLYQLLRGLKYIHTANVFHRD 241 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~~------------------------l~~~~~~~i~~qil~aL~yLHs~gIiHrD 241 (595)
...+|+||||++ ++|.+++..... +++..++.++.||+.||.|||++||+|||
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 345899999998 699999987543 89999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCC
Q 007629 242 LKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPL 320 (595)
Q Consensus 242 LKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~p 320 (595)
|||+|||++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cchheEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999986543322 111234567889999999877 678999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHH
Q 007629 321 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400 (595)
Q Consensus 321 F~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~el 400 (595)
|.+.........+... .. ......+++.+.+||.+||..||.+|||+.++
T Consensus 253 ~~~~~~~~~~~~~~~~---------------------------~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 302 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTG---------------------------HR---MERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302 (314)
T ss_dssp STTCCGGGHHHHHHTT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHhhcC---------------------------Cc---CCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9877653332222110 00 11224578899999999999999999999999
Q ss_pred hcC
Q 007629 401 LAD 403 (595)
Q Consensus 401 L~H 403 (595)
+++
T Consensus 303 ~~~ 305 (314)
T 2ivs_A 303 SKD 305 (314)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=379.13 Aligned_cols=273 Identities=22% Similarity=0.243 Sum_probs=206.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|++.+.||+|+||+||+|.+. ++.||||++... ........+|+.+|+.++||||+++++++.... .....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~ 96 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVD 96 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCce
Confidence 468999999999999999999875 799999998632 233445667999999999999999999986432 11345
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CeeecCCCCCceeeCCCCcEEEccc
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA----------NVFHRDLKPKNILANADCKLKICDF 260 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~----------gIiHrDLKP~NILl~~~~~vKL~DF 260 (595)
+|+|||||+ ++|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 899999998 5999999764 699999999999999999999999 9999999999999999999999999
Q ss_pred CcceeccCCCCCcccccccccCCcccccccccccC---CCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhc
Q 007629 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337 (595)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~---~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~l 337 (595)
|+++........ ......+||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.+......+.......
T Consensus 176 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 176 GLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp TTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999876443322 1234468999999999987521 245568899999999999999999998765433333333333
Q ss_pred CCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCC--CCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP--NADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 338 g~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~--~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
+.+....+... .. .......+...+. ..++.+.+||.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~~--------~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 255 QHPSLEDMQEV--------VV--HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp SSCCHHHHHHH--------HT--TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCchhhhhhh--------hh--cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 34443322211 10 1111111111111 12355899999999999999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=369.45 Aligned_cols=260 Identities=20% Similarity=0.304 Sum_probs=199.4
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECC---CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~---~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
..++|.+.+.||+|+||.||+|.+.. ++..||||+++...........+.+|+.+|+.++||||+++++++......
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 34689999999999999999998765 566899999875544555667889999999999999999999999765544
Q ss_pred CcccEEEEEeccc-ccHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEccc
Q 007629 188 EFKDIYVVFELME-SDLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 260 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~------~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DF 260 (595)
.....|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 3446799999998 589998843 356999999999999999999999999999999999999999999999999
Q ss_pred CcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCC
Q 007629 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGT 339 (595)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~ 339 (595)
|++......... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.........+...
T Consensus 192 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--- 265 (313)
T 3brb_A 192 GLSKKIYSGDYY-RQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG--- 265 (313)
T ss_dssp SCC-----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---
T ss_pred Ccceeccccccc-CcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC---
Confidence 999765332211 11233467889999999877 689999999999999999999 89999877654333322111
Q ss_pred CChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 340 p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
. . ......+++.+.+||.+||..||.+|||+.+++++
T Consensus 266 --------------------~----~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 266 --------------------H----R---LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp --------------------C----C---CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------------C----C---CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0 01124567889999999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=377.85 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=207.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 183 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~-------~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 183 (595)
.++|++.+.||+|+||.||+|.+.. .+..||||+++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4689999999999999999999753 3358999999753 3344567889999999999 89999999999854
Q ss_pred CCccCcccEEEEEeccc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCc
Q 007629 184 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (595)
Q Consensus 184 ~~~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~N 246 (595)
. ..+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 147 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 147 D-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred C-----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 3 45899999998 59999998754 49999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCC
Q 007629 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325 (595)
Q Consensus 247 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~ 325 (595)
||++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999865432211 11234568899999999877 689999999999999999999 999998876
Q ss_pred hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 326 ~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.......+... .. ......+++.+.+||.+||..||.+|||+.|++++
T Consensus 299 ~~~~~~~~~~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLKEG---------------------------HR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHTT---------------------------CC---CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcC---------------------------CC---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 54433322211 00 01123568899999999999999999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=363.70 Aligned_cols=249 Identities=20% Similarity=0.309 Sum_probs=202.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||+||+|.+. ++..||||+++... .....+.+|+.+|+.++||||+++++++.. ...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 93 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRP 93 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSS
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEec-----CCC
Confidence 468999999999999999999876 67789999997432 234668899999999999999999999843 346
Q ss_pred EEEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 899999997 689999876 457999999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+......
T Consensus 174 ~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------- 240 (283)
T 3gen_A 174 EY--TSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--------- 240 (283)
T ss_dssp HH--HSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred cc--ccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC---------
Confidence 11 11233467888999999887 678999999999999999998 99999887754444333221100
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
......++.+.+||.+||..||.+|||+.++++|
T Consensus 241 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 241 ---------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ---------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0113457889999999999999999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=363.34 Aligned_cols=250 Identities=25% Similarity=0.417 Sum_probs=195.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~---g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
.++|++.+.||+|+||.||+|.+..+ +..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 87 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-----
Confidence 46899999999999999999998654 457999998643 233455678999999999999999999998732
Q ss_pred cccEEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 189 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
..+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 88 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred -CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 34799999998 58999998654 6999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.+..+...
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~--------- 233 (281)
T 1mp8_A 167 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------- 233 (281)
T ss_dssp --------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---------
T ss_pred Cccccc--ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC---------
Confidence 432211 1233467889999999876 678999999999999999996 99999887654433332211
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
... ...+.+++.+.+||.+||..||.+|||+.++++
T Consensus 234 ------------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 234 ------------------ERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp ------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 001 122467889999999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=391.96 Aligned_cols=258 Identities=28% Similarity=0.410 Sum_probs=193.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.+|.+.+.||+|+||+|+. ....+|+.||||++..... ..+.+|+.+|+.+ +|||||++++++. +...
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~ 92 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEK-----DRQF 92 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCE
Confidence 4699999999999998664 3456899999999864221 2246899999999 7999999999884 3456
Q ss_pred EEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC-----CCcEEEcccCccee
Q 007629 192 IYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-----DCKLKICDFGLARV 265 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~-----~~~vKL~DFGla~~ 265 (595)
+|||||||+++|.+++.... .+.+..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||+|+.
T Consensus 93 ~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 93 QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 89999999999999998654 4666778899999999999999999999999999999953 23588999999987
Q ss_pred ccCCCCCcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
..............+||++|+|||++.+. ...++.++|||||||++|||++ |..||...... +...+ .+..
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-~~~~~---~~~~--- 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-QANIL---LGAC--- 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-HHHHH---TTCC---
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-HHHHH---hccC---
Confidence 64433222223557899999999998642 2567889999999999999999 89999654321 11111 0100
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
...........++.+.+||.+||+.||.+|||++|+|+||||..+
T Consensus 246 ---------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 246 ---------------------SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp ---------------------CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ---------------------CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 000111112235568999999999999999999999999999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=371.56 Aligned_cols=250 Identities=27% Similarity=0.437 Sum_probs=201.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hhHHHHHHHHHHHHhc----CCCceeeeeeeecC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLL----RHPDIVEIKHIMLP 183 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~----~~~~~~~~Ei~il~~l----~HpnIv~l~~~~~~ 183 (595)
.++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.+ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 468999999999999999999999999999999986432211 1233456799999998 89999999999844
Q ss_pred CCccCcccEEEEEec-cc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC-CCCcEEEccc
Q 007629 184 PSRREFKDIYVVFEL-ME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDF 260 (595)
Q Consensus 184 ~~~~~~~~lylV~E~-~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~-~~~~vKL~DF 260 (595)
. ...|+|||+ +. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+||
T Consensus 110 ~-----~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 110 Q-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp --------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred C-----CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 3 457999998 55 69999999888899999999999999999999999999999999999999 8899999999
Q ss_pred CcceeccCCCCCcccccccccCCcccccccccccCCCC-CCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCC
Q 007629 261 GLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339 (595)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~-~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~ 339 (595)
|++....... .....||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+... +.
T Consensus 185 g~~~~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~----- 246 (312)
T 2iwi_A 185 GSGALLHDEP-----YTDFDGTRVYSPPEWISR--HQYHALPATVWSLGILLYDMVCGDIPFERDQE------IL----- 246 (312)
T ss_dssp SSCEECCSSC-----BCCCCSCTTTSCHHHHHH--SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH-----
T ss_pred chhhhcccCc-----ccccCCcccccCceeeec--CCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hh-----
Confidence 9998754322 245679999999999876 344 4589999999999999999999965211 00
Q ss_pred CChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 340 p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
. ... .....+++.+.+||.+||..||.+|||++|+|+||||+...
T Consensus 247 ------------------~---~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 247 ------------------E---AEL-----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp ------------------H---TCC-----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ------------------h---hcc-----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 0 000 11235688999999999999999999999999999998643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=373.10 Aligned_cols=252 Identities=21% Similarity=0.357 Sum_probs=197.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEE----EEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERV----AIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~v----AIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
..+|++.+.||+|+||+||+|++..++..| |+|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence 468999999999999999999998887765 77766432 1223456789999999999999999999998643
Q ss_pred CcccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
..++|+||+. ++|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 90 ---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 90 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp ---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred ---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 3688999988 6899988774 5799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+.......+....
T Consensus 167 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~------- 236 (327)
T 3poz_A 167 LGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------- 236 (327)
T ss_dssp HTTTCC--------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------
T ss_pred ccCCccc-ccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-------
Confidence 5433322 12234567889999999987 689999999999999999999 999998766543322221110
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.. ...+.+++.+.+||.+||..||.+||++.+++++
T Consensus 237 ------------------~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 237 ------------------RL-----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ------------------CC-----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ------------------CC-----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00 1123467889999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=372.10 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=206.5
Q ss_pred CCCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 185 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~-----~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 185 (595)
..++|++++.||+|+||.||+|.+. .++..||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV-- 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--
Confidence 3568999999999999999999987 456899999987432 23445678999999999999999999999854
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKAN------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHR 240 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHr 240 (595)
...+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 122 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 122 ---GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ---CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 345899999998 5999999764 569999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCC
Q 007629 241 DLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKP 319 (595)
Q Consensus 241 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~ 319 (595)
||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999765332211 11234578999999999877 679999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHH
Q 007629 320 LFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399 (595)
Q Consensus 320 pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~e 399 (595)
||.+.+.......+... .. ......+++.+.+||.+||..||.+||++.+
T Consensus 276 p~~~~~~~~~~~~~~~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 325 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDG---------------------------NI---LACPENCPLELYNLMRLCWSKLPADRPSFCS 325 (343)
T ss_dssp TTTTSCHHHHHHHHHTT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCCChHHHHHHHhCC---------------------------Cc---CCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 99887654433222110 00 0112356789999999999999999999999
Q ss_pred Hhc
Q 007629 400 ALA 402 (595)
Q Consensus 400 lL~ 402 (595)
+++
T Consensus 326 ~~~ 328 (343)
T 1luf_A 326 IHR 328 (343)
T ss_dssp HHH
T ss_pred HHH
Confidence 987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=362.74 Aligned_cols=253 Identities=21% Similarity=0.312 Sum_probs=204.9
Q ss_pred CCCeEEee-eeeecCceEEEEEE--ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQE-VIGKGSYGVVGSAV--DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~-~LG~G~fG~V~~a~--~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
..+|++.+ .||+|+||.||+|. +..++..||||+++...........+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 89 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA----- 89 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC-----
Confidence 35799998 99999999999994 46678999999997654444456788999999999999999999999822
Q ss_pred cccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
..+|+||||++ ++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 90 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 90 -ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 35899999998 6899999988889999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
.............+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+...
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------- 236 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---------- 236 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----------
T ss_pred cCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------
Confidence 43322222233457789999999876 578899999999999999999 99999887654332222110
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.. ......+++.+.+||.+||..||.+||++.++++
T Consensus 237 -----------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 237 -----------------ER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -----------------CC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------CC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 0112457889999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=364.84 Aligned_cols=254 Identities=27% Similarity=0.405 Sum_probs=207.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~-----~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 185 (595)
.++|++.+.||+|+||.||+|.+ ..++..||||+++.. ........+.+|+.+|+.+ +||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~- 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG- 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-
Confidence 46899999999999999999984 457889999999743 2334567789999999999 899999999998543
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCc
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKAND------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~~------------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~N 246 (595)
..+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 100 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 100 ----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 45899999997 59999998654 48999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCC
Q 007629 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325 (595)
Q Consensus 247 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~ 325 (595)
||++.++.+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999865443321 12234568899999999877 679999999999999999999 999998765
Q ss_pred hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 326 ~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
....+..+... ... . .....+++.+.+||.+||..||.+|||+.|++++
T Consensus 253 ~~~~~~~~~~~----------------------~~~--~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIKE----------------------GFR--M-----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHHH----------------------TCC--C-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHhcc----------------------CCC--C-----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 43322211110 000 0 1123567899999999999999999999999873
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=362.01 Aligned_cols=250 Identities=22% Similarity=0.425 Sum_probs=209.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
...+|++.+.||+|+||.||+|.+..++..||||++.. .......+.+|+.+++.++||||+++++++.. ..
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 82 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EP 82 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS---CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CC
Confidence 35689999999999999999999999999999999964 23456778899999999999999999999843 34
Q ss_pred cEEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 191 DIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 5899999998 6999999874 359999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+...
T Consensus 163 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~---------- 228 (288)
T 3kfa_A 163 GDTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---------- 228 (288)
T ss_dssp SSSS--EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT----------
T ss_pred CCcc--ccccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc----------
Confidence 3322 12344567889999999877 678999999999999999999 99999887654333222111
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.. ......+++.+.+||.+||..||.+|||+.++++
T Consensus 229 -------------~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 229 -------------YR-------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -------------CC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CC-------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 00 0112456889999999999999999999999987
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=380.71 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=204.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+..++..||||+++.. ........+.+|+.+|+.++||||+++++++... ..
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QP 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----SS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----CC
Confidence 46899999999999999999999999999999998643 2233445688999999999999999999998543 45
Q ss_pred EEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+|||||+ ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 899999997 68999987654 6999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+.......+...
T Consensus 267 ~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~------------ 331 (377)
T 3cbl_A 267 VYA-ASGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG------------ 331 (377)
T ss_dssp EEE-CCSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT------------
T ss_pred cee-ecCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence 110 00112245778999999876 578999999999999999998 99999887654333222110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
...+ ....+++.+.+||.+||..||.+|||+.++++
T Consensus 332 -------------~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 332 -------------GRLP-----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp -------------CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0011 11346788999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=358.98 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=202.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhh-----HHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSD-----ATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
.++|++.+.||+|+||.||+|.+..+++.||||++......... ...+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 46899999999999999999999999999999998643222211 16788999999999999999999998543
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCceeeCCCCc-----EEE
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCK-----LKI 257 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~g--IiHrDLKP~NILl~~~~~-----vKL 257 (595)
.++||||+. ++|.+.+... ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++. +||
T Consensus 96 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 96 -----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -----TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -----CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 279999998 6898887654 47999999999999999999999999 999999999999988876 999
Q ss_pred cccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHH--HHHHHh
Q 007629 258 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQ--LDLMTD 335 (595)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~--l~~i~~ 335 (595)
+|||+++..... .....||+.|+|||++.+....++.++|||||||++|+|++|+.||.+...... ...+..
T Consensus 171 ~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 244 (287)
T 4f0f_A 171 ADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244 (287)
T ss_dssp CCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred CCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence 999999743221 245689999999999854335678999999999999999999999976543221 111100
Q ss_pred hcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 336 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 336 ~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
. ... ......+++.+.+||.+||..||.+|||++|+++
T Consensus 245 ------------------------~--~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 245 ------------------------E--GLR---PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp ------------------------S--CCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------c--CCC---CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 000 1122457889999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=365.19 Aligned_cols=254 Identities=28% Similarity=0.375 Sum_probs=198.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----DG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----CC
Confidence 4689999999999999999999999999999999865432 22335678899999999999999999999843 35
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 6899999998 499999998889999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 188 ~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------------- 249 (309)
T 2h34_A 188 KLT--QLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ-------------- 249 (309)
T ss_dssp -----------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS--------------
T ss_pred ccc--cccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc--------------
Confidence 211 1245679999999999877 6789999999999999999999999987653211111100
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-CHHHHhc
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-TAEEALA 402 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-ta~elL~ 402 (595)
.........+.+++.+.+||.+||..||.+|| +++++++
T Consensus 250 --------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 250 --------------AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp --------------CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred --------------CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 00111123356788899999999999999999 7877775
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=360.97 Aligned_cols=257 Identities=24% Similarity=0.309 Sum_probs=197.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..++|++.+.||+|+||.||+|.+. ..||||+++...........+.+|+.+|+.++||||++++++... .
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~ 92 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------P 92 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------C
Confidence 3578999999999999999999754 359999997655555667789999999999999999999997532 3
Q ss_pred cEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 191 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.+++||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 4799999998 6898888543 5799999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.... .......||+.|+|||++... ...++.++|||||||++|+|++|+.||.+......+..+...
T Consensus 173 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------- 240 (289)
T 3og7_A 173 WSGS-HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR----------- 240 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH-----------
T ss_pred cccc-ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc-----------
Confidence 2211 123456799999999998621 256888999999999999999999999876654433222111
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
......+......+++.+.+||.+||..||.+|||+.++++
T Consensus 241 --------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 241 --------------GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp --------------TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------cccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11112223334567899999999999999999999999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=371.12 Aligned_cols=256 Identities=26% Similarity=0.404 Sum_probs=205.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~-----~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 185 (595)
.++|++.+.||+|+||.||+|.+ ..++..||||+++... .......+.+|+.+|+.+ .||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS- 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-
Confidence 46899999999999999999997 3466789999997432 223456788999999999 899999999998543
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecC
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKAND-----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRD 241 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~~-----------------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrD 241 (595)
..+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+|||
T Consensus 122 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 122 ----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 45899999997 59999997653 378999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCC
Q 007629 242 LKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPL 320 (595)
Q Consensus 242 LKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~p 320 (595)
|||+|||++.++.+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccc-eeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999865443322 22344578899999999877 679999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHH
Q 007629 321 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400 (595)
Q Consensus 321 F~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~el 400 (595)
|.+......+..+.. ..... .....+++.+.+||.+||..||.+|||+.++
T Consensus 275 ~~~~~~~~~~~~~~~--------------------------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 325 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQ--------------------------NGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 325 (344)
T ss_dssp STTCCCSHHHHHHHH--------------------------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cccCCcHHHHHHHHh--------------------------cCCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 987654322221111 00000 1123468899999999999999999999999
Q ss_pred hcCCC
Q 007629 401 LADPY 405 (595)
Q Consensus 401 L~Hp~ 405 (595)
++|..
T Consensus 326 ~~~l~ 330 (344)
T 1rjb_A 326 TSFLG 330 (344)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=360.09 Aligned_cols=270 Identities=23% Similarity=0.394 Sum_probs=207.9
Q ss_pred CCCeEEeeeeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~----~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
..+|++++.||+|+||.||+|+ +..+++.||||+++... .......+.+|+.+|+.++||||+++++++....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG-- 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--
Confidence 3569999999999999999998 67789999999997432 2234567889999999999999999999986532
Q ss_pred CcccEEEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 188 EFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
...+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 97 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 97 -GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred -CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 245899999997 599999954 45799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...............||..|+|||++.+ ..++.++|||||||++|+|++|..||... ...+....+.......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGPTHGQMT 248 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCSCCGGGH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCCcccccC
Confidence 6544332222345678999999999877 67889999999999999999999987432 2222222232222111
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
. ......+......+ ..+.+++.+.+||.+||..||.+|||+.++++
T Consensus 249 ~-------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 249 V-------TRLVNTLKEGKRLP---CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp H-------HHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred H-------HHHHHHHhccCCCC---CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0 11111111111111 22467899999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=369.35 Aligned_cols=258 Identities=22% Similarity=0.365 Sum_probs=189.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCC---ccC
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPS---RRE 188 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~---~~~ 188 (595)
.+|++.+.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+|+.+. ||||+++++++.... ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC--CchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 489999999999999999999999999999999853 23345667889999999996 999999999884321 133
Q ss_pred cccEEEEEecccccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCceeeCCCCcEEEcccCcc
Q 007629 189 FKDIYVVFELMESDLHQVIKA---NDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLA 263 (595)
Q Consensus 189 ~~~lylV~E~~~g~L~~~i~~---~~~l~~~~~~~i~~qil~aL~yLHs~g--IiHrDLKP~NILl~~~~~vKL~DFGla 263 (595)
...+|+||||++++|.+++.. .+.+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 456899999999999988865 457999999999999999999999999 999999999999999999999999999
Q ss_pred eeccCCCCCc---------ccccccccCCcccccccccc-cCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHH
Q 007629 264 RVSFNDAPSA---------IFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLM 333 (595)
Q Consensus 264 ~~~~~~~~~~---------~~~~~~~gT~~Y~APE~l~~-~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i 333 (595)
+......... .......||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+......+.
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-- 263 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN-- 263 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc--
Confidence 8654332211 00124569999999999832 12568899999999999999999999997544211100
Q ss_pred HhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCC
Q 007629 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405 (595)
Q Consensus 334 ~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~ 405 (595)
.....+ .....++.+.+||.+||+.||.+|||+.|+++|-+
T Consensus 264 ----------------------------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 264 ----------------------------GKYSIP---PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ------------------------------CCCC---TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ----------------------------CcccCC---cccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 000000 11334567899999999999999999999999744
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=379.35 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=194.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC---CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT---HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~---~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
..+|.+.+.||+|+||.||+|++. .++..||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK----- 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----
Confidence 468999999999999999999876 467789999986432 33456678999999999999999999999854
Q ss_pred cccEEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 189 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
...+|+|||||+ ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 345899999997 69999998754 6999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
..............+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+....+..+...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~--------- 266 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG--------- 266 (373)
T ss_dssp ----------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT---------
T ss_pred ccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---------
Confidence 443222211223356788999999877 689999999999999999998 99999877654433322111
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.. .+ ....+++.+.+||.+||..||.+||++.++++
T Consensus 267 --------------~~--~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 267 --------------YR--LP-----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp --------------EE--CC-----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CC--CC-----CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 00 01 11346788999999999999999999999886
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=356.32 Aligned_cols=248 Identities=27% Similarity=0.448 Sum_probs=192.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH--VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|++.+.||+|+||.||+|.+. |..||||+++..... ....+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE----- 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----
Confidence 468999999999999999999874 889999998643221 22356788999999999999999999998543
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCCCceeeCC--------CCcEEE
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN---VFHRDLKPKNILANA--------DCKLKI 257 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~g---IiHrDLKP~NILl~~--------~~~vKL 257 (595)
..+|+||||++ ++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 45899999997 57777764 568999999999999999999999999 999999999999986 678999
Q ss_pred cccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhc
Q 007629 258 CDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337 (595)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~l 337 (595)
+|||++........ ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 158 ~Dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-- 228 (271)
T 3dtc_A 158 TDFGLAREWHRTTK-----MSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-- 228 (271)
T ss_dssp CCCCC------------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT--
T ss_pred ccCCcccccccccc-----cCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc--
Confidence 99999976533221 24579999999999877 6789999999999999999999999988765433222111
Q ss_pred CCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 338 g~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
..... .....+++.+.+||.+||..||.+|||+.|+++|
T Consensus 229 ------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 229 ------------------------NKLAL---PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ------------------------SCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 01111 1124567889999999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=371.95 Aligned_cols=252 Identities=21% Similarity=0.340 Sum_probs=200.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcE----EEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~----vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
..+|++++.||+|+||+||+|.+..++.. ||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 86 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---- 86 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB----
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----
Confidence 46899999999999999999999888876 6777664321 11223456789999999999999999998832
Q ss_pred CcccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
..+|+||||+. ++|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 87 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 87 --SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp --SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred --CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 34899999998 6899988764 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------- 233 (325)
T 3kex_A 165 LPPDDKQ-LLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-------- 233 (325)
T ss_dssp SCCCTTC-CC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT--------
T ss_pred cCccccc-ccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC--------
Confidence 5433322 22345678889999999987 679999999999999999999 99999876643333222111
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.... ....+++.+.+||.+||..||.+|||+.++++|
T Consensus 234 -------------------~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 234 -------------------ERLA---QPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -------------------CBCC---CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -------------------CCCC---CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 112245568999999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=370.55 Aligned_cols=270 Identities=23% Similarity=0.385 Sum_probs=210.4
Q ss_pred CCCCeEEeeeeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~----~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
+..+|++++.||+|+||.||+|+ +..++..||||++... .......+.+|+.+|+.++||||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 96 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP-- 96 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--
Confidence 45689999999999999999998 5678999999999642 334556789999999999999999999988643
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
+...+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 97 -GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp -SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred -CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 3356899999996 6899999763 569999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCC-Chh
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP-STE 343 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p-~~~ 343 (595)
................||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... . ...... ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~----~~~~~~~~~~ 248 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-L----RMMGCERDVP 248 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-H----HHCC----CC
T ss_pred ecccCCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchh-h----hhcccccccc
Confidence 76444332223344578999999999877 578999999999999999999999997533211 0 000000 000
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
... .....+...... ...+.+++.+.+||.+||..||.+|||+.|++++
T Consensus 249 ~~~--------~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 249 ALS--------RLLELLEEGQRL---PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHH--------HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHH--------HHHHHhhcccCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 111111111111 1234678999999999999999999999999764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=374.79 Aligned_cols=269 Identities=16% Similarity=0.144 Sum_probs=201.5
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhh---------HHHHHHHHHHHHhcCCCceee
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHT-----GERVAIKKINDVFEHVSD---------ATRILREIKLLRLLRHPDIVE 176 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~-----g~~vAIK~i~~~~~~~~~---------~~~~~~Ei~il~~l~HpnIv~ 176 (595)
..++|++.+.||+|+||+||+|.+..+ ++.||||++......... ...+..|+..++.+.||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 346899999999999999999998764 588999998643211000 012345666677788999999
Q ss_pred eeeeecCCCccCcccEEEEEecccccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC--CCC
Q 007629 177 IKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADC 253 (595)
Q Consensus 177 l~~~~~~~~~~~~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~--~~~ 253 (595)
+++++.... .....+|||||||+++|.+++... +.+++..+..|+.||+.||.|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 999986532 223568999999988999999876 6799999999999999999999999999999999999999 889
Q ss_pred cEEEcccCcceeccCCCCCc----ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHH
Q 007629 254 KLKICDFGLARVSFNDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQ 329 (595)
Q Consensus 254 ~vKL~DFGla~~~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~ 329 (595)
.+||+|||+++......... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 99999999998654322111 11234569999999999987 6799999999999999999999999986432222
Q ss_pred HHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 330 l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
........ ........+.... ....+++.+.+||..||..||.+||++.++++
T Consensus 270 ~~~~~~~~-----------~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIR-----------YRENIASLMDKCF---------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHH-----------HHHCHHHHHHHHS---------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHH-----------hhhhHHHHHHHhc---------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 11111100 0000111111110 01356788999999999999999999999886
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=366.23 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=199.5
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCC----cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTG----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g----~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
...+|.+.+.||+|+||.||+|.+..++ ..||||+++... .......+.+|+.+++.++||||+++++++..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 117 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--- 117 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec---
Confidence 4578999999999999999999876553 459999996432 33445678899999999999999999999843
Q ss_pred cCcccEEEEEecccc-cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 187 REFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 187 ~~~~~lylV~E~~~g-~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
...+|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 118 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 118 --YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp --SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred --CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 3568999999985 899998765 579999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
................+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+....+..+....
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~------ 267 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------ 267 (333)
T ss_dssp ---------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------
T ss_pred hhccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC------
Confidence 65443322222233457889999999876 679999999999999999999 999998776543333221110
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
..+ ....+++.+.+||.+||..||.+||++.+++++
T Consensus 268 -------------------~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 268 -------------------RLP-----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp -------------------CCC-----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------------------cCC-----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 011 123567889999999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=384.43 Aligned_cols=260 Identities=27% Similarity=0.383 Sum_probs=191.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.+.|.+.+.||+|+||+||.+ ...+|+.||||++... ....+.+|+.+|+.+ +|||||++++++.. ..
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~ 82 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETT-----DR 82 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-----SS
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CC
Confidence 356888899999999999875 4568999999998532 234578999999876 89999999998843 45
Q ss_pred cEEEEEecccccHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC-----------
Q 007629 191 DIYVVFELMESDLHQVIKANDDL-------TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----------- 252 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l-------~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~----------- 252 (595)
.+|||||||+++|.+++...... ++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 83 ~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 83 FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred eEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence 69999999999999999865432 333467899999999999999999999999999999754
Q ss_pred --CcEEEcccCcceeccCCCCC-cccccccccCCccccccccccc-----CCCCCCcceeechhHHHHHHHc-CCCCCCC
Q 007629 253 --CKLKICDFGLARVSFNDAPS-AIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323 (595)
Q Consensus 253 --~~vKL~DFGla~~~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~-----~~~~~~k~DIWSlG~il~eLlt-G~~pF~~ 323 (595)
+.+||+|||+++........ .......+||+.|+|||++.+. ...++.++|||||||++|||++ |..||.+
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 48999999999876443221 1112356899999999998651 2468999999999999999999 9999976
Q ss_pred CChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 324 ~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
..... ...+.... .. +.........+++.+.+||.+||..||.+|||+.++|+|
T Consensus 243 ~~~~~-~~i~~~~~------------------------~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 243 KYSRE-SNIIRGIF------------------------SL-DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TTTHH-HHHHHTCC------------------------CC-CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred chhhH-HHHhcCCC------------------------Cc-ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 54321 11110000 00 000000112245779999999999999999999999999
Q ss_pred CCccC
Q 007629 404 PYFHG 408 (595)
Q Consensus 404 p~f~~ 408 (595)
|||..
T Consensus 297 p~f~~ 301 (434)
T 2rio_A 297 PLFWP 301 (434)
T ss_dssp GGGSC
T ss_pred CccCC
Confidence 99964
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=366.16 Aligned_cols=253 Identities=21% Similarity=0.367 Sum_probs=206.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~-----~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
.++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.++||||+++++++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 99 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 99 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc---
Confidence 368999999999999999999876 46789999998643 233445678899999999999999999999844
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcE
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 255 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~----------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~v 255 (595)
...+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 100 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 100 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred --CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 345899999998 5999988653 357899999999999999999999999999999999999999999
Q ss_pred EEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 007629 256 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 334 (595)
Q Consensus 256 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~ 334 (595)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 178 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp EECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EECcCcccccccccccc-ccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 99999999755332211 11234467899999999877 678999999999999999999 899998876543332221
Q ss_pred hhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 335 ~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.. . .......+++.+.+||.+||..||.+|||+.|+++|
T Consensus 255 ~~---------------------------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 EG---------------------------G---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TT---------------------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC---------------------------C---cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 10 0 011124578889999999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=354.27 Aligned_cols=249 Identities=14% Similarity=0.187 Sum_probs=204.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+. +..||||+++...........+.+|+.+|+.++||||+++++++.... ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCC
Confidence 468999999999999999999874 889999999765445556678999999999999999999999986542 246
Q ss_pred EEEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 192 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~g--IiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 899999998 59999998765 4899999999999999999999999 999999999999999999999999887532
Q ss_pred cCCCCCcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
. .....||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 164 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------- 226 (271)
T 3kmu_A 164 Q--------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE--------- 226 (271)
T ss_dssp S--------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS---------
T ss_pred c--------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc---------
Confidence 1 1335789999999998762 122334799999999999999999999887654433222110
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
... ......+++.+.+||.+||..||.+|||++++++
T Consensus 227 -----------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 227 -----------------GLR---PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -----------------CCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 0112457889999999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=363.95 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=207.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~-----~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 185 (595)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 46899999999999999999984 4577899999997532 234456789999999999 699999999998543
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcee
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKANDD----------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 248 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~~~----------------l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NIL 248 (595)
...+|+||||++ ++|.+++..... +++..+..++.||+.||.|||+.||+||||||+|||
T Consensus 104 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 104 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ---CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 235899999998 599999987654 899999999999999999999999999999999999
Q ss_pred eCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChH
Q 007629 249 ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVV 327 (595)
Q Consensus 249 l~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~ 327 (595)
++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 99999999999999986543322 222345678999999999877 679999999999999999998 99999876532
Q ss_pred HHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 328 ~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
..+..... .. ... .....+++.+.+||.+||..||.+|||+.|+++|
T Consensus 258 ~~~~~~~~----------------------~~----~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 258 EEFCRRLK----------------------EG----TRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHH----------------------HT----CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhc----------------------cC----ccC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22111100 00 000 1123468899999999999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=364.79 Aligned_cols=263 Identities=25% Similarity=0.329 Sum_probs=196.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHh--cCCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL--LRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|++.+.||+|+||+||+|.+ +|+.||||++.. .....+.+|.+++.. ++||||+++++++.... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCC
Confidence 46899999999999999999987 689999999863 234556677887777 78999999999875432 234
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCeeecCCCCCceeeCCCCcEEEccc
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH--------TANVFHRDLKPKNILANADCKLKICDF 260 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLH--------s~gIiHrDLKP~NILl~~~~~vKL~DF 260 (595)
..+|+||||++ ++|.+++. ...+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+||
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred ceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 56899999998 58999985 457999999999999999999999 999999999999999999999999999
Q ss_pred CcceeccCCCCCc-ccccccccCCcccccccccccCC----CCCCcceeechhHHHHHHHcC----------CCCCCCCC
Q 007629 261 GLARVSFNDAPSA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEMLTG----------KPLFPGKN 325 (595)
Q Consensus 261 Gla~~~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~----~~~~k~DIWSlG~il~eLltG----------~~pF~~~~ 325 (595)
|+|+......... ......+||+.|+|||++.+... .++.++|||||||++|||++| ..||.+..
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9998654333211 11234589999999999876211 345789999999999999999 88886532
Q ss_pred hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 326 ~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
... ..... ..............+........++.+.+||.+||..||.+|||+.++++
T Consensus 238 ~~~-----------~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 238 PND-----------PSFED--------MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CSS-----------CCHHH--------HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCC-----------cchhh--------hhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 100 00000 00001000111111100011124567999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=357.34 Aligned_cols=258 Identities=21% Similarity=0.248 Sum_probs=203.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|+.+++.+.|++++..+..+. .....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~ 79 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDY 79 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEE----EETTE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCcccccc----CCCCc
Confidence 5789999999999999999999999999999999864322 235789999999999988777666553 23356
Q ss_pred EEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee---CCCCcEEEcccCcceecc
Q 007629 192 IYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVSF 267 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl---~~~~~vKL~DFGla~~~~ 267 (595)
+|+||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 80 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred eEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 899999998899999974 4579999999999999999999999999999999999999 478899999999998764
Q ss_pred CCCCCc----ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 268 NDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 268 ~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...... .+
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------~~ 225 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK------------RQ 225 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS------------SS
T ss_pred ccccccccccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh------------hh
Confidence 433211 11245689999999999987 6799999999999999999999999987432110 01
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.+..+...... .+.......+++.+.+||.+||+.||.+|||+.++++
T Consensus 226 ~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 226 KYERISEKKMS-----------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHHHHH-----------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhcccccC-----------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11111110000 0001112456788999999999999999999999887
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=358.60 Aligned_cols=255 Identities=22% Similarity=0.331 Sum_probs=206.8
Q ss_pred CCCeEEee-eeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQE-VIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~-~LG~G~fG~V~~a~~~--~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
.++|.+.+ .||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----- 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-----
Confidence 35687877 9999999999999854 46788999999753 234456788999999999999999999999832
Q ss_pred cccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 189 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
..+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 82 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 34899999998 4899988644 46999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
..............||+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~--------- 229 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--------- 229 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT---------
T ss_pred ccCcceeeccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC---------
Confidence 433322222233467899999999876 578999999999999999998 99999876654333222110
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~ 405 (595)
.. ....+.+++.+.+||.+||..||.+||++.++++|.+
T Consensus 230 ------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 230 ------------------KR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ------------------CC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ------------------Cc---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 00 0112467889999999999999999999999998754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=363.66 Aligned_cols=259 Identities=20% Similarity=0.242 Sum_probs=201.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.|++++..+..+. ....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~ 78 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGD 78 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETT
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeec----CCCC
Confidence 35789999999999999999999999999999998754222 234678999999999988877776653 2335
Q ss_pred cEEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee---CCCCcEEEcccCcceec
Q 007629 191 DIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVS 266 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl---~~~~~vKL~DFGla~~~ 266 (595)
..|+||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 79 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 79 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 6899999998899999975 4579999999999999999999999999999999999999 78899999999999876
Q ss_pred cCCCCCc----ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 267 FNDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 267 ~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------------ 224 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR------------ 224 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS------------
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh------------
Confidence 4433211 11235689999999999987 67999999999999999999999999875422111
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+..+...... .+.......+++.+.+||.+||+.||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 225 QKYERISEKKMS-----------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SHHHHHHHHHHH-----------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhhccccc-----------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 111111111000 0011112356788999999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=365.62 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=205.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT-------HTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 183 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~-------~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 183 (595)
.++|++.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 468999999999999999999975 46778999998643 2334567789999999999 89999999999854
Q ss_pred CCccCcccEEEEEeccc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCc
Q 007629 184 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (595)
Q Consensus 184 ~~~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~N 246 (595)
...+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 113 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 113 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp -----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred -----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 345899999998 59999998654 38999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCC
Q 007629 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325 (595)
Q Consensus 247 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~ 325 (595)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSE-ECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccc-cccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999999865432211 11233467889999999876 578999999999999999999 999998876
Q ss_pred hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 326 ~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.......+... . . ......+++.+.+||.+||..||.+|||+.|++++
T Consensus 265 ~~~~~~~~~~~-----------------------~----~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 265 VEELFKLLKEG-----------------------H----R---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHHT-----------------------C----C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcC-----------------------C----C---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 54333222110 0 0 01124568899999999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=371.62 Aligned_cols=266 Identities=15% Similarity=0.142 Sum_probs=200.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC---CCcEEEEEEecCccCChh---------hHHHHHHHHHHHHhcCCCceeeeee
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVS---------DATRILREIKLLRLLRHPDIVEIKH 179 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~---~g~~vAIK~i~~~~~~~~---------~~~~~~~Ei~il~~l~HpnIv~l~~ 179 (595)
.++|++.+.||+|+||.||+|.+.. ++..||||++........ ....+.+|+.+++.+.||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 888999999864321111 1123567889999999999999999
Q ss_pred eecCCCccCcccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC--cEEE
Q 007629 180 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC--KLKI 257 (595)
Q Consensus 180 ~~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~--~vKL 257 (595)
++.... .....+|+|||||+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 116 ~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred cccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 986522 2346799999999889999998877899999999999999999999999999999999999999887 9999
Q ss_pred cccCcceeccCCCCC----cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCC--hHHHHH
Q 007629 258 CDFGLARVSFNDAPS----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN--VVHQLD 331 (595)
Q Consensus 258 ~DFGla~~~~~~~~~----~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~--~~~~l~ 331 (595)
+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.. ......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 999999865432211 111245689999999999887 678999999999999999999999996532 211111
Q ss_pred HHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 332 ~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.........+... .. . . ....+++.+.+||.+||..||.+||+++++++
T Consensus 273 ~~~~~~~~~~~~~---------~~----~---~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 273 AKTNLLDELPQSV---------LK----W---A------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHTTTHHH---------HH----H---S------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhhcccccHHH---------Hh----h---c------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 1111111111000 00 0 0 01256888999999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=367.73 Aligned_cols=257 Identities=21% Similarity=0.314 Sum_probs=203.7
Q ss_pred CCCeEEeeeeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAV-----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~-----~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
.++|++++.||+|+||.||+|. +..++..||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 105 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-- 105 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC--
Confidence 4689999999999999999998 5668889999998643 2334556788999999999999999999998543
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC---CcE
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKL 255 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~-------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~---~~v 255 (595)
..+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+ ..+
T Consensus 106 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 ---LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ---CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 45799999996 69999998753 48999999999999999999999999999999999999954 469
Q ss_pred EEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 007629 256 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMT 334 (595)
Q Consensus 256 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~ 334 (595)
||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+....+..+.
T Consensus 183 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp EECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EECcccccccccccccc-ccCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 99999999754332211 11234578999999999877 678999999999999999998 999998876544333222
Q ss_pred hhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 335 ~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
... . ......+++.+.+||.+||..||.+||++.++++|.|+-
T Consensus 260 ~~~--------------------------~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 260 SGG--------------------------R----MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TTC--------------------------C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC--------------------------C----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 110 0 011235678899999999999999999999999998874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=367.06 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=198.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEE----EEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERV----AIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~v----AIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
..+|++++.||+|+||.||+|.+..+++.| |+|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--- 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS---
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC---
Confidence 468999999999999999999998888765 66655432 2233567789999999999999999999998643
Q ss_pred CcccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
..++|+||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 90 ---~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 90 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp ---SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred ---CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 3788999988 6899988764 5799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
....... .......||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.........+...
T Consensus 167 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-------- 235 (327)
T 3lzb_A 167 LGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-------- 235 (327)
T ss_dssp --------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--------
T ss_pred ccCcccc-ccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--------
Confidence 5433221 12234567889999999987 689999999999999999999 99999887654433222111
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
... ...+.+++.+.+||.+||..||.+||++.|+++
T Consensus 236 -------------------~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 236 -------------------ERL---PQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -------------------CCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 000 112346788999999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=361.02 Aligned_cols=245 Identities=18% Similarity=0.283 Sum_probs=198.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCC-------cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG-------ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 184 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g-------~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 184 (595)
.++|++.+.||+|+||.||+|.+..++ ..||+|++... .......+.+|+.+|+.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 468999999999999999999998877 47999998643 234457789999999999999999999998543
Q ss_pred CccCcccEEEEEeccc-ccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc--------
Q 007629 185 SRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-------- 254 (595)
Q Consensus 185 ~~~~~~~lylV~E~~~-g~L~~~i~~~~~-l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~-------- 254 (595)
...|+||||++ ++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 85 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 85 -----DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp -----TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred -----CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 45799999998 699999987654 999999999999999999999999999999999999998887
Q ss_pred EEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcC-CCCCCCCChHHHHHHH
Q 007629 255 LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLM 333 (595)
Q Consensus 255 vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i 333 (595)
+||+|||++..... .....||+.|+|||++.+. ..++.++|||||||++|||++| .+||...+........
T Consensus 160 ~kl~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 160 IKLSDPGISITVLP-------KDILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp EEECCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred eeeccCcccccccC-------ccccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 99999999864321 1335689999999998752 4689999999999999999995 4566554432222111
Q ss_pred HhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 334 TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 334 ~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.. ... .....++.+.+||.+||+.||.+|||+.++++|
T Consensus 232 ~~-------------------------~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 232 ED-------------------------RHQ-------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HT-------------------------TCC-------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hc-------------------------cCC-------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 10 000 112235568999999999999999999999984
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=364.07 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=205.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCc-----EEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGE-----RVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~-----~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 185 (595)
.++|++.+.||+|+||.||+|.+..++. .||||++... ........+.+|+.+|+.+ +||||+++++++...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHENIVNLLGACTHG- 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc-cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC-
Confidence 4689999999999999999999877664 7999998653 2334567789999999999 899999999998543
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKAN--------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~--------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~ 250 (595)
..+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 123 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 123 ----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred ----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 45899999998 5999988653 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHH
Q 007629 251 ADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQ 329 (595)
Q Consensus 251 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 329 (595)
.++.+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+......
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred CCCeEEECccccccccccccce-eecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 9999999999999865443321 12234567889999999877 679999999999999999998 9999987654332
Q ss_pred HHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 330 l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
+..+... ... . ......++.+.+||.+||..||.+|||+.|+++
T Consensus 276 ~~~~~~~----------------------~~~----~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 276 FYKLVKD----------------------GYQ----M---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHH----------------------TCC----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhc----------------------CCC----C---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 2211110 000 0 011345788999999999999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=355.88 Aligned_cols=251 Identities=23% Similarity=0.381 Sum_probs=201.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC---CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~---~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
.++|++.+.||+|+||.||+|.+.. ++..||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 85 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---- 85 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS----
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC----
Confidence 4689999999999999999998653 3456999998653 2334567789999999999999999999997432
Q ss_pred cccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 189 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
..|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 86 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 86 --PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred --CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 3699999998 6899998765 45999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||...........+...
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~--------- 230 (281)
T 3cc6_A 164 EDEDYY--KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG--------- 230 (281)
T ss_dssp -----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT---------
T ss_pred cccccc--ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC---------
Confidence 432211 1233467889999999876 678999999999999999998 99999876544333222111
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
...+ ....+++.+.+||.+||..||.+|||+.|++++
T Consensus 231 ----------------~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 231 ----------------DRLP-----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ----------------CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCC-----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 0011 123467889999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=352.49 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=204.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+. ++..||||++..... ..+.+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 77 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----AP 77 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SS
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CC
Confidence 468999999999999999999986 678899999975322 245788999999999999999999998543 45
Q ss_pred EEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 899999997 5899998765 46899999999999999999999999999999999999999999999999999754321
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
. ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+...
T Consensus 158 ~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~------------ 221 (267)
T 3t9t_A 158 Q--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG------------ 221 (267)
T ss_dssp H--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT------------
T ss_pred c--ccccccccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC------------
Confidence 1 111233467889999999876 678999999999999999999 89999887654433322211
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.. . ......++.+.+||.+||..||.+|||+.+++++
T Consensus 222 -----------~~----~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 222 -----------FR----L---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp -----------CC----C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------Cc----C---CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 0 0112457889999999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=370.49 Aligned_cols=267 Identities=23% Similarity=0.324 Sum_probs=204.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+ .+|..||||++... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 109 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNE 109 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-----TTC
T ss_pred HhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCe
Confidence 46899999999999999999986 47899999988643 23456778999999999999999999999843 346
Q ss_pred EEEEEeccc-ccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 192 IYVVFELME-SDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~----~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 899999998 58988886543 5899999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+..
T Consensus 190 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~----------- 255 (321)
T 2qkw_B 190 TELDQT-HLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW----------- 255 (321)
T ss_dssp SSSSCC-CCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH-----------
T ss_pred cccccc-ccccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH-----------
Confidence 332221 11244579999999999877 6799999999999999999999999976543211110000
Q ss_pred HHhhHHHHHHhhhcccC-CCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCC
Q 007629 347 RIRNEKARRYLGSMRKK-QPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp 404 (595)
... ......+... .+.......+..+..+.+|+.+||..||.+|||+.|+++|.
T Consensus 256 --~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 256 --AVE--SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp --THH--HHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --hhh--ccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 000 0000000000 00001111223456789999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=366.88 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=201.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEE--EEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERV--AIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~v--AIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 188 (595)
.++|++.+.||+|+||.||+|++..+|..+ |||.++.. ........+.+|+.+|+.+ +||||+++++++. .
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~ 97 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----H 97 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----E
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeee-----e
Confidence 368999999999999999999998888865 99988642 2233456788999999999 8999999999984 3
Q ss_pred cccEEEEEeccc-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC
Q 007629 189 FKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 251 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~ 251 (595)
...+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 456999999997 59999997654 6999999999999999999999999999999999999999
Q ss_pred CCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHH
Q 007629 252 DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQL 330 (595)
Q Consensus 252 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l 330 (595)
++.+||+|||+++....... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.....
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp GGCEEECCTTCEESSCEECC----C----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCeEEEcccCcCcccccccc----ccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 99999999999974322111 133467889999999876 578999999999999999998 99999887654332
Q ss_pred HHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 331 DLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 331 ~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
..+.. .... .....+++.+.+||.+||..||.+|||+++++++
T Consensus 252 ~~~~~---------------------------~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 252 EKLPQ---------------------------GYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHGGG---------------------------TCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhc---------------------------CCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22211 0000 1123568899999999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=355.50 Aligned_cols=248 Identities=28% Similarity=0.384 Sum_probs=203.8
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC-------
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS------- 185 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------- 185 (595)
.+|++.+.||+|+||.||+|.+..+|+.||||+++... ..+.+|+.+++.++||||+++++++....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 47999999999999999999999999999999986421 24568999999999999999999874311
Q ss_pred ----ccCcccEEEEEecccc-cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEc
Q 007629 186 ----RREFKDIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258 (595)
Q Consensus 186 ----~~~~~~lylV~E~~~g-~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~ 258 (595)
......+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 1223568999999995 999999754 579999999999999999999999999999999999999999999999
Q ss_pred ccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcC
Q 007629 259 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLG 338 (595)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg 338 (595)
|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ..
T Consensus 165 Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~------ 227 (284)
T 2a19_B 165 DFGLVTSLKNDGK----RTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETS-----KF------ 227 (284)
T ss_dssp CCTTCEESSCCSC----CCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----HH------
T ss_pred cchhheecccccc----ccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHH-----HH------
Confidence 9999987644322 234579999999999877 678999999999999999999998873211 00
Q ss_pred CCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 339 TPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 339 ~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
.. . .... .....+++.+.+||.+||..||.+|||+.|+++|+|.-
T Consensus 228 ------~~--------~----~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 228 ------FT--------D----LRDG------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp ------HH--------H----HHTT------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HH--------H----hhcc------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 0 0000 01134678899999999999999999999999998864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=355.24 Aligned_cols=254 Identities=23% Similarity=0.370 Sum_probs=201.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~---g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
..+|++.+.||+|+||.||+|.+..+ +..||+|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 98 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---- 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----
Confidence 34799999999999999999987543 346899998752 3344567789999999999999999999987543
Q ss_pred cccEEEEEecccc-cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 189 FKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~g-~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
....|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 2457999999985 999999764 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCC-CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 267 FNDAP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 267 ~~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
..... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~-------- 248 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-------- 248 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT--------
T ss_pred cccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC--------
Confidence 33221 1112244578899999999877 679999999999999999999 66788776543332222110
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.. . .....+++.+.+||.+||..||.+|||+.|+++
T Consensus 249 ------------------~~-~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 249 ------------------RR-L---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ------------------CC-C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CC-C---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 0 011346788999999999999999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=386.48 Aligned_cols=249 Identities=21% Similarity=0.420 Sum_probs=207.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|++.+.||+|+||.||+|.+..++..||||+++... .....+.+|+.+|+.++||||+++++++... ..
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 290 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PP 290 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecC-----Cc
Confidence 467999999999999999999999899999999996432 2456789999999999999999999998543 45
Q ss_pred EEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+|||||||. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 899999998 6999999864 3589999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+.......+...
T Consensus 371 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----------- 435 (495)
T 1opk_A 371 DTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD----------- 435 (495)
T ss_dssp CCE--ECCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-----------
T ss_pred Cce--eecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 221 11233456788999999876 678999999999999999999 99999887654333222110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.+ . .....+++.+.+||.+||..||.+|||+.++++
T Consensus 436 ------------~~----~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 436 ------------YR----M---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ------------CC----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CC----C---CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 00 0 112356889999999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=362.92 Aligned_cols=261 Identities=24% Similarity=0.407 Sum_probs=202.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+++.++||||+++++++.... .....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCce
Confidence 4689999999999999999999999999999999854 23455677899999999999999999999985321 23356
Q ss_pred EEEEEecccc-cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 192 IYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 192 lylV~E~~~g-~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
+|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 8999999985 89988875 467999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCc------ccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCC
Q 007629 267 FNDAPSA------IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339 (595)
Q Consensus 267 ~~~~~~~------~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~ 339 (595)
....... .......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||...... +
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------~- 253 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK----------G- 253 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT----------T-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc----------c-
Confidence 2211110 011234689999999998652 123788999999999999999999999431100 0
Q ss_pred CChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 340 p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.... .... ..... ...+.+++.+.+||.+||..||.+|||+.+++++
T Consensus 254 --~~~~---------~~~~---~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 254 --DSVA---------LAVQ---NQLSI---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp --SCHH---------HHHH---CC--C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --chhh---------HHhh---ccCCC---CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 0000 0000 00001 1124578899999999999999999999999995
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=370.25 Aligned_cols=261 Identities=12% Similarity=0.164 Sum_probs=200.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC--------CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHT--------GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP 183 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~--------g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 183 (595)
.++|++.+.||+|+||.||+|++..+ ++.||||++... ..+.+|+.+++.++||||+++++.+..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 46899999999999999999999874 889999998642 357789999999999999985433211
Q ss_pred C-----------CccCcccEEEEEecccccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC
Q 007629 184 P-----------SRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 250 (595)
Q Consensus 184 ~-----------~~~~~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~ 250 (595)
. .......+|+||||++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 0 00124568999999988999999876 6899999999999999999999999999999999999999
Q ss_pred CCC--cEEEcccCcceeccCCCCC----cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCC
Q 007629 251 ADC--KLKICDFGLARVSFNDAPS----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK 324 (595)
Q Consensus 251 ~~~--~vKL~DFGla~~~~~~~~~----~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~ 324 (595)
.++ .+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 998 8999999999765432211 111234589999999999987 67999999999999999999999999865
Q ss_pred C-hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 325 N-VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 325 ~-~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
. ....+.... ..+.... .........+..+++.+.+||.+||..||.+|||++++++
T Consensus 272 ~~~~~~~~~~~-------------------~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQK-------------------QKFVDKP--GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHH-------------------HHHHHSC--CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHH-------------------HhccCCh--hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 3 111111110 0000000 0000111123457899999999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=355.83 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=193.6
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
..++|++.+.||+|+||.||+|.+..+|..||||++... .........+.+|+.+|+.++||||+++++++.. .
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~ 104 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----D 104 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----C
Confidence 346899999999999999999999999999999999642 2234456778899999999999999999999853 3
Q ss_pred ccEEEEEecccc-cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 190 KDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 190 ~~lylV~E~~~g-~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
..+|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 468999999985 89888864 4569999999999999999999999999999999999999999999999999997
Q ss_pred eccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....
T Consensus 185 ~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~----------- 247 (310)
T 2wqm_A 185 FFSSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLC----------- 247 (310)
T ss_dssp -----------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHH-----------
T ss_pred eecCCCc---cccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHH-----------
Confidence 6533221 1234579999999999877 678999999999999999999999997643110 0000
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
. .+... ..+ ......+++.+.+||.+||..||.+|||+.++++
T Consensus 248 -~---------~~~~~--~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 248 -K---------KIEQC--DYP---PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp -H---------HHHTT--CSC---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -H---------Hhhcc--cCC---CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 00000 000 0112456889999999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=353.00 Aligned_cols=253 Identities=26% Similarity=0.381 Sum_probs=201.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCc---EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~---~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
-.|.+.+.||+|+||+||+|.+..++. .||+|++... ......+.+.+|+.+|+.++||||+++++++....
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 95 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE---- 95 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----
Confidence 367888999999999999998765544 7999998652 33345678899999999999999999999986432
Q ss_pred ccEEEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 190 KDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
...|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 23589999996 699999976 3578999999999999999999999999999999999999999999999999997543
Q ss_pred CCCC-CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcC-CCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 268 NDAP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 268 ~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
.... .........+|+.|+|||++.+ ..++.++|||||||++|+|++| .+||.+.+.......+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-------- 245 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-------- 245 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC--------
T ss_pred CCcccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC--------
Confidence 2211 1111234578899999999977 6789999999999999999995 56666555433322221110
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.. .....+++.+.+||.+||..||.+|||+.++++
T Consensus 246 -------------------~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 246 -------------------RL---PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp -------------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CC---CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00 112346788999999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=350.93 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=202.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||.||+|.+. ++..||||+++... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcC------CC
Confidence 368999999999999999999875 56789999986432 235678899999999999999999998742 24
Q ss_pred EEEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 799999997 69999886543 699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+....+..+...
T Consensus 162 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~----------- 226 (279)
T 1qpc_A 162 NEY--TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG----------- 226 (279)
T ss_dssp SCE--ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------
T ss_pred ccc--ccccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-----------
Confidence 221 11234467889999999876 578999999999999999999 99999887654433322110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
. .. .....+++.+.+||.+||..||.+|||+.++++
T Consensus 227 ------------~----~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 227 ------------Y----RM---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ------------C----CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------c----CC---CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 00 112356789999999999999999999999886
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=376.11 Aligned_cols=243 Identities=23% Similarity=0.400 Sum_probs=200.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|... |..||||+++.. ...+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~ 261 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GG 261 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----Cc
Confidence 468999999999999999999874 789999999743 24567889999999999999999999975432 35
Q ss_pred EEEEEeccc-ccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~--l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+|||||||+ ++|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 899999998 599999987653 79999999999999999999999999999999999999999999999999985422
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.. ....+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+...
T Consensus 342 ~~------~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~----------- 402 (450)
T 1k9a_A 342 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----------- 402 (450)
T ss_dssp -----------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-----------
T ss_pred cc------cCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 11 22367889999999977 689999999999999999998 99999876543332222110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
. .. .....+++.+.+||.+||..||.+|||+.++++
T Consensus 403 ------------~--~~-----~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 403 ------------Y--KM-----DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ------------C--CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------C--CC-----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 00 112357889999999999999999999999876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=393.29 Aligned_cols=250 Identities=21% Similarity=0.317 Sum_probs=201.6
Q ss_pred eEEe-eeeeecCceEEEEEEE--CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 115 YQIQ-EVIGKGSYGVVGSAVD--THTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 115 Y~i~-~~LG~G~fG~V~~a~~--~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
+.+. +.||+|+||+||+|.+ ..+++.||||+++...........+.+|+.+|+.++|||||++++++.. ..
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~ 443 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ES 443 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SS
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CC
Confidence 4443 4899999999999954 5677899999997655555556789999999999999999999998832 24
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+|||||. ++|.+++.....+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 799999998 6899999988899999999999999999999999999999999999999999999999999998664433
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
......+...+|+.|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+.......+....
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~------------ 589 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE------------ 589 (635)
T ss_dssp -----------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------
T ss_pred cccccccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------
Confidence 22222334467889999999977 689999999999999999998 999999877654443332210
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.. .....+++.+.+||.+||..||.+||+++++++
T Consensus 590 -------------~~-----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 590 -------------RM-----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -------------CC-----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------CC-----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 00 112356889999999999999999999999876
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=380.70 Aligned_cols=254 Identities=18% Similarity=0.178 Sum_probs=194.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCC-Cceeeeee-----------
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRH-PDIVEIKH----------- 179 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~----------- 179 (595)
..|.+.+.||+|+||+||+|.+..+|+.||||+++... ......+.+.+|+.+++.+.| +++..+..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 34899999999999999999999999999999987322 222335678899999999987 32211111
Q ss_pred ----------eecCCCccCcccEEEEEecccccHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCC
Q 007629 180 ----------IMLPPSRREFKDIYVVFELMESDLHQVIKA-------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL 242 (595)
Q Consensus 180 ----------~~~~~~~~~~~~lylV~E~~~g~L~~~i~~-------~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDL 242 (595)
++..........++++|+++.++|.+++.. ...+++..+..++.||+.||+|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 111111111345789999999999988852 234778889999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccc--------cCCCCCCcceeechhHHHHHH
Q 007629 243 KPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWSIGCIFAEM 314 (595)
Q Consensus 243 KP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~~~~~k~DIWSlG~il~eL 314 (595)
||+|||++.++.+||+|||+++..... ....+| +.|+|||++.+ ....|+.++|||||||++|||
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 999999999999999999999864322 345678 99999999831 114588899999999999999
Q ss_pred HcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCC
Q 007629 315 LTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR 394 (595)
Q Consensus 315 ltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~R 394 (595)
++|+.||.+.+...... ........+++.+.+||.+||..||.+|
T Consensus 311 ltg~~Pf~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSE-----------------------------------WIFRSCKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp HHSSCCCCTTGGGSCSG-----------------------------------GGGSSCCCCCHHHHHHHHHHTCSSGGGS
T ss_pred HHCCCCCCCcchhhhHH-----------------------------------HHHhhcccCCHHHHHHHHHHccCChhhC
Confidence 99999997754211100 0011223567899999999999999999
Q ss_pred CCHHHHhcCCCccC
Q 007629 395 PTAEEALADPYFHG 408 (595)
Q Consensus 395 pta~elL~Hp~f~~ 408 (595)
|++.++|+||||+.
T Consensus 356 pt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 356 LLPLQAMETPEYEQ 369 (413)
T ss_dssp CCHHHHTTSHHHHH
T ss_pred cCHHHHHhCHHHHH
Confidence 99999999999964
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=379.01 Aligned_cols=247 Identities=25% Similarity=0.406 Sum_probs=203.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+. .+..||||+++... ...+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~ 256 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP 256 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC------Cc
Confidence 468999999999999999999885 47789999997432 346778999999999999999999999842 34
Q ss_pred EEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+|+|||||. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 799999997 6999999754 3689999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
... .......+|+.|+|||++.. ..++.++|||||||++|||++ |+.||.+.+..+.+..+....
T Consensus 337 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------- 402 (454)
T 1qcf_A 337 NEY--TAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---------- 402 (454)
T ss_dssp HHH--HTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC----------
T ss_pred Cce--eccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 111 11123456788999999876 679999999999999999999 999999877554443332110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+ ....+++.+.+||.+||..||.+|||++++++
T Consensus 403 ---------------~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 403 ---------------RMP-----RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ---------------CCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCC-----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 011 11356789999999999999999999999876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=365.95 Aligned_cols=270 Identities=21% Similarity=0.329 Sum_probs=203.3
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..++|++.+.||+|+||.||+|.+ .+|+.||||++...... .....+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 100 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----T 100 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-----S
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC-----C
Confidence 356899999999999999999975 46899999998643221 1223578999999999999999999998543 4
Q ss_pred cEEEEEeccc-ccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCCCceeeCCCCcEEEcccCc
Q 007629 191 DIYVVFELME-SDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTA---NVFHRDLKPKNILANADCKLKICDFGL 262 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~----~l~~~~~~~i~~qil~aL~yLHs~---gIiHrDLKP~NILl~~~~~vKL~DFGl 262 (595)
..|+|||||. ++|.+++.... .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 180 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence 5799999998 58999997643 499999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCC-----hHHHHHHHHhhc
Q 007629 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN-----VVHQLDLMTDLL 337 (595)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~-----~~~~l~~i~~~l 337 (595)
++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......+...+
T Consensus 181 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 181 AKLMDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CEECCSSSS--CEECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred ccccCcccc--cccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 986543322 12345679999999999876 578999999999999999999999995211 000111111000
Q ss_pred CCCChhHHHHHhhHHHHHHhhhcccCCCCCC-CCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPF-SHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 338 g~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.... +........ .......++.+.+|+.+||..||.+|||+.|+++|-+-..+
T Consensus 257 ~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 257 KEKK------------------LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp SSCC------------------STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hchh------------------hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 0000 000000000 01112234678999999999999999999999998764433
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=354.80 Aligned_cols=254 Identities=22% Similarity=0.358 Sum_probs=196.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-CCc--EEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTH-TGE--RVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~-~g~--~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
.++|++.+.||+|+||.||+|.+.. ++. .||||+++... ........+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 4689999999999999999998643 333 68999886432 2234567889999999999999999999998543
Q ss_pred CcccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
.+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 94 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 94 ---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ---CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 2799999998 6899888764 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+....+..+...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-------- 240 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-------- 240 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS--------
T ss_pred ccccccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc--------
Confidence 6443332222334568889999999876 578899999999999999999 99999887754433322111
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.... .....+++.+.+||.+||..||.+|||+.++++
T Consensus 241 ------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 241 ------------------GERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp ------------------CCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCC---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0000 112457889999999999999999999999998
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=353.53 Aligned_cols=242 Identities=26% Similarity=0.422 Sum_probs=189.2
Q ss_pred CCCeEEe-eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHH-HhcCCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQ-EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL-RLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~-~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|.+. +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++ +.+.||||+++++++.... ...
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCC
Confidence 3568887 789999999999999999999999999853 23567899888 6678999999999884311 224
Q ss_pred ccEEEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC---CCcEEEcccCcc
Q 007629 190 KDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLA 263 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~---~~~vKL~DFGla 263 (595)
..+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 56899999998 59999998764 6999999999999999999999999999999999999998 788999999998
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
.... + ..|+.++|||||||++|||++|+.||.+.........+.
T Consensus 168 ~~~~-------------------------~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~--------- 211 (299)
T 3m2w_A 168 KETT-------------------------G--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------- 211 (299)
T ss_dssp EECT-------------------------T--CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC---------
T ss_pred cccc-------------------------c--ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH---------
Confidence 6421 1 346779999999999999999999997654321110000
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
..............+..+++.+.+||.+||..||.+|||+.|+|+||||++...
T Consensus 212 --------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 212 --------------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp --------------CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred --------------HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 000000000000112457889999999999999999999999999999986543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=374.70 Aligned_cols=274 Identities=22% Similarity=0.369 Sum_probs=205.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+..+|+.||||+++.... ......+.+|+.+|+.++||||+++++++.... ...
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~ 83 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRH 83 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCe
Confidence 4689999999999999999999999999999999964321 233566789999999999999999999985432 246
Q ss_pred EEEEEeccc-ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee----CCCCcEEEcccCcc
Q 007629 192 IYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGLA 263 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl----~~~~~vKL~DFGla 263 (595)
+|+|||||. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999997 68999987543 39999999999999999999999999999999999999 78888999999999
Q ss_pred eeccCCCCCcccccccccCCccccccccccc------CCCCCCcceeechhHHHHHHHcCCCCCCCCCh-HHHHHHHHhh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV-VHQLDLMTDL 336 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~------~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~ 336 (595)
+...... .....+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+... ....+.+...
T Consensus 164 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 164 RELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp EECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred eEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 8653322 12456899999999987531 03577899999999999999999999975332 1111222222
Q ss_pred cCCCChhHHHHHhhHHHHHHhhhcccCCCCCCC-------CCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFS-------HKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 337 lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~-------~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
+...+...+..+.. ....+..|. .....+++.+.+||.+||.+||++||++.+++++
T Consensus 240 ~~~~p~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 240 ITGKPSGAISGVQK----------AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHSCCTTCCEEEEC----------STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred hcCCCcccchhhee----------ccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 21111111100000 000001111 1112345678899999999999999999998653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=350.64 Aligned_cols=243 Identities=22% Similarity=0.386 Sum_probs=194.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+ +|..||||+++.. ...+.+.+|+.+++.++||||+++++++... ...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~ 89 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 89 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCc
Confidence 46899999999999999999987 4889999998642 2456788999999999999999999987543 235
Q ss_pred EEEEEecccc-cHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~g-~L~~~i~~~~~--l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+|+||||+++ +|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999985 99999976543 89999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.. ....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 170 ~~------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~------------ 229 (278)
T 1byg_A 170 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 229 (278)
T ss_dssp ------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT------------
T ss_pred cc------cCCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------------
Confidence 21 23467899999999877 678999999999999999998 9999987654332222211
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 230 ---------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 230 ---------------GYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCC---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 000 1112457889999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=364.06 Aligned_cols=279 Identities=22% Similarity=0.268 Sum_probs=197.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHH--HHhcCCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKL--LRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|++++.||+|+||.||+|.+ +++.||||++... ....+..|..+ +..++||||+++++.+........
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 46899999999999999999976 6899999998632 22333444444 556899999999976543333444
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CeeecCCCCCceeeCCCCcEEEcc
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---------NVFHRDLKPKNILANADCKLKICD 259 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~---------gIiHrDLKP~NILl~~~~~vKL~D 259 (595)
..+|+|||||+ ++|.+++... .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred ceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 56899999997 5999999765 468999999999999999999999 999999999999999999999999
Q ss_pred cCcceeccCCCC-----CcccccccccCCcccccccccccC-----CCCCCcceeechhHHHHHHHcCCCC-CCCCChHH
Q 007629 260 FGLARVSFNDAP-----SAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEMLTGKPL-FPGKNVVH 328 (595)
Q Consensus 260 FGla~~~~~~~~-----~~~~~~~~~gT~~Y~APE~l~~~~-----~~~~~k~DIWSlG~il~eLltG~~p-F~~~~~~~ 328 (595)
||+++....... ........+||+.|+|||++.+.. ..++.++|||||||++|||++|..| |++.....
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999986543221 111223567999999999986521 2456789999999999999999654 44433211
Q ss_pred HHHHH-HhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCC---CCCHHHHHHHHhhCcCCCCCCCCHHHHh---
Q 007629 329 QLDLM-TDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFP---NADPLALHLLERLLAFDPKDRPTAEEAL--- 401 (595)
Q Consensus 329 ~l~~i-~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~---~~~~~~~dLl~~~L~~DP~~Rpta~elL--- 401 (595)
....+ ......+..+.+.. ..... .....+...++ .+++.+.+||.+||..||.+|||+.|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQV--------LVSRE--KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHH--------HHTTS--CCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHh--------hhccc--ccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 11111 11122222222111 11111 11112222222 2456799999999999999999999994
Q ss_pred ---cCCCccC
Q 007629 402 ---ADPYFHG 408 (595)
Q Consensus 402 ---~Hp~f~~ 408 (595)
-++|-++
T Consensus 314 ~~ll~~~~~~ 323 (336)
T 3g2f_A 314 AELMMIWERN 323 (336)
T ss_dssp HHHHHCCCC-
T ss_pred HHHHHHHHhc
Confidence 4666654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=353.88 Aligned_cols=243 Identities=30% Similarity=0.437 Sum_probs=192.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+. ++.||||++.. ....+.+.+|+.+|+.++||||+++++++.. .
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~ 73 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN-------P 73 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------T
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------C
Confidence 457999999999999999999874 78999999853 2345678999999999999999999998752 2
Q ss_pred EEEEEeccc-ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCCCceeeCCCCc-EEEcccCcc
Q 007629 192 IYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHT---ANVFHRDLKPKNILANADCK-LKICDFGLA 263 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~qil~aL~yLHs---~gIiHrDLKP~NILl~~~~~-vKL~DFGla 263 (595)
+|+||||++ ++|.+++.... .+++..+..++.||++||.|||+ +||+||||||+|||++.++. +||+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence 699999997 59999998665 37889999999999999999999 89999999999999998887 799999999
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.
T Consensus 154 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~--------- 215 (307)
T 2eva_A 154 CDIQTH------MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RIMW--------- 215 (307)
T ss_dssp -----------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HHHH---------
T ss_pred cccccc------cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HHHH---------
Confidence 754322 234579999999999987 6899999999999999999999999975432110 0000
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
. ...... ......+++.+.+||.+||..||.+|||+++++++
T Consensus 216 ---~------------~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 216 ---A------------VHNGTR---PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp ---H------------HHTTCC---CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---H------------HhcCCC---CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0 000000 11234578899999999999999999999999883
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=359.65 Aligned_cols=266 Identities=23% Similarity=0.342 Sum_probs=203.0
Q ss_pred eEEeeeeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 115 YQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~----~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
|++++.||+|+||+||+|. +..+++.||||+++.. ........+.+|+.+|+.++||||+++++++... ...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 108 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAA 108 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTT
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCc
Confidence 4999999999999998774 4458899999999753 2334567789999999999999999999998543 235
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||++ ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 6899999998 5899988654 5999999999999999999999999999999999999999999999999999876443
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+...... .
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~-~--- 256 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQM-T--- 256 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHHH-H---
T ss_pred ccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccch-h---
Confidence 322222344578899999999877 57889999999999999999999999653211 111111111111 0
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.......+ ...... .....+++.+.+||.+||..||.+|||+.|+++
T Consensus 257 ~~~~~~~~---~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 257 VLRLTELL---ERGERL---PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHH---HTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHH---hcccCC---CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01111111 111111 122457889999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=355.39 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=201.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc--CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
...|...+.||+|+||.||+|.+ ++..||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 30 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 102 (307)
T 2nru_A 30 RPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG----- 102 (307)
T ss_dssp SBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----
T ss_pred ccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC-----
Confidence 34566679999999999999975 68899999986432 2233467788999999999999999999998543
Q ss_pred ccEEEEEeccc-ccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 190 KDIYVVFELME-SDLHQVIKA---NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~---~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
..+|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 182 (307)
T 2nru_A 103 DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA 182 (307)
T ss_dssp SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccc
Confidence 45899999997 689998874 34699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...... ........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+..+...+.....
T Consensus 183 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 255 (307)
T 2nru_A 183 SEKFAQ-TVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK--- 255 (307)
T ss_dssp CCSCSS-CEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC---
T ss_pred cccccc-cccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh---
Confidence 543222 112234679999999999865 5789999999999999999999999875532221111111000000
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
....++. . .........+..+.+||.+||..||.+|||+.+++++
T Consensus 256 ------~~~~~~~---~----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 256 ------TIEDYID---K----KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp ------CHHHHSC---S----SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------hhhhhcc---c----cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0000100 0 0111112234668999999999999999999999873
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=365.55 Aligned_cols=245 Identities=15% Similarity=0.181 Sum_probs=194.5
Q ss_pred CCCeEEeeeeeecCceEEEEE-----EECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC---CCceeeeeeeecC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSA-----VDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR---HPDIVEIKHIMLP 183 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a-----~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~ 183 (595)
..+|.+.+.||+|+||+||+| .+..+++.||||+++.. ....+.+|+.+++.+. |+||+.+++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 468999999999999999999 46778999999998642 3456778888888887 9999999999854
Q ss_pred CCccCcccEEEEEeccc-ccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC------
Q 007629 184 PSRREFKDIYVVFELME-SDLHQVIKA-----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA------ 251 (595)
Q Consensus 184 ~~~~~~~~lylV~E~~~-g~L~~~i~~-----~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~------ 251 (595)
. ...|||||||+ ++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 139 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 139 Q-----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp S-----SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred C-----CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 3 45899999998 699999974 457999999999999999999999999999999999999998
Q ss_pred -----CCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCCh
Q 007629 252 -----DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV 326 (595)
Q Consensus 252 -----~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~ 326 (595)
++.+||+|||+|+....... ....+..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.....
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999976543222 223456789999999999987 6799999999999999999999999964321
Q ss_pred HHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCC
Q 007629 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (595)
Q Consensus 327 ~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp 404 (595)
.. .... ..+.. . ..++.+.+|+.+||..+|.+|++..+.|.+.
T Consensus 291 ~~-----------------------------~~~~----~~~~~-~-~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 291 GE-----------------------------CKPE----GLFRR-L-PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp TE-----------------------------EEEC----SCCTT-C-SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred Cc-----------------------------eeec----hhccc-c-CcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 00 0000 00000 0 2356788999999999999997655555443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=368.10 Aligned_cols=254 Identities=22% Similarity=0.357 Sum_probs=193.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~---g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
.+|++.+.||+|+||.||+|.+..+ +..||||.++.. ........+.+|+.+|+.++||||+++++++... .
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----S
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----C
Confidence 4689999999999999999987543 346899998643 3345567899999999999999999999987543 2
Q ss_pred ccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 190 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
...|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 35799999998 5999999765 358899999999999999999999999999999999999999999999999998653
Q ss_pred CCCCC-cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 268 NDAPS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 268 ~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
..... ........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~--------- 312 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--------- 312 (373)
T ss_dssp --------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT---------
T ss_pred ccccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC---------
Confidence 32211 111234568889999999877 689999999999999999999 78889876543322221110
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
..+ .....+++.+.+||.+||..||.+|||+.|++++
T Consensus 313 -----------------~~~----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 313 -----------------RRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -----------------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 0113467889999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=374.12 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=198.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cc
Confidence 4679999999999999999999864 4679999987432 234678999999999999999999999843 34
Q ss_pred EEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+|||||||. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 799999998 5999998643 4699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+....+.+..+....
T Consensus 333 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------- 398 (452)
T 1fmk_A 333 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------- 398 (452)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred Ccee--cccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 2211 1233457889999999876 689999999999999999999 999998877544433322110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+ ..+.+++.+.+||.+||..||.+|||++++++
T Consensus 399 ---------------~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 399 ---------------RMP-----CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp ---------------CCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCC-----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 011 11356788999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=375.60 Aligned_cols=258 Identities=19% Similarity=0.255 Sum_probs=201.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.|.|++++..+..+. .....
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~ 77 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFG----VEGDY 77 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEE----EETTE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCE
Confidence 46899999999999999999999999999999988643222 34678999999998755444443332 23456
Q ss_pred EEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceee---CCCCcEEEcccCcceecc
Q 007629 192 IYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVSF 267 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl---~~~~~vKL~DFGla~~~~ 267 (595)
.||||||++++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++...
T Consensus 78 ~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 78 NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 899999998899999975 4679999999999999999999999999999999999999 588999999999998765
Q ss_pred CCCCCc----ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 268 NDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 268 ~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
...... ......+||+.|+|||++.+ ..++.++||||||||||||++|+.||.+.........+..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-------- 227 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK-------- 227 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH--------
T ss_pred CCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH--------
Confidence 433211 11235689999999999987 6799999999999999999999999987553222222111
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
+........+.. ....+++.+.+||.+||..||.+||++.+|++
T Consensus 228 ----i~~~~~~~~~~~-----------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 228 ----ISEKKVATSIEA-----------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp ----HHHHHHHSCHHH-----------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ----HhhccccccHHH-----------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111111111111 11345788999999999999999999998765
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=352.99 Aligned_cols=270 Identities=22% Similarity=0.365 Sum_probs=207.3
Q ss_pred CCCeEEeeeeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAV----DTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~----~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
..+|++++.||+|+||.||+|. +..+|+.||||++... .......+.+|+.+|+.++||||+++++++....
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 115 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG-- 115 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC--
Confidence 4579999999999999999998 4678999999999752 3345677899999999999999999999986532
Q ss_pred CcccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
...+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 116 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 116 -RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred -CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 235899999998 5999999876 4699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...............+|..|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+.......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDKQGQM 267 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHHCTTCCTHH
T ss_pred ccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhhccccchhh
Confidence 6443322111233467888999999877 578899999999999999999999885421 111222222221111
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.. ......+ ......+ ....+++.+.+||.+||..||.+|||+.|+++
T Consensus 268 ~~---~~~~~~~---~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 268 IV---FHLIELL---KNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HH---HHHHHHH---HTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hH---HHHHHHh---hcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 0111111 1111111 12457889999999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=383.41 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=198.6
Q ss_pred CCCeEEee-eeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQE-VIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~-~LG~G~fG~V~~a~~~--~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
..+|.+.+ .||+|+||.||+|.++ .++..||||+++.. ........+.+|+.+|+.++|||||++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----- 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----- 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----
Confidence 34566666 8999999999999775 35667999999754 223456789999999999999999999999843
Q ss_pred cccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 189 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
..+|||||||. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 34899999998 5899988654 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
..............+|+.|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+.+..+...
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~--------- 555 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--------- 555 (613)
T ss_dssp C--------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT---------
T ss_pred cCCCceeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------
Confidence 433221111223356789999999976 689999999999999999998 99999987754443333211
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
... ...+.+++.+.+||.+||..||.+||++.++++
T Consensus 556 ----------------~~~-----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 556 ----------------KRM-----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ----------------CCC-----CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ----------------CCC-----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 000 112357889999999999999999999998753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=355.86 Aligned_cols=262 Identities=26% Similarity=0.339 Sum_probs=191.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHh--cCCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL--LRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|++.+.||+|+||.||+|.+. |+.||||++.. .......+|..++.. ++||||+++++++.... ...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFT-----TEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEG-----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEec-----cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCC
Confidence 357999999999999999999875 89999999853 223445556666655 48999999999986542 223
Q ss_pred ccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeecCCCCCceeeCCCCcEEEccc
Q 007629 190 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICDF 260 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~--------gIiHrDLKP~NILl~~~~~vKL~DF 260 (595)
..+|+||||++ ++|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 56899999998 5999999764 799999999999999999999998 9999999999999999999999999
Q ss_pred CcceeccCCCCC-cccccccccCCcccccccccccCCCCCCc------ceeechhHHHHHHHcC----------CCCCCC
Q 007629 261 GLARVSFNDAPS-AIFWTDYVATRWYRAPELCGSFFSKYTPA------IDIWSIGCIFAEMLTG----------KPLFPG 323 (595)
Q Consensus 261 Gla~~~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~~~~~k------~DIWSlG~il~eLltG----------~~pF~~ 323 (595)
|+++........ .......+||+.|+|||++.+ ..++.+ +|||||||++|||++| ..||..
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999765433221 111234689999999999876 344444 9999999999999999 666654
Q ss_pred CChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 324 ~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.... .+....+ .............+.......+++.+.+||.+||..||.+|||+.++++|
T Consensus 265 ~~~~-----------~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 265 LVPS-----------DPSYEDM--------REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TSCS-----------SCCHHHH--------HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcCC-----------CCchhhh--------HHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 3210 0111110 00000000001111000112345678999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=395.87 Aligned_cols=283 Identities=26% Similarity=0.355 Sum_probs=210.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC-ccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~~~~ 191 (595)
++|++.+.||+|+||.||+|.+..+|..||||+++.. ........+.+|+.+|+.++||||+++++++.... ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 6899999999999999999999999999999998653 23445677899999999999999999999875421 123466
Q ss_pred EEEEEeccc-ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCc---EEEcccCcce
Q 007629 192 IYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLAR 264 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~---vKL~DFGla~ 264 (595)
.|+|||||+ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 899999996 69999998654 6999999999999999999999999999999999999997765 9999999998
Q ss_pred eccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+... ........
T Consensus 173 ~~~~~~~----~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~ 243 (676)
T 3qa8_A 173 ELDQGEL----CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEH 243 (676)
T ss_dssp BTTSCCC----CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------
T ss_pred ccccccc----cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchh
Confidence 6543322 245689999999999977 68999999999999999999999999876432211000 00000000
Q ss_pred HHHHhhHHHHHHhhhcccCCCCC-CCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVP-FSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
+.... .......-....+ .....+.+++.+.+||.+||.+||.+|||+.|+|+||||+.+.
T Consensus 244 ~~~~~-----~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 244 IVVYD-----DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp CCSCC-----CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred hhhhh-----hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 00000 0000000000001 1122334678899999999999999999999999999997643
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=378.30 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=202.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+|+.|+||||+++++++.. ..
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~ 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------cc
Confidence 4579999999999999999999864 4679999997532 234678999999999999999999999843 34
Q ss_pred EEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+|||||||. ++|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 799999998 5999999643 4699999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
... .......+|..|+|||++.+ ..++.++|||||||+||||++ |+.||.+....+.+..+....
T Consensus 416 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------- 481 (535)
T 2h8h_A 416 NEY--TARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------- 481 (535)
T ss_dssp HHH--HTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred Cce--ecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 110 11123457788999999876 689999999999999999999 999998877544433332110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
..+ ....+++.+.+||.+||..||.+|||++++++
T Consensus 482 ---------------~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 482 ---------------RMP-----CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp ---------------CCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCC-----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 001 11356788999999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=367.12 Aligned_cols=253 Identities=19% Similarity=0.158 Sum_probs=188.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC------ChhhHHHHHHHHHHHHhcC---------CCceee
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE------HVSDATRILREIKLLRLLR---------HPDIVE 176 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~------~~~~~~~~~~Ei~il~~l~---------HpnIv~ 176 (595)
.++|++++.||+|+||+||+|++ +|+.||||++..... .......+.+|+.+|+.++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 45799999999999999999987 689999999965321 2233467889999999886 666666
Q ss_pred eeeeecCCC-------------------------ccCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 007629 177 IKHIMLPPS-------------------------RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 230 (595)
Q Consensus 177 l~~~~~~~~-------------------------~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~ 230 (595)
+.+++.... ......+|||||||. |++.+.+.. +.+++..++.|+.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 665542110 012467999999997 445555533 57899999999999999999
Q ss_pred HHH-hCCeeecCCCCCceeeCCCC--------------------cEEEcccCcceeccCCCCCcccccccccCCcccccc
Q 007629 231 YIH-TANVFHRDLKPKNILANADC--------------------KLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289 (595)
Q Consensus 231 yLH-s~gIiHrDLKP~NILl~~~~--------------------~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE 289 (595)
||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCCTTCSG
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeecccChh
Confidence 999 99999999999999999887 899999999986532 2348999999999
Q ss_pred cccccCCCCCCcceeechhHH-HHHHHcCCCCCCCCChHH-HHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCC
Q 007629 290 LCGSFFSKYTPAIDIWSIGCI-FAEMLTGKPLFPGKNVVH-QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVP 367 (595)
Q Consensus 290 ~l~~~~~~~~~k~DIWSlG~i-l~eLltG~~pF~~~~~~~-~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~ 367 (595)
++.+. . +.++||||||++ .+++++|..||.+..... ....+. .... .....
T Consensus 248 ~~~g~--~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~-----------------------~~~~-~~~~~ 300 (336)
T 2vuw_A 248 LFTGD--G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKML-----------------------KQMT-FKTKC 300 (336)
T ss_dssp GGCCC--S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHH-----------------------HTCC-CSSCC
T ss_pred hhcCC--C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhh-----------------------hhhc-cCccc
Confidence 99872 3 889999998777 778899999984321100 000111 0000 00011
Q ss_pred CCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHh-cCCCcc
Q 007629 368 FSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL-ADPYFH 407 (595)
Q Consensus 368 ~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL-~Hp~f~ 407 (595)
....++.+++.+.+||++||++| |++|+| +||||+
T Consensus 301 ~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 11112345778999999999987 999999 999995
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=352.96 Aligned_cols=259 Identities=22% Similarity=0.281 Sum_probs=199.8
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..++|++.+.||+|+||.||+|.+.. .||+|+++...........+.+|+.+++.++||||+++++++... .
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-----P 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-----S
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----C
Confidence 35789999999999999999998753 499999875433333445577899999999999999999998543 4
Q ss_pred cEEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 191 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
.+|+||||++ ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++.....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 5899999998 68999987654 699999999999999999999999999999999999998 78999999999875422
Q ss_pred CCC--CcccccccccCCccccccccccc-------CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCC
Q 007629 269 DAP--SAIFWTDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339 (595)
Q Consensus 269 ~~~--~~~~~~~~~gT~~Y~APE~l~~~-------~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~ 339 (595)
... .........||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.........+...
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--- 258 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG--- 258 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT---
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC---
Confidence 111 11112345699999999998642 135788999999999999999999999877654333222110
Q ss_pred CChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 340 p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
..+. .....+++.+.+||.+||..||.+|||+.++++ .|+.+
T Consensus 259 -----------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l 300 (319)
T 2y4i_B 259 -----------------------MKPN---LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKL 300 (319)
T ss_dssp -----------------------CCCC---CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC
T ss_pred -----------------------CCCC---CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHH
Confidence 0000 011245677999999999999999999999998 45444
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=351.05 Aligned_cols=262 Identities=24% Similarity=0.304 Sum_probs=197.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHh--cCCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL--LRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|++.+.||+|+||.||+|.+ +|+.||||++.. .....+.+|+.+++. ++||||+++++++.... ...
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Ccc
Confidence 35799999999999999999987 589999999863 234567889999988 78999999999986543 222
Q ss_pred ccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCeeecCCCCCceeeCCCCcEEEccc
Q 007629 190 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH--------TANVFHRDLKPKNILANADCKLKICDF 260 (595)
Q Consensus 190 ~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLH--------s~gIiHrDLKP~NILl~~~~~vKL~DF 260 (595)
..+|+||||+++ +|.+++.. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 468999999985 99999976 46999999999999999999999 899999999999999999999999999
Q ss_pred CcceeccCCCCCc-ccccccccCCcccccccccccCC----CCCCcceeechhHHHHHHHcC----------CCCCCCCC
Q 007629 261 GLARVSFNDAPSA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEMLTG----------KPLFPGKN 325 (595)
Q Consensus 261 Gla~~~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~----~~~~k~DIWSlG~il~eLltG----------~~pF~~~~ 325 (595)
|++.......... .......||+.|+|||++.+... .++.++|||||||++|||++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9998654433211 11244589999999999876211 233689999999999999999 67886542
Q ss_pred hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCC--CCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF--PNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 326 ~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.. .+..+.+ ...+. .......+...+ ..+...+.+||.+||..||.+|||+.++++|
T Consensus 272 ~~-----------~~~~~~~--------~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PS-----------DPSVEEM--------RKVVC--EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CS-----------SCCHHHH--------HHHHT--TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cC-----------cccHHHH--------HHHHH--HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 10 0000000 00000 000001111111 1234568999999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=377.54 Aligned_cols=250 Identities=25% Similarity=0.430 Sum_probs=202.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHT---GERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~---g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
.++|++.+.||+|+||.||+|.+..+ +..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 46899999999999999999998654 467999988642 233445678999999999999999999998832
Q ss_pred cccEEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 189 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
..+|+||||++ ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 24799999998 69999998654 6999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+...
T Consensus 542 ~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~--------- 608 (656)
T 2j0j_A 542 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------- 608 (656)
T ss_dssp CC------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT---------
T ss_pred CCCcce--eccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---------
Confidence 332211 1233467889999999876 689999999999999999997 99999987765444333211
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
...+ ..+.+++.+.+||.+||..||.+|||+.++++
T Consensus 609 ------------------~~~~---~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 609 ------------------ERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ------------------CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCC---CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0001 12457889999999999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=380.37 Aligned_cols=245 Identities=25% Similarity=0.365 Sum_probs=197.3
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTH-TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~-~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++.+.||+|+||+||+|.+.. +|+.||||++... ........+.+|+.+|+.++||||+++++++.........
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4789999999999999999999976 7899999998642 2234456788999999999999999999998654332223
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|||||||+ ++|.+++.. .+++..+..|+.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 3799999998 578777654 79999999999999999999999999999999999999875 9999999999865322
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
...+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.... +.+....
T Consensus 235 -------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~~~----- 289 (681)
T 2pzi_A 235 -------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPEDDP----- 289 (681)
T ss_dssp -------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTTCH-----
T ss_pred -------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCcccccc----------ccccccc-----
Confidence 34579999999999876 3588999999999999999999998753210 0010000
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
....++.+.+||.+||.+||.+||++.+++.|+|+.
T Consensus 290 ----------------------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 290 ----------------------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ----------------------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----------------------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 001246689999999999999999999999998875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=330.76 Aligned_cols=227 Identities=17% Similarity=0.104 Sum_probs=182.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CC
Confidence 46899999999999999999999999999999999754332 3445778999999999999999999999843 35
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|+||||++ ++|.+++.. ...+.++..|+.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred cEEEEEEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 6899999998 589998854 24666788999999999999999999999999999999999999998543
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
|++ .++.++|||||||++|||++|+.||.+.+....+.....
T Consensus 175 ---------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~-------------- 216 (286)
T 3uqc_A 175 ---------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER-------------- 216 (286)
T ss_dssp ---------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB--------------
T ss_pred ---------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH--------------
Confidence 333 367899999999999999999999988653211100000
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.....+.+.....+.+++.+.+||.+||..||.+| |+.|+++
T Consensus 217 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 217 ----------DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp ----------CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred ----------HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 00001111112235678999999999999999999 9999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=321.63 Aligned_cols=188 Identities=18% Similarity=0.124 Sum_probs=134.4
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccC--------ChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCc
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE--------HVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~--------~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 189 (595)
..++.|++|.+..++...+|+.||+|++.+... .....+++.+|+++|+++ .|+||+++++++ ++.
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~ 314 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENA 314 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECS
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EEC
Confidence 456788899888888888999999999864321 112345689999999999 699999999998 555
Q ss_pred ccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 190 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 190 ~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
..+||||||++| +|.++|...+++++. .|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred CEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 679999999995 899999998888765 4789999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCC
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL 320 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~p 320 (595)
... ..++.+||+.|||||++.+ .+..++|+||+|+++++|+++..+
T Consensus 392 ~~~---~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS---WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C---CSHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred CCc---cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccch
Confidence 322 2356789999999999876 467789999999999988776533
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-28 Score=271.24 Aligned_cols=190 Identities=21% Similarity=0.267 Sum_probs=141.5
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChh------hHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS------DATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
+...+.||+|+||.||+| ...+..+|+|++........ ..+++.+|+.+|+.++||||+++..++..
T Consensus 338 ~~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----- 410 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD----- 410 (540)
T ss_dssp ----------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-----
T ss_pred CCCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-----
Confidence 345679999999999999 45688999998643221111 23457899999999999999944333322
Q ss_pred cccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 189 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
....|||||||+ ++|.+++.. +..++.||++||.|||++||+||||||+|||++. .+||+|||+|+...
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred CCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 123699999998 799998865 5689999999999999999999999999999998 99999999998763
Q ss_pred CCCCCc----ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCC
Q 007629 268 NDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLF 321 (595)
Q Consensus 268 ~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF 321 (595)
...... ......+||+.|||||++......|+..+|+|+..+-..+.+.++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 321111 012357899999999998764456888899999999999888877766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.7e-25 Score=224.86 Aligned_cols=146 Identities=16% Similarity=0.173 Sum_probs=116.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----------------hhHHHHHHHHHHHHhcCCCceee
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----------------SDATRILREIKLLRLLRHPDIVE 176 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~----------------~~~~~~~~Ei~il~~l~HpnIv~ 176 (595)
..|.+.+.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|+.++ | +.
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 4577779999999999999999 889999999986321110 13456889999999999 4 55
Q ss_pred eeeeecCCCccCcccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcE
Q 007629 177 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 255 (595)
Q Consensus 177 l~~~~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~v 255 (595)
+.+++. ....|+|||||+| +|.+ + .......++.||+.||.|||++||+||||||+|||++ ++.+
T Consensus 166 v~~~~~------~~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 166 VPKVYA------WEGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp SCCEEE------EETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEE
T ss_pred cCeEEe------ccceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcE
Confidence 555442 1346999999985 7876 3 2244567999999999999999999999999999999 9999
Q ss_pred EEcccCcceeccCCCCCcccccccccCCccccccccc
Q 007629 256 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292 (595)
Q Consensus 256 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~ 292 (595)
||+|||+|+. +..|+|||++.
T Consensus 232 kl~DFG~a~~----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 232 WIIDFPQSVE----------------VGEEGWREILE 252 (282)
T ss_dssp EECCCTTCEE----------------TTSTTHHHHHH
T ss_pred EEEECCCCeE----------------CCCCCHHHHHH
Confidence 9999999863 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.9e-21 Score=195.90 Aligned_cols=139 Identities=17% Similarity=0.149 Sum_probs=108.9
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcE--EEEEEecCccCCh----------------------hhHHHHHHHHHHHHhc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHV----------------------SDATRILREIKLLRLL 169 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~--vAIK~i~~~~~~~----------------------~~~~~~~~Ei~il~~l 169 (595)
-|.+.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 488999999999999999998778999 9999875321110 1123578999999999
Q ss_pred CCCce--eeeeeeecCCCccCcccEEEEEecccc------cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeec
Q 007629 170 RHPDI--VEIKHIMLPPSRREFKDIYVVFELMES------DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH-TANVFHR 240 (595)
Q Consensus 170 ~HpnI--v~l~~~~~~~~~~~~~~lylV~E~~~g------~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLH-s~gIiHr 240 (595)
.|++| ..++.. ...||||||+++ .|.++... .++..+..++.||+.||.||| ++||+||
T Consensus 128 ~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred HhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 88764 333322 235999999953 56665432 346678899999999999999 9999999
Q ss_pred CCCCCceeeCCCCcEEEcccCcceec
Q 007629 241 DLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 241 DLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999988 9999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=4.7e-18 Score=179.91 Aligned_cols=137 Identities=16% Similarity=0.169 Sum_probs=96.0
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc---CC---------hhhHHH--------HHHHHHHHHhcCCCc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF---EH---------VSDATR--------ILREIKLLRLLRHPD 173 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~---~~---------~~~~~~--------~~~Ei~il~~l~Hpn 173 (595)
-|.+...||.|+||.||+|.+. +|+.||||+++... .. ...... ..+|...|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999874 69999999875211 00 001111 234555566554433
Q ss_pred eeeeeeeecCCCccCcccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC
Q 007629 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 252 (595)
Q Consensus 174 Iv~l~~~~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~ 252 (595)
+....-+. ....+|||||++| .|.++ ...+....++.||+.+|.|||++|||||||||.|||++.+
T Consensus 175 v~vp~p~~-------~~~~~LVME~i~G~~L~~l------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 175 FPVPEPIA-------QSRHTIVMSLVDALPMRQV------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp CSCCCEEE-------EETTEEEEECCSCEEGGGC------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred CCCCeeee-------ccCceEEEEecCCccHhhh------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 32111110 1123799999986 45432 2234567788999999999999999999999999999988
Q ss_pred C----------cEEEcccCcce
Q 007629 253 C----------KLKICDFGLAR 264 (595)
Q Consensus 253 ~----------~vKL~DFGla~ 264 (595)
| .+.|+||+-+.
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCE
T ss_pred CCcccccccccceEEEEeCCcc
Confidence 7 38999999765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=2.3e-11 Score=121.44 Aligned_cols=138 Identities=13% Similarity=0.104 Sum_probs=105.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..|++...+|.|+++.||++.. .+..|++|....... .....+.+|+.+|+.|. +..+.+++++.. ....
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~ 84 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGW 84 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCc
Confidence 3588999999999999999964 368899999864211 12235788999999985 667778887763 2345
Q ss_pred EEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 007629 192 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT------------------------------------ 234 (595)
Q Consensus 192 lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs------------------------------------ 234 (595)
.|+|||+++| +|.+.+ .+......++.++.++|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred eEEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 7999999997 565542 1233445788999999999998
Q ss_pred -----------------------CCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 235 -----------------------ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 235 -----------------------~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876556799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.3e-10 Score=115.05 Aligned_cols=132 Identities=14% Similarity=0.066 Sum_probs=93.4
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCc--eeeeeeeecCCCccCccc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~~~~ 191 (595)
.|.+....+.|..+.||++.. .+|..|++|..... ....+.+|+.+|+.+.+.+ +.+++.+... ...
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~ 89 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGR 89 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSC
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCC
Confidence 456555445667799999953 56778999987542 1234678999999886544 4557776532 234
Q ss_pred EEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 007629 192 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN---------------------------------- 236 (595)
Q Consensus 192 lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~g---------------------------------- 236 (595)
.|+||||++| .| . . .... ...++.++++.|..||+..
T Consensus 90 ~~~v~e~i~G~~l-~-~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 90 DWLLLGEVPGQDL-L-S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEEEEECCSSEET-T-T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred CEEEEEecCCccc-C-c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 7999999997 44 2 1 1111 2356677777888887643
Q ss_pred ------------------------eeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 237 ------------------------VFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 237 ------------------------IiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=1.3e-10 Score=119.01 Aligned_cols=184 Identities=19% Similarity=0.272 Sum_probs=118.3
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCc--eeeeeeeecCCCccCcccEEE
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPD--IVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hpn--Iv~l~~~~~~~~~~~~~~lyl 194 (595)
++.++.|.+..||++. ..+++|+... ......+.+|+.+|+.+. +.. +.+++..... .......|+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceE
Confidence 3569999999999873 4688997642 234567889999998884 332 3333333211 111233589
Q ss_pred EEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 007629 195 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT--------------------------------------- 234 (595)
Q Consensus 195 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs--------------------------------------- 234 (595)
|||+++| .|..... ..++.++...++.|++..|..||+
T Consensus 94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999997 4443222 246777778888888888888885
Q ss_pred -------------------CCeeecCCCCCceeeCC--CCcEEEcccCcceeccCCCCCcccccccccCCcc---ccccc
Q 007629 235 -------------------ANVFHRDLKPKNILANA--DCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY---RAPEL 290 (595)
Q Consensus 235 -------------------~gIiHrDLKP~NILl~~--~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y---~APE~ 290 (595)
..++|+|++|.|||++. .+.+.|+||+.+...... .+......+ ..|+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-------~Dl~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-------NDFISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-------HHHHTTCCTTTSCCHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-------HHHHHHHhhccccCHHH
Confidence 13799999999999998 456789999998753211 111111111 23332
Q ss_pred ccccCCCC------------CCcceeechhHHHHHHHcCCCCC
Q 007629 291 CGSFFSKY------------TPAIDIWSIGCIFAEMLTGKPLF 321 (595)
Q Consensus 291 l~~~~~~~------------~~k~DIWSlG~il~eLltG~~pF 321 (595)
.......| ....+.|++|.++|.+.+|.++|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11100111 11258999999999999998776
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.4e-09 Score=113.82 Aligned_cols=143 Identities=15% Similarity=0.239 Sum_probs=102.5
Q ss_pred EEeeeeeecCceEEEEEEECCCCcEEEEEEec--CccCChhhHHHHHHHHHHHHhcC--CCceeeeeeeecCCCccCccc
Q 007629 116 QIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN--DVFEHVSDATRILREIKLLRLLR--HPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 116 ~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~--~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..++.|+.|.++.||++... +..+++|+.. .. ........+.+|+.+|+.|. +..+.+++.++.... ....
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~-~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~ 115 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKS-KLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGR 115 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSS
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCC-CCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCC
Confidence 34678999999999999753 4678888764 21 11122346788999999997 455777877764431 1244
Q ss_pred EEEEEeccccc-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 007629 192 IYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT------------------------------------ 234 (595)
Q Consensus 192 lylV~E~~~g~-L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs------------------------------------ 234 (595)
.|+||||++|. +.+. ....+++.....++.+++++|..||+
T Consensus 116 ~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp CEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred eEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 79999999973 3221 12347788888999999999999997
Q ss_pred ----------------------CCeeecCCCCCceeeCCCCc--EEEcccCccee
Q 007629 235 ----------------------ANVFHRDLKPKNILANADCK--LKICDFGLARV 265 (595)
Q Consensus 235 ----------------------~gIiHrDLKP~NILl~~~~~--vKL~DFGla~~ 265 (595)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35999999999999997753 68999999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=2.6e-06 Score=87.23 Aligned_cols=133 Identities=22% Similarity=0.205 Sum_probs=87.8
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCC---ceeeeeeeecCCCccCcccEEE
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP---DIVEIKHIMLPPSRREFKDIYV 194 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~~~~~~~~lyl 194 (595)
++.++.|....||+. |..+++|+.. .......+.+|+.+|+.|.+. .+.+++.+... .....|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEE
Confidence 456899999999998 5678888753 223456788999999999752 23444444421 1234689
Q ss_pred EEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 007629 195 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-------------------------------------- 235 (595)
Q Consensus 195 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~-------------------------------------- 235 (595)
|||+++| .+..... ..++......++.++.+.|..||+.
T Consensus 91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999997 3433211 1234444444455555554444432
Q ss_pred ----------------------CeeecCCCCCceeeCC---CCcE-EEcccCccee
Q 007629 236 ----------------------NVFHRDLKPKNILANA---DCKL-KICDFGLARV 265 (595)
Q Consensus 236 ----------------------gIiHrDLKP~NILl~~---~~~v-KL~DFGla~~ 265 (595)
.++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3699999999999987 4565 8999998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=2.4e-05 Score=77.77 Aligned_cols=131 Identities=18% Similarity=0.202 Sum_probs=86.5
Q ss_pred eeeecCce-EEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCcccEEEEEe
Q 007629 120 VIGKGSYG-VVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVFE 197 (595)
Q Consensus 120 ~LG~G~fG-~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~lylV~E 197 (595)
.+..|..| .||+......+..+.+|+-.. .....+.+|..+|+.|. +--+.+++.++.. ....|+|||
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme 100 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTT 100 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEE
Confidence 45556555 799988777778899997642 34556788999999885 3235556665532 245799999
Q ss_pred cccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 007629 198 LMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA----------------------------------------- 235 (595)
Q Consensus 198 ~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~----------------------------------------- 235 (595)
+++| .+.+.... .......+..++...|.-||..
T Consensus 101 ~l~G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9987 44443322 1122233444444444444421
Q ss_pred -----------------CeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 236 -----------------NVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 236 -----------------gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 27999999999999987767799999876
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=1.2e-05 Score=85.13 Aligned_cols=77 Identities=17% Similarity=0.082 Sum_probs=48.1
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccC----C-hhhHHHHHHHHHHHHhcCC--Cc-eeeeeeeecCCCccCc
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE----H-VSDATRILREIKLLRLLRH--PD-IVEIKHIMLPPSRREF 189 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~----~-~~~~~~~~~Ei~il~~l~H--pn-Iv~l~~~~~~~~~~~~ 189 (595)
.+.||.|.++.||++.....+..|+||....... . .....++..|+.+|+.+.. |. +.+++.+. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~----- 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T----- 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T-----
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C-----
Confidence 5679999999999997665678899998643211 0 0123456789999888742 33 33555432 1
Q ss_pred ccEEEEEecccc
Q 007629 190 KDIYVVFELMES 201 (595)
Q Consensus 190 ~~lylV~E~~~g 201 (595)
...++|||++++
T Consensus 108 ~~~~lvmE~l~g 119 (397)
T 2olc_A 108 EMAVTVMEDLSH 119 (397)
T ss_dssp TTTEEEECCCTT
T ss_pred CccEEEEEeCCC
Confidence 124899999975
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.08 E-value=2.4e-05 Score=80.18 Aligned_cols=30 Identities=20% Similarity=0.324 Sum_probs=27.4
Q ss_pred CCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 235 ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 235 ~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999775
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=4.6e-05 Score=79.11 Aligned_cols=84 Identities=8% Similarity=0.141 Sum_probs=51.0
Q ss_pred EEeeee-eecCceEEEEEEECC------CCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcC-C--CceeeeeeeecCC
Q 007629 116 QIQEVI-GKGSYGVVGSAVDTH------TGERVAIKKINDVFE-HVSDATRILREIKLLRLLR-H--PDIVEIKHIMLPP 184 (595)
Q Consensus 116 ~i~~~L-G~G~fG~V~~a~~~~------~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~ 184 (595)
...+.| +.|....+|+..... ++..+++|+...... .......+.+|+.+|+.|. + -.+.+++.+....
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345778 889999999886430 156788987643110 0001134668888888874 2 3456666665332
Q ss_pred CccCcccEEEEEecccc
Q 007629 185 SRREFKDIYVVFELMES 201 (595)
Q Consensus 185 ~~~~~~~lylV~E~~~g 201 (595)
. .....|+|||+++|
T Consensus 103 ~--~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 D--VLGTPFFLMDYVEG 117 (357)
T ss_dssp T--TTSSCEEEEECCCC
T ss_pred C--ccCCceEEEEecCC
Confidence 1 11345899999986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00099 Score=70.88 Aligned_cols=32 Identities=16% Similarity=0.313 Sum_probs=28.0
Q ss_pred HhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 233 HTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 233 Hs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
+...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 346799999999999998776 99999998874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0019 Score=65.22 Aligned_cols=29 Identities=21% Similarity=0.290 Sum_probs=25.0
Q ss_pred CeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 236 NVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 236 gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
.++|+|+.|.||| ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 3899999999999 5677899999998763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0062 Score=62.27 Aligned_cols=73 Identities=16% Similarity=0.101 Sum_probs=53.2
Q ss_pred EeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC---CCceeeeeeeecCCCccCcccEE
Q 007629 117 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR---HPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 117 i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
-.+.|+.|....||+... .+..+++|+... .....+.+|...|+.|. ...+.+++.+... ....|
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~ 107 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINER-----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSF 107 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEG-----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCc-----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceE
Confidence 357799999999999964 467888997642 23556788999988874 2456677666532 24579
Q ss_pred EEEecccc
Q 007629 194 VVFELMES 201 (595)
Q Consensus 194 lV~E~~~g 201 (595)
+|||+++|
T Consensus 108 lvme~l~G 115 (312)
T 3jr1_A 108 LLLEALNK 115 (312)
T ss_dssp EEEECCCC
T ss_pred EEEEeccC
Confidence 99999985
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0098 Score=59.52 Aligned_cols=75 Identities=12% Similarity=0.002 Sum_probs=51.0
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCC---ceeeeeeeecCCCccCcc
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP---DIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~~~~~~~ 190 (595)
+..-++.+|.|..+.||++.. .+|+.|.+|+-..... .....+.+|+..|+.|.-- -+.+++.+.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--------- 83 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--------- 83 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc---------
Confidence 455678899999999999974 5789999997643211 1123467899999988521 234444432
Q ss_pred cEEEEEeccc
Q 007629 191 DIYVVFELME 200 (595)
Q Consensus 191 ~lylV~E~~~ 200 (595)
.-++||||+.
T Consensus 84 ~~~lv~e~l~ 93 (288)
T 3f7w_A 84 DRTLAMEWVD 93 (288)
T ss_dssp TTEEEEECCC
T ss_pred CceEEEEeec
Confidence 1378999986
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0047 Score=62.65 Aligned_cols=143 Identities=13% Similarity=0.096 Sum_probs=76.6
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCc--eeeeeeeecCCC--ccCcc
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPS--RREFK 190 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~--~~~~~ 190 (595)
..-++.|+.|....||++... .| .+++|..... .....+..|+.+++.|.... +.+++... ... .....
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~~~~~g 96 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELLGELSG 96 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSCEEETT
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEEEEECC
Confidence 344567888998999999653 34 6889987542 11234557888887775222 23332211 000 00113
Q ss_pred cEEEEEeccccc-H-----------HHH---HH-hcCCC--------CHHHHHHH---------------HHHHHHHHHH
Q 007629 191 DIYVVFELMESD-L-----------HQV---IK-ANDDL--------TPEHYQFF---------------LYQLLRGLKY 231 (595)
Q Consensus 191 ~lylV~E~~~g~-L-----------~~~---i~-~~~~l--------~~~~~~~i---------------~~qil~aL~y 231 (595)
..+++|++++|. + -.. +. ....+ ........ -..+...+.+
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 468999999862 1 001 11 11111 10000000 0113344555
Q ss_pred HHh-------CCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 232 IHT-------ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 232 LHs-------~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
+.. .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 552 369999999999999877656899999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0072 Score=61.43 Aligned_cols=76 Identities=14% Similarity=0.065 Sum_probs=45.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCc--eeeeeeeecCCCc--cCcccEEE
Q 007629 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD--IVEIKHIMLPPSR--REFKDIYV 194 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~--~~~~~lyl 194 (595)
..|+ |....||++.. .+|..+++|...... .....+..|+.+++.|.... +++++.. .... ...+..++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEE
Confidence 4566 88889998753 356679999875211 12345677888888875222 3444332 1110 11235688
Q ss_pred EEecccc
Q 007629 195 VFELMES 201 (595)
Q Consensus 195 V~E~~~g 201 (595)
||++++|
T Consensus 105 l~~~i~G 111 (328)
T 1zyl_A 105 VFPSVGG 111 (328)
T ss_dssp EEECCCC
T ss_pred EEEecCC
Confidence 9999986
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0079 Score=58.00 Aligned_cols=96 Identities=19% Similarity=0.130 Sum_probs=64.2
Q ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH-HhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccccccc
Q 007629 202 DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 279 (595)
Q Consensus 202 ~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yL-Hs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 279 (595)
+|.+++.. ..+++|+++|.+++|.+.+|.-+ +...-..+=+-|..|++..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 68888875 45899999999999999998776 222222344557899999999987774 2211
Q ss_pred ccCCcccccccccccCCCCCCcceeechhHHHHHHHc
Q 007629 280 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT 316 (595)
Q Consensus 280 ~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt 316 (595)
.....+.|||... ...+.+.=|||||+++|.-+-
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhh
Confidence 1122366888753 245667889999999999885
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.60 E-value=0.018 Score=61.40 Aligned_cols=71 Identities=13% Similarity=0.104 Sum_probs=47.1
Q ss_pred eeeeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCce-eeeeeeecCCCccCc
Q 007629 118 QEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI-VEIKHIMLPPSRREF 189 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~-------~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~~ 189 (595)
++.|+.|....||++.... .+..|.+|+.... . ....+.+|+.+++.|...++ .++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~-----~- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E--TESHLVAESVIFTLLSERHLGPKLYGIFS-----G- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C--CHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T-
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--C--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC-----C-
Confidence 5678889999999997542 2578999987421 1 11345579999988853333 45665541 1
Q ss_pred ccEEEEEecccc
Q 007629 190 KDIYVVFELMES 201 (595)
Q Consensus 190 ~~lylV~E~~~g 201 (595)
.+||||++|
T Consensus 148 ---g~v~e~l~G 156 (429)
T 1nw1_A 148 ---GRLEEYIPS 156 (429)
T ss_dssp ---EEEECCCCE
T ss_pred ---CEEEEEeCC
Confidence 378999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0053 Score=63.84 Aligned_cols=72 Identities=8% Similarity=0.002 Sum_probs=41.1
Q ss_pred eeeeeecCceEEEEEEECC--------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCc-eeeeeeeecCCCccC
Q 007629 118 QEVIGKGSYGVVGSAVDTH--------TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPPSRRE 188 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~--------~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~ 188 (595)
.+.|+.|....||++.... .+..|++|+..... ........|..+++.|...+ +.++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~---- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N---- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T----
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C----
Confidence 4668888889999997542 13678888764311 11112357888888775333 33555443 1
Q ss_pred cccEEEEEecccc
Q 007629 189 FKDIYVVFELMES 201 (595)
Q Consensus 189 ~~~lylV~E~~~g 201 (595)
-++||||++|
T Consensus 109 ---~~~v~e~i~G 118 (369)
T 3c5i_A 109 ---GGRIEEWLYG 118 (369)
T ss_dssp ---TEEEEECCCS
T ss_pred ---CcEEEEEecC
Confidence 1689999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0068 Score=61.94 Aligned_cols=31 Identities=26% Similarity=0.470 Sum_probs=27.2
Q ss_pred CCeeecCCCCCceeeCCC----CcEEEcccCccee
Q 007629 235 ANVFHRDLKPKNILANAD----CKLKICDFGLARV 265 (595)
Q Consensus 235 ~gIiHrDLKP~NILl~~~----~~vKL~DFGla~~ 265 (595)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999875 6799999998864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.014 Score=61.23 Aligned_cols=135 Identities=13% Similarity=0.149 Sum_probs=78.6
Q ss_pred eeeeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCc
Q 007629 118 QEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~-------~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~ 189 (595)
++.|..|-...+|++.... .+..|.+|+.... ......+.+|..+++.|. +.-..++++++. +
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-----~- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFP-----E- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET-----T-
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC-----C-
Confidence 3567778888999987532 3578999975321 123445668999998875 322345555541 1
Q ss_pred ccEEEEEeccccc------H---------HHHHH---hcC-----CC--CHHHHHHHHHHHHH-----------------
Q 007629 190 KDIYVVFELMESD------L---------HQVIK---AND-----DL--TPEHYQFFLYQLLR----------------- 227 (595)
Q Consensus 190 ~~lylV~E~~~g~------L---------~~~i~---~~~-----~l--~~~~~~~i~~qil~----------------- 227 (595)
.+||||++|. + .+.+. ... .. -+..+..++.++..
T Consensus 126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 2899999851 1 11111 111 11 13455556554422
Q ss_pred --HHHHHH----h----CCeeecCCCCCceeeCCC----CcEEEcccCcce
Q 007629 228 --GLKYIH----T----ANVFHRDLKPKNILANAD----CKLKICDFGLAR 264 (595)
Q Consensus 228 --aL~yLH----s----~gIiHrDLKP~NILl~~~----~~vKL~DFGla~ 264 (595)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 233333 2 248999999999999876 789999999875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.02 E-value=0.021 Score=58.79 Aligned_cols=31 Identities=19% Similarity=0.326 Sum_probs=27.6
Q ss_pred CCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 235 ANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 235 ~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
..++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3599999999999999888899999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.86 E-value=0.11 Score=55.72 Aligned_cols=72 Identities=17% Similarity=0.186 Sum_probs=45.4
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCce-eeeeeeecCCCccCcccEEEEE
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI-VEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~~~~lylV~ 196 (595)
++.|+.|-...+|++.....+..|++|+........-+ ..+|..+|+.|...++ .++++++. . .+||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id---R~~E~~vl~~L~~~gl~P~ll~~~~--~-------G~v~ 180 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN---REREKKISCILYNKNIAKKIYVFFT--N-------GRIE 180 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC---HHHHHHHHHHHTTSSSBCCEEEEET--T-------EEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC---HHHHHHHHHHHHhcCCCCCEEEEeC--C-------eEEE
Confidence 56788899999999976544578889976432111111 2479999999875444 45666551 1 2599
Q ss_pred ecccc
Q 007629 197 ELMES 201 (595)
Q Consensus 197 E~~~g 201 (595)
||++|
T Consensus 181 e~I~G 185 (458)
T 2qg7_A 181 EFMDG 185 (458)
T ss_dssp ECCCS
T ss_pred EeeCC
Confidence 99875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.81 E-value=0.12 Score=54.93 Aligned_cols=72 Identities=11% Similarity=-0.027 Sum_probs=44.2
Q ss_pred eeeeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCc
Q 007629 118 QEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~-------~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~ 189 (595)
++.|..|-...+|++.... .+..|++++....... .-...+|..+++.|. +.-..++++.+.
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~~------- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADFP------- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEET-------
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEcC-------
Confidence 4567778888999997642 1578999875332111 112347888888775 222344544331
Q ss_pred ccEEEEEecccc
Q 007629 190 KDIYVVFELMES 201 (595)
Q Consensus 190 ~~lylV~E~~~g 201 (595)
-++||||++|
T Consensus 145 --~~~I~efI~G 154 (424)
T 3mes_A 145 --EGRIEEFIDG 154 (424)
T ss_dssp --TEEEEECCCS
T ss_pred --CCEEEEEeCC
Confidence 1789999986
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.78 E-value=1 Score=47.13 Aligned_cols=29 Identities=31% Similarity=0.421 Sum_probs=24.7
Q ss_pred eeecCCCCCceee------CCCCcEEEcccCccee
Q 007629 237 VFHRDLKPKNILA------NADCKLKICDFGLARV 265 (595)
Q Consensus 237 IiHrDLKP~NILl------~~~~~vKL~DFGla~~ 265 (595)
++|.|+.+.|||+ +.+..+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999998 4466799999998763
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.92 E-value=0.06 Score=58.03 Aligned_cols=62 Identities=16% Similarity=0.119 Sum_probs=17.0
Q ss_pred EeeeeeecCceEEEEEEECCCCcEEEE------EEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeee
Q 007629 117 IQEVIGKGSYGVVGSAVDTHTGERVAI------KKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIM 181 (595)
Q Consensus 117 i~~~LG~G~fG~V~~a~~~~~g~~vAI------K~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 181 (595)
+.+.|| ||.||++........||| |..+...........+.+|..+++.++|||+++.+.+.
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 445676 999999987655568898 66543222333445678899999999999999987755
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 595 | ||||
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-97 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-90 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-89 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-78 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-78 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-75 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-73 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-72 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-71 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-71 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-70 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-70 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-68 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-68 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-67 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-66 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-66 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-66 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-65 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-65 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-63 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-63 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-59 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-59 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-58 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-56 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-54 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-52 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-49 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-49 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-49 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-40 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-24 |
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 299 bits (767), Expect = 1e-97
Identities = 161/341 (47%), Positives = 220/341 (64%), Gaps = 5/341 (1%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
RY IG+G+YG+V SA D RVAIKKI+ FEH + R LREIK+L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRH 65
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
+I+ I I+ P+ + KD+Y+V LM +DL++++K L+ +H +FLYQ+LRGLKY
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKY 124
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
IH+ANV HRDLKP N+L N C LKICDFGLARV+ D F T+YVATRWYRAPE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
+ YT +IDIWS+GCI AEML+ +P+FPGK+ + QL+ + +LG+PS E ++ I N
Sbjct: 185 LNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411
KAR YL S+ K VP++ FPNAD AL LL+++L F+P R E+ALA PY +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 412 VDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQ 452
EP + +F+ E L K+ ++E+I+ E + P
Sbjct: 304 PSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPG 342
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 281 bits (720), Expect = 1e-90
Identities = 148/346 (42%), Positives = 217/346 (62%), Gaps = 12/346 (3%)
Query: 107 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 166
T + RYQ +G G+YG V +A DT TG RVA+KK++ F+ + A R RE++LL
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 167 RLLRHPDIVEIKHIMLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 225
+ ++H +++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQI 130
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
LRGLKYIH+A++ HRDLKP N+ N DC+LKI DFGLAR + ++ T YVATRWY
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MTGYVATRWY 184
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
RAPE+ + + Y +DIWS+GCI AE+LTG+ LFPG + + QL L+ L+GTP E +
Sbjct: 185 RAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
+I +E AR Y+ S+ + + F++ F A+PLA+ LLE++L D R TA +ALA Y
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 406 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
F + D EP P + FE R L D+ + + Y E++ + P
Sbjct: 304 FAQYHDPDDEPVADPY---DQSFESRDLLIDEWKSLTYDEVISFVP 346
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 278 bits (711), Expect = 3e-89
Identities = 137/346 (39%), Positives = 212/346 (61%), Gaps = 12/346 (3%)
Query: 107 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 166
T + + Y+ + +G G+YG V SAVD TG +VAIKK+ F+ A R RE++LL
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 167 RLLRHPDIVEIKHIMLPPSRRE-FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 225
+ +RH +++ + + P + F D Y+V M +DL +++K ++ L + QF +YQ+
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQM 130
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
L+GL+YIH A + HRDLKP N+ N DC+LKI DFGLAR + ++ T YV TRWY
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTRWY 184
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
RAPE+ + + +YT +DIWS+GCI AEM+TGK LF G + + QL + + GTP E +
Sbjct: 185 RAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
R+++++A+ Y+ + + + F+ NA PLA++LLE++L D + R TA EALA PY
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303
Query: 406 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHP 451
F L + + EP Q K + F+ D+ + + Y+E+L + P
Sbjct: 304 FESLHDTEDEPQVQ---KYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (639), Expect = 1e-78
Identities = 120/354 (33%), Positives = 194/354 (54%), Gaps = 23/354 (6%)
Query: 107 TEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLL 166
+ + RYQ + IG G+ G+V +A D VAIKK++ F++ + A R RE+ L+
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 167 RLLRHPDIVEIKHIMLPPSR-REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 225
+ + H +I+ + ++ P EF+D+Y+V ELM+++L QVI+ D E + LYQ+
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQM 128
Query: 226 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
L G+K++H+A + HRDLKP NI+ +DC LKI DFGLAR + T YV TR+Y
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTPYVVTRYY 184
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
RAPE+ Y +DIWS+GCI EM+ K LFPG++ + Q + + + LGTP E +
Sbjct: 185 RAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNA------------DPLALHLLERLLAFDPKD 393
++ R Y+ + K + F FP++ A LL ++L DP
Sbjct: 243 KKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 394 RPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREIL 447
R + ++AL PY + + E P + + + R+ ++ +E+IY+E++
Sbjct: 302 RISVDDALQHPYINVWYDPA-EVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (635), Expect = 2e-78
Identities = 106/303 (34%), Positives = 153/303 (50%), Gaps = 7/303 (2%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
E S+Y+ IG+G++G V A TG++VA+KK+ E LREIK+L+LL+
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 67
Query: 171 HPDIVEIKHIMLPPSRREFKD---IYVVFELMESDLHQV-IKANDDLTPEHYQFFLYQLL 226
H ++V + I + + IY+VF+ E DL + T + + LL
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWY 285
GL YIH + HRD+K N+L D LK+ DFGLAR S +T+ V T WY
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
R PEL Y P ID+W GCI AEM T P+ G HQL L++ L G+ + E
Sbjct: 188 RPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 346 SRIRNEKARRYLGSMR-KKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
+ N + L ++ +K+ V K DP AL L+++LL DP R +++AL
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 405 YFH 407
+F
Sbjct: 307 FFW 309
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (616), Expect = 3e-75
Identities = 105/331 (31%), Positives = 170/331 (51%), Gaps = 21/331 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCN 74
Query: 174 IVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVI----KANDDLTPEHYQFFLYQLLRG 228
IV +++ ++ + + +V + + +++V +A L + + ++YQL R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 229 LKYIHTANVFHRDLKPKNILANADCKL-KICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
L YIH+ + HRD+KP+N+L + D + K+CDFG A+ P Y+ +R+YRA
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRA 190
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
PEL YT +ID+WS GC+ AE+L G+P+FPG + V QL + +LGTP+ E I
Sbjct: 191 PELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKF-PNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+ ++ P++ F P P A+ L RLL + P R T EA A +F
Sbjct: 250 MNPNYTEFKFPQIKAH---PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 407 HGLANVDREPSTQPISKLEFEFERRKLAKDD 437
L + + + + F F ++L+ +
Sbjct: 307 DELRDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 1e-73
Identities = 103/310 (33%), Positives = 154/310 (49%), Gaps = 22/310 (7%)
Query: 119 EVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDAT---RILREIKLLRLLRHPDIV 175
+ +G+G + V A D +T + VAIKKI + LREIKLL+ L HP+I+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 176 EIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 234
+ S +I +VF+ ME+D + + LTP H + ++ L+GL+Y+H
Sbjct: 64 GLLDAFGHKS-----NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 235 ANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSF 294
+ HRDLKP N+L + + LK+ DFGLA+ + + +T V TRWYRAPEL
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YTHQVVTRWYRAPELL-FG 174
Query: 295 FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354
Y +D+W++GCI AE+L P PG + + QL + + LGTP+ E + +
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDR 414
+ +P H F A L L++ L F+P R TA +AL YF
Sbjct: 235 VT---FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF------SN 285
Query: 415 EPSTQPISKL 424
P P +L
Sbjct: 286 RPGPTPGCQL 295
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 6e-72
Identities = 115/313 (36%), Positives = 167/313 (53%), Gaps = 21/313 (6%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Q E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKY 231
IV++ ++ ++ +Y+VFE + DL + + A+ + + +L+QLL+GL +
Sbjct: 63 IVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
H+ V HRDLKP+N+L N + +K+ DFGLAR +T V T WYRAPE+
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEIL 174
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
Y+ A+DIWS+GCIFAEM+T + LFPG + + QL + LGTP
Sbjct: 175 LG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP--GVT 231
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411
Y S K FS P D LL ++L +DP R +A+ ALA P+F +
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV-- 289
Query: 412 VDREPSTQPISKL 424
T+P+ L
Sbjct: 290 ------TKPVPHL 296
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (586), Expect = 2e-71
Identities = 103/305 (33%), Positives = 151/305 (49%), Gaps = 16/305 (5%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGER-VAIKKINDVFEHVSDATRILREIKLLRLL--- 169
+Y+ IG+G+YG V A D G R VA+K++ +RE+ +LR L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 227
HP++V + + + +VFE ++ DL + + + E + ++QLLR
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
GL ++H+ V HRDLKP+NIL + ++K+ DFGLAR+ T V T WYRA
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----LTSVVVTLWYRA 183
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
PE+ S Y +D+WS+GCIFAEM KPLF G + V QL + D++G P E R
Sbjct: 184 PEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
+ + K P + D L LL + L F+P R +A AL+ PYF
Sbjct: 242 DVALPRQAF----HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
Query: 408 GLANV 412
L
Sbjct: 298 DLERC 302
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 2e-71
Identities = 64/308 (20%), Positives = 119/308 (38%), Gaps = 28/308 (9%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
++ +G G+ GVV +G +A K I+ + + +I+RE+++L P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSPY 65
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
IV +I + E M+ L QV+K + + +++GL Y+
Sbjct: 66 IVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 233 HTAN-VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+ + HRD+KP NIL N+ ++K+CDFG++ + +V TR Y +PE
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----NSFVGTRSYMSPERL 175
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
+ Y+ DIWS+G EM G+ P + + + + E+ R R
Sbjct: 176 --QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 352 KARRYLGSMRKKQPVPFSHKFPNA-------------DPLALHLLERLLAFDPKDRPTAE 398
M + P+ + + L +P +R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 399 EALADPYF 406
+ + +
Sbjct: 294 QLMVHAFI 301
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 227 bits (579), Expect = 1e-70
Identities = 106/294 (36%), Positives = 159/294 (54%), Gaps = 13/294 (4%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y E IG+G+YGVV A + + GE A+KKI E + +REI +L+ L+H +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
IV++ ++ K + +VFE + + + L + FL QLL G+ Y
Sbjct: 62 IVKLYDVI-----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H V HRDLKP+N+L N + +LKI DFGLAR +T + T WYRAP++
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLM 173
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
KY+ IDIWS+GCIFAEM+ G PLFPG + QL + +LGTP++++ + +
Sbjct: 174 G-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--E 230
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
+Y + +P+P+ D + LL ++L DP R TA++AL YF
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 7e-70
Identities = 105/294 (35%), Positives = 151/294 (51%), Gaps = 11/294 (3%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
IV + ++ + K V + N DL PE + FL+QLL+GL + H
Sbjct: 63 IVRLHDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ NV HRDLKP+N+L N + +LK+ +FGLAR ++ V T WYR P++
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC---YSAEVVTLWYRPPDVLFG 175
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
Y+ +ID+WS GCIFAE+ PLFPG +V QL + LLGTP+ E + K
Sbjct: 176 -AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT--K 232
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
Y + P + LL+ LL +P R +AEEAL PYF
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 5e-68
Identities = 71/295 (24%), Positives = 120/295 (40%), Gaps = 37/295 (12%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+ + + +G+G+YG V AV+ T E VA+K + D+ V I +EI + ++L H +
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHEN 64
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLH-QVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+V+ + Y+ E I+ + + Q F +QL+ G+ Y+
Sbjct: 65 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H + HRD+KP+N+L + LKI DFGLA V F T Y APEL
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
+ +D+WS G + ML G+ + + Q
Sbjct: 179 R-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--------------------- 216
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407
K+ + + + D L LL ++L +P R T + D +++
Sbjct: 217 -------SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 220 bits (562), Expect = 7e-68
Identities = 80/326 (24%), Positives = 135/326 (41%), Gaps = 43/326 (13%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
Y ++V+G G++ V A D T + VAIK I + EI +L ++HP+
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPN 68
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
IV + I +Y++ +L+ +L I T ++Q+L +KY+
Sbjct: 69 IVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123
Query: 233 HTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
H + HRDLKP+N+L + D K+ I DFGL+++ + + T Y APE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL----STACGTPGYVAPE 179
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ Y+ A+D WSIG I +L G P F +N +
Sbjct: 180 VLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE------------------ 219
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409
+ K + S + + A + L+ DP+ R T E+AL P+ G
Sbjct: 220 ---------QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270
Query: 410 ANVDREPSTQPISKLEFEFERRKLAK 435
+D+ +++ F + K +
Sbjct: 271 TALDKNIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 7e-68
Identities = 70/293 (23%), Positives = 120/293 (40%), Gaps = 40/293 (13%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y E IG+G+ G V +A+D TG+ VAI+++N + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
IV L +++VV E + + + + L+ L+++H
Sbjct: 79 IVNYLDSYL-----VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 234 TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGS 293
+ V HRD+K NIL D +K+ DFG + + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR 190
Query: 294 FFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKA 353
Y P +DIWS+G + EM+ G+P + +N + L L+
Sbjct: 191 --KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------------------- 228
Query: 354 RRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
P + L R L D + R +A+E L +
Sbjct: 229 --------ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 219 bits (558), Expect = 4e-67
Identities = 76/350 (21%), Positives = 135/350 (38%), Gaps = 53/350 (15%)
Query: 103 TEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILR 161
E F + + IG GS+G V A D E VAIKK++ + I++
Sbjct: 5 AELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 162 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQF 220
E++ L+ LRHP+ ++ + L ++V E S + L
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119
Query: 221 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 280
+ L+GL Y+H+ N+ HRD+K NIL + +K+ DFG A + +V
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFV 172
Query: 281 ATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339
T ++ APE + +Y +D+WS+G E+ KP N + L +
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------ 226
Query: 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
+ + P S + + ++ L P+DRPT+E
Sbjct: 227 --------------------AQNESPALQSGHWS---EYFRNFVDSCLQKIPQDRPTSEV 263
Query: 400 ALADPYFHGLANVDREPSTQPISKLEFEF----ERRKLAKDDVREMIYRE 445
L + + P T + ++ E L +++++++E
Sbjct: 264 LLKHRFV-----LRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQE 308
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 217 bits (554), Expect = 2e-66
Identities = 91/312 (29%), Positives = 153/312 (49%), Gaps = 26/312 (8%)
Query: 108 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR 167
E+G YQ+ +G+G Y V A++ E+V +K + V + +I REIK+L
Sbjct: 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILE 84
Query: 168 LLR-HPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQL 225
LR P+I+ + I+ P R +VFE + +D Q+ + LT +F++Y++
Sbjct: 85 NLRGGPNIITLADIVKDPVSRT---PALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEI 138
Query: 226 LRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
L+ L Y H+ + HRD+KP N++ + + KL++ D+GLA + VA+R+
Sbjct: 139 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE----YNVRVASRY 194
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPSTE 343
++ PEL + Y ++D+WS+GC+ A M+ K P F G + QL + +LGT
Sbjct: 195 FKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 344 SISRIRNEKARRYLGSMRKKQP------VPFSHKFPNADPLALHLLERLLAFDPKDRPTA 397
N + + + S P AL L++LL +D + R TA
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 398 EEALADPYFHGL 409
EA+ PYF+ +
Sbjct: 314 REAMEHPYFYTV 325
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 214 bits (546), Expect = 7e-66
Identities = 74/306 (24%), Positives = 124/306 (40%), Gaps = 49/306 (16%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDA-------TRILREIKLL 166
Y+ +E++G+G VV + T + A+K I+ A L+E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 167 RLLR-HPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 224
R + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 64 RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
LL + +H N+ HRDLKP+NIL + D +K+ DFG + + T
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTPS 174
Query: 285 YRAPELC----GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340
Y APE+ Y +D+WS G I +L G P F + + L +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-------- 226
Query: 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400
+ S ++ + L+ R L P+ R TAEEA
Sbjct: 227 -------------------IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
Query: 401 LADPYF 406
LA P+F
Sbjct: 268 LAHPFF 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 7e-66
Identities = 71/333 (21%), Positives = 140/333 (42%), Gaps = 48/333 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
+Y I E +G+G +G+V V+T + + K + +D + +EI +L + RH +
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRN 62
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKY 231
I+ + +++ ++FE + D+ + I + +L +++Q+ L++
Sbjct: 63 ILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 232 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+H+ N+ H D++P+NI+ +KI +FG AR + +T Y APE
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT----APEYYAPE 173
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ + A D+WS+G + +L+G F + ++
Sbjct: 174 VHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE------------------ 213
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409
++ + F A+ ++RLL + K R TA EAL P+
Sbjct: 214 ---------NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ- 263
Query: 410 ANVDREPSTQPISKLEFEFERRKLAKDDVREMI 442
++R ST+ I L+ L K D+ ++
Sbjct: 264 -KIER-VSTKVIRTLKHRRYYHTLIKKDLNMVV 294
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 1e-65
Identities = 67/316 (21%), Positives = 113/316 (35%), Gaps = 50/316 (15%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
++I +G G++G V A + T A K I+ + + + EI +L HP+
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPN 70
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGLKY 231
IV++ +++++ E + + LT Q Q L L Y
Sbjct: 71 IVKLLDAF-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 125
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+H + HRDLK NIL D +K+ DFG++ + ++ T ++ APE+
Sbjct: 126 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEVV 182
Query: 292 GSFFSK---YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
SK Y D+WS+G EM +P N + L +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-------------- 228
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408
K P + L++ L + R T + L P+
Sbjct: 229 --------------KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV-- 272
Query: 409 LANVDREPSTQPISKL 424
S +PI +L
Sbjct: 273 -----TVDSNKPIREL 283
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 215 bits (549), Expect = 2e-65
Identities = 74/333 (22%), Positives = 127/333 (38%), Gaps = 45/333 (13%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPT 84
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI-KANDDLTPEHYQFFLYQLLRGLKY 231
+V + + ++ +++E M +L + + ++ ++ + ++ Q+ +GL +
Sbjct: 85 LVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139
Query: 232 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+H N H DLKP+NI+ +LK+ DFGL T + APE
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH----LDPKQSVKVTTGTAEFAAPE 195
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ D+WS+G + +L+G F G+N L
Sbjct: 196 VA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN----------------- 236
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409
++ F + +LL DP R T +AL P+
Sbjct: 237 ----------VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP- 285
Query: 410 ANVDREPSTQPISKLEFEFERRKLAKDDVREMI 442
N S P S+ + K D E +
Sbjct: 286 GNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPL 318
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 3e-65
Identities = 69/296 (23%), Positives = 118/296 (39%), Gaps = 45/296 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRH 171
++I +GKG +G V A + + +A+K + E ++ RE+++ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
P+I+ + +R +Y++ E +++ ++ + ++ +L L
Sbjct: 66 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
Y H+ V HRD+KP+N+L + +LKI DFG + APS+ T T Y PE+
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTT-LCGTLDYLPPEM 175
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
+ +D+WS+G + E L GKP F +
Sbjct: 176 IEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------- 216
Query: 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
R + P A L+ RLL +P RP E L P+
Sbjct: 217 ---------SRVEFTFP-----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 214 bits (546), Expect = 5e-65
Identities = 75/326 (23%), Positives = 129/326 (39%), Gaps = 48/326 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
Y I E +G G++GVV V+ TG K IN + D + EI ++ L HP
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPK 87
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKY 231
++ + + ++ ++ E + +L I A D ++ ++ Q GLK+
Sbjct: 88 LINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142
Query: 232 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+H ++ H D+KP+NI+ +KI DFGLA D AT + APE
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KVTTATAEFAAPE 198
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ D+W+IG + +L+G F G++ + L +
Sbjct: 199 IVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV---------------- 240
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409
++ F + P A ++ LL +P+ R T +AL P+ G
Sbjct: 241 -----------KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG- 288
Query: 410 ANVDREPSTQPISKLEFEFERRKLAK 435
D T I + R+K+ +
Sbjct: 289 ---DHSNLTSRIPSSRYNKIRQKIKE 311
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 2e-64
Identities = 79/304 (25%), Positives = 118/304 (38%), Gaps = 48/304 (15%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
A Y++ IG GSYG G+ + K+++ ++ ++ E+ LLR L+H
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD----LTPEHYQFFLYQLL 226
P+IV ++ + +Y+V E E DL VI L E + QL
Sbjct: 63 PNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 227 RGLKYIH-----TANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVA 281
LK H V HRDLKP N+ + +K+ DFGLAR+ +D A +V
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KAFVG 176
Query: 282 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
T +Y +PE Y DIWS+GC+ E+ P F +
Sbjct: 177 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---------- 224
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+IR K RR ++ R+L RP+ EE L
Sbjct: 225 -----KIREGKFRRI---------------PYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
Query: 402 ADPY 405
+P
Sbjct: 265 ENPL 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 3e-63
Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 41/296 (13%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+ IG+GS+ V +DT T VA ++ D S+ R E ++L+ L+HP+I
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 175 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 233
V + + K I +V ELM S L +K + + + + Q+L+GL+++H
Sbjct: 71 VRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 234 TAN--VFHRDLKPKNIL-ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
T + HRDLK NI +KI D GLA + F + T + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEM 184
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
+ KY ++D+++ G EM T + + Q+
Sbjct: 185 ---YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-------------------- 221
Query: 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406
R V + A P ++E + + +R + ++ L +F
Sbjct: 222 --------YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 6e-63
Identities = 78/351 (22%), Positives = 140/351 (39%), Gaps = 46/351 (13%)
Query: 114 RYQI-QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIK-LLRLLRH 171
Y++ +V+G G G V + T E+ A+K + D + RE++ R +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQC 64
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRG 228
P IV I + K + +V E ++ +L I+ D T + +
Sbjct: 65 PHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 229 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWY 285
++Y+H+ N+ HRD+KP+N+L + LK+ DFG A+ + S T T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHNSLTTPCYTPYY 179
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
APE+ G KY + D+WS+G I +L G P F + + M +
Sbjct: 180 VAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI-------- 229
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPY 405
R Q + ++ L+ LL +P R T E + P+
Sbjct: 230 ---------------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274
Query: 406 FHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQE 456
V + P L+ + ER + K+++ + ++Y +++
Sbjct: 275 IMQSTKVPQTPLHTSRV-LKEDKERWEDVKEEMTSALATMRVDYEQIKIKK 324
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 8e-62
Identities = 72/304 (23%), Positives = 121/304 (39%), Gaps = 47/304 (15%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
++ +++G+GS+ V A + T AIK + + + RE ++ L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
V++ + +Y + +L + I+ +F+ +++ L+Y
Sbjct: 69 FFVKLYFTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
+H + HRDLKP+NIL N D ++I DFG A+V ++ A +V T Y +PEL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPELL 182
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
+ D+W++GCI +++ G P F N +
Sbjct: 183 TE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------------------ 222
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA------LADPY 405
K F KF P A L+E+LL D R EE A P+
Sbjct: 223 ----------IKLEYDFPEKFF---PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 406 FHGL 409
F +
Sbjct: 270 FESV 273
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 3e-59
Identities = 63/293 (21%), Positives = 104/293 (35%), Gaps = 38/293 (12%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+ + + IG GS+G V VA+K +N E+ +LR RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLK 230
+I+ + +V + E S L+ + + Q +G+
Sbjct: 65 NILLFMGYS------TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE- 289
Y+H ++ HRDLK NI + D +KI DFGLA V + S F + + APE
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAPEV 177
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
+ + Y+ D+++ G + E++TG+ + N Q+ M
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--------------- 222
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
R S N L+ L +RP + LA
Sbjct: 223 ----------GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 196 bits (499), Expect = 5e-59
Identities = 72/293 (24%), Positives = 119/293 (40%), Gaps = 33/293 (11%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
RY++ E++G G V A D VA+K + D+ S R RE + L HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 231
IV + + Y+V E ++ L ++ +TP+ + + L +
Sbjct: 68 AIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 232 IHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELC 291
H + HRD+KP NI+ +A +K+ DFG+AR + S + T Y +PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 292 GSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
D++S+GC+ E+LTG+P F G + V
Sbjct: 187 RG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----------------- 227
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-TAEEALAD 403
++ P+P S + ++ + LA +P++R TA E AD
Sbjct: 228 ----------REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-58
Identities = 74/304 (24%), Positives = 115/304 (37%), Gaps = 47/304 (15%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRLL 169
Y E +G G + VV + TG + A K I I RE+ +L+ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRG 228
+HP+++ + + D+ ++ EL+ L + + LT E FL Q+L G
Sbjct: 71 QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 229 LKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
+ Y+H+ + H DLKP+NI+ ++KI DFGLA + T
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPE 181
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
+ APE+ D+WSIG I +L+G F G L +
Sbjct: 182 FVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----------- 228
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404
F N LA + RLL DPK R T +++L P
Sbjct: 229 ----------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272
Query: 405 YFHG 408
+
Sbjct: 273 WIKP 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 5e-57
Identities = 69/307 (22%), Positives = 118/307 (38%), Gaps = 57/307 (18%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLR 167
S+YQ+ ++G G +G V S + VAIK + + + + TR+ E+ LL+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 168 LLR--HPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLY 223
+ ++ + P ++ E E DL I L E + F +
Sbjct: 63 KVSSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 224 QLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVSFNDAPSAIFWTDYVAT 282
Q+L +++ H V HRD+K +NIL + + +LK+ DFG + + +TD+ T
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGT 172
Query: 283 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342
R Y PE + + + +WS+G + +M+ G F +
Sbjct: 173 RVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------- 216
Query: 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
+ V F + HL+ LA P DRPT EE
Sbjct: 217 -------------------IRGQVFFRQRVS---SECQHLIRWCLALRPSDRPTFEEIQN 254
Query: 403 DPYFHGL 409
P+ +
Sbjct: 255 HPWMQDV 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 6e-56
Identities = 65/300 (21%), Positives = 113/300 (37%), Gaps = 45/300 (15%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLL-RLLRH 171
+ + +++GKGS+G V A T + AIK + DV D + E ++L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
P + + ++ V E + DL I++ F+ +++ GL+
Sbjct: 63 PFLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
++H+ + +RDLK NIL + D +KI DFG+ + + + T Y APE+
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEI 174
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350
KY ++D WS G + EML G+ F G++
Sbjct: 175 LLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH------------------- 213
Query: 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE-EALADPYFHGL 409
+ + A LL +L +P+ R + P F +
Sbjct: 214 ---------SIRMDNPFYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-54
Identities = 68/302 (22%), Positives = 125/302 (41%), Gaps = 48/302 (15%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 173
+ +++GKG++G V + TG A+K + +V + + E ++L+ RHP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+ +K+ R + V E L + T E +F+ +++ L+Y+
Sbjct: 67 LTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+ +V +RD+K +N++ + D +KI DFGL + +D + + T Y APE+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEVLE 178
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
+ Y A+D W +G + EM+ G+ F ++ +L+
Sbjct: 179 D--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------------------- 217
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFH 407
+ + F P A LL LL DPK R A+E + +F
Sbjct: 218 ---------LMEEIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 408 GL 409
+
Sbjct: 266 SI 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 180 bits (458), Expect = 4e-52
Identities = 66/306 (21%), Positives = 115/306 (37%), Gaps = 49/306 (16%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN----DVFEHVSDATRILREIKLLRLL 169
+ + +IG+G +G V TG+ A+K ++ + + + A + L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 228
P IV + + P + + + +LM DLH + + + +F+ +++ G
Sbjct: 65 DCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
L+++H V +RDLKP NIL + ++I D GLA P A T Y AP
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-----THGYMAP 174
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
E+ Y + D +S+GC+ ++L G F + ++
Sbjct: 175 EVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------- 218
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALAD 403
+ + P LLE LL D R A+E
Sbjct: 219 -------------RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265
Query: 404 PYFHGL 409
P+F L
Sbjct: 266 PFFRSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 178 bits (453), Expect = 6e-52
Identities = 65/302 (21%), Positives = 117/302 (38%), Gaps = 51/302 (16%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 173
+QI +G GS+G V H G A+K + ++ + E +L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKYI 232
I+ + ++ + I+++ + +E + P +F+ ++ L+Y+
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+ ++ +RDLKP+NIL + + +KI DFG A+ + T Y APE+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVS 174
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
+ Y +ID WS G + EML G F N + + +
Sbjct: 175 T--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------------------- 213
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFH 407
+ + P P + LL RL+ D R E+ P+F
Sbjct: 214 -------LNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
Query: 408 GL 409
+
Sbjct: 262 EV 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-50
Identities = 58/293 (19%), Positives = 111/293 (37%), Gaps = 52/293 (17%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
++ + IGKG +G V + G +VA+K I + + A L E ++ LRH
Sbjct: 7 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHS 60
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGL 229
++V++ +++ E +Y+V E M L +++ L + F + +
Sbjct: 61 NLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+Y+ N HRDL +N+L + D K+ DFGL + + + + APE
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------QDTGKLPVKWTAPE 170
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
K++ D+WS G + E+ + G+ +P + + + R+
Sbjct: 171 AL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------------KDVVPRV 213
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
K P P +++ D RP+ +
Sbjct: 214 EKG----------YKMDAP-----DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-50
Identities = 67/304 (22%), Positives = 112/304 (36%), Gaps = 30/304 (9%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
A +QE IGKG +G V GE VA+K + + EI +LRH
Sbjct: 2 ARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRH 56
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 230
+I+ + + +++V + E L + +T E GL
Sbjct: 57 ENILGFIAADNKDNGT-WTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLA 114
Query: 231 YIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSA-IFWTDYVA 281
++H + HRDLK KNIL + I D GLA + + I V
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 282 TRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLL 337
T+ Y APE+ + + DI+++G +F E+ + G + +QL +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 338 GTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTA 397
PS E + ++ E+ R +P + A + ++ + R TA
Sbjct: 234 SDPSVEEMRKVVCEQKLRP--------NIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
Query: 398 EEAL 401
Sbjct: 286 LRIK 289
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-49
Identities = 59/294 (20%), Positives = 111/294 (37%), Gaps = 45/294 (15%)
Query: 120 VIGKGSYGVV--GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 177
+G G++G V G + VA+K + + + +L E +++ L +P IV +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 178 KHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 236
I E + +V E+ E L++ ++ N + ++ ++Q+ G+KY+ +N
Sbjct: 74 IGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 237 VFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFS 296
HRDL +N+L KI DFGL++ D T + APE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--Y 185
Query: 297 KYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARR 355
K++ D+WS G + E + G+ + G +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM----------------------- 222
Query: 356 YLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE---ALADPYF 406
+ K + + P L+ +D ++RP L + Y+
Sbjct: 223 ----LEKGERMGCPAGCP---REMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-49
Identities = 62/326 (19%), Positives = 128/326 (39%), Gaps = 47/326 (14%)
Query: 98 KSALETEFFTEYGE---ASRYQIQEVIGKGSYGVVGSAVDTH---TGERVAIKKIN--DV 149
K L T T + E +++ +V+G G+YG V TG+ A+K + +
Sbjct: 6 KHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI 65
Query: 150 FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIK 208
+ E ++L +R + + L + + ++++ + + +L +
Sbjct: 66 VQKAKTTEHTRTERQVLEHIRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLS 121
Query: 209 ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268
+ T Q ++ +++ L+++H + +RD+K +NIL +++ + + DFGL++ F
Sbjct: 122 QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFV 180
Query: 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH 328
+ + + + G S + A+D WS+G + E+LTG F +
Sbjct: 181 ADETERAYDFCGTIEYMAPDIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239
Query: 329 QLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLA 388
+ ++ + P P LA L++RLL
Sbjct: 240 SQAEI----------------------SRRILKSEPPYP-----QEMSALAKDLIQRLLM 272
Query: 389 FDPKDRP-----TAEEALADPYFHGL 409
DPK R A+E +F +
Sbjct: 273 KDPKKRLGCGPRDADEIKEHLFFQKI 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 171 bits (433), Expect = 2e-49
Identities = 49/298 (16%), Positives = 95/298 (31%), Gaps = 43/298 (14%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH 171
Y++ IG+GS+GV+ + ++VAIK SDA ++ E + +LL
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAG 59
Query: 172 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLK 230
+ + +E +V +L+ L ++ + + Q+L ++
Sbjct: 60 CTGIPNVYYFG----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 231 YIHTANVFHRDLKPKNILANADC-----KLKICDFGLARVSFNDAPSAIFW----TDYVA 281
IH ++ +RD+KP N L + + DFG+ + + +
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 282 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341
T Y + + + D+ ++G +F L G + G
Sbjct: 176 TARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----------- 222
Query: 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE 399
+ RI KKQ P + P +
Sbjct: 223 -QKYERI-----------GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDY 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (433), Expect = 3e-49
Identities = 54/304 (17%), Positives = 96/304 (31%), Gaps = 44/304 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 173
RY++ IG GS+G + D GE VAIK +H ++ E K+ ++++
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGV 63
Query: 174 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+ E +V EL+ S + + + Q++ ++YI
Sbjct: 64 GIPTIRW----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 233 HTANVFHRDLKPKNILAN---ADCKLKICDFGLARVSFNDAPSAIFW----TDYVATRWY 285
H+ N HRD+KP N L + I DFGLA+ + + T Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 286 RAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345
+ + + D+ S+G + G + G +
Sbjct: 180 ASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-------------- 223
Query: 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE---EALA 402
+Y KK P L + D+P +
Sbjct: 224 ---------KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 403 DPYF 406
+ +
Sbjct: 275 NLFH 278
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-49
Identities = 70/314 (22%), Positives = 115/314 (36%), Gaps = 55/314 (17%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+++ +G+G +G V T RVAIK + L+E ++++ LRH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 72
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME---SDLHQVIKANDDLTPEHYQFFLYQLLRGL 229
+V++ ++ + IY+V E M + L Q+ G+
Sbjct: 73 KLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ +A + APE
Sbjct: 127 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR--QGAKFPIKWTAPE 184
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
++T D+WS G + E+ T G+ +PG LD + P
Sbjct: 185 AALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP-- 240
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA--DPYF 406
L+ + +P++RPT E A + YF
Sbjct: 241 ----------------------------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
Query: 407 HGLANVDREPSTQP 420
EP QP
Sbjct: 273 -----TSTEPQYQP 281
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 172 bits (436), Expect = 4e-49
Identities = 66/340 (19%), Positives = 116/340 (34%), Gaps = 47/340 (13%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
+RY + +G G + V A D VA+K + EIKLL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDA 69
Query: 173 DIVE------------IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQF 220
D + + H + + + + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 221 FLYQLLRGLKYIHTA-NVFHRDLKPKNILANAD------CKLKICDFGLARVSFNDAPSA 273
QLL GL Y+H + H D+KP+N+L ++KI D G A
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---- 185
Query: 274 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNV------V 327
+T+ + TR YR+PE+ + + DIWS C+ E++TG LF
Sbjct: 186 --YTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 328 HQLDLMTDLLGTPSTESISRIRNEK----ARRYLGSMRKKQPVPFSHKF-------PNAD 376
+ + +LLG + + + + +R L ++ K + P +
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 377 PLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREP 416
L +L DP+ R A + P+ ++
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (435), Expect = 5e-49
Identities = 55/301 (18%), Positives = 107/301 (35%), Gaps = 49/301 (16%)
Query: 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 172
++ + +G GS+G V +G A+K ++ + L E ++L+ + P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
+V+++ + V+ + ++ ++ + H +F+ Q++ +Y+
Sbjct: 102 FLVKLEFSF----KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
H+ ++ +RDLKP+N+L + +++ DFG A+ T APE+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEIIL 211
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352
S Y A+D W++G + EM G P F + +
Sbjct: 212 S--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE--------------------- 248
Query: 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDR-----PTAEEALADPYFH 407
V F F LL LL D R + +F
Sbjct: 249 -------KIVSGKVRFPSHFS---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 408 G 408
Sbjct: 299 T 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (431), Expect = 6e-49
Identities = 63/318 (19%), Positives = 114/318 (35%), Gaps = 48/318 (15%)
Query: 94 DPHKKSALE--TEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGER---VAIKKIND 148
DP F + + S +I++VIG G +G V S G+R VAIK +
Sbjct: 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS 64
Query: 149 VFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK 208
+ L E ++ HP+++ ++ ++ + + ++ E ME+
Sbjct: 65 GYTE-KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFL 118
Query: 209 ANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266
+D T L + G+KY+ N HRDL +NIL N++ K+ DFGL+R
Sbjct: 119 RQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 267 FNDAPSAIFWT--DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPG 323
+D + + + AP + K+T A D+WS G + E+++ G+ +
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAP--EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236
Query: 324 KNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLL 383
++ + P L+
Sbjct: 237 MTNQDVINAIEQDYRLPPPMDCP------------------------------SALHQLM 266
Query: 384 ERLLAFDPKDRPTAEEAL 401
D RP + +
Sbjct: 267 LDCWQKDRNHRPKFGQIV 284
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 8e-49
Identities = 63/295 (21%), Positives = 106/295 (35%), Gaps = 44/295 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAV---DTHTGERVAIKKIN-DVFEHVSDATRILREIKLLRLL 169
++ E +G GS+GVV + VA+K + DV +RE+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 227
H +++ + ++ + +V EL S L ++ K + Q+
Sbjct: 69 DHRNLIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
G+ Y+ + HRDL +N+L +KI DFGL R + + + A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
PE + ++ A D W G EM T G+ + G N L
Sbjct: 183 PESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH--------------- 225
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
+I E R P P + +++ + A P+DRPT
Sbjct: 226 KIDKEGERL---------PRP-----EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (421), Expect = 1e-47
Identities = 59/310 (19%), Positives = 117/310 (37%), Gaps = 45/310 (14%)
Query: 93 MDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH 152
MDP + + E E + ++ +G G YG V V VA+K + E
Sbjct: 2 MDPSSPNYDKWEM-----ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---ED 53
Query: 153 VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD 212
+ L+E +++ ++HP++V++ + ++ + + L + +
Sbjct: 54 TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQE 111
Query: 213 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272
++ + Q+ ++Y+ N HRDL +N L + +K+ DFGL+R+ D +
Sbjct: 112 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171
Query: 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLD 331
A + APE +K++ D+W+ G + E+ T G +PG ++ +
Sbjct: 172 A--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 227
Query: 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP 391
L + K + P L+ ++P
Sbjct: 228 L---------------------------LEKDYRMERPEGCP---EKVYELMRACWQWNP 257
Query: 392 KDRPTAEEAL 401
DRP+ E
Sbjct: 258 SDRPSFAEIH 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 5e-47
Identities = 63/300 (21%), Positives = 108/300 (36%), Gaps = 50/300 (16%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
++ E +G G +G V + +VA+K + + L E L++ L+H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQ 68
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELMESDL---HQVIKANDDLTPEHYQFFLYQLLRGL 229
+V + ++ + IY++ E ME+ + LT Q+ G+
Sbjct: 69 RLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 230 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPE 289
+I N HRDL+ NIL + KI DFGLAR + + APE
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPE 180
Query: 290 LCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348
+ +T D+WS G + E++T G+ +PG + +
Sbjct: 181 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------- 225
Query: 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA--DPYF 406
R +P N L+ P+DRPT + + + +F
Sbjct: 226 ----------GYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 7e-47
Identities = 66/321 (20%), Positives = 122/321 (38%), Gaps = 69/321 (21%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGER-----VAIKKINDVFEHVSDATRILREIKLL- 166
+ +V+G G++G V +A + VA+K + + + S+ ++ E+K++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMT 95
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD------------- 212
+L H +IV + IY++FE DL +++ +
Sbjct: 96 QLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 213 ----------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262
LT E F YQ+ +G++++ + HRDL +N+L +KICDFGL
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLF 321
AR +D+ + + + APE F YT D+WS G + E+ + G +
Sbjct: 211 ARDIMSDSNY-VVRGNARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVNPY 267
Query: 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH 381
PG V + ++ + A
Sbjct: 268 PGIPVDANFYKL--------------------------IQNGFKMDQP---FYATEEIYI 298
Query: 382 LLERLLAFDPKDRPTAEEALA 402
+++ AFD + RP+ +
Sbjct: 299 IMQSCWAFDSRKRPSFPNLTS 319
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-46
Identities = 60/309 (19%), Positives = 116/309 (37%), Gaps = 48/309 (15%)
Query: 114 RYQIQEV-IGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLLRLLR 170
I ++ +G G++G V V ++ VAIK + E +D ++RE +++ L
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLD 67
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRG 228
+P IV + + + + + +V E+ LH+ + +++ + L+Q+ G
Sbjct: 68 NPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAP 288
+KY+ N HRDL +N+L KI DFGL++ D + + AP
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 289 ELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347
E K++ D+WS G E L+ G+ + +
Sbjct: 182 ECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--------------- 224
Query: 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE---ALADP 404
+ + + + P P L+ + +DRP +
Sbjct: 225 ------------IEQGKRMECP---PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
Query: 405 YFHGLANVD 413
Y+ + V+
Sbjct: 270 YYSLASKVE 278
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-46
Identities = 51/292 (17%), Positives = 101/292 (34%), Gaps = 46/292 (15%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 174
+ +G G +GVV VAIK I E + E K++ L H +
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 175 VEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 232
V++ + + + I+++ E M L+ + + + + ++Y+
Sbjct: 62 VQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 233 HTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCG 292
+ HRDL +N L N +K+ DFGL+R +D ++ + PE+
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SVGSKFPVRWSPPEVLM 174
Query: 293 SFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351
SK++ DIW+ G + E+ + GK + +
Sbjct: 175 Y--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH------------------- 213
Query: 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+ + + H ++ +RPT + L++
Sbjct: 214 --------IAQGLRLYRPHLAS---EKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-45
Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 46/292 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP 172
S + IG G +G+V ++VAIK I E + E +++ L HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHP 60
Query: 173 DIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHY-QFFLYQLLRGLK 230
+V++ + L + I +VFE ME L ++ L + G+
Sbjct: 61 KLVQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 231 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPEL 290
Y+ A V HRDL +N L + +K+ DFG+ R +D T + +PE+
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEV 173
Query: 291 CGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349
FS+Y+ D+WS G + E+ + GK + ++ ++ ++
Sbjct: 174 F--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-------------- 217
Query: 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEAL 401
R +P A ++ P+DRP L
Sbjct: 218 ---------GFRLYKP-------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-44
Identities = 59/298 (19%), Positives = 115/298 (38%), Gaps = 43/298 (14%)
Query: 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLL 166
S Q+VIG G +G V + + + VAIK + + L E ++
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIM 63
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQ 224
H +I+ ++ ++ ++K + ++ E ME + + + + + + L
Sbjct: 64 GQFSHHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 225 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRW 284
+ G+KY+ N HRDL +NIL N++ K+ DFGL+RV +D + +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 285 YRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTES 344
+ APE K+T A D+WS G + E++T + H++
Sbjct: 179 WTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------------- 222
Query: 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
+ ++ +P P L+ + + RP + ++
Sbjct: 223 ------------MKAINDGFRLPTPMDCP---SAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-43
Identities = 55/297 (18%), Positives = 108/297 (36%), Gaps = 43/297 (14%)
Query: 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGER----VAIKKINDVFEHVSDATRILREIKLLR 167
+ ++ +V+G G++G V + GE+ VAIK++ + ++ IL E ++
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 66
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR 227
+ +P + + I L + + + L V + D++ ++ + Q+ +
Sbjct: 67 SVDNPHVCRLLGICLTSTVQ----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
G+ Y+ + HRDL +N+L +KI DFGLA++ + A
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMA 181
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
E YT D+WS G E++T G + G ++
Sbjct: 182 LESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----------- 228
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
++ P P P ++ + D RP E + +
Sbjct: 229 --------------GERLPQP-----PICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-43
Identities = 62/297 (20%), Positives = 108/297 (36%), Gaps = 47/297 (15%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGER---VAIKKINDVFEHVSDATRILREIKLLRLL 169
R ++ IG+G +G V + VAIK + S + L+E +R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQF 65
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 227
HP IV++ ++ ++++ EL + L + YQL
Sbjct: 66 DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 228 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRA 287
L Y+ + HRD+ +N+L +++ +K+ DFGL+R + + + + + A
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMA 177
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
PE ++T A D+W G E+L G F G +
Sbjct: 178 PESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-------------- 221
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403
+ + +P PN P L+ + A+DP RP E A
Sbjct: 222 -------------IENGERLPMP---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-43
Identities = 57/296 (19%), Positives = 109/296 (36%), Gaps = 44/296 (14%)
Query: 114 RYQIQEVIGKGSYGVVGSAVD---THTGERVAIKKINDVFEHVSDATRILREIKLLRLLR 170
EVIG+G +G V A+K +N + + + ++ L E +++
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFS 86
Query: 171 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ--FFLYQLLRG 228
HP+++ + I L VV M+ + N+ P F Q+ +G
Sbjct: 87 HPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142
Query: 229 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWYRA 287
+K++ + HRDL +N + + +K+ DFGLAR + + S T + A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 288 PELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346
E + K+T D+WS G + E++T G P +P N
Sbjct: 203 LESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-------------- 246
Query: 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402
+ + + + P+ ++ + + RP+ E ++
Sbjct: 247 -------------LLQGRRLLQPEYCPDP---LYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 4e-43
Identities = 54/320 (16%), Positives = 104/320 (32%), Gaps = 70/320 (21%)
Query: 113 SRYQIQEVIGKGSYGVV-----GSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLR 167
+ + IG+G++G V + VA+K + + RE L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMA 71
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD-------------- 212
+P+IV++ + + ++FE M DL++ +++
Sbjct: 72 EFDNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 213 ----------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 262
L+ Q+ G+ Y+ HRDL +N L + +KI DFGL
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLF 321
+R ++ D + RW + ++YT D+W+ G + E+ + G +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFY---NRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 322 PGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALH 381
G + +R + P +
Sbjct: 244 YGMAHEEVIYY---------------------------VRDGNILACPENCP---LELYN 273
Query: 382 LLERLLAFDPKDRPTAEEAL 401
L+ + P DRP+
Sbjct: 274 LMRLCWSKLPADRPSFCSIH 293
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-42
Identities = 64/311 (20%), Positives = 110/311 (35%), Gaps = 63/311 (20%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLL-RLL 169
+ + Q+VIG+G++G V A G R AIK++ + D E+++L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLG 68
Query: 170 RHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD---------------- 212
HP+I+ + +Y+ E +L ++ +
Sbjct: 69 HHPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 213 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272
L+ + F + RG+ Y+ HRDL +NIL + KI DFGL+R
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
Query: 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLD 331
T + A E S YT D+WS G + E+++ G + G +
Sbjct: 184 ----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237
Query: 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDP 391
+ R ++P N D L+ + P
Sbjct: 238 KLPQ-----------------------GYRLEKP-------LNCDDEVYDLMRQCWREKP 267
Query: 392 KDRPTAEEALA 402
+RP+ + L
Sbjct: 268 YERPSFAQILV 278
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-42
Identities = 66/315 (20%), Positives = 114/315 (36%), Gaps = 64/315 (20%)
Query: 113 SRYQIQEVIGKGSYGVVGSA-----VDTHTGERVAIKKINDVFEHVSDATRILREIKLL- 166
+R + +G G++G V A + + VA+K + H+++ ++ E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKVLS 81
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD------------- 212
L H +IV + V+ E DL ++ D
Sbjct: 82 YLGNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 213 -----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267
L E F YQ+ +G+ ++ + N HRDL +NIL KICDFGLAR
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNV 326
ND+ + + +W + YT D+WS G E+ + G +PG V
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 386
+ M +++ + P +++
Sbjct: 254 DSKFYKM--------------------------IKEGFRMLSPEHAP---AEMYDIMKTC 284
Query: 387 LAFDPKDRPTAEEAL 401
DP RPT ++ +
Sbjct: 285 WDADPLKRPTFKQIV 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-41
Identities = 59/317 (18%), Positives = 115/317 (36%), Gaps = 65/317 (20%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTHTGE-------RVAIKKINDVFEHVSDATRILREIKL 165
R + + +G+G++G V A + +VA+K + D + ++ E+++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEM 71
Query: 166 L-RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIK--------------- 208
+ + +H +I+ + + +YV+ E +L + ++
Sbjct: 72 MKMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 209 -ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267
+ L+ + YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNV 326
+ + +W L YT D+WS G + E+ T G +PG V
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 327 VHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERL 386
L +++ + N ++
Sbjct: 244 EELFKL---------------------------LKEGHRMDKPSNCTNE---LYMMMRDC 273
Query: 387 LAFDPKDRPTAEEALAD 403
P RPT ++ + D
Sbjct: 274 WHAVPSQRPTFKQLVED 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 54/307 (17%), Positives = 104/307 (33%), Gaps = 56/307 (18%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLR 167
+ + +G+GS+G+V V RVAIK +N+ + L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMK 78
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD----------LTPE 216
+V + ++ V+ ELM DL +++ +
Sbjct: 79 EFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 217 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFW 276
++ G+ Y++ HRDL +N + D +KI DFG+ R +
Sbjct: 134 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKG 192
Query: 277 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTD 335
+ + +PE +T D+WS G + E+ T + + G + L + +
Sbjct: 193 GKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
Query: 336 LLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP 395
P N + L+ ++PK RP
Sbjct: 251 -------------------------GGLLDKP-----DNCPDMLFELMRMCWQYNPKMRP 280
Query: 396 TAEEALA 402
+ E ++
Sbjct: 281 SFLEIIS 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 3e-40
Identities = 64/312 (20%), Positives = 114/312 (36%), Gaps = 59/312 (18%)
Query: 113 SRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLR 167
R ++ + +G+G++G V A T T VA+K + + H + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 168 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN---------------- 210
+ H ++V + P + V+ E + +L +++
Sbjct: 73 IGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 211 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270
D LT EH + +Q+ +G++++ + HRDL +NIL + +KICDFGLAR + D
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD- 187
Query: 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQ 329
P + D + APE YT D+WS G + E+ + +PG + +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 330 LDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAF 389
R+ + P +
Sbjct: 246 F-----------------------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 276
Query: 390 DPKDRPTAEEAL 401
+P RPT E +
Sbjct: 277 EPSQRPTFSELV 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 98.7 bits (245), Expect = 2e-24
Identities = 25/203 (12%), Positives = 59/203 (29%), Gaps = 27/203 (13%)
Query: 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKI--------NDVFEHVSDATRILREIKLL 166
I +++G+G V + +K +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 167 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL 226
+ +++ + +P ++ V+ EL+++ ++ E+ L +L
Sbjct: 61 ARNEFRALQKLQGLAVPK-VYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMIL 113
Query: 227 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VSFNDAPSAIFWTDYVATRWY 285
+ + + H DL N+L ++ + I DF + V + ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVL-VSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 286 RAPELCGSFFSKYTPAIDIWSIG 308
Y DI S
Sbjct: 173 S---------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 595 | |||
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.14 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.8 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.33 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.91 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.26 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.39 |
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-61 Score=504.24 Aligned_cols=330 Identities=41% Similarity=0.775 Sum_probs=275.1
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REF 189 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~ 189 (595)
..++|++++.||+|+||+||+|.++.+|+.||||+++.........+.+.+|+++|+.++|||||+++++|..... ...
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4579999999999999999999999999999999998665555667789999999999999999999999976532 334
Q ss_pred ccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 190 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 190 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.++|||||||+.+|..+++. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~ 174 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174 (346)
T ss_dssp CCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred ceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc
Confidence 56899999998888877654 57999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.+..+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+....+.++.+.+....
T Consensus 175 ------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 175 ------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp ------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ------cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 2457899999999998763 567899999999999999999999999999999999999999999998888777
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHH
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFE 429 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e 429 (595)
......+...........+...++.+++.+++||.+||.+||.+||||.|+|+||||+.+.+...+|..+ +++..++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~---~~~~~~~ 324 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYDDSFD 324 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCCCC--
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC---CCCCchh
Confidence 7767777777777667777778889999999999999999999999999999999999987766655443 4455566
Q ss_pred HhhhcHHHHHHHHHHHHHhhCh
Q 007629 430 RRKLAKDDVREMIYREILEYHP 451 (595)
Q Consensus 430 ~~~~~~~~~~~~i~~ei~~~~~ 451 (595)
......++++++++.|+++++|
T Consensus 325 ~~~~~~~e~k~~~~~e~~~~~~ 346 (346)
T d1cm8a_ 325 DVDRTLDEWKRVTYKEVLSFKP 346 (346)
T ss_dssp ---CCHHHHHHHHHHHHHTCCC
T ss_pred hhhcCHHHHHHHHHHHhhcCCC
Confidence 6677889999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-59 Score=490.99 Aligned_cols=337 Identities=47% Similarity=0.831 Sum_probs=278.2
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
..++|++++.||+|+||+||+|+++.+|+.||||+++.. ......+.+.+|+.+|+.|+||||+++++++.........
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 346899999999999999999999999999999999643 2344567889999999999999999999999877665566
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+||+|++++++|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred eEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 7889988888999999975 479999999999999999999999999999999999999999999999999998765444
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
.........+||+.|+|||++... ..|+.++||||+||++|||++|++||.+.+..++...+...++.+..........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred ccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 333334567899999999998553 5788999999999999999999999999999999999999999998877665555
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHHH
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e~ 430 (595)
.....+..........++...++.+++.+++||.+||.+||.+||||+|+|+||||+.......++.... ...+..+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~--~~~~~~~~ 320 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMEL 320 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CC------
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccC--ccCCChhh
Confidence 5556666666666666777778889999999999999999999999999999999997766544443322 33445566
Q ss_pred hhhcHHHHHHHHHHHHHhhChh
Q 007629 431 RKLAKDDVREMIYREILEYHPQ 452 (595)
Q Consensus 431 ~~~~~~~~~~~i~~ei~~~~~~ 452 (595)
..+..+++++++++|...++|+
T Consensus 321 ~~~~~~~l~~l~~~e~~~~~~~ 342 (345)
T d1pmea_ 321 DDLPKEKLKELIFEETARFQPG 342 (345)
T ss_dssp --CCHHHHHHHHHHHSGGGSTT
T ss_pred hhCCHHHHHHHHHHHHHhcCCC
Confidence 6788899999999998888875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-59 Score=487.36 Aligned_cols=330 Identities=44% Similarity=0.827 Sum_probs=279.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~~ 190 (595)
.+||++++.||+|+||+||+|+++.+|+.||||++++........+++.+|+.+|+.++|||||++++++..... ++..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 578999999999999999999999999999999998766666677789999999999999999999999865533 3344
Q ss_pred cEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 191 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
.+|+++++++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence 5667766666899998854 5799999999999999999999999999999999999999999999999999975422
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......+....+.+..+.......
T Consensus 174 ----~~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 174 ----EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp ----GGSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred ----ccccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 23456899999999987663 4578999999999999999999999999999999999999999998887776666
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCCCCcccchHHHH
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFER 430 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~e~ 430 (595)
.....+...........+...+..+++.+++||.+||.+||.+||||+|+|+||||+++.+++.++...+ +.+.++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~---~~~~~~~ 325 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQSFES 325 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCC---CCCGGGG
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCC---CCCcccc
Confidence 6666666666555555566667789999999999999999999999999999999999888777766544 4456778
Q ss_pred hhhcHHHHHHHHHHHHHhhChh
Q 007629 431 RKLAKDDVREMIYREILEYHPQ 452 (595)
Q Consensus 431 ~~~~~~~~~~~i~~ei~~~~~~ 452 (595)
.+...+++++++++|++++.|.
T Consensus 326 ~~~~~~~~k~~~~~e~~~~~p~ 347 (348)
T d2gfsa1 326 RDLLIDEWKSLTYDEVISFVPP 347 (348)
T ss_dssp CCCCHHHHHHHHHHHHHTCCCC
T ss_pred hhcCHHHHHHHHHHHhhccCCC
Confidence 8899999999999999988763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-59 Score=470.97 Aligned_cols=254 Identities=25% Similarity=0.431 Sum_probs=218.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++|||||++++++.. ..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----AT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-----CC
Confidence 357999999999999999999999999999999986422 122335678899999999999999999999954 45
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|||||||+ |+|.+++...+.+++..++.|+.||++||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 6999999998 699999998889999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
. ....+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+....+..+...
T Consensus 160 ~-----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------- 219 (263)
T d2j4za1 160 R-----RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------- 219 (263)
T ss_dssp C-----CEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------
T ss_pred c-----ccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence 2 245689999999999987 67999999999999999999999999988765544433221
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
. .. ....+++.+.+||.+||++||.+|||++|+|+||||+.
T Consensus 220 -------------~--~~---~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 -------------E--FT---FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -------------C--CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -------------C--CC---CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 0 00 11346889999999999999999999999999999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-59 Score=476.04 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=213.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... ....+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Cce
Confidence 4579999999999999999999999999999999864321 2234568899999999999999999999943 456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|||||||+ |+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred eEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999998 5999999888899999999999999999999999999999999999999999999999999998754332
Q ss_pred CCcccccccccCCcccccccccccCCC-CCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~-~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. ...+..+||+.|||||++.+ .. ++.++|||||||++|||++|++||.+.+...+......
T Consensus 158 ~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-------------- 220 (271)
T d1nvra_ 158 RE-RLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-------------- 220 (271)
T ss_dssp EE-CCBCCCCSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH--------------
T ss_pred cc-ccccceeeCcCccCHhHhcC--CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh--------------
Confidence 21 22356789999999999876 44 46789999999999999999999987653222111100
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
. .......++.+++.+.+||.+||+.||++|||++|+|+||||+.
T Consensus 221 ------------~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 221 ------------E--KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ------------T--TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ------------c--CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0 01112234567899999999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-58 Score=473.62 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=217.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..+|++++.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDE 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCE
Confidence 357999999999999999999999999999999986432 2345678999999999999999999999843 456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|||||||+ |+|.+++.. +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 92 ~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999998 588887765 579999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. .....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..+.... .
T Consensus 171 ~---~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~----------- 233 (293)
T d1yhwa1 171 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-T----------- 233 (293)
T ss_dssp C---CBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-S-----------
T ss_pred c---cccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-C-----------
Confidence 2 2355689999999999987 689999999999999999999999999887665554432210 0
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
. .....+.+++.+++||.+||.+||.+|||++|+|+||||+.
T Consensus 234 -------------~---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 234 -------------P---ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp -------------C---CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred -------------C---CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0 01122457889999999999999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-58 Score=472.72 Aligned_cols=261 Identities=26% Similarity=0.454 Sum_probs=218.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++|||||++++++.. ...
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-----SSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-----CCE
Confidence 57999999999999999999999999999999986422 122345678999999999999999999999843 456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|||||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999998 5899999998999999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
.. ......+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+....+..+...
T Consensus 163 ~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-------------- 225 (288)
T d1uu3a_ 163 KQ-ARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-------------- 225 (288)
T ss_dssp --------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--------------
T ss_pred cc-cccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--------------
Confidence 22 22355789999999999987 68999999999999999999999999988765544433211
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHH------HhcCCCccCCCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEE------ALADPYFHGLANV 412 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~e------lL~Hp~f~~~~~~ 412 (595)
. ..+ ...+++.+++||.+||++||.+|||++| +++||||+++.+.
T Consensus 226 ------------~--~~~---p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 226 ------------E--YDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp ------------C--CCC---CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred ------------C--CCC---CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 0 011 1357899999999999999999999987 5899999987543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-58 Score=463.14 Aligned_cols=258 Identities=27% Similarity=0.386 Sum_probs=214.4
Q ss_pred CCe-EEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRY-QIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y-~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
+|| ++.++||+|+||+||+|+++.++..||+|++..........+.+.+|+++|+.++|||||++++++.... .....
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCE
Confidence 455 7888999999999999999999999999999765555556778899999999999999999999985432 23456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCceeeC-CCCcEEEcccCcceecc
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVSF 267 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~g--IiHrDLKP~NILl~-~~~~vKL~DFGla~~~~ 267 (595)
+|||||||+ ++|.+++.....+++..++.|+.||++||+|||+++ |+||||||+|||++ .++.+||+|||+|+...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 899999998 599999998889999999999999999999999998 99999999999996 47899999999997542
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.. .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+......+...... +
T Consensus 167 ~~-----~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~--------- 228 (270)
T d1t4ha_ 167 AS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G--------- 228 (270)
T ss_dssp TT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T---------
T ss_pred CC-----ccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-C---------
Confidence 22 1245789999999999865 6999999999999999999999999876543332211100 0
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
..+.. .....++++.+||.+||.+||++|||++|+|+||||+
T Consensus 229 ---------------~~~~~---~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 229 ---------------VKPAS---FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ---------------CCCGG---GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ---------------CCCcc---cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 01111 1234678899999999999999999999999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-58 Score=465.49 Aligned_cols=257 Identities=29% Similarity=0.470 Sum_probs=207.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+++|+.++|||||++++++.+. ....
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCE
Confidence 4679999999999999999999999999999999976555555677889999999999999999999998643 2346
Q ss_pred EEEEEeccc-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCCCceeeCCCCcEEEcccC
Q 007629 192 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFG 261 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~qil~aL~yLHs~g-----IiHrDLKP~NILl~~~~~vKL~DFG 261 (595)
+|||||||+ |+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 899999998 689998864 457999999999999999999999976 9999999999999999999999999
Q ss_pred cceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCC
Q 007629 262 LARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPS 341 (595)
Q Consensus 262 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~ 341 (595)
+|+....... ..+..+||+.|||||++.+ ..|+.++|||||||++|||+||++||.+.+..+....+...
T Consensus 160 ~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~----- 229 (269)
T d2java1 160 LARILNHDTS---FAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----- 229 (269)
T ss_dssp HHHHC--------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----
T ss_pred ceeecccCCC---ccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----
Confidence 9987543322 2356789999999999977 68999999999999999999999999987765443333210
Q ss_pred hhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCc
Q 007629 342 TESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYF 406 (595)
Q Consensus 342 ~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f 406 (595)
. +......+++.+.+||.+||+.||.+|||++|+|+|||+
T Consensus 230 ----------------------~---~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 230 ----------------------K---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ----------------------C---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----------------------C---CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0 011123578899999999999999999999999999996
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-58 Score=474.95 Aligned_cols=282 Identities=36% Similarity=0.590 Sum_probs=227.5
Q ss_pred EeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChh---hHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEE
Q 007629 117 IQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVS---DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 193 (595)
Q Consensus 117 i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ly 193 (595)
.+++||+|+||+||+|+++.+|+.||||+++....... ....+.+|+.+|+.++|||||++++++... ..+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-----~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-----Ccee
Confidence 47899999999999999999999999999864322211 134688999999999999999999999543 4689
Q ss_pred EEEecccccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCC
Q 007629 194 VVFELMESDLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPS 272 (595)
Q Consensus 194 lV~E~~~g~L~~~i~-~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 272 (595)
||||||.+++...+. ....+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 999999976555554 4567999999999999999999999999999999999999999999999999999865433222
Q ss_pred cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHH
Q 007629 273 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEK 352 (595)
Q Consensus 273 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~ 352 (595)
....+||++|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+..+++..|.+.+|+|..+.+.......
T Consensus 157 ---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 ---YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp ---CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred ---ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 3456899999999998652 568999999999999999999999999999999999999999998876543221100
Q ss_pred HHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 353 ARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 353 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
....+......++...++.+++.+++||.+||++||++||||+|+|+||||+...
T Consensus 233 ---~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 233 ---DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp ---TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ---hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 0001111222333344567899999999999999999999999999999998654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-58 Score=481.10 Aligned_cols=283 Identities=22% Similarity=0.361 Sum_probs=216.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .......+.+|+.+|+.++|||||+++++|... ..
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 78 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 78 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----SE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CE
Confidence 357999999999999999999999999999999997532 234456789999999999999999999999543 46
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|||||||+ |+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+.....
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999998 5899999988899999999999999999999997 59999999999999999999999999999865432
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHH-HHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH-QLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~-~l~~i~~~lg~p~~~~i~~i 348 (595)
. .++.+||++|||||++.+ ..|+.++||||||||+|||++|+.||.+.+... ++..+....|.+........
T Consensus 159 ~-----~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 159 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp T-----C---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred c-----cccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 2 245799999999999988 689999999999999999999999998876432 22223333332221110000
Q ss_pred hhH--------------HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 349 RNE--------------KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 349 ~~~--------------~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
... .....+.......+... .....++++++||.+||.+||.+||||+|+|+||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCC--CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 000 00000111111111111 112357899999999999999999999999999999753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.5e-58 Score=471.45 Aligned_cols=258 Identities=29% Similarity=0.464 Sum_probs=204.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++++.||+|+||+||+|+++.+|+.||||++.+.... .....+.+|+.+|+.++|||||++++++.. ...+
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~ 82 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYES-----GGHL 82 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence 5699999999999999999999999999999999653322 223567899999999999999999999843 4569
Q ss_pred EEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC---CCCcEEEcccCcceeccC
Q 007629 193 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVSFN 268 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~---~~~~vKL~DFGla~~~~~ 268 (595)
|||||||+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+....
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999998 69999999988999999999999999999999999999999999999994 578999999999986533
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.. .....+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+.......+...
T Consensus 163 ~~----~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------------ 224 (307)
T d1a06a_ 163 GS----VLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA------------ 224 (307)
T ss_dssp --------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT------------
T ss_pred CC----eeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc------------
Confidence 22 1345689999999999987 68999999999999999999999999987765544443221
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
........++.+++.+.+||.+||.+||.+|||++|+|+||||++.
T Consensus 225 ---------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 225 ---------------EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ---------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ---------------CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1111122346789999999999999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-57 Score=463.26 Aligned_cols=261 Identities=28% Similarity=0.452 Sum_probs=221.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC----ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE----HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
.++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---- 84 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN---- 84 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----
Confidence 3579999999999999999999999999999999864322 11235778999999999999999999999944
Q ss_pred CcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC----cEEEcccCc
Q 007629 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGL 262 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~----~vKL~DFGl 262 (595)
...+|||||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 85 -~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 85 -KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred -CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence 456999999998 69999999888999999999999999999999999999999999999998877 499999999
Q ss_pred ceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
|+...... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+....+..+...-.....
T Consensus 164 a~~~~~~~----~~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1jksa_ 164 AHKIDFGN----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237 (293)
T ss_dssp CEECTTSC----BCSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred hhhcCCCc----cccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 98754322 1345689999999999987 67999999999999999999999999998876666555433222111
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
..++.+++.+++||.+||..||.+|||++|+|+||||+...
T Consensus 238 ---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 238 ---------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp ---------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred ---------------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 11245788999999999999999999999999999998643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=479.17 Aligned_cols=326 Identities=36% Similarity=0.673 Sum_probs=252.3
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc-cCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~~~ 191 (595)
.+|+++++||+|+||+||+|+++.+|+.||||++++.........++.+|+.+|+.++|||||++++++..... +...+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999999999999999998766666667789999999999999999999999965432 34578
Q ss_pred EEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 192 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
+|+|||||.+++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~- 173 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 173 (355)
T ss_dssp EEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred eEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc-
Confidence 99999999998888774 569999999999999999999999999999999999999999999999999988653322
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
..+..+||+.|+|||++.+ ..|++++||||+||++|+|++|++||.+.+...++..+...++.+..+.+.....
T Consensus 174 ---~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 247 (355)
T d2b1pa1 174 ---MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP- 247 (355)
T ss_dssp ----------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH-
T ss_pred ---ccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh-
Confidence 2356689999999999987 6899999999999999999999999999999999999999999988887765443
Q ss_pred HHHHHhhhcccCCCCCCCCCC------------CCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCCCCCCCC
Q 007629 352 KARRYLGSMRKKQPVPFSHKF------------PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQ 419 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~------------~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~~~~~~~ 419 (595)
....+...........+...+ ...++.+++||.+||.+||++||||+|||+||||+...++..+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~~ 327 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 327 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCCC
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccCCC
Confidence 223333322222111111101 12356789999999999999999999999999999765432222221
Q ss_pred CCcccchHHHHhhhcHHHHHHHHHHHHHh
Q 007629 420 PISKLEFEFERRKLAKDDVREMIYREILE 448 (595)
Q Consensus 420 ~~~~~~~~~e~~~~~~~~~~~~i~~ei~~ 448 (595)
+ ...+.+.+++.+..++|+++|+.|+++
T Consensus 328 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (355)
T d2b1pa1 328 P-QIYDKQLDEREHTIEEWKELIYKEVMN 355 (355)
T ss_dssp C--------CCCCCCHHHHHHHHHHHHHC
T ss_pred C-CCCCcchhhhhcCHHHHHHHHHHHhcC
Confidence 1 234445667788889999999999873
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-58 Score=469.36 Aligned_cols=288 Identities=39% Similarity=0.638 Sum_probs=233.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|+++|+.++|||||++++++.. ...+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence 58999999999999999999999999999999996543333345678899999999999999999999943 4569
Q ss_pred EEEEecccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 193 YVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 193 ylV~E~~~g~L~~~i~~--~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
|+|||||.+++..++.. ...+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999999887776654 3579999999999999999999999999999999999999999999999999998654332
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. .....+||+.|+|||++... ..++.++|||||||++|+|++|+.||.+.+..+++..+....+.+....+.....
T Consensus 157 ~---~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 R---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp B---CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c---cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 2 23456899999999987663 4568899999999999999999999999999999999998888887655443211
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
...+...........+...++.+++.+.+||.+||.+||++|||++|+|+||||+.+..
T Consensus 233 --~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 233 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp --STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred --ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 01111111111122223345678899999999999999999999999999999987744
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=469.70 Aligned_cols=290 Identities=35% Similarity=0.603 Sum_probs=236.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCC-CcEEEEEEecCccCChhhHHHHHHHHHHHHhc---CCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHT-GERVAIKKINDVFEHVSDATRILREIKLLRLL---RHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~-g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~ 187 (595)
.++|++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +||||+++++++......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36899999999999999999999766 67899999865433333334566788877766 799999999998655445
Q ss_pred CcccEEEEEecccccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 188 EFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~g~L~~~i~~--~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
....+|++||||++++..+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 5577999999999876655443 35799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
.... ......+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..+...+|.|....+
T Consensus 166 ~~~~----~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 166 YSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hccc----ccCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 4322 22356789999999999987 68999999999999999999999999999999999999999998877654
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLAN 411 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~ 411 (595)
....... ...+......+.......+++.+++||.+||++||++||||+|+|+||||+++..
T Consensus 240 ~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 240 PRDVALP----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CTTCSSC----GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccch----hhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 3211100 0112223334444556778999999999999999999999999999999997643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-57 Score=473.04 Aligned_cols=256 Identities=25% Similarity=0.444 Sum_probs=220.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++|||||++++++. +...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec-----cccc
Confidence 57999999999999999999999999999999996432 12234677899999999999999999999994 4456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999998 6899999999999999999999999999999999999999999999999999999999999998654332
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. .....+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+....+..+...
T Consensus 160 ~---~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-------------- 220 (337)
T d1o6la_ 160 A---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------- 220 (337)
T ss_dssp C---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------
T ss_pred c---ccccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--------------
Confidence 2 2356799999999999987 68999999999999999999999999998865444333210
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGL 409 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~ 409 (595)
. .. ....+++.+++||.+||++||.+|++ ++|+++||||+++
T Consensus 221 -------------~-~~---~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 221 -------------E-IR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp -------------C-CC---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -------------C-CC---CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 0 11 12457899999999999999999994 9999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=466.88 Aligned_cols=258 Identities=24% Similarity=0.348 Sum_probs=215.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
+.|++++.||+|+||+||+|+++.+|..||||+++.. .....+.+.+|+++|+.++|||||++++++.. ...+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~ 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNL 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeE
Confidence 4699999999999999999999999999999999653 23445678899999999999999999999843 4569
Q ss_pred EEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 193 YVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
|||||||+ |+|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 99999998 588888765 4579999999999999999999999999999999999999999999999999997543211
Q ss_pred CCcccccccccCCccccccccccc---CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~---~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
......+||+.|||||++... ...|+.++|||||||++|||++|++||.+.+..+.+..+...
T Consensus 165 ---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~----------- 230 (288)
T d2jfla1 165 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS----------- 230 (288)
T ss_dssp ---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS-----------
T ss_pred ---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 123457899999999998431 256899999999999999999999999987765554433221
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
.. +.....+.+++.+.+||.+||++||.+|||++|+|+||||+.
T Consensus 231 ---------------~~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 231 ---------------EP--PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ---------------CC--CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ---------------CC--CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00 111122457889999999999999999999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.9e-57 Score=475.02 Aligned_cols=261 Identities=26% Similarity=0.424 Sum_probs=222.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+.+.+|+.+|+.|+|||||++++++. +...+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~ 98 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEM 98 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 5899999999999999999999999999999999643 3445677899999999999999999999984 44679
Q ss_pred EEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC--CCcEEEcccCcceeccC
Q 007629 193 YVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVSFN 268 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~--~~~vKL~DFGla~~~~~ 268 (595)
|||||||+ |+|.+++.. .+.+++..++.|+.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+....
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999998 699998854 457999999999999999999999999999999999999964 57899999999987543
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... ....+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+......+.
T Consensus 179 ~~~----~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------- 245 (350)
T d1koaa2 179 KQS----VKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD------- 245 (350)
T ss_dssp TSC----EEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-------
T ss_pred ccc----cceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence 322 345789999999999987 6899999999999999999999999999887666655543322211
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~ 413 (595)
...++.+++.+++||.+||.+||++|||++|+|+||||+....+.
T Consensus 246 --------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 246 --------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 290 (350)
T ss_dssp --------------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred --------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence 122345788999999999999999999999999999998765443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.3e-57 Score=473.30 Aligned_cols=257 Identities=27% Similarity=0.435 Sum_probs=221.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ...+...+.+|+.+|+.|+|||||++++++.. ...+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~ 101 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEM 101 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence 4799999999999999999999999999999999753 23445678899999999999999999999943 4569
Q ss_pred EEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeC--CCCcEEEcccCcceeccC
Q 007629 193 YVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADCKLKICDFGLARVSFN 268 (595)
Q Consensus 193 ylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~--~~~~vKL~DFGla~~~~~ 268 (595)
|||||||+ |+|.+.+...+ ++++.+++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+....
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999998 68988776554 699999999999999999999999999999999999998 578999999999987644
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... ....+||+.|||||++.+ ..|+.++|||||||++|||+||++||.+.+....+..+.....
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------- 245 (352)
T d1koba_ 182 DEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW---------- 245 (352)
T ss_dssp TSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC----------
T ss_pred CCc----eeeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 322 345689999999999987 6899999999999999999999999999887666555533211
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
......++.+++.+.+||.+||++||.+|||++|+|+||||++.
T Consensus 246 -----------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 246 -----------------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -----------------CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -----------------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 11223456789999999999999999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-56 Score=458.13 Aligned_cols=284 Identities=38% Similarity=0.663 Sum_probs=234.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
++|+++++||+|+||+||+|+++ +|+.||||+++.........+.+.+|+.+|+.++|||||++++++... ..+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence 58999999999999999999985 789999999975443334457889999999999999999999999544 568
Q ss_pred EEEEecccccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELMESDLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~g~L~~~i~-~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
|++|||+.+++...+. ..+.+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|........
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9999999976655554 467899999999999999999999999999999999999999999999999999986543222
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhH
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNE 351 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~ 351 (595)
.....+||+.|+|||++.+. ..++.++|||||||++|||++|++||.+.+..+++..+...+|.+....+.....
T Consensus 156 ---~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 230 (286)
T d1ob3a_ 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE- 230 (286)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG-
T ss_pred ---ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh-
Confidence 12445799999999998763 5679999999999999999999999999999999999999999887765543221
Q ss_pred HHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 352 KARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 352 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
...+........+.++....+.+++.+.|||++||++||++|||++|+|+||||++
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 -LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp -STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred -hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 11222223333445556667788999999999999999999999999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-56 Score=461.56 Aligned_cols=255 Identities=26% Similarity=0.382 Sum_probs=214.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.+|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+.+|+.+|+.|+|||||++++++.. ...
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence 359999999999999999999999999999999975433 23345678999999999999999999999854 356
Q ss_pred EEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|||||||.+ +|..++...+++++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 9999999985 5555666778899999999999999999999999999999999999999999999999999985432
Q ss_pred CCcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
....+||+.|||||++.+. ...|+.++|||||||++|||++|..||.+.+....+..+...
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~------------- 229 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------- 229 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------------
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-------------
Confidence 2346899999999998652 246899999999999999999999999887765544333211
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
..+.. ....+++.+.+||.+||++||.+|||++|+|+||||..
T Consensus 230 -------------~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 230 -------------ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp -------------CCCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -------------CCCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 11111 12356889999999999999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-56 Score=462.81 Aligned_cols=254 Identities=25% Similarity=0.445 Sum_probs=219.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-----CCe
Confidence 57999999999999999999999999999999996432 122345778999999999999999999999954 456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+|||||. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 999999998 578899998889999999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------- 216 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------- 216 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------------
T ss_pred -----cccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--------------
Confidence 245689999999999987 67999999999999999999999999988765544433221
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~~ 410 (595)
.. ...+.+++.+.+||.+||.+||.+|+ |++++|+||||+++.
T Consensus 217 ------------~~-----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 217 ------------EL-----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp ------------CC-----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred ------------CC-----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 00 11135788999999999999999996 999999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-56 Score=468.81 Aligned_cols=253 Identities=21% Similarity=0.369 Sum_probs=218.9
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+++|+.+|+.++|||||++++++.. ...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-----ccc
Confidence 58999999999999999999999999999999986422 222345678999999999999999999999844 456
Q ss_pred EEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCC
Q 007629 192 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 270 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 270 (595)
+|+||||+. |+|..++...+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 899999998 589999998889999999999999999999999999999999999999999999999999999876432
Q ss_pred CCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 271 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 271 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
....+||+.|||||++.+ ..|+.++|||||||++|||+||++||.+.+....+..+....
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------- 254 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK------------- 254 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------
T ss_pred -----cccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC-------------
Confidence 245689999999999987 689999999999999999999999999887655544442210
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGL 409 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~ 409 (595)
+ .....+++.+.+||.+||.+||.+|+ |++|+|+||||+++
T Consensus 255 --------------~----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 255 --------------V----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp --------------C----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred --------------C----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 0 11245789999999999999999995 99999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-56 Score=465.68 Aligned_cols=286 Identities=35% Similarity=0.622 Sum_probs=234.0
Q ss_pred CeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC-ccCcccE
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFKDI 192 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~~~~l 192 (595)
+|+.+++||+|+||+||+|+++.+|+.||||+++.... ...+|+.+|+.++|||||++++++.... ..+..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 69999999999999999999999999999999965322 1247999999999999999999986543 2345678
Q ss_pred EEEEecccccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC-cEEEcccCcceecc
Q 007629 193 YVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVSF 267 (595)
Q Consensus 193 ylV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~-~vKL~DFGla~~~~ 267 (595)
|||||||++++...+. ....+++..++.|++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 9999999987655543 456799999999999999999999999999999999999999875 89999999998764
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.... ....+||+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+++..+.+.+|.+..+.+..
T Consensus 175 ~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 175 RGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp TTSC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred CCcc----cccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 3332 3456899999999987653 5799999999999999999999999999999999999999999999887665
Q ss_pred HhhHHHHHHhhhcccCCCCCCC-CCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCCCCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFS-HKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVD 413 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~~~~ 413 (595)
........ .+......++. ...+..++.+.+||.+||.+||++||||.|+|+||||+.+.+..
T Consensus 250 ~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 250 MNPNYTEF---KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp HCC---CC---CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred hccchhhc---cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence 43221111 11111111221 23456799999999999999999999999999999999876543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-55 Score=448.91 Aligned_cols=261 Identities=28% Similarity=0.445 Sum_probs=220.4
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh-------hhHHHHHHHHHHHHhcC-CCceeeeeeeecCC
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV-------SDATRILREIKLLRLLR-HPDIVEIKHIMLPP 184 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~-------~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 184 (595)
++|++++.||+|+||+||+|+++.+|+.||||++++..... ...+.+.+|+.+|+.++ |||||++++++.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 80 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-- 80 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc--
Confidence 68999999999999999999999999999999996532221 12346889999999997 999999999994
Q ss_pred CccCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcc
Q 007629 185 SRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263 (595)
Q Consensus 185 ~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla 263 (595)
+...+|||||||+ ++|.+++...+.+++..++.|+.||++||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 81 ---~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 81 ---TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp ---CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ---cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhe
Confidence 4457999999998 599999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCCccccccccccc----CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCC
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 339 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~ 339 (595)
+....... .+..+||+.|+|||++.+. ...|+.++||||+||++|||++|+.||.+.+....+..+...-
T Consensus 158 ~~~~~~~~----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~-- 231 (277)
T d1phka_ 158 CQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN-- 231 (277)
T ss_dssp EECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--
T ss_pred eEccCCCc----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC--
Confidence 87643322 3557899999999988531 2457889999999999999999999999887655544443210
Q ss_pred CChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 340 PSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 340 p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.......++.+++++++||.+||+.||++|||++|+|+||||+..
T Consensus 232 -------------------------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 232 -------------------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp -------------------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred -------------------------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 111122345688999999999999999999999999999999853
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.8e-55 Score=464.83 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=212.4
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHH---HHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILR---EIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~---Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
.++|+++++||+|+||+||+|+++.+|+.||||++.+... .......+.+ |+.+++.++|||||++++++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~---- 78 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---- 78 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE----
Confidence 3689999999999999999999999999999999863211 1111223334 4667777789999999999844
Q ss_pred CcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 188 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
...+|||||||+ ++|.+++.....+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..
T Consensus 79 -~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 79 -PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred -CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 356999999998 699999999899999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
.... ....+||+.|||||++.+. ..|+.++|||||||++|||+||++||.+.+...........
T Consensus 158 ~~~~-----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---------- 221 (364)
T d1omwa3 158 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---------- 221 (364)
T ss_dssp SSSC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS----------
T ss_pred CCCc-----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------
Confidence 4332 2456899999999998642 56899999999999999999999999876543222211110
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCC-----HHHHhcCCCccCCC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPT-----AEEALADPYFHGLA 410 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpt-----a~elL~Hp~f~~~~ 410 (595)
...+ ......+++.+.+||.+||.+||.+||| |+|+|+||||+++.
T Consensus 222 ---------------~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 222 ---------------LTMA---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp ---------------SSCC---CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred ---------------ccCC---CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 0111 1123467899999999999999999999 89999999999764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=457.73 Aligned_cols=256 Identities=25% Similarity=0.434 Sum_probs=219.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+...+.+|+.+|+.++|||||++++++. +...
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~ 75 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFE-----SMEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCE
Confidence 36899999999999999999999999999999999753 234456789999999999999999999984 4456
Q ss_pred EEEEEeccc-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC--CcEEEcccCcceecc
Q 007629 192 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVSF 267 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~--~~vKL~DFGla~~~~ 267 (595)
+|||||||+ ++|.+++...+ .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 999999998 58999998665 79999999999999999999999999999999999999854 479999999998653
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+....+..|......++.
T Consensus 156 ~~~----~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----- 224 (321)
T d1tkia_ 156 PGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE----- 224 (321)
T ss_dssp TTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH-----
T ss_pred cCC----cccccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh-----
Confidence 322 2345689999999999887 67999999999999999999999999998876666655443222221
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
..++.+++++++||.+||.+||.+|||++|+|+||||++
T Consensus 225 ----------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 225 ----------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ----------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ----------------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 123457889999999999999999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-55 Score=454.17 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=217.6
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHH-hcCCCceeeeeeeecCCCccCcc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF-EHVSDATRILREIKLLR-LLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~-~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.++. .++|||||++++++.. ..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-----~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----KE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----SS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-----CC
Confidence 57999999999999999999999999999999996422 12233556777887765 6899999999999954 45
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|||||||+ |+|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 6999999998 599999999899999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
.. ..+..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-------------- 217 (320)
T d1xjda_ 157 DA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------------- 217 (320)
T ss_dssp TC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------
T ss_pred cc---cccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------
Confidence 22 2355789999999999987 6899999999999999999999999998876554443321
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHH-HHhcCCCccCCC
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE-EALADPYFHGLA 410 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~-elL~Hp~f~~~~ 410 (595)
..+ . ....+++.+.+||.+||.+||.+|||+. |+++||||+++.
T Consensus 218 -------------~~~-~---~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 218 -------------DNP-F---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp -------------CCC-C---CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred -------------CCC-C---CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 011 1 1135789999999999999999999995 899999998753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-55 Score=454.36 Aligned_cols=295 Identities=35% Similarity=0.562 Sum_probs=227.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc---cC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR---RE 188 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---~~ 188 (595)
.++|++++.||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.++||||+++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 579999999999999999999999999999999986544444455678899999999999999999999865421 22
Q ss_pred cccEEEEEecccccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 189 FKDIYVVFELMESDLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 189 ~~~lylV~E~~~g~L~~~i~-~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
...+|+|||||++++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 35689999999977666554 34579999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCC-cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 268 NDAPS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 268 ~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
..... .......+||++|+|||++.+. ..|++++|||||||++|||++|++||.+.+....+..+...++.+..+...
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 32211 1122446899999999998763 578999999999999999999999999999999999999999988776544
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCC--CCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKF--PNADPLALHLLERLLAFDPKDRPTAEEALADPYFHG 408 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~ 408 (595)
..........+...... .......+ ...++.++|||.+||++||++||||+|+|+||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 248 NVDNYELYEKLELVKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TCCCC-------CCSSC-CBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccchhhhhhhhcccccc-cccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 33222111111111000 00000000 023678899999999999999999999999999984
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=440.39 Aligned_cols=287 Identities=36% Similarity=0.589 Sum_probs=234.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccE
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 192 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~l 192 (595)
+||++++.||+|+||+||+|+++.+|+.||||+++..........++.+|+.+|+.++||||+++++++... ..+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cce
Confidence 589999999999999999999999999999999976555555678899999999999999999999999544 468
Q ss_pred EEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCC
Q 007629 193 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAP 271 (595)
Q Consensus 193 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 271 (595)
++|||++.+ +|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+.......
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999985 6677777778999999999999999999999999999999999999999999999999999987643332
Q ss_pred CcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCC-CCCCChHHHHHHHHhhcCCCChhHHHHHhh
Q 007629 272 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGKNVVHQLDLMTDLLGTPSTESISRIRN 350 (595)
Q Consensus 272 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~p-F~~~~~~~~l~~i~~~lg~p~~~~i~~i~~ 350 (595)
. .....+++.|+|||++.+. ..++.++|||||||++|||++|+.| |.+.+..+++..+....+.+....+.....
T Consensus 157 ~---~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 C---YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp C---CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred c---ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 2 2445788999999998763 4579999999999999999999876 677778888888888888877654332211
Q ss_pred HHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 351 EKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 351 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
. ..+................+..++.+.+||.+||++||++||||+|+|+||||+++.
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 233 L--PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp S--TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred c--ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 0 000000000111233345567899999999999999999999999999999998764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-55 Score=443.41 Aligned_cols=250 Identities=27% Similarity=0.443 Sum_probs=207.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hhHHHHHHHHHHHHhcC--CCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHV----SDATRILREIKLLRLLR--HPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~ 185 (595)
.++|++.+.||+|+||+||+|+++.+|+.||||++++..... ....++.+|+.+|+.++ |||||++++++..
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 468999999999999999999999999999999986432111 12234678999999997 8999999999944
Q ss_pred ccCcccEEEEEeccc--ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC-CcEEEcccCc
Q 007629 186 RREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGL 262 (595)
Q Consensus 186 ~~~~~~lylV~E~~~--g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~-~~vKL~DFGl 262 (595)
...+|+||||+. +++.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 81 ---~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 81 ---PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp ---SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ---CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence 356899999997 4788888888899999999999999999999999999999999999999854 7999999999
Q ss_pred ceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 263 ARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 263 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
|+...... .++.+||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+. +..
T Consensus 158 a~~~~~~~-----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~------- 218 (273)
T d1xwsa_ 158 GALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR------- 218 (273)
T ss_dssp CEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-------
T ss_pred ceeccccc-----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH------Hhh-------
Confidence 98653322 3567899999999998762 3346789999999999999999999975321 000
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.. . ...+.+++++.+||.+||.+||++|||++|+|+||||+++
T Consensus 219 -------------------~~--~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 219 -------------------GQ--V---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp -------------------CC--C---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -------------------cc--c---CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 00 0 1123578999999999999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-55 Score=455.72 Aligned_cols=261 Identities=26% Similarity=0.417 Sum_probs=208.6
Q ss_pred CCCeEEee-eeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHh-cCCCceeeeeeeecCCCccCc
Q 007629 112 ASRYQIQE-VIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRL-LRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 112 ~~~Y~i~~-~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~~ 189 (595)
.++|++++ .||+|+||+||+|+++.+|+.||||++++ ...+.+|+.++.+ ++|||||+++++|.+.. ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCC
Confidence 35798875 69999999999999999999999999863 2456789998754 58999999999984321 224
Q ss_pred ccEEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC---CCcEEEcccCcc
Q 007629 190 KDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLA 263 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~---~~~vKL~DFGla 263 (595)
..+|||||||+ |+|.+++... ..+++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 56999999998 6999999874 36999999999999999999999999999999999999986 467999999999
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
+....... ....+||+.|||||++.+ ..|+.++||||||||+|+|+||++||.+.+.......+....
T Consensus 162 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i------ 229 (335)
T d2ozaa1 162 KETTSHNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI------ 229 (335)
T ss_dssp EECCCCCC----CCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC------
T ss_pred eeccCCCc----cccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH------
Confidence 87644332 245689999999999987 679999999999999999999999998776433322221111
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
...........++.+++++.+||.+||++||.+|||+.|+|+||||...
T Consensus 230 -----------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 230 -----------------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp -----------------CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred -----------------hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 0000000111223578999999999999999999999999999999753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.1e-54 Score=436.67 Aligned_cols=266 Identities=25% Similarity=0.384 Sum_probs=211.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++.+.||+|+||+||+|++..+|+.||||+++.... .......+.+|+.+|+.++|||||++++++.... ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 4689999999999999999999999999999999975433 3344567899999999999999999999986432 2234
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
.+|||||||+ ++|.+++...+.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 5899999998 589999988889999999999999999999999999999999999999999999999999999765444
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHHh
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIR 349 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~ 349 (595)
..........+||+.|||||++.+ ..|++++||||||||+|||+||++||.+.+..+.+..+..
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~-------------- 228 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-------------- 228 (277)
T ss_dssp --------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--------------
T ss_pred cccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh--------------
Confidence 433334466789999999999987 6899999999999999999999999998876544433221
Q ss_pred hHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCcc
Q 007629 350 NEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFH 407 (595)
Q Consensus 350 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~ 407 (595)
..+.+.....+.+++.+.+||.+||++||.+||+..+.|.|+|++
T Consensus 229 -------------~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 229 -------------EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp -------------CCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -------------cCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 122223344567899999999999999999999544445566653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.2e-54 Score=444.95 Aligned_cols=287 Identities=31% Similarity=0.565 Sum_probs=224.1
Q ss_pred ccCCCCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCc
Q 007629 108 EYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSR 186 (595)
Q Consensus 108 ~~~~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 186 (595)
+++..++|+++++||+|+||+||+|+++.+|+.||||+++.. ..+++.+|+.+|+.+. ||||+++++++...
T Consensus 30 ~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~-- 102 (328)
T d3bqca1 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDP-- 102 (328)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT--
T ss_pred CCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEec--
Confidence 455668999999999999999999999999999999999642 3467889999999996 99999999998543
Q ss_pred cCcccEEEEEecccc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCC-cEEEcccCcce
Q 007629 187 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLAR 264 (595)
Q Consensus 187 ~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~-~vKL~DFGla~ 264 (595)
....+|+|||||.+ +|..+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 103 -~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 103 -VSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp -TTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred -CCCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence 23569999999995 66554 35699999999999999999999999999999999999998765 69999999998
Q ss_pred eccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCC-ChHHHHHHHHhhcCCCChh
Q 007629 265 VSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGK-NVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 265 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~-~~~~~l~~i~~~lg~p~~~ 343 (595)
....... ....+||+.|+|||++.+. ..|+.++|||||||++|||++|+.||... +...+...+...+|.+...
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 179 FYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp ECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred eccCCCc----ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence 7544332 3556899999999998763 46899999999999999999999998654 5666777787777765433
Q ss_pred HHHHHhhH-HHHHHhhhcccCCCC-----CCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCCC
Q 007629 344 SISRIRNE-KARRYLGSMRKKQPV-----PFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 344 ~i~~i~~~-~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~~ 410 (595)
........ ....+.......... ........++++++|||++||.+||++|||++|+|+||||+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 22111000 000111111111111 11122345789999999999999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-53 Score=429.69 Aligned_cols=257 Identities=24% Similarity=0.298 Sum_probs=206.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||+||+|+.. ..||||+++.........+.+.+|+.+|++++|||||++++++.. ..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence 468999999999999999999643 469999997655555667889999999999999999999998743 24
Q ss_pred EEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|||||||+ |+|.+++... ..+++..+..|+.||++||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 799999998 6999999765 56999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccCCccccccccccc-CCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... ...+...||+.|||||++.+. ...|+.++|||||||++|||+||+.||.+.+...++..+....
T Consensus 158 ~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~----------- 225 (276)
T d1uwha_ 158 SGS-HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG----------- 225 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT-----------
T ss_pred CCc-ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC-----------
Confidence 222 223567899999999998652 2458999999999999999999999998876544433222110
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
..+.........+++.+.+||.+||..||.+|||+.|++++
T Consensus 226 --------------~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 226 --------------YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp --------------SCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01111222345678899999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=430.38 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=203.3
Q ss_pred eeeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCcccEEEEE
Q 007629 119 EVIGKGSYGVVGSAVDT--HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 119 ~~LG~G~fG~V~~a~~~--~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
++||+|+||+||+|... .+++.||||+++.........+.+.+|+.+|++++|||||++++++.. ..+||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 47999999999999754 456789999997554444556789999999999999999999999843 2379999
Q ss_pred eccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCCCCCccc
Q 007629 197 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIF 275 (595)
Q Consensus 197 E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 275 (595)
|||+ |+|.+++.....+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...........
T Consensus 87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9998 689999999889999999999999999999999999999999999999999999999999999876544333322
Q ss_pred ccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHH
Q 007629 276 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKAR 354 (595)
Q Consensus 276 ~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~ 354 (595)
.....||+.|||||++.+ ..|+.++|||||||++|||+| |++||.+.+..+....+...
T Consensus 167 ~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~------------------ 226 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG------------------ 226 (277)
T ss_dssp ----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------------
T ss_pred ccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC------------------
Confidence 344679999999999877 679999999999999999998 89999987754433332210
Q ss_pred HHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHH---hcCCCcc
Q 007629 355 RYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA---LADPYFH 407 (595)
Q Consensus 355 ~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~el---L~Hp~f~ 407 (595)
...+ ....+++.+.+||.+||+.||.+|||++++ |+|+|+.
T Consensus 227 -------~~~~-----~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 227 -------ERMG-----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp -------CCCC-----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------CCCC-----CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 0111 113568899999999999999999999998 5666653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-52 Score=425.89 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=197.0
Q ss_pred CCCCeEEeeeeeecCceEEEEEEECCCCc---EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 111 EASRYQIQEVIGKGSYGVVGSAVDTHTGE---RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 111 ~~~~Y~i~~~LG~G~fG~V~~a~~~~~g~---~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
..++|++.++||+|+||+||+|+++.+++ .||||++... ......+.+.+|+.+|+.++|||||++++++...
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--- 99 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--- 99 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC---
Confidence 45689999999999999999999987765 5889988643 2334566799999999999999999999999543
Q ss_pred CcccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 188 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
..+|||||||+ |+|.+++... +.+++..+..|+.||++||.|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus 100 --~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 100 --TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp --SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred --CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence 45899999998 5898888764 4799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcc--cccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 266 SFNDAPSAI--FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 266 ~~~~~~~~~--~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
......... ......||+.|||||++.+ ..|+.++|||||||++|||+| |++||.+.+..+.+..+...
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~------ 249 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD------ 249 (299)
T ss_dssp ------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT------
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------
Confidence 644332211 1123468999999999877 689999999999999999998 89999887765444333211
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
...+ ....+++.+.+||.+||+.||.+|||+.|++++
T Consensus 250 -------------------~~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 250 -------------------YRLP-----PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -------------------CCCC-----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------------------CCCC-----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0111 123578899999999999999999999998873
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-52 Score=427.20 Aligned_cols=254 Identities=21% Similarity=0.407 Sum_probs=207.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||+||+|+++.+|+.||||+++.. ....+++.+|+.+|+.++|||||++++++... ..
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~ 87 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PP 87 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeC-----Ce
Confidence 35899999999999999999999999999999998643 23456789999999999999999999999543 45
Q ss_pred EEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 899999998 6899988764 4789999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCC-CCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPL-FPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~p-F~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
... ...+...||+.|+|||++.+ ..|+.++|||||||++|||++|..| |.+.+.......+..
T Consensus 168 ~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~------------ 231 (287)
T d1opja_ 168 DTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------ 231 (287)
T ss_dssp SSS--EEETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT------------
T ss_pred CCc--eeeccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc------------
Confidence 322 22344568999999999887 6899999999999999999997655 544443222222111
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCCCccCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGL 409 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp~f~~~ 409 (595)
.... .....+++.+.+||.+||..||++|||++|+++ +|+.+
T Consensus 232 ---------------~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 232 ---------------DYRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp ---------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred ---------------CCCC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence 0001 112457889999999999999999999999976 55443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=424.73 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=210.2
Q ss_pred CCeEEeee-eeecCceEEEEEEECC--CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 113 SRYQIQEV-IGKGSYGVVGSAVDTH--TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 113 ~~Y~i~~~-LG~G~fG~V~~a~~~~--~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
++|.+.+. ||+|+||+||+|.++. ++..||||+++.. ......+.+.+|+++|+.++|||||++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------ 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------
Confidence 56888885 9999999999998764 4558999999753 334556789999999999999999999999843
Q ss_pred ccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 190 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
..+|||||||+ |+|.+++... ..+++..+..|+.||++||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 24799999999 5899887654 579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
............+||+.|||||++.+ ..|+.++|||||||++|||+| |++||.+.+..+.+..+...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~---------- 228 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---------- 228 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT----------
T ss_pred ccccccccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----------
Confidence 44333333345679999999999877 679999999999999999998 89999887654443333210
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHH---hcCCCcc
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA---LADPYFH 407 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~el---L~Hp~f~ 407 (595)
...+ ..+.+++.+.+||.+||..||++|||+.++ |+|+|+.
T Consensus 229 ---------------~~~~-----~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 229 ---------------KRME-----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ---------------CCCC-----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------CCCC-----CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0011 124578899999999999999999999887 6788874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-52 Score=418.17 Aligned_cols=249 Identities=24% Similarity=0.409 Sum_probs=196.1
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||+||+|++. ++..||||+++... ...+.+.+|+++|+.++|||||++++++... ..
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~ 74 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----AP 74 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccC-----Cc
Confidence 468999999999999999999975 57789999997532 2346789999999999999999999999544 45
Q ss_pred EEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+|||||+ |+|.+++... ..++++.+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred eEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC
Confidence 899999998 6899988755 56899999999999999999999999999999999999999999999999999865443
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
.... .....||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+....+..+....
T Consensus 155 ~~~~--~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~----------- 219 (263)
T d1sm2a_ 155 QYTS--STGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------- 219 (263)
T ss_dssp ------------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC-----------
T ss_pred Ccee--ecceecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC-----------
Confidence 3221 234679999999999987 689999999999999999999 567777666544443332210
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
+ .+ .....++.+.+||.+||+.||++|||++|+|+|
T Consensus 220 ------------~--~~-----~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 220 ------------R--LY-----KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ------------C--CC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------C--CC-----CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 0 00 113457889999999999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-52 Score=431.15 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=205.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCc-----EEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGE-----RVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~-----~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 185 (595)
.++|+++++||+|+||+||+|++..+++ .||||++.... .......+.+|+.+|+.+ +|||||++++++...
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~- 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS- 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC-
Confidence 3689999999999999999999876543 69999986432 223446788999999988 899999999999543
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecC
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKAND-----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRD 241 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~~-----------------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrD 241 (595)
..+|||||||+ |+|.+++.... .+++..++.|+.||++||+|||++||||||
T Consensus 114 ----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 114 ----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ----CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 45899999998 69999997542 489999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCC
Q 007629 242 LKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPL 320 (595)
Q Consensus 242 LKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~p 320 (595)
|||+|||++.++.+||+|||+|+........ ......+||+.|||||++.+ ..|+.++|||||||++|||+| |++|
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CchhccccccCCeEEEeeccccccccCCCce-eeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCC
Confidence 9999999999999999999999875443322 22345679999999999887 689999999999999999998 8999
Q ss_pred CCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHH
Q 007629 321 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400 (595)
Q Consensus 321 F~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~el 400 (595)
|.+.+....+..+..- .... .....+++.+.+||.+||+.||++|||++||
T Consensus 267 f~~~~~~~~~~~~~~~--------------------------~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei 317 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQN--------------------------GFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317 (325)
T ss_dssp STTCCCSHHHHHHHHT--------------------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHhc--------------------------CCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9887654433322210 0000 1123568899999999999999999999999
Q ss_pred hcC
Q 007629 401 LAD 403 (595)
Q Consensus 401 L~H 403 (595)
++|
T Consensus 318 ~~~ 320 (325)
T d1rjba_ 318 TSF 320 (325)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=422.03 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=205.7
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||+||+|.++ ++..||||+++... ...+.+.+|+.+|++++|||||++++++.. ..
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~ 81 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP 81 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CC
Confidence 368999999999999999999975 67889999997432 234678999999999999999999998743 24
Q ss_pred EEEEEeccc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+|||||||+ |+|.+++... ..+++..+..|+.||++||.|||+++|+||||||+||||+.++.+||+|||+|+....
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence 799999998 6888866433 3699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcC-CCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
... ...+...||+.|||||++.+ ..|+.++|||||||++|||+|| .+||...+..+.+..+...
T Consensus 162 ~~~--~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~----------- 226 (272)
T d1qpca_ 162 NEY--TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG----------- 226 (272)
T ss_dssp SCE--ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------
T ss_pred Ccc--ccccccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-----------
Confidence 321 22345679999999999876 6799999999999999999995 5666665544333322110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc--CCCcc
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA--DPYFH 407 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~--Hp~f~ 407 (595)
. ..+ ....+++.+.+||.+||+.||++|||++|+++ |+||.
T Consensus 227 ------------~--~~~-----~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 ------------Y--RMV-----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ------------C--CCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------C--CCC-----CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 0 011 11357889999999999999999999999998 78875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=410.94 Aligned_cols=249 Identities=20% Similarity=0.313 Sum_probs=207.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|+++++||+|+||+||+|+++ ++..||||+++... .....+++|+.+|+.++|||||++++++... ..
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~ 73 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RP 73 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SS
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----Cc
Confidence 357899999999999999999984 78899999997532 2346789999999999999999999999543 45
Q ss_pred EEEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+||||++ |+|..++.. ...+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred eEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 999999998 678888665 457999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHHH
Q 007629 270 APSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISRI 348 (595)
Q Consensus 270 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~i 348 (595)
... ......||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+....+....
T Consensus 154 ~~~--~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~----------- 218 (258)
T d1k2pa_ 154 EYT--SSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------- 218 (258)
T ss_dssp SCC--CCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-----------
T ss_pred Cce--eecccCCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 222 2244679999999999987 689999999999999999998 899999887655444332210
Q ss_pred hhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 349 RNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 349 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
..+. ....++.+.+||.+||+.||++|||++++|+|
T Consensus 219 --------------~~~~-----p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 219 --------------RLYR-----PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp --------------CCCC-----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCC-----cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 0111 13467889999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=430.43 Aligned_cols=264 Identities=23% Similarity=0.385 Sum_probs=213.9
Q ss_pred CCeEEeeeeeecCceEEEEEEE---CCCCcEEEEEEecCcc--CChhhHHHHHHHHHHHHhcCC-CceeeeeeeecCCCc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVD---THTGERVAIKKINDVF--EHVSDATRILREIKLLRLLRH-PDIVEIKHIMLPPSR 186 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~---~~~g~~vAIK~i~~~~--~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~ 186 (595)
++|++++.||+|+||+||+|++ +.+|+.||||++++.. ......+.+.+|+++|++++| |||+++++++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~---- 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---- 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec----
Confidence 6799999999999999999987 4478999999986432 122234567899999999976 89999999984
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 187 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
+...+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 100 -~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 100 -TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp -ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred -cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 3456999999998 69999999999999999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
....... ......||+.|+|||++.+....++.++|||||||+||||++|+.||.+.+.......+...
T Consensus 179 ~~~~~~~--~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--------- 247 (322)
T d1vzoa_ 179 FVADETE--RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--------- 247 (322)
T ss_dssp CCGGGGG--GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH---------
T ss_pred hcccccc--cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh---------
Confidence 5433221 23456899999999998764346788999999999999999999999887643333222110
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCC-----CHHHHhcCCCccCCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRP-----TAEEALADPYFHGLA 410 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rp-----ta~elL~Hp~f~~~~ 410 (595)
. ..... .....+++.+.+||.+||.+||.+|| |++|+|+||||+++.
T Consensus 248 ----------~---~~~~~-----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 248 ----------I---LKSEP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp ----------H---HHCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ----------c---ccCCC-----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 0 00111 11245789999999999999999999 589999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=411.38 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=193.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCC----cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG----ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 187 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g----~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 187 (595)
.+.|++.++||+|+||+||+|..+.++ ..||||+++... .......+++|+.+|+.++|||||++++++...
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~--- 81 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--- 81 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC---
Confidence 467999999999999999999877654 479999996432 334456789999999999999999999999543
Q ss_pred CcccEEEEEecccc-cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCccee
Q 007629 188 EFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 265 (595)
Q Consensus 188 ~~~~lylV~E~~~g-~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~ 265 (595)
..+|+|||||.+ .+.+++... ..+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.
T Consensus 82 --~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 --KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred --CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 458999999984 677766554 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCC-CCCCCCChHHHHHHHHhhcCCCChhH
Q 007629 266 SFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLDLMTDLLGTPSTES 344 (595)
Q Consensus 266 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~-~pF~~~~~~~~l~~i~~~lg~p~~~~ 344 (595)
...............||+.|||||++.+ ..|+.++|||||||++|||++|. +||.+.+....+..+...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-------- 229 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-------- 229 (283)
T ss_dssp --------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT--------
T ss_pred ccCCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc--------
Confidence 6544333222344678999999999877 68999999999999999999965 555544433322222110
Q ss_pred HHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 345 ISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 345 i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
...+ ....+++.+.+||.+||..||++|||+.|+++
T Consensus 230 -----------------~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 230 -----------------FRLP-----TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -----------------CCCC-----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------CCCC-----CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 0111 11346788999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=410.35 Aligned_cols=250 Identities=25% Similarity=0.414 Sum_probs=195.7
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCC---cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTG---ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g---~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 189 (595)
++|++++.||+|+||+||+|++..++ ..||||+++.. ........+.+|+.+|+.++|||||++++++..
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 58999999999999999999987543 56899988643 233445678999999999999999999999843
Q ss_pred ccEEEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceecc
Q 007629 190 KDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSF 267 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~ 267 (595)
..+|+|||||. |+|.+++.. ...+++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 34799999998 578877655 4579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHH
Q 007629 268 NDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESIS 346 (595)
Q Consensus 268 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~ 346 (595)
..... ..+...||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+...
T Consensus 160 ~~~~~--~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~---------- 225 (273)
T d1mp8a_ 160 DSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---------- 225 (273)
T ss_dssp -------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT----------
T ss_pred CCcce--eccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------
Confidence 32221 1244578999999999987 689999999999999999998 89999887765443333211
Q ss_pred HHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 347 RIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 347 ~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
... ...+.+++.+.+||.+||..||.+|||++|+++|
T Consensus 226 -----------------~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 226 -----------------ERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -----------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 001 1235678999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=416.74 Aligned_cols=252 Identities=22% Similarity=0.364 Sum_probs=199.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCc----EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccC
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGE----RVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 188 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~----~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 188 (595)
++|+++++||+|+||+||+|.+..+|+ .||||+++.. ......+.+.+|+.+|+.++|||||++++++...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 579999999999999999999988876 5888887643 2233467789999999999999999999998643
Q ss_pred cccEEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceec
Q 007629 189 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVS 266 (595)
Q Consensus 189 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~ 266 (595)
..+++|||+. ++|.+.+... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++++||+|||+|+..
T Consensus 84 --~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 84 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp --SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred --CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 3677888876 6888777654 57999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHH
Q 007629 267 FNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESI 345 (595)
Q Consensus 267 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i 345 (595)
...... .......||+.|||||++.+ ..|+.++|||||||++|||+| |.+||.+.+.......+...
T Consensus 162 ~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~--------- 229 (317)
T d1xkka_ 162 GAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--------- 229 (317)
T ss_dssp TTTCC---------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT---------
T ss_pred cccccc-ccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------
Confidence 443322 22344579999999999887 689999999999999999998 78999877654333222110
Q ss_pred HHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcCC
Q 007629 346 SRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADP 404 (595)
Q Consensus 346 ~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~Hp 404 (595)
...+ ..+.+++.+.+||.+||..||.+|||+.|+++|.
T Consensus 230 ----------------~~~~-----~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 230 ----------------ERLP-----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp ----------------CCCC-----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ----------------CCCC-----CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 0111 1245788999999999999999999999999873
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=409.60 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=201.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++.+.||+|+||.||+|+++.+ ..||||+++... ...+.+.+|+.+|++++|||||++++++.. ..
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~ 85 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 85 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec------CC
Confidence 36899999999999999999998755 579999997432 234678999999999999999999998843 23
Q ss_pred EEEEEeccc-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+|+|||||. |+|..++.. ...+++.++..|+.||+.||+|||++||+||||||+||||+.++++||+|||+|+....
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 799999999 567777643 35799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcC-CCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
.... ..+...||+.|+|||++.. ..++.++|||||||++|||++| .+||.+......+..+....
T Consensus 166 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~---------- 231 (285)
T d1fmka3 166 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------- 231 (285)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred CCce--eeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC----------
Confidence 3221 1244679999999999987 7899999999999999999996 55666655544443332110
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc--CCCccCC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA--DPYFHGL 409 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~--Hp~f~~~ 409 (595)
..+ ..+.+++.+.+||.+||+.||++|||++++++ |+||...
T Consensus 232 -----------------~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 232 -----------------RMP---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -----------------CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -----------------CCC---CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 011 22457889999999999999999999999998 8899764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=407.11 Aligned_cols=256 Identities=22% Similarity=0.335 Sum_probs=198.9
Q ss_pred CCCCCeEEeeeeeecCceEEEEEEECC-CC--cEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCC
Q 007629 110 GEASRYQIQEVIGKGSYGVVGSAVDTH-TG--ERVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 185 (595)
Q Consensus 110 ~~~~~Y~i~~~LG~G~fG~V~~a~~~~-~g--~~vAIK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 185 (595)
-...+|++++.||+|+||.||+|+... ++ ..||||++++... .....+.+.+|+.+|+.++|||||++++++..+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~- 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence 345689999999999999999998643 33 3689999865332 233456889999999999999999999999543
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcc
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 263 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla 263 (595)
.+|+|||||+ +++.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 -----~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 84 -----PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp -----SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred -----chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhh
Confidence 3699999998 677776654 457999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCCh
Q 007629 264 RVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPST 342 (595)
Q Consensus 264 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 342 (595)
+................||..|+|||++.+ ..|+.++|||||||++|||+| |++||.+.+..+.+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~----- 231 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG----- 231 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC-----
T ss_pred hhcccCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC-----
Confidence 976555444333445678899999999987 679999999999999999998 899999888665544442210
Q ss_pred hHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 343 ESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 343 ~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
... ...+.+++.+.+||.+||..||++|||+.|+++
T Consensus 232 -------------------~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 232 -------------------ERL-----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -------------------CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCC-----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 000 122457889999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-50 Score=409.87 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=196.9
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~-----~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 185 (595)
.++|++++.||+|+||.||+|.+.. +++.||||+++... .......+.+|+.++.++ +|+|||.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~- 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-
Confidence 3679999999999999999998654 45789999986432 234456778888888776 689999999987543
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcee
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 248 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NIL 248 (595)
...+|+|||||+ |+|.+++... ..+++..+..|+.||++||.|||++|||||||||+|||
T Consensus 90 ---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp ---TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ---CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 245899999998 6899998753 24899999999999999999999999999999999999
Q ss_pred eCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcC-CCCCCCCChH
Q 007629 249 ANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVV 327 (595)
Q Consensus 249 l~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG-~~pF~~~~~~ 327 (595)
++.++++||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||++|||++| .+||.+.+..
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp ECGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ECCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999865433322 22355689999999999987 6899999999999999999987 5788876543
Q ss_pred HHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 328 HQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 328 ~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
..+..+... .. .. .....+++.+.+||.+||+.||++|||++|+++|
T Consensus 244 ~~~~~~~~~----------------------~~--~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 244 EEFCRRLKE----------------------GT--RM-----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHH----------------------TC--CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhc----------------------CC--CC-----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 332221110 00 00 1123578899999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-49 Score=404.62 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=205.5
Q ss_pred CCCeEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDT-----HTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~-----~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
.++|++++.||+|+||+||+|+.+ .++..||||+++.. ......+.+.+|+.+|+.++||||+++++++...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-- 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-- 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccC--
Confidence 357999999999999999999865 35678999998643 2333456789999999999999999999999543
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecC
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAND------------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRD 241 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~~------------------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrD 241 (595)
..+++|||||+ ++|.+++.... .+++..+..|+.||+.||+|||+++|||||
T Consensus 89 ---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 89 ---KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ---CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 45899999998 68999886532 388999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCC-CC
Q 007629 242 LKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PL 320 (595)
Q Consensus 242 LKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~-~p 320 (595)
|||+|||++.++.+||+|||+|+........ ...+...||+.|+|||++.+ ..|+.++|||||||++|||++|. +|
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccc-cccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCC
Confidence 9999999999999999999999865433221 22345679999999999987 68999999999999999999985 78
Q ss_pred CCCCChHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHH
Q 007629 321 FPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEA 400 (595)
Q Consensus 321 F~~~~~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~el 400 (595)
|.+.+..+.+..+.+. .. ......+++.+.+||.+||+.||++|||+.||
T Consensus 243 ~~~~~~~e~~~~v~~~---------------------------~~---~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev 292 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDG---------------------------NI---LACPENCPLELYNLMRLCWSKLPADRPSFCSI 292 (301)
T ss_dssp TTTSCHHHHHHHHHTT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHcC---------------------------CC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 8887765544333211 00 01124578899999999999999999999999
Q ss_pred hc
Q 007629 401 LA 402 (595)
Q Consensus 401 L~ 402 (595)
++
T Consensus 293 ~~ 294 (301)
T d1lufa_ 293 HR 294 (301)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-49 Score=395.00 Aligned_cols=244 Identities=23% Similarity=0.388 Sum_probs=195.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||.||+|.. .|..||||++++. ...+.+.+|+++|++++|||||++++++.... ..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~ 75 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GG 75 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----Cc
Confidence 35799999999999999999987 4789999999642 34567899999999999999999999986432 34
Q ss_pred EEEEEeccc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccC
Q 007629 192 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFN 268 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 268 (595)
+||||||++ |+|.+++.... .+++..+..|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 799999998 68999986543 589999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCChHHHHHHHHhhcCCCChhHHHH
Q 007629 269 DAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKNVVHQLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 269 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~~~i~~ 347 (595)
. .....+|..|+|||++.+ ..|+.++|||||||++|||+| |++||.+.+..+....+..
T Consensus 156 ~------~~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~------------ 215 (262)
T d1byga_ 156 T------QDTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 215 (262)
T ss_dssp ------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT------------
T ss_pred C------CccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc------------
Confidence 2 233578999999999987 689999999999999999998 7889987665443332211
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
....+ ..+.+++.+.+||.+||..||.+|||+.+++++
T Consensus 216 -------------~~~~~-----~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 216 -------------GYKMD-----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp -------------TCCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCC-----CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00111 123567899999999999999999999999873
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=398.63 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=201.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCC-------cEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTG-------ERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLP 183 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g-------~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 183 (595)
.++|++++.||+|+||.||+|++..++ ..||||+++... .......+.+|+..+.++ +|||||++++++..
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 468999999999999999999876554 479999997533 334557788999999888 79999999999954
Q ss_pred CCccCcccEEEEEeccc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCc
Q 007629 184 PSRREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (595)
Q Consensus 184 ~~~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~N 246 (595)
. ..+|+|||||+ |+|.++|... ..+++..+..++.||+.||+|||+.+||||||||+|
T Consensus 91 ~-----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 91 D-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp S-----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred C-----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 3 45899999998 6899999754 248999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCC
Q 007629 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325 (595)
Q Consensus 247 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~ 325 (595)
||++.++.+||+|||+++......... .....+||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTC-CCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eeecCCCCeEeccchhhcccccccccc-ccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999999999999999998765443322 2345689999999999977 689999999999999999998 789998776
Q ss_pred hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 326 ~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
.......+.. ....+ ....+++.+.+||.+||+.||.+|||+.|+|+
T Consensus 243 ~~~~~~~i~~---------------------------~~~~~---~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKE---------------------------GHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHT---------------------------TCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHc---------------------------CCCCC---CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 5433322211 00011 12356889999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=403.74 Aligned_cols=249 Identities=25% Similarity=0.364 Sum_probs=201.0
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcE--EEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCCccCc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGER--VAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~--vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 189 (595)
++|++.++||+|+||+||+|+++.+|.. ||||+++... .....+.+.+|+++|+.+ +|||||++++++.. .
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~ 83 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R 83 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----T
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----C
Confidence 5799999999999999999999888874 6778775322 223456789999999998 69999999999954 3
Q ss_pred ccEEEEEeccc-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCC
Q 007629 190 KDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 252 (595)
Q Consensus 190 ~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~ 252 (595)
..+|||||||+ |+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 56999999999 6999998654 468999999999999999999999999999999999999999
Q ss_pred CcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCC-CCCCCCChHHHHH
Q 007629 253 CKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK-PLFPGKNVVHQLD 331 (595)
Q Consensus 253 ~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~-~pF~~~~~~~~l~ 331 (595)
+.+||+|||+|+....... .....||..|+|||.+.+ ..|+.++|||||||++|||++|. +||.+.+..+.+.
T Consensus 164 ~~~kl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp GCEEECCTTCEESSCEECC----C----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CceEEcccccccccccccc----ccceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999985433222 134579999999999977 68999999999999999999975 6788776544333
Q ss_pred HHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 332 LMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 332 ~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.+.+. ..+ .....+++.+.+||.+||..||++|||+.|+++|
T Consensus 238 ~i~~~--------------------------~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 238 KLPQG--------------------------YRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HGGGT--------------------------CCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhc--------------------------CCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22110 011 1124578899999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=396.63 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=207.2
Q ss_pred CCCeEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCC
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVD-----THTGERVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPS 185 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~-----~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 185 (595)
.++|++.+.||+|+||.||+|+. ..+++.||||+++.. ........+.+|+.+++.+ +|||||++++++...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~- 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG- 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-
Confidence 36899999999999999999975 346789999999753 3345566789999999999 699999999999543
Q ss_pred ccCcccEEEEEeccc-ccHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCc
Q 007629 186 RREFKDIYVVFELME-SDLHQVIKAND------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 246 (595)
Q Consensus 186 ~~~~~~lylV~E~~~-g~L~~~i~~~~------------------~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~N 246 (595)
..+|||||||+ |+|.+++.... .+++..+..|+.||+.||+|||++||+||||||+|
T Consensus 100 ----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 100 ----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 45899999998 68998887543 58999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHc-CCCCCCCCC
Q 007629 247 ILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLT-GKPLFPGKN 325 (595)
Q Consensus 247 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLlt-G~~pF~~~~ 325 (595)
||++.++.+||+|||+++....... ....+..+||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999987644332 233455789999999999987 689999999999999999998 677777766
Q ss_pred hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 326 VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 326 ~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
....+..+... ..+.. ....+++.+.+||.+||+.||++|||++|||+
T Consensus 253 ~~~~~~~~i~~----------------------~~~~~-------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKE----------------------GFRML-------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHH----------------------TCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhc----------------------CCCCC-------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 54433322211 01100 11346788999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-48 Score=396.64 Aligned_cols=264 Identities=19% Similarity=0.243 Sum_probs=203.0
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
.++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++|++++..+..+. .+...
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~ 77 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDY 77 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEE----ecCCE
Confidence 4689999999999999999999999999999999864322 234678999999998877665555442 23356
Q ss_pred EEEEEecccccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC---CCcEEEcccCcceecc
Q 007629 192 IYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVSF 267 (595)
Q Consensus 192 lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~---~~~vKL~DFGla~~~~ 267 (595)
.|+|||||+++|...+.. .+.+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+...
T Consensus 78 ~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 78 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 899999999988777654 458999999999999999999999999999999999998764 4569999999998765
Q ss_pred CCCCCc----ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCCChh
Q 007629 268 NDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTE 343 (595)
Q Consensus 268 ~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~~ 343 (595)
...... ......+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.........+...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~------- 228 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI------- 228 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH-------
T ss_pred ccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh-------
Confidence 433221 12245689999999999987 67999999999999999999999999876543332222110
Q ss_pred HHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHH---HHhcCCCccC
Q 007629 344 SISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAE---EALADPYFHG 408 (595)
Q Consensus 344 ~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~---elL~Hp~f~~ 408 (595)
..... ..+.....+.+++++.+||.+||..||.+||+++ ++|+|+|.+.
T Consensus 229 -----~~~~~-----------~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 229 -----SEKKM-----------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp -----HHHHH-----------HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -----hcccC-----------CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 00000 0011112346788999999999999999999986 5578887653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=397.89 Aligned_cols=257 Identities=22% Similarity=0.368 Sum_probs=209.8
Q ss_pred CCCeEEeeeeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTH-----TGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 186 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~-----~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 186 (595)
.++|++++.||+|+||+||+|.+.. ++..||||+++.. ........+.+|+.+|++++|||||++++++...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-- 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC--
Confidence 4789999999999999999998752 4578999999743 3334556789999999999999999999999543
Q ss_pred cCcccEEEEEeccc-ccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcE
Q 007629 187 REFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 255 (595)
Q Consensus 187 ~~~~~lylV~E~~~-g~L~~~i~~~----------~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~v 255 (595)
..+|+|||||. |+|.+++... ..+++..+..++.||++||.|||+++|+||||||+|||++.++++
T Consensus 96 ---~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 ---QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ---CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 45899999998 6888887542 246889999999999999999999999999999999999999999
Q ss_pred EEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcC-CCCCCCCChHHHHHHHH
Q 007629 256 KICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTG-KPLFPGKNVVHQLDLMT 334 (595)
Q Consensus 256 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~ 334 (595)
||+|||+|+....... ....+..+||+.|+|||.+.+ ..|+.++|||||||++|||+|| .+||.+.+....+..+.
T Consensus 173 Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp EECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EEeecccceeccCCcc-eeeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999986543322 222344579999999999987 6899999999999999999998 58888877655444332
Q ss_pred hhcCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc------CCCcc
Q 007629 335 DLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA------DPYFH 407 (595)
Q Consensus 335 ~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~------Hp~f~ 407 (595)
+. ...+ ..+.+++.+.+||.+||+.||.+|||++++++ +|+|+
T Consensus 250 ~~-------------------------~~~~-----~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 250 EG-------------------------GLLD-----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp TT-------------------------CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred hC-------------------------CCCC-----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 21 0011 12356789999999999999999999999998 56654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.7e-47 Score=396.42 Aligned_cols=282 Identities=24% Similarity=0.336 Sum_probs=211.2
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-----------CCceeeeeeee
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-----------HPDIVEIKHIM 181 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~~ 181 (595)
+||+++++||+|+||+||+|+++.+|+.||||++++. ......+.+|+++|+.+. |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 5799999999999999999999999999999999742 223456788999988875 47788888887
Q ss_pred cCCCccCcccEEEEEeccc--ccHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCceeeCCCCc--
Q 007629 182 LPPSRREFKDIYVVFELME--SDLHQVI--KANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCK-- 254 (595)
Q Consensus 182 ~~~~~~~~~~lylV~E~~~--g~L~~~i--~~~~~l~~~~~~~i~~qil~aL~yLHs-~gIiHrDLKP~NILl~~~~~-- 254 (595)
... .....+++|+++. ++..... .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 90 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHK---GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEE---ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred eec---cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 432 2234556666554 3333333 334579999999999999999999998 89999999999999987653
Q ss_pred ----EEEcccCcceeccCCCCCcccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCC-----
Q 007629 255 ----LKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKN----- 325 (595)
Q Consensus 255 ----vKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~----- 325 (595)
+||+|||.|....... ...+||+.|+|||++.+ ..|+.++||||+||++++|++|+.||...+
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp TEEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeeEeeccccccccccc------ccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 9999999998643222 34589999999999887 689999999999999999999999997543
Q ss_pred -hHHHHHHHHhhcCCCChhHHHHHhhHHHHHHhhhcccCCCCC-------------CCCCCCCCCHHHHHHHHhhCcCCC
Q 007629 326 -VVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVP-------------FSHKFPNADPLALHLLERLLAFDP 391 (595)
Q Consensus 326 -~~~~l~~i~~~lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~-------------~~~~~~~~~~~~~dLl~~~L~~DP 391 (595)
..+.+..+...+|.++.+.+...... ..+........... ........++.++|||.+||.+||
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred chhHHHHHHHHHhCCCCHHHhhccccc--ccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 34567777888898887665433211 11111100000000 001112346789999999999999
Q ss_pred CCCCCHHHHhcCCCccCCC
Q 007629 392 KDRPTAEEALADPYFHGLA 410 (595)
Q Consensus 392 ~~Rpta~elL~Hp~f~~~~ 410 (595)
.+||||+|||+||||+...
T Consensus 317 ~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TTCBCHHHHHTCGGGTTCT
T ss_pred hHCcCHHHHhcCcccCCCC
Confidence 9999999999999998654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=389.16 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=198.0
Q ss_pred eEEeeeeeecCceEEEEEEECCCC---cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCceeeeeeeecCCCccCccc
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTG---ERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g---~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 191 (595)
+.+.++||+|+||+||+|++..++ ..||||+++.. ......+++.+|+++|++++|||||++++++... ...
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~ 103 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGS 103 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCc
Confidence 344688999999999999986643 36999999642 3455678899999999999999999999987532 245
Q ss_pred EEEEEeccc-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEcccCcceeccCC
Q 007629 192 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFND 269 (595)
Q Consensus 192 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 269 (595)
+|+|||||+ ++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 899999999 5788877754 35778889999999999999999999999999999999999999999999999876443
Q ss_pred CCC-cccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHH-HHHHHHhhcCCCChhHHHH
Q 007629 270 APS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVH-QLDLMTDLLGTPSTESISR 347 (595)
Q Consensus 270 ~~~-~~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~-~l~~i~~~lg~p~~~~i~~ 347 (595)
... ........||+.|+|||++.+ ..++.++|||||||++|||+||..||....... ....+
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i-------------- 247 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------------- 247 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH--------------
T ss_pred ccccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH--------------
Confidence 322 122344679999999999887 689999999999999999999877775433211 11111
Q ss_pred HhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhcC
Q 007629 348 IRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALAD 403 (595)
Q Consensus 348 i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~H 403 (595)
.. ...+ . ..+.+++.+.+||.+||..||++||++.|+++|
T Consensus 248 ---------~~---g~~~-~---~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 248 ---------LQ---GRRL-L---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ---------HT---TCCC-C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------Hc---CCCC-C---CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 00 0111 0 113467899999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-46 Score=385.51 Aligned_cols=257 Identities=18% Similarity=0.233 Sum_probs=203.6
Q ss_pred CCCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC-CceeeeeeeecCCCccCcc
Q 007629 112 ASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRH-PDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 112 ~~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~~~ 190 (595)
.++|++++.||+|+||+||+|++..+|+.||||+++... +...+.+|+++++.|.| +||+.+++++. ...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~ 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGL 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETT
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCC
Confidence 368999999999999999999999999999999885432 22346789999999975 89999998873 445
Q ss_pred cEEEEEecccccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCC-----CCcEEEcccCcce
Q 007629 191 DIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-----DCKLKICDFGLAR 264 (595)
Q Consensus 191 ~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~-----~~~vKL~DFGla~ 264 (595)
..|+|||||+++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 75 ~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 689999999999999887654 7999999999999999999999999999999999999974 5789999999998
Q ss_pred eccCCCCCc----ccccccccCCcccccccccccCCCCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhhcCCC
Q 007629 265 VSFNDAPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTP 340 (595)
Q Consensus 265 ~~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p 340 (595)
......... ......+||+.|||||++.+ ..|+.++|||||||++|||++|..||.+............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~----- 227 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER----- 227 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-----
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH-----
Confidence 764432211 12345689999999999987 6899999999999999999999999987653222211111
Q ss_pred ChhHHHHHhhHHHHHHhhhcccCCCCCCCCCCCCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 341 STESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 341 ~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
+...+.. .+.....+.+++++.+|+..|+..+|.+||+.+.+.+
T Consensus 228 -------i~~~~~~-----------~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 228 -------IGEKKQS-----------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp -------HHHHHHH-----------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -------HHhccCC-----------CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1100000 0111123456788999999999999999999876654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=391.18 Aligned_cols=270 Identities=23% Similarity=0.270 Sum_probs=193.1
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHH--HHHHHHHhcCCCceeeeeeeecCCCccCcc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRIL--REIKLLRLLRHPDIVEIKHIMLPPSRREFK 190 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~--~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 190 (595)
.+|.+.+.||+|+||+||+|+. +|+.||||+++.. ...... .|+..++.++|||||++++++.... ....
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-Ccce
Confidence 4799999999999999999985 6899999998632 223333 4555556789999999999996543 2334
Q ss_pred cEEEEEeccc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCeeecCCCCCceeeCCCCcEEEcccC
Q 007629 191 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT--------ANVFHRDLKPKNILANADCKLKICDFG 261 (595)
Q Consensus 191 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs--------~gIiHrDLKP~NILl~~~~~vKL~DFG 261 (595)
.+|+|||||. |+|.+++.+. .+++..+..++.|++.||.|||+ +||+||||||+||||+.++.+||+|||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 6899999998 6999999765 69999999999999999999996 599999999999999999999999999
Q ss_pred cceeccCCCCC-cccccccccCCcccccccccccCC----CCCCcceeechhHHHHHHHcCCCCCCCCChHHHHHHHHhh
Q 007629 262 LARVSFNDAPS-AIFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDL 336 (595)
Q Consensus 262 la~~~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~----~~~~k~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~ 336 (595)
+++........ .......+||+.|||||++.+... .++.++|||||||+||||+||.+||........ ......
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~-~~~~~~ 232 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-PYYDLV 232 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-TTTTTS
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc-chhhcc
Confidence 99876543322 112345789999999999865211 257789999999999999999988754332110 000000
Q ss_pred cCCCChhHHHHHhhHHHHHHhhhcccCCCCCCCCCC--CCCCHHHHHHHHhhCcCCCCCCCCHHHHhc
Q 007629 337 LGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKF--PNADPLALHLLERLLAFDPKDRPTAEEALA 402 (595)
Q Consensus 337 lg~p~~~~i~~i~~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~dLl~~~L~~DP~~Rpta~elL~ 402 (595)
...+....+ ...+..-..++ ++...+ ......+.+|+.+||..||++|||+.|+++
T Consensus 233 ~~~~~~~~~--------~~~~~~~~~~p--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 233 PSDPSVEEM--------RKVVCEQKLRP--NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CSSCCHHHH--------HHHHTTSCCCC--CCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccchHHHH--------HHHHhccccCC--CCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 111111111 11111000011 111111 112245889999999999999999999987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=9.5e-26 Score=214.74 Aligned_cols=166 Identities=17% Similarity=0.095 Sum_probs=122.0
Q ss_pred eEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCC----------------hhhHHHHHHHHHHHHhcCCCceeeee
Q 007629 115 YQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEH----------------VSDATRILREIKLLRLLRHPDIVEIK 178 (595)
Q Consensus 115 Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~----------------~~~~~~~~~Ei~il~~l~HpnIv~l~ 178 (595)
|.+.++||+|+||+||+|.+. +|+.||||+++..... ......+.+|+..|..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568899999999999999984 7899999987521100 01123345788999999999999887
Q ss_pred eeecCCCccCcccEEEEEecccccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCceeeCCCCcEEEc
Q 007629 179 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 258 (595)
Q Consensus 179 ~~~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~qil~aL~yLHs~gIiHrDLKP~NILl~~~~~vKL~ 258 (595)
++.. .+++|||+++... ..+++..+..++.||++||.|||++||+||||||+|||++.+ .++|+
T Consensus 81 ~~~~---------~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 81 AWEG---------NAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EEET---------TEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEEC
T ss_pred EecC---------CEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEE
Confidence 6541 2799999996422 236677788999999999999999999999999999999865 59999
Q ss_pred ccCcceeccCCCCCcccccccccCCcccc------cccccccCCCCCCcceeechhHHH
Q 007629 259 DFGLARVSFNDAPSAIFWTDYVATRWYRA------PELCGSFFSKYTPAIDIWSIGCIF 311 (595)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~gT~~Y~A------PE~l~~~~~~~~~k~DIWSlG~il 311 (595)
|||+|........ ..|.. .+.+. ..|+.++|+||+.--+
T Consensus 145 DFG~a~~~~~~~~-----------~~~l~rd~~~~~~~f~---r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGW-----------REILERDVRNIITYFS---RTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTH-----------HHHHHHHHHHHHHHHH---HHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCc-----------HHHHHHHHHHHHHHHc---CCCCCcccHHHHHHHH
Confidence 9999975422211 01111 11221 4688899999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.14 E-value=6.8e-06 Score=78.96 Aligned_cols=80 Identities=14% Similarity=0.120 Sum_probs=51.5
Q ss_pred CCeEEeeeeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCCccCccc
Q 007629 113 SRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 191 (595)
Q Consensus 113 ~~Y~i~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~ 191 (595)
..|++.+..+-++.+.||+.. ..+..+.||+....... ....+.+|..+|+.|. +--+.+++.+. .....
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCc
Confidence 356777766666667999884 45667888887532221 2334678888888774 32345555544 22345
Q ss_pred EEEEEecccc
Q 007629 192 IYVVFELMES 201 (595)
Q Consensus 192 lylV~E~~~g 201 (595)
.|+||++++|
T Consensus 85 ~~lv~~~l~G 94 (263)
T d1j7la_ 85 SNLLMSEADG 94 (263)
T ss_dssp EEEEEECCSS
T ss_pred eEEEEEeccc
Confidence 7999999986
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.80 E-value=4.5e-05 Score=78.29 Aligned_cols=77 Identities=18% Similarity=0.052 Sum_probs=47.6
Q ss_pred eeeeeecCceEEEEEEECCCCcEEEEEEecCcc----C-ChhhHHHHHHHHHHHHhcC-C--CceeeeeeeecCCCccCc
Q 007629 118 QEVIGKGSYGVVGSAVDTHTGERVAIKKINDVF----E-HVSDATRILREIKLLRLLR-H--PDIVEIKHIMLPPSRREF 189 (595)
Q Consensus 118 ~~~LG~G~fG~V~~a~~~~~g~~vAIK~i~~~~----~-~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~~~~~~ 189 (595)
.+.||.|....||++.+..+++.|+||.-.... . ......+...|...|+.+. + ..+.+++.+.-
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~------- 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT------- 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-------
Confidence 457899999999999887778899999743211 1 1123345667888887763 2 34555554431
Q ss_pred ccEEEEEecccc
Q 007629 190 KDIYVVFELMES 201 (595)
Q Consensus 190 ~~lylV~E~~~g 201 (595)
...++|||++++
T Consensus 104 ~~~~lvmE~L~~ 115 (392)
T d2pula1 104 EMAVTVMEDLSH 115 (392)
T ss_dssp TTTEEEECCCTT
T ss_pred CCCEEEEeccCC
Confidence 124789999974
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.33 E-value=0.0005 Score=64.94 Aligned_cols=134 Identities=11% Similarity=0.026 Sum_probs=75.9
Q ss_pred eeeecC-ceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCC--ceeeeeeeecCCCccCcccEEEEE
Q 007629 120 VIGKGS-YGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHP--DIVEIKHIMLPPSRREFKDIYVVF 196 (595)
Q Consensus 120 ~LG~G~-fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~~~~~~~~lylV~ 196 (595)
.+..|. -+.||+... ..+..+.+|..... ....+.+|+..|+.|... .+.+++.+... ....|+||
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~ 85 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLL 85 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEE
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEE
Confidence 344554 468898864 45667888876432 123456788888877532 24556655432 24579999
Q ss_pred ecccc-cH--------------HHHHHhcC-------CCCHHHHHHH--H--------------------HHHHHHHHHH
Q 007629 197 ELMES-DL--------------HQVIKAND-------DLTPEHYQFF--L--------------------YQLLRGLKYI 232 (595)
Q Consensus 197 E~~~g-~L--------------~~~i~~~~-------~l~~~~~~~i--~--------------------~qil~aL~yL 232 (595)
++++| .+ ...+..-. ++.......+ . ......+..+
T Consensus 86 ~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (255)
T d1nd4a_ 86 GEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 165 (255)
T ss_dssp ECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred EeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHH
Confidence 99975 22 11111100 1110000000 0 0011223333
Q ss_pred HhC-------CeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 233 HTA-------NVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 233 Hs~-------gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
... .++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 166 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 332 38999999999999987667899999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.91 E-value=0.0024 Score=63.01 Aligned_cols=72 Identities=15% Similarity=0.027 Sum_probs=42.6
Q ss_pred ceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCcee--eeeeeecCCCccCcccEEEEEecccc
Q 007629 126 YGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV--EIKHIMLPPSRREFKDIYVVFELMES 201 (595)
Q Consensus 126 fG~V~~a~~~~~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv--~l~~~~~~~~~~~~~~lylV~E~~~g 201 (595)
--.||++.. .+|..|++|+.+.. .....++..|+..|..|....|. ..+...-..........+.++++++|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~---~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCC---CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 347999964 57888999986521 22346677899988887533322 11111100111223457889998875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.26 E-value=0.017 Score=58.31 Aligned_cols=74 Identities=14% Similarity=0.078 Sum_probs=48.0
Q ss_pred CeEEeeeeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCC
Q 007629 114 RYQIQEVIGKGSYGVVGSAVDTH-------TGERVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPS 185 (595)
Q Consensus 114 ~Y~i~~~LG~G~fG~V~~a~~~~-------~g~~vAIK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 185 (595)
..++ +.|+.|-.-.+|++.... ....|.+++.-. ........+|..+++.+. +.-..++++++-.
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~----~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN----PETESHLVAESVIFTLLSERHLGPKLYGIFSG-- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS----CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC----cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--
Confidence 3444 678889999999997643 245677776532 112334568999998885 4334467776621
Q ss_pred ccCcccEEEEEecccc
Q 007629 186 RREFKDIYVVFELMES 201 (595)
Q Consensus 186 ~~~~~~lylV~E~~~g 201 (595)
.+||||++|
T Consensus 117 -------g~I~efi~g 125 (395)
T d1nw1a_ 117 -------GRLEEYIPS 125 (395)
T ss_dssp -------EEEECCCCE
T ss_pred -------ceEEEEecc
Confidence 678999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.39 E-value=0.021 Score=55.28 Aligned_cols=30 Identities=33% Similarity=0.339 Sum_probs=26.9
Q ss_pred CCeeecCCCCCceeeCCCCcEEEcccCcce
Q 007629 235 ANVFHRDLKPKNILANADCKLKICDFGLAR 264 (595)
Q Consensus 235 ~gIiHrDLKP~NILl~~~~~vKL~DFGla~ 264 (595)
.||||+|+.++|||++.+...-|+||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999875
|